data_1x4z_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1x4z _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 mt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.822 0.344 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.436 ' O ' ' CD1' ' A' ' 99' ' ' LEU . 1.8 m -144.39 161.51 44.03 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.665 0.745 . . . . 0.0 110.863 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 169.3 19.25 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.642 2.228 . . . . 0.0 112.363 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 53.7 Cg_endo -69.77 154.33 67.8 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.671 2.248 . . . . 0.0 112.334 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.419 ' C ' ' HB2' ' A' ' 102' ' ' SER . 4.7 pt-20 -98.46 167.69 10.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.841 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.15 122.84 77.81 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.544 0.688 . . . . 0.0 111.076 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 164.38 34.81 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.629 2.219 . . . . 0.0 112.278 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -50.45 176.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.832 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -80.59 123.13 82.89 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.599 0.714 . . . . 0.0 110.863 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 144.0 52.58 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.618 2.212 . . . . 0.0 112.383 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.0 t -94.58 167.44 11.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.128 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.8 mm -125.75 126.0 69.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.141 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.0 m -129.8 160.42 33.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.6 m -80.46 104.14 10.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.062 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.439 ' HB3' ' N ' ' A' ' 35' ' ' TYR . . . -106.59 -38.86 6.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.073 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.9 m -164.76 176.57 8.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.62 -17.26 51.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 p -116.91 -3.65 11.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.442 ' CB ' ' HA ' ' A' ' 81' ' ' THR . 5.5 p -143.07 174.81 10.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.482 HG12 ' CE2' ' A' ' 111' ' ' TYR . 31.0 m -151.85 145.34 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.155 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.439 ' N ' ' HB3' ' A' ' 29' ' ' ALA . 12.3 m-85 -79.67 120.59 24.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.96 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 93.8 t -117.0 130.78 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.149 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 59.1 m -128.96 120.52 26.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.098 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.564 ' CD1' HG13 ' A' ' 93' ' ' VAL . 28.4 p90 -117.68 171.25 8.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 mm -135.99 107.03 9.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.633 0.73 . . . . 0.0 111.136 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 143.73 52.03 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.709 2.273 . . . . 0.0 112.357 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -112.68 -69.95 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.39 146.7 16.28 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.55 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -116.24 7.34 14.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.981 0.42 . . . . 0.0 110.956 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 79.7 2.07 87.7 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.472 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.35 -26.67 12.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.52 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -106.5 161.8 21.73 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.572 0.701 . . . . 0.0 110.899 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 119.21 6.19 Favored 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.712 2.275 . . . . 0.0 112.339 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.491 HD11 ' CE1' ' A' ' 51' ' ' PHE . 93.3 mt -48.25 136.17 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.448 ' N ' HG22 ' A' ' 48' ' ' ILE . 47.2 mt-30 -93.15 -49.44 5.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.943 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.2 p -159.41 158.4 32.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.491 ' CE1' HD11 ' A' ' 48' ' ' ILE . 58.7 m-85 -108.38 173.65 6.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.896 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -144.09 128.51 17.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.4 t -113.08 122.83 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -124.81 157.74 35.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.486 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 39.0 p90 -133.07 174.91 9.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 89' ' ' TYR . 5.7 ttpm? -146.83 133.53 19.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -84.68 120.82 26.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.3 mt . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.967 179.896 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 53.4 m95 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.718 0.294 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.486 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 2.6 mm -115.63 170.63 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.137 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.9 tp -103.75 118.9 37.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.964 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.92 -71.58 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.11 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 t -123.83 -179.4 4.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.128 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.7 p -174.5 174.17 2.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 67.05 30.08 7.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.111 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.466 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 56.0 mt -81.58 138.04 47.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.657 0.742 . . . . 0.0 111.149 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.466 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 54.0 Cg_endo -69.74 157.85 59.01 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.661 2.24 . . . . 0.0 112.334 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.69 -19.81 35.96 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.704 2.269 . . . . 0.0 112.407 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 t -85.19 -15.91 42.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.46 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 16.4 ttt180 -97.87 101.21 12.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.854 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.5 mt -98.33 7.72 45.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.959 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 t -150.33 132.1 15.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.804 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.458 HG13 ' CD ' ' A' ' 75' ' ' ARG . 2.2 m -146.69 164.39 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.091 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -98.43 111.01 23.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.3 mm -78.49 101.81 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.169 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.442 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 35.2 p -98.96 163.95 12.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.076 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.74 36.96 6.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.504 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.9 mt -104.83 168.49 9.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.76 0.314 . . . . 0.0 110.904 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -112.85 125.77 54.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.65 155.09 34.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.01 10.54 59.23 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.415 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.475 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 32.0 mm -121.98 107.87 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.839 0.352 . . . . 0.0 111.148 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.86 140.52 47.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.798 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.475 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -163.59 164.31 24.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.864 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.2 mttt -109.57 -174.83 2.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.892 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -145.4 159.5 42.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.902 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -150.47 174.31 13.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.564 HG13 ' CD1' ' A' ' 38' ' ' TRP . 89.1 t -139.2 142.41 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.122 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.401 ' N ' HG11 ' A' ' 93' ' ' VAL . 33.8 mtt180 -133.15 143.07 49.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.833 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 102' ' ' SER . . . -103.97 129.04 51.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.078 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.1 mp -122.24 118.14 27.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.422 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 41.0 p-10 -123.04 -174.01 2.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 18.8 ptm -67.15 -2.69 6.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.839 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.436 ' CD1' ' O ' ' A' ' 16' ' ' SER . 67.4 mt -104.4 -26.01 12.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.946 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.6 -165.71 28.74 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.475 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.46 157.25 16.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.872 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.419 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 6.4 p -92.86 175.21 6.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.802 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -73.42 159.49 84.66 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.696 0.76 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.69 107.49 1.86 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.708 2.272 . . . . 0.0 112.316 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.1 p -51.2 152.62 2.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -48.81 138.37 12.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.627 0.727 . . . . 0.0 111.012 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 104.86 1.39 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.634 2.223 . . . . 0.0 112.38 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.4 p -51.31 171.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -62.36 150.7 84.39 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.648 0.737 . . . . 0.0 110.899 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.65 120.82 7.56 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.698 2.265 . . . . 0.0 112.339 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.482 ' CE2' HG12 ' A' ' 34' ' ' VAL . 85.8 t80 -111.04 120.05 41.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.963 0.411 . . . . 0.0 110.912 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 52.0 t -91.42 103.35 14.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 t -70.11 106.51 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.148 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -179.872 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.555 HD11 ' CE2' ' A' ' 46' ' ' PHE . 6.3 mt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.773 0.32 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.408 ' O ' ' O ' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -146.81 161.52 37.14 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.578 0.704 . . . . 0.0 110.904 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 170.03 17.54 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.661 2.241 . . . . 0.0 112.361 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.429 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 53.5 Cg_endo -69.67 156.49 63.45 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.732 2.288 . . . . 0.0 112.333 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.419 ' C ' ' HB2' ' A' ' 102' ' ' SER . 9.3 pt-20 -100.59 166.45 10.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.07 121.53 56.1 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.646 0.736 . . . . 0.0 111.087 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 162.89 40.3 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.698 2.266 . . . . 0.0 112.353 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -51.57 175.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.793 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.422 ' NE ' ' HA ' ' A' ' 108' ' ' SER . 18.2 ttt180 -79.88 123.29 83.8 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.537 0.684 . . . . 0.0 110.917 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 142.94 48.95 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.682 2.254 . . . . 0.0 112.326 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 t -94.05 165.42 12.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.435 HG22 ' CG ' ' A' ' 111' ' ' TYR . 4.3 mm -124.49 119.34 56.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.084 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.3 m -122.66 162.02 22.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.2 m -83.46 98.79 9.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.461 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . . . -97.85 -42.22 7.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.068 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.2 m -161.09 -177.75 6.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -84.44 -14.58 48.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.899 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 51.4 p -121.06 -1.73 9.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.106 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.462 ' CB ' ' HA ' ' A' ' 81' ' ' THR . 10.7 p -145.54 171.89 14.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.1 m -147.88 147.28 17.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.128 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.461 ' CD2' ' CB ' ' A' ' 29' ' ' ALA . 13.4 m-85 -82.74 113.66 20.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.851 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.5 t -108.43 128.49 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.153 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.9 m -125.95 122.33 35.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.117 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.569 ' CD1' HG13 ' A' ' 93' ' ' VAL . 29.4 p90 -120.79 171.27 8.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.4 mm -136.61 106.24 9.12 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.562 0.696 . . . . 0.0 111.12 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.412 ' CD ' HD22 ' A' ' 76' ' ' LEU . 52.9 Cg_endo -69.79 130.07 18.67 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.707 2.272 . . . . 0.0 112.329 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 mmt85 -94.54 -69.33 0.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.867 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.51 146.05 16.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.445 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -113.52 7.92 17.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.922 0.391 . . . . 0.0 110.904 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 80.56 -1.73 81.28 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.494 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.85 -24.51 11.84 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.473 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.555 ' CE2' HD11 ' A' ' 15' ' ' LEU . 2.0 m-85 -108.32 162.19 20.8 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.646 0.736 . . . . 0.0 110.885 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.85 116.49 4.59 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.698 2.265 . . . . 0.0 112.278 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.427 HD13 ' CE1' ' A' ' 51' ' ' PHE . 85.9 mt -46.86 125.64 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -80.75 -51.51 8.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.2 m -156.6 162.28 39.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.858 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.427 ' CE1' HD13 ' A' ' 48' ' ' ILE . 61.3 m-85 -111.08 178.47 4.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.922 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 75.4 mtt-85 -149.61 124.94 10.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.5 t -110.24 126.47 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.11 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -124.07 155.87 37.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.501 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 39.1 p90 -132.86 158.43 42.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.88 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.442 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 28.9 ttpt -131.78 127.42 36.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.869 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -81.14 115.88 20.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 57.5 mt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.952 179.904 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.442 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 87.4 m95 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.782 0.325 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.501 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 4.0 mm -136.41 166.93 25.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.133 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.3 tp -97.95 126.13 43.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.94 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -95.62 -69.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.097 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.5 t -130.71 165.14 23.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.142 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 75.5 p -157.9 172.91 17.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 71.92 27.4 2.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.067 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.462 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 76.3 mt -78.16 138.52 60.5 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.56 0.695 . . . . 0.0 111.184 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.462 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 53.2 Cg_endo -69.79 155.99 64.41 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.652 2.235 . . . . 0.0 112.364 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.77 -21.79 32.92 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.615 2.21 . . . . 0.0 112.352 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 54.6 p -82.73 -13.53 56.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.809 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.446 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.3 ttt180 -100.72 106.46 17.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.946 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.412 HD22 ' CD ' ' A' ' 40' ' ' PRO . 45.2 mt -101.78 7.33 41.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.938 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 t -151.84 131.86 13.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.23 167.94 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.079 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.434 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 33.4 tt0 -104.43 110.62 22.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.6 mm -80.91 104.03 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.099 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.462 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 30.3 p -98.13 165.57 11.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.107 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.98 39.07 6.61 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.49 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 65.6 mt -102.91 171.88 7.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.737 0.304 . . . . 0.0 110.945 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -114.99 127.99 56.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -69.9 151.31 45.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.72 10.51 76.55 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.453 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.2 mm -124.27 114.55 41.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.856 0.36 . . . . 0.0 111.136 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.77 137.66 37.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.82 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.34 161.9 37.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -107.46 -174.87 2.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -145.82 158.15 43.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -149.05 176.05 10.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.569 HG13 ' CD1' ' A' ' 38' ' ' TRP . 59.9 t -141.95 146.43 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.112 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -136.4 140.82 43.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.62 124.23 45.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.47 118.69 31.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.429 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 41.4 p-10 -123.09 -173.95 2.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.495 ' HE2' ' CG ' ' A' ' 46' ' ' PHE . 5.5 ptp -69.01 -0.41 5.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.84 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.9 mt -107.62 -24.04 11.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.427 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 146.64 -168.4 27.99 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.54 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.68 157.43 16.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.878 0.37 . . . . 0.0 110.891 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.419 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 4.1 p -93.56 175.2 6.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.877 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -69.88 160.36 80.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.631 0.729 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 111.7 2.86 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.638 2.225 . . . . 0.0 112.439 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.0 p -53.9 150.36 7.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.825 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.12 140.66 6.51 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.586 0.708 . . . . 0.0 111.101 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.66 94.29 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.724 2.283 . . . . 0.0 112.383 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.422 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 4.4 p -43.26 165.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -59.81 150.93 66.03 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.645 0.736 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 135.75 31.22 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.694 2.263 . . . . 0.0 112.329 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.435 ' CG ' HG22 ' A' ' 26' ' ' ILE . 70.4 t80 -124.86 126.64 45.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.969 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.3 t -98.41 104.46 15.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.111 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 t -72.06 107.19 2.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.13 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.863 -179.861 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.511 HD12 ' CE2' ' A' ' 46' ' ' PHE . 5.9 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.734 0.302 . . . . 0.0 110.959 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.31 161.44 50.32 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.637 0.732 . . . . 0.0 110.855 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 170.1 17.48 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.633 2.222 . . . . 0.0 112.322 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.431 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 53.5 Cg_endo -69.75 156.13 64.15 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.756 2.304 . . . . 0.0 112.308 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' HB2' ' A' ' 102' ' ' SER . 7.2 pt-20 -101.37 171.81 7.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.04 121.03 74.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.543 0.687 . . . . 0.0 111.116 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 164.88 32.85 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.67 2.247 . . . . 0.0 112.36 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -49.78 174.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.816 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.414 ' HB3' ' NH1' ' A' ' 23' ' ' ARG . 13.8 ttp-105 -79.95 124.32 83.19 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.594 0.712 . . . . 0.0 110.869 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 145.36 56.97 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.687 2.258 . . . . 0.0 112.341 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.5 t -97.42 166.86 11.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.161 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.421 HD11 ' CD1' ' A' ' 91' ' ' PHE . 8.7 mm -124.7 130.46 73.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.133 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 m -132.9 172.78 12.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.899 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 85.0 m -91.37 105.55 17.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.163 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.552 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . . . -108.61 -38.21 5.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.071 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.9 m -162.98 -176.64 5.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -84.67 -16.79 40.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.5 p -122.2 0.99 9.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.433 ' CB ' ' HA ' ' A' ' 81' ' ' THR . 22.2 p -145.08 164.65 30.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.997 0.427 . . . . 0.0 110.848 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.553 HG13 ' CE2' ' A' ' 111' ' ' TYR . 34.8 m -144.08 145.33 21.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.081 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.552 ' CD2' ' CB ' ' A' ' 29' ' ' ALA . 25.3 m-85 -78.33 119.28 21.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.936 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.4 t -113.81 131.82 64.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.096 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.9 m -128.81 123.57 33.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.085 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.569 ' CD1' HG11 ' A' ' 93' ' ' VAL . 24.0 p90 -123.01 169.23 11.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.881 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.1 mm -134.64 108.56 10.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.677 0.751 . . . . 0.0 111.133 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 140.3 42.17 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.697 2.265 . . . . 0.0 112.346 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -107.39 -69.88 0.82 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.29 142.55 15.78 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.496 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -112.44 7.88 19.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 0.0 110.865 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.07 -1.42 86.87 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.55 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.75 -24.69 11.72 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.516 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.511 ' CE2' HD12 ' A' ' 15' ' ' LEU . 2.4 m-85 -108.06 161.9 21.74 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.656 0.741 . . . . 0.0 110.873 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 117.06 4.86 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.663 2.242 . . . . 0.0 112.362 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.56 HD13 ' CE1' ' A' ' 51' ' ' PHE . 80.6 mt -45.14 135.21 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.412 ' N ' HG21 ' A' ' 48' ' ' ILE . 40.8 mt-30 -91.97 -46.09 8.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.841 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.0 m -163.24 158.22 21.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.991 0.424 . . . . 0.0 110.857 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.56 ' CE1' HD13 ' A' ' 48' ' ' ILE . 59.5 m-85 -108.67 170.13 8.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.83 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -144.24 120.77 11.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.9 t -103.67 133.41 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.107 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -130.67 160.99 32.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.913 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.461 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 27.5 p90 -141.93 143.09 33.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.46 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 26.9 ttpt -117.33 133.45 55.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.872 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -79.1 124.54 28.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.921 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.1 mt . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.99 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.46 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 69.0 m95 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.719 0.295 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.461 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.6 mm -123.42 156.12 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.9 tp -89.5 120.96 31.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.931 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.91 -59.33 2.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.2 t -147.63 174.55 11.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.164 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.451 ' OG ' ' N ' ' A' ' 70' ' ' ALA . 4.9 t -168.24 177.06 5.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.853 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.451 ' N ' ' OG ' ' A' ' 69' ' ' SER . . . 69.34 25.74 5.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.111 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.467 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 76.1 mt -78.18 138.72 60.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.623 0.725 . . . . 0.0 111.191 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.467 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 53.9 Cg_endo -69.76 157.07 61.65 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.736 2.291 . . . . 0.0 112.345 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -22.9 31.64 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.695 2.263 . . . . 0.0 112.337 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.2 m -82.57 -9.1 59.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.432 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.4 ttt180 -107.54 102.1 11.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.852 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.9 mt -99.89 12.56 36.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.938 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.6 t -153.32 131.68 12.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.838 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 m -145.88 162.32 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -98.25 111.5 23.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.7 mm -81.32 102.08 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.169 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.433 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 30.2 p -97.71 168.82 10.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.31 40.04 9.43 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.6 mt -101.32 170.87 7.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.687 0.28 . . . . 0.0 110.969 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -112.45 126.49 55.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -68.79 152.05 45.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.835 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.13 12.25 62.63 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.465 HG23 ' CD2' ' A' ' 89' ' ' TYR . 28.6 mm -122.68 101.12 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.871 0.367 . . . . 0.0 111.104 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.36 133.37 49.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.465 ' CD2' HG23 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -156.55 164.12 38.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.941 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -111.17 178.45 4.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.887 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.421 ' CD1' HD11 ' A' ' 26' ' ' ILE . 38.9 m-85 -135.44 155.06 51.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.41 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 5.8 ptp180 -144.6 179.15 7.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.569 HG11 ' CD1' ' A' ' 38' ' ' TRP . 96.7 t -145.4 141.89 22.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.076 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.41 ' N ' HG12 ' A' ' 93' ' ' VAL . 25.6 mtt180 -133.28 137.15 45.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.969 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 102' ' ' SER . . . -98.29 130.4 44.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.045 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mp -123.12 119.6 30.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.431 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.5 p-10 -123.56 -174.46 2.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.908 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.8 ptp -67.36 -2.62 6.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.5 mt -104.73 -24.94 12.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 146.5 -168.91 27.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.442 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -97.54 158.49 15.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.845 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.417 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 5.5 p -94.02 175.2 6.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.89 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -73.37 159.56 84.55 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.711 0.767 . . . . 0.0 110.894 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.402 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.9 Cg_endo -69.77 109.26 2.27 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.714 2.276 . . . . 0.0 112.394 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 93.8 p -52.62 158.14 1.38 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.846 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.55 140.67 46.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.515 0.674 . . . . 0.0 111.132 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 100.72 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.652 2.235 . . . . 0.0 112.378 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.0 p -47.27 170.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -59.38 150.52 64.08 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.595 0.712 . . . . 0.0 110.881 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.87 122.44 9.09 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.716 2.277 . . . . 0.0 112.267 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.553 ' CE2' HG13 ' A' ' 34' ' ' VAL . 56.2 t80 -111.16 116.46 31.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.953 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 94.7 t -92.28 103.48 14.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.213 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.8 t -70.73 107.09 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.097 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.892 -179.85 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.509 HD13 ' CE2' ' A' ' 46' ' ' PHE . 9.7 mt . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.837 0.351 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m -144.51 161.08 45.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.718 0.771 . . . . 0.0 110.806 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 170.01 17.56 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.628 2.219 . . . . 0.0 112.354 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.425 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 53.6 Cg_endo -69.86 154.24 67.58 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.664 2.243 . . . . 0.0 112.317 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.4 pt-20 -97.29 168.35 10.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.71 121.62 65.79 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.662 0.744 . . . . 0.0 111.154 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 160.9 48.0 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.684 2.256 . . . . 0.0 112.396 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -48.46 175.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.0 ttm105 -80.58 123.84 82.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.595 0.712 . . . . 0.0 110.817 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 143.85 52.27 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.674 2.25 . . . . 0.0 112.374 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.403 ' C ' HD12 ' A' ' 26' ' ' ILE . 4.8 t -96.9 167.59 10.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.112 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.403 HD12 ' C ' ' A' ' 25' ' ' THR . 3.1 mm -125.01 131.78 72.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.153 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 m -135.71 167.31 21.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.7 m -85.73 104.26 15.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.103 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.563 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -106.26 -40.71 5.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.056 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 m -162.77 163.96 26.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -67.73 -14.41 62.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.964 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 p -122.67 -1.13 9.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.165 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.9 p -142.19 172.37 12.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.0 m -148.02 147.91 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.105 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.563 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 11.7 m-85 -83.42 115.09 21.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.934 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.4 t -109.78 129.05 65.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.12 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 84.9 m -129.19 123.59 32.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.566 ' CD1' HG13 ' A' ' 93' ' ' VAL . 33.6 p90 -120.98 171.16 8.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.5 mm -134.77 106.14 10.68 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.612 0.72 . . . . 0.0 111.188 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 136.12 32.23 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.661 2.24 . . . . 0.0 112.36 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -102.74 -69.48 0.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.73 146.91 16.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.463 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 46.0 p-10 -113.84 6.34 16.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.92 0.39 . . . . 0.0 110.937 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.62 -1.52 87.73 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.458 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.15 -25.1 10.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.509 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.5 m-85 -109.21 161.86 22.26 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.63 0.729 . . . . 0.0 110.901 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 114.14 3.6 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.666 2.244 . . . . 0.0 112.366 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.409 HD13 ' CE1' ' A' ' 51' ' ' PHE . 94.6 mt -44.59 131.86 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -85.97 -47.97 9.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.7 p -160.54 163.32 32.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.851 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.409 ' CE1' HD13 ' A' ' 48' ' ' ILE . 65.3 m-85 -111.41 176.38 5.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.886 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -149.03 125.83 11.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.845 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 t -109.22 129.71 63.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.094 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.424 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 2.6 mp0 -126.58 154.87 43.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.872 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -135.58 142.64 45.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.987 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.498 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 33.6 ttpt -115.92 129.22 56.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -78.56 121.56 24.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 69.8 mt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.913 179.911 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.567 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 83.8 m95 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.774 0.321 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.1 mm -120.51 162.03 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.159 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.2 tp -98.65 123.0 42.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.401 ' CB ' HG22 ' A' ' 80' ' ' ILE . . . -91.51 -71.69 0.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.018 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.7 t -125.11 178.36 5.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.141 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 92.6 p -172.1 176.09 3.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 69.45 26.61 5.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.468 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 83.6 mt -78.22 138.51 60.26 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.574 0.702 . . . . 0.0 111.156 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.468 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 53.4 Cg_endo -69.8 158.28 57.43 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.755 2.303 . . . . 0.0 112.285 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -24.77 29.21 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.686 2.257 . . . . 0.0 112.367 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.8 p -78.95 -19.9 50.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.447 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 6.1 ttt85 -94.42 108.3 20.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.836 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.0 mt -102.7 11.41 37.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.419 ' C ' HG12 ' A' ' 78' ' ' VAL . 25.9 t -155.29 136.07 13.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.419 HG12 ' C ' ' A' ' 77' ' ' SER . 2.4 m -146.03 165.92 9.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.091 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -101.35 110.09 22.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.401 HG22 ' CB ' ' A' ' 67' ' ' ALA . 27.9 mm -80.16 100.16 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.166 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.6 p -97.41 168.96 10.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.126 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.63 37.47 11.9 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.495 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.5 mt -96.42 177.37 5.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.762 0.315 . . . . 0.0 110.935 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -119.68 119.29 33.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.832 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.63 153.11 28.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.921 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.59 14.15 64.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.486 HG21 ' CD2' ' A' ' 89' ' ' TYR . 29.0 mm -124.57 113.67 37.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.38 . . . . 0.0 111.092 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.3 131.89 36.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.823 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.486 ' CD2' HG21 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -154.36 162.87 40.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.856 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -107.95 -175.13 2.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.855 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -142.92 154.39 44.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.567 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 4.8 ptp180 -146.56 174.21 11.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.895 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.566 HG13 ' CD1' ' A' ' 38' ' ' TRP . 57.8 t -140.99 143.59 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.458 ' N ' HG11 ' A' ' 93' ' ' VAL . 29.4 mtt180 -133.78 139.58 46.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 102' ' ' SER . . . -98.88 128.68 45.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.2 mp -123.08 118.87 28.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.425 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.5 p-10 -123.52 -173.65 2.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.424 ' HE3' ' CG ' ' A' ' 46' ' ' PHE . 5.8 ptp -68.89 -0.52 5.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.852 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.7 mt -107.07 -24.74 11.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 147.43 -167.26 28.57 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.494 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.59 158.34 16.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 0.0 110.934 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.417 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 5.1 p -94.32 175.18 6.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -70.89 160.23 82.89 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.603 0.716 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 108.01 1.98 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.725 2.284 . . . . 0.0 112.393 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.9 p -51.7 150.9 3.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.806 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.79 139.7 6.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.58 0.705 . . . . 0.0 111.114 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 99.5 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.684 2.256 . . . . 0.0 112.325 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 95.7 p -44.8 162.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.872 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.3 mtp85 -56.74 153.01 23.72 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.607 0.718 . . . . 0.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.87 129.59 17.74 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.608 2.205 . . . . 0.0 112.305 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -122.14 117.02 25.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 45.0 t -90.66 102.77 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.0 t -67.84 103.37 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.057 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.829 -179.827 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.566 HD13 ' CE2' ' A' ' 46' ' ' PHE . 6.3 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.809 0.338 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.407 ' O ' ' CD1' ' A' ' 99' ' ' LEU . 1.9 m -144.32 161.38 44.87 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.664 0.745 . . . . 0.0 110.877 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 169.94 17.77 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.725 2.283 . . . . 0.0 112.356 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 53.5 Cg_endo -69.75 155.5 65.82 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.746 2.297 . . . . 0.0 112.36 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.41 ' C ' ' HB2' ' A' ' 102' ' ' SER . 7.0 pt-20 -97.97 170.08 9.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.874 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.69 122.07 78.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.646 0.736 . . . . 0.0 111.037 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 161.8 44.52 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.711 2.274 . . . . 0.0 112.358 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -47.36 174.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.833 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -80.47 122.84 82.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.599 0.714 . . . . 0.0 110.821 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 144.35 53.62 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.679 2.253 . . . . 0.0 112.323 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.5 t -94.81 167.89 11.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.075 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.559 HG22 ' CD1' ' A' ' 111' ' ' TYR . 5.8 mm -125.85 123.08 63.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.117 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -128.09 162.89 25.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.829 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m -83.46 98.56 9.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.079 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.476 ' HB1' ' CG ' ' A' ' 35' ' ' TYR . . . -98.4 -37.66 9.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.08 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.7 m -162.43 -179.47 6.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -79.59 -21.6 44.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.838 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.8 p -120.25 3.46 10.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.246 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.458 ' CB ' ' HA ' ' A' ' 81' ' ' THR . 12.4 p -145.58 165.74 27.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.4 m -144.16 149.9 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.162 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.476 ' CG ' ' HB1' ' A' ' 29' ' ' ALA . 12.3 m-85 -84.48 117.49 23.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.919 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 91.1 t -112.61 131.22 64.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.113 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.0 m -129.1 124.69 35.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.205 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.567 ' CD1' HG13 ' A' ' 93' ' ' VAL . 31.4 p90 -124.52 170.81 10.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 mm -134.93 110.23 10.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.582 0.706 . . . . 0.0 111.12 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 145.19 56.18 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.72 2.28 . . . . 0.0 112.316 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -113.66 -69.21 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.81 143.9 15.82 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.481 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 50.8 p-10 -113.33 9.14 18.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.92 0.39 . . . . 0.0 110.88 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.64 0.1 78.75 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.481 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.87 -25.33 11.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.458 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.566 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.3 m-85 -107.94 162.0 21.34 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.656 0.741 . . . . 0.0 110.877 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 117.57 5.16 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.691 2.261 . . . . 0.0 112.365 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 82.0 mt -48.11 133.37 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.135 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -89.33 -52.51 5.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.7 m -155.91 160.44 40.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.806 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -109.77 171.27 7.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.929 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.401 ' HE ' ' CD1' ' A' ' 66' ' ' LEU . 23.1 mtp180 -143.63 123.7 13.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.9 t -104.32 117.04 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -115.78 155.35 27.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.521 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 38.9 p90 -133.62 170.28 15.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.44 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 29.4 ttpt -142.32 131.66 23.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -80.17 128.91 34.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.866 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 38.0 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.957 179.868 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.561 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 75.5 m95 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.757 0.313 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.521 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 1.8 mm -125.74 155.16 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.401 ' CD1' ' HE ' ' A' ' 52' ' ' ARG . 57.5 tp -88.26 121.87 31.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.926 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.455 ' CB ' HG23 ' A' ' 80' ' ' ILE . . . -84.91 -67.4 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.5 t -129.08 -179.64 5.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.3 p -170.35 170.39 7.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 72.01 32.83 1.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.147 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.471 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 58.2 mt -86.05 137.83 35.13 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.646 0.736 . . . . 0.0 111.107 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.471 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 54.1 Cg_endo -69.74 157.36 60.69 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.727 2.285 . . . . 0.0 112.364 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.61 -24.7 30.06 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.71 2.273 . . . . 0.0 112.369 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 t -79.53 -15.77 57.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.908 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.445 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 13.8 ttt180 -97.87 105.15 17.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.852 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.5 mt -100.75 13.71 34.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.5 t -155.73 137.35 14.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.417 HG11 ' CD1' ' A' ' 71' ' ' ILE . 2.0 m -150.11 162.12 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.083 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -98.06 117.07 31.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.455 HG23 ' CB ' ' A' ' 67' ' ' ALA . 31.9 mm -85.9 95.17 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.118 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.458 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 23.6 p -88.83 171.72 9.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.189 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.29 44.06 14.45 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.437 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.6 mt -104.59 162.18 13.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.794 0.33 . . . . 0.0 110.924 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -106.58 123.7 48.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.411 ' CG ' HG12 ' A' ' 113' ' ' VAL . 14.2 mttt -64.73 159.98 21.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.12 11.88 20.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.48 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.8 mm -121.09 94.12 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 111.091 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.76 135.36 57.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.929 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -159.51 160.35 34.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -107.52 -179.39 3.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.838 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -139.72 156.66 46.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.561 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 3.8 ptp180 -147.69 178.16 8.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.834 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.567 HG13 ' CD1' ' A' ' 38' ' ' TRP . 91.9 t -141.0 140.71 32.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.128 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -132.49 135.57 46.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.831 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 102' ' ' SER . . . -96.56 129.85 43.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.135 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.8 mp -122.5 115.33 22.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.428 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.5 p-10 -119.87 -173.92 2.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 14.4 ptm -67.77 -1.83 6.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.407 ' CD1' ' O ' ' A' ' 16' ' ' SER . 51.1 mt -105.42 -25.58 12.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.83 -165.99 28.83 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.403 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -99.09 158.07 15.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 0.0 110.901 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 95' ' ' ALA . 5.2 p -92.75 175.23 6.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -72.69 158.83 86.69 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.709 0.766 . . . . 0.0 110.835 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.411 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.8 Cg_endo -69.72 103.81 1.21 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.729 2.286 . . . . 0.0 112.332 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.4 p -48.21 152.18 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.892 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.38 140.8 5.27 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.585 0.707 . . . . 0.0 111.116 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 100.43 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.685 2.257 . . . . 0.0 112.333 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 52.0 p -48.45 157.17 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -49.57 151.6 2.82 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.592 0.711 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 129.04 16.85 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.649 2.233 . . . . 0.0 112.332 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.559 ' CD1' HG22 ' A' ' 26' ' ' ILE . 52.3 t80 -117.58 122.65 44.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.1 t -98.22 101.29 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.064 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.411 HG12 ' CG ' ' A' ' 85' ' ' LYS . 22.0 t -69.1 107.08 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.097 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.89 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.525 HD11 ' CE2' ' A' ' 46' ' ' PHE . 10.3 mt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.78 0.324 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.4 ' O ' ' O ' ' A' ' 44' ' ' GLY . 1.0 OUTLIER -134.42 160.59 67.91 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.704 0.764 . . . . 0.0 110.891 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 170.05 17.53 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.697 2.265 . . . . 0.0 112.341 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.423 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 52.8 Cg_endo -69.81 152.48 69.06 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.648 2.232 . . . . 0.0 112.337 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.423 ' C ' ' HB2' ' A' ' 102' ' ' SER . 7.5 pt-20 -96.12 161.08 14.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.909 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.61 123.93 69.81 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.518 0.675 . . . . 0.0 111.136 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 165.86 29.55 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.666 2.244 . . . . 0.0 112.304 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -53.97 177.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -80.04 123.58 83.42 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.557 0.694 . . . . 0.0 110.886 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 144.27 53.35 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.664 2.243 . . . . 0.0 112.34 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.4 ' C ' HD11 ' A' ' 26' ' ' ILE . 14.8 t -94.18 165.7 12.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.174 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.519 HG23 ' CD2' ' A' ' 111' ' ' TYR . 4.2 mm -129.98 121.62 52.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.148 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 m -122.93 -175.99 3.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.3 m -99.85 97.57 8.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.165 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.54 ' HB1' ' CD2' ' A' ' 35' ' ' TYR . . . -98.18 -42.72 7.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.098 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 t -157.43 -175.98 5.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.829 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -81.77 -21.33 37.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 36.0 p -120.61 -0.72 10.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.154 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 99.4 p -135.29 173.33 11.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.808 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.3 m -154.83 142.89 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.185 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.54 ' CD2' ' HB1' ' A' ' 29' ' ' ALA . 18.6 m-85 -76.95 120.64 22.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.943 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.0 t -116.13 125.56 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.086 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.7 m -126.09 121.62 33.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.152 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.428 ' CG ' HG22 ' A' ' 93' ' ' VAL . 25.3 p90 -119.06 171.09 8.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.8 mm -134.04 107.28 11.46 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.6 0.714 . . . . 0.0 111.193 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 130.88 20.09 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -94.16 -67.76 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.26 161.79 12.82 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.532 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -125.66 4.67 7.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.884 0.373 . . . . 0.0 110.895 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 81.72 2.29 90.48 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.433 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.44 -25.54 17.39 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.42 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.525 ' CE2' HD11 ' A' ' 15' ' ' LEU . 2.5 m-85 -108.36 162.05 21.31 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.63 0.728 . . . . 0.0 110.891 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.8 116.18 4.44 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.711 2.274 . . . . 0.0 112.303 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 49' ' ' GLN . 96.4 mt -46.59 135.76 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.437 ' N ' HG23 ' A' ' 48' ' ' ILE . 58.9 mt-30 -90.0 -49.12 6.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 m -161.58 160.1 28.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.863 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -108.0 175.97 5.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -149.22 128.08 12.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.2 t -110.35 130.22 64.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.102 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.467 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 21.4 mt-10 -125.56 157.86 36.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.854 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.44 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 26.9 p90 -139.81 145.4 38.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.988 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -120.94 134.33 55.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.822 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.4 mttt -82.65 128.54 34.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.917 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.5 mt . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.884 179.976 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 78.3 m95 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.767 0.318 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.44 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.7 mm -115.03 162.75 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.109 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.1 tp -98.91 118.06 34.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.35 -68.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.095 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.7 t -128.51 175.79 8.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.15 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 90.0 p -168.14 167.34 12.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.795 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 74.39 25.98 1.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.058 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.414 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 52.3 mt -76.9 136.98 66.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.667 0.746 . . . . 0.0 111.139 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.449 ' HG2' ' CB ' ' A' ' 75' ' ' ARG . 53.9 Cg_endo -69.74 156.67 62.81 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.69 2.26 . . . . 0.0 112.358 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.71 -18.54 37.17 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.701 2.267 . . . . 0.0 112.446 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 86.5 p -86.58 -13.05 46.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.449 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 8.6 ttt85 -101.67 98.96 9.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 51.9 mt -96.74 11.62 34.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.836 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 t -153.39 131.72 12.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 m -145.7 163.91 11.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.109 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -100.47 108.83 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 26.7 mm -75.82 107.39 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.193 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.0 p -102.89 165.85 10.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.167 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.66 41.11 7.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.464 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.6 mt -99.16 -178.91 4.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.757 0.313 . . . . 0.0 110.9 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -125.05 122.33 36.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -63.83 161.04 16.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.9 12.0 9.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.417 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 26.9 mm -122.23 108.26 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 0.0 111.24 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.26 136.54 42.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.417 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -157.54 168.59 26.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -114.09 -175.45 2.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.904 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -143.85 158.4 43.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.817 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.467 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 2.7 ptp180 -150.45 175.16 12.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.428 HG22 ' CG ' ' A' ' 38' ' ' TRP . 90.8 t -143.18 135.56 24.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.085 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -126.49 144.32 50.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.85 129.52 53.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.155 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mp -123.41 117.32 24.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.867 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.423 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 37.9 p-10 -119.81 -172.61 2.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.508 ' HE1' ' CE2' ' A' ' 46' ' ' PHE . 12.6 ptm -69.48 1.45 3.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.809 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.3 mt -108.81 -26.59 10.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.908 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.54 -163.09 29.51 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.532 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -104.59 158.14 16.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 110.861 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.423 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 7.5 p -95.39 175.06 6.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.825 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -70.76 157.01 91.18 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.575 0.703 . . . . 0.0 110.943 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.409 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.7 Cg_endo -69.73 105.2 1.44 Allowed 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.683 2.255 . . . . 0.0 112.294 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.0 p -45.94 150.52 0.55 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -44.0 141.44 2.4 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.556 0.694 . . . . 0.0 111.148 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 97.66 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.684 2.256 . . . . 0.0 112.36 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 t -43.53 154.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.84 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -51.43 153.71 3.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.617 0.722 . . . . 0.0 110.829 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 121.92 8.6 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.722 2.281 . . . . 0.0 112.306 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.519 ' CD2' HG23 ' A' ' 26' ' ' ILE . 46.8 t80 -112.79 120.19 40.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.31 104.96 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.196 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.3 t -73.65 106.45 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.4 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.816 -179.821 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.675 ' CD1' ' CE2' ' A' ' 46' ' ' PHE . 13.3 mt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.826 0.346 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.425 ' O ' ' CD1' ' A' ' 99' ' ' LEU . 1.8 m -145.11 161.21 43.25 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.58 0.705 . . . . 0.0 110.892 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 170.14 17.27 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.641 2.227 . . . . 0.0 112.377 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 54.3 Cg_endo -69.73 156.63 62.92 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.664 2.242 . . . . 0.0 112.331 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.42 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.4 pt-20 -98.11 174.53 6.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.2 123.44 87.38 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.597 0.713 . . . . 0.0 111.082 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 161.33 46.33 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.665 2.243 . . . . 0.0 112.376 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -49.39 174.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -80.43 122.16 82.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.602 0.715 . . . . 0.0 110.908 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 143.15 50.25 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.666 2.244 . . . . 0.0 112.402 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.434 ' C ' ' CD1' ' A' ' 26' ' ' ILE . 5.4 t -95.27 165.98 12.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.106 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.434 ' CD1' ' C ' ' A' ' 25' ' ' THR . 2.8 mm -126.81 125.34 66.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.184 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.6 t -131.44 166.99 20.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.4 m -80.88 107.27 13.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.523 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . . . -111.13 -36.31 5.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 m -164.87 -179.71 5.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -82.99 -19.5 36.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.832 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.8 p -120.33 -1.9 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.2 p -140.4 171.25 14.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.9 m -149.65 147.43 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.163 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.523 ' CD2' ' CB ' ' A' ' 29' ' ' ALA . 15.1 m-85 -82.78 120.49 25.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.3 t -115.71 131.46 68.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.105 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.9 m -128.36 120.59 27.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.152 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.56 ' CD1' HG12 ' A' ' 93' ' ' VAL . 28.6 p90 -120.13 170.27 9.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.1 mm -134.3 110.5 11.63 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.59 0.709 . . . . 0.0 111.137 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 137.99 36.66 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.727 2.285 . . . . 0.0 112.312 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -103.58 -69.68 0.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.849 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.48 158.85 14.81 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.509 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -124.25 5.57 8.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.833 0.349 . . . . 0.0 110.815 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.11 0.69 89.27 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.519 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.58 -18.1 32.76 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.548 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.675 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 2.1 m-85 -114.68 162.24 24.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.617 0.723 . . . . 0.0 110.922 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 114.61 3.75 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.711 2.274 . . . . 0.0 112.33 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 49' ' ' GLN . 95.8 mt -46.46 141.2 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.454 ' N ' HG23 ' A' ' 48' ' ' ILE . 88.4 mt-30 -93.36 -52.11 4.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.868 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.7 p -159.69 160.61 34.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -108.83 168.32 9.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.4 mtt-85 -143.39 136.77 28.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.8 t -116.63 134.8 58.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -133.63 158.84 42.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.492 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 26.4 p90 -136.82 175.02 10.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.944 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.452 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 36.9 ttpt -147.69 135.62 21.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.944 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -82.34 129.63 34.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 28.8 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.907 179.924 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.453 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 78.0 m95 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.73 0.3 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.492 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.9 mm -115.14 159.42 15.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.14 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 tp -91.5 122.52 34.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -91.41 -71.33 0.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.081 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 t -130.29 165.08 23.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.151 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.9 m -162.85 -175.34 4.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 64.25 29.77 13.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.055 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.475 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 61.3 mt -83.37 137.42 42.24 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.641 0.734 . . . . 0.0 111.176 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.475 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 53.9 Cg_endo -69.7 158.19 57.9 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.633 2.222 . . . . 0.0 112.379 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.72 -11.41 30.82 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.661 2.24 . . . . 0.0 112.323 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.0 t -92.52 -18.16 23.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.854 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.429 ' CD ' HG12 ' A' ' 78' ' ' VAL . 17.0 ttt180 -98.57 103.65 15.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.822 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.9 mt -99.46 7.62 45.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.974 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 t -149.45 132.85 16.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.809 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.429 HG12 ' CD ' ' A' ' 75' ' ' ARG . 2.0 m -148.35 165.17 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.131 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.419 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 28.8 tt0 -99.47 116.03 30.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.9 mm -83.3 101.21 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.117 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.4 p -99.67 168.63 9.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.162 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.09 34.34 9.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.2 mt -102.43 179.5 4.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.769 0.319 . . . . 0.0 110.949 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -124.22 135.57 53.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -71.63 157.3 38.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.35 12.84 59.3 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.457 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.406 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 25.8 mm -124.09 113.9 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 111.147 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.87 139.8 35.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.825 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.406 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -160.76 170.46 20.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.944 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -114.49 -176.14 2.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.843 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -144.43 154.23 42.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.453 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 5.3 ptp180 -146.91 179.86 7.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.56 HG12 ' CD1' ' A' ' 38' ' ' TRP . 74.6 t -145.1 143.58 22.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.115 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -132.77 146.02 51.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -107.39 130.22 54.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.086 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.421 ' HG ' ' CB ' ' A' ' 101' ' ' GLU . 4.3 mp -123.87 120.77 33.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.934 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.424 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 37.0 p-10 -123.74 -172.64 2.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.3 ptm -68.98 0.78 4.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.797 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.425 ' CD1' ' O ' ' A' ' 16' ' ' SER . 51.2 mt -108.6 -26.38 10.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.935 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.56 -167.5 29.18 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.485 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.421 ' CB ' ' HG ' ' A' ' 96' ' ' LEU . 0.6 OUTLIER -100.54 158.39 15.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 110.866 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.42 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 14.0 p -94.81 175.22 6.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.816 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -71.41 160.68 81.83 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.621 0.724 . . . . 0.0 110.897 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 107.69 1.92 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.741 2.294 . . . . 0.0 112.286 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.8 p -47.95 158.88 0.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.35 138.61 48.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.587 0.708 . . . . 0.0 111.128 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 96.89 0.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.73 2.287 . . . . 0.0 112.38 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.5 p -47.21 160.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.841 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -52.42 150.94 8.1 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.607 0.718 . . . . 0.0 110.854 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.61 129.21 17.36 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.724 2.283 . . . . 0.0 112.392 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.42 ' CD1' HG22 ' A' ' 26' ' ' ILE . 57.9 t80 -117.53 120.23 37.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.926 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.0 t -92.94 107.42 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.142 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.0 t -73.25 104.56 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.823 -179.837 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.572 ' CD1' ' CE2' ' A' ' 46' ' ' PHE . 9.0 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.832 0.349 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 44' ' ' GLY . 1.4 m -139.76 161.87 53.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.682 0.753 . . . . 0.0 110.832 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.74 170.09 17.37 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.674 2.249 . . . . 0.0 112.343 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 54.6 Cg_endo -69.69 155.48 66.07 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.74 2.293 . . . . 0.0 112.375 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.421 ' C ' ' HB2' ' A' ' 102' ' ' SER . 5.0 pt-20 -98.06 175.29 6.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.94 121.12 80.43 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.611 0.72 . . . . 0.0 111.153 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 162.14 43.23 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.711 2.274 . . . . 0.0 112.325 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -50.42 174.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.824 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -80.15 123.63 83.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.583 0.706 . . . . 0.0 110.851 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 144.04 52.78 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.713 2.276 . . . . 0.0 112.369 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.3 t -94.4 166.17 12.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.203 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.432 HG22 ' CD2' ' A' ' 111' ' ' TYR . 7.9 mm -128.21 121.42 55.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.129 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -121.17 -177.72 3.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.887 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.3 m -98.68 99.74 10.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.549 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . . . -100.79 -41.1 7.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.016 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.6 m -163.16 -178.75 6.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.834 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -84.91 -15.04 45.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.852 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.6 p -117.94 -7.1 10.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.179 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.433 ' CB ' ' HA ' ' A' ' 81' ' ' THR . 36.7 p -143.56 171.9 13.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 m -147.64 150.94 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.137 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.549 ' CD2' ' CB ' ' A' ' 29' ' ' ALA . 18.3 m-85 -84.89 119.81 25.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.3 t -113.91 130.61 67.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.167 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 42.0 m -128.28 124.07 35.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.571 ' CD1' HG11 ' A' ' 93' ' ' VAL . 27.4 p90 -121.3 168.39 11.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.1 mm -132.09 108.13 13.82 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.631 0.729 . . . . 0.0 111.153 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 142.92 49.13 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.711 2.274 . . . . 0.0 112.309 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -111.98 -66.86 1.04 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.6 144.52 16.32 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.496 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -115.12 10.0 16.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.965 0.412 . . . . 0.0 110.963 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 78.73 -0.59 76.65 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.467 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.37 -22.88 21.77 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.487 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.572 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 2.3 m-85 -109.89 162.03 21.97 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.574 0.702 . . . . 0.0 110.944 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 113.0 3.22 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.655 2.237 . . . . 0.0 112.428 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 80.6 mt -47.07 134.75 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -83.62 -49.96 8.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.952 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 m -162.9 162.7 26.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.809 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -108.42 169.72 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.831 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -145.15 130.25 18.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.7 t -108.83 136.78 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.409 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 4.0 mp0 -127.59 156.34 42.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.825 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -141.08 147.33 38.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.855 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -129.72 140.65 51.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.971 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.7 mtmm -83.79 129.84 34.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.922 179.918 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 60.8 m95 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.698 0.285 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.1 mm -129.76 157.97 42.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.183 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 tp -85.43 111.59 20.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.0 -61.64 1.78 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.111 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.3 t -150.88 161.09 43.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.191 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.7 m -152.5 -179.59 7.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.854 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 71.67 25.25 3.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.07 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.473 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 71.4 mt -81.5 137.99 48.03 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.594 0.711 . . . . 0.0 111.103 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.473 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 53.7 Cg_endo -69.79 156.17 63.95 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.616 2.211 . . . . 0.0 112.285 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -12.72 33.44 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.698 2.266 . . . . 0.0 112.375 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.3 t -92.43 -17.32 24.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.806 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.463 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 7.2 ttt85 -96.44 97.54 9.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.2 mt -94.06 13.59 22.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.91 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -154.17 130.95 10.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.8 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.6 m -145.4 160.34 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.114 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.421 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 24.2 tt0 -96.8 115.82 28.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.925 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.2 mm -83.63 105.35 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.433 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 64.2 p -102.56 171.43 7.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.166 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.09 38.38 11.31 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.5 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.5 mt -105.33 176.37 5.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.81 0.338 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -120.19 136.09 54.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.85 150.5 42.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.96 10.66 68.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.46 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.49 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 28.0 mm -121.41 103.88 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.369 . . . . 0.0 111.105 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.02 141.81 52.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.49 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -163.22 163.02 25.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -111.89 169.59 8.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.811 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -129.71 153.89 47.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.409 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 5.3 ptp180 -143.82 -178.94 6.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.571 HG11 ' CD1' ' A' ' 38' ' ' TRP . 86.4 t -145.13 144.55 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.093 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.403 ' N ' HG12 ' A' ' 93' ' ' VAL . 25.4 mtt180 -134.87 139.13 44.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.822 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.69 132.77 44.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.096 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.4 mp -126.35 119.59 27.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.928 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.433 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 38.5 p-10 -123.61 -173.95 2.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.436 ' HE1' ' CG ' ' A' ' 46' ' ' PHE . 6.3 ptp -68.87 -0.63 5.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.798 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.4 mt -106.62 -25.66 11.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.972 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.26 -165.98 29.02 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -102.01 158.03 16.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.421 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 5.2 p -94.33 175.04 6.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.801 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -71.22 160.39 82.66 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.606 0.717 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 110.33 2.53 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.683 2.255 . . . . 0.0 112.354 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.0 p -53.34 152.14 4.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.43 139.44 8.06 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.599 0.714 . . . . 0.0 111.073 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 100.41 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.66 2.24 . . . . 0.0 112.352 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.3 p -46.1 163.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.85 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -56.83 152.4 27.5 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.529 0.68 . . . . 0.0 110.939 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 123.2 9.87 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.64 2.227 . . . . 0.0 112.395 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.432 ' CD2' HG22 ' A' ' 26' ' ' ILE . 48.5 t80 -112.89 117.21 31.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.8 t -91.76 101.79 12.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.175 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.9 t -67.99 110.55 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 -179.888 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.567 HD11 ' CE2' ' A' ' 46' ' ' PHE . 15.9 mt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.877 0.37 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 p -141.65 160.17 57.42 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.72 0.772 . . . . 0.0 110.819 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 169.83 17.96 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.691 2.261 . . . . 0.0 112.347 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.421 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 53.0 Cg_endo -69.84 152.72 68.99 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.664 2.243 . . . . 0.0 112.256 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' HB2' ' A' ' 102' ' ' SER . 4.2 pt-20 -94.68 172.46 8.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.01 121.72 79.36 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.544 0.688 . . . . 0.0 111.109 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 161.96 43.93 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.625 2.217 . . . . 0.0 112.337 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -51.27 174.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.832 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -79.99 123.08 83.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.542 0.687 . . . . 0.0 110.849 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 143.51 51.21 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.677 2.252 . . . . 0.0 112.352 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.8 t -93.38 164.42 13.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.184 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.554 HG22 ' CD2' ' A' ' 111' ' ' TYR . 12.4 mm -128.07 120.76 54.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.051 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -123.28 -178.76 4.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.858 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.2 m -97.05 98.97 10.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.461 ' HB2' ' N ' ' A' ' 35' ' ' TYR . . . -100.41 -33.84 10.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.146 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.43 -175.02 3.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -83.49 -20.03 34.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.962 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.7 p -122.92 -0.58 8.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.179 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.406 ' CB ' ' HA ' ' A' ' 81' ' ' THR . 3.8 p -139.27 163.89 31.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.82 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.72 144.82 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.152 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.461 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 16.8 m-85 -77.8 116.66 18.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.904 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.9 t -108.98 130.72 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.127 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 m -129.16 121.9 28.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.129 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.569 ' CD1' HG11 ' A' ' 93' ' ' VAL . 35.3 p90 -121.63 170.95 9.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.7 mm -135.76 106.0 9.82 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.631 0.729 . . . . 0.0 111.17 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.416 ' CD ' HD23 ' A' ' 76' ' ' LEU . 53.7 Cg_endo -69.68 129.87 18.44 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.712 2.274 . . . . 0.0 112.347 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -93.0 -70.41 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.49 151.37 16.92 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.445 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 42.4 p-10 -118.03 10.7 13.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 0.0 110.9 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.57 -4.25 60.79 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.436 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.96 -18.05 19.43 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.483 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.567 ' CE2' HD11 ' A' ' 15' ' ' LEU . 2.1 m-85 -114.3 162.03 25.33 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.674 0.75 . . . . 0.0 110.873 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 114.8 3.81 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.668 2.245 . . . . 0.0 112.36 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 89.4 mt -45.6 130.37 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -84.99 -46.18 11.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.6 p -162.19 162.53 28.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.757 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -108.89 172.7 6.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.868 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.439 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 55.9 mtt180 -145.04 121.29 10.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.977 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.3 t -105.62 128.21 59.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.135 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.408 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 13.9 mt-10 -128.89 152.54 48.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.823 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.504 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 36.7 p90 -133.34 173.84 11.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.917 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -149.14 137.35 20.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.94 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -83.53 125.91 32.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.966 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 77.8 mt . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.912 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 82.9 m95 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.77 0.319 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.504 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 2.6 mm -120.47 158.93 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.8 tp -93.31 121.93 35.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.417 ' CB ' HG23 ' A' ' 80' ' ' ILE . . . -90.19 -69.0 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.096 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 t -126.49 178.57 5.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.115 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.9 p -173.86 178.35 2.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.835 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 67.98 30.67 5.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.079 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.471 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 72.2 mt -84.56 137.73 38.72 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.591 0.71 . . . . 0.0 111.151 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.471 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 53.8 Cg_endo -69.76 159.56 52.95 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.739 2.293 . . . . 0.0 112.321 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 -17.67 37.51 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.71 2.274 . . . . 0.0 112.325 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.4 m -86.48 -23.19 26.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.42 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 15.0 ttt180 -90.01 100.99 13.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.813 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.416 HD23 ' CD ' ' A' ' 40' ' ' PRO . 52.6 mt -95.95 9.58 40.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.839 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.402 ' C ' HG12 ' A' ' 78' ' ' VAL . 11.6 t -153.79 136.6 15.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.431 HG13 ' CD1' ' A' ' 71' ' ' ILE . 1.9 m -147.31 163.81 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.135 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -100.4 111.59 23.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.833 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.417 HG23 ' CB ' ' A' ' 67' ' ' ALA . 26.3 mm -80.86 102.94 7.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.102 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.406 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 77.2 p -97.25 165.35 12.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.059 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.78 37.46 8.58 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.436 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 88.1 mt -97.62 -179.68 4.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.792 0.329 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -126.71 125.25 41.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -65.11 163.06 15.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.64 17.94 22.08 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.536 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.501 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 28.1 mm -129.37 105.05 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 111.114 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.89 141.82 49.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.501 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -162.75 164.53 26.25 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.944 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -111.08 -175.6 2.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.93 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -146.64 161.46 40.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.84 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.409 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 3.5 ptp180 -151.95 173.41 14.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.884 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.569 HG11 ' CD1' ' A' ' 38' ' ' TRP . 71.6 t -140.02 136.4 38.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.125 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -127.05 138.21 53.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.863 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.95 126.35 43.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.067 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.439 HD22 ' CZ ' ' A' ' 52' ' ' ARG . 7.0 mp -120.53 118.41 30.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.421 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.7 p-10 -123.39 -173.72 2.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.1 ptm -68.07 -1.48 5.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.5 mt -105.65 -25.78 12.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.988 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.99 -166.04 28.9 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.511 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.4 156.39 17.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.858 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.417 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 5.5 p -93.39 175.11 6.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.895 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -70.27 157.89 88.86 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.634 0.731 . . . . 0.0 110.856 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.409 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.5 Cg_endo -69.74 102.95 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.66 2.24 . . . . 0.0 112.324 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.9 p -43.93 153.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.81 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.71 141.65 17.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.586 0.707 . . . . 0.0 111.076 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 98.05 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.687 2.258 . . . . 0.0 112.373 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.0 p -45.8 151.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.817 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.2 mmm-85 -45.57 156.18 0.43 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.593 0.711 . . . . 0.0 110.823 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 131.45 21.15 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.638 2.226 . . . . 0.0 112.28 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.554 ' CD2' HG22 ' A' ' 26' ' ' ILE . 39.7 t80 -121.04 113.28 19.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.9 t -91.13 102.81 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.146 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.9 t -69.09 105.7 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.164 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.6 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 -179.894 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.668 ' CD1' ' CE2' ' A' ' 46' ' ' PHE . 9.1 mt . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.884 0.373 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.438 ' O ' ' CD1' ' A' ' 99' ' ' LEU . 0.9 OUTLIER -134.84 159.63 71.42 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.716 0.769 . . . . 0.0 110.835 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 170.22 17.03 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.727 2.285 . . . . 0.0 112.323 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.425 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 53.5 Cg_endo -69.83 154.56 67.31 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.612 2.208 . . . . 0.0 112.341 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.415 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.1 pt-20 -95.7 174.11 7.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.868 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.65 122.04 84.46 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.645 0.736 . . . . 0.0 111.071 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 160.79 48.38 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.644 2.229 . . . . 0.0 112.343 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -49.51 174.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -80.03 123.51 83.48 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.702 0.763 . . . . 0.0 110.83 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 144.27 53.23 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.629 2.219 . . . . 0.0 112.319 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.4 t -93.87 166.41 12.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.109 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.562 HG21 ' CD1' ' A' ' 111' ' ' TYR . 8.1 mm -126.01 125.83 68.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -125.79 179.23 5.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.5 m -98.23 98.68 9.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.116 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.538 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -102.48 -40.02 6.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.072 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.2 m -165.2 168.99 16.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.819 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -74.29 -14.03 60.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.2 p -118.24 -3.28 11.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.123 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.46 ' CB ' ' HA ' ' A' ' 81' ' ' THR . 6.5 p -146.45 177.46 9.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.8 m -154.56 149.19 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.178 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.538 ' CE2' ' HB3' ' A' ' 29' ' ' ALA . 17.1 m-85 -82.44 118.16 23.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 91.7 t -113.4 130.84 66.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.069 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.7 m -128.88 120.34 26.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.197 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.562 ' CD1' HG12 ' A' ' 93' ' ' VAL . 26.3 p90 -118.76 170.92 8.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mm -134.93 108.56 10.65 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.615 0.722 . . . . 0.0 111.102 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 140.23 42.38 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.704 2.269 . . . . 0.0 112.363 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -109.43 -69.14 0.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.85 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.23 147.6 16.31 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.528 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 51.9 p-10 -117.82 5.79 12.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.804 0.335 . . . . 0.0 110.84 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 81.89 4.36 90.32 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.485 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.38 -16.78 44.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.487 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.668 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 1.9 m-85 -115.44 162.24 25.82 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.654 0.74 . . . . 0.0 110.869 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.64 118.24 5.56 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.7 2.266 . . . . 0.0 112.399 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.462 HD12 ' CE1' ' A' ' 51' ' ' PHE . 91.7 mt -49.26 131.88 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.172 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -85.77 -49.27 8.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.954 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.1 m -161.51 161.29 29.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.841 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.462 ' CE1' HD12 ' A' ' 48' ' ' ILE . 60.9 m-85 -109.91 171.26 7.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -146.19 134.3 21.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.863 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.2 135.02 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.155 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.474 ' N ' ' OE1' ' A' ' 54' ' ' GLU . 26.4 mp0 -136.25 146.01 46.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.531 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 26.3 p90 -124.43 179.27 4.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.445 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 22.4 ttpp -149.4 136.41 19.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -84.23 119.87 25.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.3 mt . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 179.948 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.445 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 84.0 m95 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.684 0.278 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.531 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 5.2 mm -115.02 159.62 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.151 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.4 tp -93.37 125.32 37.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -94.16 -69.84 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.126 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.2 t -131.63 173.19 11.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.146 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.439 ' OG ' ' N ' ' A' ' 70' ' ' ALA . 6.3 t -169.45 176.74 4.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.801 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.439 ' N ' ' OG ' ' A' ' 69' ' ' SER . . . 69.68 28.65 4.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.106 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.469 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 73.6 mt -80.26 137.88 52.47 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.65 0.738 . . . . 0.0 111.155 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.469 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 54.2 Cg_endo -69.64 158.06 58.42 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.757 2.305 . . . . 0.0 112.378 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -21.89 33.05 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.686 2.258 . . . . 0.0 112.324 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.6 m -82.01 -14.99 55.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -101.84 107.59 18.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.857 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.7 mt -103.86 11.47 35.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -153.2 132.48 12.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.776 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.9 165.63 9.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.098 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -102.55 109.32 20.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.808 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.1 mm -79.04 103.32 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.15 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.46 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 29.7 p -102.84 167.95 9.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.085 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.75 36.69 7.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.462 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.8 mt -103.65 -178.85 3.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 110.93 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -118.55 126.84 52.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -67.66 153.74 43.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.43 11.96 62.89 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.458 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.457 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 23.2 mm -124.47 112.66 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.804 0.335 . . . . 0.0 111.194 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.23 141.56 45.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.851 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.457 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -161.66 162.78 30.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.947 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -107.54 -175.82 2.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -145.83 151.43 37.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.405 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 1.9 ptp180 -144.12 176.73 9.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.562 HG12 ' CD1' ' A' ' 38' ' ' TRP . 86.8 t -142.87 139.78 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.13 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 -129.57 139.97 51.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 102' ' ' SER . . . -101.23 128.87 47.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.403 HD11 ' C ' ' A' ' 95' ' ' ALA . 8.3 mp -122.21 120.0 32.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.425 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 38.1 p-10 -123.55 -173.1 2.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.7 ptm -68.72 0.65 3.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.438 ' CD1' ' O ' ' A' ' 16' ' ' SER . 38.7 mt -108.37 -26.2 10.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.62 -167.38 29.22 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.525 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.36 158.27 15.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 110.879 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 95' ' ' ALA . 5.2 p -93.81 175.29 6.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -71.6 158.14 88.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.638 0.732 . . . . 0.0 110.93 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.405 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 52.9 Cg_endo -69.77 102.86 1.08 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.687 2.258 . . . . 0.0 112.276 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.3 p -46.32 154.57 0.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.855 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.04 143.39 4.61 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.5 0.667 . . . . 0.0 111.149 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 92.98 0.52 Allowed 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.726 2.284 . . . . 0.0 112.344 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.0 t -40.67 146.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -44.62 150.22 0.71 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.654 0.74 . . . . 0.0 110.845 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 124.31 10.95 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.661 2.241 . . . . 0.0 112.357 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.562 ' CD1' HG21 ' A' ' 26' ' ' ILE . 65.4 t80 -115.25 120.7 40.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.5 t -93.64 107.18 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.139 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.8 t -72.6 102.63 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.14 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.8 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.904 -179.861 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.557 HD13 ' CE2' ' A' ' 46' ' ' PHE . 13.7 mt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.79 0.328 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.421 ' C ' HD11 ' A' ' 99' ' ' LEU . 3.1 m -137.78 160.08 66.23 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.699 0.762 . . . . 0.0 110.874 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 170.09 17.5 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.678 2.252 . . . . 0.0 112.302 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 53.6 Cg_endo -69.72 155.75 65.25 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.694 2.263 . . . . 0.0 112.337 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.421 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.6 pt-20 -99.12 168.83 9.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.92 123.01 82.52 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.534 0.683 . . . . 0.0 111.117 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 165.1 32.15 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.72 2.28 . . . . 0.0 112.266 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -52.44 175.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -79.99 122.83 83.61 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.622 0.725 . . . . 0.0 110.912 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 143.3 50.46 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.707 2.272 . . . . 0.0 112.375 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.8 t -94.24 165.25 12.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.133 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.9 mm -125.92 125.61 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.159 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 m -127.7 178.18 6.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.6 m -95.48 101.01 12.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.138 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.47 ' HB3' ' N ' ' A' ' 35' ' ' TYR . . . -102.1 -41.4 6.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.08 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.02 -175.0 5.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -85.0 -16.75 39.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.7 p -123.27 2.04 9.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.112 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.442 ' CB ' ' HA ' ' A' ' 81' ' ' THR . 18.7 p -144.7 168.0 21.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.832 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.9 m -147.07 145.81 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.47 ' N ' ' HB3' ' A' ' 29' ' ' ALA . 19.7 m-85 -77.85 117.71 19.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.859 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.1 t -111.97 129.7 66.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.095 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.6 m -128.74 123.51 33.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.187 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.567 ' CD1' HG11 ' A' ' 93' ' ' VAL . 25.5 p90 -122.43 169.66 10.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.899 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.0 mm -133.29 107.35 12.24 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.668 0.747 . . . . 0.0 111.191 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 135.5 30.62 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.726 2.284 . . . . 0.0 112.332 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -100.32 -70.44 0.74 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.5 159.89 14.72 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.516 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -125.1 4.72 7.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.878 0.37 . . . . 0.0 110.85 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.55 0.56 90.07 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.549 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.32 -24.05 19.07 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.503 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.557 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.4 m-85 -108.68 162.24 20.7 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.637 0.732 . . . . 0.0 110.851 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 116.32 4.5 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.659 2.239 . . . . 0.0 112.379 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 49' ' ' GLN . 96.3 mt -47.81 135.0 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.187 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.439 ' N ' HG22 ' A' ' 48' ' ' ILE . 63.6 mt-30 -86.07 -52.51 5.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.856 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.1 m -160.3 162.16 33.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.862 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -109.85 166.96 10.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.447 ' CZ ' ' OG ' ' A' ' 69' ' ' SER . 21.6 mtp85 -142.22 143.26 32.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.821 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -120.61 137.47 54.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.107 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -133.7 162.55 31.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.46 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 46.1 p90 -142.05 158.94 43.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.458 ' HD3' ' NE1' ' A' ' 64' ' ' TRP . 37.6 ttpt -130.7 129.72 42.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.931 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -80.07 120.34 24.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.2 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.906 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.458 ' NE1' ' HD3' ' A' ' 56' ' ' LYS . 47.1 m95 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.736 0.303 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.46 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 1.8 mm -128.04 160.28 38.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.108 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 39.6 tp -99.89 116.11 31.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.22 -69.79 0.62 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.121 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 t -128.0 166.66 17.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.213 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.447 ' OG ' ' CZ ' ' A' ' 52' ' ' ARG . 12.2 m -161.8 178.65 8.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 70.56 27.54 3.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.103 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.47 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 74.9 mt -78.32 138.15 59.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.584 0.707 . . . . 0.0 111.16 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.47 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 54.1 Cg_endo -69.73 156.49 63.3 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.678 2.252 . . . . 0.0 112.375 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.64 -17.54 38.05 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.647 2.231 . . . . 0.0 112.403 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.3 m -87.6 -13.46 42.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.444 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 15.7 ttt180 -101.04 104.52 15.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.842 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.4 mt -100.4 12.49 37.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -154.93 132.05 10.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 m -147.37 165.27 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.101 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -100.26 118.28 36.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.7 mm -86.98 98.19 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.083 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.442 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 32.0 p -93.4 174.15 7.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.3 40.04 17.21 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.509 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.1 mt -100.67 -179.24 4.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.729 0.299 . . . . 0.0 110.921 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -125.27 130.45 52.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.935 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.0 151.57 43.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.77 10.5 64.39 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.452 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.419 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 25.9 mm -122.22 112.66 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.352 . . . . 0.0 111.103 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.22 138.75 38.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.83 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.419 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -161.59 161.21 29.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.951 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -107.53 177.22 4.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -135.31 158.89 43.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.413 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 1.2 ptp180 -151.13 177.9 9.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.567 HG11 ' CD1' ' A' ' 38' ' ' TRP . 95.0 t -143.58 141.83 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.152 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.2 mtt180 -131.94 143.42 50.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.97 131.18 53.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.108 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.444 HD11 ' N ' ' A' ' 96' ' ' LEU . 9.1 mp -124.39 120.74 32.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.915 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.428 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 38.3 p-10 -123.61 -172.77 2.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.935 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.0 ptm -69.03 0.73 4.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.421 HD11 ' C ' ' A' ' 16' ' ' SER . 46.3 mt -108.5 -26.14 10.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.926 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.39 -166.56 29.09 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.499 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.13 158.74 15.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.889 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.421 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 4.8 p -95.51 175.23 6.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.839 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -70.93 157.98 89.13 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.57 0.7 . . . . 0.0 110.907 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.413 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.9 Cg_endo -69.75 104.72 1.36 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.649 2.233 . . . . 0.0 112.385 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.5 p -44.31 151.95 0.22 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.01 139.38 6.96 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.562 0.696 . . . . 0.0 111.106 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 97.11 0.62 Allowed 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.682 2.255 . . . . 0.0 112.373 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 t -48.3 159.59 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.75 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.98 152.58 5.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.675 0.75 . . . . 0.0 110.857 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.65 131.91 22.4 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.698 2.265 . . . . 0.0 112.372 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -117.85 119.47 34.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.977 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.4 t -95.15 102.2 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.099 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.5 t -69.67 106.47 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.828 -179.858 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.639 ' CD1' ' CE2' ' A' ' 46' ' ' PHE . 16.8 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.411 ' C ' HD13 ' A' ' 99' ' ' LEU . 1.4 p -141.7 160.01 57.86 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.738 0.78 . . . . 0.0 110.861 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 169.19 19.49 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.7 2.267 . . . . 0.0 112.302 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.482 ' O ' ' CB ' ' A' ' 102' ' ' SER . 53.4 Cg_endo -69.78 157.41 60.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.698 2.265 . . . . 0.0 112.334 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.429 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.6 pt-20 -99.25 163.25 12.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.35 122.32 58.72 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.539 0.685 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 163.76 37.1 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.672 2.248 . . . . 0.0 112.34 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -50.0 177.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -83.27 124.39 76.12 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.648 0.737 . . . . 0.0 110.85 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 147.36 62.76 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.676 2.251 . . . . 0.0 112.336 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.1 t -99.58 164.51 12.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.15 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.498 HG22 ' CD1' ' A' ' 111' ' ' TYR . 8.7 mm -122.67 118.25 54.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.103 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.1 m -121.69 165.31 15.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.836 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.1 m -83.03 104.75 13.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.553 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . . . -108.45 -37.96 5.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.059 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 m -166.16 175.72 8.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.64 -16.73 55.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.898 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.7 p -119.0 -6.35 10.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.145 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.466 ' HB3' ' CG2' ' A' ' 81' ' ' THR . 89.3 p -138.51 171.96 13.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 m -149.55 145.47 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.123 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.553 ' CD2' ' CB ' ' A' ' 29' ' ' ALA . 17.6 m-85 -81.63 115.34 20.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.0 t -109.11 127.24 65.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.149 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.8 m -125.78 121.71 34.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.058 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.53 ' CD1' HG11 ' A' ' 93' ' ' VAL . 29.4 p90 -121.47 171.07 9.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.5 mm -135.1 107.12 10.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.632 0.73 . . . . 0.0 111.068 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 139.8 41.16 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.697 2.265 . . . . 0.0 112.343 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 mmt85 -103.31 -70.45 0.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.72 159.21 14.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.489 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -123.03 4.51 9.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 110.887 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.56 -1.41 87.87 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.491 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.32 -23.85 13.29 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.639 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 2.1 m-85 -110.11 162.25 21.17 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.641 0.734 . . . . 0.0 110.869 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.71 114.72 3.79 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.676 2.251 . . . . 0.0 112.427 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 81.6 mt -47.09 132.08 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.128 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -85.15 -50.36 7.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.2 p -159.7 163.24 34.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -108.86 171.78 7.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -143.45 129.01 19.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.827 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.4 t -111.4 133.14 57.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.07 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -135.42 152.4 51.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.455 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 31.1 p90 -129.37 175.75 8.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.486 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 24.6 ttpt -147.88 132.24 17.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.869 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -81.43 126.23 31.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.5 mt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 179.919 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.486 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 77.1 m95 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.783 0.325 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.455 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 2.7 mm -116.71 164.2 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.8 tp -96.96 124.1 40.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.444 ' CB ' HG22 ' A' ' 80' ' ' ILE . . . -92.52 -64.71 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.058 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 t -131.83 179.33 6.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.0 p -173.15 178.16 2.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 64.15 32.33 12.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.094 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.47 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 88.2 mt -84.61 138.55 38.18 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.582 0.706 . . . . 0.0 111.129 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.47 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 54.0 Cg_endo -69.75 156.9 62.18 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.719 2.28 . . . . 0.0 112.305 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 -19.56 35.83 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.742 2.295 . . . . 0.0 112.33 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 t -84.7 -15.26 45.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.425 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 8.5 ttt85 -99.17 101.33 12.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.4 mt -96.64 8.99 42.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.928 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.5 t -151.34 134.08 15.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.1 m -146.5 161.95 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.131 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.409 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 39.5 tt0 -97.97 110.23 22.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.444 HG22 ' CB ' ' A' ' 67' ' ' ALA . 17.6 mm -80.1 109.76 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.154 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.466 ' CG2' ' HB3' ' A' ' 33' ' ' SER . 66.1 p -107.57 166.42 10.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.97 33.46 8.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.498 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.3 mt -101.65 170.31 8.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.736 0.303 . . . . 0.0 110.898 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -114.2 132.86 55.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.855 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -68.01 156.84 36.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.54 12.01 44.36 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.516 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.512 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 32.1 mm -120.76 103.23 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.836 0.351 . . . . 0.0 111.134 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.44 140.16 51.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.512 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -163.12 163.11 25.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.992 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -109.08 -175.97 2.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.936 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -141.82 164.6 29.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.917 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -157.54 170.09 23.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.53 HG11 ' CD1' ' A' ' 38' ' ' TRP . 99.7 t -137.2 140.14 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.134 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.452 ' N ' HG12 ' A' ' 93' ' ' VAL . 33.8 mtt180 -129.28 136.35 49.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.847 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.64 128.5 39.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.101 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mp -123.6 120.12 31.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.431 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 38.3 p-10 -123.56 -172.79 2.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.3 ptm -69.84 1.56 4.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.834 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.411 HD13 ' C ' ' A' ' 16' ' ' SER . 30.3 mt -108.83 -26.25 10.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.953 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 149.49 -162.54 29.08 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.513 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.408 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 26.3 pm0 -107.09 157.42 17.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.892 0.377 . . . . 0.0 110.918 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 54.4 p -96.2 174.99 6.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.851 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -68.47 157.82 86.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.654 0.74 . . . . 0.0 110.884 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 111.23 2.76 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.669 2.246 . . . . 0.0 112.284 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.7 p -50.44 154.17 1.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.49 141.0 7.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.539 0.685 . . . . 0.0 111.047 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 98.06 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.637 2.224 . . . . 0.0 112.388 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.4 p -45.19 164.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.892 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.3 mtm105 -58.31 152.12 44.62 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.505 0.669 . . . . 0.0 110.942 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 122.61 9.28 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.637 2.225 . . . . 0.0 112.345 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.498 ' CD1' HG22 ' A' ' 26' ' ' ILE . 52.7 t80 -111.98 121.1 44.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.933 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.9 t -95.03 105.43 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.114 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.0 t -74.95 108.68 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.083 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.878 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.565 ' CD1' ' CE2' ' A' ' 46' ' ' PHE . 6.4 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.833 0.349 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.401 ' O ' ' O ' ' A' ' 44' ' ' GLY . 1.4 p -137.65 160.34 65.44 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.681 0.753 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 169.98 17.66 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.682 2.255 . . . . 0.0 112.355 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.488 ' O ' ' CB ' ' A' ' 102' ' ' SER . 53.9 Cg_endo -69.81 152.74 69.12 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.628 2.219 . . . . 0.0 112.348 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' HB2' ' A' ' 102' ' ' SER . 9.2 pt-20 -98.16 160.48 14.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.09 122.79 50.26 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.559 0.695 . . . . 0.0 111.069 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 166.42 27.7 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.7 2.266 . . . . 0.0 112.304 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -51.67 174.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -80.22 122.73 83.18 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.624 0.726 . . . . 0.0 110.932 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 142.44 47.98 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.671 2.248 . . . . 0.0 112.306 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.6 t -93.43 167.49 11.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.164 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.471 HG21 ' CD2' ' A' ' 111' ' ' TYR . 10.4 mm -127.44 124.68 64.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.193 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 m -128.31 175.75 8.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.813 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.4 m -94.51 101.36 13.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.1 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.522 ' HB2' ' CE2' ' A' ' 35' ' ' TYR . . . -102.42 -41.15 6.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 t -156.86 -178.34 7.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.833 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -81.17 -20.52 41.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.3 p -121.72 4.59 10.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.151 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 84.1 p -139.6 175.97 9.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.3 m -154.64 143.67 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.522 ' CE2' ' HB2' ' A' ' 29' ' ' ALA . 11.0 m-85 -79.69 117.52 20.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.8 t -111.93 129.17 67.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.133 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.5 m -128.91 118.39 22.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.14 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.485 ' CD1' HG13 ' A' ' 93' ' ' VAL . 33.1 p90 -118.58 169.16 10.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 mm -133.59 108.39 12.06 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.62 0.724 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 141.73 45.95 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.693 2.262 . . . . 0.0 112.333 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -109.81 -70.34 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.66 147.06 16.15 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.526 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 48.2 p-10 -114.47 2.55 14.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 0.0 110.925 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 85.26 2.3 87.84 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.507 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.3 -15.04 39.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.438 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.565 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 2.5 m-85 -118.24 161.98 32.29 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.629 0.728 . . . . 0.0 110.839 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 115.52 4.14 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.68 2.253 . . . . 0.0 112.311 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 92.4 mt -47.71 131.22 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.046 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -82.68 -48.23 11.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.87 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.9 p -163.7 164.16 23.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -109.39 174.53 5.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.1 mtt-85 -149.56 124.04 9.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.2 t -107.99 136.39 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.135 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -137.2 152.66 50.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.875 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.553 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 44.0 p90 -127.84 144.1 51.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.513 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 22.1 ttpt -114.37 128.98 56.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.907 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -76.67 136.02 39.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.415 ' CD1' ' HB3' ' A' ' 110' ' ' PRO . 51.4 mt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.907 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.513 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 97.3 m95 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.783 0.325 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.553 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 4.6 mm -134.89 141.83 41.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.198 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.9 tp -78.41 126.09 30.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.467 ' CB ' HG23 ' A' ' 80' ' ' ILE . . . -101.69 -58.58 1.86 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.8 t -136.48 165.29 26.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.165 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 99.9 p -160.51 175.77 12.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.789 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 68.95 26.94 5.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.149 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.476 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 58.8 mt -79.76 137.43 54.45 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.635 0.731 . . . . 0.0 111.163 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.476 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 54.0 Cg_endo -69.66 159.06 54.9 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.728 2.285 . . . . 0.0 112.306 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.75 -25.4 28.68 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.688 2.259 . . . . 0.0 112.361 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 81.1 p -77.57 -25.72 50.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.854 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.449 ' CD ' HG11 ' A' ' 78' ' ' VAL . 11.1 ttt180 -86.4 106.59 17.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.838 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.6 mt -101.74 9.89 40.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.957 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.3 t -155.82 137.16 13.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.449 HG11 ' CD ' ' A' ' 75' ' ' ARG . 2.2 m -149.92 168.67 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.148 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -103.26 115.43 30.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.467 HG23 ' CB ' ' A' ' 67' ' ' ALA . 37.0 mm -81.83 102.69 8.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.7 p -97.46 164.04 12.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.117 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.37 33.59 19.43 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.503 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.8 mt -87.45 -176.26 5.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.803 0.335 . . . . 0.0 110.915 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -126.64 122.4 34.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.4 155.92 37.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.43 15.41 45.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.484 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.478 HG22 ' CD2' ' A' ' 89' ' ' TYR . 27.3 mm -126.87 103.68 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.861 0.362 . . . . 0.0 111.114 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.54 137.87 52.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.856 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.478 ' CD2' HG22 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -158.77 167.83 28.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.92 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -110.73 -176.49 2.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.909 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -146.26 142.9 28.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.417 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 5.5 ptt180 -139.26 177.89 7.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.485 HG13 ' CD1' ' A' ' 38' ' ' TRP . 87.2 t -140.73 143.02 29.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.097 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -131.0 140.59 50.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.2 127.54 50.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.087 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.07 120.68 35.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.908 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.431 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 36.5 p-10 -123.61 -172.41 2.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.4 ptm -69.58 1.69 3.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.0 mt -109.67 -26.35 9.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.99 -165.93 29.33 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.526 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.61 158.05 16.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.814 0.34 . . . . 0.0 110.903 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 19.9 p -97.44 175.17 6.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -69.13 157.16 90.0 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.622 0.725 . . . . 0.0 110.918 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.417 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.4 Cg_endo -69.81 104.56 1.35 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.674 2.249 . . . . 0.0 112.318 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.5 p -41.7 150.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.843 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -43.07 140.48 1.97 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.601 0.715 . . . . 0.0 111.097 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 88.81 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.68 2.253 . . . . 0.0 112.285 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 99.2 p -41.06 153.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.861 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -48.96 151.81 2.08 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.628 0.728 . . . . 0.0 110.829 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.415 ' HB3' ' CD1' ' A' ' 58' ' ' LEU . 53.2 Cg_endo -69.81 144.65 54.45 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.664 2.243 . . . . 0.0 112.315 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.471 ' CD2' HG21 ' A' ' 26' ' ' ILE . 43.0 t80 -132.7 115.75 15.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.849 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.6 t -88.95 103.18 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.083 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.5 t -73.66 111.66 9.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.13 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 -179.814 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.57 HD11 ' CE2' ' A' ' 46' ' ' PHE . 9.0 mt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.805 0.336 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 m -144.99 161.62 41.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.69 0.757 . . . . 0.0 110.863 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 170.35 16.75 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.727 2.284 . . . . 0.0 112.358 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.453 ' HA ' ' N ' ' A' ' 44' ' ' GLY . 53.6 Cg_endo -69.76 155.39 66.07 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.693 2.262 . . . . 0.0 112.403 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' HB2' ' A' ' 102' ' ' SER . 9.6 pt-20 -99.26 167.89 10.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.03 121.32 68.2 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.556 0.693 . . . . 0.0 111.096 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 161.59 45.35 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.685 2.257 . . . . 0.0 112.359 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -46.88 174.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 ttm180 -80.1 124.08 83.07 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.611 0.719 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 140.74 43.43 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.702 2.268 . . . . 0.0 112.387 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.4 t -94.0 155.77 16.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.159 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.566 HG22 ' CD1' ' A' ' 111' ' ' TYR . 18.9 mm -117.28 128.4 74.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.077 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 m -132.72 176.12 8.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.797 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.5 m -93.47 110.6 22.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.191 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.494 ' HB2' ' CE2' ' A' ' 35' ' ' TYR . . . -111.9 -38.2 4.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.05 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.0 m -161.43 -178.75 6.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.838 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.8 -14.68 47.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.899 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.5 p -121.4 -0.02 9.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.161 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.474 ' CB ' HG21 ' A' ' 81' ' ' THR . 6.4 p -145.8 173.13 12.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.0 m -148.98 146.28 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.196 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.494 ' CE2' ' HB2' ' A' ' 29' ' ' ALA . 12.0 m-85 -77.21 123.14 26.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.6 t -119.45 124.38 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.203 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.2 m -126.98 123.24 36.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.152 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.572 ' CD1' HG13 ' A' ' 93' ' ' VAL . 24.4 p90 -120.76 171.27 8.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.953 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.7 mm -135.08 106.01 10.38 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.592 0.711 . . . . 0.0 111.224 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 142.86 49.26 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.719 2.279 . . . . 0.0 112.357 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -111.54 -70.74 0.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.38 143.58 15.69 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -115.74 17.07 16.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.823 0.344 . . . . 0.0 110.904 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.453 ' N ' ' HA ' ' A' ' 18' ' ' PRO . . . 75.97 -6.35 34.94 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.424 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.59 -19.65 11.36 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.504 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.57 ' CE2' HD11 ' A' ' 15' ' ' LEU . 1.6 m-85 -111.92 162.83 19.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.735 0.778 . . . . 0.0 110.91 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 115.98 4.35 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.69 2.26 . . . . 0.0 112.355 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.446 HD13 ' CE1' ' A' ' 51' ' ' PHE . 97.3 mt -48.0 124.41 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.136 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -79.04 -46.55 17.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.5 m -162.83 161.75 26.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.446 ' CE1' HD13 ' A' ' 48' ' ' ILE . 50.4 m-85 -108.59 175.25 5.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.94 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -147.81 120.19 8.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.908 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.91 131.79 51.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.099 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -131.59 160.91 33.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.936 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.539 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 18.4 p90 -139.07 175.89 9.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.919 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.422 ' HD3' ' NE1' ' A' ' 64' ' ' TRP . 16.4 ttpp -146.62 134.08 20.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -81.78 118.36 22.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.93 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.3 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.96 179.887 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.442 ' C ' ' CD1' ' A' ' 65' ' ' ILE . 61.0 m95 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.759 0.314 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.539 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 2.1 mm -131.47 151.18 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.075 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 52.4 tp -84.9 134.6 34.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.881 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -103.18 -68.35 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.057 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.2 t -125.55 157.83 36.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.099 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 92.4 p -153.4 169.44 23.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 75.05 25.07 1.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.051 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.472 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 64.3 mt -77.08 138.13 65.14 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.599 0.714 . . . . 0.0 111.132 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.472 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 54.1 Cg_endo -69.77 157.98 58.53 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.679 2.253 . . . . 0.0 112.32 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -24.0 29.91 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.72 2.28 . . . . 0.0 112.296 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 t -78.54 -28.8 46.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.463 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.5 ttt180 -83.73 101.91 11.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.849 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.9 mt -99.37 11.71 38.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.8 t -153.89 130.33 10.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.834 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -146.43 160.31 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.09 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -99.25 111.9 24.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.8 mm -77.82 102.67 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.474 HG21 ' CB ' ' A' ' 33' ' ' SER . 41.2 p -97.2 162.56 13.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.118 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.34 40.63 5.38 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.47 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.2 mt -105.77 177.9 4.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.821 0.344 . . . . 0.0 110.921 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -123.62 128.62 49.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.859 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -67.15 155.88 37.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.76 14.95 63.73 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.512 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.427 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 25.6 mm -127.96 112.67 28.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.811 0.339 . . . . 0.0 111.145 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.05 141.69 40.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.813 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.427 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -162.25 159.79 26.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.016 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -107.38 179.37 4.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -140.76 160.88 39.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -152.32 -178.6 6.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.572 HG13 ' CD1' ' A' ' 38' ' ' TRP . 83.9 t -144.5 146.69 20.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -138.79 134.45 33.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.837 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.71 129.5 44.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.082 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.9 mp -122.01 120.19 33.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.434 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 39.4 p-10 -123.74 -172.82 2.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.424 ' HE3' ' CE2' ' A' ' 46' ' ' PHE . 18.4 ptm -69.7 1.13 4.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.852 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.6 mt -109.48 -24.73 10.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.901 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 146.36 -169.98 27.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.467 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.2 pm0 -95.96 158.43 15.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 110.868 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.417 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 4.3 p -94.63 175.45 6.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.881 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.53 157.9 88.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.668 0.747 . . . . 0.0 110.886 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 104.88 1.38 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.706 2.271 . . . . 0.0 112.358 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.9 p -47.14 148.2 1.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -45.96 136.99 6.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.648 0.737 . . . . 0.0 111.057 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.87 99.52 0.77 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.629 2.22 . . . . 0.0 112.375 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.4 p -47.8 170.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -60.61 149.56 78.23 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.609 0.719 . . . . 0.0 110.854 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 122.69 9.37 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.741 2.294 . . . . 0.0 112.325 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.566 ' CD1' HG22 ' A' ' 26' ' ' ILE . 48.7 t80 -108.81 122.93 48.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 37.3 t -97.45 105.99 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.6 t -76.35 107.51 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.083 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.897 -179.892 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.547 HD12 ' CE2' ' A' ' 46' ' ' PHE . 7.8 mt . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.827 0.346 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 m -138.51 160.9 61.69 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.686 0.755 . . . . 0.0 110.766 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 169.9 17.74 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.718 2.279 . . . . 0.0 112.337 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 102' ' ' SER . 53.1 Cg_endo -69.77 154.88 67.17 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.713 2.276 . . . . 0.0 112.284 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.422 ' C ' ' HB2' ' A' ' 102' ' ' SER . 10.3 pt-20 -96.97 169.94 9.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.82 121.89 78.01 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.553 0.692 . . . . 0.0 111.079 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 162.23 42.84 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.712 2.275 . . . . 0.0 112.362 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -48.03 174.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.894 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -80.22 124.11 82.84 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.625 0.726 . . . . 0.0 110.857 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.81 143.19 49.83 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.695 2.263 . . . . 0.0 112.34 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.8 t -92.64 165.81 12.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.57 HG22 ' CD2' ' A' ' 111' ' ' TYR . 5.6 mm -128.84 119.52 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 t -123.55 173.95 7.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.0 m -89.41 103.18 15.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.167 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.573 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . . . -106.57 -40.37 5.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.098 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.9 m -160.57 168.07 25.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -72.49 -17.47 61.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.834 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.4 p -119.55 -4.56 10.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.112 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 p -141.75 171.16 14.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.854 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.465 HG11 ' CE1' ' A' ' 111' ' ' TYR . 27.7 m -149.12 149.2 15.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.07 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.573 ' CD2' ' CB ' ' A' ' 29' ' ' ALA . 21.3 m-85 -82.84 117.47 22.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.998 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.1 t -112.08 130.57 65.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.153 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.4 m -129.25 125.06 36.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.14 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.562 ' CD1' HG13 ' A' ' 93' ' ' VAL . 25.0 p90 -122.39 169.92 10.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.8 mm -133.46 107.88 12.14 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.645 0.735 . . . . 0.0 111.131 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.77 143.13 49.81 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.666 2.244 . . . . 0.0 112.27 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 mmm-85 -110.88 -70.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.19 153.34 18.1 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.423 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -121.0 5.82 10.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.813 0.339 . . . . 0.0 110.851 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.05 1.36 89.91 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.448 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.97 -23.75 20.63 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.5 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.547 ' CE2' HD12 ' A' ' 15' ' ' LEU . 1.9 m-85 -109.68 162.33 20.7 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.69 0.757 . . . . 0.0 110.865 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 118.42 5.67 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.748 2.299 . . . . 0.0 112.361 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.447 HD13 ' CE1' ' A' ' 51' ' ' PHE . 87.6 mt -48.33 138.3 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -92.85 -51.27 5.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.957 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.1 p -158.39 165.03 35.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.874 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.447 ' CE1' HD13 ' A' ' 48' ' ' ILE . 48.3 m-85 -114.36 170.05 8.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.928 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.556 ' NE ' ' CD1' ' A' ' 96' ' ' LEU . 50.2 mtm180 -145.57 138.35 25.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -117.25 133.98 62.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.125 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -127.14 160.92 29.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.517 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 17.9 p90 -144.55 144.89 31.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.479 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 17.3 ttpp -127.82 133.71 49.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.904 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.57 140.56 48.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.903 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.469 ' CD1' ' HB3' ' A' ' 110' ' ' PRO . 65.0 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.564 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 83.2 m95 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.717 0.294 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.517 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.4 mm -128.4 154.59 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.138 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.8 tp -87.35 115.6 24.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.84 -58.48 2.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.104 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 t -139.74 179.7 6.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.123 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 t -174.73 172.22 3.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.856 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 71.59 34.08 1.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.115 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.466 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 76.9 mt -88.64 137.93 30.06 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.605 0.717 . . . . 0.0 111.201 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.466 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 54.1 Cg_endo -69.7 158.35 57.35 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.639 2.226 . . . . 0.0 112.348 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -20.47 34.63 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.698 2.265 . . . . 0.0 112.336 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 79.6 p -84.74 -13.7 50.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.943 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.44 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 12.8 ttt85 -101.28 104.59 15.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.872 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.2 mt -103.31 13.92 32.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.852 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.416 ' C ' HG11 ' A' ' 78' ' ' VAL . 1.7 t -152.22 129.74 11.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.82 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.456 HG12 ' CD1' ' A' ' 71' ' ' ILE . 2.1 m -146.16 159.54 11.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.09 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -98.62 114.67 27.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.7 mm -82.05 103.28 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.175 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 49.5 p -101.9 164.0 11.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.86 38.99 5.93 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.538 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.3 mt -106.75 175.92 5.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.778 0.323 . . . . 0.0 110.917 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -120.09 133.42 55.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -68.05 160.19 29.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.0 13.86 58.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.445 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.418 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 17.7 mm -124.17 110.96 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.796 0.332 . . . . 0.0 111.094 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.89 134.16 35.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.866 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.418 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -156.29 163.43 39.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -108.0 178.33 4.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.98 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.454 ' CD1' HD13 ' A' ' 26' ' ' ILE . 51.3 m-85 -135.61 152.8 51.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.912 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.564 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 6.3 ptp180 -147.49 171.55 15.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.562 HG13 ' CD1' ' A' ' 38' ' ' TRP . 84.6 t -137.4 140.36 42.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.435 ' N ' HG11 ' A' ' 93' ' ' VAL . 30.1 mtt180 -128.5 134.96 48.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.54 132.71 38.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.152 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.556 ' CD1' ' NE ' ' A' ' 52' ' ' ARG . 4.0 mp -127.26 120.72 29.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.429 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 39.9 p-10 -123.45 -172.26 2.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.931 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.4 ptm -70.28 2.31 3.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.862 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.9 mt -109.75 -26.36 9.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.947 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.03 -164.67 29.66 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.541 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -104.9 158.45 16.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.839 0.352 . . . . 0.0 110.877 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 53.2 p -96.86 175.08 6.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -70.79 157.69 89.67 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.631 0.729 . . . . 0.0 110.881 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 92' ' ' ARG . 54.0 Cg_endo -69.79 105.32 1.47 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.653 2.235 . . . . 0.0 112.371 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.0 p -44.54 157.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.844 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.58 140.89 18.06 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.625 0.726 . . . . 0.0 111.069 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 100.98 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.658 2.239 . . . . 0.0 112.339 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.9 p -48.0 159.04 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -51.18 152.03 4.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.607 0.718 . . . . 0.0 110.818 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.469 ' HB3' ' CD1' ' A' ' 58' ' ' LEU . 53.6 Cg_endo -69.75 126.71 13.64 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.665 2.243 . . . . 0.0 112.347 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.57 ' CD2' HG22 ' A' ' 26' ' ' ILE . 55.5 t80 -117.28 113.94 22.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.935 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 42.4 t -88.02 106.94 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.175 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.8 t -72.17 106.94 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.141 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.822 -179.815 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.563 HD13 ' CE2' ' A' ' 46' ' ' PHE . 13.5 mt . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.766 0.317 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.42 ' O ' ' CD1' ' A' ' 99' ' ' LEU . 1.6 m -144.4 161.91 42.08 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.684 0.754 . . . . 0.0 110.899 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 169.92 17.8 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.696 2.264 . . . . 0.0 112.314 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.434 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 53.5 Cg_endo -69.82 154.44 67.51 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.691 2.261 . . . . 0.0 112.342 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.423 ' C ' ' HB2' ' A' ' 102' ' ' SER . 4.7 pt-20 -98.89 173.71 6.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.15 121.16 75.02 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.666 0.746 . . . . 0.0 111.101 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 162.83 40.62 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.674 2.25 . . . . 0.0 112.347 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -48.41 172.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -79.9 123.06 83.9 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.581 0.705 . . . . 0.0 110.889 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 144.15 53.56 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.754 2.303 . . . . 0.0 112.399 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.1 t -95.72 167.26 11.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.508 HG23 ' CG ' ' A' ' 111' ' ' TYR . 8.2 mm -129.79 118.64 45.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.144 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -120.82 178.96 4.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.825 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.5 m -94.35 98.53 10.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.141 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.663 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . . . -100.72 -40.71 7.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.5 m -159.64 -179.8 8.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -81.8 -21.33 37.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.845 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.2 p -118.27 3.6 11.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.107 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.3 p -144.92 174.66 10.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.7 m -153.2 142.16 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.203 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.663 ' CD2' ' CB ' ' A' ' 29' ' ' ALA . 22.6 m-85 -77.77 120.17 22.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.878 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.9 t -114.88 130.61 69.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.105 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.4 m -128.81 120.29 26.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.501 ' CG ' HG22 ' A' ' 93' ' ' VAL . 24.9 p90 -121.31 170.79 9.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 mm -134.98 110.86 10.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.549 0.69 . . . . 0.0 111.107 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 131.2 20.64 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.667 2.245 . . . . 0.0 112.351 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -95.58 -70.15 0.72 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.15 149.72 16.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.49 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -118.69 8.95 12.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.884 0.373 . . . . 0.0 110.871 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.27 3.05 75.54 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.28 -22.7 28.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.494 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.563 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.4 m-85 -109.91 161.9 22.46 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.738 0.78 . . . . 0.0 110.849 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 114.94 3.86 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.613 2.209 . . . . 0.0 112.377 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.412 HD12 ' CE1' ' A' ' 51' ' ' PHE . 97.7 mt -45.22 128.17 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.142 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -82.33 -47.4 12.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.1 m -163.27 160.76 24.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.844 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.412 ' CE1' HD12 ' A' ' 48' ' ' ILE . 60.7 m-85 -108.09 178.18 4.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.954 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.3 mtt-85 -149.65 121.71 8.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.401 ' CG1' HD12 ' A' ' 80' ' ' ILE . 23.5 t -105.38 125.57 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -131.83 146.26 52.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.516 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 38.5 p90 -120.14 175.91 5.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.966 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.508 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 13.3 tttt -148.71 135.24 19.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.3 mttp -82.66 125.73 31.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.43 ' CD1' ' HB3' ' A' ' 110' ' ' PRO . 73.5 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.934 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.508 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 77.7 m95 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.722 0.296 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.516 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 3.1 mm -120.67 169.73 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.192 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.0 tp -104.5 121.16 42.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.931 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.454 ' HB1' ' CG2' ' A' ' 80' ' ' ILE . . . -86.76 -67.69 0.8 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.09 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.6 t -129.8 -176.61 3.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.216 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 98.2 p -174.29 -178.03 1.36 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.874 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 58.91 27.14 15.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.46 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 58.2 mt -77.17 137.76 64.84 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.591 0.71 . . . . 0.0 111.11 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.46 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 53.2 Cg_endo -69.8 157.26 60.92 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.727 2.284 . . . . 0.0 112.371 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 -24.16 30.39 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.738 2.292 . . . . 0.0 112.335 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 86.6 p -79.75 -18.19 51.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.453 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.0 ttt180 -96.66 102.68 14.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.9 mt -100.19 14.29 31.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.926 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.0 t -156.02 132.61 10.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.833 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.1 m -146.98 162.61 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.119 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -98.51 110.72 23.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.454 ' CG2' ' HB1' ' A' ' 67' ' ' ALA . 40.1 mm -76.69 106.38 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.163 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.9 p -99.6 167.57 10.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.14 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.92 44.19 8.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.573 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.9 mt -98.88 -175.62 3.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.83 0.348 . . . . 0.0 110.93 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -132.85 119.72 20.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.69 156.69 22.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.892 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.47 13.54 44.97 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.45 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.526 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 33.3 mm -126.38 101.63 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.832 0.349 . . . . 0.0 111.175 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.21 141.81 57.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -164.06 162.43 23.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -109.11 -174.76 2.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.863 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.417 ' CD1' HD11 ' A' ' 26' ' ' ILE . 76.9 m-85 -144.57 150.85 38.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.421 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 2.3 ptp180 -141.75 175.07 9.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.501 HG22 ' CG ' ' A' ' 38' ' ' TRP . 57.8 t -142.03 135.7 29.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.1 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.0 mtt180 -124.98 142.5 51.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.813 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.41 130.77 50.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.1 mp -124.26 119.12 28.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.434 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.3 p-10 -123.71 -173.6 2.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.915 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.7 ptm -68.49 -0.66 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.838 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.42 ' CD1' ' O ' ' A' ' 16' ' ' SER . 51.7 mt -106.29 -26.02 11.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.956 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.19 -164.37 28.95 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.481 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.49 157.24 17.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.873 0.368 . . . . 0.0 110.906 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.423 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 7.3 p -96.38 174.92 6.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.936 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -71.11 159.48 85.44 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.663 0.744 . . . . 0.0 110.892 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.421 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.5 Cg_endo -69.65 106.89 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.698 2.265 . . . . 0.0 112.386 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.0 p -45.82 154.46 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.845 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -48.71 139.41 11.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.552 0.691 . . . . 0.0 111.087 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 94.74 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.664 2.243 . . . . 0.0 112.35 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.9 p -42.14 158.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -51.47 152.34 4.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.614 0.721 . . . . 0.0 110.864 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.43 ' HB3' ' CD1' ' A' ' 58' ' ' LEU . 54.8 Cg_endo -69.68 129.35 17.52 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.68 2.254 . . . . 0.0 112.393 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.508 ' CG ' HG23 ' A' ' 26' ' ' ILE . 60.1 t80 -119.41 118.08 30.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.4 t -93.3 102.5 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.118 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.6 t -68.67 106.8 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.06 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.854 -179.894 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.567 HD11 ' CE2' ' A' ' 46' ' ' PHE . 3.0 mt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.788 0.328 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.4 ' O ' ' O ' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -144.42 161.61 43.47 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.675 0.75 . . . . 0.0 110.815 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 169.98 17.64 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.668 2.245 . . . . 0.0 112.332 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.425 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 53.4 Cg_endo -69.76 156.47 63.27 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.732 2.288 . . . . 0.0 112.372 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.416 ' C ' ' HB2' ' A' ' 102' ' ' SER . 4.5 pt-20 -101.6 165.66 11.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.927 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.83 122.76 64.36 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.546 0.689 . . . . 0.0 111.133 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 164.0 36.19 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.72 2.28 . . . . 0.0 112.338 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -51.63 176.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -80.29 122.38 82.71 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.577 0.703 . . . . 0.0 110.895 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.84 142.52 47.79 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.731 2.287 . . . . 0.0 112.357 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.416 ' C ' HD11 ' A' ' 26' ' ' ILE . 6.3 t -93.13 163.14 13.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.116 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.488 HG22 ' CD1' ' A' ' 111' ' ' TYR . 8.4 mm -123.63 129.55 74.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.116 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 t -136.05 165.49 25.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.807 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.5 m -80.91 109.16 15.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.167 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.526 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . . . -111.86 -35.83 5.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.148 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.9 m -165.19 -177.8 4.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.902 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.92 -14.68 44.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.89 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 36.6 p -122.96 -1.38 8.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.165 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.47 ' CB ' ' HA ' ' A' ' 81' ' ' THR . 4.7 p -143.18 175.28 10.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.0 m -153.35 144.3 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.526 ' CD2' ' CB ' ' A' ' 29' ' ' ALA . 19.0 m-85 -78.39 124.75 28.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.3 t -119.93 131.47 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.3 m -129.0 118.66 22.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.101 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.566 ' CD1' HG11 ' A' ' 93' ' ' VAL . 30.2 p90 -115.67 169.92 8.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.4 mm -132.23 107.35 13.53 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.589 0.709 . . . . 0.0 111.131 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.441 ' CD ' HD21 ' A' ' 76' ' ' LEU . 53.5 Cg_endo -69.66 134.08 27.32 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.715 2.277 . . . . 0.0 112.355 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -103.89 -70.26 0.77 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.856 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.96 144.09 15.73 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.423 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -116.15 13.21 15.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 0.0 110.827 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 75.31 -0.72 59.0 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.435 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.417 ' HA3' ' CD2' ' A' ' 15' ' ' LEU . . . 111.6 -22.48 19.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.567 ' CE2' HD11 ' A' ' 15' ' ' LEU . 2.0 m-85 -109.34 161.74 22.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.651 0.739 . . . . 0.0 110.892 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.66 113.67 3.43 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.68 2.253 . . . . 0.0 112.332 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.514 HD11 ' CE1' ' A' ' 51' ' ' PHE . 91.0 mt -42.69 127.79 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.153 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -82.55 -46.24 13.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.3 p -164.02 160.07 21.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.514 ' CE1' HD11 ' A' ' 48' ' ' ILE . 61.5 m-85 -107.93 173.33 6.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -148.27 124.17 10.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.2 140.01 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.099 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.43 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 42.0 mt-10 -136.45 151.1 49.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.44 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 35.6 p90 -125.79 165.04 19.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.953 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 89' ' ' TYR . 6.7 ttpm? -143.71 133.06 23.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -81.3 138.05 35.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.2 mt . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 179.895 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.6 m95 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.739 0.304 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.44 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 1.8 mm -117.3 171.69 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.6 tp -104.31 130.6 52.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -103.31 -69.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.2 t -116.88 171.42 7.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.133 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.4 p -167.7 167.76 13.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.797 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 71.29 27.77 3.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.045 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.473 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 63.9 mt -78.04 137.55 61.25 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.653 0.739 . . . . 0.0 111.104 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.473 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 54.7 Cg_endo -69.66 157.24 61.25 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.743 2.295 . . . . 0.0 112.362 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -20.07 35.05 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.674 2.249 . . . . 0.0 112.34 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 92.4 p -83.38 -23.68 32.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.464 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 10.0 ttt180 -90.34 99.24 12.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.441 HD21 ' CD ' ' A' ' 40' ' ' PRO . 54.3 mt -95.96 15.33 20.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.906 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 t -155.54 136.48 13.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.9 m -150.08 163.06 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.151 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -98.91 112.47 24.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 47.6 mm -79.77 101.73 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.192 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.47 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 27.7 p -98.1 168.28 10.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.182 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.72 40.28 8.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.48 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 46.2 mt -104.27 -175.29 2.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -127.97 130.85 49.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.43 155.92 40.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.64 11.5 57.27 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.462 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.2 mm -125.01 116.52 47.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.866 0.365 . . . . 0.0 111.132 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.15 135.76 35.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.446 ' CB ' ' O ' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -154.77 162.74 41.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.942 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -107.25 178.21 4.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.947 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.455 ' CD1' HD12 ' A' ' 26' ' ' ILE . 77.4 m-85 -137.16 160.42 39.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.907 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.43 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 2.1 ptp180 -150.97 177.75 9.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.566 HG11 ' CD1' ' A' ' 38' ' ' TRP . 91.6 t -147.44 137.97 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.124 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -129.56 141.65 50.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.45 132.17 47.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.022 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mp -125.24 119.59 28.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.944 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.425 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.8 p-10 -123.59 -173.71 2.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.93 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.52 ' HE1' ' CE2' ' A' ' 46' ' ' PHE . 15.4 ptm -68.26 -1.07 5.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.893 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.2 mt -106.25 -25.48 11.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.958 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.28 -165.55 28.62 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.458 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -100.5 158.11 16.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 110.869 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.416 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 4.0 p -94.47 175.22 6.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.842 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -70.34 159.72 83.7 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.649 0.738 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.413 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.5 Cg_endo -69.78 109.12 2.24 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.74 2.293 . . . . 0.0 112.31 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.7 p -51.01 153.47 1.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.88 140.34 30.17 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.572 0.701 . . . . 0.0 111.128 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 97.42 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.713 2.275 . . . . 0.0 112.354 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 88.2 p -45.75 167.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.16 152.68 50.7 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.666 0.746 . . . . 0.0 110.91 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 135.04 29.51 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.703 2.269 . . . . 0.0 112.32 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.488 ' CD1' HG22 ' A' ' 26' ' ' ILE . 54.0 t80 -124.22 124.34 42.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.921 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.09 101.78 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.152 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.3 t -70.09 105.73 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.055 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 -179.918 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.556 HD11 ' CE2' ' A' ' 46' ' ' PHE . 3.2 mt . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.764 0.316 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.428 ' O ' ' CD1' ' A' ' 99' ' ' LEU . 1.7 m -146.43 161.54 38.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.68 0.752 . . . . 0.0 110.865 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 169.59 18.57 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.723 2.282 . . . . 0.0 112.337 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.43 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 53.0 Cg_endo -69.79 150.78 68.47 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.661 2.24 . . . . 0.0 112.32 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' HB2' ' A' ' 102' ' ' SER . 9.1 pt-20 -92.69 174.71 7.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.8 122.4 83.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.573 0.702 . . . . 0.0 111.079 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 161.82 44.46 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.697 2.264 . . . . 0.0 112.317 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -51.77 175.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -80.28 122.82 83.21 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.603 0.716 . . . . 0.0 110.869 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 142.87 49.13 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.701 2.267 . . . . 0.0 112.419 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 t -93.32 159.1 15.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.564 HG22 ' CD2' ' A' ' 111' ' ' TYR . 3.9 mm -122.13 119.18 57.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.142 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -119.31 -174.96 2.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.918 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 47.0 m -103.15 100.76 10.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.136 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.51 ' HB1' ' CZ ' ' A' ' 35' ' ' TYR . . . -103.48 -38.3 7.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.086 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.1 m -161.11 -179.64 7.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -81.47 -21.53 38.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.9 p -116.67 -2.26 11.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.152 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.432 ' CB ' ' HA ' ' A' ' 81' ' ' THR . 3.9 p -142.58 164.01 31.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.817 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.3 m -143.39 145.19 22.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.179 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.51 ' CZ ' ' HB1' ' A' ' 29' ' ' ALA . 18.1 m-85 -75.49 113.9 13.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.94 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.7 t -107.07 124.62 62.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.13 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.9 m -124.71 121.31 34.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.122 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.535 ' CD1' HG13 ' A' ' 93' ' ' VAL . 25.0 p90 -118.18 169.63 9.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.915 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.2 mm -134.35 106.18 11.11 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.632 0.729 . . . . 0.0 111.152 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 142.29 47.55 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.676 2.251 . . . . 0.0 112.321 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -111.69 -69.52 0.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.887 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.0 142.16 15.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.534 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 47.2 p-10 -112.54 9.55 19.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.904 0.383 . . . . 0.0 110.893 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 79.01 0.67 83.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.454 ' HA3' ' CD2' ' A' ' 15' ' ' LEU . . . 111.6 -24.5 15.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.556 ' CE2' HD11 ' A' ' 15' ' ' LEU . 2.5 m-85 -108.16 162.11 21.04 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.629 0.728 . . . . 0.0 110.908 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 113.82 3.5 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.669 2.246 . . . . 0.0 112.385 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.489 HD11 ' CE1' ' A' ' 51' ' ' PHE . 97.6 mt -43.58 127.35 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -81.77 -48.32 11.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.936 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.6 m -162.13 162.03 28.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.921 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.489 ' CE1' HD11 ' A' ' 48' ' ' ILE . 51.5 m-85 -109.03 176.31 5.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -149.93 123.42 9.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.411 ' CG1' HD11 ' A' ' 80' ' ' ILE . 21.7 t -105.36 133.19 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.136 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -132.13 162.97 29.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.938 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.565 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 16.1 p90 -148.34 146.18 28.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.501 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 14.8 ttpp -121.93 131.73 54.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.879 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -76.37 128.73 35.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.868 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.2 mt . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.889 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.501 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 35.9 m95 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.707 0.289 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.565 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 2.3 mm -133.12 164.02 36.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.17 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.8 tp -102.66 123.36 46.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.78 -66.9 0.89 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.071 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.8 t -128.04 177.81 6.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.113 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.2 p -171.31 167.65 6.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.867 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 71.49 36.13 1.35 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.474 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 72.8 mt -87.48 138.29 31.98 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.624 0.726 . . . . 0.0 111.144 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.474 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 53.9 Cg_endo -69.8 156.69 62.59 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.676 2.251 . . . . 0.0 112.341 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.87 -20.69 33.97 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.696 2.264 . . . . 0.0 112.338 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.1 t -84.32 -10.67 57.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.432 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 12.2 ttt180 -103.38 102.97 12.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.1 mt -100.69 10.47 41.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 t -151.92 129.2 11.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.7 165.04 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.086 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -98.52 113.73 25.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.865 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.411 HD11 ' CG1' ' A' ' 53' ' ' VAL . 40.0 mm -83.63 98.57 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.091 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.432 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 73.7 p -95.78 165.3 12.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.193 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.69 35.33 9.34 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.497 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.9 mt -94.45 176.49 6.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.866 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -121.7 120.26 34.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -62.82 156.73 23.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.948 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.28 13.9 45.26 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.555 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.478 HG21 ' CD2' ' A' ' 89' ' ' TYR . 27.1 mm -124.95 104.93 14.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 0.0 111.117 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.55 134.16 47.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.478 ' CD2' HG21 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -157.01 163.12 39.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.934 -179.813 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -111.01 176.63 4.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.894 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.561 ' CD1' HD12 ' A' ' 26' ' ' ILE . 8.0 m-85 -131.96 158.1 42.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -149.63 171.87 15.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.535 HG13 ' CD1' ' A' ' 38' ' ' TRP . 94.5 t -139.68 142.77 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.448 ' N ' HG11 ' A' ' 93' ' ' VAL . 34.0 mtt180 -132.41 141.59 48.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.98 125.18 48.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.075 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mp -119.76 118.02 29.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.43 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.3 p-10 -123.6 -174.28 2.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.511 ' HE3' ' CE1' ' A' ' 46' ' ' PHE . 5.0 ptp -67.61 -2.12 6.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.428 ' CD1' ' O ' ' A' ' 16' ' ' SER . 29.4 mt -105.29 -25.63 12.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.944 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.53 -167.16 28.63 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.519 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -101.4 157.54 16.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.819 0.343 . . . . 0.0 110.896 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.417 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 8.7 p -94.22 174.27 7.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.805 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -70.23 160.39 81.08 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.59 0.71 . . . . 0.0 110.929 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 105.48 1.49 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.742 2.294 . . . . 0.0 112.306 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.4 p -45.2 156.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.803 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.51 139.93 27.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.564 0.697 . . . . 0.0 111.117 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.69 89.26 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.719 2.279 . . . . 0.0 112.382 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 t -40.7 152.28 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.2 mtt-85 -44.75 153.57 0.47 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.6 0.714 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 132.95 24.33 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.651 2.234 . . . . 0.0 112.367 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.564 ' CD2' HG22 ' A' ' 26' ' ' ILE . 20.5 t80 -121.17 116.57 25.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.79 107.32 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.094 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.27 111.73 13.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.817 -179.827 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.566 HD11 ' CE2' ' A' ' 46' ' ' PHE . 7.7 mt . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.746 0.308 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.465 ' O ' ' CD1' ' A' ' 99' ' ' LEU . 1.6 m -141.26 161.77 51.28 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.704 0.764 . . . . 0.0 110.772 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 169.77 18.13 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.665 2.244 . . . . 0.0 112.284 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.441 ' O ' ' CB ' ' A' ' 102' ' ' SER . 54.2 Cg_endo -69.86 159.02 54.84 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.618 2.212 . . . . 0.0 112.316 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.55 165.15 11.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.926 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.2 120.55 52.13 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.621 0.724 . . . . 0.0 111.126 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 166.56 27.17 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.718 2.278 . . . . 0.0 112.307 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -52.53 172.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.935 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.439 ' NE ' ' HB1' ' A' ' 106' ' ' ALA . 13.7 ttm105 -79.83 123.03 84.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.598 0.713 . . . . 0.0 110.849 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.443 ' HB2' ' CG1' ' A' ' 36' ' ' VAL . 53.1 Cg_endo -69.79 141.79 46.07 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.658 2.239 . . . . 0.0 112.35 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.9 t -92.47 169.22 10.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.119 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.1 mm -129.13 131.99 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.131 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 t -139.31 167.59 21.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.4 m -80.22 108.16 13.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.48 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . . . -113.01 -35.43 5.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.075 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.0 m -164.32 178.84 7.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.812 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.78 -16.68 46.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.851 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 p -122.2 -2.12 9.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.168 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.42 ' CB ' ' HA ' ' A' ' 81' ' ' THR . 7.0 p -141.11 171.22 14.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.6 m -147.82 145.44 18.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.148 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.48 ' CD2' ' CB ' ' A' ' 29' ' ' ALA . 9.7 m-85 -78.86 119.28 21.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.443 ' CG1' ' HB2' ' A' ' 24' ' ' PRO . 92.4 t -115.95 132.17 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.183 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.7 m -129.2 124.44 34.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.169 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.559 ' CD1' HG12 ' A' ' 93' ' ' VAL . 24.7 p90 -123.13 171.54 9.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.956 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.6 mm -137.2 106.25 8.66 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.677 0.751 . . . . 0.0 111.163 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 135.91 31.47 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.626 2.217 . . . . 0.0 112.35 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.2 mmm-85 -102.17 -70.63 0.74 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.36 152.54 18.41 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.484 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 52.6 p-10 -122.54 12.63 10.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.854 0.359 . . . . 0.0 110.862 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.63 -0.84 59.93 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.511 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.18 -18.79 25.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.464 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.566 ' CE2' HD11 ' A' ' 15' ' ' LEU . 2.1 m-85 -113.08 162.32 22.47 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.584 0.707 . . . . 0.0 110.915 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 115.47 4.11 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.639 2.226 . . . . 0.0 112.365 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.532 HD13 ' CE1' ' A' ' 51' ' ' PHE . 96.7 mt -45.7 132.0 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.106 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -86.87 -47.14 9.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.9 p -164.22 159.14 19.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.861 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.532 ' CE1' HD13 ' A' ' 48' ' ' ILE . 54.7 m-85 -107.97 173.12 6.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.897 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -150.1 124.92 9.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.0 t -103.14 136.32 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.168 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -133.89 146.65 50.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.841 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.524 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 26.9 p90 -125.08 174.81 7.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.979 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.441 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 29.6 ttpt -146.47 125.12 12.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -75.03 126.23 30.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 15.4 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.857 179.94 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.567 ' CH2' ' HD3' ' A' ' 92' ' ' ARG . 89.5 m95 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.802 0.335 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.524 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.2 mm -114.6 164.08 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.125 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.8 tp -98.33 130.36 45.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -102.58 -70.27 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.091 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.427 HG23 ' CD1' ' A' ' 80' ' ' ILE . 12.0 t -124.63 164.72 19.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 t -163.43 171.26 16.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.89 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 73.13 25.28 2.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.173 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.465 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 80.4 mt -76.11 138.12 68.74 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.585 0.707 . . . . 0.0 111.156 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.465 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 53.8 Cg_endo -69.75 157.04 61.76 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.726 2.284 . . . . 0.0 112.311 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 -17.55 37.16 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.645 2.23 . . . . 0.0 112.357 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 t -87.08 -17.44 32.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.872 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.46 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 6.5 ttt85 -97.21 98.33 9.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.9 mt -92.23 9.94 31.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.7 t -154.92 137.78 15.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -147.51 167.95 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.101 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -101.26 104.19 15.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.427 ' CD1' HG23 ' A' ' 68' ' ' THR . 48.4 mm -71.48 101.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.113 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.42 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 38.8 p -101.22 161.63 13.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.141 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.72 37.34 6.13 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.452 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.4 mt -100.28 176.58 5.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.73 0.3 . . . . 0.0 110.935 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -120.32 117.92 29.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.81 150.65 27.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.96 12.56 71.47 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.512 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.466 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 39.0 mm -125.11 109.7 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.893 0.378 . . . . 0.0 111.193 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.44 140.71 46.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.466 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -164.11 167.03 20.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.883 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.491 ' O ' ' CB ' ' A' ' 55' ' ' TYR . 58.1 mttt -112.85 -177.18 3.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.862 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -146.19 152.43 39.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.567 ' HD3' ' CH2' ' A' ' 64' ' ' TRP . 6.4 mtm180 -143.62 -178.37 5.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.914 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.559 HG12 ' CD1' ' A' ' 38' ' ' TRP . 61.5 t -142.67 139.02 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.166 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.441 ' N ' HG13 ' A' ' 93' ' ' VAL . 44.4 mtt180 -126.87 145.3 50.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.769 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.5 125.25 49.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.101 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.2 mp -120.86 117.78 28.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.438 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 41.1 p-10 -123.85 -173.27 2.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.2 ptm -68.92 -0.39 5.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.926 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.465 ' CD1' ' O ' ' A' ' 16' ' ' SER . 62.8 mt -106.21 -26.28 11.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.993 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.76 -163.43 29.05 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.499 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -108.83 155.63 20.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.88 0.371 . . . . 0.0 110.838 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 59.3 p -98.99 172.5 7.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.842 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.2 mp0 -69.19 157.32 89.62 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.614 0.721 . . . . 0.0 110.933 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 116.1 4.4 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.723 2.282 . . . . 0.0 112.346 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.459 ' O ' ' C ' ' A' ' 106' ' ' ALA . 74.7 p -54.47 148.21 12.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.893 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 105' ' ' SER . . . -32.67 141.7 0.18 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.62 0.724 . . . . 0.0 111.061 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 97.69 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.634 2.223 . . . . 0.0 112.322 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.1 p -42.69 149.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -46.75 151.89 1.01 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.59 0.71 . . . . 0.0 110.871 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 119.82 6.7 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.666 2.244 . . . . 0.0 112.303 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -110.47 120.13 41.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.0 t -94.36 102.62 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.174 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.7 t -71.66 109.83 4.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.11 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.883 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.514 HD13 ' CE2' ' A' ' 46' ' ' PHE . 7.2 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.789 0.328 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.447 ' O ' ' CD1' ' A' ' 99' ' ' LEU . 1.7 m -142.89 161.38 49.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.662 0.744 . . . . 0.0 110.905 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 168.67 20.86 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.667 2.245 . . . . 0.0 112.393 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.45 ' O ' ' CB ' ' A' ' 102' ' ' SER . 53.8 Cg_endo -69.72 159.34 53.82 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.689 2.26 . . . . 0.0 112.334 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.421 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.0 pt-20 -103.64 160.03 15.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.7 122.25 44.57 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.556 0.693 . . . . 0.0 111.102 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 163.96 36.34 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.661 2.241 . . . . 0.0 112.365 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -51.5 176.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.84 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -80.05 123.95 83.21 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.654 0.74 . . . . 0.0 110.876 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.45 ' O ' ' CB ' ' A' ' 108' ' ' SER . 53.4 Cg_endo -69.73 143.0 49.59 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.718 2.279 . . . . 0.0 112.283 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 t -95.53 166.8 11.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.568 HG21 ' CD2' ' A' ' 111' ' ' TYR . 5.1 mm -124.06 118.17 53.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.137 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -117.84 168.59 10.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.6 m -87.52 102.07 14.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.503 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . . . -104.85 -36.04 7.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.05 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.8 m -173.08 173.45 3.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.885 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -78.41 -15.26 58.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.992 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.2 p -114.8 -6.97 12.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.165 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.0 p -144.99 171.53 14.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.5 m -145.87 147.32 18.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.158 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.503 ' CG ' ' HB3' ' A' ' 29' ' ' ALA . 13.6 m-85 -82.98 115.33 21.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 81.6 t -108.35 130.33 61.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.096 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.9 m -128.44 120.52 27.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.112 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.528 ' CD1' HG11 ' A' ' 93' ' ' VAL . 27.9 p90 -118.14 170.67 8.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.96 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.6 mm -133.96 106.59 11.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.634 0.731 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 136.82 33.93 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.752 2.301 . . . . 0.0 112.311 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -104.78 -69.98 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.37 145.05 16.31 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.515 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -113.55 4.74 16.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 110.895 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 82.89 1.88 90.64 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.467 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.53 -26.64 11.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.454 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.514 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.4 m-85 -106.81 161.7 22.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.642 0.734 . . . . 0.0 110.898 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 113.82 3.5 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.691 2.261 . . . . 0.0 112.371 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 89.1 mt -42.32 129.43 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.125 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -83.66 -49.02 9.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.908 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.9 p -160.09 163.2 34.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.848 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -108.96 177.89 4.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -149.83 119.85 7.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.13 130.01 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.158 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -132.65 148.31 52.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.417 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 45.2 p90 -123.53 172.91 8.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.411 ' HD3' ' NE1' ' A' ' 64' ' ' TRP . 17.4 ttpt -147.91 135.35 20.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -83.33 130.69 35.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.959 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 43.2 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.88 179.987 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.411 ' NE1' ' HD3' ' A' ' 56' ' ' LYS . 73.3 m95 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.796 0.332 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.417 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 1.8 mm -119.95 167.57 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.127 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.6 tp -102.31 118.97 38.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.964 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.42 -69.37 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.161 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.8 t -128.67 -178.94 4.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.127 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.3 p -174.42 -177.3 1.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.841 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 61.4 32.64 19.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.103 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.47 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 85.3 mt -84.68 138.47 38.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.581 0.705 . . . . 0.0 111.128 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.47 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 53.7 Cg_endo -69.74 158.25 57.62 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.705 2.27 . . . . 0.0 112.414 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -29.57 23.78 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.724 2.283 . . . . 0.0 112.397 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.2 m -74.69 -14.24 60.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.428 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.8 ttt180 -99.99 111.25 23.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.811 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.5 mt -107.25 7.18 29.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 t -150.73 131.73 14.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.0 174.82 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.142 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -111.9 115.0 28.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.826 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 23.4 mm -84.66 104.91 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.052 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.3 p -98.84 168.29 10.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.144 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.01 38.96 8.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.489 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.4 mt -103.25 168.79 8.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.743 0.306 . . . . 0.0 110.874 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -113.29 127.18 56.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.79 153.37 43.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.27 12.57 72.63 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.49 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.406 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 20.1 mm -125.24 111.74 28.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.909 0.385 . . . . 0.0 111.09 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.89 139.42 40.22 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.406 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -160.72 167.35 27.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -113.4 -176.69 2.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.872 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -143.05 152.22 41.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.932 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -141.63 179.78 6.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.528 HG11 ' CD1' ' A' ' 38' ' ' TRP . 92.7 t -147.48 140.15 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.142 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.403 ' N ' HG12 ' A' ' 93' ' ' VAL . 27.2 mtt180 -130.27 141.45 50.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.38 125.06 47.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.082 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.449 ' HG ' ' CB ' ' A' ' 101' ' ' GLU . 8.3 mp -121.71 119.67 32.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.949 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.429 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.2 p-10 -123.6 -173.98 2.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.506 ' HE1' ' CG ' ' A' ' 46' ' ' PHE . 4.9 ptp -67.09 -2.59 5.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.447 ' CD1' ' O ' ' A' ' 16' ' ' SER . 33.9 mt -105.15 -25.31 12.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.898 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 146.38 -168.47 27.82 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.451 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.449 ' CB ' ' HG ' ' A' ' 96' ' ' LEU . 3.8 pt-20 -101.84 158.03 16.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 0.0 110.923 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 52.6 p -98.94 167.27 10.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -61.4 157.84 42.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.684 0.754 . . . . 0.0 110.865 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 115.04 3.91 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.71 2.273 . . . . 0.0 112.319 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 92.6 p -54.17 158.95 2.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.831 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.19 142.89 56.85 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.566 0.698 . . . . 0.0 111.159 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 102.12 0.99 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.663 2.242 . . . . 0.0 112.377 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 24' ' ' PRO . 59.5 p -51.55 159.48 0.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -50.39 151.22 3.98 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.608 0.718 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 136.69 33.77 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.684 2.256 . . . . 0.0 112.353 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.568 ' CD2' HG21 ' A' ' 26' ' ' ILE . 49.0 t80 -124.73 117.47 24.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 55.3 t -92.6 103.73 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.154 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.7 t -69.47 113.07 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.3 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.891 -179.88 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 1' ' ' GLY . 69.0 m 38.1 42.27 0.46 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.921 0.391 . . . . 0.0 110.89 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.7 t -43.79 147.71 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.838 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.48 -131.63 5.42 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.484 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 6' ' ' SER . 90.3 p -77.07 -47.72 19.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.904 0.383 . . . . 0.0 110.869 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 5' ' ' SER . 58.0 p 37.42 43.36 0.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.889 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -113.88 126.14 7.22 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.466 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.9 m -85.44 124.52 32.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.806 0.336 . . . . 0.0 110.868 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -152.15 151.34 27.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.576 0.703 . . . . 0.0 110.932 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 98.03 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.695 2.263 . . . . 0.0 112.359 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.21 167.13 5.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -126.0 -44.86 1.75 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.13 -62.81 0.16 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.432 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.4 mmm-85 -67.42 90.62 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.902 0.382 . . . . 0.0 110.842 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 mt -81.69 -175.1 5.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.943 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.436 ' O ' ' CD1' ' A' ' 99' ' ' LEU . 1.8 m -144.39 161.51 44.03 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.665 0.745 . . . . 0.0 110.863 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 169.3 19.25 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.642 2.228 . . . . 0.0 112.363 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 53.7 Cg_endo -69.77 154.33 67.8 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.671 2.248 . . . . 0.0 112.334 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.419 ' C ' ' HB2' ' A' ' 102' ' ' SER . 4.7 pt-20 -98.46 167.69 10.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.841 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.15 122.84 77.81 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.544 0.688 . . . . 0.0 111.076 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 164.38 34.81 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.629 2.219 . . . . 0.0 112.278 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -50.45 176.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.832 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -80.59 123.13 82.89 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.599 0.714 . . . . 0.0 110.863 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 144.0 52.58 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.618 2.212 . . . . 0.0 112.383 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.0 t -94.58 167.44 11.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.128 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.8 mm -125.75 126.0 69.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.141 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.0 m -129.8 160.42 33.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.6 m -80.46 104.14 10.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.062 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.439 ' HB3' ' N ' ' A' ' 35' ' ' TYR . . . -106.59 -38.86 6.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.073 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.9 m -164.76 176.57 8.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.62 -17.26 51.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 p -116.91 -3.65 11.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.442 ' CB ' ' HA ' ' A' ' 81' ' ' THR . 5.5 p -143.07 174.81 10.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.482 HG12 ' CE2' ' A' ' 111' ' ' TYR . 31.0 m -151.85 145.34 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.155 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.439 ' N ' ' HB3' ' A' ' 29' ' ' ALA . 12.3 m-85 -79.67 120.59 24.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.96 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 93.8 t -117.0 130.78 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.149 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 59.1 m -128.96 120.52 26.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.098 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.564 ' CD1' HG13 ' A' ' 93' ' ' VAL . 28.4 p90 -117.68 171.25 8.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 mm -135.99 107.03 9.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.633 0.73 . . . . 0.0 111.136 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 143.73 52.03 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.709 2.273 . . . . 0.0 112.357 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -112.68 -69.95 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.39 146.7 16.28 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.55 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -116.24 7.34 14.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.981 0.42 . . . . 0.0 110.956 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 79.7 2.07 87.7 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.472 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.35 -26.67 12.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.52 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -106.5 161.8 21.73 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.572 0.701 . . . . 0.0 110.899 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 119.21 6.19 Favored 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.712 2.275 . . . . 0.0 112.339 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.491 HD11 ' CE1' ' A' ' 51' ' ' PHE . 93.3 mt -48.25 136.17 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.448 ' N ' HG22 ' A' ' 48' ' ' ILE . 47.2 mt-30 -93.15 -49.44 5.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.943 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.2 p -159.41 158.4 32.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.491 ' CE1' HD11 ' A' ' 48' ' ' ILE . 58.7 m-85 -108.38 173.65 6.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.896 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -144.09 128.51 17.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.4 t -113.08 122.83 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -124.81 157.74 35.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.486 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 39.0 p90 -133.07 174.91 9.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 89' ' ' TYR . 5.7 ttpm? -146.83 133.53 19.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -84.68 120.82 26.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.3 mt -82.59 -53.62 5.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.967 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.54 -34.12 75.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -109.19 138.95 44.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.911 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 p -74.02 131.32 35.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.167 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.99 129.15 1.0 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.497 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -52.15 -179.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.776 0.322 . . . . 0.0 110.841 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -66.62 145.74 55.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.486 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 2.6 mm -115.63 170.63 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.137 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.9 tp -103.75 118.9 37.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.964 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.92 -71.58 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.11 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 t -123.83 -179.4 4.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.128 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.7 p -174.5 174.17 2.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 67.05 30.08 7.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.111 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.466 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 56.0 mt -81.58 138.04 47.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.657 0.742 . . . . 0.0 111.149 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.466 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 54.0 Cg_endo -69.74 157.85 59.01 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.661 2.24 . . . . 0.0 112.334 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.69 -19.81 35.96 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.704 2.269 . . . . 0.0 112.407 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 t -85.19 -15.91 42.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.46 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 16.4 ttt180 -97.87 101.21 12.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.854 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.5 mt -98.33 7.72 45.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.959 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 t -150.33 132.1 15.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.804 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.458 HG13 ' CD ' ' A' ' 75' ' ' ARG . 2.2 m -146.69 164.39 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.091 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -98.43 111.01 23.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.3 mm -78.49 101.81 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.169 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.442 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 35.2 p -98.96 163.95 12.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.076 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.74 36.96 6.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.504 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.9 mt -104.83 168.49 9.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.76 0.314 . . . . 0.0 110.904 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -112.85 125.77 54.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.65 155.09 34.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.01 10.54 59.23 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.415 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.475 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 32.0 mm -121.98 107.87 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.839 0.352 . . . . 0.0 111.148 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.86 140.52 47.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.798 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.475 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -163.59 164.31 24.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.864 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.2 mttt -109.57 -174.83 2.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.892 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -145.4 159.5 42.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.902 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -150.47 174.31 13.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.564 HG13 ' CD1' ' A' ' 38' ' ' TRP . 89.1 t -139.2 142.41 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.122 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.401 ' N ' HG11 ' A' ' 93' ' ' VAL . 33.8 mtt180 -133.15 143.07 49.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.833 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 102' ' ' SER . . . -103.97 129.04 51.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.078 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.1 mp -122.24 118.14 27.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.422 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 41.0 p-10 -123.04 -174.01 2.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 18.8 ptm -67.15 -2.69 6.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.839 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.436 ' CD1' ' O ' ' A' ' 16' ' ' SER . 67.4 mt -104.4 -26.01 12.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.946 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.6 -165.71 28.74 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.475 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.46 157.25 16.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.872 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.419 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 6.4 p -92.86 175.21 6.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.802 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -73.42 159.49 84.66 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.696 0.76 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.69 107.49 1.86 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.708 2.272 . . . . 0.0 112.316 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.1 p -51.2 152.62 2.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -48.81 138.37 12.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.627 0.727 . . . . 0.0 111.012 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 104.86 1.39 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.634 2.223 . . . . 0.0 112.38 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.4 p -51.31 171.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -62.36 150.7 84.39 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.648 0.737 . . . . 0.0 110.899 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.65 120.82 7.56 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.698 2.265 . . . . 0.0 112.339 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.482 ' CE2' HG12 ' A' ' 34' ' ' VAL . 85.8 t80 -111.04 120.05 41.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.963 0.411 . . . . 0.0 110.912 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 52.0 t -91.42 103.35 14.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 t -70.11 106.51 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.148 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 t -100.9 -51.32 3.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -166.24 -150.05 6.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.455 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 85.2 p -87.41 43.93 1.14 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.905 0.383 . . . . 0.0 110.884 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 53.27 -152.17 8.92 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.467 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -168.24 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.694 2.262 . . . . 0.0 112.379 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.3 m -135.46 170.35 16.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.92 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.8 t -92.3 -40.67 10.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.937 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.516 179.931 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.5 p 46.37 41.66 9.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.903 0.382 . . . . 0.0 110.852 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 99.4 p -100.09 166.97 10.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.28 -137.7 9.86 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.491 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 p -147.17 106.3 3.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.916 0.389 . . . . 0.0 110.837 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 m -120.55 139.81 52.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.829 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.37 -42.08 0.11 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.4 m -41.52 128.34 3.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.829 0.347 . . . . 0.0 110.896 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -121.07 146.66 44.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.614 0.721 . . . . 0.0 110.916 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.412 ' O ' ' CG ' ' A' ' 11' ' ' ASP . 54.4 Cg_endo -69.65 96.68 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.661 2.241 . . . . 0.0 112.436 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 13' ' ' GLY . 3.7 m-20 -174.71 -177.87 1.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.881 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -40.62 96.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.828 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . 151.96 -88.15 0.13 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.438 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -67.39 91.19 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.905 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.555 HD11 ' CE2' ' A' ' 46' ' ' PHE . 6.3 mt -92.76 -175.67 4.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.408 ' O ' ' O ' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -146.81 161.52 37.14 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.578 0.704 . . . . 0.0 110.904 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 170.03 17.54 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.661 2.241 . . . . 0.0 112.361 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.429 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 53.5 Cg_endo -69.67 156.49 63.45 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.732 2.288 . . . . 0.0 112.333 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.419 ' C ' ' HB2' ' A' ' 102' ' ' SER . 9.3 pt-20 -100.59 166.45 10.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.07 121.53 56.1 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.646 0.736 . . . . 0.0 111.087 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 162.89 40.3 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.698 2.266 . . . . 0.0 112.353 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -51.57 175.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.793 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.422 ' NE ' ' HA ' ' A' ' 108' ' ' SER . 18.2 ttt180 -79.88 123.29 83.8 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.537 0.684 . . . . 0.0 110.917 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 142.94 48.95 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.682 2.254 . . . . 0.0 112.326 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 t -94.05 165.42 12.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.435 HG22 ' CG ' ' A' ' 111' ' ' TYR . 4.3 mm -124.49 119.34 56.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.084 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.3 m -122.66 162.02 22.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.2 m -83.46 98.79 9.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.461 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . . . -97.85 -42.22 7.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.068 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.2 m -161.09 -177.75 6.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -84.44 -14.58 48.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.899 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 51.4 p -121.06 -1.73 9.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.106 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.462 ' CB ' ' HA ' ' A' ' 81' ' ' THR . 10.7 p -145.54 171.89 14.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.1 m -147.88 147.28 17.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.128 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.461 ' CD2' ' CB ' ' A' ' 29' ' ' ALA . 13.4 m-85 -82.74 113.66 20.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.851 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.5 t -108.43 128.49 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.153 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.9 m -125.95 122.33 35.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.117 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.569 ' CD1' HG13 ' A' ' 93' ' ' VAL . 29.4 p90 -120.79 171.27 8.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.4 mm -136.61 106.24 9.12 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.562 0.696 . . . . 0.0 111.12 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.412 ' CD ' HD22 ' A' ' 76' ' ' LEU . 52.9 Cg_endo -69.79 130.07 18.67 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.707 2.272 . . . . 0.0 112.329 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 mmt85 -94.54 -69.33 0.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.867 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.51 146.05 16.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.445 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -113.52 7.92 17.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.922 0.391 . . . . 0.0 110.904 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 80.56 -1.73 81.28 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.494 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.85 -24.51 11.84 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.473 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.555 ' CE2' HD11 ' A' ' 15' ' ' LEU . 2.0 m-85 -108.32 162.19 20.8 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.646 0.736 . . . . 0.0 110.885 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.85 116.49 4.59 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.698 2.265 . . . . 0.0 112.278 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.427 HD13 ' CE1' ' A' ' 51' ' ' PHE . 85.9 mt -46.86 125.64 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -80.75 -51.51 8.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.2 m -156.6 162.28 39.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.858 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.427 ' CE1' HD13 ' A' ' 48' ' ' ILE . 61.3 m-85 -111.08 178.47 4.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.922 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 75.4 mtt-85 -149.61 124.94 10.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.5 t -110.24 126.47 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.11 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -124.07 155.87 37.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.501 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 39.1 p90 -132.86 158.43 42.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.88 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.442 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 28.9 ttpt -131.78 127.42 36.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.869 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -81.14 115.88 20.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 57.5 mt -78.67 -70.85 0.47 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.952 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -39.03 -67.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.888 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -79.83 138.56 37.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.4 p -62.64 131.48 28.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.086 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.91 148.25 5.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.5 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -83.54 -175.08 5.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.794 0.33 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.442 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 87.4 m95 -63.95 155.15 31.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.501 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 4.0 mm -136.41 166.93 25.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.133 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.3 tp -97.95 126.13 43.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.94 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -95.62 -69.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.097 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.5 t -130.71 165.14 23.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.142 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 75.5 p -157.9 172.91 17.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 71.92 27.4 2.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.067 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.462 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 76.3 mt -78.16 138.52 60.5 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.56 0.695 . . . . 0.0 111.184 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.462 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 53.2 Cg_endo -69.79 155.99 64.41 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.652 2.235 . . . . 0.0 112.364 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.77 -21.79 32.92 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.615 2.21 . . . . 0.0 112.352 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 54.6 p -82.73 -13.53 56.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.809 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.446 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.3 ttt180 -100.72 106.46 17.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.946 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.412 HD22 ' CD ' ' A' ' 40' ' ' PRO . 45.2 mt -101.78 7.33 41.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.938 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 t -151.84 131.86 13.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.23 167.94 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.079 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.434 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 33.4 tt0 -104.43 110.62 22.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.6 mm -80.91 104.03 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.099 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.462 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 30.3 p -98.13 165.57 11.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.107 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.98 39.07 6.61 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.49 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 65.6 mt -102.91 171.88 7.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.737 0.304 . . . . 0.0 110.945 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -114.99 127.99 56.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -69.9 151.31 45.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.72 10.51 76.55 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.453 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.2 mm -124.27 114.55 41.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.856 0.36 . . . . 0.0 111.136 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.77 137.66 37.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.82 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.34 161.9 37.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -107.46 -174.87 2.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -145.82 158.15 43.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -149.05 176.05 10.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.569 HG13 ' CD1' ' A' ' 38' ' ' TRP . 59.9 t -141.95 146.43 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.112 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -136.4 140.82 43.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.62 124.23 45.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.47 118.69 31.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.429 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 41.4 p-10 -123.09 -173.95 2.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.495 ' HE2' ' CG ' ' A' ' 46' ' ' PHE . 5.5 ptp -69.01 -0.41 5.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.84 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.9 mt -107.62 -24.04 11.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.427 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 146.64 -168.4 27.99 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.54 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.68 157.43 16.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.878 0.37 . . . . 0.0 110.891 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.419 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 4.1 p -93.56 175.2 6.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.877 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -69.88 160.36 80.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.631 0.729 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 111.7 2.86 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.638 2.225 . . . . 0.0 112.439 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.0 p -53.9 150.36 7.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.825 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.12 140.66 6.51 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.586 0.708 . . . . 0.0 111.101 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.66 94.29 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.724 2.283 . . . . 0.0 112.383 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.422 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 4.4 p -43.26 165.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -59.81 150.93 66.03 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.645 0.736 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 135.75 31.22 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.694 2.263 . . . . 0.0 112.329 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.435 ' CG ' HG22 ' A' ' 26' ' ' ILE . 70.4 t80 -124.86 126.64 45.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.969 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.3 t -98.41 104.46 15.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.111 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 t -72.06 107.19 2.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.13 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.0 t -102.88 -52.05 3.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.863 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -174.01 -122.08 0.66 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.446 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 87.6 p -96.23 50.56 1.17 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.885 0.374 . . . . 0.0 110.84 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 95.95 -175.27 32.28 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.457 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 119' ' ' SER . 53.8 Cg_endo -69.73 94.78 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.619 2.213 . . . . 0.0 112.353 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 118' ' ' PRO . 10.2 t -35.89 101.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 50.0 m -116.43 105.19 12.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.81 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.402 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.53 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.2 m -126.49 164.39 21.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 110.856 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 94.6 p -55.5 134.93 50.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.848 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.38 107.84 3.53 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.52 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.6 p -101.65 -44.76 5.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.847 0.355 . . . . 0.0 110.849 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 t -38.5 -62.14 0.63 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.88 126.45 8.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.523 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.0 m -85.0 163.74 18.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.784 0.326 . . . . 0.0 110.845 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -76.66 151.31 82.58 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.595 0.712 . . . . 0.0 110.903 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -170.82 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.647 2.231 . . . . 0.0 112.3 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -67.1 -64.75 0.79 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.802 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.507 ' CG ' ' O ' ' A' ' 12' ' ' HIS . 6.4 p-80 -46.36 120.03 2.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.87 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.39 -125.86 2.09 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.508 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -66.71 79.43 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.832 0.349 . . . . 0.0 110.842 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.511 HD12 ' CE2' ' A' ' 46' ' ' PHE . 5.9 mt -89.82 -175.41 4.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.959 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.31 161.44 50.32 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.637 0.732 . . . . 0.0 110.855 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 170.1 17.48 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.633 2.222 . . . . 0.0 112.322 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.431 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 53.5 Cg_endo -69.75 156.13 64.15 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.756 2.304 . . . . 0.0 112.308 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' HB2' ' A' ' 102' ' ' SER . 7.2 pt-20 -101.37 171.81 7.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.04 121.03 74.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.543 0.687 . . . . 0.0 111.116 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 164.88 32.85 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.67 2.247 . . . . 0.0 112.36 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -49.78 174.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.816 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.414 ' HB3' ' NH1' ' A' ' 23' ' ' ARG . 13.8 ttp-105 -79.95 124.32 83.19 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.594 0.712 . . . . 0.0 110.869 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 145.36 56.97 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.687 2.258 . . . . 0.0 112.341 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.5 t -97.42 166.86 11.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.161 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.421 HD11 ' CD1' ' A' ' 91' ' ' PHE . 8.7 mm -124.7 130.46 73.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.133 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 m -132.9 172.78 12.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.899 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 85.0 m -91.37 105.55 17.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.163 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.552 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . . . -108.61 -38.21 5.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.071 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.9 m -162.98 -176.64 5.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -84.67 -16.79 40.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.5 p -122.2 0.99 9.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.433 ' CB ' ' HA ' ' A' ' 81' ' ' THR . 22.2 p -145.08 164.65 30.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.997 0.427 . . . . 0.0 110.848 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.553 HG13 ' CE2' ' A' ' 111' ' ' TYR . 34.8 m -144.08 145.33 21.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.081 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.552 ' CD2' ' CB ' ' A' ' 29' ' ' ALA . 25.3 m-85 -78.33 119.28 21.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.936 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.4 t -113.81 131.82 64.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.096 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.9 m -128.81 123.57 33.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.085 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.569 ' CD1' HG11 ' A' ' 93' ' ' VAL . 24.0 p90 -123.01 169.23 11.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.881 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.1 mm -134.64 108.56 10.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.677 0.751 . . . . 0.0 111.133 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 140.3 42.17 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.697 2.265 . . . . 0.0 112.346 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -107.39 -69.88 0.82 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.29 142.55 15.78 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.496 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -112.44 7.88 19.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 0.0 110.865 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.07 -1.42 86.87 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.55 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.75 -24.69 11.72 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.516 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.511 ' CE2' HD12 ' A' ' 15' ' ' LEU . 2.4 m-85 -108.06 161.9 21.74 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.656 0.741 . . . . 0.0 110.873 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 117.06 4.86 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.663 2.242 . . . . 0.0 112.362 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.56 HD13 ' CE1' ' A' ' 51' ' ' PHE . 80.6 mt -45.14 135.21 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.412 ' N ' HG21 ' A' ' 48' ' ' ILE . 40.8 mt-30 -91.97 -46.09 8.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.841 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.0 m -163.24 158.22 21.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.991 0.424 . . . . 0.0 110.857 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.56 ' CE1' HD13 ' A' ' 48' ' ' ILE . 59.5 m-85 -108.67 170.13 8.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.83 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -144.24 120.77 11.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.9 t -103.67 133.41 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.107 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -130.67 160.99 32.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.913 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.461 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 27.5 p90 -141.93 143.09 33.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.46 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 26.9 ttpt -117.33 133.45 55.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.872 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -79.1 124.54 28.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.921 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.1 mt -85.38 -60.88 1.9 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -53.94 -46.94 71.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.8 ttpp -91.92 157.24 16.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.437 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 7.6 p -93.46 116.15 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.165 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.76 131.92 1.65 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.519 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -52.02 177.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.756 0.312 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.46 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 69.0 m95 -61.18 151.5 31.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.961 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.461 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.6 mm -123.42 156.12 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.9 tp -89.5 120.96 31.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.931 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.91 -59.33 2.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.2 t -147.63 174.55 11.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.164 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.451 ' OG ' ' N ' ' A' ' 70' ' ' ALA . 4.9 t -168.24 177.06 5.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.853 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.451 ' N ' ' OG ' ' A' ' 69' ' ' SER . . . 69.34 25.74 5.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.111 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.467 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 76.1 mt -78.18 138.72 60.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.623 0.725 . . . . 0.0 111.191 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.467 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 53.9 Cg_endo -69.76 157.07 61.65 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.736 2.291 . . . . 0.0 112.345 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -22.9 31.64 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.695 2.263 . . . . 0.0 112.337 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.2 m -82.57 -9.1 59.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.432 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.4 ttt180 -107.54 102.1 11.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.852 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.9 mt -99.89 12.56 36.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.938 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.6 t -153.32 131.68 12.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.838 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 m -145.88 162.32 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -98.25 111.5 23.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.7 mm -81.32 102.08 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.169 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.433 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 30.2 p -97.71 168.82 10.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.31 40.04 9.43 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.6 mt -101.32 170.87 7.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.687 0.28 . . . . 0.0 110.969 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -112.45 126.49 55.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -68.79 152.05 45.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.835 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.13 12.25 62.63 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.465 HG23 ' CD2' ' A' ' 89' ' ' TYR . 28.6 mm -122.68 101.12 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.871 0.367 . . . . 0.0 111.104 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.36 133.37 49.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.465 ' CD2' HG23 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -156.55 164.12 38.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.941 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -111.17 178.45 4.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.887 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.421 ' CD1' HD11 ' A' ' 26' ' ' ILE . 38.9 m-85 -135.44 155.06 51.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.41 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 5.8 ptp180 -144.6 179.15 7.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.569 HG11 ' CD1' ' A' ' 38' ' ' TRP . 96.7 t -145.4 141.89 22.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.076 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.41 ' N ' HG12 ' A' ' 93' ' ' VAL . 25.6 mtt180 -133.28 137.15 45.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.969 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 102' ' ' SER . . . -98.29 130.4 44.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.045 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mp -123.12 119.6 30.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.431 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.5 p-10 -123.56 -174.46 2.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.908 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.8 ptp -67.36 -2.62 6.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.5 mt -104.73 -24.94 12.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 146.5 -168.91 27.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.442 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -97.54 158.49 15.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.845 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.417 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 5.5 p -94.02 175.2 6.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.89 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -73.37 159.56 84.55 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.711 0.767 . . . . 0.0 110.894 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.402 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.9 Cg_endo -69.77 109.26 2.27 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.714 2.276 . . . . 0.0 112.394 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 93.8 p -52.62 158.14 1.38 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.846 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.55 140.67 46.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.515 0.674 . . . . 0.0 111.132 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 100.72 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.652 2.235 . . . . 0.0 112.378 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.0 p -47.27 170.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -59.38 150.52 64.08 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.595 0.712 . . . . 0.0 110.881 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.87 122.44 9.09 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.716 2.277 . . . . 0.0 112.267 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.553 ' CE2' HG13 ' A' ' 34' ' ' VAL . 56.2 t80 -111.16 116.46 31.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.953 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 94.7 t -92.28 103.48 14.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.213 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.8 t -70.73 107.09 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.097 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.5 t -111.23 46.9 1.04 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.892 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.1 -160.48 54.0 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.451 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 86.8 p -40.35 -47.08 2.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.962 0.41 . . . . 0.0 110.873 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.79 -159.46 21.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.494 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 2.05 3.87 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.693 2.262 . . . . 0.0 112.34 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.1 p -38.57 119.98 0.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.911 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.1 p -130.83 172.34 12.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.879 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.418 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 91.6 p -90.67 138.44 31.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.877 0.37 . . . . 0.0 110.847 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m -107.41 -44.43 4.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.48 177.38 18.57 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.451 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.3 t -163.62 132.91 3.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.822 0.344 . . . . 0.0 110.865 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 t -135.84 164.25 28.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.801 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.01 -56.28 1.28 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.495 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.3 p -58.35 110.72 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.821 0.343 . . . . 0.0 110.897 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -50.77 150.22 5.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.562 0.696 . . . . 0.0 110.939 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.78 5.56 1.65 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.678 2.252 . . . . 0.0 112.34 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.82 141.9 46.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -55.81 150.02 13.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.82 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 179.34 -49.62 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.474 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -47.87 96.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.88 0.372 . . . . 0.0 110.868 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.509 HD13 ' CE2' ' A' ' 46' ' ' PHE . 9.7 mt -99.85 -175.92 3.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m -144.51 161.08 45.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.718 0.771 . . . . 0.0 110.806 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 170.01 17.56 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.628 2.219 . . . . 0.0 112.354 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.425 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 53.6 Cg_endo -69.86 154.24 67.58 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.664 2.243 . . . . 0.0 112.317 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.4 pt-20 -97.29 168.35 10.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.71 121.62 65.79 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.662 0.744 . . . . 0.0 111.154 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 160.9 48.0 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.684 2.256 . . . . 0.0 112.396 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -48.46 175.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.0 ttm105 -80.58 123.84 82.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.595 0.712 . . . . 0.0 110.817 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 143.85 52.27 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.674 2.25 . . . . 0.0 112.374 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.403 ' C ' HD12 ' A' ' 26' ' ' ILE . 4.8 t -96.9 167.59 10.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.112 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.403 HD12 ' C ' ' A' ' 25' ' ' THR . 3.1 mm -125.01 131.78 72.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.153 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 m -135.71 167.31 21.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.7 m -85.73 104.26 15.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.103 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.563 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -106.26 -40.71 5.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.056 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 m -162.77 163.96 26.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -67.73 -14.41 62.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.964 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 p -122.67 -1.13 9.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.165 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.9 p -142.19 172.37 12.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.0 m -148.02 147.91 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.105 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.563 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 11.7 m-85 -83.42 115.09 21.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.934 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.4 t -109.78 129.05 65.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.12 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 84.9 m -129.19 123.59 32.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.566 ' CD1' HG13 ' A' ' 93' ' ' VAL . 33.6 p90 -120.98 171.16 8.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.5 mm -134.77 106.14 10.68 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.612 0.72 . . . . 0.0 111.188 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 136.12 32.23 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.661 2.24 . . . . 0.0 112.36 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -102.74 -69.48 0.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.73 146.91 16.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.463 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 46.0 p-10 -113.84 6.34 16.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.92 0.39 . . . . 0.0 110.937 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.62 -1.52 87.73 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.458 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.15 -25.1 10.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.509 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.5 m-85 -109.21 161.86 22.26 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.63 0.729 . . . . 0.0 110.901 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 114.14 3.6 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.666 2.244 . . . . 0.0 112.366 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.409 HD13 ' CE1' ' A' ' 51' ' ' PHE . 94.6 mt -44.59 131.86 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -85.97 -47.97 9.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.7 p -160.54 163.32 32.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.851 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.409 ' CE1' HD13 ' A' ' 48' ' ' ILE . 65.3 m-85 -111.41 176.38 5.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.886 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -149.03 125.83 11.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.845 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 t -109.22 129.71 63.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.094 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.424 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 2.6 mp0 -126.58 154.87 43.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.872 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -135.58 142.64 45.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.987 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.498 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 33.6 ttpt -115.92 129.22 56.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -78.56 121.56 24.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 69.8 mt -84.22 174.12 10.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.913 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt 42.35 31.65 0.28 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -154.83 140.22 17.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.8 p -77.79 122.5 32.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.14 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.78 -130.46 1.71 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.473 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -168.21 -178.65 3.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.785 0.326 . . . . 0.0 110.854 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.567 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 83.8 m95 -66.38 142.47 57.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.1 mm -120.51 162.03 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.159 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.2 tp -98.65 123.0 42.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.401 ' CB ' HG22 ' A' ' 80' ' ' ILE . . . -91.51 -71.69 0.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.018 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.7 t -125.11 178.36 5.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.141 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 92.6 p -172.1 176.09 3.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 69.45 26.61 5.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.468 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 83.6 mt -78.22 138.51 60.26 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.574 0.702 . . . . 0.0 111.156 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.468 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 53.4 Cg_endo -69.8 158.28 57.43 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.755 2.303 . . . . 0.0 112.285 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -24.77 29.21 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.686 2.257 . . . . 0.0 112.367 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.8 p -78.95 -19.9 50.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.447 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 6.1 ttt85 -94.42 108.3 20.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.836 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.0 mt -102.7 11.41 37.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.419 ' C ' HG12 ' A' ' 78' ' ' VAL . 25.9 t -155.29 136.07 13.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.419 HG12 ' C ' ' A' ' 77' ' ' SER . 2.4 m -146.03 165.92 9.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.091 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -101.35 110.09 22.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.401 HG22 ' CB ' ' A' ' 67' ' ' ALA . 27.9 mm -80.16 100.16 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.166 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.6 p -97.41 168.96 10.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.126 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.63 37.47 11.9 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.495 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.5 mt -96.42 177.37 5.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.762 0.315 . . . . 0.0 110.935 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -119.68 119.29 33.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.832 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.403 ' HG2' ' N ' ' A' ' 115' ' ' GLY . 0.5 OUTLIER -61.63 153.11 28.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.921 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.59 14.15 64.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.486 HG21 ' CD2' ' A' ' 89' ' ' TYR . 29.0 mm -124.57 113.67 37.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.38 . . . . 0.0 111.092 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.3 131.89 36.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.823 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.486 ' CD2' HG21 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -154.36 162.87 40.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.856 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -107.95 -175.13 2.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.855 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -142.92 154.39 44.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.567 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 4.8 ptp180 -146.56 174.21 11.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.895 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.566 HG13 ' CD1' ' A' ' 38' ' ' TRP . 57.8 t -140.99 143.59 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.458 ' N ' HG11 ' A' ' 93' ' ' VAL . 29.4 mtt180 -133.78 139.58 46.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 102' ' ' SER . . . -98.88 128.68 45.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.2 mp -123.08 118.87 28.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.425 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.5 p-10 -123.52 -173.65 2.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.424 ' HE3' ' CG ' ' A' ' 46' ' ' PHE . 5.8 ptp -68.89 -0.52 5.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.852 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.7 mt -107.07 -24.74 11.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 147.43 -167.26 28.57 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.494 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.59 158.34 16.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 0.0 110.934 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.417 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 5.1 p -94.32 175.18 6.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -70.89 160.23 82.89 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.603 0.716 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 108.01 1.98 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.725 2.284 . . . . 0.0 112.393 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.9 p -51.7 150.9 3.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.806 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.79 139.7 6.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.58 0.705 . . . . 0.0 111.114 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 99.5 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.684 2.256 . . . . 0.0 112.325 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 95.7 p -44.8 162.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.872 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.3 mtp85 -56.74 153.01 23.72 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.607 0.718 . . . . 0.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.87 129.59 17.74 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.608 2.205 . . . . 0.0 112.305 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -122.14 117.02 25.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 45.0 t -90.66 102.77 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.0 t -67.84 103.37 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.057 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.3 t -99.89 44.21 1.03 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.829 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.403 ' N ' ' HG2' ' A' ' 85' ' ' LYS . . . 41.96 67.0 0.91 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.508 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.2 t -120.71 103.28 8.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.942 0.401 . . . . 0.0 110.884 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -94.24 174.01 33.46 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.524 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -34.14 15.18 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.751 2.3 . . . . 0.0 112.329 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.9 t 55.13 41.5 31.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.809 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 73.7 m -58.45 138.93 56.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.39 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.506 -179.972 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -164.0 173.58 12.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.374 . . . . 0.0 110.879 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 t -138.74 171.77 13.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.65 103.8 3.08 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.489 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 88.9 p -103.44 164.21 11.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.895 0.379 . . . . 0.0 110.871 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.7 p -86.82 110.72 20.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.796 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.25 -178.42 36.99 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.511 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 t -44.77 95.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.777 0.322 . . . . 0.0 110.881 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -156.85 135.18 7.44 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.572 0.701 . . . . 0.0 110.891 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -167.79 0.24 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.725 2.283 . . . . 0.0 112.377 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -79.4 48.16 0.87 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.528 ' CG ' ' O ' ' A' ' 12' ' ' HIS . 0.5 OUTLIER -93.38 70.02 4.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.846 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.54 -102.71 0.16 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.53 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -79.97 85.5 5.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.834 0.349 . . . . 0.0 110.894 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.566 HD13 ' CE2' ' A' ' 46' ' ' PHE . 6.3 mt -90.08 -175.07 4.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.93 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.407 ' O ' ' CD1' ' A' ' 99' ' ' LEU . 1.9 m -144.32 161.38 44.87 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.664 0.745 . . . . 0.0 110.877 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 169.94 17.77 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.725 2.283 . . . . 0.0 112.356 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 53.5 Cg_endo -69.75 155.5 65.82 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.746 2.297 . . . . 0.0 112.36 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.41 ' C ' ' HB2' ' A' ' 102' ' ' SER . 7.0 pt-20 -97.97 170.08 9.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.874 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.69 122.07 78.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.646 0.736 . . . . 0.0 111.037 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 161.8 44.52 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.711 2.274 . . . . 0.0 112.358 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -47.36 174.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.833 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -80.47 122.84 82.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.599 0.714 . . . . 0.0 110.821 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 144.35 53.62 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.679 2.253 . . . . 0.0 112.323 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.5 t -94.81 167.89 11.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.075 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.559 HG22 ' CD1' ' A' ' 111' ' ' TYR . 5.8 mm -125.85 123.08 63.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.117 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -128.09 162.89 25.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.829 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m -83.46 98.56 9.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.079 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.476 ' HB1' ' CG ' ' A' ' 35' ' ' TYR . . . -98.4 -37.66 9.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.08 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.7 m -162.43 -179.47 6.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -79.59 -21.6 44.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.838 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.8 p -120.25 3.46 10.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.246 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.458 ' CB ' ' HA ' ' A' ' 81' ' ' THR . 12.4 p -145.58 165.74 27.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.4 m -144.16 149.9 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.162 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.476 ' CG ' ' HB1' ' A' ' 29' ' ' ALA . 12.3 m-85 -84.48 117.49 23.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.919 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 91.1 t -112.61 131.22 64.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.113 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.0 m -129.1 124.69 35.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.205 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.567 ' CD1' HG13 ' A' ' 93' ' ' VAL . 31.4 p90 -124.52 170.81 10.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 mm -134.93 110.23 10.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.582 0.706 . . . . 0.0 111.12 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 145.19 56.18 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.72 2.28 . . . . 0.0 112.316 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -113.66 -69.21 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.81 143.9 15.82 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.481 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 50.8 p-10 -113.33 9.14 18.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.92 0.39 . . . . 0.0 110.88 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.64 0.1 78.75 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.481 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.87 -25.33 11.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.458 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.566 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.3 m-85 -107.94 162.0 21.34 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.656 0.741 . . . . 0.0 110.877 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 117.57 5.16 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.691 2.261 . . . . 0.0 112.365 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 82.0 mt -48.11 133.37 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.135 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -89.33 -52.51 5.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.7 m -155.91 160.44 40.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.806 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -109.77 171.27 7.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.929 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.401 ' HE ' ' CD1' ' A' ' 66' ' ' LEU . 23.1 mtp180 -143.63 123.7 13.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.9 t -104.32 117.04 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -115.78 155.35 27.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.521 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 38.9 p90 -133.62 170.28 15.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.44 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 29.4 ttpt -142.32 131.66 23.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -80.17 128.91 34.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.866 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 38.0 mt -91.29 147.52 22.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.957 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt 53.94 30.73 12.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.871 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.0 mmmt -139.4 -175.03 4.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.03 138.6 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.106 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 124.2 142.65 6.02 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.475 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.449 ' O ' ' CD1' ' A' ' 65' ' ' ILE . 12.0 m-20 -84.12 -177.5 6.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.831 0.348 . . . . 0.0 110.906 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.561 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 75.5 m95 -52.36 146.4 9.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.868 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.521 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 1.8 mm -125.74 155.16 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.401 ' CD1' ' HE ' ' A' ' 52' ' ' ARG . 57.5 tp -88.26 121.87 31.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.926 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.455 ' CB ' HG23 ' A' ' 80' ' ' ILE . . . -84.91 -67.4 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.5 t -129.08 -179.64 5.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.3 p -170.35 170.39 7.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 72.01 32.83 1.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.147 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.471 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 58.2 mt -86.05 137.83 35.13 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.646 0.736 . . . . 0.0 111.107 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.471 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 54.1 Cg_endo -69.74 157.36 60.69 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.727 2.285 . . . . 0.0 112.364 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.61 -24.7 30.06 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.71 2.273 . . . . 0.0 112.369 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 t -79.53 -15.77 57.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.908 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.445 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 13.8 ttt180 -97.87 105.15 17.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.852 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.5 mt -100.75 13.71 34.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.5 t -155.73 137.35 14.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.417 HG11 ' CD1' ' A' ' 71' ' ' ILE . 2.0 m -150.11 162.12 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.083 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -98.06 117.07 31.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.455 HG23 ' CB ' ' A' ' 67' ' ' ALA . 31.9 mm -85.9 95.17 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.118 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.458 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 23.6 p -88.83 171.72 9.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.189 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.29 44.06 14.45 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.437 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.6 mt -104.59 162.18 13.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.794 0.33 . . . . 0.0 110.924 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -106.58 123.7 48.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.411 ' CG ' HG12 ' A' ' 113' ' ' VAL . 14.2 mttt -64.73 159.98 21.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.12 11.88 20.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.48 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.8 mm -121.09 94.12 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 111.091 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.76 135.36 57.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.929 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -159.51 160.35 34.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -107.52 -179.39 3.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.838 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -139.72 156.66 46.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.561 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 3.8 ptp180 -147.69 178.16 8.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.834 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.567 HG13 ' CD1' ' A' ' 38' ' ' TRP . 91.9 t -141.0 140.71 32.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.128 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -132.49 135.57 46.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.831 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 102' ' ' SER . . . -96.56 129.85 43.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.135 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.8 mp -122.5 115.33 22.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.428 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.5 p-10 -119.87 -173.92 2.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 14.4 ptm -67.77 -1.83 6.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.407 ' CD1' ' O ' ' A' ' 16' ' ' SER . 51.1 mt -105.42 -25.58 12.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.83 -165.99 28.83 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.403 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -99.09 158.07 15.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 0.0 110.901 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 95' ' ' ALA . 5.2 p -92.75 175.23 6.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -72.69 158.83 86.69 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.709 0.766 . . . . 0.0 110.835 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.411 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.8 Cg_endo -69.72 103.81 1.21 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.729 2.286 . . . . 0.0 112.332 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.4 p -48.21 152.18 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.892 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.38 140.8 5.27 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.585 0.707 . . . . 0.0 111.116 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 100.43 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.685 2.257 . . . . 0.0 112.333 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 52.0 p -48.45 157.17 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -49.57 151.6 2.82 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.592 0.711 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 129.04 16.85 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.649 2.233 . . . . 0.0 112.332 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.559 ' CD1' HG22 ' A' ' 26' ' ' ILE . 52.3 t80 -117.58 122.65 44.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.1 t -98.22 101.29 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.064 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.411 HG12 ' CG ' ' A' ' 85' ' ' LYS . 22.0 t -69.1 107.08 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.097 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.6 t -104.94 21.81 16.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.45 -121.83 6.57 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.522 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.1 m -83.27 95.22 8.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.924 0.392 . . . . 0.0 110.905 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.26 -156.69 24.88 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.448 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 135.7 31.11 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.674 2.249 . . . . 0.0 112.409 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.5 m -119.08 135.36 54.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.824 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 65.3 p -151.67 165.48 34.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.917 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.438 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.6 t -167.6 149.52 5.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.955 0.407 . . . . 0.0 110.838 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m -93.27 158.22 15.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.6 -163.9 39.66 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.461 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.8 p -137.23 123.64 20.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.85 0.357 . . . . 0.0 110.856 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 t -69.11 151.45 46.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.836 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.89 -161.19 31.82 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.494 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.3 t -68.54 132.56 47.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.821 0.343 . . . . 0.0 110.863 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.444 ' CG ' ' HD2' ' A' ' 10' ' ' PRO . 51.0 tt0 -96.29 138.77 21.53 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.602 0.715 . . . . 0.0 110.835 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.444 ' HD2' ' CG ' ' A' ' 9' ' ' GLN . 54.1 Cg_endo -69.77 3.85 2.54 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.66 2.24 . . . . 0.0 112.345 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -139.81 149.6 43.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -46.5 113.55 0.66 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -163.92 -78.52 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.47 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -73.0 92.42 1.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.847 0.356 . . . . 0.0 110.921 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.525 HD11 ' CE2' ' A' ' 46' ' ' PHE . 10.3 mt -92.72 -175.46 3.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.943 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.4 ' O ' ' O ' ' A' ' 44' ' ' GLY . 1.0 OUTLIER -134.42 160.59 67.91 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.704 0.764 . . . . 0.0 110.891 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 170.05 17.53 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.697 2.265 . . . . 0.0 112.341 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.423 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 52.8 Cg_endo -69.81 152.48 69.06 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.648 2.232 . . . . 0.0 112.337 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.423 ' C ' ' HB2' ' A' ' 102' ' ' SER . 7.5 pt-20 -96.12 161.08 14.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.909 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.61 123.93 69.81 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.518 0.675 . . . . 0.0 111.136 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 165.86 29.55 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.666 2.244 . . . . 0.0 112.304 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -53.97 177.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -80.04 123.58 83.42 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.557 0.694 . . . . 0.0 110.886 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 144.27 53.35 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.664 2.243 . . . . 0.0 112.34 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.4 ' C ' HD11 ' A' ' 26' ' ' ILE . 14.8 t -94.18 165.7 12.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.174 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.519 HG23 ' CD2' ' A' ' 111' ' ' TYR . 4.2 mm -129.98 121.62 52.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.148 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 m -122.93 -175.99 3.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.3 m -99.85 97.57 8.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.165 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.54 ' HB1' ' CD2' ' A' ' 35' ' ' TYR . . . -98.18 -42.72 7.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.098 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 t -157.43 -175.98 5.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.829 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -81.77 -21.33 37.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 36.0 p -120.61 -0.72 10.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.154 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 99.4 p -135.29 173.33 11.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.808 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.3 m -154.83 142.89 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.185 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.54 ' CD2' ' HB1' ' A' ' 29' ' ' ALA . 18.6 m-85 -76.95 120.64 22.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.943 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.0 t -116.13 125.56 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.086 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.7 m -126.09 121.62 33.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.152 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.428 ' CG ' HG22 ' A' ' 93' ' ' VAL . 25.3 p90 -119.06 171.09 8.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.8 mm -134.04 107.28 11.46 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.6 0.714 . . . . 0.0 111.193 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 130.88 20.09 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -94.16 -67.76 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.26 161.79 12.82 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.532 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -125.66 4.67 7.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.884 0.373 . . . . 0.0 110.895 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 81.72 2.29 90.48 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.433 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.44 -25.54 17.39 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.42 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.525 ' CE2' HD11 ' A' ' 15' ' ' LEU . 2.5 m-85 -108.36 162.05 21.31 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.63 0.728 . . . . 0.0 110.891 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.8 116.18 4.44 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.711 2.274 . . . . 0.0 112.303 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 49' ' ' GLN . 96.4 mt -46.59 135.76 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.437 ' N ' HG23 ' A' ' 48' ' ' ILE . 58.9 mt-30 -90.0 -49.12 6.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 m -161.58 160.1 28.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.863 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -108.0 175.97 5.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -149.22 128.08 12.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.2 t -110.35 130.22 64.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.102 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.467 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 21.4 mt-10 -125.56 157.86 36.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.854 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.44 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 26.9 p90 -139.81 145.4 38.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.988 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -120.94 134.33 55.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.822 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.4 mttt -82.65 128.54 34.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.917 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 60' ' ' LYS . 58.5 mt -91.73 -71.31 0.64 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.884 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -40.53 -26.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -118.97 140.11 50.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -73.93 127.89 36.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.113 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.06 179.85 48.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.481 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -101.0 -175.6 2.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.9 0.381 . . . . 0.0 110.81 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -75.24 139.82 42.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.44 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.7 mm -115.03 162.75 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.109 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.1 tp -98.91 118.06 34.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.35 -68.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.095 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.7 t -128.51 175.79 8.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.15 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 90.0 p -168.14 167.34 12.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.795 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 74.39 25.98 1.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.058 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.414 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 52.3 mt -76.9 136.98 66.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.667 0.746 . . . . 0.0 111.139 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.449 ' HG2' ' CB ' ' A' ' 75' ' ' ARG . 53.9 Cg_endo -69.74 156.67 62.81 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.69 2.26 . . . . 0.0 112.358 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.71 -18.54 37.17 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.701 2.267 . . . . 0.0 112.446 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 86.5 p -86.58 -13.05 46.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.449 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 8.6 ttt85 -101.67 98.96 9.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 51.9 mt -96.74 11.62 34.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.836 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 t -153.39 131.72 12.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 m -145.7 163.91 11.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.109 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -100.47 108.83 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 26.7 mm -75.82 107.39 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.193 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.0 p -102.89 165.85 10.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.167 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.66 41.11 7.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.464 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.6 mt -99.16 -178.91 4.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.757 0.313 . . . . 0.0 110.9 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -125.05 122.33 36.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -63.83 161.04 16.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.9 12.0 9.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.417 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 26.9 mm -122.23 108.26 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 0.0 111.24 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.26 136.54 42.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.417 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -157.54 168.59 26.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -114.09 -175.45 2.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.904 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -143.85 158.4 43.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.817 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.467 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 2.7 ptp180 -150.45 175.16 12.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.428 HG22 ' CG ' ' A' ' 38' ' ' TRP . 90.8 t -143.18 135.56 24.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.085 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -126.49 144.32 50.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.85 129.52 53.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.155 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mp -123.41 117.32 24.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.867 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.423 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 37.9 p-10 -119.81 -172.61 2.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.508 ' HE1' ' CE2' ' A' ' 46' ' ' PHE . 12.6 ptm -69.48 1.45 3.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.809 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.3 mt -108.81 -26.59 10.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.908 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.54 -163.09 29.51 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.532 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -104.59 158.14 16.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 110.861 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.423 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 7.5 p -95.39 175.06 6.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.825 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -70.76 157.01 91.18 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.575 0.703 . . . . 0.0 110.943 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.409 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.7 Cg_endo -69.73 105.2 1.44 Allowed 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.683 2.255 . . . . 0.0 112.294 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.0 p -45.94 150.52 0.55 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -44.0 141.44 2.4 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.556 0.694 . . . . 0.0 111.148 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 97.66 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.684 2.256 . . . . 0.0 112.36 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 t -43.53 154.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.84 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -51.43 153.71 3.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.617 0.722 . . . . 0.0 110.829 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 121.92 8.6 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.722 2.281 . . . . 0.0 112.306 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.519 ' CD2' HG23 ' A' ' 26' ' ' ILE . 46.8 t80 -112.79 120.19 40.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.31 104.96 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.196 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.3 t -73.65 106.45 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.4 t -103.77 -45.2 4.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.816 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -165.04 -174.67 34.99 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.461 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 93.8 p -86.14 106.28 17.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.938 0.399 . . . . 0.0 110.846 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 51.09 -156.44 2.93 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.465 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 119' ' ' SER . 52.7 Cg_endo -69.92 3.96 2.54 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.705 2.27 . . . . 0.0 112.327 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 118' ' ' PRO . 41.6 t -34.01 -40.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.814 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.9 m -89.85 -64.32 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.446 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.0 t -64.23 164.37 11.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.932 0.396 . . . . 0.0 110.871 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 m -124.7 -43.67 2.0 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.864 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.86 -170.93 21.06 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.452 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.6 m -47.61 122.2 4.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.872 0.368 . . . . 0.0 110.783 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.7 p -63.51 170.3 3.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.77 -154.59 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.462 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.8 m -128.69 112.19 13.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.822 0.344 . . . . 0.0 110.826 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -39.66 154.65 0.17 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.614 0.721 . . . . 0.0 110.836 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 3.94 2.48 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.704 2.269 . . . . 0.0 112.342 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -83.29 168.15 16.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -171.61 171.81 5.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.99 85.44 1.36 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.43 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.0 mtt-85 -73.59 89.96 1.75 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.91 0.386 . . . . 0.0 110.874 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.675 ' CD1' ' CE2' ' A' ' 46' ' ' PHE . 13.3 mt -91.96 -175.03 3.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.425 ' O ' ' CD1' ' A' ' 99' ' ' LEU . 1.8 m -145.11 161.21 43.25 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.58 0.705 . . . . 0.0 110.892 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 170.14 17.27 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.641 2.227 . . . . 0.0 112.377 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 54.3 Cg_endo -69.73 156.63 62.92 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.664 2.242 . . . . 0.0 112.331 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.42 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.4 pt-20 -98.11 174.53 6.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.2 123.44 87.38 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.597 0.713 . . . . 0.0 111.082 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 161.33 46.33 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.665 2.243 . . . . 0.0 112.376 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -49.39 174.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -80.43 122.16 82.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.602 0.715 . . . . 0.0 110.908 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 143.15 50.25 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.666 2.244 . . . . 0.0 112.402 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.434 ' C ' ' CD1' ' A' ' 26' ' ' ILE . 5.4 t -95.27 165.98 12.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.106 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.434 ' CD1' ' C ' ' A' ' 25' ' ' THR . 2.8 mm -126.81 125.34 66.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.184 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.6 t -131.44 166.99 20.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.4 m -80.88 107.27 13.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.523 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . . . -111.13 -36.31 5.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 m -164.87 -179.71 5.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -82.99 -19.5 36.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.832 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.8 p -120.33 -1.9 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.2 p -140.4 171.25 14.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.9 m -149.65 147.43 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.163 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.523 ' CD2' ' CB ' ' A' ' 29' ' ' ALA . 15.1 m-85 -82.78 120.49 25.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.3 t -115.71 131.46 68.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.105 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.9 m -128.36 120.59 27.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.152 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.56 ' CD1' HG12 ' A' ' 93' ' ' VAL . 28.6 p90 -120.13 170.27 9.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.1 mm -134.3 110.5 11.63 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.59 0.709 . . . . 0.0 111.137 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 137.99 36.66 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.727 2.285 . . . . 0.0 112.312 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -103.58 -69.68 0.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.849 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.48 158.85 14.81 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.509 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -124.25 5.57 8.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.833 0.349 . . . . 0.0 110.815 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.11 0.69 89.27 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.519 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.58 -18.1 32.76 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.548 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.675 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 2.1 m-85 -114.68 162.24 24.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.617 0.723 . . . . 0.0 110.922 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 114.61 3.75 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.711 2.274 . . . . 0.0 112.33 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 49' ' ' GLN . 95.8 mt -46.46 141.2 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.454 ' N ' HG23 ' A' ' 48' ' ' ILE . 88.4 mt-30 -93.36 -52.11 4.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.868 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.7 p -159.69 160.61 34.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -108.83 168.32 9.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.4 mtt-85 -143.39 136.77 28.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.8 t -116.63 134.8 58.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -133.63 158.84 42.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.492 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 26.4 p90 -136.82 175.02 10.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.944 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.452 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 36.9 ttpt -147.69 135.62 21.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.944 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -82.34 129.63 34.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 28.8 mt -96.31 -65.46 0.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.907 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -50.98 -21.28 1.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.942 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -128.27 128.57 44.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.856 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.1 p -58.95 118.12 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.84 131.27 2.0 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.484 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -59.88 -175.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.789 0.328 . . . . 0.0 110.872 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.453 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 78.0 m95 -75.21 135.59 41.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.89 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.492 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.9 mm -115.14 159.42 15.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.14 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 tp -91.5 122.52 34.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -91.41 -71.33 0.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.081 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 t -130.29 165.08 23.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.151 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.9 m -162.85 -175.34 4.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 64.25 29.77 13.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.055 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.475 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 61.3 mt -83.37 137.42 42.24 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.641 0.734 . . . . 0.0 111.176 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.475 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 53.9 Cg_endo -69.7 158.19 57.9 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.633 2.222 . . . . 0.0 112.379 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.72 -11.41 30.82 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.661 2.24 . . . . 0.0 112.323 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.0 t -92.52 -18.16 23.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.854 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.429 ' CD ' HG12 ' A' ' 78' ' ' VAL . 17.0 ttt180 -98.57 103.65 15.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.822 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.9 mt -99.46 7.62 45.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.974 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 t -149.45 132.85 16.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.809 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.429 HG12 ' CD ' ' A' ' 75' ' ' ARG . 2.0 m -148.35 165.17 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.131 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.419 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 28.8 tt0 -99.47 116.03 30.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.9 mm -83.3 101.21 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.117 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.4 p -99.67 168.63 9.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.162 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.09 34.34 9.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.2 mt -102.43 179.5 4.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.769 0.319 . . . . 0.0 110.949 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -124.22 135.57 53.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -71.63 157.3 38.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.35 12.84 59.3 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.457 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.406 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 25.8 mm -124.09 113.9 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 111.147 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.87 139.8 35.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.825 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.406 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -160.76 170.46 20.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.944 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -114.49 -176.14 2.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.843 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -144.43 154.23 42.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.453 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 5.3 ptp180 -146.91 179.86 7.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.56 HG12 ' CD1' ' A' ' 38' ' ' TRP . 74.6 t -145.1 143.58 22.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.115 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -132.77 146.02 51.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -107.39 130.22 54.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.086 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.421 ' HG ' ' CB ' ' A' ' 101' ' ' GLU . 4.3 mp -123.87 120.77 33.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.934 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.424 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 37.0 p-10 -123.74 -172.64 2.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.3 ptm -68.98 0.78 4.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.797 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.425 ' CD1' ' O ' ' A' ' 16' ' ' SER . 51.2 mt -108.6 -26.38 10.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.935 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.56 -167.5 29.18 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.485 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.421 ' CB ' ' HG ' ' A' ' 96' ' ' LEU . 0.6 OUTLIER -100.54 158.39 15.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 110.866 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.42 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 14.0 p -94.81 175.22 6.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.816 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -71.41 160.68 81.83 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.621 0.724 . . . . 0.0 110.897 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 107.69 1.92 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.741 2.294 . . . . 0.0 112.286 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.8 p -47.95 158.88 0.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.35 138.61 48.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.587 0.708 . . . . 0.0 111.128 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 96.89 0.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.73 2.287 . . . . 0.0 112.38 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.5 p -47.21 160.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.841 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -52.42 150.94 8.1 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.607 0.718 . . . . 0.0 110.854 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.61 129.21 17.36 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.724 2.283 . . . . 0.0 112.392 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.42 ' CD1' HG22 ' A' ' 26' ' ' ILE . 57.9 t80 -117.53 120.23 37.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.926 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.0 t -92.94 107.42 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.142 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.0 t -73.25 104.56 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 t -102.06 146.29 28.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.823 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -48.75 -54.2 14.78 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.46 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.6 t -112.38 134.8 53.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.855 0.359 . . . . 0.0 110.857 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -148.55 -177.06 22.49 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.493 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 134.73 28.69 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.68 2.253 . . . . 0.0 112.316 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 55.2 m -131.0 127.87 39.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.2 m -151.05 150.33 30.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.519 179.974 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.8 m -141.82 175.41 9.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.835 0.35 . . . . 0.0 110.895 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.4 p -60.47 133.87 56.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.911 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.11 -55.48 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.531 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.7 p -61.7 169.22 2.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.931 0.396 . . . . 0.0 110.867 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.8 p -101.94 167.57 9.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -108.67 166.45 12.82 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.548 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 52.0 p -57.85 130.07 44.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 110.847 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -161.75 153.8 16.32 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.618 0.723 . . . . 0.0 110.898 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 3.23 2.84 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.751 2.301 . . . . 0.0 112.368 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -111.72 93.09 4.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -45.38 124.95 5.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.829 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.12 -106.23 1.5 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.506 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -63.42 89.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.902 0.382 . . . . 0.0 110.828 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.572 ' CD1' ' CE2' ' A' ' 46' ' ' PHE . 9.0 mt -84.59 178.77 7.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.913 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 44' ' ' GLY . 1.4 m -139.76 161.87 53.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.682 0.753 . . . . 0.0 110.832 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.74 170.09 17.37 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.674 2.249 . . . . 0.0 112.343 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 54.6 Cg_endo -69.69 155.48 66.07 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.74 2.293 . . . . 0.0 112.375 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.421 ' C ' ' HB2' ' A' ' 102' ' ' SER . 5.0 pt-20 -98.06 175.29 6.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.94 121.12 80.43 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.611 0.72 . . . . 0.0 111.153 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 162.14 43.23 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.711 2.274 . . . . 0.0 112.325 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -50.42 174.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.824 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -80.15 123.63 83.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.583 0.706 . . . . 0.0 110.851 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 144.04 52.78 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.713 2.276 . . . . 0.0 112.369 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.3 t -94.4 166.17 12.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.203 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.432 HG22 ' CD2' ' A' ' 111' ' ' TYR . 7.9 mm -128.21 121.42 55.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.129 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -121.17 -177.72 3.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.887 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.3 m -98.68 99.74 10.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.549 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . . . -100.79 -41.1 7.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.016 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.6 m -163.16 -178.75 6.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.834 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -84.91 -15.04 45.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.852 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.6 p -117.94 -7.1 10.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.179 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.433 ' CB ' ' HA ' ' A' ' 81' ' ' THR . 36.7 p -143.56 171.9 13.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 m -147.64 150.94 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.137 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.549 ' CD2' ' CB ' ' A' ' 29' ' ' ALA . 18.3 m-85 -84.89 119.81 25.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.3 t -113.91 130.61 67.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.167 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 42.0 m -128.28 124.07 35.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.571 ' CD1' HG11 ' A' ' 93' ' ' VAL . 27.4 p90 -121.3 168.39 11.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.1 mm -132.09 108.13 13.82 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.631 0.729 . . . . 0.0 111.153 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 142.92 49.13 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.711 2.274 . . . . 0.0 112.309 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -111.98 -66.86 1.04 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.6 144.52 16.32 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.496 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -115.12 10.0 16.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.965 0.412 . . . . 0.0 110.963 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 78.73 -0.59 76.65 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.467 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.37 -22.88 21.77 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.487 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.572 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 2.3 m-85 -109.89 162.03 21.97 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.574 0.702 . . . . 0.0 110.944 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 113.0 3.22 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.655 2.237 . . . . 0.0 112.428 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 80.6 mt -47.07 134.75 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -83.62 -49.96 8.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.952 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 m -162.9 162.7 26.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.809 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -108.42 169.72 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.831 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -145.15 130.25 18.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.7 t -108.83 136.78 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.409 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 4.0 mp0 -127.59 156.34 42.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.825 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -141.08 147.33 38.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.855 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -129.72 140.65 51.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.971 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.7 mtmm -83.79 129.84 34.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 77.5 mt -85.62 -31.16 22.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.922 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 60' ' ' LYS . 7.9 mtpp -91.81 35.11 0.97 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.83 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.49 ' CG ' ' O ' ' A' ' 59' ' ' LYS . 35.3 mttt -165.32 178.68 6.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.893 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 62' ' ' GLY . 1.4 p -99.55 -29.51 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.132 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 61' ' ' VAL . . . -35.48 122.21 0.58 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.485 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.06 -175.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.78 0.324 . . . . 0.0 110.842 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -62.15 152.14 33.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.97 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.1 mm -129.76 157.97 42.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.183 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 tp -85.43 111.59 20.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.0 -61.64 1.78 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.111 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.3 t -150.88 161.09 43.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.191 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.7 m -152.5 -179.59 7.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.854 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 71.67 25.25 3.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.07 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.473 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 71.4 mt -81.5 137.99 48.03 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.594 0.711 . . . . 0.0 111.103 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.473 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 53.7 Cg_endo -69.79 156.17 63.95 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.616 2.211 . . . . 0.0 112.285 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -12.72 33.44 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.698 2.266 . . . . 0.0 112.375 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.3 t -92.43 -17.32 24.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.806 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.463 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 7.2 ttt85 -96.44 97.54 9.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.2 mt -94.06 13.59 22.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.91 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -154.17 130.95 10.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.8 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.6 m -145.4 160.34 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.114 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.421 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 24.2 tt0 -96.8 115.82 28.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.925 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.2 mm -83.63 105.35 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.433 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 64.2 p -102.56 171.43 7.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.166 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.09 38.38 11.31 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.5 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.5 mt -105.33 176.37 5.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.81 0.338 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -120.19 136.09 54.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.85 150.5 42.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.96 10.66 68.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.46 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.49 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 28.0 mm -121.41 103.88 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.369 . . . . 0.0 111.105 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.02 141.81 52.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.49 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -163.22 163.02 25.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -111.89 169.59 8.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.811 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -129.71 153.89 47.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.409 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 5.3 ptp180 -143.82 -178.94 6.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.571 HG11 ' CD1' ' A' ' 38' ' ' TRP . 86.4 t -145.13 144.55 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.093 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.403 ' N ' HG12 ' A' ' 93' ' ' VAL . 25.4 mtt180 -134.87 139.13 44.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.822 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.69 132.77 44.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.096 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.4 mp -126.35 119.59 27.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.928 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.433 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 38.5 p-10 -123.61 -173.95 2.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.436 ' HE1' ' CG ' ' A' ' 46' ' ' PHE . 6.3 ptp -68.87 -0.63 5.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.798 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.4 mt -106.62 -25.66 11.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.972 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.26 -165.98 29.02 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -102.01 158.03 16.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.421 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 5.2 p -94.33 175.04 6.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.801 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -71.22 160.39 82.66 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.606 0.717 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 110.33 2.53 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.683 2.255 . . . . 0.0 112.354 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.0 p -53.34 152.14 4.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.43 139.44 8.06 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.599 0.714 . . . . 0.0 111.073 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 100.41 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.66 2.24 . . . . 0.0 112.352 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.3 p -46.1 163.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.85 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -56.83 152.4 27.5 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.529 0.68 . . . . 0.0 110.939 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 123.2 9.87 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.64 2.227 . . . . 0.0 112.395 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.432 ' CD2' HG22 ' A' ' 26' ' ' ILE . 48.5 t80 -112.89 117.21 31.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.8 t -91.76 101.79 12.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.175 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.9 t -67.99 110.55 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.9 t -107.07 158.25 17.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -40.7 -66.44 0.87 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.479 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.4 m -123.15 175.81 6.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.893 0.378 . . . . 0.0 110.902 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 172.1 -160.06 31.46 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.455 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 90.36 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.675 2.25 . . . . 0.0 112.351 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.5 m -93.81 169.87 9.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.7 t -133.09 -43.78 0.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.82 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.517 -179.953 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.6 m -160.84 178.2 9.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.915 0.388 . . . . 0.0 110.832 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.7 m -141.36 177.1 8.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.863 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.87 -166.09 19.99 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.474 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 t -164.05 124.42 2.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.899 0.381 . . . . 0.0 110.838 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 t -125.9 175.95 7.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.831 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.38 -134.98 6.88 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.467 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -174.58 177.51 2.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 0.0 110.828 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -147.28 143.98 18.94 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.645 0.736 . . . . 0.0 110.863 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -175.17 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.72 2.28 . . . . 0.0 112.384 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -162.91 148.96 12.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.856 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -148.59 162.46 39.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.56 126.42 4.65 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.434 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -72.98 83.06 1.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.359 . . . . 0.0 110.864 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.567 HD11 ' CE2' ' A' ' 46' ' ' PHE . 15.9 mt -99.71 -176.32 3.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 p -141.65 160.17 57.42 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.72 0.772 . . . . 0.0 110.819 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 169.83 17.96 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.691 2.261 . . . . 0.0 112.347 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.421 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 53.0 Cg_endo -69.84 152.72 68.99 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.664 2.243 . . . . 0.0 112.256 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' HB2' ' A' ' 102' ' ' SER . 4.2 pt-20 -94.68 172.46 8.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.01 121.72 79.36 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.544 0.688 . . . . 0.0 111.109 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 161.96 43.93 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.625 2.217 . . . . 0.0 112.337 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -51.27 174.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.832 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -79.99 123.08 83.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.542 0.687 . . . . 0.0 110.849 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 143.51 51.21 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.677 2.252 . . . . 0.0 112.352 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.8 t -93.38 164.42 13.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.184 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.554 HG22 ' CD2' ' A' ' 111' ' ' TYR . 12.4 mm -128.07 120.76 54.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.051 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -123.28 -178.76 4.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.858 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.2 m -97.05 98.97 10.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.461 ' HB2' ' N ' ' A' ' 35' ' ' TYR . . . -100.41 -33.84 10.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.146 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.43 -175.02 3.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -83.49 -20.03 34.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.962 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.7 p -122.92 -0.58 8.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.179 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.406 ' CB ' ' HA ' ' A' ' 81' ' ' THR . 3.8 p -139.27 163.89 31.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.82 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.72 144.82 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.152 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.461 ' N ' ' HB2' ' A' ' 29' ' ' ALA . 16.8 m-85 -77.8 116.66 18.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.904 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.9 t -108.98 130.72 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.127 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 m -129.16 121.9 28.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.129 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.569 ' CD1' HG11 ' A' ' 93' ' ' VAL . 35.3 p90 -121.63 170.95 9.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.7 mm -135.76 106.0 9.82 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.631 0.729 . . . . 0.0 111.17 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.416 ' CD ' HD23 ' A' ' 76' ' ' LEU . 53.7 Cg_endo -69.68 129.87 18.44 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.712 2.274 . . . . 0.0 112.347 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -93.0 -70.41 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.49 151.37 16.92 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.445 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 42.4 p-10 -118.03 10.7 13.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 0.0 110.9 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.57 -4.25 60.79 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.436 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.96 -18.05 19.43 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.483 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.567 ' CE2' HD11 ' A' ' 15' ' ' LEU . 2.1 m-85 -114.3 162.03 25.33 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.674 0.75 . . . . 0.0 110.873 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 114.8 3.81 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.668 2.245 . . . . 0.0 112.36 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 89.4 mt -45.6 130.37 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -84.99 -46.18 11.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.6 p -162.19 162.53 28.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.757 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -108.89 172.7 6.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.868 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.439 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 55.9 mtt180 -145.04 121.29 10.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.977 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.3 t -105.62 128.21 59.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.135 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.408 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 13.9 mt-10 -128.89 152.54 48.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.823 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.504 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 36.7 p90 -133.34 173.84 11.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.917 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -149.14 137.35 20.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.94 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -83.53 125.91 32.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.966 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.441 ' O ' ' C ' ' A' ' 59' ' ' LYS . 77.8 mt -87.48 -70.71 0.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.912 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 58' ' ' LEU . 12.2 tttm -34.72 -38.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.844 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -116.03 131.66 56.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.895 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.04 119.77 7.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.067 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -167.75 159.06 32.21 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.497 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.54 -175.26 4.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.793 0.33 . . . . 0.0 110.822 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -79.85 142.51 35.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.504 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 2.6 mm -120.47 158.93 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.8 tp -93.31 121.93 35.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.417 ' CB ' HG23 ' A' ' 80' ' ' ILE . . . -90.19 -69.0 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.096 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 t -126.49 178.57 5.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.115 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.9 p -173.86 178.35 2.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.835 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 67.98 30.67 5.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.079 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.471 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 72.2 mt -84.56 137.73 38.72 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.591 0.71 . . . . 0.0 111.151 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.471 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 53.8 Cg_endo -69.76 159.56 52.95 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.739 2.293 . . . . 0.0 112.321 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 -17.67 37.51 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.71 2.274 . . . . 0.0 112.325 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.4 m -86.48 -23.19 26.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.42 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 15.0 ttt180 -90.01 100.99 13.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.813 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.416 HD23 ' CD ' ' A' ' 40' ' ' PRO . 52.6 mt -95.95 9.58 40.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.839 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.402 ' C ' HG12 ' A' ' 78' ' ' VAL . 11.6 t -153.79 136.6 15.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.431 HG13 ' CD1' ' A' ' 71' ' ' ILE . 1.9 m -147.31 163.81 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.135 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -100.4 111.59 23.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.833 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.417 HG23 ' CB ' ' A' ' 67' ' ' ALA . 26.3 mm -80.86 102.94 7.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.102 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.406 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 77.2 p -97.25 165.35 12.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.059 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.78 37.46 8.58 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.436 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 88.1 mt -97.62 -179.68 4.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.792 0.329 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -126.71 125.25 41.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -65.11 163.06 15.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.64 17.94 22.08 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.536 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.501 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 28.1 mm -129.37 105.05 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 111.114 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.89 141.82 49.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.501 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -162.75 164.53 26.25 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.944 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -111.08 -175.6 2.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.93 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -146.64 161.46 40.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.84 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.409 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 3.5 ptp180 -151.95 173.41 14.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.884 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.569 HG11 ' CD1' ' A' ' 38' ' ' TRP . 71.6 t -140.02 136.4 38.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.125 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -127.05 138.21 53.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.863 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.95 126.35 43.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.067 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.439 HD22 ' CZ ' ' A' ' 52' ' ' ARG . 7.0 mp -120.53 118.41 30.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.421 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.7 p-10 -123.39 -173.72 2.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.1 ptm -68.07 -1.48 5.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.5 mt -105.65 -25.78 12.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.988 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.99 -166.04 28.9 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.511 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.4 156.39 17.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.858 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.417 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 5.5 p -93.39 175.11 6.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.895 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -70.27 157.89 88.86 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.634 0.731 . . . . 0.0 110.856 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.409 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.5 Cg_endo -69.74 102.95 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.66 2.24 . . . . 0.0 112.324 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.9 p -43.93 153.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.81 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.71 141.65 17.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.586 0.707 . . . . 0.0 111.076 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 98.05 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.687 2.258 . . . . 0.0 112.373 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.0 p -45.8 151.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.817 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.2 mmm-85 -45.57 156.18 0.43 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.593 0.711 . . . . 0.0 110.823 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 131.45 21.15 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.638 2.226 . . . . 0.0 112.28 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.554 ' CD2' HG22 ' A' ' 26' ' ' ILE . 39.7 t80 -121.04 113.28 19.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.9 t -91.13 102.81 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.146 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.9 t -69.09 105.7 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.164 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.6 t -104.84 43.01 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 51.27 68.63 1.42 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.498 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 80.8 p -131.27 118.61 20.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.926 0.393 . . . . 0.0 110.826 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -162.38 -158.09 9.39 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.438 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 170.07 17.45 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.634 2.223 . . . . 0.0 112.371 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.7 m -99.46 -44.24 6.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.906 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.0 t -136.4 110.43 8.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.857 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.455 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.1 p -168.43 169.07 10.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 110.869 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.1 p -144.11 155.18 43.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.825 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.59 144.65 18.5 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.462 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 p -71.7 172.67 9.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.894 0.378 . . . . 0.0 110.857 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 t -61.96 156.41 21.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.77 -89.71 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.476 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 t 51.65 29.29 5.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.819 0.342 . . . . 0.0 110.887 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -107.47 141.41 22.94 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.587 0.708 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.86 82.96 0.74 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.655 2.237 . . . . 0.0 112.28 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -132.82 168.24 18.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -38.19 -51.18 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.29 -81.52 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.448 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -77.21 90.64 3.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 0.0 110.877 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.668 ' CD1' ' CE2' ' A' ' 46' ' ' PHE . 9.1 mt -105.01 -174.62 2.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.845 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.438 ' O ' ' CD1' ' A' ' 99' ' ' LEU . 0.9 OUTLIER -134.84 159.63 71.42 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.716 0.769 . . . . 0.0 110.835 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 170.22 17.03 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.727 2.285 . . . . 0.0 112.323 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.425 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 53.5 Cg_endo -69.83 154.56 67.31 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.612 2.208 . . . . 0.0 112.341 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.415 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.1 pt-20 -95.7 174.11 7.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.868 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.65 122.04 84.46 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.645 0.736 . . . . 0.0 111.071 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 160.79 48.38 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.644 2.229 . . . . 0.0 112.343 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -49.51 174.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -80.03 123.51 83.48 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.702 0.763 . . . . 0.0 110.83 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 144.27 53.23 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.629 2.219 . . . . 0.0 112.319 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.4 t -93.87 166.41 12.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.109 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.562 HG21 ' CD1' ' A' ' 111' ' ' TYR . 8.1 mm -126.01 125.83 68.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -125.79 179.23 5.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.5 m -98.23 98.68 9.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.116 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.538 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -102.48 -40.02 6.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.072 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.2 m -165.2 168.99 16.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.819 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -74.29 -14.03 60.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.2 p -118.24 -3.28 11.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.123 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.46 ' CB ' ' HA ' ' A' ' 81' ' ' THR . 6.5 p -146.45 177.46 9.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.8 m -154.56 149.19 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.178 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.538 ' CE2' ' HB3' ' A' ' 29' ' ' ALA . 17.1 m-85 -82.44 118.16 23.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 91.7 t -113.4 130.84 66.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.069 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.7 m -128.88 120.34 26.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.197 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.562 ' CD1' HG12 ' A' ' 93' ' ' VAL . 26.3 p90 -118.76 170.92 8.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mm -134.93 108.56 10.65 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.615 0.722 . . . . 0.0 111.102 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 140.23 42.38 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.704 2.269 . . . . 0.0 112.363 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -109.43 -69.14 0.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.85 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.23 147.6 16.31 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.528 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 51.9 p-10 -117.82 5.79 12.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.804 0.335 . . . . 0.0 110.84 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 81.89 4.36 90.32 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.485 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.38 -16.78 44.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.487 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.668 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 1.9 m-85 -115.44 162.24 25.82 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.654 0.74 . . . . 0.0 110.869 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.64 118.24 5.56 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.7 2.266 . . . . 0.0 112.399 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.462 HD12 ' CE1' ' A' ' 51' ' ' PHE . 91.7 mt -49.26 131.88 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.172 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -85.77 -49.27 8.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.954 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.1 m -161.51 161.29 29.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.841 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.462 ' CE1' HD12 ' A' ' 48' ' ' ILE . 60.9 m-85 -109.91 171.26 7.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -146.19 134.3 21.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.863 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.2 135.02 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.155 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.474 ' N ' ' OE1' ' A' ' 54' ' ' GLU . 26.4 mp0 -136.25 146.01 46.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.531 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 26.3 p90 -124.43 179.27 4.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.445 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 22.4 ttpp -149.4 136.41 19.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -84.23 119.87 25.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.3 mt -90.37 -68.55 0.78 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.45 -31.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.895 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -121.19 139.71 53.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.919 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.3 p -63.28 129.67 27.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 174.81 161.78 25.17 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.478 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -90.27 -179.3 5.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.85 0.357 . . . . 0.0 110.881 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.445 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 84.0 m95 -69.28 136.58 52.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.867 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.531 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 5.2 mm -115.02 159.62 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.151 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.4 tp -93.37 125.32 37.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -94.16 -69.84 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.126 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.2 t -131.63 173.19 11.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.146 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.439 ' OG ' ' N ' ' A' ' 70' ' ' ALA . 6.3 t -169.45 176.74 4.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.801 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.439 ' N ' ' OG ' ' A' ' 69' ' ' SER . . . 69.68 28.65 4.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.106 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.469 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 73.6 mt -80.26 137.88 52.47 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.65 0.738 . . . . 0.0 111.155 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.469 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 54.2 Cg_endo -69.64 158.06 58.42 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.757 2.305 . . . . 0.0 112.378 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -21.89 33.05 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.686 2.258 . . . . 0.0 112.324 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.6 m -82.01 -14.99 55.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -101.84 107.59 18.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.857 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.7 mt -103.86 11.47 35.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -153.2 132.48 12.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.776 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.9 165.63 9.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.098 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -102.55 109.32 20.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.808 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.1 mm -79.04 103.32 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.15 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.46 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 29.7 p -102.84 167.95 9.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.085 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.75 36.69 7.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.462 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.8 mt -103.65 -178.85 3.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 110.93 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -118.55 126.84 52.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -67.66 153.74 43.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.43 11.96 62.89 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.458 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.457 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 23.2 mm -124.47 112.66 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.804 0.335 . . . . 0.0 111.194 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.23 141.56 45.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.851 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.457 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -161.66 162.78 30.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.947 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -107.54 -175.82 2.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -145.83 151.43 37.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.405 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 1.9 ptp180 -144.12 176.73 9.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.562 HG12 ' CD1' ' A' ' 38' ' ' TRP . 86.8 t -142.87 139.78 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.13 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 -129.57 139.97 51.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 102' ' ' SER . . . -101.23 128.87 47.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.403 HD11 ' C ' ' A' ' 95' ' ' ALA . 8.3 mp -122.21 120.0 32.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.425 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 38.1 p-10 -123.55 -173.1 2.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.7 ptm -68.72 0.65 3.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.438 ' CD1' ' O ' ' A' ' 16' ' ' SER . 38.7 mt -108.37 -26.2 10.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.62 -167.38 29.22 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.525 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.36 158.27 15.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 110.879 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 95' ' ' ALA . 5.2 p -93.81 175.29 6.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -71.6 158.14 88.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.638 0.732 . . . . 0.0 110.93 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.405 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 52.9 Cg_endo -69.77 102.86 1.08 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.687 2.258 . . . . 0.0 112.276 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.3 p -46.32 154.57 0.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.855 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.04 143.39 4.61 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.5 0.667 . . . . 0.0 111.149 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 92.98 0.52 Allowed 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.726 2.284 . . . . 0.0 112.344 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.0 t -40.67 146.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -44.62 150.22 0.71 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.654 0.74 . . . . 0.0 110.845 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 124.31 10.95 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.661 2.241 . . . . 0.0 112.357 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.562 ' CD1' HG21 ' A' ' 26' ' ' ILE . 65.4 t80 -115.25 120.7 40.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.5 t -93.64 107.18 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.139 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.8 t -72.6 102.63 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.14 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.8 t -91.62 -60.07 1.97 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.904 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -167.29 -170.63 32.39 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.45 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.4 t -74.26 108.96 7.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.915 0.388 . . . . 0.0 110.866 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.12 -168.42 0.36 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.441 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 1.83 4.09 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.637 2.225 . . . . 0.0 112.348 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.0 t 74.51 51.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.8 t -125.89 128.75 48.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.905 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.503 -179.962 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 m -163.89 144.59 8.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.358 . . . . 0.0 110.832 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.9 p -155.49 176.76 12.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.787 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.82 -136.07 4.03 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.551 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.5 t 62.29 45.43 6.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.803 0.335 . . . . 0.0 110.857 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.1 p -116.98 149.99 39.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -129.37 164.99 22.16 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.49 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.2 m -138.39 163.05 32.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 110.829 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -68.73 140.31 91.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.523 0.678 . . . . 0.0 110.965 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 103.08 1.11 Allowed 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 122.746 2.298 . . . . 0.0 112.278 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 12' ' ' HIS . 50.1 m-20 -109.07 98.56 8.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.895 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 11' ' ' ASP . 17.2 m-70 -35.86 152.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.81 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.34 -55.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.508 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -57.1 95.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.934 0.397 . . . . 0.0 110.848 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.557 HD13 ' CE2' ' A' ' 46' ' ' PHE . 13.7 mt -104.34 -175.09 2.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.888 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.421 ' C ' HD11 ' A' ' 99' ' ' LEU . 3.1 m -137.78 160.08 66.23 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.699 0.762 . . . . 0.0 110.874 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 170.09 17.5 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.678 2.252 . . . . 0.0 112.302 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 53.6 Cg_endo -69.72 155.75 65.25 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.694 2.263 . . . . 0.0 112.337 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.421 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.6 pt-20 -99.12 168.83 9.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.92 123.01 82.52 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.534 0.683 . . . . 0.0 111.117 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 165.1 32.15 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.72 2.28 . . . . 0.0 112.266 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -52.44 175.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -79.99 122.83 83.61 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.622 0.725 . . . . 0.0 110.912 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 143.3 50.46 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.707 2.272 . . . . 0.0 112.375 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.8 t -94.24 165.25 12.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.133 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.9 mm -125.92 125.61 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.159 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 m -127.7 178.18 6.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.6 m -95.48 101.01 12.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.138 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.47 ' HB3' ' N ' ' A' ' 35' ' ' TYR . . . -102.1 -41.4 6.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.08 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.02 -175.0 5.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -85.0 -16.75 39.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.7 p -123.27 2.04 9.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.112 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.442 ' CB ' ' HA ' ' A' ' 81' ' ' THR . 18.7 p -144.7 168.0 21.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.832 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.9 m -147.07 145.81 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.47 ' N ' ' HB3' ' A' ' 29' ' ' ALA . 19.7 m-85 -77.85 117.71 19.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.859 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.1 t -111.97 129.7 66.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.095 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.6 m -128.74 123.51 33.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.187 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.567 ' CD1' HG11 ' A' ' 93' ' ' VAL . 25.5 p90 -122.43 169.66 10.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.899 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.0 mm -133.29 107.35 12.24 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.668 0.747 . . . . 0.0 111.191 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 135.5 30.62 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.726 2.284 . . . . 0.0 112.332 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -100.32 -70.44 0.74 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.5 159.89 14.72 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.516 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -125.1 4.72 7.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.878 0.37 . . . . 0.0 110.85 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.55 0.56 90.07 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.549 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.32 -24.05 19.07 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.503 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.557 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.4 m-85 -108.68 162.24 20.7 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.637 0.732 . . . . 0.0 110.851 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 116.32 4.5 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.659 2.239 . . . . 0.0 112.379 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 49' ' ' GLN . 96.3 mt -47.81 135.0 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.187 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.439 ' N ' HG22 ' A' ' 48' ' ' ILE . 63.6 mt-30 -86.07 -52.51 5.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.856 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.1 m -160.3 162.16 33.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.862 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -109.85 166.96 10.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.447 ' CZ ' ' OG ' ' A' ' 69' ' ' SER . 21.6 mtp85 -142.22 143.26 32.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.821 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -120.61 137.47 54.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.107 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -133.7 162.55 31.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.46 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 46.1 p90 -142.05 158.94 43.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.458 ' HD3' ' NE1' ' A' ' 64' ' ' TRP . 37.6 ttpt -130.7 129.72 42.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.931 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -80.07 120.34 24.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.2 mt -82.53 -40.13 21.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -91.89 35.54 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.862 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -169.19 160.42 9.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 p -92.16 152.52 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.194 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 127.09 125.09 2.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.482 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -50.34 -179.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.731 0.3 . . . . 0.0 110.859 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.458 ' NE1' ' HD3' ' A' ' 56' ' ' LYS . 47.1 m95 -58.67 159.91 6.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.95 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.46 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 1.8 mm -128.04 160.28 38.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.108 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 39.6 tp -99.89 116.11 31.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.22 -69.79 0.62 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.121 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 t -128.0 166.66 17.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.213 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.447 ' OG ' ' CZ ' ' A' ' 52' ' ' ARG . 12.2 m -161.8 178.65 8.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 70.56 27.54 3.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.103 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.47 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 74.9 mt -78.32 138.15 59.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.584 0.707 . . . . 0.0 111.16 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.47 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 54.1 Cg_endo -69.73 156.49 63.3 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.678 2.252 . . . . 0.0 112.375 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.64 -17.54 38.05 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.647 2.231 . . . . 0.0 112.403 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.3 m -87.6 -13.46 42.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.444 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 15.7 ttt180 -101.04 104.52 15.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.842 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.4 mt -100.4 12.49 37.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -154.93 132.05 10.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 m -147.37 165.27 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.101 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -100.26 118.28 36.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.7 mm -86.98 98.19 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.083 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.442 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 32.0 p -93.4 174.15 7.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.3 40.04 17.21 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.509 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.1 mt -100.67 -179.24 4.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.729 0.299 . . . . 0.0 110.921 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -125.27 130.45 52.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.935 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.0 151.57 43.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.77 10.5 64.39 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.452 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.419 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 25.9 mm -122.22 112.66 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.352 . . . . 0.0 111.103 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.22 138.75 38.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.83 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.419 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -161.59 161.21 29.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.951 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -107.53 177.22 4.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -135.31 158.89 43.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.413 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 1.2 ptp180 -151.13 177.9 9.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.567 HG11 ' CD1' ' A' ' 38' ' ' TRP . 95.0 t -143.58 141.83 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.152 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.2 mtt180 -131.94 143.42 50.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.97 131.18 53.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.108 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.444 HD11 ' N ' ' A' ' 96' ' ' LEU . 9.1 mp -124.39 120.74 32.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.915 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.428 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 38.3 p-10 -123.61 -172.77 2.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.935 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.0 ptm -69.03 0.73 4.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.421 HD11 ' C ' ' A' ' 16' ' ' SER . 46.3 mt -108.5 -26.14 10.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.926 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.39 -166.56 29.09 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.499 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.13 158.74 15.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.889 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.421 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 4.8 p -95.51 175.23 6.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.839 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -70.93 157.98 89.13 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.57 0.7 . . . . 0.0 110.907 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.413 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.9 Cg_endo -69.75 104.72 1.36 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.649 2.233 . . . . 0.0 112.385 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.5 p -44.31 151.95 0.22 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.01 139.38 6.96 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.562 0.696 . . . . 0.0 111.106 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 97.11 0.62 Allowed 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.682 2.255 . . . . 0.0 112.373 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 t -48.3 159.59 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.75 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.98 152.58 5.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.675 0.75 . . . . 0.0 110.857 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.65 131.91 22.4 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.698 2.265 . . . . 0.0 112.372 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -117.85 119.47 34.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.977 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.4 t -95.15 102.2 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.099 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.5 t -69.67 106.47 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 t -114.67 50.01 0.99 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.828 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 59.41 -119.41 18.01 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.482 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 92.3 p -77.04 121.32 23.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.927 0.394 . . . . 0.0 110.846 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -108.8 173.74 17.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.53 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 125.87 12.65 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.706 2.27 . . . . 0.0 112.318 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.8 m -143.08 162.7 34.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.2 t -159.59 159.09 32.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.89 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.45 179.99 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.4 m -158.4 159.49 35.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 110.871 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.2 m -87.81 173.44 8.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.833 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.16 139.61 47.49 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.458 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.3 m -161.43 175.29 12.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.902 0.382 . . . . 0.0 110.806 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.2 p -61.9 112.28 2.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.837 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 155.44 122.54 0.79 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.451 ' C ' ' OE1' ' A' ' 9' ' ' GLN . 77.6 p -148.43 151.67 35.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.451 ' OE1' ' C ' ' A' ' 8' ' ' SER . 0.8 OUTLIER -119.27 143.5 34.39 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.559 0.695 . . . . 0.0 110.977 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.78 108.54 2.11 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.745 2.297 . . . . 0.0 112.244 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -167.95 143.5 3.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.817 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -65.21 99.53 0.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 15' ' ' LEU . . . 175.85 -54.0 0.12 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.489 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -48.0 91.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.756 0.312 . . . . 0.0 110.807 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.639 ' CD1' ' CE2' ' A' ' 46' ' ' PHE . 16.8 mt -94.94 -174.89 3.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.923 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.411 ' C ' HD13 ' A' ' 99' ' ' LEU . 1.4 p -141.7 160.01 57.86 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.738 0.78 . . . . 0.0 110.861 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 169.19 19.49 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.7 2.267 . . . . 0.0 112.302 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.482 ' O ' ' CB ' ' A' ' 102' ' ' SER . 53.4 Cg_endo -69.78 157.41 60.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.698 2.265 . . . . 0.0 112.334 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.429 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.6 pt-20 -99.25 163.25 12.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.35 122.32 58.72 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.539 0.685 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 163.76 37.1 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.672 2.248 . . . . 0.0 112.34 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -50.0 177.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -83.27 124.39 76.12 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.648 0.737 . . . . 0.0 110.85 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 147.36 62.76 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.676 2.251 . . . . 0.0 112.336 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.1 t -99.58 164.51 12.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.15 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.498 HG22 ' CD1' ' A' ' 111' ' ' TYR . 8.7 mm -122.67 118.25 54.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.103 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.1 m -121.69 165.31 15.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.836 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.1 m -83.03 104.75 13.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.553 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . . . -108.45 -37.96 5.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.059 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 m -166.16 175.72 8.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.64 -16.73 55.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.898 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.7 p -119.0 -6.35 10.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.145 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.466 ' HB3' ' CG2' ' A' ' 81' ' ' THR . 89.3 p -138.51 171.96 13.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 m -149.55 145.47 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.123 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.553 ' CD2' ' CB ' ' A' ' 29' ' ' ALA . 17.6 m-85 -81.63 115.34 20.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.0 t -109.11 127.24 65.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.149 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.8 m -125.78 121.71 34.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.058 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.53 ' CD1' HG11 ' A' ' 93' ' ' VAL . 29.4 p90 -121.47 171.07 9.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.5 mm -135.1 107.12 10.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.632 0.73 . . . . 0.0 111.068 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 139.8 41.16 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.697 2.265 . . . . 0.0 112.343 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 mmt85 -103.31 -70.45 0.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.72 159.21 14.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.489 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -123.03 4.51 9.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 110.887 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.56 -1.41 87.87 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.491 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.32 -23.85 13.29 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.639 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 2.1 m-85 -110.11 162.25 21.17 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.641 0.734 . . . . 0.0 110.869 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.71 114.72 3.79 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.676 2.251 . . . . 0.0 112.427 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 81.6 mt -47.09 132.08 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.128 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -85.15 -50.36 7.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.2 p -159.7 163.24 34.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -108.86 171.78 7.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -143.45 129.01 19.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.827 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.4 t -111.4 133.14 57.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.07 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -135.42 152.4 51.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.455 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 31.1 p90 -129.37 175.75 8.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.486 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 24.6 ttpt -147.88 132.24 17.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.869 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -81.43 126.23 31.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 59' ' ' LYS . 58.5 mt -91.13 -61.85 1.57 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 58' ' ' LEU . 3.3 tmtt? -37.4 -36.45 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.887 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.1 mtmm -127.69 136.26 51.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.929 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 p -60.43 117.21 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.173 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.09 129.42 1.94 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.491 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.34 -176.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.817 0.342 . . . . 0.0 110.842 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.486 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 77.1 m95 -80.27 142.59 34.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.879 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.455 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 2.7 mm -116.71 164.2 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.8 tp -96.96 124.1 40.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.444 ' CB ' HG22 ' A' ' 80' ' ' ILE . . . -92.52 -64.71 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.058 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 t -131.83 179.33 6.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.0 p -173.15 178.16 2.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 64.15 32.33 12.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.094 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.47 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 88.2 mt -84.61 138.55 38.18 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.582 0.706 . . . . 0.0 111.129 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.47 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 54.0 Cg_endo -69.75 156.9 62.18 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.719 2.28 . . . . 0.0 112.305 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 -19.56 35.83 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.742 2.295 . . . . 0.0 112.33 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 t -84.7 -15.26 45.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.425 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 8.5 ttt85 -99.17 101.33 12.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.4 mt -96.64 8.99 42.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.928 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.5 t -151.34 134.08 15.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.1 m -146.5 161.95 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.131 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.409 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 39.5 tt0 -97.97 110.23 22.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.444 HG22 ' CB ' ' A' ' 67' ' ' ALA . 17.6 mm -80.1 109.76 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.154 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.466 ' CG2' ' HB3' ' A' ' 33' ' ' SER . 66.1 p -107.57 166.42 10.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.97 33.46 8.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.498 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.3 mt -101.65 170.31 8.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.736 0.303 . . . . 0.0 110.898 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -114.2 132.86 55.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.855 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -68.01 156.84 36.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.54 12.01 44.36 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.516 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.512 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 32.1 mm -120.76 103.23 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.836 0.351 . . . . 0.0 111.134 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.44 140.16 51.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.512 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -163.12 163.11 25.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.992 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -109.08 -175.97 2.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.936 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -141.82 164.6 29.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.917 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -157.54 170.09 23.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.53 HG11 ' CD1' ' A' ' 38' ' ' TRP . 99.7 t -137.2 140.14 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.134 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.452 ' N ' HG12 ' A' ' 93' ' ' VAL . 33.8 mtt180 -129.28 136.35 49.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.847 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.64 128.5 39.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.101 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mp -123.6 120.12 31.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.431 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 38.3 p-10 -123.56 -172.79 2.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.3 ptm -69.84 1.56 4.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.834 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.411 HD13 ' C ' ' A' ' 16' ' ' SER . 30.3 mt -108.83 -26.25 10.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.953 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 149.49 -162.54 29.08 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.513 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.408 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 26.3 pm0 -107.09 157.42 17.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.892 0.377 . . . . 0.0 110.918 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 54.4 p -96.2 174.99 6.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.851 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -68.47 157.82 86.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.654 0.74 . . . . 0.0 110.884 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 111.23 2.76 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.669 2.246 . . . . 0.0 112.284 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.7 p -50.44 154.17 1.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.49 141.0 7.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.539 0.685 . . . . 0.0 111.047 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 98.06 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.637 2.224 . . . . 0.0 112.388 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.4 p -45.19 164.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.892 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.3 mtm105 -58.31 152.12 44.62 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.505 0.669 . . . . 0.0 110.942 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 122.61 9.28 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.637 2.225 . . . . 0.0 112.345 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.498 ' CD1' HG22 ' A' ' 26' ' ' ILE . 52.7 t80 -111.98 121.1 44.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.933 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.9 t -95.03 105.43 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.114 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.0 t -74.95 108.68 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.083 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.0 t -108.14 164.37 12.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 116' ' ' SER . . . -45.8 -53.26 8.81 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.543 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 115' ' ' GLY . 42.1 m -36.52 136.94 0.31 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.866 0.365 . . . . 0.0 110.921 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 174.73 164.79 30.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.543 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.66 -169.27 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.645 2.23 . . . . 0.0 112.372 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.4 p -125.5 139.23 53.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.6 t -80.61 -52.8 7.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.529 -179.951 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.1 p -171.37 166.08 7.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.905 0.383 . . . . 0.0 110.844 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.7 p -112.61 171.04 7.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.863 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.68 163.57 36.35 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.535 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 t -62.39 142.62 57.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.0 110.806 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.7 m -88.99 158.71 17.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.857 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.63 -116.78 3.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.451 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.441 ' C ' ' OE1' ' A' ' 9' ' ' GLN . 82.8 p -130.21 118.85 22.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.818 0.342 . . . . 0.0 110.853 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.441 ' OE1' ' C ' ' A' ' 8' ' ' SER . 2.3 mp0 -119.51 143.96 35.73 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.656 0.741 . . . . 0.0 110.939 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 169.03 19.84 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.726 2.284 . . . . 0.0 112.331 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.87 78.58 3.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -165.78 142.88 5.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.29 -57.56 2.76 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.52 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 30.1 mtm-85 -70.74 91.05 0.8 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.893 0.378 . . . . 0.0 110.867 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.565 ' CD1' ' CE2' ' A' ' 46' ' ' PHE . 6.4 mt -105.19 -174.79 2.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.964 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.401 ' O ' ' O ' ' A' ' 44' ' ' GLY . 1.4 p -137.65 160.34 65.44 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.681 0.753 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 169.98 17.66 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.682 2.255 . . . . 0.0 112.355 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.488 ' O ' ' CB ' ' A' ' 102' ' ' SER . 53.9 Cg_endo -69.81 152.74 69.12 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.628 2.219 . . . . 0.0 112.348 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' HB2' ' A' ' 102' ' ' SER . 9.2 pt-20 -98.16 160.48 14.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.09 122.79 50.26 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.559 0.695 . . . . 0.0 111.069 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 166.42 27.7 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.7 2.266 . . . . 0.0 112.304 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -51.67 174.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -80.22 122.73 83.18 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.624 0.726 . . . . 0.0 110.932 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 142.44 47.98 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.671 2.248 . . . . 0.0 112.306 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.6 t -93.43 167.49 11.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.164 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.471 HG21 ' CD2' ' A' ' 111' ' ' TYR . 10.4 mm -127.44 124.68 64.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.193 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 m -128.31 175.75 8.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.813 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.4 m -94.51 101.36 13.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.1 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.522 ' HB2' ' CE2' ' A' ' 35' ' ' TYR . . . -102.42 -41.15 6.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 t -156.86 -178.34 7.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.833 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -81.17 -20.52 41.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.3 p -121.72 4.59 10.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.151 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 84.1 p -139.6 175.97 9.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.3 m -154.64 143.67 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.522 ' CE2' ' HB2' ' A' ' 29' ' ' ALA . 11.0 m-85 -79.69 117.52 20.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.8 t -111.93 129.17 67.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.133 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.5 m -128.91 118.39 22.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.14 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.485 ' CD1' HG13 ' A' ' 93' ' ' VAL . 33.1 p90 -118.58 169.16 10.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 mm -133.59 108.39 12.06 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.62 0.724 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 141.73 45.95 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.693 2.262 . . . . 0.0 112.333 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -109.81 -70.34 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.66 147.06 16.15 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.526 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 48.2 p-10 -114.47 2.55 14.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 0.0 110.925 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 85.26 2.3 87.84 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.507 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.3 -15.04 39.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.438 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.565 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 2.5 m-85 -118.24 161.98 32.29 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.629 0.728 . . . . 0.0 110.839 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 115.52 4.14 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.68 2.253 . . . . 0.0 112.311 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 92.4 mt -47.71 131.22 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.046 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -82.68 -48.23 11.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.87 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.9 p -163.7 164.16 23.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -109.39 174.53 5.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.1 mtt-85 -149.56 124.04 9.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.2 t -107.99 136.39 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.135 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -137.2 152.66 50.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.875 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.553 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 44.0 p90 -127.84 144.1 51.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.513 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 22.1 ttpt -114.37 128.98 56.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.907 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -76.67 136.02 39.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.415 ' CD1' ' HB3' ' A' ' 110' ' ' PRO . 51.4 mt -105.56 -71.25 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.907 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -40.85 -35.9 0.56 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -123.6 122.78 39.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.892 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.1 p -45.71 126.35 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.119 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 63' ' ' ASP . . . 177.85 112.96 0.34 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.407 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 62' ' ' GLY . 8.2 p-10 -50.09 -178.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.787 0.327 . . . . 0.0 110.891 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.513 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 97.3 m95 -59.25 153.56 18.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.553 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 4.6 mm -134.89 141.83 41.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.198 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.9 tp -78.41 126.09 30.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.467 ' CB ' HG23 ' A' ' 80' ' ' ILE . . . -101.69 -58.58 1.86 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.8 t -136.48 165.29 26.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.165 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 99.9 p -160.51 175.77 12.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.789 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 68.95 26.94 5.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.149 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.476 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 58.8 mt -79.76 137.43 54.45 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.635 0.731 . . . . 0.0 111.163 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.476 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 54.0 Cg_endo -69.66 159.06 54.9 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.728 2.285 . . . . 0.0 112.306 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.75 -25.4 28.68 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.688 2.259 . . . . 0.0 112.361 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 81.1 p -77.57 -25.72 50.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.854 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.449 ' CD ' HG11 ' A' ' 78' ' ' VAL . 11.1 ttt180 -86.4 106.59 17.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.838 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.6 mt -101.74 9.89 40.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.957 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.3 t -155.82 137.16 13.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.449 HG11 ' CD ' ' A' ' 75' ' ' ARG . 2.2 m -149.92 168.67 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.148 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -103.26 115.43 30.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.467 HG23 ' CB ' ' A' ' 67' ' ' ALA . 37.0 mm -81.83 102.69 8.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.7 p -97.46 164.04 12.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.117 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.37 33.59 19.43 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.503 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.8 mt -87.45 -176.26 5.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.803 0.335 . . . . 0.0 110.915 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -126.64 122.4 34.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.4 155.92 37.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.43 15.41 45.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.484 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.478 HG22 ' CD2' ' A' ' 89' ' ' TYR . 27.3 mm -126.87 103.68 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.861 0.362 . . . . 0.0 111.114 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.54 137.87 52.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.856 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.478 ' CD2' HG22 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -158.77 167.83 28.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.92 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -110.73 -176.49 2.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.909 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -146.26 142.9 28.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.417 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 5.5 ptt180 -139.26 177.89 7.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.485 HG13 ' CD1' ' A' ' 38' ' ' TRP . 87.2 t -140.73 143.02 29.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.097 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -131.0 140.59 50.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.2 127.54 50.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.087 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.07 120.68 35.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.908 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.431 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 36.5 p-10 -123.61 -172.41 2.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.4 ptm -69.58 1.69 3.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.0 mt -109.67 -26.35 9.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.99 -165.93 29.33 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.526 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.61 158.05 16.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.814 0.34 . . . . 0.0 110.903 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 19.9 p -97.44 175.17 6.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -69.13 157.16 90.0 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.622 0.725 . . . . 0.0 110.918 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.417 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.4 Cg_endo -69.81 104.56 1.35 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.674 2.249 . . . . 0.0 112.318 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.5 p -41.7 150.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.843 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -43.07 140.48 1.97 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.601 0.715 . . . . 0.0 111.097 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 88.81 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.68 2.253 . . . . 0.0 112.285 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 99.2 p -41.06 153.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.861 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -48.96 151.81 2.08 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.628 0.728 . . . . 0.0 110.829 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.415 ' HB3' ' CD1' ' A' ' 58' ' ' LEU . 53.2 Cg_endo -69.81 144.65 54.45 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.664 2.243 . . . . 0.0 112.315 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.471 ' CD2' HG21 ' A' ' 26' ' ' ILE . 43.0 t80 -132.7 115.75 15.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.849 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.6 t -88.95 103.18 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.083 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.5 t -73.66 111.66 9.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.13 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.1 t -107.94 174.01 6.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 116' ' ' SER . . . -69.34 -134.35 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.466 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 115' ' ' GLY . 3.2 t -35.02 123.33 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.906 0.384 . . . . 0.0 110.815 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -141.41 -160.89 8.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.45 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 177.25 5.75 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.713 2.276 . . . . 0.0 112.364 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 60.6 p -114.14 165.37 12.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 18.2 t -151.23 121.51 7.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.908 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.461 -179.943 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.548 -0.221 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m -149.16 150.2 32.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.982 0.42 . . . . 0.0 110.865 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.9 m -56.0 164.45 1.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.903 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.37 -168.08 17.57 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.405 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.2 m -65.06 152.56 43.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.901 0.381 . . . . 0.0 110.806 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.6 m -132.22 -55.7 0.97 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.946 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.25 147.87 22.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.464 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.9 t -63.44 126.22 26.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 0.0 110.852 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -70.09 138.8 87.37 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.56 0.695 . . . . 0.0 110.956 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 176.51 6.6 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.758 2.306 . . . . 0.0 112.323 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.411 ' CG ' ' O ' ' A' ' 11' ' ' ASP . 4.8 p-10 -41.59 100.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -137.36 -179.69 5.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.63 109.77 0.22 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.513 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -66.73 104.3 1.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.899 0.38 . . . . 0.0 110.877 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.57 HD11 ' CE2' ' A' ' 46' ' ' PHE . 9.0 mt -99.86 -176.38 3.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 m -144.99 161.62 41.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.69 0.757 . . . . 0.0 110.863 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 170.35 16.75 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.727 2.284 . . . . 0.0 112.358 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.453 ' HA ' ' N ' ' A' ' 44' ' ' GLY . 53.6 Cg_endo -69.76 155.39 66.07 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.693 2.262 . . . . 0.0 112.403 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' HB2' ' A' ' 102' ' ' SER . 9.6 pt-20 -99.26 167.89 10.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.03 121.32 68.2 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.556 0.693 . . . . 0.0 111.096 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 161.59 45.35 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.685 2.257 . . . . 0.0 112.359 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -46.88 174.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 ttm180 -80.1 124.08 83.07 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.611 0.719 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 140.74 43.43 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.702 2.268 . . . . 0.0 112.387 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.4 t -94.0 155.77 16.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.159 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.566 HG22 ' CD1' ' A' ' 111' ' ' TYR . 18.9 mm -117.28 128.4 74.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.077 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 m -132.72 176.12 8.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.797 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.5 m -93.47 110.6 22.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.191 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.494 ' HB2' ' CE2' ' A' ' 35' ' ' TYR . . . -111.9 -38.2 4.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.05 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.0 m -161.43 -178.75 6.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.838 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.8 -14.68 47.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.899 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.5 p -121.4 -0.02 9.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.161 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.474 ' CB ' HG21 ' A' ' 81' ' ' THR . 6.4 p -145.8 173.13 12.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.0 m -148.98 146.28 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.196 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.494 ' CE2' ' HB2' ' A' ' 29' ' ' ALA . 12.0 m-85 -77.21 123.14 26.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.6 t -119.45 124.38 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.203 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.2 m -126.98 123.24 36.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.152 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.572 ' CD1' HG13 ' A' ' 93' ' ' VAL . 24.4 p90 -120.76 171.27 8.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.953 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.7 mm -135.08 106.01 10.38 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.592 0.711 . . . . 0.0 111.224 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 142.86 49.26 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.719 2.279 . . . . 0.0 112.357 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -111.54 -70.74 0.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.38 143.58 15.69 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -115.74 17.07 16.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.823 0.344 . . . . 0.0 110.904 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.453 ' N ' ' HA ' ' A' ' 18' ' ' PRO . . . 75.97 -6.35 34.94 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.424 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.59 -19.65 11.36 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.504 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.57 ' CE2' HD11 ' A' ' 15' ' ' LEU . 1.6 m-85 -111.92 162.83 19.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.735 0.778 . . . . 0.0 110.91 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 115.98 4.35 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.69 2.26 . . . . 0.0 112.355 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.446 HD13 ' CE1' ' A' ' 51' ' ' PHE . 97.3 mt -48.0 124.41 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.136 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -79.04 -46.55 17.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.5 m -162.83 161.75 26.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.446 ' CE1' HD13 ' A' ' 48' ' ' ILE . 50.4 m-85 -108.59 175.25 5.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.94 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -147.81 120.19 8.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.908 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.91 131.79 51.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.099 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -131.59 160.91 33.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.936 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.539 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 18.4 p90 -139.07 175.89 9.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.919 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' A' ' 63' ' ' ASP . 16.4 ttpp -146.62 134.08 20.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -81.78 118.36 22.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.93 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.3 mt -86.06 -42.52 13.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.96 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -85.67 36.89 0.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -172.97 -177.67 1.65 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.411 HG21 ' N ' ' A' ' 62' ' ' GLY . 6.2 p -92.3 142.66 12.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.097 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.411 ' N ' HG21 ' A' ' 61' ' ' VAL . . . 138.57 141.55 4.16 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.503 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.515 ' O ' ' CD1' ' A' ' 64' ' ' TRP . 0.5 OUTLIER -79.38 -73.77 0.32 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.869 0.366 . . . . 0.0 110.899 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.515 ' CD1' ' O ' ' A' ' 63' ' ' ASP . 61.0 m95 -152.94 149.94 28.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.539 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 2.1 mm -131.47 151.18 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.075 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 52.4 tp -84.9 134.6 34.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.881 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -103.18 -68.35 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.057 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.2 t -125.55 157.83 36.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.099 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 92.4 p -153.4 169.44 23.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 75.05 25.07 1.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.051 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.472 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 64.3 mt -77.08 138.13 65.14 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.599 0.714 . . . . 0.0 111.132 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.472 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 54.1 Cg_endo -69.77 157.98 58.53 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.679 2.253 . . . . 0.0 112.32 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -24.0 29.91 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.72 2.28 . . . . 0.0 112.296 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 t -78.54 -28.8 46.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.463 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.5 ttt180 -83.73 101.91 11.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.849 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.9 mt -99.37 11.71 38.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.8 t -153.89 130.33 10.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.834 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -146.43 160.31 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.09 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -99.25 111.9 24.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.8 mm -77.82 102.67 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.474 HG21 ' CB ' ' A' ' 33' ' ' SER . 41.2 p -97.2 162.56 13.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.118 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.34 40.63 5.38 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.47 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.2 mt -105.77 177.9 4.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.821 0.344 . . . . 0.0 110.921 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -123.62 128.62 49.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.859 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -67.15 155.88 37.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.76 14.95 63.73 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.512 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.427 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 25.6 mm -127.96 112.67 28.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.811 0.339 . . . . 0.0 111.145 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.05 141.69 40.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.813 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.427 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -162.25 159.79 26.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.016 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -107.38 179.37 4.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -140.76 160.88 39.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -152.32 -178.6 6.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.572 HG13 ' CD1' ' A' ' 38' ' ' TRP . 83.9 t -144.5 146.69 20.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -138.79 134.45 33.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.837 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.71 129.5 44.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.082 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.9 mp -122.01 120.19 33.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.434 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 39.4 p-10 -123.74 -172.82 2.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.424 ' HE3' ' CE2' ' A' ' 46' ' ' PHE . 18.4 ptm -69.7 1.13 4.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.852 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.6 mt -109.48 -24.73 10.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.901 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 146.36 -169.98 27.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.467 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.2 pm0 -95.96 158.43 15.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 110.868 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.417 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 4.3 p -94.63 175.45 6.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.881 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.53 157.9 88.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.668 0.747 . . . . 0.0 110.886 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 104.88 1.38 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.706 2.271 . . . . 0.0 112.358 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.9 p -47.14 148.2 1.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -45.96 136.99 6.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.648 0.737 . . . . 0.0 111.057 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.87 99.52 0.77 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.629 2.22 . . . . 0.0 112.375 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.4 p -47.8 170.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -60.61 149.56 78.23 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.609 0.719 . . . . 0.0 110.854 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 122.69 9.37 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.741 2.294 . . . . 0.0 112.325 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.566 ' CD1' HG22 ' A' ' 26' ' ' ILE . 48.7 t80 -108.81 122.93 48.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 37.3 t -97.45 105.99 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.6 t -76.35 107.51 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.083 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.0 t -107.79 -41.11 5.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.897 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.61 86.78 1.83 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.482 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.0 m -111.93 -59.5 1.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.381 . . . . 0.0 110.813 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 123.44 170.76 13.47 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.522 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 124.2 10.83 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.644 2.229 . . . . 0.0 112.305 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.3 m -87.29 -50.08 6.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 93.5 p -93.44 94.11 8.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.834 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.458 -179.983 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.7 t -74.09 122.69 23.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.878 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.2 m -89.18 144.39 26.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.23 63.71 0.31 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.472 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.4 m -138.53 137.05 36.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.0 110.834 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.5 m -66.62 -62.06 1.65 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.86 45.78 5.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.505 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -68.99 171.98 7.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 110.886 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -153.21 150.96 24.96 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.622 0.725 . . . . 0.0 110.986 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.436 ' HD3' ' CE ' ' A' ' 98' ' ' MET . 54.0 Cg_endo -69.69 128.56 16.27 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.781 2.321 . . . . 0.0 112.328 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -147.8 148.01 30.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 65.3 m80 51.97 42.24 30.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.61 97.04 0.11 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.504 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -74.19 98.97 3.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.797 0.332 . . . . 0.0 110.79 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.547 HD12 ' CE2' ' A' ' 46' ' ' PHE . 7.8 mt -94.25 -174.99 3.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.928 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 m -138.51 160.9 61.69 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.686 0.755 . . . . 0.0 110.766 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 169.9 17.74 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.718 2.279 . . . . 0.0 112.337 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 102' ' ' SER . 53.1 Cg_endo -69.77 154.88 67.17 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.713 2.276 . . . . 0.0 112.284 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.422 ' C ' ' HB2' ' A' ' 102' ' ' SER . 10.3 pt-20 -96.97 169.94 9.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.82 121.89 78.01 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.553 0.692 . . . . 0.0 111.079 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 162.23 42.84 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.712 2.275 . . . . 0.0 112.362 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -48.03 174.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.894 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -80.22 124.11 82.84 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.625 0.726 . . . . 0.0 110.857 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.81 143.19 49.83 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.695 2.263 . . . . 0.0 112.34 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.8 t -92.64 165.81 12.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.57 HG22 ' CD2' ' A' ' 111' ' ' TYR . 5.6 mm -128.84 119.52 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 t -123.55 173.95 7.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.0 m -89.41 103.18 15.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.167 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.573 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . . . -106.57 -40.37 5.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.098 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.9 m -160.57 168.07 25.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -72.49 -17.47 61.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.834 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.4 p -119.55 -4.56 10.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.112 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 p -141.75 171.16 14.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.854 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.465 HG11 ' CE1' ' A' ' 111' ' ' TYR . 27.7 m -149.12 149.2 15.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.07 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.573 ' CD2' ' CB ' ' A' ' 29' ' ' ALA . 21.3 m-85 -82.84 117.47 22.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.998 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.1 t -112.08 130.57 65.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.153 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.4 m -129.25 125.06 36.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.14 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.562 ' CD1' HG13 ' A' ' 93' ' ' VAL . 25.0 p90 -122.39 169.92 10.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.8 mm -133.46 107.88 12.14 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.645 0.735 . . . . 0.0 111.131 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.77 143.13 49.81 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.666 2.244 . . . . 0.0 112.27 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 mmm-85 -110.88 -70.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.19 153.34 18.1 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.423 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -121.0 5.82 10.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.813 0.339 . . . . 0.0 110.851 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.05 1.36 89.91 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.448 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.97 -23.75 20.63 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.5 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.547 ' CE2' HD12 ' A' ' 15' ' ' LEU . 1.9 m-85 -109.68 162.33 20.7 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.69 0.757 . . . . 0.0 110.865 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 118.42 5.67 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.748 2.299 . . . . 0.0 112.361 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.447 HD13 ' CE1' ' A' ' 51' ' ' PHE . 87.6 mt -48.33 138.3 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -92.85 -51.27 5.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.957 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.1 p -158.39 165.03 35.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.874 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.447 ' CE1' HD13 ' A' ' 48' ' ' ILE . 48.3 m-85 -114.36 170.05 8.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.928 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.556 ' NE ' ' CD1' ' A' ' 96' ' ' LEU . 50.2 mtm180 -145.57 138.35 25.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -117.25 133.98 62.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.125 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -127.14 160.92 29.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.517 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 17.9 p90 -144.55 144.89 31.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.479 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 17.3 ttpp -127.82 133.71 49.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.904 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.57 140.56 48.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.903 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.469 ' CD1' ' HB3' ' A' ' 110' ' ' PRO . 65.0 mt -108.4 -47.74 3.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -42.92 -34.39 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.42 165.59 34.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.446 ' CG2' ' N ' ' A' ' 62' ' ' GLY . 11.6 p -46.73 165.81 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.129 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.446 ' N ' ' CG2' ' A' ' 61' ' ' VAL . . . 140.21 100.0 0.43 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.484 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -48.81 176.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.748 0.309 . . . . 0.0 110.903 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.564 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 83.2 m95 -67.25 149.31 50.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.975 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.517 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.4 mm -128.4 154.59 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.138 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.8 tp -87.35 115.6 24.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.84 -58.48 2.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.104 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 t -139.74 179.7 6.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.123 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 t -174.73 172.22 3.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.856 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 71.59 34.08 1.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.115 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.466 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 76.9 mt -88.64 137.93 30.06 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.605 0.717 . . . . 0.0 111.201 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.466 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 54.1 Cg_endo -69.7 158.35 57.35 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.639 2.226 . . . . 0.0 112.348 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -20.47 34.63 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.698 2.265 . . . . 0.0 112.336 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 79.6 p -84.74 -13.7 50.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.943 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.44 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 12.8 ttt85 -101.28 104.59 15.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.872 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.2 mt -103.31 13.92 32.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.852 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.416 ' C ' HG11 ' A' ' 78' ' ' VAL . 1.7 t -152.22 129.74 11.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.82 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.456 HG12 ' CD1' ' A' ' 71' ' ' ILE . 2.1 m -146.16 159.54 11.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.09 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -98.62 114.67 27.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.7 mm -82.05 103.28 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.175 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 49.5 p -101.9 164.0 11.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.86 38.99 5.93 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.538 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.3 mt -106.75 175.92 5.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.778 0.323 . . . . 0.0 110.917 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -120.09 133.42 55.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -68.05 160.19 29.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.0 13.86 58.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.445 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.418 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 17.7 mm -124.17 110.96 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.796 0.332 . . . . 0.0 111.094 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.89 134.16 35.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.866 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.418 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -156.29 163.43 39.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -108.0 178.33 4.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.98 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.454 ' CD1' HD13 ' A' ' 26' ' ' ILE . 51.3 m-85 -135.61 152.8 51.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.912 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.564 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 6.3 ptp180 -147.49 171.55 15.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.562 HG13 ' CD1' ' A' ' 38' ' ' TRP . 84.6 t -137.4 140.36 42.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.435 ' N ' HG11 ' A' ' 93' ' ' VAL . 30.1 mtt180 -128.5 134.96 48.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.54 132.71 38.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.152 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.556 ' CD1' ' NE ' ' A' ' 52' ' ' ARG . 4.0 mp -127.26 120.72 29.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.429 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 39.9 p-10 -123.45 -172.26 2.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.931 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.436 ' CE ' ' HD3' ' A' ' 10' ' ' PRO . 21.4 ptm -70.28 2.31 3.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.862 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.9 mt -109.75 -26.36 9.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.947 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.03 -164.67 29.66 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.541 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -104.9 158.45 16.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.839 0.352 . . . . 0.0 110.877 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 53.2 p -96.86 175.08 6.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -70.79 157.69 89.67 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.631 0.729 . . . . 0.0 110.881 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 92' ' ' ARG . 54.0 Cg_endo -69.79 105.32 1.47 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.653 2.235 . . . . 0.0 112.371 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.0 p -44.54 157.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.844 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.58 140.89 18.06 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.625 0.726 . . . . 0.0 111.069 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 100.98 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.658 2.239 . . . . 0.0 112.339 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.9 p -48.0 159.04 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -51.18 152.03 4.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.607 0.718 . . . . 0.0 110.818 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.469 ' HB3' ' CD1' ' A' ' 58' ' ' LEU . 53.6 Cg_endo -69.75 126.71 13.64 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.665 2.243 . . . . 0.0 112.347 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.57 ' CD2' HG22 ' A' ' 26' ' ' ILE . 55.5 t80 -117.28 113.94 22.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.935 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 42.4 t -88.02 106.94 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.175 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.8 t -72.17 106.94 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.141 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 t -106.85 169.64 8.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.822 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -79.32 97.38 1.55 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.52 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.9 t -171.88 171.32 5.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 0.0 110.878 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -164.25 172.49 40.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 107.75 1.93 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.665 2.243 . . . . 0.0 112.392 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.0 m -50.9 121.94 6.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.0 m -166.35 131.21 2.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.837 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.436 179.965 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m -159.73 138.17 10.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.371 . . . . 0.0 110.882 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.2 p -59.4 137.08 58.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.923 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -42.25 148.84 0.45 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.449 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 m -96.92 170.97 8.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.89 0.376 . . . . 0.0 110.827 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 t -153.35 125.29 7.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.897 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.75 133.74 12.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.476 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.9 m -84.18 128.99 34.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.843 0.354 . . . . 0.0 110.88 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -88.11 147.25 40.12 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.6 0.714 . . . . 0.0 110.965 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 132.61 23.66 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.659 2.239 . . . . 0.0 112.325 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -109.95 144.54 38.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.809 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -112.69 -38.93 4.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.81 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.36 86.21 0.52 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.494 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.2 ptt85 -88.57 104.89 17.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.847 0.356 . . . . 0.0 110.883 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.563 HD13 ' CE2' ' A' ' 46' ' ' PHE . 13.5 mt -105.53 -175.01 2.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.945 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.42 ' O ' ' CD1' ' A' ' 99' ' ' LEU . 1.6 m -144.4 161.91 42.08 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.684 0.754 . . . . 0.0 110.899 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 169.92 17.8 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.696 2.264 . . . . 0.0 112.314 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.434 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 53.5 Cg_endo -69.82 154.44 67.51 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.691 2.261 . . . . 0.0 112.342 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.423 ' C ' ' HB2' ' A' ' 102' ' ' SER . 4.7 pt-20 -98.89 173.71 6.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.15 121.16 75.02 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.666 0.746 . . . . 0.0 111.101 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 162.83 40.62 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.674 2.25 . . . . 0.0 112.347 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -48.41 172.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -79.9 123.06 83.9 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.581 0.705 . . . . 0.0 110.889 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 144.15 53.56 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.754 2.303 . . . . 0.0 112.399 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.1 t -95.72 167.26 11.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.508 HG23 ' CG ' ' A' ' 111' ' ' TYR . 8.2 mm -129.79 118.64 45.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.144 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -120.82 178.96 4.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.825 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.5 m -94.35 98.53 10.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.141 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.663 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . . . -100.72 -40.71 7.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.5 m -159.64 -179.8 8.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -81.8 -21.33 37.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.845 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.2 p -118.27 3.6 11.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.107 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.3 p -144.92 174.66 10.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.7 m -153.2 142.16 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.203 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.663 ' CD2' ' CB ' ' A' ' 29' ' ' ALA . 22.6 m-85 -77.77 120.17 22.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.878 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.9 t -114.88 130.61 69.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.105 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.4 m -128.81 120.29 26.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.501 ' CG ' HG22 ' A' ' 93' ' ' VAL . 24.9 p90 -121.31 170.79 9.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 mm -134.98 110.86 10.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.549 0.69 . . . . 0.0 111.107 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 131.2 20.64 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.667 2.245 . . . . 0.0 112.351 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -95.58 -70.15 0.72 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.15 149.72 16.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.49 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -118.69 8.95 12.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.884 0.373 . . . . 0.0 110.871 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.27 3.05 75.54 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.28 -22.7 28.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.494 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.563 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.4 m-85 -109.91 161.9 22.46 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.738 0.78 . . . . 0.0 110.849 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 114.94 3.86 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.613 2.209 . . . . 0.0 112.377 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.412 HD12 ' CE1' ' A' ' 51' ' ' PHE . 97.7 mt -45.22 128.17 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.142 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -82.33 -47.4 12.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.1 m -163.27 160.76 24.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.844 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.412 ' CE1' HD12 ' A' ' 48' ' ' ILE . 60.7 m-85 -108.09 178.18 4.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.954 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.3 mtt-85 -149.65 121.71 8.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.401 ' CG1' HD12 ' A' ' 80' ' ' ILE . 23.5 t -105.38 125.57 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -131.83 146.26 52.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.516 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 38.5 p90 -120.14 175.91 5.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.966 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.508 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 13.3 tttt -148.71 135.24 19.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.3 mttp -82.66 125.73 31.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.43 ' CD1' ' HB3' ' A' ' 110' ' ' PRO . 73.5 mt -85.83 -49.01 8.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.934 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.3 tptt -92.39 48.52 1.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -159.54 -178.43 7.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.89 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.4 p -101.32 -25.96 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.116 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -54.75 136.69 44.43 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.489 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.464 ' O ' ' CD1' ' A' ' 65' ' ' ILE . 0.7 OUTLIER -84.69 -175.92 6.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.837 0.351 . . . . 0.0 110.797 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.508 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 77.7 m95 -49.3 134.93 17.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.938 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.516 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 3.1 mm -120.67 169.73 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.192 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.0 tp -104.5 121.16 42.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.931 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.454 ' HB1' ' CG2' ' A' ' 80' ' ' ILE . . . -86.76 -67.69 0.8 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.09 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.6 t -129.8 -176.61 3.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.216 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 98.2 p -174.29 -178.03 1.36 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.874 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 58.91 27.14 15.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.46 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 58.2 mt -77.17 137.76 64.84 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.591 0.71 . . . . 0.0 111.11 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.46 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 53.2 Cg_endo -69.8 157.26 60.92 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.727 2.284 . . . . 0.0 112.371 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 -24.16 30.39 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.738 2.292 . . . . 0.0 112.335 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 86.6 p -79.75 -18.19 51.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.453 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.0 ttt180 -96.66 102.68 14.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.9 mt -100.19 14.29 31.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.926 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.0 t -156.02 132.61 10.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.833 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.1 m -146.98 162.61 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.119 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -98.51 110.72 23.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.454 ' CG2' ' HB1' ' A' ' 67' ' ' ALA . 40.1 mm -76.69 106.38 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.163 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.9 p -99.6 167.57 10.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.14 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.92 44.19 8.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.573 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.9 mt -98.88 -175.62 3.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.83 0.348 . . . . 0.0 110.93 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -132.85 119.72 20.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.69 156.69 22.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.892 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.47 13.54 44.97 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.45 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.526 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 33.3 mm -126.38 101.63 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.832 0.349 . . . . 0.0 111.175 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.21 141.81 57.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -164.06 162.43 23.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -109.11 -174.76 2.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.863 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.417 ' CD1' HD11 ' A' ' 26' ' ' ILE . 76.9 m-85 -144.57 150.85 38.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.421 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 2.3 ptp180 -141.75 175.07 9.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.501 HG22 ' CG ' ' A' ' 38' ' ' TRP . 57.8 t -142.03 135.7 29.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.1 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.0 mtt180 -124.98 142.5 51.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.813 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.41 130.77 50.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.1 mp -124.26 119.12 28.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.434 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.3 p-10 -123.71 -173.6 2.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.915 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.7 ptm -68.49 -0.66 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.838 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.42 ' CD1' ' O ' ' A' ' 16' ' ' SER . 51.7 mt -106.29 -26.02 11.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.956 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.19 -164.37 28.95 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.481 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.49 157.24 17.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.873 0.368 . . . . 0.0 110.906 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.423 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 7.3 p -96.38 174.92 6.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.936 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -71.11 159.48 85.44 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.663 0.744 . . . . 0.0 110.892 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.421 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.5 Cg_endo -69.65 106.89 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.698 2.265 . . . . 0.0 112.386 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.0 p -45.82 154.46 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.845 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -48.71 139.41 11.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.552 0.691 . . . . 0.0 111.087 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 94.74 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.664 2.243 . . . . 0.0 112.35 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.9 p -42.14 158.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -51.47 152.34 4.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.614 0.721 . . . . 0.0 110.864 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.43 ' HB3' ' CD1' ' A' ' 58' ' ' LEU . 54.8 Cg_endo -69.68 129.35 17.52 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.68 2.254 . . . . 0.0 112.393 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.508 ' CG ' HG23 ' A' ' 26' ' ' ILE . 60.1 t80 -119.41 118.08 30.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.4 t -93.3 102.5 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.118 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.6 t -68.67 106.8 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.06 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 t -100.97 -38.36 8.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.854 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.52 -79.82 0.32 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.498 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 60.1 p -47.68 162.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.871 0.367 . . . . 0.0 110.873 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 162.05 169.89 26.02 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.85 -164.56 0.13 Allowed 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.678 2.252 . . . . 0.0 112.357 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 97.1 p -138.06 146.25 42.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.836 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.9 t -52.65 -50.54 62.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.874 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.249 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.464 179.995 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 t -158.68 149.28 20.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.911 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.6 p -166.82 159.76 13.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.0 127.48 1.03 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.442 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.0 t -142.85 126.23 16.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.373 . . . . 0.0 110.839 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.0 t -166.17 144.29 5.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.869 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 157.93 56.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.537 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 m -168.76 164.45 11.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.837 0.351 . . . . 0.0 110.878 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -52.92 137.9 45.19 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.636 0.732 . . . . 0.0 110.952 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 104.3 1.29 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.697 2.265 . . . . 0.0 112.376 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.18 157.69 19.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.848 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.45 ' CG ' ' O ' ' A' ' 12' ' ' HIS . 1.1 p80 -78.42 125.03 28.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.29 -128.28 4.82 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.536 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -59.55 84.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.934 0.397 . . . . 0.0 110.875 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.567 HD11 ' CE2' ' A' ' 46' ' ' PHE . 3.0 mt -89.05 -176.96 5.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.943 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.4 ' O ' ' O ' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -144.42 161.61 43.47 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.675 0.75 . . . . 0.0 110.815 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 169.98 17.64 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.668 2.245 . . . . 0.0 112.332 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.425 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 53.4 Cg_endo -69.76 156.47 63.27 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.732 2.288 . . . . 0.0 112.372 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.416 ' C ' ' HB2' ' A' ' 102' ' ' SER . 4.5 pt-20 -101.6 165.66 11.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.927 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.83 122.76 64.36 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.546 0.689 . . . . 0.0 111.133 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 164.0 36.19 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.72 2.28 . . . . 0.0 112.338 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -51.63 176.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -80.29 122.38 82.71 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.577 0.703 . . . . 0.0 110.895 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.84 142.52 47.79 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.731 2.287 . . . . 0.0 112.357 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.416 ' C ' HD11 ' A' ' 26' ' ' ILE . 6.3 t -93.13 163.14 13.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.116 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.488 HG22 ' CD1' ' A' ' 111' ' ' TYR . 8.4 mm -123.63 129.55 74.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.116 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 t -136.05 165.49 25.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.807 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.5 m -80.91 109.16 15.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.167 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.526 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . . . -111.86 -35.83 5.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.148 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.9 m -165.19 -177.8 4.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.902 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.92 -14.68 44.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.89 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 36.6 p -122.96 -1.38 8.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.165 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.47 ' CB ' ' HA ' ' A' ' 81' ' ' THR . 4.7 p -143.18 175.28 10.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.0 m -153.35 144.3 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.526 ' CD2' ' CB ' ' A' ' 29' ' ' ALA . 19.0 m-85 -78.39 124.75 28.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.3 t -119.93 131.47 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.3 m -129.0 118.66 22.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.101 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.566 ' CD1' HG11 ' A' ' 93' ' ' VAL . 30.2 p90 -115.67 169.92 8.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.4 mm -132.23 107.35 13.53 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.589 0.709 . . . . 0.0 111.131 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.441 ' CD ' HD21 ' A' ' 76' ' ' LEU . 53.5 Cg_endo -69.66 134.08 27.32 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.715 2.277 . . . . 0.0 112.355 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -103.89 -70.26 0.77 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.856 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.96 144.09 15.73 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.423 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -116.15 13.21 15.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 0.0 110.827 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 75.31 -0.72 59.0 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.435 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.417 ' HA3' ' CD2' ' A' ' 15' ' ' LEU . . . 111.6 -22.48 19.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.567 ' CE2' HD11 ' A' ' 15' ' ' LEU . 2.0 m-85 -109.34 161.74 22.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.651 0.739 . . . . 0.0 110.892 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.66 113.67 3.43 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.68 2.253 . . . . 0.0 112.332 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.514 HD11 ' CE1' ' A' ' 51' ' ' PHE . 91.0 mt -42.69 127.79 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.153 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -82.55 -46.24 13.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.3 p -164.02 160.07 21.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.514 ' CE1' HD11 ' A' ' 48' ' ' ILE . 61.5 m-85 -107.93 173.33 6.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -148.27 124.17 10.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.2 140.01 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.099 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.43 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 42.0 mt-10 -136.45 151.1 49.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.44 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 35.6 p90 -125.79 165.04 19.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.953 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 89' ' ' TYR . 6.7 ttpm? -143.71 133.06 23.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -81.3 138.05 35.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.2 mt -99.6 -40.45 7.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -57.98 -71.54 0.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.891 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.457 ' O ' ' C ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -93.82 -174.5 3.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.457 ' C ' ' O ' ' A' ' 60' ' ' LYS . 7.6 p -32.35 107.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.164 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.84 114.74 3.89 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.478 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -141.75 137.53 31.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.75 0.309 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -71.13 119.49 15.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.44 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 1.8 mm -117.3 171.69 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.6 tp -104.31 130.6 52.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -103.31 -69.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.2 t -116.88 171.42 7.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.133 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.4 p -167.7 167.76 13.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.797 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 71.29 27.77 3.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.045 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.473 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 63.9 mt -78.04 137.55 61.25 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.653 0.739 . . . . 0.0 111.104 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.473 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 54.7 Cg_endo -69.66 157.24 61.25 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.743 2.295 . . . . 0.0 112.362 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -20.07 35.05 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.674 2.249 . . . . 0.0 112.34 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 92.4 p -83.38 -23.68 32.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.464 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 10.0 ttt180 -90.34 99.24 12.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.441 HD21 ' CD ' ' A' ' 40' ' ' PRO . 54.3 mt -95.96 15.33 20.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.906 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 t -155.54 136.48 13.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.9 m -150.08 163.06 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.151 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -98.91 112.47 24.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 47.6 mm -79.77 101.73 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.192 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.47 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 27.7 p -98.1 168.28 10.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.182 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.72 40.28 8.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.48 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 46.2 mt -104.27 -175.29 2.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -127.97 130.85 49.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.43 155.92 40.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.64 11.5 57.27 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.462 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.414 HD13 ' NZ ' ' A' ' 60' ' ' LYS . 26.2 mm -125.01 116.52 47.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.866 0.365 . . . . 0.0 111.132 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.15 135.76 35.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.446 ' CB ' ' O ' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -154.77 162.74 41.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.942 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -107.25 178.21 4.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.947 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.455 ' CD1' HD12 ' A' ' 26' ' ' ILE . 77.4 m-85 -137.16 160.42 39.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.907 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.43 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 2.1 ptp180 -150.97 177.75 9.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.566 HG11 ' CD1' ' A' ' 38' ' ' TRP . 91.6 t -147.44 137.97 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.124 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -129.56 141.65 50.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.45 132.17 47.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.022 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mp -125.24 119.59 28.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.944 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.425 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.8 p-10 -123.59 -173.71 2.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.93 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.52 ' HE1' ' CE2' ' A' ' 46' ' ' PHE . 15.4 ptm -68.26 -1.07 5.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.893 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.2 mt -106.25 -25.48 11.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.958 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.28 -165.55 28.62 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.458 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -100.5 158.11 16.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 110.869 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.416 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 4.0 p -94.47 175.22 6.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.842 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -70.34 159.72 83.7 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.649 0.738 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.413 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.5 Cg_endo -69.78 109.12 2.24 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.74 2.293 . . . . 0.0 112.31 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.7 p -51.01 153.47 1.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.88 140.34 30.17 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.572 0.701 . . . . 0.0 111.128 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 97.42 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.713 2.275 . . . . 0.0 112.354 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 88.2 p -45.75 167.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.16 152.68 50.7 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.666 0.746 . . . . 0.0 110.91 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 135.04 29.51 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.703 2.269 . . . . 0.0 112.32 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.488 ' CD1' HG22 ' A' ' 26' ' ' ILE . 54.0 t80 -124.22 124.34 42.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.921 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.09 101.78 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.152 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.3 t -70.09 105.73 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.055 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 115' ' ' GLY . 1.4 t -115.88 110.07 18.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 114' ' ' SER . . . 34.62 -147.23 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.455 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 65.7 m -81.51 132.8 35.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.951 0.405 . . . . 0.0 110.848 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.33 -160.52 34.34 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.538 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 165.82 29.61 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.733 2.288 . . . . 0.0 112.321 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.7 t -125.99 132.94 51.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.922 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.4 m -93.66 103.22 15.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.539 -179.981 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.531 -0.227 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 m -38.39 157.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.914 0.388 . . . . 0.0 110.781 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 m -124.26 157.02 35.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.831 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.86 -159.63 27.23 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.512 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.0 p -92.2 133.71 35.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 0.0 110.88 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.5 t -87.03 163.89 16.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.846 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -129.55 155.62 20.95 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.518 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -63.59 150.61 43.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.81 0.338 . . . . 0.0 110.867 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.47 ' CG ' ' HD2' ' A' ' 10' ' ' PRO . 17.9 tt0 -61.36 140.27 94.65 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.597 0.713 . . . . 0.0 110.942 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HD2' ' CG ' ' A' ' 9' ' ' GLN . 53.4 Cg_endo -69.77 157.44 60.35 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.638 2.225 . . . . 0.0 112.362 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -130.53 123.76 30.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -113.52 154.2 27.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.854 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.11 66.2 0.88 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.0 ptt-85 -75.08 96.5 3.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 110.843 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.556 HD11 ' CE2' ' A' ' 46' ' ' PHE . 3.2 mt -85.35 -176.66 6.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.428 ' O ' ' CD1' ' A' ' 99' ' ' LEU . 1.7 m -146.43 161.54 38.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.68 0.752 . . . . 0.0 110.865 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 169.59 18.57 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.723 2.282 . . . . 0.0 112.337 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.43 ' HD3' ' CG ' ' A' ' 97' ' ' ASN . 53.0 Cg_endo -69.79 150.78 68.47 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.661 2.24 . . . . 0.0 112.32 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' HB2' ' A' ' 102' ' ' SER . 9.1 pt-20 -92.69 174.71 7.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.8 122.4 83.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.573 0.702 . . . . 0.0 111.079 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 161.82 44.46 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.697 2.264 . . . . 0.0 112.317 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -51.77 175.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -80.28 122.82 83.21 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.603 0.716 . . . . 0.0 110.869 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 142.87 49.13 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.701 2.267 . . . . 0.0 112.419 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 t -93.32 159.1 15.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.564 HG22 ' CD2' ' A' ' 111' ' ' TYR . 3.9 mm -122.13 119.18 57.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.142 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -119.31 -174.96 2.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.918 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 47.0 m -103.15 100.76 10.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.136 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.51 ' HB1' ' CZ ' ' A' ' 35' ' ' TYR . . . -103.48 -38.3 7.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.086 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.1 m -161.11 -179.64 7.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -81.47 -21.53 38.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.9 p -116.67 -2.26 11.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.152 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.432 ' CB ' ' HA ' ' A' ' 81' ' ' THR . 3.9 p -142.58 164.01 31.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.817 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.3 m -143.39 145.19 22.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.179 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.51 ' CZ ' ' HB1' ' A' ' 29' ' ' ALA . 18.1 m-85 -75.49 113.9 13.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.94 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.7 t -107.07 124.62 62.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.13 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.9 m -124.71 121.31 34.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.122 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.535 ' CD1' HG13 ' A' ' 93' ' ' VAL . 25.0 p90 -118.18 169.63 9.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.915 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.2 mm -134.35 106.18 11.11 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.632 0.729 . . . . 0.0 111.152 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 142.29 47.55 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.676 2.251 . . . . 0.0 112.321 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -111.69 -69.52 0.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.887 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.0 142.16 15.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.534 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 47.2 p-10 -112.54 9.55 19.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.904 0.383 . . . . 0.0 110.893 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 79.01 0.67 83.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.454 ' HA3' ' CD2' ' A' ' 15' ' ' LEU . . . 111.6 -24.5 15.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.556 ' CE2' HD11 ' A' ' 15' ' ' LEU . 2.5 m-85 -108.16 162.11 21.04 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.629 0.728 . . . . 0.0 110.908 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 113.82 3.5 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.669 2.246 . . . . 0.0 112.385 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.489 HD11 ' CE1' ' A' ' 51' ' ' PHE . 97.6 mt -43.58 127.35 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -81.77 -48.32 11.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.936 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.6 m -162.13 162.03 28.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.921 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.489 ' CE1' HD11 ' A' ' 48' ' ' ILE . 51.5 m-85 -109.03 176.31 5.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -149.93 123.42 9.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.411 ' CG1' HD11 ' A' ' 80' ' ' ILE . 21.7 t -105.36 133.19 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.136 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -132.13 162.97 29.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.938 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.565 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 16.1 p90 -148.34 146.18 28.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.501 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 14.8 ttpp -121.93 131.73 54.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.879 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -76.37 128.73 35.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.868 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.2 mt -86.11 160.34 19.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt 58.75 27.23 15.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -150.49 165.18 33.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.833 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.5 p -101.23 139.23 22.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.35 129.55 2.88 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.448 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -52.51 177.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.711 0.291 . . . . 0.0 110.923 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.501 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 35.9 m95 -61.5 176.68 0.46 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.942 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.565 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 2.3 mm -133.12 164.02 36.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.17 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.8 tp -102.66 123.36 46.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.78 -66.9 0.89 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.071 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.8 t -128.04 177.81 6.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.113 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.2 p -171.31 167.65 6.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.867 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 71.49 36.13 1.35 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.474 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 72.8 mt -87.48 138.29 31.98 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.624 0.726 . . . . 0.0 111.144 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.474 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 53.9 Cg_endo -69.8 156.69 62.59 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.676 2.251 . . . . 0.0 112.341 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.87 -20.69 33.97 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.696 2.264 . . . . 0.0 112.338 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.1 t -84.32 -10.67 57.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.432 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 12.2 ttt180 -103.38 102.97 12.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.1 mt -100.69 10.47 41.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 t -151.92 129.2 11.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.7 165.04 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.086 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -98.52 113.73 25.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.865 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.411 HD11 ' CG1' ' A' ' 53' ' ' VAL . 40.0 mm -83.63 98.57 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.091 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.432 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 73.7 p -95.78 165.3 12.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.193 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.69 35.33 9.34 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.497 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.9 mt -94.45 176.49 6.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.866 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -121.7 120.26 34.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -62.82 156.73 23.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.948 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.28 13.9 45.26 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.555 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.478 HG21 ' CD2' ' A' ' 89' ' ' TYR . 27.1 mm -124.95 104.93 14.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 0.0 111.117 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.55 134.16 47.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.478 ' CD2' HG21 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -157.01 163.12 39.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.934 -179.813 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -111.01 176.63 4.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.894 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.561 ' CD1' HD12 ' A' ' 26' ' ' ILE . 8.0 m-85 -131.96 158.1 42.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -149.63 171.87 15.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.535 HG13 ' CD1' ' A' ' 38' ' ' TRP . 94.5 t -139.68 142.77 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.448 ' N ' HG11 ' A' ' 93' ' ' VAL . 34.0 mtt180 -132.41 141.59 48.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.98 125.18 48.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.075 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mp -119.76 118.02 29.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.43 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.3 p-10 -123.6 -174.28 2.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.511 ' HE3' ' CE1' ' A' ' 46' ' ' PHE . 5.0 ptp -67.61 -2.12 6.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.428 ' CD1' ' O ' ' A' ' 16' ' ' SER . 29.4 mt -105.29 -25.63 12.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.944 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.53 -167.16 28.63 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.519 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -101.4 157.54 16.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.819 0.343 . . . . 0.0 110.896 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.417 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 8.7 p -94.22 174.27 7.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.805 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -70.23 160.39 81.08 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.59 0.71 . . . . 0.0 110.929 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 105.48 1.49 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.742 2.294 . . . . 0.0 112.306 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.4 p -45.2 156.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.803 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.51 139.93 27.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.564 0.697 . . . . 0.0 111.117 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.69 89.26 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.719 2.279 . . . . 0.0 112.382 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 t -40.7 152.28 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.2 mtt-85 -44.75 153.57 0.47 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.6 0.714 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 132.95 24.33 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.651 2.234 . . . . 0.0 112.367 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.564 ' CD2' HG22 ' A' ' 26' ' ' ILE . 20.5 t80 -121.17 116.57 25.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.79 107.32 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.094 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.27 111.73 13.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.3 t -113.19 -31.57 6.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.817 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.75 -174.84 46.03 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.465 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 88.4 p -103.86 177.8 4.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.877 0.37 . . . . 0.0 110.935 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -132.04 -158.02 8.86 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.493 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 114.87 3.84 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.692 2.261 . . . . 0.0 112.372 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.7 t -74.08 148.73 41.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.84 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 t -110.26 117.7 34.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.499 -179.962 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 m -105.43 125.97 51.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.905 0.383 . . . . 0.0 110.881 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.8 t -105.94 149.42 26.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.889 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.06 103.3 2.23 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.5 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 t -150.48 134.91 17.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.89 0.376 . . . . 0.0 110.849 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.1 p -125.88 172.19 10.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.871 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.3 140.24 14.78 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.442 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.5 p -167.97 147.15 4.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.9 0.381 . . . . 0.0 110.835 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.6 pm0 -39.86 144.16 0.54 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.609 0.718 . . . . 0.0 110.911 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 113.52 3.4 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.691 2.26 . . . . 0.0 112.308 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 12' ' ' HIS . 5.4 m-20 -83.74 103.5 13.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.463 ' CG ' ' O ' ' A' ' 12' ' ' HIS . 39.4 p-80 -36.19 115.78 0.36 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.854 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.3 -83.53 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.51 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.7 mmt-85 -61.52 87.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.833 0.349 . . . . 0.0 110.917 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.566 HD11 ' CE2' ' A' ' 46' ' ' PHE . 7.7 mt -92.29 -175.35 4.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.465 ' O ' ' CD1' ' A' ' 99' ' ' LEU . 1.6 m -141.26 161.77 51.28 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.704 0.764 . . . . 0.0 110.772 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 169.77 18.13 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.665 2.244 . . . . 0.0 112.284 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.441 ' O ' ' CB ' ' A' ' 102' ' ' SER . 54.2 Cg_endo -69.86 159.02 54.84 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.618 2.212 . . . . 0.0 112.316 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.55 165.15 11.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.926 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.2 120.55 52.13 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.621 0.724 . . . . 0.0 111.126 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 166.56 27.17 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.718 2.278 . . . . 0.0 112.307 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -52.53 172.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.935 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.439 ' NE ' ' HB1' ' A' ' 106' ' ' ALA . 13.7 ttm105 -79.83 123.03 84.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.598 0.713 . . . . 0.0 110.849 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.443 ' HB2' ' CG1' ' A' ' 36' ' ' VAL . 53.1 Cg_endo -69.79 141.79 46.07 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.658 2.239 . . . . 0.0 112.35 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.9 t -92.47 169.22 10.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.119 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.1 mm -129.13 131.99 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.131 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 t -139.31 167.59 21.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.4 m -80.22 108.16 13.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.48 ' CB ' ' CD2' ' A' ' 35' ' ' TYR . . . -113.01 -35.43 5.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.075 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.0 m -164.32 178.84 7.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.812 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.78 -16.68 46.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.851 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 p -122.2 -2.12 9.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.168 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.42 ' CB ' ' HA ' ' A' ' 81' ' ' THR . 7.0 p -141.11 171.22 14.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.6 m -147.82 145.44 18.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.148 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.48 ' CD2' ' CB ' ' A' ' 29' ' ' ALA . 9.7 m-85 -78.86 119.28 21.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.443 ' CG1' ' HB2' ' A' ' 24' ' ' PRO . 92.4 t -115.95 132.17 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.183 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.7 m -129.2 124.44 34.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.169 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.559 ' CD1' HG12 ' A' ' 93' ' ' VAL . 24.7 p90 -123.13 171.54 9.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.956 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.6 mm -137.2 106.25 8.66 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.677 0.751 . . . . 0.0 111.163 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 135.91 31.47 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.626 2.217 . . . . 0.0 112.35 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.2 mmm-85 -102.17 -70.63 0.74 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.36 152.54 18.41 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.484 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 52.6 p-10 -122.54 12.63 10.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.854 0.359 . . . . 0.0 110.862 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.63 -0.84 59.93 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.511 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.18 -18.79 25.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.464 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.566 ' CE2' HD11 ' A' ' 15' ' ' LEU . 2.1 m-85 -113.08 162.32 22.47 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.584 0.707 . . . . 0.0 110.915 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 115.47 4.11 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.639 2.226 . . . . 0.0 112.365 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.532 HD13 ' CE1' ' A' ' 51' ' ' PHE . 96.7 mt -45.7 132.0 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.106 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -86.87 -47.14 9.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.9 p -164.22 159.14 19.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.861 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.532 ' CE1' HD13 ' A' ' 48' ' ' ILE . 54.7 m-85 -107.97 173.12 6.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.897 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -150.1 124.92 9.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.0 t -103.14 136.32 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.168 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -133.89 146.65 50.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.841 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.524 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 26.9 p90 -125.08 174.81 7.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.979 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.441 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 29.6 ttpt -146.47 125.12 12.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -75.03 126.23 30.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 15.4 mt -94.93 -60.67 1.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.857 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -39.03 -41.24 0.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.952 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -122.4 164.2 18.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.955 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.7 p -71.23 158.94 5.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.169 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 140.87 125.09 2.11 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.543 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -62.43 -174.87 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.779 0.323 . . . . 0.0 110.859 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.567 ' CH2' ' HD3' ' A' ' 92' ' ' ARG . 89.5 m95 -67.52 137.15 55.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.524 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.2 mm -114.6 164.08 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.125 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.8 tp -98.33 130.36 45.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -102.58 -70.27 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.091 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.427 HG23 ' CD1' ' A' ' 80' ' ' ILE . 12.0 t -124.63 164.72 19.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 t -163.43 171.26 16.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.89 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 73.13 25.28 2.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.173 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.465 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 80.4 mt -76.11 138.12 68.74 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.585 0.707 . . . . 0.0 111.156 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.465 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 53.8 Cg_endo -69.75 157.04 61.76 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.726 2.284 . . . . 0.0 112.311 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 -17.55 37.16 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.645 2.23 . . . . 0.0 112.357 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 t -87.08 -17.44 32.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.872 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.46 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 6.5 ttt85 -97.21 98.33 9.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.9 mt -92.23 9.94 31.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.7 t -154.92 137.78 15.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -147.51 167.95 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.101 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -101.26 104.19 15.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.427 ' CD1' HG23 ' A' ' 68' ' ' THR . 48.4 mm -71.48 101.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.113 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.42 ' HA ' ' CB ' ' A' ' 33' ' ' SER . 38.8 p -101.22 161.63 13.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.141 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.72 37.34 6.13 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.452 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.4 mt -100.28 176.58 5.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.73 0.3 . . . . 0.0 110.935 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -120.32 117.92 29.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.81 150.65 27.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.96 12.56 71.47 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.512 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.466 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 39.0 mm -125.11 109.7 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.893 0.378 . . . . 0.0 111.193 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.44 140.71 46.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.466 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -164.11 167.03 20.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.883 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.491 ' O ' ' CB ' ' A' ' 55' ' ' TYR . 58.1 mttt -112.85 -177.18 3.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.862 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -146.19 152.43 39.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.567 ' HD3' ' CH2' ' A' ' 64' ' ' TRP . 6.4 mtm180 -143.62 -178.37 5.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.914 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.559 HG12 ' CD1' ' A' ' 38' ' ' TRP . 61.5 t -142.67 139.02 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.166 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.441 ' N ' HG13 ' A' ' 93' ' ' VAL . 44.4 mtt180 -126.87 145.3 50.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.769 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.5 125.25 49.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.101 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.2 mp -120.86 117.78 28.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.438 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 41.1 p-10 -123.85 -173.27 2.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.2 ptm -68.92 -0.39 5.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.926 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.465 ' CD1' ' O ' ' A' ' 16' ' ' SER . 62.8 mt -106.21 -26.28 11.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.993 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.76 -163.43 29.05 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.499 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -108.83 155.63 20.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.88 0.371 . . . . 0.0 110.838 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 59.3 p -98.99 172.5 7.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.842 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.2 mp0 -69.19 157.32 89.62 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.614 0.721 . . . . 0.0 110.933 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 116.1 4.4 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.723 2.282 . . . . 0.0 112.346 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.459 ' O ' ' C ' ' A' ' 106' ' ' ALA . 74.7 p -54.47 148.21 12.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.893 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 105' ' ' SER . . . -32.67 141.7 0.18 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.62 0.724 . . . . 0.0 111.061 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 97.69 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.634 2.223 . . . . 0.0 112.322 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.1 p -42.69 149.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -46.75 151.89 1.01 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.59 0.71 . . . . 0.0 110.871 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 119.82 6.7 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.666 2.244 . . . . 0.0 112.303 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -110.47 120.13 41.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.0 t -94.36 102.62 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.174 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.7 t -71.66 109.83 4.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.11 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.9 t -124.07 49.1 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.3 -175.9 38.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.455 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 99.8 p -97.29 131.92 43.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.929 0.395 . . . . 0.0 110.919 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 157.93 164.73 14.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.506 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 91.21 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.736 2.291 . . . . 0.0 112.319 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 58.7 m 56.74 43.16 25.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.793 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 61.0 p -74.96 129.8 38.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.892 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.537 -179.995 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.484 -0.247 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 m -145.62 127.09 15.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 0.0 110.847 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.2 m 62.58 44.67 6.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.866 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.74 140.49 15.35 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.475 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 99.6 p -129.21 133.43 47.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.854 0.359 . . . . 0.0 110.825 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.9 p -83.44 165.53 19.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.62 166.93 32.63 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.486 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.9 m -148.53 146.4 28.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.751 0.31 . . . . 0.0 110.843 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -115.51 142.83 29.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.539 0.685 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.66 144.23 53.91 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -111.34 -45.86 3.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -73.2 101.13 3.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.93 173.6 50.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.475 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.2 62.45 2.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 0.0 110.887 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.514 HD13 ' CE2' ' A' ' 46' ' ' PHE . 7.2 mt -77.55 -175.12 3.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.972 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.447 ' O ' ' CD1' ' A' ' 99' ' ' LEU . 1.7 m -142.89 161.38 49.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.662 0.744 . . . . 0.0 110.905 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 168.67 20.86 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.667 2.245 . . . . 0.0 112.393 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.45 ' O ' ' CB ' ' A' ' 102' ' ' SER . 53.8 Cg_endo -69.72 159.34 53.82 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.689 2.26 . . . . 0.0 112.334 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.421 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.0 pt-20 -103.64 160.03 15.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.7 122.25 44.57 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.556 0.693 . . . . 0.0 111.102 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 163.96 36.34 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.661 2.241 . . . . 0.0 112.365 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -51.5 176.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.84 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -80.05 123.95 83.21 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.654 0.74 . . . . 0.0 110.876 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.45 ' O ' ' CB ' ' A' ' 108' ' ' SER . 53.4 Cg_endo -69.73 143.0 49.59 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.718 2.279 . . . . 0.0 112.283 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 t -95.53 166.8 11.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.568 HG21 ' CD2' ' A' ' 111' ' ' TYR . 5.1 mm -124.06 118.17 53.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.137 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -117.84 168.59 10.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.6 m -87.52 102.07 14.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.503 ' HB3' ' CG ' ' A' ' 35' ' ' TYR . . . -104.85 -36.04 7.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.05 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.8 m -173.08 173.45 3.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.885 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -78.41 -15.26 58.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.992 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.2 p -114.8 -6.97 12.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.165 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.0 p -144.99 171.53 14.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.5 m -145.87 147.32 18.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.158 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.503 ' CG ' ' HB3' ' A' ' 29' ' ' ALA . 13.6 m-85 -82.98 115.33 21.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 81.6 t -108.35 130.33 61.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.096 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.9 m -128.44 120.52 27.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.112 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.528 ' CD1' HG11 ' A' ' 93' ' ' VAL . 27.9 p90 -118.14 170.67 8.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.96 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.6 mm -133.96 106.59 11.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.634 0.731 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 136.82 33.93 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.752 2.301 . . . . 0.0 112.311 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -104.78 -69.98 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.37 145.05 16.31 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.515 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -113.55 4.74 16.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 110.895 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 82.89 1.88 90.64 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.467 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.53 -26.64 11.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.454 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.514 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.4 m-85 -106.81 161.7 22.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.642 0.734 . . . . 0.0 110.898 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 113.82 3.5 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.691 2.261 . . . . 0.0 112.371 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 89.1 mt -42.32 129.43 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.125 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -83.66 -49.02 9.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.908 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.9 p -160.09 163.2 34.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.848 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -108.96 177.89 4.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -149.83 119.85 7.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.13 130.01 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.158 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -132.65 148.31 52.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.417 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 45.2 p90 -123.53 172.91 8.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.411 ' HD3' ' NE1' ' A' ' 64' ' ' TRP . 17.4 ttpt -147.91 135.35 20.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -83.33 130.69 35.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.959 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 59' ' ' LYS . 43.2 mt -97.52 -61.09 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.88 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.434 ' C ' ' HD3' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -36.16 -60.81 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.938 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -105.31 159.32 15.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.22 134.52 29.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.105 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.15 127.1 0.99 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.531 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -66.51 -176.19 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 0.0 110.876 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.411 ' NE1' ' HD3' ' A' ' 56' ' ' LYS . 73.3 m95 -72.72 140.26 47.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.417 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 1.8 mm -119.95 167.57 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.127 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.6 tp -102.31 118.97 38.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.964 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.42 -69.37 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.161 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.8 t -128.67 -178.94 4.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.127 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.3 p -174.42 -177.3 1.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.841 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 61.4 32.64 19.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.103 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.47 ' CG2' ' HD2' ' A' ' 72' ' ' PRO . 85.3 mt -84.68 138.47 38.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.581 0.705 . . . . 0.0 111.128 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.47 ' HD2' ' CG2' ' A' ' 71' ' ' ILE . 53.7 Cg_endo -69.74 158.25 57.62 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.705 2.27 . . . . 0.0 112.414 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -29.57 23.78 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.724 2.283 . . . . 0.0 112.397 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.2 m -74.69 -14.24 60.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.428 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.8 ttt180 -99.99 111.25 23.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.811 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.5 mt -107.25 7.18 29.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 t -150.73 131.73 14.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.0 174.82 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.142 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -111.9 115.0 28.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.826 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 23.4 mm -84.66 104.91 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.052 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.3 p -98.84 168.29 10.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.144 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.01 38.96 8.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.489 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.4 mt -103.25 168.79 8.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.743 0.306 . . . . 0.0 110.874 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -113.29 127.18 56.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.79 153.37 43.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.27 12.57 72.63 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.49 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.406 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 20.1 mm -125.24 111.74 28.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.909 0.385 . . . . 0.0 111.09 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.89 139.42 40.22 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.406 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -160.72 167.35 27.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -113.4 -176.69 2.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.872 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -143.05 152.22 41.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.932 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -141.63 179.78 6.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.528 HG11 ' CD1' ' A' ' 38' ' ' TRP . 92.7 t -147.48 140.15 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.142 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.403 ' N ' HG12 ' A' ' 93' ' ' VAL . 27.2 mtt180 -130.27 141.45 50.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.38 125.06 47.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.082 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.449 ' HG ' ' CB ' ' A' ' 101' ' ' GLU . 8.3 mp -121.71 119.67 32.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.949 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.429 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.2 p-10 -123.6 -173.98 2.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.506 ' HE1' ' CG ' ' A' ' 46' ' ' PHE . 4.9 ptp -67.09 -2.59 5.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.447 ' CD1' ' O ' ' A' ' 16' ' ' SER . 33.9 mt -105.15 -25.31 12.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.898 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 146.38 -168.47 27.82 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.451 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.449 ' CB ' ' HG ' ' A' ' 96' ' ' LEU . 3.8 pt-20 -101.84 158.03 16.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 0.0 110.923 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 52.6 p -98.94 167.27 10.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -61.4 157.84 42.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.684 0.754 . . . . 0.0 110.865 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 115.04 3.91 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.71 2.273 . . . . 0.0 112.319 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 92.6 p -54.17 158.95 2.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.831 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.19 142.89 56.85 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.566 0.698 . . . . 0.0 111.159 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 102.12 0.99 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.663 2.242 . . . . 0.0 112.377 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 24' ' ' PRO . 59.5 p -51.55 159.48 0.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -50.39 151.22 3.98 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.608 0.718 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 136.69 33.77 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.684 2.256 . . . . 0.0 112.353 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.568 ' CD2' HG21 ' A' ' 26' ' ' ILE . 49.0 t80 -124.73 117.47 24.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 55.3 t -92.6 103.73 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.154 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.7 t -69.47 113.07 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.3 t -113.42 143.39 44.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.891 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 116' ' ' SER . . . -54.08 -90.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.55 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 115' ' ' GLY . 74.3 m -37.03 115.52 0.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.887 0.375 . . . . 0.0 110.832 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -148.67 -164.75 11.68 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.479 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.87 152.63 68.79 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.626 2.217 . . . . 0.0 112.33 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.4 t -93.11 -58.62 2.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.833 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.2 t -165.31 118.05 1.18 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.479 -179.983 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.607 HD22 ' HA3' ' A' ' 45' ' ' GLY . 9.2 mt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.822 0.344 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.549 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.8 m -144.39 161.51 44.03 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.665 0.745 . . . . 0.0 110.863 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 169.3 19.25 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.642 2.228 . . . . 0.0 112.363 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.557 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.7 Cg_endo -69.77 154.33 67.8 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.671 2.248 . . . . 0.0 112.334 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.421 ' C ' ' HB2' ' A' ' 102' ' ' SER . 4.7 pt-20 -98.46 167.69 10.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.841 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.15 122.84 77.81 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.544 0.688 . . . . 0.0 111.076 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.41 ' HG3' HG12 ' A' ' 93' ' ' VAL . 53.4 Cg_endo -69.81 164.38 34.81 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.629 2.219 . . . . 0.0 112.278 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -50.45 176.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.832 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -80.59 123.13 82.89 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.599 0.714 . . . . 0.0 110.863 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 144.0 52.58 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.618 2.212 . . . . 0.0 112.383 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.826 ' O ' HD13 ' A' ' 26' ' ' ILE . 4.0 t -94.58 167.44 11.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.128 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.826 HD13 ' O ' ' A' ' 25' ' ' THR . 6.8 mm -125.75 126.0 69.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.141 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.0 m -129.8 160.42 33.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.6 m -80.46 104.14 10.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.062 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.726 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -106.59 -38.86 6.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.073 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.9 m -164.76 176.57 8.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.62 -17.26 51.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 p -116.91 -3.65 11.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.629 ' CB ' HG22 ' A' ' 81' ' ' THR . 5.5 p -143.07 174.81 10.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.468 HG11 ' CE2' ' A' ' 111' ' ' TYR . 31.0 m -151.85 145.34 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.155 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.726 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 12.3 m-85 -79.67 120.59 24.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.96 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 93.8 t -117.0 130.78 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.149 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 59.1 m -128.96 120.52 26.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.098 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.632 ' CD1' HG11 ' A' ' 93' ' ' VAL . 28.4 p90 -117.68 171.25 8.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 mm -135.99 107.03 9.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.633 0.73 . . . . 0.0 111.136 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 143.73 52.03 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.709 2.273 . . . . 0.0 112.357 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -112.68 -69.95 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.39 146.7 16.28 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.55 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -116.24 7.34 14.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.981 0.42 . . . . 0.0 110.956 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 79.7 2.07 87.7 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.472 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.607 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 110.35 -26.67 12.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.52 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -106.5 161.8 21.73 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.572 0.701 . . . . 0.0 110.899 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 119.21 6.19 Favored 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.712 2.275 . . . . 0.0 112.339 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.539 HD13 ' CE1' ' A' ' 51' ' ' PHE . 93.3 mt -48.25 136.17 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -93.15 -49.44 5.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.943 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.2 p -159.41 158.4 32.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.539 ' CE1' HD13 ' A' ' 48' ' ' ILE . 58.7 m-85 -108.38 173.65 6.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.896 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -144.09 128.51 17.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.573 HG11 HD11 ' A' ' 80' ' ' ILE . 42.4 t -113.08 122.83 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -124.81 157.74 35.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 39.0 p90 -133.07 174.91 9.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 89' ' ' TYR . 5.7 ttpm? -146.83 133.53 19.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -84.68 120.82 26.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.426 HD11 ' HB3' ' A' ' 110' ' ' PRO . 60.3 mt . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.967 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 53.4 m95 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.718 0.294 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.566 HG22 ' H ' ' A' ' 66' ' ' LEU . 2.6 mm -115.63 170.63 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.137 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.566 ' H ' HG22 ' A' ' 65' ' ' ILE . 48.9 tp -103.75 118.9 37.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.964 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.68 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -87.92 -71.58 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.11 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.586 HG21 HD11 ' A' ' 71' ' ' ILE . 3.9 t -123.83 -179.4 4.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.128 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 23.7 p -174.5 174.17 2.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 67.05 30.08 7.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.111 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.691 HD13 HG11 ' A' ' 78' ' ' VAL . 56.0 mt -81.58 138.04 47.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.657 0.742 . . . . 0.0 111.149 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.652 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.0 Cg_endo -69.74 157.85 59.01 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.661 2.24 . . . . 0.0 112.334 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.69 -19.81 35.96 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.704 2.269 . . . . 0.0 112.407 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 t -85.19 -15.91 42.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.472 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 16.4 ttt180 -97.87 101.21 12.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.854 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.5 mt -98.33 7.72 45.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.959 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 t -150.33 132.1 15.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.804 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.691 HG11 HD13 ' A' ' 71' ' ' ILE . 2.2 m -146.69 164.39 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.091 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.466 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 37.3 tt0 -98.43 111.01 23.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.68 HG23 ' HB1' ' A' ' 67' ' ' ALA . 31.3 mm -78.49 101.81 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.169 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.629 HG22 ' CB ' ' A' ' 33' ' ' SER . 35.2 p -98.96 163.95 12.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.076 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.74 36.96 6.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.504 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.9 mt -104.83 168.49 9.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.76 0.314 . . . . 0.0 110.904 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -112.85 125.77 54.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.65 155.09 34.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.01 10.54 59.23 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.415 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.475 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 32.0 mm -121.98 107.87 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.839 0.352 . . . . 0.0 111.148 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.86 140.52 47.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.798 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.475 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -163.59 164.31 24.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.864 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.2 mttt -109.57 -174.83 2.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.892 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -145.4 159.5 42.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.902 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.414 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 2.7 ptp180 -150.47 174.31 13.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.632 HG11 ' CD1' ' A' ' 38' ' ' TRP . 89.1 t -139.2 142.41 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.122 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 33.8 mtt180 -133.15 143.07 49.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.833 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -103.97 129.04 51.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.078 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.1 mp -122.24 118.14 27.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.438 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 41.0 p-10 -123.04 -174.01 2.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 18.8 ptm -67.15 -2.69 6.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.839 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 16' ' ' SER . 67.4 mt -104.4 -26.01 12.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.946 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.6 -165.71 28.74 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.475 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.46 157.25 16.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.872 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.421 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 6.4 p -92.86 175.21 6.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.802 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -73.42 159.49 84.66 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.696 0.76 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.414 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.3 Cg_endo -69.69 107.49 1.86 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.708 2.272 . . . . 0.0 112.316 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.1 p -51.2 152.62 2.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -48.81 138.37 12.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.627 0.727 . . . . 0.0 111.012 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 104.86 1.39 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.634 2.223 . . . . 0.0 112.38 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.4 p -51.31 171.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -62.36 150.7 84.39 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.648 0.737 . . . . 0.0 110.899 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.426 ' HB3' HD11 ' A' ' 58' ' ' LEU . 54.7 Cg_endo -69.65 120.82 7.56 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.698 2.265 . . . . 0.0 112.339 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.512 ' CB ' HG21 ' A' ' 26' ' ' ILE . 85.8 t80 -111.04 120.05 41.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.963 0.411 . . . . 0.0 110.912 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 52.0 t -91.42 103.35 14.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 t -70.11 106.51 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.148 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -179.872 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.545 HD13 ' CE2' ' A' ' 46' ' ' PHE . 6.3 mt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.773 0.32 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.503 ' O ' HD12 ' A' ' 99' ' ' LEU . 0.6 OUTLIER -146.81 161.52 37.14 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.578 0.704 . . . . 0.0 110.904 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 170.03 17.54 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.661 2.241 . . . . 0.0 112.361 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.549 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.5 Cg_endo -69.67 156.49 63.45 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.732 2.288 . . . . 0.0 112.333 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.423 ' C ' ' HB2' ' A' ' 102' ' ' SER . 9.3 pt-20 -100.59 166.45 10.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.07 121.53 56.1 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.646 0.736 . . . . 0.0 111.087 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 162.89 40.3 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.698 2.266 . . . . 0.0 112.353 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -51.57 175.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.793 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.43 ' NE ' ' HA ' ' A' ' 108' ' ' SER . 18.2 ttt180 -79.88 123.29 83.8 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.537 0.684 . . . . 0.0 110.917 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 142.94 48.95 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.682 2.254 . . . . 0.0 112.326 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.798 ' C ' HD13 ' A' ' 26' ' ' ILE . 2.2 t -94.05 165.42 12.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.798 HD13 ' C ' ' A' ' 25' ' ' THR . 4.3 mm -124.49 119.34 56.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.084 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.3 m -122.66 162.02 22.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.2 m -83.46 98.79 9.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.698 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -97.85 -42.22 7.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.068 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.2 m -161.09 -177.75 6.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.528 ' HG3' HG23 ' A' ' 32' ' ' THR . 15.1 pt-20 -84.44 -14.58 48.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.899 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.528 HG23 ' HG3' ' A' ' 31' ' ' GLU . 51.4 p -121.06 -1.73 9.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.106 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.62 ' CB ' HG22 ' A' ' 81' ' ' THR . 10.7 p -145.54 171.89 14.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.1 m -147.88 147.28 17.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.128 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.698 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 13.4 m-85 -82.74 113.66 20.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.851 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.5 t -108.43 128.49 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.153 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.433 HG23 ' HB2' ' A' ' 77' ' ' SER . 39.9 m -125.95 122.33 35.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.117 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.578 ' CD1' HG11 ' A' ' 93' ' ' VAL . 29.4 p90 -120.79 171.27 8.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.4 mm -136.61 106.24 9.12 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.562 0.696 . . . . 0.0 111.12 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 130.07 18.67 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.707 2.272 . . . . 0.0 112.329 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 mmt85 -94.54 -69.33 0.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.867 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.51 146.05 16.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.445 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -113.52 7.92 17.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.922 0.391 . . . . 0.0 110.904 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 80.56 -1.73 81.28 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.494 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.85 -24.51 11.84 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.473 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.613 ' CG ' ' HE3' ' A' ' 98' ' ' MET . 2.0 m-85 -108.32 162.19 20.8 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.646 0.736 . . . . 0.0 110.885 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.85 116.49 4.59 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.698 2.265 . . . . 0.0 112.278 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.54 HD13 ' CE1' ' A' ' 51' ' ' PHE . 85.9 mt -46.86 125.64 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -80.75 -51.51 8.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.2 m -156.6 162.28 39.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.858 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.54 ' CE1' HD13 ' A' ' 48' ' ' ILE . 61.3 m-85 -111.08 178.47 4.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.922 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 75.4 mtt-85 -149.61 124.94 10.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.5 t -110.24 126.47 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.11 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -124.07 155.87 37.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.513 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 39.1 p90 -132.86 158.43 42.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.88 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.459 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 28.9 ttpt -131.78 127.42 36.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.869 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -81.14 115.88 20.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' A' ' 110' ' ' PRO . 57.5 mt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.952 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.69 ' O ' HD13 ' A' ' 65' ' ' ILE . 87.4 m95 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.782 0.325 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.69 HD13 ' O ' ' A' ' 64' ' ' TRP . 4.0 mm -136.41 166.93 25.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.133 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.502 ' H ' HG22 ' A' ' 65' ' ' ILE . 50.3 tp -97.95 126.13 43.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.94 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.659 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -95.62 -69.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.097 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.503 ' CG2' HD11 ' A' ' 71' ' ' ILE . 6.5 t -130.71 165.14 23.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.142 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.504 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 75.5 p -157.9 172.91 17.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 71.92 27.4 2.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.067 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.667 HG23 ' HD2' ' A' ' 72' ' ' PRO . 76.3 mt -78.16 138.52 60.5 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.56 0.695 . . . . 0.0 111.184 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.667 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.2 Cg_endo -69.79 155.99 64.41 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.652 2.235 . . . . 0.0 112.364 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.77 -21.79 32.92 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.615 2.21 . . . . 0.0 112.352 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 54.6 p -82.73 -13.53 56.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.809 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.455 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.3 ttt180 -100.72 106.46 17.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.946 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.2 mt -101.78 7.33 41.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.433 ' HB2' HG23 ' A' ' 37' ' ' THR . 1.4 t -151.84 131.86 13.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.409 HG11 HD13 ' A' ' 71' ' ' ILE . 2.4 m -144.23 167.94 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.079 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.44 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 33.4 tt0 -104.43 110.62 22.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.659 HG23 ' HB1' ' A' ' 67' ' ' ALA . 8.6 mm -80.91 104.03 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.099 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.62 HG22 ' CB ' ' A' ' 33' ' ' SER . 30.3 p -98.13 165.57 11.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.107 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.98 39.07 6.61 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.49 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 65.6 mt -102.91 171.88 7.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.737 0.304 . . . . 0.0 110.945 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -114.99 127.99 56.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -69.9 151.31 45.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.72 10.51 76.55 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.453 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.2 mm -124.27 114.55 41.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.856 0.36 . . . . 0.0 111.136 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.77 137.66 37.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.82 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.34 161.9 37.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -107.46 -174.87 2.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -145.82 158.15 43.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -149.05 176.05 10.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.578 HG11 ' CD1' ' A' ' 38' ' ' TRP . 59.9 t -141.95 146.43 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.112 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -136.4 140.82 43.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -100.62 124.23 45.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.47 118.69 31.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.446 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 41.4 p-10 -123.09 -173.95 2.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.613 ' HE3' ' CG ' ' A' ' 46' ' ' PHE . 5.5 ptp -69.01 -0.41 5.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.84 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.59 HD21 ' CD2' ' A' ' 46' ' ' PHE . 23.9 mt -107.62 -24.04 11.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.937 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.427 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 146.64 -168.4 27.99 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.54 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.68 157.43 16.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.878 0.37 . . . . 0.0 110.891 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.423 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 4.1 p -93.56 175.2 6.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.877 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -69.88 160.36 80.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.631 0.729 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 111.7 2.86 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.638 2.225 . . . . 0.0 112.439 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.0 p -53.9 150.36 7.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.825 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.12 140.66 6.51 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.586 0.708 . . . . 0.0 111.101 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.66 94.29 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.724 2.283 . . . . 0.0 112.383 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.43 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 4.4 p -43.26 165.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -59.81 150.93 66.03 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.645 0.736 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.478 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.9 Cg_endo -69.77 135.75 31.22 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.694 2.263 . . . . 0.0 112.329 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.428 ' CB ' HG21 ' A' ' 26' ' ' ILE . 70.4 t80 -124.86 126.64 45.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.969 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.3 t -98.41 104.46 15.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.111 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 t -72.06 107.19 2.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.13 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.863 -179.861 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.511 HD13 ' CE2' ' A' ' 46' ' ' PHE . 5.9 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.734 0.302 . . . . 0.0 110.959 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.581 ' O ' HD12 ' A' ' 99' ' ' LEU . 0.5 OUTLIER -142.31 161.44 50.32 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.637 0.732 . . . . 0.0 110.855 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 170.1 17.48 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.633 2.222 . . . . 0.0 112.322 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.558 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.5 Cg_endo -69.75 156.13 64.15 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.756 2.304 . . . . 0.0 112.308 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.42 ' C ' ' HB2' ' A' ' 102' ' ' SER . 7.2 pt-20 -101.37 171.81 7.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.431 ' HB1' ' HA ' ' A' ' 105' ' ' SER . . . -66.04 121.03 74.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.543 0.687 . . . . 0.0 111.116 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 164.88 32.85 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.67 2.247 . . . . 0.0 112.36 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -49.78 174.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.816 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.429 ' NH1' ' HB3' ' A' ' 23' ' ' ARG . 13.8 ttp-105 -79.95 124.32 83.19 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.594 0.712 . . . . 0.0 110.869 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 145.36 56.97 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.687 2.258 . . . . 0.0 112.341 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.753 ' O ' HD13 ' A' ' 26' ' ' ILE . 6.5 t -97.42 166.86 11.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.161 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.753 HD13 ' O ' ' A' ' 25' ' ' THR . 8.7 mm -124.7 130.46 73.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.133 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 m -132.9 172.78 12.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.899 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 85.0 m -91.37 105.55 17.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.163 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.798 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -108.61 -38.21 5.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.071 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.9 m -162.98 -176.64 5.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.577 ' HG3' HG23 ' A' ' 32' ' ' THR . 12.3 pt-20 -84.67 -16.79 40.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.577 HG23 ' HG3' ' A' ' 31' ' ' GLU . 46.5 p -122.2 0.99 9.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.654 ' CB ' HG22 ' A' ' 81' ' ' THR . 22.2 p -145.08 164.65 30.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.997 0.427 . . . . 0.0 110.848 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.455 HG11 ' CE2' ' A' ' 111' ' ' TYR . 34.8 m -144.08 145.33 21.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.081 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.798 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 25.3 m-85 -78.33 119.28 21.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.936 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.4 t -113.81 131.82 64.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.096 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.44 ' HB ' HG22 ' A' ' 25' ' ' THR . 55.9 m -128.81 123.57 33.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.085 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.643 ' CD1' HG11 ' A' ' 93' ' ' VAL . 24.0 p90 -123.01 169.23 11.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.881 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.1 mm -134.64 108.56 10.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.677 0.751 . . . . 0.0 111.133 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 140.3 42.17 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.697 2.265 . . . . 0.0 112.346 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -107.39 -69.88 0.82 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.29 142.55 15.78 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.496 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -112.44 7.88 19.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 0.0 110.865 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.07 -1.42 86.87 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.55 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.503 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 113.75 -24.69 11.72 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.516 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.606 ' CD2' HD21 ' A' ' 99' ' ' LEU . 2.4 m-85 -108.06 161.9 21.74 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.656 0.741 . . . . 0.0 110.873 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 117.06 4.86 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.663 2.242 . . . . 0.0 112.362 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.682 HD13 ' CZ ' ' A' ' 51' ' ' PHE . 80.6 mt -45.14 135.21 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -91.97 -46.09 8.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.841 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.0 m -163.24 158.22 21.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.991 0.424 . . . . 0.0 110.857 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.682 ' CZ ' HD13 ' A' ' 48' ' ' ILE . 59.5 m-85 -108.67 170.13 8.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.83 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -144.24 120.77 11.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.427 ' HB ' HG22 ' A' ' 68' ' ' THR . 62.9 t -103.67 133.41 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.107 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -130.67 160.99 32.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.913 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.549 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 27.5 p90 -141.93 143.09 33.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.479 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 26.9 ttpt -117.33 133.45 55.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.872 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -79.1 124.54 28.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.921 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.1 mt . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.99 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.479 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 69.0 m95 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.719 0.295 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.477 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.6 mm -123.42 156.12 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.9 tp -89.5 120.96 31.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.931 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.661 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -89.91 -59.33 2.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.427 HG22 ' HB ' ' A' ' 53' ' ' VAL . 6.2 t -147.63 174.55 11.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.164 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.451 ' OG ' ' N ' ' A' ' 70' ' ' ALA . 4.9 t -168.24 177.06 5.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.853 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.451 ' N ' ' OG ' ' A' ' 69' ' ' SER . . . 69.34 25.74 5.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.111 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.676 HG23 ' HD2' ' A' ' 72' ' ' PRO . 76.1 mt -78.18 138.72 60.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.623 0.725 . . . . 0.0 111.191 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.676 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.9 Cg_endo -69.76 157.07 61.65 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.736 2.291 . . . . 0.0 112.345 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -22.9 31.64 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.695 2.263 . . . . 0.0 112.337 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.2 m -82.57 -9.1 59.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.442 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.4 ttt180 -107.54 102.1 11.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.852 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.9 mt -99.89 12.56 36.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.938 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.6 t -153.32 131.68 12.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.838 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.618 HG11 HD13 ' A' ' 71' ' ' ILE . 2.2 m -145.88 162.32 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.556 ' OE1' ' HB1' ' A' ' 29' ' ' ALA . 32.6 tt0 -98.25 111.5 23.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.661 HG23 ' HB1' ' A' ' 67' ' ' ALA . 33.7 mm -81.32 102.08 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.169 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.654 HG22 ' CB ' ' A' ' 33' ' ' SER . 30.2 p -97.71 168.82 10.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.31 40.04 9.43 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.493 HD21 HG22 ' A' ' 80' ' ' ILE . 25.6 mt -101.32 170.87 7.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.687 0.28 . . . . 0.0 110.969 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -112.45 126.49 55.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -68.79 152.05 45.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.835 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.13 12.25 62.63 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 28.6 mm -122.68 101.12 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.871 0.367 . . . . 0.0 111.104 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.36 133.37 49.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -156.55 164.12 38.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.941 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -111.17 178.45 4.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.887 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -135.44 155.06 51.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 5.8 ptp180 -144.6 179.15 7.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.643 HG11 ' CD1' ' A' ' 38' ' ' TRP . 96.7 t -145.4 141.89 22.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.076 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.6 mtt180 -133.28 137.15 45.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.969 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -98.29 130.4 44.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.045 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mp -123.12 119.6 30.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.444 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.5 p-10 -123.56 -174.46 2.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.908 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.8 ptp -67.36 -2.62 6.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.606 HD21 ' CD2' ' A' ' 46' ' ' PHE . 23.5 mt -104.73 -24.94 12.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 146.5 -168.91 27.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.442 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -97.54 158.49 15.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.845 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.42 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 5.5 p -94.02 175.2 6.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.89 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -73.37 159.56 84.55 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.711 0.767 . . . . 0.0 110.894 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.43 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.9 Cg_endo -69.77 109.26 2.27 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.714 2.276 . . . . 0.0 112.394 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.431 ' HA ' ' HB1' ' A' ' 20' ' ' ALA . 93.8 p -52.62 158.14 1.38 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.846 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.55 140.67 46.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.515 0.674 . . . . 0.0 111.132 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 100.72 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.652 2.235 . . . . 0.0 112.378 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.0 p -47.27 170.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -59.38 150.52 64.08 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.595 0.712 . . . . 0.0 110.881 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.87 122.44 9.09 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.716 2.277 . . . . 0.0 112.267 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.623 ' CG ' HG21 ' A' ' 26' ' ' ILE . 56.2 t80 -111.16 116.46 31.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.953 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 94.7 t -92.28 103.48 14.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.213 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.8 t -70.73 107.09 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.097 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.892 -179.85 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.689 HD13 ' CE2' ' A' ' 46' ' ' PHE . 9.7 mt . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.837 0.351 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.585 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.9 m -144.51 161.08 45.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.718 0.771 . . . . 0.0 110.806 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 170.01 17.56 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.628 2.219 . . . . 0.0 112.354 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.554 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.6 Cg_endo -69.86 154.24 67.58 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.664 2.243 . . . . 0.0 112.317 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.418 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.4 pt-20 -97.29 168.35 10.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.71 121.62 65.79 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.662 0.744 . . . . 0.0 111.154 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 160.9 48.0 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.684 2.256 . . . . 0.0 112.396 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -48.46 175.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.0 ttm105 -80.58 123.84 82.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.595 0.712 . . . . 0.0 110.817 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 143.85 52.27 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.674 2.25 . . . . 0.0 112.374 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.898 ' C ' HD13 ' A' ' 26' ' ' ILE . 4.8 t -96.9 167.59 10.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.112 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.898 HD13 ' C ' ' A' ' 25' ' ' THR . 3.1 mm -125.01 131.78 72.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.153 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 m -135.71 167.31 21.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.7 m -85.73 104.26 15.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.103 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.787 ' HB1' ' OE2' ' A' ' 79' ' ' GLU . . . -106.26 -40.71 5.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.056 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 m -162.77 163.96 26.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -67.73 -14.41 62.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.964 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 p -122.67 -1.13 9.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.165 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.67 ' CB ' HG22 ' A' ' 81' ' ' THR . 51.9 p -142.19 172.37 12.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.402 HG22 HD11 ' A' ' 83' ' ' LEU . 30.0 m -148.02 147.91 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.105 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.741 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 11.7 m-85 -83.42 115.09 21.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.934 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.4 t -109.78 129.05 65.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.12 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.478 ' HB ' HG22 ' A' ' 25' ' ' THR . 84.9 m -129.19 123.59 32.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.657 ' CD1' HG11 ' A' ' 93' ' ' VAL . 33.6 p90 -120.98 171.16 8.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.5 mm -134.77 106.14 10.68 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.612 0.72 . . . . 0.0 111.188 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 136.12 32.23 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.661 2.24 . . . . 0.0 112.36 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -102.74 -69.48 0.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.73 146.91 16.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.463 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 46.0 p-10 -113.84 6.34 16.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.92 0.39 . . . . 0.0 110.937 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.62 -1.52 87.73 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.458 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.15 -25.1 10.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.689 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.5 m-85 -109.21 161.86 22.26 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.63 0.729 . . . . 0.0 110.901 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 114.14 3.6 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.666 2.244 . . . . 0.0 112.366 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.529 HD13 ' CE1' ' A' ' 51' ' ' PHE . 94.6 mt -44.59 131.86 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -85.97 -47.97 9.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.7 p -160.54 163.32 32.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.851 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.529 ' CE1' HD13 ' A' ' 48' ' ' ILE . 65.3 m-85 -111.41 176.38 5.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.886 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -149.03 125.83 11.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.845 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 t -109.22 129.71 63.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.094 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.431 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 2.6 mp0 -126.58 154.87 43.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.872 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.53 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 33.5 p90 -135.58 142.64 45.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.987 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.517 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 33.6 ttpt -115.92 129.22 56.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -78.56 121.56 24.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 69.8 mt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.913 179.911 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.567 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 83.8 m95 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.774 0.321 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.406 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.1 mm -120.51 162.03 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.159 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.2 tp -98.65 123.0 42.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.61 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -91.51 -71.69 0.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.018 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.487 ' CG2' HD11 ' A' ' 71' ' ' ILE . 3.7 t -125.11 178.36 5.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.141 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 92.6 p -172.1 176.09 3.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 69.45 26.61 5.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.668 HG23 ' HD2' ' A' ' 72' ' ' PRO . 83.6 mt -78.22 138.51 60.26 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.574 0.702 . . . . 0.0 111.156 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.668 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.4 Cg_endo -69.8 158.28 57.43 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.755 2.303 . . . . 0.0 112.285 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -24.77 29.21 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.686 2.257 . . . . 0.0 112.367 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.8 p -78.95 -19.9 50.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.457 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 6.1 ttt85 -94.42 108.3 20.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.836 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.0 mt -102.7 11.41 37.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.9 t -155.29 136.07 13.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.464 HG11 HD13 ' A' ' 71' ' ' ILE . 2.4 m -146.03 165.92 9.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.091 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.787 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 39.9 tt0 -101.35 110.09 22.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.61 HG23 ' HB1' ' A' ' 67' ' ' ALA . 27.9 mm -80.16 100.16 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.166 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.67 HG22 ' CB ' ' A' ' 33' ' ' SER . 27.6 p -97.41 168.96 10.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.126 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.63 37.47 11.9 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.495 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.537 HD21 HG22 ' A' ' 80' ' ' ILE . 31.5 mt -96.42 177.37 5.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.762 0.315 . . . . 0.0 110.935 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -119.68 119.29 33.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.832 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.63 153.11 28.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.921 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.59 14.15 64.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.493 HG22 ' CD2' ' A' ' 89' ' ' TYR . 29.0 mm -124.57 113.67 37.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.38 . . . . 0.0 111.092 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.3 131.89 36.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.823 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.493 ' CD2' HG22 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -154.36 162.87 40.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.856 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -107.95 -175.13 2.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.855 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -142.92 154.39 44.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.567 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 4.8 ptp180 -146.56 174.21 11.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.895 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.657 HG11 ' CD1' ' A' ' 38' ' ' TRP . 57.8 t -140.99 143.59 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -133.78 139.58 46.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -98.88 128.68 45.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.2 mp -123.08 118.87 28.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.443 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.5 p-10 -123.52 -173.65 2.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.436 ' HE1' ' CD1' ' A' ' 46' ' ' PHE . 5.8 ptp -68.89 -0.52 5.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.852 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.591 HD21 ' CD2' ' A' ' 46' ' ' PHE . 27.7 mt -107.07 -24.74 11.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 147.43 -167.26 28.57 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.494 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.59 158.34 16.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 0.0 110.934 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.441 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 5.1 p -94.32 175.18 6.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -70.89 160.23 82.89 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.603 0.716 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 108.01 1.98 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.725 2.284 . . . . 0.0 112.393 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.9 p -51.7 150.9 3.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.806 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.79 139.7 6.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.58 0.705 . . . . 0.0 111.114 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 99.5 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.684 2.256 . . . . 0.0 112.325 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 95.7 p -44.8 162.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.872 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.3 mtp85 -56.74 153.01 23.72 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.607 0.718 . . . . 0.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.87 129.59 17.74 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.608 2.205 . . . . 0.0 112.305 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -122.14 117.02 25.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 45.0 t -90.66 102.77 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 113' ' ' VAL . 14.0 t -67.84 103.37 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.057 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.829 -179.827 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.54 HD13 ' CE2' ' A' ' 46' ' ' PHE . 6.3 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.809 0.338 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.591 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.9 m -144.32 161.38 44.87 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.664 0.745 . . . . 0.0 110.877 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 169.94 17.77 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.725 2.283 . . . . 0.0 112.356 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.531 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.5 Cg_endo -69.75 155.5 65.82 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.746 2.297 . . . . 0.0 112.36 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.416 ' C ' ' HB2' ' A' ' 102' ' ' SER . 7.0 pt-20 -97.97 170.08 9.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.874 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.69 122.07 78.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.646 0.736 . . . . 0.0 111.037 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.463 ' HG3' HG12 ' A' ' 93' ' ' VAL . 53.5 Cg_endo -69.76 161.8 44.52 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.711 2.274 . . . . 0.0 112.358 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -47.36 174.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.833 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -80.47 122.84 82.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.599 0.714 . . . . 0.0 110.821 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 144.35 53.62 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.679 2.253 . . . . 0.0 112.323 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.806 ' O ' HD13 ' A' ' 26' ' ' ILE . 6.5 t -94.81 167.89 11.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.075 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.806 HD13 ' O ' ' A' ' 25' ' ' THR . 5.8 mm -125.85 123.08 63.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.117 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -128.09 162.89 25.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.829 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m -83.46 98.56 9.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.079 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.683 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -98.4 -37.66 9.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.08 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.7 m -162.43 -179.47 6.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -79.59 -21.6 44.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.838 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.8 p -120.25 3.46 10.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.246 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.535 ' CB ' HG22 ' A' ' 81' ' ' THR . 12.4 p -145.58 165.74 27.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.4 m -144.16 149.9 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.162 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.683 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 12.3 m-85 -84.48 117.49 23.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.919 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 91.1 t -112.61 131.22 64.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.113 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.0 m -129.1 124.69 35.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.205 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.61 ' CD1' HG11 ' A' ' 93' ' ' VAL . 31.4 p90 -124.52 170.81 10.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 mm -134.93 110.23 10.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.582 0.706 . . . . 0.0 111.12 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 145.19 56.18 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.72 2.28 . . . . 0.0 112.316 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -113.66 -69.21 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.81 143.9 15.82 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.481 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 50.8 p-10 -113.33 9.14 18.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.92 0.39 . . . . 0.0 110.88 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.64 0.1 78.75 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.481 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.5 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 112.87 -25.33 11.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.458 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.54 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.3 m-85 -107.94 162.0 21.34 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.656 0.741 . . . . 0.0 110.877 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 117.57 5.16 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.691 2.261 . . . . 0.0 112.365 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.542 HD13 ' CE1' ' A' ' 51' ' ' PHE . 82.0 mt -48.11 133.37 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.135 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -89.33 -52.51 5.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.7 m -155.91 160.44 40.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.806 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.542 ' CE1' HD13 ' A' ' 48' ' ' ILE . 61.4 m-85 -109.77 171.27 7.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.929 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.687 HH21 HD22 ' A' ' 66' ' ' LEU . 23.1 mtp180 -143.63 123.7 13.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.484 HG11 HD11 ' A' ' 80' ' ' ILE . 25.9 t -104.32 117.04 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -115.78 155.35 27.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.533 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 38.9 p90 -133.62 170.28 15.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 29.4 ttpt -142.32 131.66 23.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -80.17 128.91 34.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.866 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.421 HD11 ' HB3' ' A' ' 110' ' ' PRO . 38.0 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.957 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.561 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 75.5 m95 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.757 0.313 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.533 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 1.8 mm -125.74 155.16 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.687 HD22 HH21 ' A' ' 52' ' ' ARG . 57.5 tp -88.26 121.87 31.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.926 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.683 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -84.91 -67.4 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.448 ' CG2' HD11 ' A' ' 71' ' ' ILE . 13.5 t -129.08 -179.64 5.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.508 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 60.3 p -170.35 170.39 7.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 72.01 32.83 1.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.147 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.762 HD13 HG11 ' A' ' 78' ' ' VAL . 58.2 mt -86.05 137.83 35.13 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.646 0.736 . . . . 0.0 111.107 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.628 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.1 Cg_endo -69.74 157.36 60.69 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.727 2.285 . . . . 0.0 112.364 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.61 -24.7 30.06 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.71 2.273 . . . . 0.0 112.369 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 t -79.53 -15.77 57.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.908 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.457 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 13.8 ttt180 -97.87 105.15 17.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.852 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.5 mt -100.75 13.71 34.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.5 t -155.73 137.35 14.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.762 HG11 HD13 ' A' ' 71' ' ' ILE . 2.0 m -150.11 162.12 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.083 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.496 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 36.7 tt0 -98.06 117.07 31.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.683 HG23 ' HB1' ' A' ' 67' ' ' ALA . 31.9 mm -85.9 95.17 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.118 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.535 HG22 ' CB ' ' A' ' 33' ' ' SER . 23.6 p -88.83 171.72 9.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.189 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.29 44.06 14.45 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.437 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.588 HD21 HG22 ' A' ' 80' ' ' ILE . 39.6 mt -104.59 162.18 13.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.794 0.33 . . . . 0.0 110.924 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -106.58 123.7 48.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.407 ' CG ' HG12 ' A' ' 113' ' ' VAL . 14.2 mttt -64.73 159.98 21.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.12 11.88 20.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.48 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.8 mm -121.09 94.12 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 111.091 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.76 135.36 57.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.929 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -159.51 160.35 34.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -107.52 -179.39 3.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.838 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -139.72 156.66 46.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.561 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 3.8 ptp180 -147.69 178.16 8.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.834 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.61 HG11 ' CD1' ' A' ' 38' ' ' TRP . 91.9 t -141.0 140.71 32.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.128 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -132.49 135.57 46.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.831 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -96.56 129.85 43.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.135 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.8 mp -122.5 115.33 22.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.441 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.5 p-10 -119.87 -173.92 2.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 14.4 ptm -67.77 -1.83 6.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.591 HD12 ' O ' ' A' ' 16' ' ' SER . 51.1 mt -105.42 -25.58 12.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.83 -165.99 28.83 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.403 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -99.09 158.07 15.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 0.0 110.901 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.498 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 5.2 p -92.75 175.23 6.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -72.69 158.83 86.69 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.709 0.766 . . . . 0.0 110.835 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.439 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.8 Cg_endo -69.72 103.81 1.21 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.729 2.286 . . . . 0.0 112.332 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.4 p -48.21 152.18 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.892 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.38 140.8 5.27 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.585 0.707 . . . . 0.0 111.116 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 100.43 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.685 2.257 . . . . 0.0 112.333 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 52.0 p -48.45 157.17 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -49.57 151.6 2.82 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.592 0.711 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.421 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.1 Cg_endo -69.82 129.04 16.85 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.649 2.233 . . . . 0.0 112.332 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.484 ' CG ' HG21 ' A' ' 26' ' ' ILE . 52.3 t80 -117.58 122.65 44.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.1 t -98.22 101.29 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.064 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.407 HG12 ' CG ' ' A' ' 85' ' ' LYS . 22.0 t -69.1 107.08 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.097 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.89 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.612 HD22 ' HA3' ' A' ' 45' ' ' GLY . 10.3 mt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.78 0.324 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.651 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -134.42 160.59 67.91 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.704 0.764 . . . . 0.0 110.891 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 170.05 17.53 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.697 2.265 . . . . 0.0 112.341 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.541 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 52.8 Cg_endo -69.81 152.48 69.06 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.648 2.232 . . . . 0.0 112.337 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.43 ' C ' ' HB2' ' A' ' 102' ' ' SER . 7.5 pt-20 -96.12 161.08 14.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.909 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 103' ' ' GLU . . . -58.61 123.93 69.81 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.518 0.675 . . . . 0.0 111.136 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 165.86 29.55 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.666 2.244 . . . . 0.0 112.304 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -53.97 177.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -80.04 123.58 83.42 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.557 0.694 . . . . 0.0 110.886 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 144.27 53.35 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.664 2.243 . . . . 0.0 112.34 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.88 ' O ' HD13 ' A' ' 26' ' ' ILE . 14.8 t -94.18 165.7 12.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.174 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.88 HD13 ' O ' ' A' ' 25' ' ' THR . 4.2 mm -129.98 121.62 52.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.148 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 m -122.93 -175.99 3.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.3 m -99.85 97.57 8.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.165 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.904 ' HB1' ' OE1' ' A' ' 79' ' ' GLU . . . -98.18 -42.72 7.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.098 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 t -157.43 -175.98 5.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.829 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -81.77 -21.33 37.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 36.0 p -120.61 -0.72 10.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.154 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.533 ' HB3' HG22 ' A' ' 81' ' ' THR . 99.4 p -135.29 173.33 11.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.808 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.3 m -154.83 142.89 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.185 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.586 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 18.6 m-85 -76.95 120.64 22.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.943 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.0 t -116.13 125.56 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.086 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.7 m -126.09 121.62 33.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.152 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.744 ' CD1' HG11 ' A' ' 93' ' ' VAL . 25.3 p90 -119.06 171.09 8.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.8 mm -134.04 107.28 11.46 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.6 0.714 . . . . 0.0 111.193 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 130.88 20.09 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -94.16 -67.76 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.26 161.79 12.82 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.532 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -125.66 4.67 7.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.884 0.373 . . . . 0.0 110.895 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 81.72 2.29 90.48 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.433 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.612 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 109.44 -25.54 17.39 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.42 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.495 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 2.5 m-85 -108.36 162.05 21.31 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.63 0.728 . . . . 0.0 110.891 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.8 116.18 4.44 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.711 2.274 . . . . 0.0 112.303 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.517 HD13 ' CE1' ' A' ' 51' ' ' PHE . 96.4 mt -46.59 135.76 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -90.0 -49.12 6.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 m -161.58 160.1 28.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.863 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.517 ' CE1' HD13 ' A' ' 48' ' ' ILE . 64.4 m-85 -108.0 175.97 5.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -149.22 128.08 12.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.43 HG11 HD11 ' A' ' 80' ' ' ILE . 60.2 t -110.35 130.22 64.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.102 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.475 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 21.4 mt-10 -125.56 157.86 36.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.854 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.504 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 26.9 p90 -139.81 145.4 38.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.988 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.404 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 31.8 ttpt -120.94 134.33 55.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.822 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.4 mttt -82.65 128.54 34.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.917 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.46 HD11 ' HB3' ' A' ' 110' ' ' PRO . 58.5 mt . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.884 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.404 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 78.3 m95 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.767 0.318 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.456 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.7 mm -115.03 162.75 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.109 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.1 tp -98.91 118.06 34.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.643 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -83.35 -68.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.095 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.564 HG21 HD11 ' A' ' 71' ' ' ILE . 7.7 t -128.51 175.79 8.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.15 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.552 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 90.0 p -168.14 167.34 12.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.795 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.552 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 74.39 25.98 1.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.058 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.684 HD13 HG11 ' A' ' 78' ' ' VAL . 52.3 mt -76.9 136.98 66.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.667 0.746 . . . . 0.0 111.139 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.603 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.9 Cg_endo -69.74 156.67 62.81 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.69 2.26 . . . . 0.0 112.358 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.71 -18.54 37.17 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.701 2.267 . . . . 0.0 112.446 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 86.5 p -86.58 -13.05 46.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.461 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 8.6 ttt85 -101.67 98.96 9.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 51.9 mt -96.74 11.62 34.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.836 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 t -153.39 131.72 12.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.684 HG11 HD13 ' A' ' 71' ' ' ILE . 2.2 m -145.7 163.91 11.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.109 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.904 ' OE1' ' HB1' ' A' ' 29' ' ' ALA . 33.5 tt0 -100.47 108.83 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.643 HG23 ' HB1' ' A' ' 67' ' ' ALA . 26.7 mm -75.82 107.39 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.193 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.533 HG22 ' HB3' ' A' ' 33' ' ' SER . 72.0 p -102.89 165.85 10.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.167 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.66 41.11 7.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.464 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.6 mt -99.16 -178.91 4.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.757 0.313 . . . . 0.0 110.9 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -125.05 122.33 36.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -63.83 161.04 16.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.9 12.0 9.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.417 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 26.9 mm -122.23 108.26 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 0.0 111.24 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.26 136.54 42.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.417 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -157.54 168.59 26.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -114.09 -175.45 2.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.904 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -143.85 158.4 43.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.817 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.475 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 2.7 ptp180 -150.45 175.16 12.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.744 HG11 ' CD1' ' A' ' 38' ' ' TRP . 90.8 t -143.18 135.56 24.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.085 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -126.49 144.32 50.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.541 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -104.85 129.52 53.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.155 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mp -123.41 117.32 24.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.867 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.439 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 37.9 p-10 -119.81 -172.61 2.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 12.6 ptm -69.48 1.45 3.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.809 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 16' ' ' SER . 34.3 mt -108.81 -26.59 10.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.908 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.54 -163.09 29.51 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.532 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -104.59 158.14 16.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 110.861 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.43 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 7.5 p -95.39 175.06 6.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.825 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 30.1 mt-10 -70.76 157.01 91.18 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.575 0.703 . . . . 0.0 110.943 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.434 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.7 Cg_endo -69.73 105.2 1.44 Allowed 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.683 2.255 . . . . 0.0 112.294 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.0 p -45.94 150.52 0.55 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -44.0 141.44 2.4 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.556 0.694 . . . . 0.0 111.148 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 97.66 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.684 2.256 . . . . 0.0 112.36 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 t -43.53 154.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.84 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -51.43 153.71 3.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.617 0.722 . . . . 0.0 110.829 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.46 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.5 Cg_endo -69.77 121.92 8.6 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.722 2.281 . . . . 0.0 112.306 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -112.79 120.19 40.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.31 104.96 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.196 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.3 t -73.65 106.45 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.4 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.816 -179.821 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.763 HD13 ' CE2' ' A' ' 46' ' ' PHE . 13.3 mt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.826 0.346 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.654 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.8 m -145.11 161.21 43.25 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.58 0.705 . . . . 0.0 110.892 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 170.14 17.27 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.641 2.227 . . . . 0.0 112.377 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.495 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 54.3 Cg_endo -69.73 156.63 62.92 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.664 2.242 . . . . 0.0 112.331 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.426 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.4 pt-20 -98.11 174.53 6.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.2 123.44 87.38 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.597 0.713 . . . . 0.0 111.082 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 161.33 46.33 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.665 2.243 . . . . 0.0 112.376 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -49.39 174.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -80.43 122.16 82.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.602 0.715 . . . . 0.0 110.908 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HB2' HG13 ' A' ' 36' ' ' VAL . 53.9 Cg_endo -69.69 143.15 50.25 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.666 2.244 . . . . 0.0 112.402 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.917 ' C ' HD13 ' A' ' 26' ' ' ILE . 5.4 t -95.27 165.98 12.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.106 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.917 HD13 ' C ' ' A' ' 25' ' ' THR . 2.8 mm -126.81 125.34 66.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.184 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.6 t -131.44 166.99 20.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.4 m -80.88 107.27 13.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.732 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -111.13 -36.31 5.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 m -164.87 -179.71 5.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -82.99 -19.5 36.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.832 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.8 p -120.33 -1.9 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.715 ' CB ' HG22 ' A' ' 81' ' ' THR . 24.2 p -140.4 171.25 14.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.9 m -149.65 147.43 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.163 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.732 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 15.1 m-85 -82.78 120.49 25.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.407 HG13 ' HB2' ' A' ' 24' ' ' PRO . 92.3 t -115.71 131.46 68.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.105 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.9 m -128.36 120.59 27.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.152 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.568 ' CD1' HG11 ' A' ' 93' ' ' VAL . 28.6 p90 -120.13 170.27 9.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.1 mm -134.3 110.5 11.63 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.59 0.709 . . . . 0.0 111.137 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.453 ' HD3' HD22 ' A' ' 76' ' ' LEU . 53.9 Cg_endo -69.79 137.99 36.66 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.727 2.285 . . . . 0.0 112.312 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -103.58 -69.68 0.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.849 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.48 158.85 14.81 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.509 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -124.25 5.57 8.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.833 0.349 . . . . 0.0 110.815 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.11 0.69 89.27 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.519 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.411 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 108.58 -18.1 32.76 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.548 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.763 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.1 m-85 -114.68 162.24 24.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.617 0.723 . . . . 0.0 110.922 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 114.61 3.75 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.711 2.274 . . . . 0.0 112.33 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.537 HD13 ' CE1' ' A' ' 51' ' ' PHE . 95.8 mt -46.46 141.2 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.36 -52.11 4.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.7 p -159.69 160.61 34.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.537 ' CE1' HD13 ' A' ' 48' ' ' ILE . 52.4 m-85 -108.83 168.32 9.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.928 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.4 mtt-85 -143.39 136.77 28.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.429 ' HB ' HG22 ' A' ' 68' ' ' THR . 58.8 t -116.63 134.8 58.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -133.63 158.84 42.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.545 ' CD2' ' HB2' ' A' ' 67' ' ' ALA . 26.4 p90 -136.82 175.02 10.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.944 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.466 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 36.9 ttpt -147.69 135.62 21.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.944 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -82.34 129.63 34.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 110' ' ' PRO . 28.8 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.907 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.466 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 78.0 m95 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.73 0.3 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.508 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.9 mm -115.14 159.42 15.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.14 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 tp -91.5 122.52 34.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.762 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -91.41 -71.33 0.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.081 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.464 ' CG2' HD11 ' A' ' 71' ' ' ILE . 1.3 t -130.29 165.08 23.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.151 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.9 m -162.85 -175.34 4.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 64.25 29.77 13.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.055 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.594 HG23 ' HD2' ' A' ' 72' ' ' PRO . 61.3 mt -83.37 137.42 42.24 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.641 0.734 . . . . 0.0 111.176 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.594 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.9 Cg_endo -69.7 158.19 57.9 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.633 2.222 . . . . 0.0 112.379 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.72 -11.41 30.82 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.661 2.24 . . . . 0.0 112.323 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.0 t -92.52 -18.16 23.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.854 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.427 ' NE ' HG12 ' A' ' 78' ' ' VAL . 17.0 ttt180 -98.57 103.65 15.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.822 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.453 HD22 ' HD3' ' A' ' 40' ' ' PRO . 46.9 mt -99.46 7.62 45.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.974 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 t -149.45 132.85 16.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.809 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.467 HG11 HD13 ' A' ' 71' ' ' ILE . 2.0 m -148.35 165.17 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.131 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.422 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 28.8 tt0 -99.47 116.03 30.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.762 HG23 ' HB1' ' A' ' 67' ' ' ALA . 45.9 mm -83.3 101.21 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.117 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.715 HG22 ' CB ' ' A' ' 33' ' ' SER . 27.4 p -99.67 168.63 9.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.162 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.09 34.34 9.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.2 mt -102.43 179.5 4.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.769 0.319 . . . . 0.0 110.949 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -124.22 135.57 53.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -71.63 157.3 38.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.35 12.84 59.3 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.457 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.406 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 25.8 mm -124.09 113.9 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 111.147 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.87 139.8 35.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.825 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.406 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -160.76 170.46 20.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.944 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -114.49 -176.14 2.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.843 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -144.43 154.23 42.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.453 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 5.3 ptp180 -146.91 179.86 7.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.568 HG11 ' CD1' ' A' ' 38' ' ' TRP . 74.6 t -145.1 143.58 22.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.115 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -132.77 146.02 51.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -107.39 130.22 54.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.086 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.424 ' HG ' ' CB ' ' A' ' 101' ' ' GLU . 4.3 mp -123.87 120.77 33.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.934 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.438 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 37.0 p-10 -123.74 -172.64 2.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.3 ptm -68.98 0.78 4.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.797 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 16' ' ' SER . 51.2 mt -108.6 -26.38 10.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.935 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.56 -167.5 29.18 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.485 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.424 ' CB ' ' HG ' ' A' ' 96' ' ' LEU . 0.6 OUTLIER -100.54 158.39 15.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 110.866 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.426 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 14.0 p -94.81 175.22 6.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.816 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -71.41 160.68 81.83 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.621 0.724 . . . . 0.0 110.897 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.411 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.9 Cg_endo -69.8 107.69 1.92 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.741 2.294 . . . . 0.0 112.286 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.8 p -47.95 158.88 0.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.35 138.61 48.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.587 0.708 . . . . 0.0 111.128 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 96.89 0.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.73 2.287 . . . . 0.0 112.38 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.5 p -47.21 160.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.841 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -52.42 150.94 8.1 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.607 0.718 . . . . 0.0 110.854 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.465 ' HB3' HD11 ' A' ' 58' ' ' LEU . 54.4 Cg_endo -69.61 129.21 17.36 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.724 2.283 . . . . 0.0 112.392 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -117.53 120.23 37.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.926 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.0 t -92.94 107.42 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.142 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.0 t -73.25 104.56 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.823 -179.837 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.618 HD13 ' CE2' ' A' ' 46' ' ' PHE . 9.0 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.832 0.349 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.65 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.4 m -139.76 161.87 53.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.682 0.753 . . . . 0.0 110.832 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.74 170.09 17.37 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.674 2.249 . . . . 0.0 112.343 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.468 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 54.6 Cg_endo -69.69 155.48 66.07 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.74 2.293 . . . . 0.0 112.375 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.423 ' C ' ' HB2' ' A' ' 102' ' ' SER . 5.0 pt-20 -98.06 175.29 6.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.94 121.12 80.43 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.611 0.72 . . . . 0.0 111.153 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 162.14 43.23 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.711 2.274 . . . . 0.0 112.325 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -50.42 174.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.824 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -80.15 123.63 83.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.583 0.706 . . . . 0.0 110.851 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 144.04 52.78 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.713 2.276 . . . . 0.0 112.369 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.871 ' O ' HD13 ' A' ' 26' ' ' ILE . 4.3 t -94.4 166.17 12.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.203 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 25' ' ' THR . 7.9 mm -128.21 121.42 55.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.129 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -121.17 -177.72 3.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.887 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.3 m -98.68 99.74 10.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.772 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -100.79 -41.1 7.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.016 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.6 m -163.16 -178.75 6.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.834 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.432 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 3.8 pm0 -84.91 -15.04 45.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.852 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.6 p -117.94 -7.1 10.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.179 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.766 ' CB ' HG22 ' A' ' 81' ' ' THR . 36.7 p -143.56 171.9 13.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 m -147.64 150.94 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.137 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.772 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 18.3 m-85 -84.89 119.81 25.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.3 t -113.91 130.61 67.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.167 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 42.0 m -128.28 124.07 35.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.592 ' CD1' HG11 ' A' ' 93' ' ' VAL . 27.4 p90 -121.3 168.39 11.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.1 mm -132.09 108.13 13.82 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.631 0.729 . . . . 0.0 111.153 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 142.92 49.13 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.711 2.274 . . . . 0.0 112.309 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -111.98 -66.86 1.04 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.6 144.52 16.32 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.496 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -115.12 10.0 16.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.965 0.412 . . . . 0.0 110.963 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 78.73 -0.59 76.65 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.467 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.53 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 110.37 -22.88 21.77 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.487 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.62 ' CD2' HD21 ' A' ' 99' ' ' LEU . 2.3 m-85 -109.89 162.03 21.97 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.574 0.702 . . . . 0.0 110.944 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 113.0 3.22 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.655 2.237 . . . . 0.0 112.428 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.518 HD13 ' CE1' ' A' ' 51' ' ' PHE . 80.6 mt -47.07 134.75 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -83.62 -49.96 8.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.952 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 m -162.9 162.7 26.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.809 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.518 ' CE1' HD13 ' A' ' 48' ' ' ILE . 65.5 m-85 -108.42 169.72 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.831 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -145.15 130.25 18.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 92' ' ' ARG . 61.7 t -108.83 136.78 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.417 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 4.0 mp0 -127.59 156.34 42.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.825 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.621 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 12.8 p90 -141.08 147.33 38.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.855 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -129.72 140.65 51.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.971 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.7 mtmm -83.79 129.84 34.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.441 HD11 ' HB3' ' A' ' 110' ' ' PRO . 77.5 mt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.922 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.453 ' O ' HD13 ' A' ' 65' ' ' ILE . 60.8 m95 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.698 0.285 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 64' ' ' TRP . 2.1 mm -129.76 157.97 42.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.183 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 53' ' ' VAL . 1.7 tp -85.43 111.59 20.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.621 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . . . -74.0 -61.64 1.78 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.111 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.421 HG23 HD11 ' A' ' 71' ' ' ILE . 5.3 t -150.88 161.09 43.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.191 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 15.7 m -152.5 -179.59 7.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.854 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 71.67 25.25 3.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.07 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.638 HD13 HG11 ' A' ' 78' ' ' VAL . 71.4 mt -81.5 137.99 48.03 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.594 0.711 . . . . 0.0 111.103 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.638 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.7 Cg_endo -69.79 156.17 63.95 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.616 2.211 . . . . 0.0 112.285 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -12.72 33.44 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.698 2.266 . . . . 0.0 112.375 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.3 t -92.43 -17.32 24.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.806 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.474 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 7.2 ttt85 -96.44 97.54 9.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.2 mt -94.06 13.59 22.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.91 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -154.17 130.95 10.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.8 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.638 HG11 HD13 ' A' ' 71' ' ' ILE . 2.6 m -145.4 160.34 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.114 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.426 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 24.2 tt0 -96.8 115.82 28.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.925 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.601 HG23 ' HB1' ' A' ' 67' ' ' ALA . 22.2 mm -83.63 105.35 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.766 HG22 ' CB ' ' A' ' 33' ' ' SER . 64.2 p -102.56 171.43 7.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.166 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.09 38.38 11.31 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.5 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.5 mt -105.33 176.37 5.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.81 0.338 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -120.19 136.09 54.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.85 150.5 42.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.96 10.66 68.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.46 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.49 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 28.0 mm -121.41 103.88 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.369 . . . . 0.0 111.105 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.02 141.81 52.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.49 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -163.22 163.02 25.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -111.89 169.59 8.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.811 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -129.71 153.89 47.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.429 ' O ' HG13 ' A' ' 53' ' ' VAL . 5.3 ptp180 -143.82 -178.94 6.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.592 HG11 ' CD1' ' A' ' 38' ' ' TRP . 86.4 t -145.13 144.55 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.093 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -134.87 139.13 44.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.822 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -99.69 132.77 44.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.096 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.4 mp -126.35 119.59 27.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.928 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.448 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 38.5 p-10 -123.61 -173.95 2.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.3 ptp -68.87 -0.63 5.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.798 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.65 HD12 ' O ' ' A' ' 16' ' ' SER . 22.4 mt -106.62 -25.66 11.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.972 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 148.26 -165.98 29.02 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -102.01 158.03 16.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.423 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 5.2 p -94.33 175.04 6.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.801 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -71.22 160.39 82.66 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.606 0.717 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 110.33 2.53 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.683 2.255 . . . . 0.0 112.354 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.0 p -53.34 152.14 4.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.43 139.44 8.06 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.599 0.714 . . . . 0.0 111.073 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 100.41 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.66 2.24 . . . . 0.0 112.352 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.3 p -46.1 163.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.85 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -56.83 152.4 27.5 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.529 0.68 . . . . 0.0 110.939 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.441 ' HB3' HD11 ' A' ' 58' ' ' LEU . 54.2 Cg_endo -69.77 123.2 9.87 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.64 2.227 . . . . 0.0 112.395 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.411 ' CB ' HG21 ' A' ' 26' ' ' ILE . 48.5 t80 -112.89 117.21 31.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.8 t -91.76 101.79 12.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.175 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.9 t -67.99 110.55 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 -179.888 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.565 HD13 ' CE2' ' A' ' 46' ' ' PHE . 15.9 mt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.877 0.37 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.601 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.5 p -141.65 160.17 57.42 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.72 0.772 . . . . 0.0 110.819 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 169.83 17.96 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.691 2.261 . . . . 0.0 112.347 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.561 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.0 Cg_endo -69.84 152.72 68.99 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.664 2.243 . . . . 0.0 112.256 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.421 ' C ' ' HB2' ' A' ' 102' ' ' SER . 4.2 pt-20 -94.68 172.46 8.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.01 121.72 79.36 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.544 0.688 . . . . 0.0 111.109 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 161.96 43.93 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.625 2.217 . . . . 0.0 112.337 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -51.27 174.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.832 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -79.99 123.08 83.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.542 0.687 . . . . 0.0 110.849 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 143.51 51.21 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.677 2.252 . . . . 0.0 112.352 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.71 ' O ' HD13 ' A' ' 26' ' ' ILE . 4.8 t -93.38 164.42 13.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.184 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 25' ' ' THR . 12.4 mm -128.07 120.76 54.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.051 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -123.28 -178.76 4.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.858 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.2 m -97.05 98.97 10.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.636 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -100.41 -33.84 10.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.146 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.43 -175.02 3.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -83.49 -20.03 34.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.962 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.7 p -122.92 -0.58 8.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.179 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.652 ' CB ' HG22 ' A' ' 81' ' ' THR . 3.8 p -139.27 163.89 31.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.82 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.72 144.82 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.152 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.636 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 16.8 m-85 -77.8 116.66 18.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.904 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.9 t -108.98 130.72 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.127 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.766 HG23 ' HB2' ' A' ' 77' ' ' SER . 8.8 m -129.16 121.9 28.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.129 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.575 ' CD1' HG11 ' A' ' 93' ' ' VAL . 35.3 p90 -121.63 170.95 9.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.519 HD13 ' O ' ' A' ' 38' ' ' TRP . 18.7 mm -135.76 106.0 9.82 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.631 0.729 . . . . 0.0 111.17 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.411 ' CD ' HD22 ' A' ' 76' ' ' LEU . 53.7 Cg_endo -69.68 129.87 18.44 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.712 2.274 . . . . 0.0 112.347 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -93.0 -70.41 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.49 151.37 16.92 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.445 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 42.4 p-10 -118.03 10.7 13.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 0.0 110.9 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.57 -4.25 60.79 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.436 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.402 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 113.96 -18.05 19.43 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.483 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.565 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.1 m-85 -114.3 162.03 25.33 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.674 0.75 . . . . 0.0 110.873 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 114.8 3.81 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.668 2.245 . . . . 0.0 112.36 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.49 HD13 ' CE1' ' A' ' 51' ' ' PHE . 89.4 mt -45.6 130.37 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -84.99 -46.18 11.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.6 p -162.19 162.53 28.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.757 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.49 ' CE1' HD13 ' A' ' 48' ' ' ILE . 50.1 m-85 -108.89 172.7 6.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.499 ' CZ ' HD21 ' A' ' 96' ' ' LEU . 55.9 mtt180 -145.04 121.29 10.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.977 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.3 t -105.62 128.21 59.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.135 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.422 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 13.9 mt-10 -128.89 152.54 48.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.823 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.54 ' CD2' ' HB2' ' A' ' 67' ' ' ALA . 36.7 p90 -133.34 173.84 11.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.917 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -149.14 137.35 20.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.94 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -83.53 125.91 32.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.966 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 77.8 mt . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.912 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 82.9 m95 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.77 0.319 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.515 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 2.6 mm -120.47 158.93 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.8 tp -93.31 121.93 35.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.712 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -90.19 -69.0 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.096 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.497 ' CG2' HD11 ' A' ' 71' ' ' ILE . 1.4 t -126.49 178.57 5.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.115 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 59.9 p -173.86 178.35 2.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.835 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 67.98 30.67 5.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.079 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.629 HG23 ' HD2' ' A' ' 72' ' ' PRO . 72.2 mt -84.56 137.73 38.72 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.591 0.71 . . . . 0.0 111.151 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.629 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.8 Cg_endo -69.76 159.56 52.95 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.739 2.293 . . . . 0.0 112.321 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 -17.67 37.51 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.71 2.274 . . . . 0.0 112.325 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.4 m -86.48 -23.19 26.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.431 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 15.0 ttt180 -90.01 100.99 13.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.813 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.411 HD22 ' CD ' ' A' ' 40' ' ' PRO . 52.6 mt -95.95 9.58 40.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.839 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.766 ' HB2' HG23 ' A' ' 37' ' ' THR . 11.6 t -153.79 136.6 15.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.563 HG11 HD13 ' A' ' 71' ' ' ILE . 1.9 m -147.31 163.81 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.135 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.561 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 35.0 tt0 -100.4 111.59 23.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.833 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.712 HG23 ' HB1' ' A' ' 67' ' ' ALA . 26.3 mm -80.86 102.94 7.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.102 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.652 HG22 ' CB ' ' A' ' 33' ' ' SER . 77.2 p -97.25 165.35 12.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.059 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.78 37.46 8.58 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.436 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 88.1 mt -97.62 -179.68 4.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.792 0.329 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -126.71 125.25 41.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -65.11 163.06 15.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.64 17.94 22.08 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.536 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.501 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 28.1 mm -129.37 105.05 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 111.114 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.89 141.82 49.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.501 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -162.75 164.53 26.25 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.944 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -111.08 -175.6 2.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.93 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -146.64 161.46 40.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.84 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.439 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 3.5 ptp180 -151.95 173.41 14.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.884 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.575 HG11 ' CD1' ' A' ' 38' ' ' TRP . 71.6 t -140.02 136.4 38.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.125 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -127.05 138.21 53.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.863 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -97.95 126.35 43.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.067 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.499 HD21 ' CZ ' ' A' ' 52' ' ' ARG . 7.0 mp -120.53 118.41 30.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.437 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.7 p-10 -123.39 -173.72 2.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.1 ptm -68.07 -1.48 5.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 16' ' ' SER . 44.5 mt -105.65 -25.78 12.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.988 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.99 -166.04 28.9 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.511 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.4 156.39 17.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.858 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.421 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 5.5 p -93.39 175.11 6.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.895 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -70.27 157.89 88.86 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.634 0.731 . . . . 0.0 110.856 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.439 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.5 Cg_endo -69.74 102.95 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.66 2.24 . . . . 0.0 112.324 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.9 p -43.93 153.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.81 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.71 141.65 17.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.586 0.707 . . . . 0.0 111.076 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 98.05 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.687 2.258 . . . . 0.0 112.373 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.0 p -45.8 151.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.817 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.2 mmm-85 -45.57 156.18 0.43 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.593 0.711 . . . . 0.0 110.823 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 131.45 21.15 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.638 2.226 . . . . 0.0 112.28 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.579 ' CG ' HG21 ' A' ' 26' ' ' ILE . 39.7 t80 -121.04 113.28 19.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.9 t -91.13 102.81 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.146 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.9 t -69.09 105.7 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.164 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.6 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 -179.894 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.668 ' CD1' ' CE2' ' A' ' 46' ' ' PHE . 9.1 mt . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.884 0.373 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.694 ' O ' HD12 ' A' ' 99' ' ' LEU . 0.9 OUTLIER -134.84 159.63 71.42 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.716 0.769 . . . . 0.0 110.835 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 170.22 17.03 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.727 2.285 . . . . 0.0 112.323 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.51 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.5 Cg_endo -69.83 154.56 67.31 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.612 2.208 . . . . 0.0 112.341 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.416 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.1 pt-20 -95.7 174.11 7.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.868 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.65 122.04 84.46 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.645 0.736 . . . . 0.0 111.071 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 160.79 48.38 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.644 2.229 . . . . 0.0 112.343 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -49.51 174.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -80.03 123.51 83.48 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.702 0.763 . . . . 0.0 110.83 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.427 ' HB2' HG13 ' A' ' 36' ' ' VAL . 53.8 Cg_endo -69.81 144.27 53.23 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.629 2.219 . . . . 0.0 112.319 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.727 ' O ' HD13 ' A' ' 26' ' ' ILE . 13.4 t -93.87 166.41 12.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.109 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.727 HD13 ' O ' ' A' ' 25' ' ' THR . 8.1 mm -126.01 125.83 68.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -125.79 179.23 5.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.5 m -98.23 98.68 9.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.116 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.684 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -102.48 -40.02 6.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.072 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.2 m -165.2 168.99 16.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.819 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -74.29 -14.03 60.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.2 p -118.24 -3.28 11.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.123 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.845 ' CB ' HG22 ' A' ' 81' ' ' THR . 6.5 p -146.45 177.46 9.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.8 m -154.56 149.19 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.178 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.684 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 17.1 m-85 -82.44 118.16 23.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' A' ' 24' ' ' PRO . 91.7 t -113.4 130.84 66.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.069 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.417 ' HB ' HG22 ' A' ' 25' ' ' THR . 62.7 m -128.88 120.34 26.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.197 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.564 ' CD1' HG11 ' A' ' 93' ' ' VAL . 26.3 p90 -118.76 170.92 8.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mm -134.93 108.56 10.65 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.615 0.722 . . . . 0.0 111.102 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 140.23 42.38 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.704 2.269 . . . . 0.0 112.363 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -109.43 -69.14 0.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.85 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.23 147.6 16.31 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.528 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 51.9 p-10 -117.82 5.79 12.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.804 0.335 . . . . 0.0 110.84 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 81.89 4.36 90.32 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.485 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.446 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 105.38 -16.78 44.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.487 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.668 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 1.9 m-85 -115.44 162.24 25.82 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.654 0.74 . . . . 0.0 110.869 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.64 118.24 5.56 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.7 2.266 . . . . 0.0 112.399 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.569 HD13 ' CE1' ' A' ' 51' ' ' PHE . 91.7 mt -49.26 131.88 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.172 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -85.77 -49.27 8.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.954 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.1 m -161.51 161.29 29.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.841 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.569 ' CE1' HD13 ' A' ' 48' ' ' ILE . 60.9 m-85 -109.91 171.26 7.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -146.19 134.3 21.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.863 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.2 135.02 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.155 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.474 ' N ' ' OE1' ' A' ' 54' ' ' GLU . 26.4 mp0 -136.25 146.01 46.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.547 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 26.3 p90 -124.43 179.27 4.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.462 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 22.4 ttpp -149.4 136.41 19.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -84.23 119.87 25.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.3 mt . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 179.948 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.462 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 84.0 m95 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.684 0.278 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.547 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 5.2 mm -115.02 159.62 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.151 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.4 tp -93.37 125.32 37.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.749 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -94.16 -69.84 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.126 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.2 t -131.63 173.19 11.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.146 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.452 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 6.3 t -169.45 176.74 4.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.801 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 69.68 28.65 4.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.106 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.637 HG23 ' HD2' ' A' ' 72' ' ' PRO . 73.6 mt -80.26 137.88 52.47 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.65 0.738 . . . . 0.0 111.155 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.637 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.2 Cg_endo -69.64 158.06 58.42 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.757 2.305 . . . . 0.0 112.378 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -21.89 33.05 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.686 2.258 . . . . 0.0 112.324 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.6 m -82.01 -14.99 55.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -101.84 107.59 18.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.857 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.7 mt -103.86 11.47 35.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -153.2 132.48 12.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.776 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.511 HG11 HD13 ' A' ' 71' ' ' ILE . 2.4 m -145.9 165.63 9.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.098 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.455 ' OE1' ' HB1' ' A' ' 29' ' ' ALA . 33.1 tt0 -102.55 109.32 20.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.808 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.749 HG23 ' HB1' ' A' ' 67' ' ' ALA . 16.1 mm -79.04 103.32 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.15 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.845 HG22 ' CB ' ' A' ' 33' ' ' SER . 29.7 p -102.84 167.95 9.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.085 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.75 36.69 7.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.462 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.8 mt -103.65 -178.85 3.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 110.93 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -118.55 126.84 52.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -67.66 153.74 43.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.43 11.96 62.89 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.458 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.457 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 23.2 mm -124.47 112.66 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.804 0.335 . . . . 0.0 111.194 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.23 141.56 45.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.851 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.457 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -161.66 162.78 30.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.947 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -107.54 -175.82 2.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -145.83 151.43 37.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 1.9 ptp180 -144.12 176.73 9.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.564 HG11 ' CD1' ' A' ' 38' ' ' TRP . 86.8 t -142.87 139.78 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.13 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 -129.57 139.97 51.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -101.23 128.87 47.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.3 mp -122.21 120.0 32.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.443 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 38.1 p-10 -123.55 -173.1 2.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.7 ptm -68.72 0.65 3.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.694 HD12 ' O ' ' A' ' 16' ' ' SER . 38.7 mt -108.37 -26.2 10.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.62 -167.38 29.22 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.525 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.36 158.27 15.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 110.879 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.444 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 5.2 p -93.81 175.29 6.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -71.6 158.14 88.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.638 0.732 . . . . 0.0 110.93 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.43 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 52.9 Cg_endo -69.77 102.86 1.08 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.687 2.258 . . . . 0.0 112.276 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.3 p -46.32 154.57 0.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.855 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.04 143.39 4.61 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.5 0.667 . . . . 0.0 111.149 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 92.98 0.52 Allowed 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.726 2.284 . . . . 0.0 112.344 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.0 t -40.67 146.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -44.62 150.22 0.71 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.654 0.74 . . . . 0.0 110.845 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 124.31 10.95 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.661 2.241 . . . . 0.0 112.357 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.556 ' CB ' HG21 ' A' ' 26' ' ' ILE . 65.4 t80 -115.25 120.7 40.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.5 t -93.64 107.18 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.139 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.8 t -72.6 102.63 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.14 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.8 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.904 -179.861 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.551 ' CD1' ' CE2' ' A' ' 46' ' ' PHE . 13.7 mt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.79 0.328 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.648 ' O ' HD12 ' A' ' 99' ' ' LEU . 3.1 m -137.78 160.08 66.23 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.699 0.762 . . . . 0.0 110.874 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 170.09 17.5 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.678 2.252 . . . . 0.0 112.302 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.464 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.6 Cg_endo -69.72 155.75 65.25 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.694 2.263 . . . . 0.0 112.337 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.426 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.6 pt-20 -99.12 168.83 9.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.92 123.01 82.52 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.534 0.683 . . . . 0.0 111.117 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 165.1 32.15 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.72 2.28 . . . . 0.0 112.266 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -52.44 175.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -79.99 122.83 83.61 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.622 0.725 . . . . 0.0 110.912 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 143.3 50.46 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.707 2.272 . . . . 0.0 112.375 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.782 ' C ' HD13 ' A' ' 26' ' ' ILE . 6.8 t -94.24 165.25 12.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.133 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.782 HD13 ' C ' ' A' ' 25' ' ' THR . 3.9 mm -125.92 125.61 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.159 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 m -127.7 178.18 6.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.6 m -95.48 101.01 12.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.138 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.645 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -102.1 -41.4 6.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.08 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.02 -175.0 5.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -85.0 -16.75 39.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.7 p -123.27 2.04 9.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.112 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.617 ' CB ' HG22 ' A' ' 81' ' ' THR . 18.7 p -144.7 168.0 21.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.832 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.9 m -147.07 145.81 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.645 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 19.7 m-85 -77.85 117.71 19.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.859 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.1 t -111.97 129.7 66.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.095 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.428 ' HB ' HG22 ' A' ' 25' ' ' THR . 87.6 m -128.74 123.51 33.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.187 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.589 ' CD1' HG11 ' A' ' 93' ' ' VAL . 25.5 p90 -122.43 169.66 10.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.899 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.423 HD13 ' O ' ' A' ' 38' ' ' TRP . 21.0 mm -133.29 107.35 12.24 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.668 0.747 . . . . 0.0 111.191 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 135.5 30.62 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.726 2.284 . . . . 0.0 112.332 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -100.32 -70.44 0.74 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.5 159.89 14.72 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.516 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -125.1 4.72 7.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.878 0.37 . . . . 0.0 110.85 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.55 0.56 90.07 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.549 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.541 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 110.32 -24.05 19.07 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.503 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.551 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 2.4 m-85 -108.68 162.24 20.7 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.637 0.732 . . . . 0.0 110.851 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 116.32 4.5 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.659 2.239 . . . . 0.0 112.379 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.526 HD13 ' CE1' ' A' ' 51' ' ' PHE . 96.3 mt -47.81 135.0 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.187 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -86.07 -52.51 5.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.856 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.1 m -160.3 162.16 33.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.862 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.526 ' CE1' HD13 ' A' ' 48' ' ' ILE . 56.7 m-85 -109.85 166.96 10.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.649 HH21 HD21 ' A' ' 66' ' ' LEU . 21.6 mtp85 -142.22 143.26 32.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.821 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.447 ' O ' HD12 ' A' ' 66' ' ' LEU . 58.6 t -120.61 137.47 54.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.107 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -133.7 162.55 31.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.473 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 46.1 p90 -142.05 158.94 43.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.46 ' HD3' ' NE1' ' A' ' 64' ' ' TRP . 37.6 ttpt -130.7 129.72 42.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.931 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -80.07 120.34 24.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.532 HD11 ' HB3' ' A' ' 110' ' ' PRO . 51.2 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.46 ' NE1' ' HD3' ' A' ' 56' ' ' LYS . 47.1 m95 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.736 0.303 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.473 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 1.8 mm -128.04 160.28 38.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.108 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.649 HD21 HH21 ' A' ' 52' ' ' ARG . 39.6 tp -99.89 116.11 31.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.581 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -84.22 -69.79 0.62 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.121 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 t -128.0 166.66 17.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.213 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 12.2 m -161.8 178.65 8.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 70.56 27.54 3.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.103 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.65 HG23 ' HD2' ' A' ' 72' ' ' PRO . 74.9 mt -78.32 138.15 59.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.584 0.707 . . . . 0.0 111.16 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.65 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.1 Cg_endo -69.73 156.49 63.3 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.678 2.252 . . . . 0.0 112.375 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.64 -17.54 38.05 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.647 2.231 . . . . 0.0 112.403 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.3 m -87.6 -13.46 42.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.455 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 15.7 ttt180 -101.04 104.52 15.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.842 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.4 mt -100.4 12.49 37.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -154.93 132.05 10.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.467 HG11 HD13 ' A' ' 71' ' ' ILE . 2.2 m -147.37 165.27 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.101 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -100.26 118.28 36.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.581 HG23 ' HB1' ' A' ' 67' ' ' ALA . 32.7 mm -86.98 98.19 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.083 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.617 HG22 ' CB ' ' A' ' 33' ' ' SER . 32.0 p -93.4 174.15 7.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.3 40.04 17.21 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.509 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.1 mt -100.67 -179.24 4.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.729 0.299 . . . . 0.0 110.921 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -125.27 130.45 52.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.935 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.0 151.57 43.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.77 10.5 64.39 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.452 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.419 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 25.9 mm -122.22 112.66 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.352 . . . . 0.0 111.103 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.22 138.75 38.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.83 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.419 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -161.59 161.21 29.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.951 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -107.53 177.22 4.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -135.31 158.89 43.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.434 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 1.2 ptp180 -151.13 177.9 9.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.589 HG11 ' CD1' ' A' ' 38' ' ' TRP . 95.0 t -143.58 141.83 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.152 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.2 mtt180 -131.94 143.42 50.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.464 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -105.97 131.18 53.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.108 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.455 HD12 ' C ' ' A' ' 95' ' ' ALA . 9.1 mp -124.39 120.74 32.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.915 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.442 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 38.3 p-10 -123.61 -172.77 2.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.935 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.0 ptm -69.03 0.73 4.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 16' ' ' SER . 46.3 mt -108.5 -26.14 10.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.926 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.39 -166.56 29.09 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.499 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.13 158.74 15.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.889 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.426 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 4.8 p -95.51 175.23 6.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.839 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -70.93 157.98 89.13 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.57 0.7 . . . . 0.0 110.907 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.434 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.9 Cg_endo -69.75 104.72 1.36 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.649 2.233 . . . . 0.0 112.385 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.5 p -44.31 151.95 0.22 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.01 139.38 6.96 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.562 0.696 . . . . 0.0 111.106 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 97.11 0.62 Allowed 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.682 2.255 . . . . 0.0 112.373 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 t -48.3 159.59 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.75 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.98 152.58 5.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.675 0.75 . . . . 0.0 110.857 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.532 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.5 Cg_endo -69.65 131.91 22.4 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.698 2.265 . . . . 0.0 112.372 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -117.85 119.47 34.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.977 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.4 t -95.15 102.2 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.099 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.5 t -69.67 106.47 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.828 -179.858 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.639 ' CD1' ' CE2' ' A' ' 46' ' ' PHE . 16.8 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.634 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.4 p -141.7 160.01 57.86 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.738 0.78 . . . . 0.0 110.861 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 169.19 19.49 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.7 2.267 . . . . 0.0 112.302 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.527 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.4 Cg_endo -69.78 157.41 60.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.698 2.265 . . . . 0.0 112.334 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.438 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.6 pt-20 -99.25 163.25 12.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.35 122.32 58.72 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.539 0.685 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 163.76 37.1 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.672 2.248 . . . . 0.0 112.34 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -50.0 177.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -83.27 124.39 76.12 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.648 0.737 . . . . 0.0 110.85 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HB2' HG13 ' A' ' 36' ' ' VAL . 53.8 Cg_endo -69.75 147.36 62.76 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.676 2.251 . . . . 0.0 112.336 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.676 ' O ' HD13 ' A' ' 26' ' ' ILE . 5.1 t -99.58 164.51 12.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.15 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.676 HD13 ' O ' ' A' ' 25' ' ' THR . 8.7 mm -122.67 118.25 54.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.103 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.1 m -121.69 165.31 15.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.836 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.1 m -83.03 104.75 13.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.767 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -108.45 -37.96 5.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.059 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 m -166.16 175.72 8.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.443 ' HG2' HG23 ' A' ' 32' ' ' THR . 1.0 OUTLIER -79.64 -16.73 55.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.898 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.443 HG23 ' HG2' ' A' ' 31' ' ' GLU . 10.7 p -119.0 -6.35 10.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.145 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.852 ' HB3' HG22 ' A' ' 81' ' ' THR . 89.3 p -138.51 171.96 13.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 m -149.55 145.47 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.123 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.767 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 17.6 m-85 -81.63 115.34 20.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.407 HG13 ' HB2' ' A' ' 24' ' ' PRO . 97.0 t -109.11 127.24 65.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.149 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.41 ' HB ' HG22 ' A' ' 25' ' ' THR . 55.8 m -125.78 121.71 34.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.058 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.645 ' CD1' HG11 ' A' ' 93' ' ' VAL . 29.4 p90 -121.47 171.07 9.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.5 mm -135.1 107.12 10.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.632 0.73 . . . . 0.0 111.068 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 139.8 41.16 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.697 2.265 . . . . 0.0 112.343 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 mmt85 -103.31 -70.45 0.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.72 159.21 14.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.489 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -123.03 4.51 9.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 110.887 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.56 -1.41 87.87 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.491 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.461 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 113.32 -23.85 13.29 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.639 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 2.1 m-85 -110.11 162.25 21.17 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.641 0.734 . . . . 0.0 110.869 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.71 114.72 3.79 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.676 2.251 . . . . 0.0 112.427 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.457 HD13 ' CE1' ' A' ' 51' ' ' PHE . 81.6 mt -47.09 132.08 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.128 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -85.15 -50.36 7.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.2 p -159.7 163.24 34.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.457 ' CE1' HD13 ' A' ' 48' ' ' ILE . 54.8 m-85 -108.86 171.78 7.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.701 ' CZ ' HD11 ' A' ' 96' ' ' LEU . 4.9 mtm180 -143.45 129.01 19.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.827 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.457 HG11 HD11 ' A' ' 80' ' ' ILE . 38.4 t -111.4 133.14 57.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.07 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -135.42 152.4 51.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.486 ' CD2' ' HB2' ' A' ' 67' ' ' ALA . 31.1 p90 -129.37 175.75 8.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.5 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 24.6 ttpt -147.88 132.24 17.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.869 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -81.43 126.23 31.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.441 HD11 ' HB3' ' A' ' 110' ' ' PRO . 58.5 mt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.5 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 77.1 m95 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.783 0.325 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.47 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 2.7 mm -116.71 164.2 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.8 tp -96.96 124.1 40.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.746 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -92.52 -64.71 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.058 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.603 ' CG2' HD11 ' A' ' 71' ' ' ILE . 1.8 t -131.83 179.33 6.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.0 p -173.15 178.16 2.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 64.15 32.33 12.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.094 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.67 HG23 ' HD2' ' A' ' 72' ' ' PRO . 88.2 mt -84.61 138.55 38.18 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.582 0.706 . . . . 0.0 111.129 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.67 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.0 Cg_endo -69.75 156.9 62.18 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.719 2.28 . . . . 0.0 112.305 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 -19.56 35.83 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.742 2.295 . . . . 0.0 112.33 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 t -84.7 -15.26 45.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.437 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 8.5 ttt85 -99.17 101.33 12.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.4 mt -96.64 8.99 42.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.928 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.5 t -151.34 134.08 15.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.589 HG11 HD13 ' A' ' 71' ' ' ILE . 2.1 m -146.5 161.95 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.131 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.559 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 39.5 tt0 -97.97 110.23 22.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.746 HG23 ' HB1' ' A' ' 67' ' ' ALA . 17.6 mm -80.1 109.76 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.154 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.852 HG22 ' HB3' ' A' ' 33' ' ' SER . 66.1 p -107.57 166.42 10.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.97 33.46 8.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.498 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.3 mt -101.65 170.31 8.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.736 0.303 . . . . 0.0 110.898 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -114.2 132.86 55.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.855 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -68.01 156.84 36.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.54 12.01 44.36 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.516 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.512 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 32.1 mm -120.76 103.23 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.836 0.351 . . . . 0.0 111.134 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.44 140.16 51.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.512 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -163.12 163.11 25.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.992 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -109.08 -175.97 2.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.936 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -141.82 164.6 29.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.917 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -157.54 170.09 23.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.645 HG11 ' CD1' ' A' ' 38' ' ' TRP . 99.7 t -137.2 140.14 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.134 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.408 HH21 ' CG ' ' A' ' 104' ' ' PRO . 33.8 mtt180 -129.28 136.35 49.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.847 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -93.64 128.5 39.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.101 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.701 HD11 ' CZ ' ' A' ' 52' ' ' ARG . 3.3 mp -123.6 120.12 31.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.448 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 38.3 p-10 -123.56 -172.79 2.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.3 ptm -69.84 1.56 4.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.834 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.634 HD12 ' O ' ' A' ' 16' ' ' SER . 30.3 mt -108.83 -26.25 10.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.953 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 149.49 -162.54 29.08 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.513 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.408 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 26.3 pm0 -107.09 157.42 17.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.892 0.377 . . . . 0.0 110.918 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 54.4 p -96.2 174.99 6.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.851 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -68.47 157.82 86.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.654 0.74 . . . . 0.0 110.884 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.408 ' CG ' HH21 ' A' ' 94' ' ' ARG . 54.1 Cg_endo -69.81 111.23 2.76 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.669 2.246 . . . . 0.0 112.284 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.7 p -50.44 154.17 1.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.49 141.0 7.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.539 0.685 . . . . 0.0 111.047 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 98.06 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.637 2.224 . . . . 0.0 112.388 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.4 p -45.19 164.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.892 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.3 mtm105 -58.31 152.12 44.62 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.505 0.669 . . . . 0.0 110.942 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.441 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.5 Cg_endo -69.78 122.61 9.28 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.637 2.225 . . . . 0.0 112.345 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.638 ' CG ' HG21 ' A' ' 26' ' ' ILE . 52.7 t80 -111.98 121.1 44.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.933 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.9 t -95.03 105.43 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.114 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.0 t -74.95 108.68 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.083 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.878 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.681 HD13 ' CE2' ' A' ' 46' ' ' PHE . 6.4 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.833 0.349 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.642 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.4 p -137.65 160.34 65.44 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.681 0.753 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 169.98 17.66 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.682 2.255 . . . . 0.0 112.355 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.503 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.9 Cg_endo -69.81 152.74 69.12 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.628 2.219 . . . . 0.0 112.348 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.424 ' C ' ' HB2' ' A' ' 102' ' ' SER . 9.2 pt-20 -98.16 160.48 14.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 103' ' ' GLU . . . -56.09 122.79 50.26 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.559 0.695 . . . . 0.0 111.069 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 166.42 27.7 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.7 2.266 . . . . 0.0 112.304 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -51.67 174.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -80.22 122.73 83.18 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.624 0.726 . . . . 0.0 110.932 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 142.44 47.98 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.671 2.248 . . . . 0.0 112.306 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.812 ' O ' HD13 ' A' ' 26' ' ' ILE . 9.6 t -93.43 167.49 11.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.164 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.812 HD13 ' O ' ' A' ' 25' ' ' THR . 10.4 mm -127.44 124.68 64.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.193 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 m -128.31 175.75 8.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.813 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.4 m -94.51 101.36 13.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.1 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.703 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -102.42 -41.15 6.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 t -156.86 -178.34 7.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.833 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -81.17 -20.52 41.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.465 HG22 ' HE3' ' A' ' 85' ' ' LYS . 16.3 p -121.72 4.59 10.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.151 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 84.1 p -139.6 175.97 9.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.3 m -154.64 143.67 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.703 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 11.0 m-85 -79.69 117.52 20.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.8 t -111.93 129.17 67.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.133 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.629 HG23 ' HB2' ' A' ' 77' ' ' SER . 32.5 m -128.91 118.39 22.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.14 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.488 ' CD1' HG11 ' A' ' 93' ' ' VAL . 33.1 p90 -118.58 169.16 10.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 mm -133.59 108.39 12.06 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.62 0.724 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.437 ' CD ' HD22 ' A' ' 76' ' ' LEU . 53.8 Cg_endo -69.78 141.73 45.95 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.693 2.262 . . . . 0.0 112.333 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -109.81 -70.34 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.66 147.06 16.15 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.526 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 48.2 p-10 -114.47 2.55 14.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 0.0 110.925 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 85.26 2.3 87.84 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.507 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.535 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 107.3 -15.04 39.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.438 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.681 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.5 m-85 -118.24 161.98 32.29 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.629 0.728 . . . . 0.0 110.839 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 115.52 4.14 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.68 2.253 . . . . 0.0 112.311 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.455 HD13 ' CE1' ' A' ' 51' ' ' PHE . 92.4 mt -47.71 131.22 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.046 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -82.68 -48.23 11.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.87 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.9 p -163.7 164.16 23.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.455 ' CE1' HD13 ' A' ' 48' ' ' ILE . 55.4 m-85 -109.39 174.53 5.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.1 mtt-85 -149.56 124.04 9.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.2 t -107.99 136.39 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.135 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -137.2 152.66 50.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.875 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.569 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 44.0 p90 -127.84 144.1 51.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.524 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 22.1 ttpt -114.37 128.98 56.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.907 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -76.67 136.02 39.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 110' ' ' PRO . 51.4 mt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.907 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.534 ' O ' HD13 ' A' ' 65' ' ' ILE . 97.3 m95 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.783 0.325 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.569 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 4.6 mm -134.89 141.83 41.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.198 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.9 tp -78.41 126.09 30.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.826 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -101.69 -58.58 1.86 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.58 ' CG2' HD11 ' A' ' 71' ' ' ILE . 6.8 t -136.48 165.29 26.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.165 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 99.9 p -160.51 175.77 12.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.789 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 68.95 26.94 5.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.149 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.598 HG23 ' HD2' ' A' ' 72' ' ' PRO . 58.8 mt -79.76 137.43 54.45 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.635 0.731 . . . . 0.0 111.163 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.598 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.0 Cg_endo -69.66 159.06 54.9 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.728 2.285 . . . . 0.0 112.306 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.75 -25.4 28.68 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.688 2.259 . . . . 0.0 112.361 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 81.1 p -77.57 -25.72 50.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.854 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.457 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.1 ttt180 -86.4 106.59 17.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.838 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.437 HD22 ' CD ' ' A' ' 40' ' ' PRO . 46.6 mt -101.74 9.89 40.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.957 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.629 ' HB2' HG23 ' A' ' 37' ' ' THR . 26.3 t -155.82 137.16 13.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.45 HG12 ' CD ' ' A' ' 75' ' ' ARG . 2.2 m -149.92 168.67 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.148 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.684 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 30.3 tt0 -103.26 115.43 30.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.826 HG23 ' HB1' ' A' ' 67' ' ' ALA . 37.0 mm -81.83 102.69 8.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.7 p -97.46 164.04 12.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.117 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.37 33.59 19.43 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.503 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.8 mt -87.45 -176.26 5.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.803 0.335 . . . . 0.0 110.915 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -126.64 122.4 34.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.465 ' HE3' HG22 ' A' ' 32' ' ' THR . 0.6 OUTLIER -67.4 155.92 37.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.43 15.41 45.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.484 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.401 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 27.3 mm -126.87 103.68 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.861 0.362 . . . . 0.0 111.114 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.54 137.87 52.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.856 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.401 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -158.77 167.83 28.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.92 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -110.73 -176.49 2.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.909 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -146.26 142.9 28.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.428 HH21 ' CB ' ' A' ' 64' ' ' TRP . 5.5 ptt180 -139.26 177.89 7.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.488 HG11 ' CD1' ' A' ' 38' ' ' TRP . 87.2 t -140.73 143.02 29.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.097 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.402 ' CZ ' HH12 ' A' ' 92' ' ' ARG . 34.7 mtt180 -131.0 140.59 50.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.503 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -103.2 127.54 50.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.087 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.07 120.68 35.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.908 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.449 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 36.5 p-10 -123.61 -172.41 2.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.4 ptm -69.58 1.69 3.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.642 HD12 ' O ' ' A' ' 16' ' ' SER . 36.0 mt -109.67 -26.35 9.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.99 -165.93 29.33 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.526 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.61 158.05 16.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.814 0.34 . . . . 0.0 110.903 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 19.9 p -97.44 175.17 6.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 17.2 mt-10 -69.13 157.16 90.0 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.622 0.725 . . . . 0.0 110.918 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.425 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.4 Cg_endo -69.81 104.56 1.35 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.674 2.249 . . . . 0.0 112.318 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.5 p -41.7 150.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.843 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -43.07 140.48 1.97 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.601 0.715 . . . . 0.0 111.097 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 88.81 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.68 2.253 . . . . 0.0 112.285 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 99.2 p -41.06 153.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.861 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -48.96 151.81 2.08 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.628 0.728 . . . . 0.0 110.829 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.474 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.2 Cg_endo -69.81 144.65 54.45 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.664 2.243 . . . . 0.0 112.315 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -132.7 115.75 15.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.849 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.6 t -88.95 103.18 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.083 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.5 t -73.66 111.66 9.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.13 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 -179.814 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.485 HD13 ' CE2' ' A' ' 46' ' ' PHE . 9.0 mt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.805 0.336 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.599 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.7 m -144.99 161.62 41.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.69 0.757 . . . . 0.0 110.863 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.417 ' C ' ' HA3' ' A' ' 44' ' ' GLY . 53.8 Cg_endo -69.74 170.35 16.75 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.727 2.284 . . . . 0.0 112.358 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.475 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.6 Cg_endo -69.76 155.39 66.07 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.693 2.262 . . . . 0.0 112.403 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.42 ' C ' ' HB2' ' A' ' 102' ' ' SER . 9.6 pt-20 -99.26 167.89 10.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 103' ' ' GLU . . . -63.03 121.32 68.2 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.556 0.693 . . . . 0.0 111.096 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 161.59 45.35 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.685 2.257 . . . . 0.0 112.359 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -46.88 174.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 ttm180 -80.1 124.08 83.07 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.611 0.719 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 140.74 43.43 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.702 2.268 . . . . 0.0 112.387 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.511 ' O ' HD13 ' A' ' 26' ' ' ILE . 2.4 t -94.0 155.77 16.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.159 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.544 HG21 ' CB ' ' A' ' 111' ' ' TYR . 18.9 mm -117.28 128.4 74.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.077 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 m -132.72 176.12 8.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.797 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.5 m -93.47 110.6 22.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.191 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.699 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -111.9 -38.2 4.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.05 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.0 m -161.43 -178.75 6.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.838 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.5 ' HG2' HG23 ' A' ' 32' ' ' THR . 0.4 OUTLIER -84.8 -14.68 47.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.899 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.5 HG23 ' HG2' ' A' ' 31' ' ' GLU . 24.5 p -121.4 -0.02 9.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.161 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.431 ' CB ' HG22 ' A' ' 81' ' ' THR . 6.4 p -145.8 173.13 12.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.0 m -148.98 146.28 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.196 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.699 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 12.0 m-85 -77.21 123.14 26.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.6 t -119.45 124.38 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.203 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.475 HG23 ' HB2' ' A' ' 77' ' ' SER . 47.2 m -126.98 123.24 36.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.152 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.587 ' CD1' HG11 ' A' ' 93' ' ' VAL . 24.4 p90 -120.76 171.27 8.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.953 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.513 HD13 ' O ' ' A' ' 38' ' ' TRP . 18.7 mm -135.08 106.01 10.38 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.592 0.711 . . . . 0.0 111.224 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 142.86 49.26 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.719 2.279 . . . . 0.0 112.357 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -111.54 -70.74 0.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.38 143.58 15.69 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -115.74 17.07 16.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.823 0.344 . . . . 0.0 110.904 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.446 ' N ' ' HA ' ' A' ' 18' ' ' PRO . . . 75.97 -6.35 34.94 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.424 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.59 -19.65 11.36 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.504 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.485 ' CE2' HD13 ' A' ' 15' ' ' LEU . 1.6 m-85 -111.92 162.83 19.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.735 0.778 . . . . 0.0 110.91 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 115.98 4.35 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.69 2.26 . . . . 0.0 112.355 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.52 HD13 ' CE1' ' A' ' 51' ' ' PHE . 97.3 mt -48.0 124.41 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.136 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -79.04 -46.55 17.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.5 m -162.83 161.75 26.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.52 ' CE1' HD13 ' A' ' 48' ' ' ILE . 50.4 m-85 -108.59 175.25 5.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.94 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -147.81 120.19 8.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.908 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.431 HG11 HD11 ' A' ' 80' ' ' ILE . 21.7 t -103.91 131.79 51.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.099 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -131.59 160.91 33.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.936 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.553 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 18.4 p90 -139.07 175.89 9.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.919 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.431 ' HD3' ' NE1' ' A' ' 64' ' ' TRP . 16.4 ttpp -146.62 134.08 20.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -81.78 118.36 22.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.93 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 110' ' ' PRO . 72.3 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.96 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.922 ' O ' HD13 ' A' ' 65' ' ' ILE . 61.0 m95 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.759 0.314 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.922 HD13 ' O ' ' A' ' 64' ' ' TRP . 2.1 mm -131.47 151.18 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.075 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 53' ' ' VAL . 52.4 tp -84.9 134.6 34.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.881 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.623 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -103.18 -68.35 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.057 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.642 ' CG2' HD11 ' A' ' 71' ' ' ILE . 5.2 t -125.55 157.83 36.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.099 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.564 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 92.4 p -153.4 169.44 23.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 75.05 25.07 1.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.051 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.653 HG23 ' HD2' ' A' ' 72' ' ' PRO . 64.3 mt -77.08 138.13 65.14 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.599 0.714 . . . . 0.0 111.132 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.653 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.1 Cg_endo -69.77 157.98 58.53 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.679 2.253 . . . . 0.0 112.32 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -24.0 29.91 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.72 2.28 . . . . 0.0 112.296 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 t -78.54 -28.8 46.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.476 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.5 ttt180 -83.73 101.91 11.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.849 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.9 mt -99.37 11.71 38.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.475 ' HB2' HG23 ' A' ' 37' ' ' THR . 7.8 t -153.89 130.33 10.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.834 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.523 HG11 HD13 ' A' ' 71' ' ' ILE . 2.5 m -146.43 160.31 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.09 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.64 ' OE1' ' HB1' ' A' ' 29' ' ' ALA . 33.6 tt0 -99.25 111.9 24.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.623 HG23 ' HB1' ' A' ' 67' ' ' ALA . 28.8 mm -77.82 102.67 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.431 HG22 ' CB ' ' A' ' 33' ' ' SER . 41.2 p -97.2 162.56 13.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.118 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.34 40.63 5.38 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.47 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.2 mt -105.77 177.9 4.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.821 0.344 . . . . 0.0 110.921 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -123.62 128.62 49.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.859 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -67.15 155.88 37.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.76 14.95 63.73 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.512 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.427 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 25.6 mm -127.96 112.67 28.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.811 0.339 . . . . 0.0 111.145 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.05 141.69 40.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.813 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.427 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -162.25 159.79 26.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.016 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -107.38 179.37 4.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -140.76 160.88 39.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -152.32 -178.6 6.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.587 HG11 ' CD1' ' A' ' 38' ' ' TRP . 83.9 t -144.5 146.69 20.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -138.79 134.45 33.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.837 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -96.71 129.5 44.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.082 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.9 mp -122.01 120.19 33.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.449 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 39.4 p-10 -123.74 -172.82 2.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 18.4 ptm -69.7 1.13 4.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.852 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.599 HD12 ' O ' ' A' ' 16' ' ' SER . 37.6 mt -109.48 -24.73 10.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.901 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.411 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 146.36 -169.98 27.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.467 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.2 pm0 -95.96 158.43 15.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 110.868 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.42 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 4.3 p -94.63 175.45 6.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.881 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 20.6 mt-10 -69.53 157.9 88.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.668 0.747 . . . . 0.0 110.886 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 104.88 1.38 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.706 2.271 . . . . 0.0 112.358 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.9 p -47.14 148.2 1.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -45.96 136.99 6.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.648 0.737 . . . . 0.0 111.057 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.87 99.52 0.77 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.629 2.22 . . . . 0.0 112.375 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.4 p -47.8 170.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -60.61 149.56 78.23 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.609 0.719 . . . . 0.0 110.854 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.455 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.6 Cg_endo -69.74 122.69 9.37 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.741 2.294 . . . . 0.0 112.325 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.544 ' CB ' HG21 ' A' ' 26' ' ' ILE . 48.7 t80 -108.81 122.93 48.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 37.3 t -97.45 105.99 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.6 t -76.35 107.51 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.083 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.897 -179.892 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.553 HD22 ' HA3' ' A' ' 45' ' ' GLY . 7.8 mt . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.827 0.346 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.564 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.7 m -138.51 160.9 61.69 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.686 0.755 . . . . 0.0 110.766 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 169.9 17.74 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.718 2.279 . . . . 0.0 112.337 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.52 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.1 Cg_endo -69.77 154.88 67.17 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.713 2.276 . . . . 0.0 112.284 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.434 ' C ' ' HB2' ' A' ' 102' ' ' SER . 10.3 pt-20 -96.97 169.94 9.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.82 121.89 78.01 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.553 0.692 . . . . 0.0 111.079 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 162.23 42.84 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.712 2.275 . . . . 0.0 112.362 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -48.03 174.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.894 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -80.22 124.11 82.84 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.625 0.726 . . . . 0.0 110.857 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.412 ' HB2' HG13 ' A' ' 36' ' ' VAL . 52.7 Cg_endo -69.81 143.19 49.83 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.695 2.263 . . . . 0.0 112.34 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.85 ' O ' HD13 ' A' ' 26' ' ' ILE . 4.8 t -92.64 165.81 12.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.85 HD13 ' O ' ' A' ' 25' ' ' THR . 5.6 mm -128.84 119.52 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 t -123.55 173.95 7.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.0 m -89.41 103.18 15.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.167 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.806 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -106.57 -40.37 5.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.098 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.9 m -160.57 168.07 25.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -72.49 -17.47 61.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.834 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.4 p -119.55 -4.56 10.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.112 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.756 ' CB ' HG22 ' A' ' 81' ' ' THR . 11.2 p -141.75 171.16 14.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.854 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.414 HG11 ' CE1' ' A' ' 111' ' ' TYR . 27.7 m -149.12 149.2 15.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.07 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.806 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 21.3 m-85 -82.84 117.47 22.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.998 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.412 HG13 ' HB2' ' A' ' 24' ' ' PRO . 88.1 t -112.08 130.57 65.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.153 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.413 HG23 ' HB2' ' A' ' 77' ' ' SER . 35.4 m -129.25 125.06 36.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.14 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.663 ' CD1' HG11 ' A' ' 93' ' ' VAL . 25.0 p90 -122.39 169.92 10.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.8 mm -133.46 107.88 12.14 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.645 0.735 . . . . 0.0 111.131 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.77 143.13 49.81 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.666 2.244 . . . . 0.0 112.27 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 mmm-85 -110.88 -70.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.19 153.34 18.1 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.423 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -121.0 5.82 10.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.813 0.339 . . . . 0.0 110.851 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.05 1.36 89.91 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.448 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.553 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 109.97 -23.75 20.63 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.5 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.522 ' CE2' HD13 ' A' ' 15' ' ' LEU . 1.9 m-85 -109.68 162.33 20.7 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.69 0.757 . . . . 0.0 110.865 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 118.42 5.67 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.748 2.299 . . . . 0.0 112.361 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.519 HD13 ' CE1' ' A' ' 51' ' ' PHE . 87.6 mt -48.33 138.3 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -92.85 -51.27 5.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.957 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.1 p -158.39 165.03 35.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.874 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.519 ' CE1' HD13 ' A' ' 48' ' ' ILE . 48.3 m-85 -114.36 170.05 8.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.928 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.761 ' NE ' HD11 ' A' ' 96' ' ' LEU . 50.2 mtm180 -145.57 138.35 25.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.55 ' HB ' HG22 ' A' ' 68' ' ' THR . 47.2 t -117.25 133.98 62.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.125 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -127.14 160.92 29.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.722 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 17.9 p90 -144.55 144.89 31.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.499 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 17.3 ttpp -127.82 133.71 49.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.904 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.57 140.56 48.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.903 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.486 ' CD1' ' HB3' ' A' ' 110' ' ' PRO . 65.0 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.564 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 83.2 m95 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.717 0.294 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.533 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.4 mm -128.4 154.59 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.138 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.8 tp -87.35 115.6 24.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.795 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -83.84 -58.48 2.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.104 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.55 HG22 ' HB ' ' A' ' 53' ' ' VAL . 14.9 t -139.74 179.7 6.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.123 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.5 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 1.5 t -174.73 172.22 3.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.856 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 71.59 34.08 1.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.115 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.687 HD13 HG11 ' A' ' 78' ' ' VAL . 76.9 mt -88.64 137.93 30.06 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.605 0.717 . . . . 0.0 111.201 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.645 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.1 Cg_endo -69.7 158.35 57.35 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.639 2.226 . . . . 0.0 112.348 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -20.47 34.63 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.698 2.265 . . . . 0.0 112.336 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 79.6 p -84.74 -13.7 50.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.943 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.45 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 12.8 ttt85 -101.28 104.59 15.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.872 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.2 mt -103.31 13.92 32.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.852 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.413 ' HB2' HG23 ' A' ' 37' ' ' THR . 1.7 t -152.22 129.74 11.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.82 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.687 HG11 HD13 ' A' ' 71' ' ' ILE . 2.1 m -146.16 159.54 11.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.09 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.516 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 43.7 tt0 -98.62 114.67 27.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.795 HG23 ' HB1' ' A' ' 67' ' ' ALA . 27.7 mm -82.05 103.28 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.175 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.756 HG22 ' CB ' ' A' ' 33' ' ' SER . 49.5 p -101.9 164.0 11.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.86 38.99 5.93 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.538 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.3 mt -106.75 175.92 5.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.778 0.323 . . . . 0.0 110.917 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -120.09 133.42 55.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -68.05 160.19 29.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.0 13.86 58.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.445 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.517 HG22 ' CD2' ' A' ' 89' ' ' TYR . 17.7 mm -124.17 110.96 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.796 0.332 . . . . 0.0 111.094 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.89 134.16 35.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.866 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.517 ' CD2' HG22 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -156.29 163.43 39.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.4 ' HE3' HD11 ' A' ' 58' ' ' LEU . 19.7 mttt -108.0 178.33 4.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.98 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -135.61 152.8 51.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.912 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.564 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 6.3 ptp180 -147.49 171.55 15.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.663 HG11 ' CD1' ' A' ' 38' ' ' TRP . 84.6 t -137.4 140.36 42.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.1 mtt180 -128.5 134.96 48.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -94.54 132.71 38.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.152 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.761 HD11 ' NE ' ' A' ' 52' ' ' ARG . 4.0 mp -127.26 120.72 29.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.443 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 39.9 p-10 -123.45 -172.26 2.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.931 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.4 ptm -70.28 2.31 3.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.862 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.564 HD12 ' O ' ' A' ' 16' ' ' SER . 39.9 mt -109.75 -26.36 9.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.947 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.03 -164.67 29.66 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.541 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -104.9 158.45 16.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.839 0.352 . . . . 0.0 110.877 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 53.2 p -96.86 175.08 6.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -70.79 157.69 89.67 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.631 0.729 . . . . 0.0 110.881 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 92' ' ' ARG . 54.0 Cg_endo -69.79 105.32 1.47 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.653 2.235 . . . . 0.0 112.371 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.0 p -44.54 157.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.844 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.58 140.89 18.06 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.625 0.726 . . . . 0.0 111.069 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 100.98 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.658 2.239 . . . . 0.0 112.339 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.9 p -48.0 159.04 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -51.18 152.03 4.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.607 0.718 . . . . 0.0 110.818 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.486 ' HB3' ' CD1' ' A' ' 58' ' ' LEU . 53.6 Cg_endo -69.75 126.71 13.64 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.665 2.243 . . . . 0.0 112.347 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.464 ' CB ' HG21 ' A' ' 26' ' ' ILE . 55.5 t80 -117.28 113.94 22.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.935 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 42.4 t -88.02 106.94 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.175 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.8 t -72.17 106.94 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.141 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.822 -179.815 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.505 HD22 ' HA3' ' A' ' 45' ' ' GLY . 13.5 mt . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.766 0.317 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.578 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.6 m -144.4 161.91 42.08 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.684 0.754 . . . . 0.0 110.899 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 169.92 17.8 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.696 2.264 . . . . 0.0 112.314 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.506 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.5 Cg_endo -69.82 154.44 67.51 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.691 2.261 . . . . 0.0 112.342 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.43 ' C ' ' HB2' ' A' ' 102' ' ' SER . 4.7 pt-20 -98.89 173.71 6.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.15 121.16 75.02 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.666 0.746 . . . . 0.0 111.101 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 162.83 40.62 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.674 2.25 . . . . 0.0 112.347 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -48.41 172.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -79.9 123.06 83.9 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.581 0.705 . . . . 0.0 110.889 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.404 ' HB2' HG13 ' A' ' 36' ' ' VAL . 54.5 Cg_endo -69.68 144.15 53.56 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.754 2.303 . . . . 0.0 112.399 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.897 ' O ' HD13 ' A' ' 26' ' ' ILE . 15.1 t -95.72 167.26 11.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.897 HD13 ' O ' ' A' ' 25' ' ' THR . 8.2 mm -129.79 118.64 45.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.144 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -120.82 178.96 4.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.825 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.5 m -94.35 98.53 10.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.141 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.868 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -100.72 -40.71 7.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.5 m -159.64 -179.8 8.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -81.8 -21.33 37.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.845 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.2 p -118.27 3.6 11.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.107 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.3 p -144.92 174.66 10.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.7 m -153.2 142.16 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.203 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.868 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 22.6 m-85 -77.77 120.17 22.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.878 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 24' ' ' PRO . 78.9 t -114.88 130.61 69.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.105 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.4 m -128.81 120.29 26.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.715 ' CD1' HG11 ' A' ' 93' ' ' VAL . 24.9 p90 -121.31 170.79 9.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 mm -134.98 110.86 10.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.549 0.69 . . . . 0.0 111.107 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.519 ' HD3' HD22 ' A' ' 76' ' ' LEU . 53.2 Cg_endo -69.83 131.2 20.64 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.667 2.245 . . . . 0.0 112.351 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -95.58 -70.15 0.72 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.15 149.72 16.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.49 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -118.69 8.95 12.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.884 0.373 . . . . 0.0 110.871 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.27 3.05 75.54 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.505 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 107.28 -22.7 28.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.494 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.45 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.4 m-85 -109.91 161.9 22.46 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.738 0.78 . . . . 0.0 110.849 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 114.94 3.86 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.613 2.209 . . . . 0.0 112.377 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.515 HD13 ' CE1' ' A' ' 51' ' ' PHE . 97.7 mt -45.22 128.17 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.142 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -82.33 -47.4 12.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.1 m -163.27 160.76 24.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.844 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.515 ' CE1' HD13 ' A' ' 48' ' ' ILE . 60.7 m-85 -108.09 178.18 4.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.954 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.3 mtt-85 -149.65 121.71 8.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.641 HG11 HD11 ' A' ' 80' ' ' ILE . 23.5 t -105.38 125.57 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -131.83 146.26 52.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.527 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 38.5 p90 -120.14 175.91 5.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.966 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.529 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 13.3 tttt -148.71 135.24 19.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.3 mttp -82.66 125.73 31.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 110' ' ' PRO . 73.5 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.934 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.529 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 77.7 m95 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.722 0.296 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.558 HG22 ' H ' ' A' ' 66' ' ' LEU . 3.1 mm -120.67 169.73 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.192 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.558 ' H ' HG22 ' A' ' 65' ' ' ILE . 53.0 tp -104.5 121.16 42.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.931 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.842 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -86.76 -67.69 0.8 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.09 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.573 ' CG2' HD11 ' A' ' 71' ' ' ILE . 12.6 t -129.8 -176.61 3.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.216 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 98.2 p -174.29 -178.03 1.36 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.874 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 58.91 27.14 15.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.658 HD13 HG11 ' A' ' 78' ' ' VAL . 58.2 mt -77.17 137.76 64.84 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.591 0.71 . . . . 0.0 111.11 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.639 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.2 Cg_endo -69.8 157.26 60.92 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.727 2.284 . . . . 0.0 112.371 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 -24.16 30.39 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.738 2.292 . . . . 0.0 112.335 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 86.6 p -79.75 -18.19 51.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.463 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.0 ttt180 -96.66 102.68 14.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.519 HD22 ' HD3' ' A' ' 40' ' ' PRO . 54.9 mt -100.19 14.29 31.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.926 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.0 t -156.02 132.61 10.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.833 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.658 HG11 HD13 ' A' ' 71' ' ' ILE . 2.1 m -146.98 162.61 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.119 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.516 ' OE1' ' HB1' ' A' ' 29' ' ' ALA . 33.4 tt0 -98.51 110.72 23.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.842 HG23 ' HB1' ' A' ' 67' ' ' ALA . 40.1 mm -76.69 106.38 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.163 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.9 p -99.6 167.57 10.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.14 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.92 44.19 8.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.573 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.9 mt -98.88 -175.62 3.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.83 0.348 . . . . 0.0 110.93 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -132.85 119.72 20.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.69 156.69 22.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.892 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.47 13.54 44.97 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.45 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.526 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 33.3 mm -126.38 101.63 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.832 0.349 . . . . 0.0 111.175 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.21 141.81 57.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -164.06 162.43 23.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -109.11 -174.76 2.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.863 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.405 ' HE2' HG21 ' A' ' 80' ' ' ILE . 76.9 m-85 -144.57 150.85 38.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.449 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 2.3 ptp180 -141.75 175.07 9.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.715 HG11 ' CD1' ' A' ' 38' ' ' TRP . 57.8 t -142.03 135.7 29.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.1 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.0 mtt180 -124.98 142.5 51.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.813 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -103.41 130.77 50.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.1 mp -124.26 119.12 28.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.453 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.3 p-10 -123.71 -173.6 2.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.915 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.7 ptm -68.49 -0.66 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.838 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.578 HD12 ' O ' ' A' ' 16' ' ' SER . 51.7 mt -106.29 -26.02 11.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.956 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.19 -164.37 28.95 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.481 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.49 157.24 17.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.873 0.368 . . . . 0.0 110.906 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.43 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 7.3 p -96.38 174.92 6.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.936 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -71.11 159.48 85.44 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.663 0.744 . . . . 0.0 110.892 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.449 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.5 Cg_endo -69.65 106.89 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.698 2.265 . . . . 0.0 112.386 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.0 p -45.82 154.46 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.845 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -48.71 139.41 11.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.552 0.691 . . . . 0.0 111.087 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 94.74 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.664 2.243 . . . . 0.0 112.35 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.9 p -42.14 158.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -51.47 152.34 4.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.614 0.721 . . . . 0.0 110.864 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.576 ' HB3' HD11 ' A' ' 58' ' ' LEU . 54.8 Cg_endo -69.68 129.35 17.52 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.68 2.254 . . . . 0.0 112.393 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -119.41 118.08 30.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.4 t -93.3 102.5 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.118 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.6 t -68.67 106.8 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.06 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.854 -179.894 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.641 HD13 ' CE2' ' A' ' 46' ' ' PHE . 3.0 mt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.788 0.328 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.554 ' O ' HD12 ' A' ' 99' ' ' LEU . 0.6 OUTLIER -144.42 161.61 43.47 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.675 0.75 . . . . 0.0 110.815 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 169.98 17.64 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.668 2.245 . . . . 0.0 112.332 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.476 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.4 Cg_endo -69.76 156.47 63.27 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.732 2.288 . . . . 0.0 112.372 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.419 ' C ' ' HB2' ' A' ' 102' ' ' SER . 4.5 pt-20 -101.6 165.66 11.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.927 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.83 122.76 64.36 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.546 0.689 . . . . 0.0 111.133 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 164.0 36.19 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.72 2.28 . . . . 0.0 112.338 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -51.63 176.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -80.29 122.38 82.71 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.577 0.703 . . . . 0.0 110.895 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.428 ' HB2' HG13 ' A' ' 36' ' ' VAL . 53.1 Cg_endo -69.84 142.52 47.79 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.731 2.287 . . . . 0.0 112.357 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.768 ' O ' HD13 ' A' ' 26' ' ' ILE . 6.3 t -93.13 163.14 13.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.116 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.768 HD13 ' O ' ' A' ' 25' ' ' THR . 8.4 mm -123.63 129.55 74.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.116 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 t -136.05 165.49 25.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.807 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.5 m -80.91 109.16 15.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.167 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.735 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -111.86 -35.83 5.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.148 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.9 m -165.19 -177.8 4.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.902 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.651 ' HG2' HG23 ' A' ' 32' ' ' THR . 0.1 OUTLIER -85.92 -14.68 44.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.89 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.651 HG23 ' HG2' ' A' ' 31' ' ' GLU . 36.6 p -122.96 -1.38 8.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.165 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.523 ' CB ' HG22 ' A' ' 81' ' ' THR . 4.7 p -143.18 175.28 10.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.0 m -153.35 144.3 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.735 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 19.0 m-85 -78.39 124.75 28.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.428 HG13 ' HB2' ' A' ' 24' ' ' PRO . 72.3 t -119.93 131.47 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.3 m -129.0 118.66 22.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.101 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.628 ' CD1' HG11 ' A' ' 93' ' ' VAL . 30.2 p90 -115.67 169.92 8.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.4 mm -132.23 107.35 13.53 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.589 0.709 . . . . 0.0 111.131 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.66 134.08 27.32 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.715 2.277 . . . . 0.0 112.355 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -103.89 -70.26 0.77 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.856 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.96 144.09 15.73 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.423 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -116.15 13.21 15.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 0.0 110.827 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 75.31 -0.72 59.0 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.435 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.422 ' HA3' ' CD2' ' A' ' 15' ' ' LEU . . . 111.6 -22.48 19.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.641 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.0 m-85 -109.34 161.74 22.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.651 0.739 . . . . 0.0 110.892 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.66 113.67 3.43 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.68 2.253 . . . . 0.0 112.332 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.588 HD13 ' CE1' ' A' ' 51' ' ' PHE . 91.0 mt -42.69 127.79 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.153 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -82.55 -46.24 13.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.3 p -164.02 160.07 21.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.588 ' CE1' HD13 ' A' ' 48' ' ' ILE . 61.5 m-85 -107.93 173.33 6.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -148.27 124.17 10.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 92' ' ' ARG . 47.6 t -106.2 140.01 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.099 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.44 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 42.0 mt-10 -136.45 151.1 49.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.454 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 35.6 p90 -125.79 165.04 19.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.953 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 89' ' ' TYR . 6.7 ttpm? -143.71 133.06 23.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -81.3 138.05 35.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.414 HD11 ' HB3' ' A' ' 110' ' ' PRO . 87.2 mt . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.6 m95 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.739 0.304 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.56 HG22 ' H ' ' A' ' 66' ' ' LEU . 1.8 mm -117.3 171.69 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.56 ' H ' HG22 ' A' ' 65' ' ' ILE . 50.6 tp -104.31 130.6 52.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.909 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.43 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -103.31 -69.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.634 ' CG2' HD11 ' A' ' 71' ' ' ILE . 13.2 t -116.88 171.42 7.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.133 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.496 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 60.4 p -167.7 167.76 13.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.797 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 71.29 27.77 3.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.045 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.634 HD11 ' CG2' ' A' ' 68' ' ' THR . 63.9 mt -78.04 137.55 61.25 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.653 0.739 . . . . 0.0 111.104 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.605 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.7 Cg_endo -69.66 157.24 61.25 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.743 2.295 . . . . 0.0 112.362 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -20.07 35.05 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.674 2.249 . . . . 0.0 112.34 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 92.4 p -83.38 -23.68 32.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.476 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 10.0 ttt180 -90.34 99.24 12.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.3 mt -95.96 15.33 20.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 t -155.54 136.48 13.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.559 HG11 HD13 ' A' ' 71' ' ' ILE . 2.9 m -150.08 163.06 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.151 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.525 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 65.4 tt0 -98.91 112.47 24.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.43 HG23 ' HB1' ' A' ' 67' ' ' ALA . 47.6 mm -79.77 101.73 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.192 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.523 HG22 ' CB ' ' A' ' 33' ' ' SER . 27.7 p -98.1 168.28 10.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.182 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.72 40.28 8.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.48 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 46.2 mt -104.27 -175.29 2.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -127.97 130.85 49.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.43 155.92 40.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.64 11.5 57.27 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.462 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.2 mm -125.01 116.52 47.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.866 0.365 . . . . 0.0 111.132 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.15 135.76 35.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.446 ' CB ' ' O ' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -154.77 162.74 41.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.942 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -107.25 178.21 4.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.947 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -137.16 160.42 39.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.907 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.44 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 2.1 ptp180 -150.97 177.75 9.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.628 HG11 ' CD1' ' A' ' 38' ' ' TRP . 91.6 t -147.44 137.97 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.124 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -129.56 141.65 50.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -101.45 132.17 47.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.022 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mp -125.24 119.59 28.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.944 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.447 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.8 p-10 -123.59 -173.71 2.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.93 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.4 ptm -68.26 -1.07 5.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.893 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 16' ' ' SER . 55.2 mt -106.25 -25.48 11.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.958 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 147.28 -165.55 28.62 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.458 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -100.5 158.11 16.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 110.869 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.419 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 4.0 p -94.47 175.22 6.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.842 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -70.34 159.72 83.7 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.649 0.738 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.432 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.5 Cg_endo -69.78 109.12 2.24 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.74 2.293 . . . . 0.0 112.31 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.7 p -51.01 153.47 1.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.88 140.34 30.17 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.572 0.701 . . . . 0.0 111.128 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 97.42 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.713 2.275 . . . . 0.0 112.354 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 88.2 p -45.75 167.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.16 152.68 50.7 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.666 0.746 . . . . 0.0 110.91 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.414 ' HB3' HD11 ' A' ' 58' ' ' LEU . 54.2 Cg_endo -69.73 135.04 29.51 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.703 2.269 . . . . 0.0 112.32 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -124.22 124.34 42.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.09 101.78 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.152 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.3 t -70.09 105.73 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.055 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 -179.918 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.698 HD13 ' CE2' ' A' ' 46' ' ' PHE . 3.2 mt . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.764 0.316 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.632 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.7 m -146.43 161.54 38.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.68 0.752 . . . . 0.0 110.865 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 169.59 18.57 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.723 2.282 . . . . 0.0 112.337 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.582 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.0 Cg_endo -69.79 150.78 68.47 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.661 2.24 . . . . 0.0 112.32 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.424 ' C ' ' HB2' ' A' ' 102' ' ' SER . 9.1 pt-20 -92.69 174.71 7.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.8 122.4 83.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.573 0.702 . . . . 0.0 111.079 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 161.82 44.46 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.697 2.264 . . . . 0.0 112.317 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -51.77 175.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -80.28 122.82 83.21 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.603 0.716 . . . . 0.0 110.869 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 142.87 49.13 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.701 2.267 . . . . 0.0 112.419 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.659 ' C ' HD13 ' A' ' 26' ' ' ILE . 2.9 t -93.32 159.1 15.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.659 HD13 ' C ' ' A' ' 25' ' ' THR . 3.9 mm -122.13 119.18 57.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.142 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -119.31 -174.96 2.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.918 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 47.0 m -103.15 100.76 10.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.136 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.763 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -103.48 -38.3 7.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.086 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.1 m -161.11 -179.64 7.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -81.47 -21.53 38.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.9 p -116.67 -2.26 11.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.152 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.624 ' CB ' HG22 ' A' ' 81' ' ' THR . 3.9 p -142.58 164.01 31.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.817 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.3 m -143.39 145.19 22.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.179 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.763 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 18.1 m-85 -75.49 113.9 13.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.94 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.7 t -107.07 124.62 62.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.13 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.515 ' HB ' HG22 ' A' ' 25' ' ' THR . 55.9 m -124.71 121.31 34.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.122 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.653 ' CD1' HG11 ' A' ' 93' ' ' VAL . 25.0 p90 -118.18 169.63 9.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.915 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.2 mm -134.35 106.18 11.11 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.632 0.729 . . . . 0.0 111.152 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 142.29 47.55 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.676 2.251 . . . . 0.0 112.321 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -111.69 -69.52 0.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.887 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.0 142.16 15.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.534 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 47.2 p-10 -112.54 9.55 19.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.904 0.383 . . . . 0.0 110.893 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 79.01 0.67 83.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.458 ' HA3' ' CD2' ' A' ' 15' ' ' LEU . . . 111.6 -24.5 15.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.698 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.5 m-85 -108.16 162.11 21.04 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.629 0.728 . . . . 0.0 110.908 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 113.82 3.5 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.669 2.246 . . . . 0.0 112.385 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.519 HD13 ' CE1' ' A' ' 51' ' ' PHE . 97.6 mt -43.58 127.35 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -81.77 -48.32 11.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.936 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.6 m -162.13 162.03 28.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.921 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.519 ' CE1' HD13 ' A' ' 48' ' ' ILE . 51.5 m-85 -109.03 176.31 5.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -149.93 123.42 9.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.36 133.19 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.136 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.405 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 9.4 mt-10 -132.13 162.97 29.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.938 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.582 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 16.1 p90 -148.34 146.18 28.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.522 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 14.8 ttpp -121.93 131.73 54.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.879 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -76.37 128.73 35.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.868 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.2 mt . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.889 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.553 ' O ' HD13 ' A' ' 65' ' ' ILE . 35.9 m95 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.707 0.289 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.582 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 2.3 mm -133.12 164.02 36.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.17 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.408 ' H ' HG22 ' A' ' 65' ' ' ILE . 14.8 tp -102.66 123.36 46.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.663 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -93.78 -66.9 0.89 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.071 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.466 HG21 HD11 ' A' ' 71' ' ' ILE . 11.8 t -128.04 177.81 6.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.113 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.499 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 83.2 p -171.31 167.65 6.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.867 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 71.49 36.13 1.35 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.657 HG23 ' HD2' ' A' ' 72' ' ' PRO . 72.8 mt -87.48 138.29 31.98 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.624 0.726 . . . . 0.0 111.144 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.657 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.9 Cg_endo -69.8 156.69 62.59 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.676 2.251 . . . . 0.0 112.341 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.87 -20.69 33.97 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.696 2.264 . . . . 0.0 112.338 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.1 t -84.32 -10.67 57.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.442 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 12.2 ttt180 -103.38 102.97 12.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.1 mt -100.69 10.47 41.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 t -151.92 129.2 11.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.528 HG11 HD13 ' A' ' 71' ' ' ILE . 2.4 m -144.7 165.04 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.086 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -98.52 113.73 25.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.865 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.663 HG23 ' HB1' ' A' ' 67' ' ' ALA . 40.0 mm -83.63 98.57 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.091 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.624 HG22 ' CB ' ' A' ' 33' ' ' SER . 73.7 p -95.78 165.3 12.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.193 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.69 35.33 9.34 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.497 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.9 mt -94.45 176.49 6.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.866 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -121.7 120.26 34.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -62.82 156.73 23.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.948 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.28 13.9 45.26 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.555 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.1 mm -124.95 104.93 14.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 0.0 111.117 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.55 134.16 47.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -157.01 163.12 39.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.934 -179.813 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -111.01 176.63 4.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.894 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 91' ' ' PHE . 8.0 m-85 -131.96 158.1 42.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.425 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 2.1 ptp180 -149.63 171.87 15.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.653 HG11 ' CD1' ' A' ' 38' ' ' TRP . 94.5 t -139.68 142.77 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -132.41 141.59 48.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.582 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -101.98 125.18 48.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.075 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mp -119.76 118.02 29.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.445 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.3 p-10 -123.6 -174.28 2.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.609 ' HE3' ' CG ' ' A' ' 46' ' ' PHE . 5.0 ptp -67.61 -2.12 6.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.632 HD12 ' O ' ' A' ' 16' ' ' SER . 29.4 mt -105.29 -25.63 12.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.944 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 147.53 -167.16 28.63 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.519 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -101.4 157.54 16.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.819 0.343 . . . . 0.0 110.896 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.424 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 8.7 p -94.22 174.27 7.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.805 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -70.23 160.39 81.08 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.59 0.71 . . . . 0.0 110.929 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.425 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.5 Cg_endo -69.77 105.48 1.49 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.742 2.294 . . . . 0.0 112.306 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.4 p -45.2 156.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.803 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.51 139.93 27.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.564 0.697 . . . . 0.0 111.117 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.69 89.26 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.719 2.279 . . . . 0.0 112.382 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 t -40.7 152.28 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.2 mtt-85 -44.75 153.57 0.47 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.6 0.714 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 132.95 24.33 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.651 2.234 . . . . 0.0 112.367 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -121.17 116.57 25.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.79 107.32 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.094 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.27 111.73 13.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.817 -179.827 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.627 HD13 ' CE2' ' A' ' 46' ' ' PHE . 7.7 mt . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.746 0.308 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.616 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.6 m -141.26 161.77 51.28 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.704 0.764 . . . . 0.0 110.772 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 169.77 18.13 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.665 2.244 . . . . 0.0 112.284 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.593 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 54.2 Cg_endo -69.86 159.02 54.84 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.618 2.212 . . . . 0.0 112.316 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.55 165.15 11.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.926 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.2 120.55 52.13 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.621 0.724 . . . . 0.0 111.126 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 166.56 27.17 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.718 2.278 . . . . 0.0 112.307 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -52.53 172.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.935 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.4 ' HB2' ' NH1' ' A' ' 23' ' ' ARG . 13.7 ttm105 -79.83 123.03 84.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.598 0.713 . . . . 0.0 110.849 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.466 ' HB2' ' CG1' ' A' ' 36' ' ' VAL . 53.1 Cg_endo -69.79 141.79 46.07 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.658 2.239 . . . . 0.0 112.35 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.852 ' O ' HD13 ' A' ' 26' ' ' ILE . 6.9 t -92.47 169.22 10.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.119 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.852 HD13 ' O ' ' A' ' 25' ' ' THR . 3.1 mm -129.13 131.99 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.131 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 t -139.31 167.59 21.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.4 m -80.22 108.16 13.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.695 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -113.01 -35.43 5.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.075 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.0 m -164.32 178.84 7.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.812 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.78 -16.68 46.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.851 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 p -122.2 -2.12 9.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.168 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.659 ' CB ' HG22 ' A' ' 81' ' ' THR . 7.0 p -141.11 171.22 14.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.6 m -147.82 145.44 18.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.148 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.695 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 9.7 m-85 -78.86 119.28 21.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.466 ' CG1' ' HB2' ' A' ' 24' ' ' PRO . 92.4 t -115.95 132.17 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.183 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.403 ' HB ' HG22 ' A' ' 25' ' ' THR . 98.7 m -129.2 124.44 34.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.169 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.74 ' CD1' HG11 ' A' ' 93' ' ' VAL . 24.7 p90 -123.13 171.54 9.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.956 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.6 mm -137.2 106.25 8.66 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.677 0.751 . . . . 0.0 111.163 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 135.91 31.47 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.626 2.217 . . . . 0.0 112.35 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.2 mmm-85 -102.17 -70.63 0.74 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.36 152.54 18.41 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.484 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 52.6 p-10 -122.54 12.63 10.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.854 0.359 . . . . 0.0 110.862 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.63 -0.84 59.93 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.511 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.473 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 111.18 -18.79 25.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.464 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.627 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.1 m-85 -113.08 162.32 22.47 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.584 0.707 . . . . 0.0 110.915 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 115.47 4.11 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.639 2.226 . . . . 0.0 112.365 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.607 HD13 ' CZ ' ' A' ' 51' ' ' PHE . 96.7 mt -45.7 132.0 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.106 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -86.87 -47.14 9.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.9 p -164.22 159.14 19.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.861 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.607 ' CZ ' HD13 ' A' ' 48' ' ' ILE . 54.7 m-85 -107.97 173.12 6.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.897 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -150.1 124.92 9.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 92' ' ' ARG . 48.0 t -103.14 136.32 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.168 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -133.89 146.65 50.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.841 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.539 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 26.9 p90 -125.08 174.81 7.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.979 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.459 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 29.6 ttpt -146.47 125.12 12.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -75.03 126.23 30.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.482 HD11 ' HB3' ' A' ' 110' ' ' PRO . 15.4 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.857 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.554 ' CH2' ' HD3' ' A' ' 92' ' ' ARG . 89.5 m95 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.802 0.335 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.539 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.2 mm -114.6 164.08 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.125 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.414 ' H ' HG22 ' A' ' 65' ' ' ILE . 43.8 tp -98.33 130.36 45.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.555 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -102.58 -70.27 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.091 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.407 ' CG2' HD11 ' A' ' 71' ' ' ILE . 12.0 t -124.63 164.72 19.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.53 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 1.3 t -163.43 171.26 16.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.89 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 73.13 25.28 2.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.173 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.649 HG23 ' HD2' ' A' ' 72' ' ' PRO . 80.4 mt -76.11 138.12 68.74 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.585 0.707 . . . . 0.0 111.156 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.649 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.8 Cg_endo -69.75 157.04 61.76 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.726 2.284 . . . . 0.0 112.311 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 -17.55 37.16 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.645 2.23 . . . . 0.0 112.357 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 t -87.08 -17.44 32.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.872 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.472 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 6.5 ttt85 -97.21 98.33 9.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.9 mt -92.23 9.94 31.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.7 t -154.92 137.78 15.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.501 HG11 HD13 ' A' ' 71' ' ' ILE . 2.5 m -147.51 167.95 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.101 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.503 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 45.5 tt0 -101.26 104.19 15.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.555 HG23 ' HB1' ' A' ' 67' ' ' ALA . 48.4 mm -71.48 101.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.113 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.659 HG22 ' CB ' ' A' ' 33' ' ' SER . 38.8 p -101.22 161.63 13.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.141 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.72 37.34 6.13 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.452 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.4 mt -100.28 176.58 5.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.73 0.3 . . . . 0.0 110.935 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -120.32 117.92 29.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.81 150.65 27.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.96 12.56 71.47 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.512 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.466 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 39.0 mm -125.11 109.7 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.893 0.378 . . . . 0.0 111.193 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.44 140.71 46.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.466 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -164.11 167.03 20.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.883 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.491 ' O ' ' CB ' ' A' ' 55' ' ' TYR . 58.1 mttt -112.85 -177.18 3.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.862 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -146.19 152.43 39.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.554 ' HD3' ' CH2' ' A' ' 64' ' ' TRP . 6.4 mtm180 -143.62 -178.37 5.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.914 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.74 HG11 ' CD1' ' A' ' 38' ' ' TRP . 61.5 t -142.67 139.02 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.166 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.4 mtt180 -126.87 145.3 50.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.769 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.593 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -103.5 125.25 49.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.101 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.2 mp -120.86 117.78 28.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.454 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 41.1 p-10 -123.85 -173.27 2.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.2 ptm -68.92 -0.39 5.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.926 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.616 HD12 ' O ' ' A' ' 16' ' ' SER . 62.8 mt -106.21 -26.28 11.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.993 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.76 -163.43 29.05 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.499 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -108.83 155.63 20.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.88 0.371 . . . . 0.0 110.838 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 59.3 p -98.99 172.5 7.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.842 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.2 mp0 -69.19 157.32 89.62 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.614 0.721 . . . . 0.0 110.933 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.4 ' HB2' ' NH1' ' A' ' 92' ' ' ARG . 54.1 Cg_endo -69.71 116.1 4.4 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.723 2.282 . . . . 0.0 112.346 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.459 ' O ' ' C ' ' A' ' 106' ' ' ALA . 74.7 p -54.47 148.21 12.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.893 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 105' ' ' SER . . . -32.67 141.7 0.18 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.62 0.724 . . . . 0.0 111.061 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 97.69 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.634 2.223 . . . . 0.0 112.322 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.1 p -42.69 149.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -46.75 151.89 1.01 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.59 0.71 . . . . 0.0 110.871 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.482 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.1 Cg_endo -69.85 119.82 6.7 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.666 2.244 . . . . 0.0 112.303 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -110.47 120.13 41.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.0 t -94.36 102.62 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.174 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.7 t -71.66 109.83 4.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.11 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.883 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.698 HD13 ' CE2' ' A' ' 46' ' ' PHE . 7.2 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.789 0.328 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.643 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.7 m -142.89 161.38 49.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.662 0.744 . . . . 0.0 110.905 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 168.67 20.86 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.667 2.245 . . . . 0.0 112.393 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.486 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.8 Cg_endo -69.72 159.34 53.82 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.689 2.26 . . . . 0.0 112.334 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.426 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.0 pt-20 -103.64 160.03 15.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.7 122.25 44.57 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.556 0.693 . . . . 0.0 111.102 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 163.96 36.34 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.661 2.241 . . . . 0.0 112.365 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -51.5 176.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.84 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -80.05 123.95 83.21 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.654 0.74 . . . . 0.0 110.876 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.45 ' O ' ' CB ' ' A' ' 108' ' ' SER . 53.4 Cg_endo -69.73 143.0 49.59 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.718 2.279 . . . . 0.0 112.283 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.73 ' O ' HD13 ' A' ' 26' ' ' ILE . 3.2 t -95.53 166.8 11.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.73 HD13 ' O ' ' A' ' 25' ' ' THR . 5.1 mm -124.06 118.17 53.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.137 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -117.84 168.59 10.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.6 m -87.52 102.07 14.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.763 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -104.85 -36.04 7.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.05 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.8 m -173.08 173.45 3.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.885 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' HG3' HG23 ' A' ' 32' ' ' THR . 13.6 pt-20 -78.41 -15.26 58.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.992 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.422 HG23 ' HG3' ' A' ' 31' ' ' GLU . 17.2 p -114.8 -6.97 12.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.165 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.625 ' HB3' HG22 ' A' ' 81' ' ' THR . 25.0 p -144.99 171.53 14.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.5 m -145.87 147.32 18.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.158 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.763 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 13.6 m-85 -82.98 115.33 21.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 81.6 t -108.35 130.33 61.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.096 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.475 ' HB ' HG22 ' A' ' 25' ' ' THR . 38.9 m -128.44 120.52 27.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.112 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.607 ' CD1' HG11 ' A' ' 93' ' ' VAL . 27.9 p90 -118.14 170.67 8.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.96 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.6 mm -133.96 106.59 11.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.634 0.731 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 136.82 33.93 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.752 2.301 . . . . 0.0 112.311 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -104.78 -69.98 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.37 145.05 16.31 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.515 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -113.55 4.74 16.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 110.895 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 82.89 1.88 90.64 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.467 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.418 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 111.53 -26.64 11.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.454 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.698 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.4 m-85 -106.81 161.7 22.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.642 0.734 . . . . 0.0 110.898 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 113.82 3.5 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.691 2.261 . . . . 0.0 112.371 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.491 HD13 ' CE1' ' A' ' 51' ' ' PHE . 89.1 mt -42.32 129.43 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.125 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -83.66 -49.02 9.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.908 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.9 p -160.09 163.2 34.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.848 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.491 ' CE1' HD13 ' A' ' 48' ' ' ILE . 52.7 m-85 -108.96 177.89 4.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -149.83 119.85 7.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.13 130.01 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.158 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -132.65 148.31 52.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.522 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 45.2 p90 -123.53 172.91 8.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.421 ' HD3' ' NE1' ' A' ' 64' ' ' TRP . 17.4 ttpt -147.91 135.35 20.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -83.33 130.69 35.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.959 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 43.2 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.88 179.987 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.421 ' NE1' ' HD3' ' A' ' 56' ' ' LYS . 73.3 m95 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.796 0.332 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.487 HG22 ' H ' ' A' ' 66' ' ' LEU . 1.8 mm -119.95 167.57 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.127 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.487 ' H ' HG22 ' A' ' 65' ' ' ILE . 47.6 tp -102.31 118.97 38.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.964 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.752 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -86.42 -69.37 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.161 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.498 ' CG2' HD11 ' A' ' 71' ' ' ILE . 2.8 t -128.67 -178.94 4.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.127 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.3 p -174.42 -177.3 1.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.841 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 61.4 32.64 19.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.103 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.667 HG23 ' HD2' ' A' ' 72' ' ' PRO . 85.3 mt -84.68 138.47 38.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.581 0.705 . . . . 0.0 111.128 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.667 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.7 Cg_endo -69.74 158.25 57.62 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.705 2.27 . . . . 0.0 112.414 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -29.57 23.78 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.724 2.283 . . . . 0.0 112.397 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.2 m -74.69 -14.24 60.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.437 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.8 ttt180 -99.99 111.25 23.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.811 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.5 mt -107.25 7.18 29.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 t -150.73 131.73 14.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.0 174.82 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.142 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 28.6 tt0 -111.9 115.0 28.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.826 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.752 HG23 ' HB1' ' A' ' 67' ' ' ALA . 23.4 mm -84.66 104.91 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.052 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.625 HG22 ' HB3' ' A' ' 33' ' ' SER . 68.3 p -98.84 168.29 10.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.144 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.01 38.96 8.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.489 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.4 mt -103.25 168.79 8.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.743 0.306 . . . . 0.0 110.874 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -113.29 127.18 56.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.79 153.37 43.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.27 12.57 72.63 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.49 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.406 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 20.1 mm -125.24 111.74 28.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.909 0.385 . . . . 0.0 111.09 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.89 139.42 40.22 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.406 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -160.72 167.35 27.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -113.4 -176.69 2.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.872 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -143.05 152.22 41.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.932 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -141.63 179.78 6.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.607 HG11 ' CD1' ' A' ' 38' ' ' TRP . 92.7 t -147.48 140.15 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.142 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -130.27 141.45 50.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -101.38 125.06 47.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.082 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.452 ' HG ' ' CB ' ' A' ' 101' ' ' GLU . 8.3 mp -121.71 119.67 32.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.949 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.449 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.2 p-10 -123.6 -173.98 2.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.476 ' HE1' ' CE1' ' A' ' 46' ' ' PHE . 4.9 ptp -67.09 -2.59 5.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 16' ' ' SER . 33.9 mt -105.15 -25.31 12.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.898 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.404 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 146.38 -168.47 27.82 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.451 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.452 ' CB ' ' HG ' ' A' ' 96' ' ' LEU . 3.8 pt-20 -101.84 158.03 16.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 0.0 110.923 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 52.6 p -98.94 167.27 10.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -61.4 157.84 42.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.684 0.754 . . . . 0.0 110.865 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 115.04 3.91 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.71 2.273 . . . . 0.0 112.319 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 92.6 p -54.17 158.95 2.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.831 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.19 142.89 56.85 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.566 0.698 . . . . 0.0 111.159 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 102.12 0.99 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.663 2.242 . . . . 0.0 112.377 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 24' ' ' PRO . 59.5 p -51.55 159.48 0.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -50.39 151.22 3.98 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.608 0.718 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 136.69 33.77 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.684 2.256 . . . . 0.0 112.353 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.525 ' CG ' HG21 ' A' ' 26' ' ' ILE . 49.0 t80 -124.73 117.47 24.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 55.3 t -92.6 103.73 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.154 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.7 t -69.47 113.07 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.3 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.891 -179.88 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 1' ' ' GLY . 69.0 m 38.1 42.27 0.46 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.921 0.391 . . . . 0.0 110.89 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.7 t -43.79 147.71 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.838 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.48 -131.63 5.42 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.484 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 6' ' ' SER . 90.3 p -77.07 -47.72 19.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.904 0.383 . . . . 0.0 110.869 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 5' ' ' SER . 58.0 p 37.42 43.36 0.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.889 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -113.88 126.14 7.22 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.466 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.9 m -85.44 124.52 32.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.806 0.336 . . . . 0.0 110.868 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -152.15 151.34 27.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.576 0.703 . . . . 0.0 110.932 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 98.03 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.695 2.263 . . . . 0.0 112.359 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.21 167.13 5.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -126.0 -44.86 1.75 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.13 -62.81 0.16 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.432 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.4 mmm-85 -67.42 90.62 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.902 0.382 . . . . 0.0 110.842 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.607 HD22 ' HA3' ' A' ' 45' ' ' GLY . 9.2 mt -81.69 -175.1 5.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.943 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.549 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.8 m -144.39 161.51 44.03 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.665 0.745 . . . . 0.0 110.863 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 169.3 19.25 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.642 2.228 . . . . 0.0 112.363 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.557 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.7 Cg_endo -69.77 154.33 67.8 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.671 2.248 . . . . 0.0 112.334 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.421 ' C ' ' HB2' ' A' ' 102' ' ' SER . 4.7 pt-20 -98.46 167.69 10.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.841 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.15 122.84 77.81 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.544 0.688 . . . . 0.0 111.076 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.41 ' HG3' HG12 ' A' ' 93' ' ' VAL . 53.4 Cg_endo -69.81 164.38 34.81 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.629 2.219 . . . . 0.0 112.278 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -50.45 176.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.832 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -80.59 123.13 82.89 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.599 0.714 . . . . 0.0 110.863 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 144.0 52.58 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.618 2.212 . . . . 0.0 112.383 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.826 ' O ' HD13 ' A' ' 26' ' ' ILE . 4.0 t -94.58 167.44 11.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.128 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.826 HD13 ' O ' ' A' ' 25' ' ' THR . 6.8 mm -125.75 126.0 69.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.141 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.0 m -129.8 160.42 33.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.434 HG21 ' HA3' ' A' ' 117' ' ' GLY . 82.6 m -80.46 104.14 10.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.062 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.726 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -106.59 -38.86 6.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.073 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.9 m -164.76 176.57 8.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.62 -17.26 51.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 p -116.91 -3.65 11.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.629 ' CB ' HG22 ' A' ' 81' ' ' THR . 5.5 p -143.07 174.81 10.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.468 HG11 ' CE2' ' A' ' 111' ' ' TYR . 31.0 m -151.85 145.34 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.155 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.726 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 12.3 m-85 -79.67 120.59 24.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.96 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 93.8 t -117.0 130.78 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.149 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 59.1 m -128.96 120.52 26.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.098 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.632 ' CD1' HG11 ' A' ' 93' ' ' VAL . 28.4 p90 -117.68 171.25 8.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 mm -135.99 107.03 9.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.633 0.73 . . . . 0.0 111.136 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 143.73 52.03 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.709 2.273 . . . . 0.0 112.357 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -112.68 -69.95 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.39 146.7 16.28 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.55 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -116.24 7.34 14.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.981 0.42 . . . . 0.0 110.956 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 79.7 2.07 87.7 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.472 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.607 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 110.35 -26.67 12.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.52 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -106.5 161.8 21.73 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.572 0.701 . . . . 0.0 110.899 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 119.21 6.19 Favored 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.712 2.275 . . . . 0.0 112.339 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.539 HD13 ' CE1' ' A' ' 51' ' ' PHE . 93.3 mt -48.25 136.17 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -93.15 -49.44 5.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.943 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.2 p -159.41 158.4 32.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.539 ' CE1' HD13 ' A' ' 48' ' ' ILE . 58.7 m-85 -108.38 173.65 6.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.896 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -144.09 128.51 17.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.573 HG11 HD11 ' A' ' 80' ' ' ILE . 42.4 t -113.08 122.83 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -124.81 157.74 35.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 39.0 p90 -133.07 174.91 9.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 89' ' ' TYR . 5.7 ttpm? -146.83 133.53 19.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -84.68 120.82 26.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.426 HD11 ' HB3' ' A' ' 110' ' ' PRO . 60.3 mt -82.59 -53.62 5.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.967 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.54 -34.12 75.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -109.19 138.95 44.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.911 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 p -74.02 131.32 35.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.167 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.99 129.15 1.0 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.497 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -52.15 -179.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.776 0.322 . . . . 0.0 110.841 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -66.62 145.74 55.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.566 HG22 ' H ' ' A' ' 66' ' ' LEU . 2.6 mm -115.63 170.63 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.137 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.566 ' H ' HG22 ' A' ' 65' ' ' ILE . 48.9 tp -103.75 118.9 37.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.964 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.68 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -87.92 -71.58 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.11 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.586 HG21 HD11 ' A' ' 71' ' ' ILE . 3.9 t -123.83 -179.4 4.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.128 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 23.7 p -174.5 174.17 2.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 67.05 30.08 7.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.111 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.691 HD13 HG11 ' A' ' 78' ' ' VAL . 56.0 mt -81.58 138.04 47.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.657 0.742 . . . . 0.0 111.149 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.652 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.0 Cg_endo -69.74 157.85 59.01 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.661 2.24 . . . . 0.0 112.334 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.69 -19.81 35.96 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.704 2.269 . . . . 0.0 112.407 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 t -85.19 -15.91 42.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.472 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 16.4 ttt180 -97.87 101.21 12.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.854 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.5 mt -98.33 7.72 45.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.959 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 t -150.33 132.1 15.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.804 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.691 HG11 HD13 ' A' ' 71' ' ' ILE . 2.2 m -146.69 164.39 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.091 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.466 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 37.3 tt0 -98.43 111.01 23.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.68 HG23 ' HB1' ' A' ' 67' ' ' ALA . 31.3 mm -78.49 101.81 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.169 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.629 HG22 ' CB ' ' A' ' 33' ' ' SER . 35.2 p -98.96 163.95 12.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.076 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.74 36.96 6.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.504 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.9 mt -104.83 168.49 9.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.76 0.314 . . . . 0.0 110.904 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -112.85 125.77 54.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.65 155.09 34.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.01 10.54 59.23 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.415 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.475 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 32.0 mm -121.98 107.87 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.839 0.352 . . . . 0.0 111.148 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.86 140.52 47.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.798 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.475 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -163.59 164.31 24.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.864 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.2 mttt -109.57 -174.83 2.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.892 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -145.4 159.5 42.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.902 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.414 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 2.7 ptp180 -150.47 174.31 13.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.632 HG11 ' CD1' ' A' ' 38' ' ' TRP . 89.1 t -139.2 142.41 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.122 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 33.8 mtt180 -133.15 143.07 49.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.833 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -103.97 129.04 51.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.078 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.1 mp -122.24 118.14 27.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.438 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 41.0 p-10 -123.04 -174.01 2.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 18.8 ptm -67.15 -2.69 6.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.839 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 16' ' ' SER . 67.4 mt -104.4 -26.01 12.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.946 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.6 -165.71 28.74 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.475 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.46 157.25 16.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.872 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.421 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 6.4 p -92.86 175.21 6.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.802 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -73.42 159.49 84.66 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.696 0.76 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.414 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.3 Cg_endo -69.69 107.49 1.86 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.708 2.272 . . . . 0.0 112.316 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.1 p -51.2 152.62 2.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -48.81 138.37 12.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.627 0.727 . . . . 0.0 111.012 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 104.86 1.39 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.634 2.223 . . . . 0.0 112.38 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.4 p -51.31 171.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -62.36 150.7 84.39 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.648 0.737 . . . . 0.0 110.899 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.426 ' HB3' HD11 ' A' ' 58' ' ' LEU . 54.7 Cg_endo -69.65 120.82 7.56 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.698 2.265 . . . . 0.0 112.339 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.512 ' CB ' HG21 ' A' ' 26' ' ' ILE . 85.8 t80 -111.04 120.05 41.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.963 0.411 . . . . 0.0 110.912 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 52.0 t -91.42 103.35 14.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 t -70.11 106.51 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.148 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 t -100.9 -51.32 3.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -166.24 -150.05 6.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.455 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 85.2 p -87.41 43.93 1.14 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.905 0.383 . . . . 0.0 110.884 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.434 ' HA3' HG21 ' A' ' 28' ' ' THR . . . 53.27 -152.17 8.92 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.467 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -168.24 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.694 2.262 . . . . 0.0 112.379 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.3 m -135.46 170.35 16.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.92 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.8 t -92.3 -40.67 10.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.937 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.516 179.931 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.5 p 46.37 41.66 9.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.903 0.382 . . . . 0.0 110.852 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 99.4 p -100.09 166.97 10.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.28 -137.7 9.86 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.491 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 p -147.17 106.3 3.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.916 0.389 . . . . 0.0 110.837 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 m -120.55 139.81 52.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.829 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.37 -42.08 0.11 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.4 m -41.52 128.34 3.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.829 0.347 . . . . 0.0 110.896 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -121.07 146.66 44.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.614 0.721 . . . . 0.0 110.916 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.412 ' O ' ' CG ' ' A' ' 11' ' ' ASP . 54.4 Cg_endo -69.65 96.68 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.661 2.241 . . . . 0.0 112.436 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 13' ' ' GLY . 3.7 m-20 -174.71 -177.87 1.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.881 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -40.62 96.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.828 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . 151.96 -88.15 0.13 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.438 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -67.39 91.19 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.905 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.545 HD13 ' CE2' ' A' ' 46' ' ' PHE . 6.3 mt -92.76 -175.67 4.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.503 ' O ' HD12 ' A' ' 99' ' ' LEU . 0.6 OUTLIER -146.81 161.52 37.14 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.578 0.704 . . . . 0.0 110.904 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 170.03 17.54 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.661 2.241 . . . . 0.0 112.361 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.549 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.5 Cg_endo -69.67 156.49 63.45 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.732 2.288 . . . . 0.0 112.333 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.423 ' C ' ' HB2' ' A' ' 102' ' ' SER . 9.3 pt-20 -100.59 166.45 10.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.07 121.53 56.1 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.646 0.736 . . . . 0.0 111.087 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 162.89 40.3 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.698 2.266 . . . . 0.0 112.353 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -51.57 175.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.793 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.43 ' NE ' ' HA ' ' A' ' 108' ' ' SER . 18.2 ttt180 -79.88 123.29 83.8 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.537 0.684 . . . . 0.0 110.917 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 142.94 48.95 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.682 2.254 . . . . 0.0 112.326 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.798 ' C ' HD13 ' A' ' 26' ' ' ILE . 2.2 t -94.05 165.42 12.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.798 HD13 ' C ' ' A' ' 25' ' ' THR . 4.3 mm -124.49 119.34 56.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.084 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.3 m -122.66 162.02 22.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.2 m -83.46 98.79 9.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.698 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -97.85 -42.22 7.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.068 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.2 m -161.09 -177.75 6.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.528 ' HG3' HG23 ' A' ' 32' ' ' THR . 15.1 pt-20 -84.44 -14.58 48.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.899 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.528 HG23 ' HG3' ' A' ' 31' ' ' GLU . 51.4 p -121.06 -1.73 9.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.106 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.62 ' CB ' HG22 ' A' ' 81' ' ' THR . 10.7 p -145.54 171.89 14.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.1 m -147.88 147.28 17.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.128 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.698 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 13.4 m-85 -82.74 113.66 20.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.851 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.5 t -108.43 128.49 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.153 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.433 HG23 ' HB2' ' A' ' 77' ' ' SER . 39.9 m -125.95 122.33 35.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.117 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.578 ' CD1' HG11 ' A' ' 93' ' ' VAL . 29.4 p90 -120.79 171.27 8.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.4 mm -136.61 106.24 9.12 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.562 0.696 . . . . 0.0 111.12 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 130.07 18.67 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.707 2.272 . . . . 0.0 112.329 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 mmt85 -94.54 -69.33 0.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.867 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.51 146.05 16.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.445 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -113.52 7.92 17.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.922 0.391 . . . . 0.0 110.904 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 80.56 -1.73 81.28 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.494 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.85 -24.51 11.84 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.473 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.613 ' CG ' ' HE3' ' A' ' 98' ' ' MET . 2.0 m-85 -108.32 162.19 20.8 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.646 0.736 . . . . 0.0 110.885 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.85 116.49 4.59 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.698 2.265 . . . . 0.0 112.278 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.54 HD13 ' CE1' ' A' ' 51' ' ' PHE . 85.9 mt -46.86 125.64 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -80.75 -51.51 8.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.2 m -156.6 162.28 39.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.858 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.54 ' CE1' HD13 ' A' ' 48' ' ' ILE . 61.3 m-85 -111.08 178.47 4.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.922 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 75.4 mtt-85 -149.61 124.94 10.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.5 t -110.24 126.47 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.11 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -124.07 155.87 37.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.513 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 39.1 p90 -132.86 158.43 42.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.88 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.459 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 28.9 ttpt -131.78 127.42 36.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.869 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -81.14 115.88 20.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' A' ' 110' ' ' PRO . 57.5 mt -78.67 -70.85 0.47 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.952 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -39.03 -67.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.888 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -79.83 138.56 37.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.4 p -62.64 131.48 28.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.086 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.91 148.25 5.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.5 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -83.54 -175.08 5.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.794 0.33 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.69 ' O ' HD13 ' A' ' 65' ' ' ILE . 87.4 m95 -63.95 155.15 31.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.69 HD13 ' O ' ' A' ' 64' ' ' TRP . 4.0 mm -136.41 166.93 25.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.133 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.502 ' H ' HG22 ' A' ' 65' ' ' ILE . 50.3 tp -97.95 126.13 43.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.94 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.659 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -95.62 -69.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.097 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.503 ' CG2' HD11 ' A' ' 71' ' ' ILE . 6.5 t -130.71 165.14 23.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.142 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.504 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 75.5 p -157.9 172.91 17.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 71.92 27.4 2.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.067 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.667 HG23 ' HD2' ' A' ' 72' ' ' PRO . 76.3 mt -78.16 138.52 60.5 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.56 0.695 . . . . 0.0 111.184 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.667 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.2 Cg_endo -69.79 155.99 64.41 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.652 2.235 . . . . 0.0 112.364 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.77 -21.79 32.92 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.615 2.21 . . . . 0.0 112.352 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 54.6 p -82.73 -13.53 56.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.809 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.455 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.3 ttt180 -100.72 106.46 17.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.946 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.2 mt -101.78 7.33 41.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.433 ' HB2' HG23 ' A' ' 37' ' ' THR . 1.4 t -151.84 131.86 13.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.409 HG11 HD13 ' A' ' 71' ' ' ILE . 2.4 m -144.23 167.94 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.079 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.44 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 33.4 tt0 -104.43 110.62 22.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.659 HG23 ' HB1' ' A' ' 67' ' ' ALA . 8.6 mm -80.91 104.03 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.099 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.62 HG22 ' CB ' ' A' ' 33' ' ' SER . 30.3 p -98.13 165.57 11.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.107 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.98 39.07 6.61 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.49 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 65.6 mt -102.91 171.88 7.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.737 0.304 . . . . 0.0 110.945 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -114.99 127.99 56.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -69.9 151.31 45.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.72 10.51 76.55 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.453 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.2 mm -124.27 114.55 41.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.856 0.36 . . . . 0.0 111.136 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.77 137.66 37.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.82 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.34 161.9 37.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -107.46 -174.87 2.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -145.82 158.15 43.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -149.05 176.05 10.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.578 HG11 ' CD1' ' A' ' 38' ' ' TRP . 59.9 t -141.95 146.43 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.112 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -136.4 140.82 43.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -100.62 124.23 45.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.47 118.69 31.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.446 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 41.4 p-10 -123.09 -173.95 2.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.613 ' HE3' ' CG ' ' A' ' 46' ' ' PHE . 5.5 ptp -69.01 -0.41 5.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.84 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.59 HD21 ' CD2' ' A' ' 46' ' ' PHE . 23.9 mt -107.62 -24.04 11.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.937 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.427 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 146.64 -168.4 27.99 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.54 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.68 157.43 16.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.878 0.37 . . . . 0.0 110.891 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.423 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 4.1 p -93.56 175.2 6.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.877 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -69.88 160.36 80.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.631 0.729 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 111.7 2.86 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.638 2.225 . . . . 0.0 112.439 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.0 p -53.9 150.36 7.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.825 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.12 140.66 6.51 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.586 0.708 . . . . 0.0 111.101 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.66 94.29 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.724 2.283 . . . . 0.0 112.383 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.43 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 4.4 p -43.26 165.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -59.81 150.93 66.03 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.645 0.736 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.478 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.9 Cg_endo -69.77 135.75 31.22 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.694 2.263 . . . . 0.0 112.329 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.428 ' CB ' HG21 ' A' ' 26' ' ' ILE . 70.4 t80 -124.86 126.64 45.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.969 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.3 t -98.41 104.46 15.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.111 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 t -72.06 107.19 2.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.13 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.0 t -102.88 -52.05 3.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.863 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -174.01 -122.08 0.66 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.446 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 87.6 p -96.23 50.56 1.17 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.885 0.374 . . . . 0.0 110.84 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 95.95 -175.27 32.28 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.457 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 119' ' ' SER . 53.8 Cg_endo -69.73 94.78 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.619 2.213 . . . . 0.0 112.353 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 118' ' ' PRO . 10.2 t -35.89 101.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 50.0 m -116.43 105.19 12.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.81 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.402 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.53 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.2 m -126.49 164.39 21.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 110.856 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 94.6 p -55.5 134.93 50.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.848 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.38 107.84 3.53 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.52 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.6 p -101.65 -44.76 5.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.847 0.355 . . . . 0.0 110.849 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 t -38.5 -62.14 0.63 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.88 126.45 8.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.523 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.0 m -85.0 163.74 18.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.784 0.326 . . . . 0.0 110.845 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -76.66 151.31 82.58 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.595 0.712 . . . . 0.0 110.903 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -170.82 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.647 2.231 . . . . 0.0 112.3 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -67.1 -64.75 0.79 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.802 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.507 ' O ' ' CG ' ' A' ' 12' ' ' HIS . 6.4 p-80 -46.36 120.03 2.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.87 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.39 -125.86 2.09 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.508 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -66.71 79.43 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.832 0.349 . . . . 0.0 110.842 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.511 HD13 ' CE2' ' A' ' 46' ' ' PHE . 5.9 mt -89.82 -175.41 4.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.959 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.581 ' O ' HD12 ' A' ' 99' ' ' LEU . 0.5 OUTLIER -142.31 161.44 50.32 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.637 0.732 . . . . 0.0 110.855 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 170.1 17.48 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.633 2.222 . . . . 0.0 112.322 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.558 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.5 Cg_endo -69.75 156.13 64.15 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.756 2.304 . . . . 0.0 112.308 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.42 ' C ' ' HB2' ' A' ' 102' ' ' SER . 7.2 pt-20 -101.37 171.81 7.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.431 ' HB1' ' HA ' ' A' ' 105' ' ' SER . . . -66.04 121.03 74.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.543 0.687 . . . . 0.0 111.116 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 164.88 32.85 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.67 2.247 . . . . 0.0 112.36 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -49.78 174.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.816 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.429 ' NH1' ' HB3' ' A' ' 23' ' ' ARG . 13.8 ttp-105 -79.95 124.32 83.19 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.594 0.712 . . . . 0.0 110.869 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 145.36 56.97 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.687 2.258 . . . . 0.0 112.341 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.753 ' O ' HD13 ' A' ' 26' ' ' ILE . 6.5 t -97.42 166.86 11.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.161 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.753 HD13 ' O ' ' A' ' 25' ' ' THR . 8.7 mm -124.7 130.46 73.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.133 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 m -132.9 172.78 12.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.899 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 85.0 m -91.37 105.55 17.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.163 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.798 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -108.61 -38.21 5.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.071 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.9 m -162.98 -176.64 5.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.577 ' HG3' HG23 ' A' ' 32' ' ' THR . 12.3 pt-20 -84.67 -16.79 40.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.577 HG23 ' HG3' ' A' ' 31' ' ' GLU . 46.5 p -122.2 0.99 9.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.654 ' CB ' HG22 ' A' ' 81' ' ' THR . 22.2 p -145.08 164.65 30.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.997 0.427 . . . . 0.0 110.848 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.455 HG11 ' CE2' ' A' ' 111' ' ' TYR . 34.8 m -144.08 145.33 21.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.081 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.798 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 25.3 m-85 -78.33 119.28 21.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.936 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.4 t -113.81 131.82 64.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.096 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.44 ' HB ' HG22 ' A' ' 25' ' ' THR . 55.9 m -128.81 123.57 33.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.085 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.643 ' CD1' HG11 ' A' ' 93' ' ' VAL . 24.0 p90 -123.01 169.23 11.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.881 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.1 mm -134.64 108.56 10.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.677 0.751 . . . . 0.0 111.133 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 140.3 42.17 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.697 2.265 . . . . 0.0 112.346 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -107.39 -69.88 0.82 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.29 142.55 15.78 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.496 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -112.44 7.88 19.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 0.0 110.865 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.07 -1.42 86.87 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.55 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.503 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 113.75 -24.69 11.72 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.516 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.606 ' CD2' HD21 ' A' ' 99' ' ' LEU . 2.4 m-85 -108.06 161.9 21.74 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.656 0.741 . . . . 0.0 110.873 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 117.06 4.86 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.663 2.242 . . . . 0.0 112.362 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.682 HD13 ' CZ ' ' A' ' 51' ' ' PHE . 80.6 mt -45.14 135.21 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -91.97 -46.09 8.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.841 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.0 m -163.24 158.22 21.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.991 0.424 . . . . 0.0 110.857 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.682 ' CZ ' HD13 ' A' ' 48' ' ' ILE . 59.5 m-85 -108.67 170.13 8.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.83 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -144.24 120.77 11.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.427 ' HB ' HG22 ' A' ' 68' ' ' THR . 62.9 t -103.67 133.41 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.107 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -130.67 160.99 32.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.913 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.549 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 27.5 p90 -141.93 143.09 33.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.479 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 26.9 ttpt -117.33 133.45 55.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.872 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -79.1 124.54 28.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.921 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.1 mt -85.38 -60.88 1.9 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -53.94 -46.94 71.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.8 ttpp -91.92 157.24 16.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.607 HG13 ' O ' ' A' ' 61' ' ' VAL . 7.6 p -93.46 116.15 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.165 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.76 131.92 1.65 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.519 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -52.02 177.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.756 0.312 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.479 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 69.0 m95 -61.18 151.5 31.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.961 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.477 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.6 mm -123.42 156.12 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.9 tp -89.5 120.96 31.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.931 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.661 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -89.91 -59.33 2.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.427 HG22 ' HB ' ' A' ' 53' ' ' VAL . 6.2 t -147.63 174.55 11.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.164 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.451 ' OG ' ' N ' ' A' ' 70' ' ' ALA . 4.9 t -168.24 177.06 5.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.853 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.451 ' N ' ' OG ' ' A' ' 69' ' ' SER . . . 69.34 25.74 5.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.111 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.676 HG23 ' HD2' ' A' ' 72' ' ' PRO . 76.1 mt -78.18 138.72 60.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.623 0.725 . . . . 0.0 111.191 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.676 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.9 Cg_endo -69.76 157.07 61.65 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.736 2.291 . . . . 0.0 112.345 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -22.9 31.64 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.695 2.263 . . . . 0.0 112.337 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.2 m -82.57 -9.1 59.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.442 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.4 ttt180 -107.54 102.1 11.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.852 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.9 mt -99.89 12.56 36.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.938 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.6 t -153.32 131.68 12.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.838 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.618 HG11 HD13 ' A' ' 71' ' ' ILE . 2.2 m -145.88 162.32 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.556 ' OE1' ' HB1' ' A' ' 29' ' ' ALA . 32.6 tt0 -98.25 111.5 23.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.661 HG23 ' HB1' ' A' ' 67' ' ' ALA . 33.7 mm -81.32 102.08 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.169 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.654 HG22 ' CB ' ' A' ' 33' ' ' SER . 30.2 p -97.71 168.82 10.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.31 40.04 9.43 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.493 HD21 HG22 ' A' ' 80' ' ' ILE . 25.6 mt -101.32 170.87 7.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.687 0.28 . . . . 0.0 110.969 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -112.45 126.49 55.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -68.79 152.05 45.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.835 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.13 12.25 62.63 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 28.6 mm -122.68 101.12 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.871 0.367 . . . . 0.0 111.104 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.36 133.37 49.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -156.55 164.12 38.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.941 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -111.17 178.45 4.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.887 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -135.44 155.06 51.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 5.8 ptp180 -144.6 179.15 7.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.643 HG11 ' CD1' ' A' ' 38' ' ' TRP . 96.7 t -145.4 141.89 22.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.076 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.6 mtt180 -133.28 137.15 45.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.969 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -98.29 130.4 44.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.045 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mp -123.12 119.6 30.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.444 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.5 p-10 -123.56 -174.46 2.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.908 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.8 ptp -67.36 -2.62 6.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.606 HD21 ' CD2' ' A' ' 46' ' ' PHE . 23.5 mt -104.73 -24.94 12.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 146.5 -168.91 27.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.442 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -97.54 158.49 15.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.845 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.42 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 5.5 p -94.02 175.2 6.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.89 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -73.37 159.56 84.55 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.711 0.767 . . . . 0.0 110.894 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.43 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.9 Cg_endo -69.77 109.26 2.27 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.714 2.276 . . . . 0.0 112.394 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.431 ' HA ' ' HB1' ' A' ' 20' ' ' ALA . 93.8 p -52.62 158.14 1.38 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.846 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.55 140.67 46.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.515 0.674 . . . . 0.0 111.132 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 100.72 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.652 2.235 . . . . 0.0 112.378 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.0 p -47.27 170.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -59.38 150.52 64.08 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.595 0.712 . . . . 0.0 110.881 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.87 122.44 9.09 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.716 2.277 . . . . 0.0 112.267 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.623 ' CG ' HG21 ' A' ' 26' ' ' ILE . 56.2 t80 -111.16 116.46 31.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.953 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 94.7 t -92.28 103.48 14.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.213 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.8 t -70.73 107.09 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.097 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.5 t -111.23 46.9 1.04 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.892 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.1 -160.48 54.0 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.451 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 86.8 p -40.35 -47.08 2.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.962 0.41 . . . . 0.0 110.873 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.79 -159.46 21.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.494 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 2.05 3.87 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.693 2.262 . . . . 0.0 112.34 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.1 p -38.57 119.98 0.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.911 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.1 p -130.83 172.34 12.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.879 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.418 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 91.6 p -90.67 138.44 31.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.877 0.37 . . . . 0.0 110.847 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m -107.41 -44.43 4.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.48 177.38 18.57 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.451 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.3 t -163.62 132.91 3.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.822 0.344 . . . . 0.0 110.865 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 t -135.84 164.25 28.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.801 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.01 -56.28 1.28 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.495 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.3 p -58.35 110.72 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.821 0.343 . . . . 0.0 110.897 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -50.77 150.22 5.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.562 0.696 . . . . 0.0 110.939 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.78 5.56 1.65 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.678 2.252 . . . . 0.0 112.34 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.82 141.9 46.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -55.81 150.02 13.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.82 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 179.34 -49.62 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.474 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -47.87 96.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.88 0.372 . . . . 0.0 110.868 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.689 HD13 ' CE2' ' A' ' 46' ' ' PHE . 9.7 mt -99.85 -175.92 3.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.585 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.9 m -144.51 161.08 45.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.718 0.771 . . . . 0.0 110.806 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 170.01 17.56 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.628 2.219 . . . . 0.0 112.354 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.554 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.6 Cg_endo -69.86 154.24 67.58 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.664 2.243 . . . . 0.0 112.317 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.418 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.4 pt-20 -97.29 168.35 10.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.71 121.62 65.79 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.662 0.744 . . . . 0.0 111.154 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 160.9 48.0 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.684 2.256 . . . . 0.0 112.396 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -48.46 175.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.0 ttm105 -80.58 123.84 82.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.595 0.712 . . . . 0.0 110.817 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 143.85 52.27 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.674 2.25 . . . . 0.0 112.374 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.898 ' C ' HD13 ' A' ' 26' ' ' ILE . 4.8 t -96.9 167.59 10.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.112 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.898 HD13 ' C ' ' A' ' 25' ' ' THR . 3.1 mm -125.01 131.78 72.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.153 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 m -135.71 167.31 21.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.7 m -85.73 104.26 15.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.103 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.787 ' HB1' ' OE2' ' A' ' 79' ' ' GLU . . . -106.26 -40.71 5.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.056 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 m -162.77 163.96 26.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -67.73 -14.41 62.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.964 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 p -122.67 -1.13 9.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.165 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.67 ' CB ' HG22 ' A' ' 81' ' ' THR . 51.9 p -142.19 172.37 12.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.402 HG22 HD11 ' A' ' 83' ' ' LEU . 30.0 m -148.02 147.91 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.105 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.741 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 11.7 m-85 -83.42 115.09 21.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.934 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.4 t -109.78 129.05 65.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.12 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.478 ' HB ' HG22 ' A' ' 25' ' ' THR . 84.9 m -129.19 123.59 32.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.657 ' CD1' HG11 ' A' ' 93' ' ' VAL . 33.6 p90 -120.98 171.16 8.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.5 mm -134.77 106.14 10.68 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.612 0.72 . . . . 0.0 111.188 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 136.12 32.23 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.661 2.24 . . . . 0.0 112.36 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -102.74 -69.48 0.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.73 146.91 16.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.463 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 46.0 p-10 -113.84 6.34 16.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.92 0.39 . . . . 0.0 110.937 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.62 -1.52 87.73 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.458 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.15 -25.1 10.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.689 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.5 m-85 -109.21 161.86 22.26 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.63 0.729 . . . . 0.0 110.901 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 114.14 3.6 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.666 2.244 . . . . 0.0 112.366 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.529 HD13 ' CE1' ' A' ' 51' ' ' PHE . 94.6 mt -44.59 131.86 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -85.97 -47.97 9.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.7 p -160.54 163.32 32.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.851 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.529 ' CE1' HD13 ' A' ' 48' ' ' ILE . 65.3 m-85 -111.41 176.38 5.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.886 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -149.03 125.83 11.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.845 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 t -109.22 129.71 63.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.094 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.431 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 2.6 mp0 -126.58 154.87 43.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.872 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.53 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 33.5 p90 -135.58 142.64 45.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.987 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.517 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 33.6 ttpt -115.92 129.22 56.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -78.56 121.56 24.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 69.8 mt -84.22 174.12 10.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.913 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt 42.35 31.65 0.28 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -154.83 140.22 17.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 61' ' ' VAL . 8.8 p -77.79 122.5 32.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.14 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.78 -130.46 1.71 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.473 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -168.21 -178.65 3.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.785 0.326 . . . . 0.0 110.854 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.567 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 83.8 m95 -66.38 142.47 57.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.406 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.1 mm -120.51 162.03 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.159 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.2 tp -98.65 123.0 42.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.61 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -91.51 -71.69 0.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.018 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.487 ' CG2' HD11 ' A' ' 71' ' ' ILE . 3.7 t -125.11 178.36 5.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.141 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 92.6 p -172.1 176.09 3.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 69.45 26.61 5.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.668 HG23 ' HD2' ' A' ' 72' ' ' PRO . 83.6 mt -78.22 138.51 60.26 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.574 0.702 . . . . 0.0 111.156 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.668 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.4 Cg_endo -69.8 158.28 57.43 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.755 2.303 . . . . 0.0 112.285 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -24.77 29.21 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.686 2.257 . . . . 0.0 112.367 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.8 p -78.95 -19.9 50.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.457 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 6.1 ttt85 -94.42 108.3 20.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.836 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.0 mt -102.7 11.41 37.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.9 t -155.29 136.07 13.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.464 HG11 HD13 ' A' ' 71' ' ' ILE . 2.4 m -146.03 165.92 9.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.091 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.787 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 39.9 tt0 -101.35 110.09 22.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.61 HG23 ' HB1' ' A' ' 67' ' ' ALA . 27.9 mm -80.16 100.16 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.166 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.67 HG22 ' CB ' ' A' ' 33' ' ' SER . 27.6 p -97.41 168.96 10.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.126 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.63 37.47 11.9 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.495 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.537 HD21 HG22 ' A' ' 80' ' ' ILE . 31.5 mt -96.42 177.37 5.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.762 0.315 . . . . 0.0 110.935 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -119.68 119.29 33.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.832 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.418 ' HG2' ' N ' ' A' ' 115' ' ' GLY . 0.5 OUTLIER -61.63 153.11 28.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.921 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.59 14.15 64.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.493 HG22 ' CD2' ' A' ' 89' ' ' TYR . 29.0 mm -124.57 113.67 37.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.38 . . . . 0.0 111.092 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.3 131.89 36.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.823 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.493 ' CD2' HG22 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -154.36 162.87 40.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.856 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -107.95 -175.13 2.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.855 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -142.92 154.39 44.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.567 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 4.8 ptp180 -146.56 174.21 11.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.895 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.657 HG11 ' CD1' ' A' ' 38' ' ' TRP . 57.8 t -140.99 143.59 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -133.78 139.58 46.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -98.88 128.68 45.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.2 mp -123.08 118.87 28.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.443 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.5 p-10 -123.52 -173.65 2.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.436 ' HE1' ' CD1' ' A' ' 46' ' ' PHE . 5.8 ptp -68.89 -0.52 5.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.852 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.591 HD21 ' CD2' ' A' ' 46' ' ' PHE . 27.7 mt -107.07 -24.74 11.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 147.43 -167.26 28.57 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.494 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.59 158.34 16.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 0.0 110.934 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.441 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 5.1 p -94.32 175.18 6.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -70.89 160.23 82.89 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.603 0.716 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 108.01 1.98 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.725 2.284 . . . . 0.0 112.393 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.9 p -51.7 150.9 3.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.806 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.79 139.7 6.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.58 0.705 . . . . 0.0 111.114 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 99.5 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.684 2.256 . . . . 0.0 112.325 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 95.7 p -44.8 162.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.872 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.3 mtp85 -56.74 153.01 23.72 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.607 0.718 . . . . 0.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.87 129.59 17.74 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.608 2.205 . . . . 0.0 112.305 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -122.14 117.02 25.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 45.0 t -90.66 102.77 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 113' ' ' VAL . 14.0 t -67.84 103.37 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.057 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.3 t -99.89 44.21 1.03 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.829 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.418 ' N ' ' HG2' ' A' ' 85' ' ' LYS . . . 41.96 67.0 0.91 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.508 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.2 t -120.71 103.28 8.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.942 0.401 . . . . 0.0 110.884 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -94.24 174.01 33.46 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.524 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -34.14 15.18 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.751 2.3 . . . . 0.0 112.329 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.9 t 55.13 41.5 31.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.809 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 73.7 m -58.45 138.93 56.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.39 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.506 -179.972 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -164.0 173.58 12.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.374 . . . . 0.0 110.879 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 t -138.74 171.77 13.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.65 103.8 3.08 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.489 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 88.9 p -103.44 164.21 11.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.895 0.379 . . . . 0.0 110.871 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.7 p -86.82 110.72 20.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.796 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.25 -178.42 36.99 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.511 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 t -44.77 95.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.777 0.322 . . . . 0.0 110.881 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -156.85 135.18 7.44 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.572 0.701 . . . . 0.0 110.891 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -167.79 0.24 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.725 2.283 . . . . 0.0 112.377 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -79.4 48.16 0.87 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.528 ' O ' ' CG ' ' A' ' 12' ' ' HIS . 0.5 OUTLIER -93.38 70.02 4.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.846 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.54 -102.71 0.16 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.53 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -79.97 85.5 5.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.834 0.349 . . . . 0.0 110.894 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.54 HD13 ' CE2' ' A' ' 46' ' ' PHE . 6.3 mt -90.08 -175.07 4.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.93 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.591 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.9 m -144.32 161.38 44.87 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.664 0.745 . . . . 0.0 110.877 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 169.94 17.77 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.725 2.283 . . . . 0.0 112.356 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.531 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.5 Cg_endo -69.75 155.5 65.82 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.746 2.297 . . . . 0.0 112.36 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.416 ' C ' ' HB2' ' A' ' 102' ' ' SER . 7.0 pt-20 -97.97 170.08 9.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.874 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.69 122.07 78.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.646 0.736 . . . . 0.0 111.037 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.463 ' HG3' HG12 ' A' ' 93' ' ' VAL . 53.5 Cg_endo -69.76 161.8 44.52 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.711 2.274 . . . . 0.0 112.358 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -47.36 174.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.833 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -80.47 122.84 82.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.599 0.714 . . . . 0.0 110.821 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 144.35 53.62 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.679 2.253 . . . . 0.0 112.323 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.806 ' O ' HD13 ' A' ' 26' ' ' ILE . 6.5 t -94.81 167.89 11.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.075 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.806 HD13 ' O ' ' A' ' 25' ' ' THR . 5.8 mm -125.85 123.08 63.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.117 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -128.09 162.89 25.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.829 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m -83.46 98.56 9.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.079 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.683 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -98.4 -37.66 9.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.08 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.7 m -162.43 -179.47 6.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -79.59 -21.6 44.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.838 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.8 p -120.25 3.46 10.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.246 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.535 ' CB ' HG22 ' A' ' 81' ' ' THR . 12.4 p -145.58 165.74 27.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.4 m -144.16 149.9 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.162 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.683 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 12.3 m-85 -84.48 117.49 23.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.919 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 91.1 t -112.61 131.22 64.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.113 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.0 m -129.1 124.69 35.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.205 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.61 ' CD1' HG11 ' A' ' 93' ' ' VAL . 31.4 p90 -124.52 170.81 10.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 mm -134.93 110.23 10.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.582 0.706 . . . . 0.0 111.12 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 145.19 56.18 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.72 2.28 . . . . 0.0 112.316 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -113.66 -69.21 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.81 143.9 15.82 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.481 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 50.8 p-10 -113.33 9.14 18.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.92 0.39 . . . . 0.0 110.88 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.64 0.1 78.75 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.481 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.5 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 112.87 -25.33 11.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.458 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.54 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.3 m-85 -107.94 162.0 21.34 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.656 0.741 . . . . 0.0 110.877 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 117.57 5.16 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.691 2.261 . . . . 0.0 112.365 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.542 HD13 ' CE1' ' A' ' 51' ' ' PHE . 82.0 mt -48.11 133.37 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.135 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -89.33 -52.51 5.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.7 m -155.91 160.44 40.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.806 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.542 ' CE1' HD13 ' A' ' 48' ' ' ILE . 61.4 m-85 -109.77 171.27 7.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.929 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.687 HH21 HD22 ' A' ' 66' ' ' LEU . 23.1 mtp180 -143.63 123.7 13.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.484 HG11 HD11 ' A' ' 80' ' ' ILE . 25.9 t -104.32 117.04 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -115.78 155.35 27.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.533 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 38.9 p90 -133.62 170.28 15.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 29.4 ttpt -142.32 131.66 23.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -80.17 128.91 34.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.866 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.421 HD11 ' HB3' ' A' ' 110' ' ' PRO . 38.0 mt -91.29 147.52 22.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.957 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt 53.94 30.73 12.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.871 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.0 mmmt -139.4 -175.03 4.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.03 138.6 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.106 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 124.2 142.65 6.02 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.475 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.449 ' O ' ' CD1' ' A' ' 65' ' ' ILE . 12.0 m-20 -84.12 -177.5 6.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.831 0.348 . . . . 0.0 110.906 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.561 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 75.5 m95 -52.36 146.4 9.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.868 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.533 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 1.8 mm -125.74 155.16 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.687 HD22 HH21 ' A' ' 52' ' ' ARG . 57.5 tp -88.26 121.87 31.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.926 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.683 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -84.91 -67.4 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.448 ' CG2' HD11 ' A' ' 71' ' ' ILE . 13.5 t -129.08 -179.64 5.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.508 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 60.3 p -170.35 170.39 7.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 72.01 32.83 1.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.147 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.762 HD13 HG11 ' A' ' 78' ' ' VAL . 58.2 mt -86.05 137.83 35.13 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.646 0.736 . . . . 0.0 111.107 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.628 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.1 Cg_endo -69.74 157.36 60.69 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.727 2.285 . . . . 0.0 112.364 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.61 -24.7 30.06 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.71 2.273 . . . . 0.0 112.369 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 t -79.53 -15.77 57.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.908 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.457 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 13.8 ttt180 -97.87 105.15 17.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.852 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.5 mt -100.75 13.71 34.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.5 t -155.73 137.35 14.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.762 HG11 HD13 ' A' ' 71' ' ' ILE . 2.0 m -150.11 162.12 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.083 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.496 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 36.7 tt0 -98.06 117.07 31.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.683 HG23 ' HB1' ' A' ' 67' ' ' ALA . 31.9 mm -85.9 95.17 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.118 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.535 HG22 ' CB ' ' A' ' 33' ' ' SER . 23.6 p -88.83 171.72 9.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.189 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.29 44.06 14.45 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.437 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.588 HD21 HG22 ' A' ' 80' ' ' ILE . 39.6 mt -104.59 162.18 13.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.794 0.33 . . . . 0.0 110.924 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -106.58 123.7 48.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.407 ' CG ' HG12 ' A' ' 113' ' ' VAL . 14.2 mttt -64.73 159.98 21.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.12 11.88 20.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.48 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.8 mm -121.09 94.12 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 111.091 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.76 135.36 57.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.929 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -159.51 160.35 34.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -107.52 -179.39 3.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.838 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -139.72 156.66 46.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.561 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 3.8 ptp180 -147.69 178.16 8.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.834 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.61 HG11 ' CD1' ' A' ' 38' ' ' TRP . 91.9 t -141.0 140.71 32.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.128 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -132.49 135.57 46.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.831 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -96.56 129.85 43.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.135 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.8 mp -122.5 115.33 22.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.441 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.5 p-10 -119.87 -173.92 2.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 14.4 ptm -67.77 -1.83 6.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.591 HD12 ' O ' ' A' ' 16' ' ' SER . 51.1 mt -105.42 -25.58 12.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.83 -165.99 28.83 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.403 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -99.09 158.07 15.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 0.0 110.901 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.498 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 5.2 p -92.75 175.23 6.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -72.69 158.83 86.69 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.709 0.766 . . . . 0.0 110.835 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.439 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.8 Cg_endo -69.72 103.81 1.21 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.729 2.286 . . . . 0.0 112.332 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.4 p -48.21 152.18 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.892 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.38 140.8 5.27 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.585 0.707 . . . . 0.0 111.116 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 100.43 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.685 2.257 . . . . 0.0 112.333 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 52.0 p -48.45 157.17 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -49.57 151.6 2.82 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.592 0.711 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.421 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.1 Cg_endo -69.82 129.04 16.85 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.649 2.233 . . . . 0.0 112.332 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.484 ' CG ' HG21 ' A' ' 26' ' ' ILE . 52.3 t80 -117.58 122.65 44.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.1 t -98.22 101.29 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.064 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.407 HG12 ' CG ' ' A' ' 85' ' ' LYS . 22.0 t -69.1 107.08 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.097 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.6 t -104.94 21.81 16.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.45 -121.83 6.57 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.522 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.1 m -83.27 95.22 8.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.924 0.392 . . . . 0.0 110.905 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.26 -156.69 24.88 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.448 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 135.7 31.11 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.674 2.249 . . . . 0.0 112.409 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.5 m -119.08 135.36 54.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.824 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 65.3 p -151.67 165.48 34.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.917 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.438 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.6 t -167.6 149.52 5.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.955 0.407 . . . . 0.0 110.838 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m -93.27 158.22 15.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.6 -163.9 39.66 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.461 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.8 p -137.23 123.64 20.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.85 0.357 . . . . 0.0 110.856 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 t -69.11 151.45 46.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.836 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.89 -161.19 31.82 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.494 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.3 t -68.54 132.56 47.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.821 0.343 . . . . 0.0 110.863 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.451 ' CG ' ' HD2' ' A' ' 10' ' ' PRO . 51.0 tt0 -96.29 138.77 21.53 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.602 0.715 . . . . 0.0 110.835 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.451 ' HD2' ' CG ' ' A' ' 9' ' ' GLN . 54.1 Cg_endo -69.77 3.85 2.54 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.66 2.24 . . . . 0.0 112.345 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -139.81 149.6 43.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -46.5 113.55 0.66 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -163.92 -78.52 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.47 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -73.0 92.42 1.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.847 0.356 . . . . 0.0 110.921 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.612 HD22 ' HA3' ' A' ' 45' ' ' GLY . 10.3 mt -92.72 -175.46 3.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.943 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.651 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -134.42 160.59 67.91 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.704 0.764 . . . . 0.0 110.891 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 170.05 17.53 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.697 2.265 . . . . 0.0 112.341 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.541 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 52.8 Cg_endo -69.81 152.48 69.06 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.648 2.232 . . . . 0.0 112.337 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.43 ' C ' ' HB2' ' A' ' 102' ' ' SER . 7.5 pt-20 -96.12 161.08 14.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.909 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 103' ' ' GLU . . . -58.61 123.93 69.81 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.518 0.675 . . . . 0.0 111.136 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 165.86 29.55 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.666 2.244 . . . . 0.0 112.304 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -53.97 177.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -80.04 123.58 83.42 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.557 0.694 . . . . 0.0 110.886 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 144.27 53.35 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.664 2.243 . . . . 0.0 112.34 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.88 ' O ' HD13 ' A' ' 26' ' ' ILE . 14.8 t -94.18 165.7 12.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.174 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.88 HD13 ' O ' ' A' ' 25' ' ' THR . 4.2 mm -129.98 121.62 52.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.148 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 m -122.93 -175.99 3.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.889 HG21 ' HA2' ' A' ' 117' ' ' GLY . 30.3 m -99.85 97.57 8.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.165 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.904 ' HB1' ' OE1' ' A' ' 79' ' ' GLU . . . -98.18 -42.72 7.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.098 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 t -157.43 -175.98 5.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.829 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -81.77 -21.33 37.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 36.0 p -120.61 -0.72 10.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.154 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.533 ' HB3' HG22 ' A' ' 81' ' ' THR . 99.4 p -135.29 173.33 11.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.808 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.3 m -154.83 142.89 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.185 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.586 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 18.6 m-85 -76.95 120.64 22.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.943 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.0 t -116.13 125.56 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.086 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.7 m -126.09 121.62 33.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.152 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.744 ' CD1' HG11 ' A' ' 93' ' ' VAL . 25.3 p90 -119.06 171.09 8.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.8 mm -134.04 107.28 11.46 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.6 0.714 . . . . 0.0 111.193 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 130.88 20.09 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -94.16 -67.76 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.26 161.79 12.82 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.532 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -125.66 4.67 7.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.884 0.373 . . . . 0.0 110.895 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 81.72 2.29 90.48 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.433 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.612 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 109.44 -25.54 17.39 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.42 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.495 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 2.5 m-85 -108.36 162.05 21.31 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.63 0.728 . . . . 0.0 110.891 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.8 116.18 4.44 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.711 2.274 . . . . 0.0 112.303 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.517 HD13 ' CE1' ' A' ' 51' ' ' PHE . 96.4 mt -46.59 135.76 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -90.0 -49.12 6.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 m -161.58 160.1 28.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.863 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.517 ' CE1' HD13 ' A' ' 48' ' ' ILE . 64.4 m-85 -108.0 175.97 5.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -149.22 128.08 12.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.43 HG11 HD11 ' A' ' 80' ' ' ILE . 60.2 t -110.35 130.22 64.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.102 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.475 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 21.4 mt-10 -125.56 157.86 36.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.854 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.504 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 26.9 p90 -139.81 145.4 38.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.988 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.404 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 31.8 ttpt -120.94 134.33 55.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.822 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.4 mttt -82.65 128.54 34.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.917 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.46 HD11 ' HB3' ' A' ' 110' ' ' PRO . 58.5 mt -91.73 -71.31 0.64 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.884 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -40.53 -26.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -118.97 140.11 50.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -73.93 127.89 36.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.113 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.06 179.85 48.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.481 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -101.0 -175.6 2.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.9 0.381 . . . . 0.0 110.81 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.404 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 78.3 m95 -75.24 139.82 42.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.456 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.7 mm -115.03 162.75 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.109 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.1 tp -98.91 118.06 34.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.643 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -83.35 -68.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.095 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.564 HG21 HD11 ' A' ' 71' ' ' ILE . 7.7 t -128.51 175.79 8.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.15 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.552 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 90.0 p -168.14 167.34 12.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.795 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.552 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 74.39 25.98 1.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.058 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.684 HD13 HG11 ' A' ' 78' ' ' VAL . 52.3 mt -76.9 136.98 66.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.667 0.746 . . . . 0.0 111.139 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.603 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.9 Cg_endo -69.74 156.67 62.81 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.69 2.26 . . . . 0.0 112.358 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.71 -18.54 37.17 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.701 2.267 . . . . 0.0 112.446 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 86.5 p -86.58 -13.05 46.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.461 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 8.6 ttt85 -101.67 98.96 9.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 51.9 mt -96.74 11.62 34.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.836 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 t -153.39 131.72 12.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.684 HG11 HD13 ' A' ' 71' ' ' ILE . 2.2 m -145.7 163.91 11.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.109 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.904 ' OE1' ' HB1' ' A' ' 29' ' ' ALA . 33.5 tt0 -100.47 108.83 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.643 HG23 ' HB1' ' A' ' 67' ' ' ALA . 26.7 mm -75.82 107.39 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.193 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.533 HG22 ' HB3' ' A' ' 33' ' ' SER . 72.0 p -102.89 165.85 10.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.167 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.66 41.11 7.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.464 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.6 mt -99.16 -178.91 4.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.757 0.313 . . . . 0.0 110.9 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -125.05 122.33 36.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -63.83 161.04 16.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.9 12.0 9.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.417 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 26.9 mm -122.23 108.26 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 0.0 111.24 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.26 136.54 42.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.417 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -157.54 168.59 26.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -114.09 -175.45 2.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.904 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -143.85 158.4 43.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.817 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.475 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 2.7 ptp180 -150.45 175.16 12.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.744 HG11 ' CD1' ' A' ' 38' ' ' TRP . 90.8 t -143.18 135.56 24.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.085 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -126.49 144.32 50.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.541 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -104.85 129.52 53.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.155 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mp -123.41 117.32 24.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.867 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.439 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 37.9 p-10 -119.81 -172.61 2.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 12.6 ptm -69.48 1.45 3.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.809 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 16' ' ' SER . 34.3 mt -108.81 -26.59 10.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.908 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.54 -163.09 29.51 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.532 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -104.59 158.14 16.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 110.861 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.43 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 7.5 p -95.39 175.06 6.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.825 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 30.1 mt-10 -70.76 157.01 91.18 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.575 0.703 . . . . 0.0 110.943 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.434 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.7 Cg_endo -69.73 105.2 1.44 Allowed 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.683 2.255 . . . . 0.0 112.294 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.0 p -45.94 150.52 0.55 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -44.0 141.44 2.4 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.556 0.694 . . . . 0.0 111.148 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 97.66 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.684 2.256 . . . . 0.0 112.36 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 t -43.53 154.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.84 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -51.43 153.71 3.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.617 0.722 . . . . 0.0 110.829 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.46 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.5 Cg_endo -69.77 121.92 8.6 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.722 2.281 . . . . 0.0 112.306 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -112.79 120.19 40.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.31 104.96 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.196 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.3 t -73.65 106.45 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.4 t -103.77 -45.2 4.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.816 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -165.04 -174.67 34.99 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.461 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 93.8 p -86.14 106.28 17.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.938 0.399 . . . . 0.0 110.846 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.889 ' HA2' HG21 ' A' ' 28' ' ' THR . . . 51.09 -156.44 2.93 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.465 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 119' ' ' SER . 52.7 Cg_endo -69.92 3.96 2.54 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.705 2.27 . . . . 0.0 112.327 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 118' ' ' PRO . 41.6 t -34.01 -40.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.814 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.9 m -89.85 -64.32 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.446 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.0 t -64.23 164.37 11.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.932 0.396 . . . . 0.0 110.871 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 m -124.7 -43.67 2.0 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.864 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.86 -170.93 21.06 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.452 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.6 m -47.61 122.2 4.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.872 0.368 . . . . 0.0 110.783 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.7 p -63.51 170.3 3.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.77 -154.59 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.462 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.8 m -128.69 112.19 13.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.822 0.344 . . . . 0.0 110.826 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -39.66 154.65 0.17 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.614 0.721 . . . . 0.0 110.836 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 3.94 2.48 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.704 2.269 . . . . 0.0 112.342 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -83.29 168.15 16.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -171.61 171.81 5.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.99 85.44 1.36 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.43 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.0 mtt-85 -73.59 89.96 1.75 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.91 0.386 . . . . 0.0 110.874 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.763 HD13 ' CE2' ' A' ' 46' ' ' PHE . 13.3 mt -91.96 -175.03 3.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.654 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.8 m -145.11 161.21 43.25 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.58 0.705 . . . . 0.0 110.892 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 170.14 17.27 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.641 2.227 . . . . 0.0 112.377 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.495 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 54.3 Cg_endo -69.73 156.63 62.92 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.664 2.242 . . . . 0.0 112.331 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.426 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.4 pt-20 -98.11 174.53 6.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.2 123.44 87.38 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.597 0.713 . . . . 0.0 111.082 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 161.33 46.33 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.665 2.243 . . . . 0.0 112.376 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -49.39 174.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -80.43 122.16 82.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.602 0.715 . . . . 0.0 110.908 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HB2' HG13 ' A' ' 36' ' ' VAL . 53.9 Cg_endo -69.69 143.15 50.25 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.666 2.244 . . . . 0.0 112.402 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.917 ' C ' HD13 ' A' ' 26' ' ' ILE . 5.4 t -95.27 165.98 12.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.106 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.917 HD13 ' C ' ' A' ' 25' ' ' THR . 2.8 mm -126.81 125.34 66.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.184 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.6 t -131.44 166.99 20.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.4 m -80.88 107.27 13.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.732 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -111.13 -36.31 5.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 m -164.87 -179.71 5.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -82.99 -19.5 36.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.832 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.8 p -120.33 -1.9 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.715 ' CB ' HG22 ' A' ' 81' ' ' THR . 24.2 p -140.4 171.25 14.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.9 m -149.65 147.43 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.163 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.732 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 15.1 m-85 -82.78 120.49 25.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.407 HG13 ' HB2' ' A' ' 24' ' ' PRO . 92.3 t -115.71 131.46 68.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.105 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.9 m -128.36 120.59 27.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.152 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.568 ' CD1' HG11 ' A' ' 93' ' ' VAL . 28.6 p90 -120.13 170.27 9.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.1 mm -134.3 110.5 11.63 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.59 0.709 . . . . 0.0 111.137 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.453 ' HD3' HD22 ' A' ' 76' ' ' LEU . 53.9 Cg_endo -69.79 137.99 36.66 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.727 2.285 . . . . 0.0 112.312 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -103.58 -69.68 0.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.849 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.48 158.85 14.81 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.509 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -124.25 5.57 8.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.833 0.349 . . . . 0.0 110.815 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.11 0.69 89.27 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.519 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.411 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 108.58 -18.1 32.76 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.548 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.763 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.1 m-85 -114.68 162.24 24.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.617 0.723 . . . . 0.0 110.922 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 114.61 3.75 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.711 2.274 . . . . 0.0 112.33 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.537 HD13 ' CE1' ' A' ' 51' ' ' PHE . 95.8 mt -46.46 141.2 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.36 -52.11 4.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.7 p -159.69 160.61 34.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.537 ' CE1' HD13 ' A' ' 48' ' ' ILE . 52.4 m-85 -108.83 168.32 9.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.928 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.4 mtt-85 -143.39 136.77 28.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.429 ' HB ' HG22 ' A' ' 68' ' ' THR . 58.8 t -116.63 134.8 58.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -133.63 158.84 42.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.545 ' CD2' ' HB2' ' A' ' 67' ' ' ALA . 26.4 p90 -136.82 175.02 10.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.944 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.466 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 36.9 ttpt -147.69 135.62 21.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.944 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -82.34 129.63 34.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 110' ' ' PRO . 28.8 mt -96.31 -65.46 0.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.907 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -50.98 -21.28 1.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.942 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -128.27 128.57 44.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.856 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 61' ' ' VAL . 6.1 p -58.95 118.12 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.84 131.27 2.0 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.484 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -59.88 -175.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.789 0.328 . . . . 0.0 110.872 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.466 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 78.0 m95 -75.21 135.59 41.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.89 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.508 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.9 mm -115.14 159.42 15.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.14 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 tp -91.5 122.52 34.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.762 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -91.41 -71.33 0.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.081 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.464 ' CG2' HD11 ' A' ' 71' ' ' ILE . 1.3 t -130.29 165.08 23.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.151 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.9 m -162.85 -175.34 4.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 64.25 29.77 13.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.055 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.594 HG23 ' HD2' ' A' ' 72' ' ' PRO . 61.3 mt -83.37 137.42 42.24 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.641 0.734 . . . . 0.0 111.176 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.594 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.9 Cg_endo -69.7 158.19 57.9 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.633 2.222 . . . . 0.0 112.379 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.72 -11.41 30.82 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.661 2.24 . . . . 0.0 112.323 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.0 t -92.52 -18.16 23.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.854 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.427 ' NE ' HG12 ' A' ' 78' ' ' VAL . 17.0 ttt180 -98.57 103.65 15.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.822 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.453 HD22 ' HD3' ' A' ' 40' ' ' PRO . 46.9 mt -99.46 7.62 45.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.974 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 t -149.45 132.85 16.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.809 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.467 HG11 HD13 ' A' ' 71' ' ' ILE . 2.0 m -148.35 165.17 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.131 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.422 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 28.8 tt0 -99.47 116.03 30.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.762 HG23 ' HB1' ' A' ' 67' ' ' ALA . 45.9 mm -83.3 101.21 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.117 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.715 HG22 ' CB ' ' A' ' 33' ' ' SER . 27.4 p -99.67 168.63 9.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.162 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.09 34.34 9.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.2 mt -102.43 179.5 4.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.769 0.319 . . . . 0.0 110.949 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -124.22 135.57 53.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -71.63 157.3 38.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.35 12.84 59.3 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.457 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.406 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 25.8 mm -124.09 113.9 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 111.147 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.87 139.8 35.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.825 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.406 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -160.76 170.46 20.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.944 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -114.49 -176.14 2.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.843 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -144.43 154.23 42.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.453 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 5.3 ptp180 -146.91 179.86 7.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.568 HG11 ' CD1' ' A' ' 38' ' ' TRP . 74.6 t -145.1 143.58 22.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.115 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -132.77 146.02 51.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -107.39 130.22 54.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.086 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.424 ' HG ' ' CB ' ' A' ' 101' ' ' GLU . 4.3 mp -123.87 120.77 33.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.934 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.438 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 37.0 p-10 -123.74 -172.64 2.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.3 ptm -68.98 0.78 4.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.797 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 16' ' ' SER . 51.2 mt -108.6 -26.38 10.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.935 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.56 -167.5 29.18 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.485 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.424 ' CB ' ' HG ' ' A' ' 96' ' ' LEU . 0.6 OUTLIER -100.54 158.39 15.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 110.866 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.426 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 14.0 p -94.81 175.22 6.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.816 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -71.41 160.68 81.83 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.621 0.724 . . . . 0.0 110.897 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.411 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.9 Cg_endo -69.8 107.69 1.92 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.741 2.294 . . . . 0.0 112.286 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.8 p -47.95 158.88 0.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.35 138.61 48.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.587 0.708 . . . . 0.0 111.128 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 96.89 0.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.73 2.287 . . . . 0.0 112.38 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.5 p -47.21 160.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.841 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -52.42 150.94 8.1 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.607 0.718 . . . . 0.0 110.854 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.465 ' HB3' HD11 ' A' ' 58' ' ' LEU . 54.4 Cg_endo -69.61 129.21 17.36 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.724 2.283 . . . . 0.0 112.392 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -117.53 120.23 37.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.926 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.0 t -92.94 107.42 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.142 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.0 t -73.25 104.56 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 t -102.06 146.29 28.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.823 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -48.75 -54.2 14.78 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.46 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.6 t -112.38 134.8 53.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.855 0.359 . . . . 0.0 110.857 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -148.55 -177.06 22.49 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.493 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 134.73 28.69 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.68 2.253 . . . . 0.0 112.316 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 55.2 m -131.0 127.87 39.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.2 m -151.05 150.33 30.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.519 179.974 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.8 m -141.82 175.41 9.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.835 0.35 . . . . 0.0 110.895 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.4 p -60.47 133.87 56.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.911 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.11 -55.48 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.531 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.7 p -61.7 169.22 2.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.931 0.396 . . . . 0.0 110.867 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.8 p -101.94 167.57 9.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -108.67 166.45 12.82 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.548 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 52.0 p -57.85 130.07 44.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 110.847 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -161.75 153.8 16.32 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.618 0.723 . . . . 0.0 110.898 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 3.23 2.84 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.751 2.301 . . . . 0.0 112.368 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -111.72 93.09 4.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -45.38 124.95 5.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.829 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.12 -106.23 1.5 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.506 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -63.42 89.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.902 0.382 . . . . 0.0 110.828 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.618 HD13 ' CE2' ' A' ' 46' ' ' PHE . 9.0 mt -84.59 178.77 7.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.913 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.65 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.4 m -139.76 161.87 53.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.682 0.753 . . . . 0.0 110.832 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.74 170.09 17.37 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.674 2.249 . . . . 0.0 112.343 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.468 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 54.6 Cg_endo -69.69 155.48 66.07 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.74 2.293 . . . . 0.0 112.375 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.423 ' C ' ' HB2' ' A' ' 102' ' ' SER . 5.0 pt-20 -98.06 175.29 6.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.94 121.12 80.43 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.611 0.72 . . . . 0.0 111.153 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 162.14 43.23 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.711 2.274 . . . . 0.0 112.325 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -50.42 174.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.824 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -80.15 123.63 83.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.583 0.706 . . . . 0.0 110.851 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 144.04 52.78 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.713 2.276 . . . . 0.0 112.369 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.871 ' O ' HD13 ' A' ' 26' ' ' ILE . 4.3 t -94.4 166.17 12.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.203 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 25' ' ' THR . 7.9 mm -128.21 121.42 55.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.129 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -121.17 -177.72 3.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.887 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.3 m -98.68 99.74 10.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.772 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -100.79 -41.1 7.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.016 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.6 m -163.16 -178.75 6.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.834 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.432 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 3.8 pm0 -84.91 -15.04 45.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.852 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.6 p -117.94 -7.1 10.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.179 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.766 ' CB ' HG22 ' A' ' 81' ' ' THR . 36.7 p -143.56 171.9 13.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 m -147.64 150.94 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.137 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.772 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 18.3 m-85 -84.89 119.81 25.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.3 t -113.91 130.61 67.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.167 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 42.0 m -128.28 124.07 35.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.592 ' CD1' HG11 ' A' ' 93' ' ' VAL . 27.4 p90 -121.3 168.39 11.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.1 mm -132.09 108.13 13.82 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.631 0.729 . . . . 0.0 111.153 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 142.92 49.13 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.711 2.274 . . . . 0.0 112.309 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -111.98 -66.86 1.04 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.6 144.52 16.32 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.496 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -115.12 10.0 16.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.965 0.412 . . . . 0.0 110.963 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 78.73 -0.59 76.65 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.467 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.53 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 110.37 -22.88 21.77 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.487 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.62 ' CD2' HD21 ' A' ' 99' ' ' LEU . 2.3 m-85 -109.89 162.03 21.97 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.574 0.702 . . . . 0.0 110.944 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 113.0 3.22 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.655 2.237 . . . . 0.0 112.428 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.518 HD13 ' CE1' ' A' ' 51' ' ' PHE . 80.6 mt -47.07 134.75 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -83.62 -49.96 8.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.952 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 m -162.9 162.7 26.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.809 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.518 ' CE1' HD13 ' A' ' 48' ' ' ILE . 65.5 m-85 -108.42 169.72 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.831 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -145.15 130.25 18.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 92' ' ' ARG . 61.7 t -108.83 136.78 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.417 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 4.0 mp0 -127.59 156.34 42.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.825 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.621 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 12.8 p90 -141.08 147.33 38.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.855 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -129.72 140.65 51.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.971 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.7 mtmm -83.79 129.84 34.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.441 HD11 ' HB3' ' A' ' 110' ' ' PRO . 77.5 mt -85.62 -31.16 22.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.922 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 60' ' ' LYS . 7.9 mtpp -91.81 35.11 0.97 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.83 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.49 ' CG ' ' O ' ' A' ' 59' ' ' LYS . 35.3 mttt -165.32 178.68 6.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.893 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 62' ' ' GLY . 1.4 p -99.55 -29.51 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.132 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 61' ' ' VAL . . . -35.48 122.21 0.58 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.485 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.06 -175.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.78 0.324 . . . . 0.0 110.842 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.453 ' O ' HD13 ' A' ' 65' ' ' ILE . 60.8 m95 -62.15 152.14 33.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.97 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 64' ' ' TRP . 2.1 mm -129.76 157.97 42.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.183 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 53' ' ' VAL . 1.7 tp -85.43 111.59 20.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.621 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . . . -74.0 -61.64 1.78 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.111 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.421 HG23 HD11 ' A' ' 71' ' ' ILE . 5.3 t -150.88 161.09 43.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.191 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 15.7 m -152.5 -179.59 7.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.854 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 71.67 25.25 3.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.07 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.638 HD13 HG11 ' A' ' 78' ' ' VAL . 71.4 mt -81.5 137.99 48.03 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.594 0.711 . . . . 0.0 111.103 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.638 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.7 Cg_endo -69.79 156.17 63.95 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.616 2.211 . . . . 0.0 112.285 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -12.72 33.44 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.698 2.266 . . . . 0.0 112.375 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.3 t -92.43 -17.32 24.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.806 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.474 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 7.2 ttt85 -96.44 97.54 9.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.2 mt -94.06 13.59 22.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.91 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -154.17 130.95 10.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.8 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.638 HG11 HD13 ' A' ' 71' ' ' ILE . 2.6 m -145.4 160.34 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.114 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.426 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 24.2 tt0 -96.8 115.82 28.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.925 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.601 HG23 ' HB1' ' A' ' 67' ' ' ALA . 22.2 mm -83.63 105.35 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.766 HG22 ' CB ' ' A' ' 33' ' ' SER . 64.2 p -102.56 171.43 7.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.166 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.09 38.38 11.31 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.5 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.5 mt -105.33 176.37 5.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.81 0.338 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -120.19 136.09 54.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.85 150.5 42.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.96 10.66 68.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.46 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.49 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 28.0 mm -121.41 103.88 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.369 . . . . 0.0 111.105 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.02 141.81 52.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.49 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -163.22 163.02 25.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -111.89 169.59 8.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.811 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -129.71 153.89 47.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.429 ' O ' HG13 ' A' ' 53' ' ' VAL . 5.3 ptp180 -143.82 -178.94 6.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.592 HG11 ' CD1' ' A' ' 38' ' ' TRP . 86.4 t -145.13 144.55 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.093 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -134.87 139.13 44.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.822 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -99.69 132.77 44.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.096 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.4 mp -126.35 119.59 27.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.928 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.448 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 38.5 p-10 -123.61 -173.95 2.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.3 ptp -68.87 -0.63 5.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.798 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.65 HD12 ' O ' ' A' ' 16' ' ' SER . 22.4 mt -106.62 -25.66 11.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.972 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 148.26 -165.98 29.02 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -102.01 158.03 16.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.423 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 5.2 p -94.33 175.04 6.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.801 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -71.22 160.39 82.66 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.606 0.717 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 110.33 2.53 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.683 2.255 . . . . 0.0 112.354 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.0 p -53.34 152.14 4.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.43 139.44 8.06 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.599 0.714 . . . . 0.0 111.073 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 100.41 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.66 2.24 . . . . 0.0 112.352 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.3 p -46.1 163.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.85 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -56.83 152.4 27.5 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.529 0.68 . . . . 0.0 110.939 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.441 ' HB3' HD11 ' A' ' 58' ' ' LEU . 54.2 Cg_endo -69.77 123.2 9.87 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.64 2.227 . . . . 0.0 112.395 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.411 ' CB ' HG21 ' A' ' 26' ' ' ILE . 48.5 t80 -112.89 117.21 31.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.8 t -91.76 101.79 12.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.175 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.9 t -67.99 110.55 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.9 t -107.07 158.25 17.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -40.7 -66.44 0.87 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.479 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.4 m -123.15 175.81 6.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.893 0.378 . . . . 0.0 110.902 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 172.1 -160.06 31.46 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.455 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 90.36 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.675 2.25 . . . . 0.0 112.351 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.5 m -93.81 169.87 9.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.7 t -133.09 -43.78 0.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.82 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.517 -179.953 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.6 m -160.84 178.2 9.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.915 0.388 . . . . 0.0 110.832 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.7 m -141.36 177.1 8.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.863 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.87 -166.09 19.99 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.474 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 t -164.05 124.42 2.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.899 0.381 . . . . 0.0 110.838 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 t -125.9 175.95 7.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.831 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.38 -134.98 6.88 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.467 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -174.58 177.51 2.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 0.0 110.828 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -147.28 143.98 18.94 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.645 0.736 . . . . 0.0 110.863 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -175.17 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.72 2.28 . . . . 0.0 112.384 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -162.91 148.96 12.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.856 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -148.59 162.46 39.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.56 126.42 4.65 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.434 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -72.98 83.06 1.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.359 . . . . 0.0 110.864 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.565 HD13 ' CE2' ' A' ' 46' ' ' PHE . 15.9 mt -99.71 -176.32 3.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.601 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.5 p -141.65 160.17 57.42 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.72 0.772 . . . . 0.0 110.819 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 169.83 17.96 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.691 2.261 . . . . 0.0 112.347 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.561 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.0 Cg_endo -69.84 152.72 68.99 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.664 2.243 . . . . 0.0 112.256 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.421 ' C ' ' HB2' ' A' ' 102' ' ' SER . 4.2 pt-20 -94.68 172.46 8.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.01 121.72 79.36 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.544 0.688 . . . . 0.0 111.109 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 161.96 43.93 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.625 2.217 . . . . 0.0 112.337 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -51.27 174.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.832 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -79.99 123.08 83.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.542 0.687 . . . . 0.0 110.849 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 143.51 51.21 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.677 2.252 . . . . 0.0 112.352 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.71 ' O ' HD13 ' A' ' 26' ' ' ILE . 4.8 t -93.38 164.42 13.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.184 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 25' ' ' THR . 12.4 mm -128.07 120.76 54.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.051 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -123.28 -178.76 4.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.858 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.2 m -97.05 98.97 10.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.636 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -100.41 -33.84 10.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.146 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.43 -175.02 3.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -83.49 -20.03 34.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.962 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.7 p -122.92 -0.58 8.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.179 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.652 ' CB ' HG22 ' A' ' 81' ' ' THR . 3.8 p -139.27 163.89 31.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.82 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.72 144.82 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.152 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.636 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 16.8 m-85 -77.8 116.66 18.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.904 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.9 t -108.98 130.72 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.127 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.766 HG23 ' HB2' ' A' ' 77' ' ' SER . 8.8 m -129.16 121.9 28.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.129 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.575 ' CD1' HG11 ' A' ' 93' ' ' VAL . 35.3 p90 -121.63 170.95 9.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.519 HD13 ' O ' ' A' ' 38' ' ' TRP . 18.7 mm -135.76 106.0 9.82 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.631 0.729 . . . . 0.0 111.17 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.411 ' CD ' HD22 ' A' ' 76' ' ' LEU . 53.7 Cg_endo -69.68 129.87 18.44 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.712 2.274 . . . . 0.0 112.347 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -93.0 -70.41 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.49 151.37 16.92 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.445 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 42.4 p-10 -118.03 10.7 13.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 0.0 110.9 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.57 -4.25 60.79 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.436 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.402 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 113.96 -18.05 19.43 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.483 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.565 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.1 m-85 -114.3 162.03 25.33 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.674 0.75 . . . . 0.0 110.873 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 114.8 3.81 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.668 2.245 . . . . 0.0 112.36 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.49 HD13 ' CE1' ' A' ' 51' ' ' PHE . 89.4 mt -45.6 130.37 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -84.99 -46.18 11.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.6 p -162.19 162.53 28.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.757 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.49 ' CE1' HD13 ' A' ' 48' ' ' ILE . 50.1 m-85 -108.89 172.7 6.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.499 ' CZ ' HD21 ' A' ' 96' ' ' LEU . 55.9 mtt180 -145.04 121.29 10.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.977 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.3 t -105.62 128.21 59.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.135 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.422 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 13.9 mt-10 -128.89 152.54 48.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.823 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.54 ' CD2' ' HB2' ' A' ' 67' ' ' ALA . 36.7 p90 -133.34 173.84 11.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.917 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -149.14 137.35 20.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.94 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -83.53 125.91 32.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.966 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.441 ' O ' ' C ' ' A' ' 59' ' ' LYS . 77.8 mt -87.48 -70.71 0.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.912 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 58' ' ' LEU . 12.2 tttm -34.72 -38.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.844 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -116.03 131.66 56.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.895 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 61' ' ' VAL . 7.5 p -63.04 119.77 7.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.067 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -167.75 159.06 32.21 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.497 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.54 -175.26 4.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.793 0.33 . . . . 0.0 110.822 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -79.85 142.51 35.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.515 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 2.6 mm -120.47 158.93 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.8 tp -93.31 121.93 35.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.712 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -90.19 -69.0 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.096 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.497 ' CG2' HD11 ' A' ' 71' ' ' ILE . 1.4 t -126.49 178.57 5.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.115 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 59.9 p -173.86 178.35 2.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.835 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 67.98 30.67 5.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.079 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.629 HG23 ' HD2' ' A' ' 72' ' ' PRO . 72.2 mt -84.56 137.73 38.72 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.591 0.71 . . . . 0.0 111.151 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.629 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.8 Cg_endo -69.76 159.56 52.95 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.739 2.293 . . . . 0.0 112.321 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 -17.67 37.51 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.71 2.274 . . . . 0.0 112.325 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.4 m -86.48 -23.19 26.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.431 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 15.0 ttt180 -90.01 100.99 13.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.813 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.411 HD22 ' CD ' ' A' ' 40' ' ' PRO . 52.6 mt -95.95 9.58 40.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.839 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.766 ' HB2' HG23 ' A' ' 37' ' ' THR . 11.6 t -153.79 136.6 15.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.563 HG11 HD13 ' A' ' 71' ' ' ILE . 1.9 m -147.31 163.81 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.135 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.561 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 35.0 tt0 -100.4 111.59 23.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.833 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.712 HG23 ' HB1' ' A' ' 67' ' ' ALA . 26.3 mm -80.86 102.94 7.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.102 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.652 HG22 ' CB ' ' A' ' 33' ' ' SER . 77.2 p -97.25 165.35 12.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.059 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.78 37.46 8.58 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.436 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 88.1 mt -97.62 -179.68 4.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.792 0.329 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -126.71 125.25 41.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -65.11 163.06 15.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.64 17.94 22.08 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.536 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.501 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 28.1 mm -129.37 105.05 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 111.114 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.89 141.82 49.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.501 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -162.75 164.53 26.25 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.944 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -111.08 -175.6 2.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.93 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -146.64 161.46 40.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.84 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.439 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 3.5 ptp180 -151.95 173.41 14.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.884 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.575 HG11 ' CD1' ' A' ' 38' ' ' TRP . 71.6 t -140.02 136.4 38.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.125 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -127.05 138.21 53.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.863 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -97.95 126.35 43.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.067 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.499 HD21 ' CZ ' ' A' ' 52' ' ' ARG . 7.0 mp -120.53 118.41 30.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.437 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.7 p-10 -123.39 -173.72 2.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.1 ptm -68.07 -1.48 5.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 16' ' ' SER . 44.5 mt -105.65 -25.78 12.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.988 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.99 -166.04 28.9 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.511 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.4 156.39 17.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.858 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.421 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 5.5 p -93.39 175.11 6.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.895 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -70.27 157.89 88.86 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.634 0.731 . . . . 0.0 110.856 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.439 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.5 Cg_endo -69.74 102.95 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.66 2.24 . . . . 0.0 112.324 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.9 p -43.93 153.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.81 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.71 141.65 17.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.586 0.707 . . . . 0.0 111.076 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 98.05 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.687 2.258 . . . . 0.0 112.373 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.0 p -45.8 151.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.817 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.2 mmm-85 -45.57 156.18 0.43 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.593 0.711 . . . . 0.0 110.823 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 131.45 21.15 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.638 2.226 . . . . 0.0 112.28 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.579 ' CG ' HG21 ' A' ' 26' ' ' ILE . 39.7 t80 -121.04 113.28 19.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.9 t -91.13 102.81 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.146 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.9 t -69.09 105.7 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.164 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.6 t -104.84 43.01 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 51.27 68.63 1.42 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.498 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 80.8 p -131.27 118.61 20.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.926 0.393 . . . . 0.0 110.826 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -162.38 -158.09 9.39 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.438 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 170.07 17.45 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.634 2.223 . . . . 0.0 112.371 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.7 m -99.46 -44.24 6.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.906 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.0 t -136.4 110.43 8.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.857 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.455 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.1 p -168.43 169.07 10.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 110.869 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.1 p -144.11 155.18 43.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.825 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.59 144.65 18.5 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.462 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 p -71.7 172.67 9.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.894 0.378 . . . . 0.0 110.857 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 t -61.96 156.41 21.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.77 -89.71 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.476 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 t 51.65 29.29 5.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.819 0.342 . . . . 0.0 110.887 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -107.47 141.41 22.94 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.587 0.708 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.86 82.96 0.74 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.655 2.237 . . . . 0.0 112.28 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -132.82 168.24 18.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -38.19 -51.18 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.29 -81.52 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.448 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -77.21 90.64 3.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 0.0 110.877 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.668 ' CD1' ' CE2' ' A' ' 46' ' ' PHE . 9.1 mt -105.01 -174.62 2.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.845 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.694 ' O ' HD12 ' A' ' 99' ' ' LEU . 0.9 OUTLIER -134.84 159.63 71.42 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.716 0.769 . . . . 0.0 110.835 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 170.22 17.03 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.727 2.285 . . . . 0.0 112.323 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.51 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.5 Cg_endo -69.83 154.56 67.31 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.612 2.208 . . . . 0.0 112.341 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.416 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.1 pt-20 -95.7 174.11 7.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.868 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.65 122.04 84.46 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.645 0.736 . . . . 0.0 111.071 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 160.79 48.38 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.644 2.229 . . . . 0.0 112.343 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -49.51 174.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -80.03 123.51 83.48 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.702 0.763 . . . . 0.0 110.83 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.427 ' HB2' HG13 ' A' ' 36' ' ' VAL . 53.8 Cg_endo -69.81 144.27 53.23 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.629 2.219 . . . . 0.0 112.319 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.727 ' O ' HD13 ' A' ' 26' ' ' ILE . 13.4 t -93.87 166.41 12.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.109 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.727 HD13 ' O ' ' A' ' 25' ' ' THR . 8.1 mm -126.01 125.83 68.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -125.79 179.23 5.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.5 m -98.23 98.68 9.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.116 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.684 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -102.48 -40.02 6.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.072 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.2 m -165.2 168.99 16.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.819 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -74.29 -14.03 60.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.2 p -118.24 -3.28 11.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.123 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.845 ' CB ' HG22 ' A' ' 81' ' ' THR . 6.5 p -146.45 177.46 9.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.8 m -154.56 149.19 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.178 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.684 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 17.1 m-85 -82.44 118.16 23.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' A' ' 24' ' ' PRO . 91.7 t -113.4 130.84 66.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.069 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.417 ' HB ' HG22 ' A' ' 25' ' ' THR . 62.7 m -128.88 120.34 26.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.197 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.564 ' CD1' HG11 ' A' ' 93' ' ' VAL . 26.3 p90 -118.76 170.92 8.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mm -134.93 108.56 10.65 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.615 0.722 . . . . 0.0 111.102 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 140.23 42.38 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.704 2.269 . . . . 0.0 112.363 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -109.43 -69.14 0.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.85 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.23 147.6 16.31 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.528 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 51.9 p-10 -117.82 5.79 12.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.804 0.335 . . . . 0.0 110.84 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 81.89 4.36 90.32 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.485 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.446 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 105.38 -16.78 44.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.487 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.668 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 1.9 m-85 -115.44 162.24 25.82 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.654 0.74 . . . . 0.0 110.869 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.64 118.24 5.56 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.7 2.266 . . . . 0.0 112.399 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.569 HD13 ' CE1' ' A' ' 51' ' ' PHE . 91.7 mt -49.26 131.88 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.172 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -85.77 -49.27 8.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.954 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.1 m -161.51 161.29 29.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.841 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.569 ' CE1' HD13 ' A' ' 48' ' ' ILE . 60.9 m-85 -109.91 171.26 7.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -146.19 134.3 21.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.863 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.2 135.02 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.155 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.474 ' N ' ' OE1' ' A' ' 54' ' ' GLU . 26.4 mp0 -136.25 146.01 46.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.547 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 26.3 p90 -124.43 179.27 4.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.462 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 22.4 ttpp -149.4 136.41 19.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -84.23 119.87 25.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.3 mt -90.37 -68.55 0.78 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.45 -31.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.895 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -121.19 139.71 53.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.919 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.3 p -63.28 129.67 27.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 174.81 161.78 25.17 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.478 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -90.27 -179.3 5.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.85 0.357 . . . . 0.0 110.881 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.462 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 84.0 m95 -69.28 136.58 52.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.867 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.547 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 5.2 mm -115.02 159.62 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.151 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.4 tp -93.37 125.32 37.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.749 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -94.16 -69.84 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.126 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.2 t -131.63 173.19 11.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.146 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.452 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 6.3 t -169.45 176.74 4.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.801 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 69.68 28.65 4.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.106 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.637 HG23 ' HD2' ' A' ' 72' ' ' PRO . 73.6 mt -80.26 137.88 52.47 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.65 0.738 . . . . 0.0 111.155 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.637 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.2 Cg_endo -69.64 158.06 58.42 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.757 2.305 . . . . 0.0 112.378 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -21.89 33.05 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.686 2.258 . . . . 0.0 112.324 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.6 m -82.01 -14.99 55.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -101.84 107.59 18.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.857 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.7 mt -103.86 11.47 35.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -153.2 132.48 12.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.776 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.511 HG11 HD13 ' A' ' 71' ' ' ILE . 2.4 m -145.9 165.63 9.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.098 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.455 ' OE1' ' HB1' ' A' ' 29' ' ' ALA . 33.1 tt0 -102.55 109.32 20.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.808 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.749 HG23 ' HB1' ' A' ' 67' ' ' ALA . 16.1 mm -79.04 103.32 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.15 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.845 HG22 ' CB ' ' A' ' 33' ' ' SER . 29.7 p -102.84 167.95 9.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.085 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.75 36.69 7.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.462 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.8 mt -103.65 -178.85 3.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 110.93 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -118.55 126.84 52.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -67.66 153.74 43.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.43 11.96 62.89 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.458 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.457 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 23.2 mm -124.47 112.66 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.804 0.335 . . . . 0.0 111.194 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.23 141.56 45.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.851 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.457 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -161.66 162.78 30.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.947 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -107.54 -175.82 2.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -145.83 151.43 37.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 1.9 ptp180 -144.12 176.73 9.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.564 HG11 ' CD1' ' A' ' 38' ' ' TRP . 86.8 t -142.87 139.78 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.13 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 -129.57 139.97 51.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -101.23 128.87 47.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.3 mp -122.21 120.0 32.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.443 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 38.1 p-10 -123.55 -173.1 2.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.7 ptm -68.72 0.65 3.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.694 HD12 ' O ' ' A' ' 16' ' ' SER . 38.7 mt -108.37 -26.2 10.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.62 -167.38 29.22 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.525 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.36 158.27 15.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 110.879 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.444 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 5.2 p -93.81 175.29 6.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -71.6 158.14 88.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.638 0.732 . . . . 0.0 110.93 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.43 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 52.9 Cg_endo -69.77 102.86 1.08 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.687 2.258 . . . . 0.0 112.276 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.3 p -46.32 154.57 0.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.855 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.04 143.39 4.61 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.5 0.667 . . . . 0.0 111.149 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 92.98 0.52 Allowed 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.726 2.284 . . . . 0.0 112.344 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.0 t -40.67 146.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -44.62 150.22 0.71 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.654 0.74 . . . . 0.0 110.845 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 124.31 10.95 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.661 2.241 . . . . 0.0 112.357 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.556 ' CB ' HG21 ' A' ' 26' ' ' ILE . 65.4 t80 -115.25 120.7 40.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.5 t -93.64 107.18 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.139 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.8 t -72.6 102.63 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.14 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.8 t -91.62 -60.07 1.97 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.904 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -167.29 -170.63 32.39 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.45 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.4 t -74.26 108.96 7.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.915 0.388 . . . . 0.0 110.866 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.12 -168.42 0.36 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.441 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 1.83 4.09 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.637 2.225 . . . . 0.0 112.348 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.0 t 74.51 51.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.8 t -125.89 128.75 48.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.905 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.503 -179.962 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 m -163.89 144.59 8.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.358 . . . . 0.0 110.832 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.9 p -155.49 176.76 12.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.787 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.82 -136.07 4.03 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.551 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.5 t 62.29 45.43 6.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.803 0.335 . . . . 0.0 110.857 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.1 p -116.98 149.99 39.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -129.37 164.99 22.16 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.49 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.2 m -138.39 163.05 32.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 110.829 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -68.73 140.31 91.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.523 0.678 . . . . 0.0 110.965 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 103.08 1.11 Allowed 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 122.746 2.298 . . . . 0.0 112.278 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 12' ' ' HIS . 50.1 m-20 -109.07 98.56 8.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.895 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 11' ' ' ASP . 17.2 m-70 -35.86 152.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.81 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.34 -55.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.508 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -57.1 95.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.934 0.397 . . . . 0.0 110.848 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.551 ' CD1' ' CE2' ' A' ' 46' ' ' PHE . 13.7 mt -104.34 -175.09 2.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.888 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.648 ' O ' HD12 ' A' ' 99' ' ' LEU . 3.1 m -137.78 160.08 66.23 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.699 0.762 . . . . 0.0 110.874 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 170.09 17.5 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.678 2.252 . . . . 0.0 112.302 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.464 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.6 Cg_endo -69.72 155.75 65.25 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.694 2.263 . . . . 0.0 112.337 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.426 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.6 pt-20 -99.12 168.83 9.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.92 123.01 82.52 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.534 0.683 . . . . 0.0 111.117 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 165.1 32.15 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.72 2.28 . . . . 0.0 112.266 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -52.44 175.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -79.99 122.83 83.61 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.622 0.725 . . . . 0.0 110.912 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 143.3 50.46 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.707 2.272 . . . . 0.0 112.375 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.782 ' C ' HD13 ' A' ' 26' ' ' ILE . 6.8 t -94.24 165.25 12.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.133 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.782 HD13 ' C ' ' A' ' 25' ' ' THR . 3.9 mm -125.92 125.61 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.159 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 m -127.7 178.18 6.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.6 m -95.48 101.01 12.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.138 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.645 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -102.1 -41.4 6.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.08 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.02 -175.0 5.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -85.0 -16.75 39.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.7 p -123.27 2.04 9.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.112 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.617 ' CB ' HG22 ' A' ' 81' ' ' THR . 18.7 p -144.7 168.0 21.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.832 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.9 m -147.07 145.81 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.645 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 19.7 m-85 -77.85 117.71 19.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.859 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.1 t -111.97 129.7 66.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.095 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.428 ' HB ' HG22 ' A' ' 25' ' ' THR . 87.6 m -128.74 123.51 33.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.187 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.589 ' CD1' HG11 ' A' ' 93' ' ' VAL . 25.5 p90 -122.43 169.66 10.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.899 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.423 HD13 ' O ' ' A' ' 38' ' ' TRP . 21.0 mm -133.29 107.35 12.24 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.668 0.747 . . . . 0.0 111.191 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 135.5 30.62 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.726 2.284 . . . . 0.0 112.332 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -100.32 -70.44 0.74 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.5 159.89 14.72 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.516 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -125.1 4.72 7.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.878 0.37 . . . . 0.0 110.85 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.55 0.56 90.07 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.549 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.541 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 110.32 -24.05 19.07 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.503 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.551 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 2.4 m-85 -108.68 162.24 20.7 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.637 0.732 . . . . 0.0 110.851 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 116.32 4.5 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.659 2.239 . . . . 0.0 112.379 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.526 HD13 ' CE1' ' A' ' 51' ' ' PHE . 96.3 mt -47.81 135.0 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.187 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -86.07 -52.51 5.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.856 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.1 m -160.3 162.16 33.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.862 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.526 ' CE1' HD13 ' A' ' 48' ' ' ILE . 56.7 m-85 -109.85 166.96 10.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.649 HH21 HD21 ' A' ' 66' ' ' LEU . 21.6 mtp85 -142.22 143.26 32.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.821 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.447 ' O ' HD12 ' A' ' 66' ' ' LEU . 58.6 t -120.61 137.47 54.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.107 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -133.7 162.55 31.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.473 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 46.1 p90 -142.05 158.94 43.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.46 ' HD3' ' NE1' ' A' ' 64' ' ' TRP . 37.6 ttpt -130.7 129.72 42.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.931 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -80.07 120.34 24.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.532 HD11 ' HB3' ' A' ' 110' ' ' PRO . 51.2 mt -82.53 -40.13 21.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -91.89 35.54 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.862 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -169.19 160.42 9.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 p -92.16 152.52 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.194 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 127.09 125.09 2.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.482 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -50.34 -179.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.731 0.3 . . . . 0.0 110.859 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.46 ' NE1' ' HD3' ' A' ' 56' ' ' LYS . 47.1 m95 -58.67 159.91 6.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.95 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.473 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 1.8 mm -128.04 160.28 38.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.108 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.649 HD21 HH21 ' A' ' 52' ' ' ARG . 39.6 tp -99.89 116.11 31.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.581 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -84.22 -69.79 0.62 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.121 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 t -128.0 166.66 17.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.213 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 12.2 m -161.8 178.65 8.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 70.56 27.54 3.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.103 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.65 HG23 ' HD2' ' A' ' 72' ' ' PRO . 74.9 mt -78.32 138.15 59.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.584 0.707 . . . . 0.0 111.16 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.65 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.1 Cg_endo -69.73 156.49 63.3 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.678 2.252 . . . . 0.0 112.375 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.64 -17.54 38.05 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.647 2.231 . . . . 0.0 112.403 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.3 m -87.6 -13.46 42.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.455 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 15.7 ttt180 -101.04 104.52 15.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.842 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.4 mt -100.4 12.49 37.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -154.93 132.05 10.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.467 HG11 HD13 ' A' ' 71' ' ' ILE . 2.2 m -147.37 165.27 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.101 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -100.26 118.28 36.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.581 HG23 ' HB1' ' A' ' 67' ' ' ALA . 32.7 mm -86.98 98.19 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.083 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.617 HG22 ' CB ' ' A' ' 33' ' ' SER . 32.0 p -93.4 174.15 7.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.3 40.04 17.21 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.509 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.1 mt -100.67 -179.24 4.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.729 0.299 . . . . 0.0 110.921 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -125.27 130.45 52.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.935 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.0 151.57 43.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.77 10.5 64.39 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.452 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.419 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 25.9 mm -122.22 112.66 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.352 . . . . 0.0 111.103 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.22 138.75 38.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.83 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.419 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -161.59 161.21 29.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.951 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -107.53 177.22 4.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -135.31 158.89 43.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.434 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 1.2 ptp180 -151.13 177.9 9.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.589 HG11 ' CD1' ' A' ' 38' ' ' TRP . 95.0 t -143.58 141.83 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.152 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.2 mtt180 -131.94 143.42 50.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.464 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -105.97 131.18 53.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.108 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.455 HD12 ' C ' ' A' ' 95' ' ' ALA . 9.1 mp -124.39 120.74 32.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.915 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.442 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 38.3 p-10 -123.61 -172.77 2.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.935 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.0 ptm -69.03 0.73 4.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 16' ' ' SER . 46.3 mt -108.5 -26.14 10.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.926 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.39 -166.56 29.09 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.499 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.13 158.74 15.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.889 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.426 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 4.8 p -95.51 175.23 6.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.839 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -70.93 157.98 89.13 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.57 0.7 . . . . 0.0 110.907 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.434 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.9 Cg_endo -69.75 104.72 1.36 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.649 2.233 . . . . 0.0 112.385 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.5 p -44.31 151.95 0.22 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.01 139.38 6.96 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.562 0.696 . . . . 0.0 111.106 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 97.11 0.62 Allowed 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.682 2.255 . . . . 0.0 112.373 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 t -48.3 159.59 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.75 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.98 152.58 5.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.675 0.75 . . . . 0.0 110.857 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.532 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.5 Cg_endo -69.65 131.91 22.4 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.698 2.265 . . . . 0.0 112.372 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -117.85 119.47 34.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.977 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.4 t -95.15 102.2 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.099 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.5 t -69.67 106.47 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 t -114.67 50.01 0.99 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.828 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 59.41 -119.41 18.01 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.482 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 92.3 p -77.04 121.32 23.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.927 0.394 . . . . 0.0 110.846 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -108.8 173.74 17.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.53 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 125.87 12.65 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.706 2.27 . . . . 0.0 112.318 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.8 m -143.08 162.7 34.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.2 t -159.59 159.09 32.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.89 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.45 179.99 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.4 m -158.4 159.49 35.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 110.871 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.2 m -87.81 173.44 8.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.833 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.16 139.61 47.49 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.458 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.3 m -161.43 175.29 12.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.902 0.382 . . . . 0.0 110.806 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.2 p -61.9 112.28 2.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.837 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 155.44 122.54 0.79 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.451 ' C ' ' OE1' ' A' ' 9' ' ' GLN . 77.6 p -148.43 151.67 35.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.451 ' OE1' ' C ' ' A' ' 8' ' ' SER . 0.8 OUTLIER -119.27 143.5 34.39 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.559 0.695 . . . . 0.0 110.977 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.78 108.54 2.11 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.745 2.297 . . . . 0.0 112.244 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -167.95 143.5 3.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.817 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -65.21 99.53 0.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 15' ' ' LEU . . . 175.85 -54.0 0.12 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.489 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -48.0 91.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.756 0.312 . . . . 0.0 110.807 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.639 ' CD1' ' CE2' ' A' ' 46' ' ' PHE . 16.8 mt -94.94 -174.89 3.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.923 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.634 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.4 p -141.7 160.01 57.86 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.738 0.78 . . . . 0.0 110.861 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 169.19 19.49 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.7 2.267 . . . . 0.0 112.302 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.527 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.4 Cg_endo -69.78 157.41 60.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.698 2.265 . . . . 0.0 112.334 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.438 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.6 pt-20 -99.25 163.25 12.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.35 122.32 58.72 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.539 0.685 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 163.76 37.1 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.672 2.248 . . . . 0.0 112.34 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -50.0 177.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -83.27 124.39 76.12 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.648 0.737 . . . . 0.0 110.85 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HB2' HG13 ' A' ' 36' ' ' VAL . 53.8 Cg_endo -69.75 147.36 62.76 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.676 2.251 . . . . 0.0 112.336 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.676 ' O ' HD13 ' A' ' 26' ' ' ILE . 5.1 t -99.58 164.51 12.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.15 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.676 HD13 ' O ' ' A' ' 25' ' ' THR . 8.7 mm -122.67 118.25 54.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.103 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.1 m -121.69 165.31 15.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.836 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.1 m -83.03 104.75 13.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.767 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -108.45 -37.96 5.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.059 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 m -166.16 175.72 8.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.443 ' HG2' HG23 ' A' ' 32' ' ' THR . 1.0 OUTLIER -79.64 -16.73 55.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.898 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.443 HG23 ' HG2' ' A' ' 31' ' ' GLU . 10.7 p -119.0 -6.35 10.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.145 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.852 ' HB3' HG22 ' A' ' 81' ' ' THR . 89.3 p -138.51 171.96 13.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 m -149.55 145.47 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.123 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.767 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 17.6 m-85 -81.63 115.34 20.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.407 HG13 ' HB2' ' A' ' 24' ' ' PRO . 97.0 t -109.11 127.24 65.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.149 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.41 ' HB ' HG22 ' A' ' 25' ' ' THR . 55.8 m -125.78 121.71 34.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.058 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.645 ' CD1' HG11 ' A' ' 93' ' ' VAL . 29.4 p90 -121.47 171.07 9.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.5 mm -135.1 107.12 10.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.632 0.73 . . . . 0.0 111.068 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 139.8 41.16 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.697 2.265 . . . . 0.0 112.343 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 mmt85 -103.31 -70.45 0.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.72 159.21 14.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.489 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -123.03 4.51 9.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 110.887 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.56 -1.41 87.87 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.491 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.461 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 113.32 -23.85 13.29 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.639 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 2.1 m-85 -110.11 162.25 21.17 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.641 0.734 . . . . 0.0 110.869 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.71 114.72 3.79 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.676 2.251 . . . . 0.0 112.427 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.457 HD13 ' CE1' ' A' ' 51' ' ' PHE . 81.6 mt -47.09 132.08 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.128 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -85.15 -50.36 7.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.2 p -159.7 163.24 34.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.457 ' CE1' HD13 ' A' ' 48' ' ' ILE . 54.8 m-85 -108.86 171.78 7.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.701 ' CZ ' HD11 ' A' ' 96' ' ' LEU . 4.9 mtm180 -143.45 129.01 19.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.827 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.457 HG11 HD11 ' A' ' 80' ' ' ILE . 38.4 t -111.4 133.14 57.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.07 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -135.42 152.4 51.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.486 ' CD2' ' HB2' ' A' ' 67' ' ' ALA . 31.1 p90 -129.37 175.75 8.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.5 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 24.6 ttpt -147.88 132.24 17.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.869 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -81.43 126.23 31.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.441 HD11 ' HB3' ' A' ' 110' ' ' PRO . 58.5 mt -91.13 -61.85 1.57 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 58' ' ' LEU . 3.3 tmtt? -37.4 -36.45 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.887 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.1 mtmm -127.69 136.26 51.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.929 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 61' ' ' VAL . 7.2 p -60.43 117.21 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.173 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.09 129.42 1.94 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.491 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.34 -176.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.817 0.342 . . . . 0.0 110.842 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.5 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 77.1 m95 -80.27 142.59 34.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.879 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.47 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 2.7 mm -116.71 164.2 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.8 tp -96.96 124.1 40.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.746 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -92.52 -64.71 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.058 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.603 ' CG2' HD11 ' A' ' 71' ' ' ILE . 1.8 t -131.83 179.33 6.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.0 p -173.15 178.16 2.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 64.15 32.33 12.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.094 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.67 HG23 ' HD2' ' A' ' 72' ' ' PRO . 88.2 mt -84.61 138.55 38.18 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.582 0.706 . . . . 0.0 111.129 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.67 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.0 Cg_endo -69.75 156.9 62.18 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.719 2.28 . . . . 0.0 112.305 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 -19.56 35.83 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.742 2.295 . . . . 0.0 112.33 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 t -84.7 -15.26 45.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.437 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 8.5 ttt85 -99.17 101.33 12.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.4 mt -96.64 8.99 42.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.928 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.5 t -151.34 134.08 15.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.589 HG11 HD13 ' A' ' 71' ' ' ILE . 2.1 m -146.5 161.95 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.131 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.559 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 39.5 tt0 -97.97 110.23 22.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.746 HG23 ' HB1' ' A' ' 67' ' ' ALA . 17.6 mm -80.1 109.76 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.154 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.852 HG22 ' HB3' ' A' ' 33' ' ' SER . 66.1 p -107.57 166.42 10.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.97 33.46 8.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.498 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.3 mt -101.65 170.31 8.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.736 0.303 . . . . 0.0 110.898 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -114.2 132.86 55.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.855 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -68.01 156.84 36.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.54 12.01 44.36 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.516 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.512 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 32.1 mm -120.76 103.23 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.836 0.351 . . . . 0.0 111.134 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.44 140.16 51.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.512 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -163.12 163.11 25.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.992 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -109.08 -175.97 2.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.936 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -141.82 164.6 29.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.917 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -157.54 170.09 23.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.645 HG11 ' CD1' ' A' ' 38' ' ' TRP . 99.7 t -137.2 140.14 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.134 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.408 HH21 ' CG ' ' A' ' 104' ' ' PRO . 33.8 mtt180 -129.28 136.35 49.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.847 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -93.64 128.5 39.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.101 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.701 HD11 ' CZ ' ' A' ' 52' ' ' ARG . 3.3 mp -123.6 120.12 31.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.448 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 38.3 p-10 -123.56 -172.79 2.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.3 ptm -69.84 1.56 4.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.834 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.634 HD12 ' O ' ' A' ' 16' ' ' SER . 30.3 mt -108.83 -26.25 10.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.953 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 149.49 -162.54 29.08 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.513 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.408 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 26.3 pm0 -107.09 157.42 17.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.892 0.377 . . . . 0.0 110.918 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 54.4 p -96.2 174.99 6.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.851 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -68.47 157.82 86.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.654 0.74 . . . . 0.0 110.884 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.408 ' CG ' HH21 ' A' ' 94' ' ' ARG . 54.1 Cg_endo -69.81 111.23 2.76 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.669 2.246 . . . . 0.0 112.284 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.7 p -50.44 154.17 1.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.49 141.0 7.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.539 0.685 . . . . 0.0 111.047 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 98.06 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.637 2.224 . . . . 0.0 112.388 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.4 p -45.19 164.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.892 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.3 mtm105 -58.31 152.12 44.62 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.505 0.669 . . . . 0.0 110.942 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.441 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.5 Cg_endo -69.78 122.61 9.28 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.637 2.225 . . . . 0.0 112.345 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.638 ' CG ' HG21 ' A' ' 26' ' ' ILE . 52.7 t80 -111.98 121.1 44.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.933 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.9 t -95.03 105.43 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.114 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.0 t -74.95 108.68 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.083 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.0 t -108.14 164.37 12.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 116' ' ' SER . . . -45.8 -53.26 8.81 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.543 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 115' ' ' GLY . 42.1 m -36.52 136.94 0.31 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.866 0.365 . . . . 0.0 110.921 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 174.73 164.79 30.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.543 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.66 -169.27 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.645 2.23 . . . . 0.0 112.372 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.4 p -125.5 139.23 53.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.6 t -80.61 -52.8 7.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.529 -179.951 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.1 p -171.37 166.08 7.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.905 0.383 . . . . 0.0 110.844 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.7 p -112.61 171.04 7.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.863 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.68 163.57 36.35 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.535 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 t -62.39 142.62 57.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.0 110.806 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.7 m -88.99 158.71 17.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.857 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.63 -116.78 3.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.451 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.441 ' C ' ' OE1' ' A' ' 9' ' ' GLN . 82.8 p -130.21 118.85 22.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.818 0.342 . . . . 0.0 110.853 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.441 ' OE1' ' C ' ' A' ' 8' ' ' SER . 2.3 mp0 -119.51 143.96 35.73 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.656 0.741 . . . . 0.0 110.939 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 169.03 19.84 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.726 2.284 . . . . 0.0 112.331 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.87 78.58 3.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -165.78 142.88 5.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.29 -57.56 2.76 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.52 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 30.1 mtm-85 -70.74 91.05 0.8 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.893 0.378 . . . . 0.0 110.867 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.681 HD13 ' CE2' ' A' ' 46' ' ' PHE . 6.4 mt -105.19 -174.79 2.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.964 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.642 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.4 p -137.65 160.34 65.44 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.681 0.753 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 169.98 17.66 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.682 2.255 . . . . 0.0 112.355 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.503 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.9 Cg_endo -69.81 152.74 69.12 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.628 2.219 . . . . 0.0 112.348 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.424 ' C ' ' HB2' ' A' ' 102' ' ' SER . 9.2 pt-20 -98.16 160.48 14.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 103' ' ' GLU . . . -56.09 122.79 50.26 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.559 0.695 . . . . 0.0 111.069 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 166.42 27.7 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.7 2.266 . . . . 0.0 112.304 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -51.67 174.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -80.22 122.73 83.18 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.624 0.726 . . . . 0.0 110.932 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 142.44 47.98 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.671 2.248 . . . . 0.0 112.306 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.812 ' O ' HD13 ' A' ' 26' ' ' ILE . 9.6 t -93.43 167.49 11.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.164 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.812 HD13 ' O ' ' A' ' 25' ' ' THR . 10.4 mm -127.44 124.68 64.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.193 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 m -128.31 175.75 8.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.813 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.431 HG21 ' HG2' ' A' ' 118' ' ' PRO . 9.4 m -94.51 101.36 13.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.1 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.703 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -102.42 -41.15 6.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 t -156.86 -178.34 7.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.833 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -81.17 -20.52 41.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.465 HG22 ' HE3' ' A' ' 85' ' ' LYS . 16.3 p -121.72 4.59 10.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.151 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 84.1 p -139.6 175.97 9.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.3 m -154.64 143.67 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.703 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 11.0 m-85 -79.69 117.52 20.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.8 t -111.93 129.17 67.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.133 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.629 HG23 ' HB2' ' A' ' 77' ' ' SER . 32.5 m -128.91 118.39 22.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.14 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.488 ' CD1' HG11 ' A' ' 93' ' ' VAL . 33.1 p90 -118.58 169.16 10.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 mm -133.59 108.39 12.06 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.62 0.724 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.437 ' CD ' HD22 ' A' ' 76' ' ' LEU . 53.8 Cg_endo -69.78 141.73 45.95 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.693 2.262 . . . . 0.0 112.333 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -109.81 -70.34 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.66 147.06 16.15 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.526 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 48.2 p-10 -114.47 2.55 14.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 0.0 110.925 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 85.26 2.3 87.84 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.507 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.535 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 107.3 -15.04 39.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.438 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.681 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.5 m-85 -118.24 161.98 32.29 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.629 0.728 . . . . 0.0 110.839 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 115.52 4.14 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.68 2.253 . . . . 0.0 112.311 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.455 HD13 ' CE1' ' A' ' 51' ' ' PHE . 92.4 mt -47.71 131.22 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.046 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -82.68 -48.23 11.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.87 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.9 p -163.7 164.16 23.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.455 ' CE1' HD13 ' A' ' 48' ' ' ILE . 55.4 m-85 -109.39 174.53 5.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.1 mtt-85 -149.56 124.04 9.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.2 t -107.99 136.39 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.135 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -137.2 152.66 50.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.875 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.569 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 44.0 p90 -127.84 144.1 51.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.524 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 22.1 ttpt -114.37 128.98 56.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.907 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -76.67 136.02 39.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 110' ' ' PRO . 51.4 mt -105.56 -71.25 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.907 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -40.85 -35.9 0.56 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -123.6 122.78 39.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.892 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.1 p -45.71 126.35 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.119 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 63' ' ' ASP . . . 177.85 112.96 0.34 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.407 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 62' ' ' GLY . 8.2 p-10 -50.09 -178.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.787 0.327 . . . . 0.0 110.891 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.534 ' O ' HD13 ' A' ' 65' ' ' ILE . 97.3 m95 -59.25 153.56 18.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.569 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 4.6 mm -134.89 141.83 41.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.198 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.9 tp -78.41 126.09 30.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.826 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -101.69 -58.58 1.86 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.58 ' CG2' HD11 ' A' ' 71' ' ' ILE . 6.8 t -136.48 165.29 26.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.165 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 99.9 p -160.51 175.77 12.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.789 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 68.95 26.94 5.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.149 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.598 HG23 ' HD2' ' A' ' 72' ' ' PRO . 58.8 mt -79.76 137.43 54.45 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.635 0.731 . . . . 0.0 111.163 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.598 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.0 Cg_endo -69.66 159.06 54.9 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.728 2.285 . . . . 0.0 112.306 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.75 -25.4 28.68 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.688 2.259 . . . . 0.0 112.361 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 81.1 p -77.57 -25.72 50.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.854 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.457 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.1 ttt180 -86.4 106.59 17.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.838 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.437 HD22 ' CD ' ' A' ' 40' ' ' PRO . 46.6 mt -101.74 9.89 40.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.957 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.629 ' HB2' HG23 ' A' ' 37' ' ' THR . 26.3 t -155.82 137.16 13.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.45 HG12 ' CD ' ' A' ' 75' ' ' ARG . 2.2 m -149.92 168.67 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.148 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.684 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 30.3 tt0 -103.26 115.43 30.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.826 HG23 ' HB1' ' A' ' 67' ' ' ALA . 37.0 mm -81.83 102.69 8.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.7 p -97.46 164.04 12.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.117 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.37 33.59 19.43 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.503 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.8 mt -87.45 -176.26 5.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.803 0.335 . . . . 0.0 110.915 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -126.64 122.4 34.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.465 ' HE3' HG22 ' A' ' 32' ' ' THR . 0.6 OUTLIER -67.4 155.92 37.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.43 15.41 45.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.484 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.401 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 27.3 mm -126.87 103.68 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.861 0.362 . . . . 0.0 111.114 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.54 137.87 52.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.856 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.401 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -158.77 167.83 28.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.92 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -110.73 -176.49 2.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.909 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -146.26 142.9 28.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.428 HH21 ' CB ' ' A' ' 64' ' ' TRP . 5.5 ptt180 -139.26 177.89 7.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.488 HG11 ' CD1' ' A' ' 38' ' ' TRP . 87.2 t -140.73 143.02 29.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.097 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.402 ' CZ ' HH12 ' A' ' 92' ' ' ARG . 34.7 mtt180 -131.0 140.59 50.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.503 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -103.2 127.54 50.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.087 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.07 120.68 35.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.908 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.449 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 36.5 p-10 -123.61 -172.41 2.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.4 ptm -69.58 1.69 3.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.642 HD12 ' O ' ' A' ' 16' ' ' SER . 36.0 mt -109.67 -26.35 9.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.99 -165.93 29.33 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.526 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.61 158.05 16.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.814 0.34 . . . . 0.0 110.903 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 19.9 p -97.44 175.17 6.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 17.2 mt-10 -69.13 157.16 90.0 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.622 0.725 . . . . 0.0 110.918 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.425 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.4 Cg_endo -69.81 104.56 1.35 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.674 2.249 . . . . 0.0 112.318 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.5 p -41.7 150.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.843 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -43.07 140.48 1.97 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.601 0.715 . . . . 0.0 111.097 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 88.81 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.68 2.253 . . . . 0.0 112.285 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 99.2 p -41.06 153.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.861 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -48.96 151.81 2.08 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.628 0.728 . . . . 0.0 110.829 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.474 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.2 Cg_endo -69.81 144.65 54.45 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.664 2.243 . . . . 0.0 112.315 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -132.7 115.75 15.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.849 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.6 t -88.95 103.18 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.083 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.5 t -73.66 111.66 9.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.13 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.1 t -107.94 174.01 6.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 116' ' ' SER . . . -69.34 -134.35 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.466 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 115' ' ' GLY . 3.2 t -35.02 123.33 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.906 0.384 . . . . 0.0 110.815 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -141.41 -160.89 8.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.45 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.431 ' HG2' HG21 ' A' ' 28' ' ' THR . 53.3 Cg_endo -69.74 177.25 5.75 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.713 2.276 . . . . 0.0 112.364 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 60.6 p -114.14 165.37 12.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 18.2 t -151.23 121.51 7.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.908 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.461 -179.943 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.548 -0.221 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m -149.16 150.2 32.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.982 0.42 . . . . 0.0 110.865 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.9 m -56.0 164.45 1.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.903 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.37 -168.08 17.57 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.405 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.2 m -65.06 152.56 43.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.901 0.381 . . . . 0.0 110.806 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.6 m -132.22 -55.7 0.97 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.946 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.25 147.87 22.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.464 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.9 t -63.44 126.22 26.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 0.0 110.852 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -70.09 138.8 87.37 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.56 0.695 . . . . 0.0 110.956 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 176.51 6.6 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.758 2.306 . . . . 0.0 112.323 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.411 ' CG ' ' O ' ' A' ' 11' ' ' ASP . 4.8 p-10 -41.59 100.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -137.36 -179.69 5.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.63 109.77 0.22 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.513 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -66.73 104.3 1.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.899 0.38 . . . . 0.0 110.877 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.485 HD13 ' CE2' ' A' ' 46' ' ' PHE . 9.0 mt -99.86 -176.38 3.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.599 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.7 m -144.99 161.62 41.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.69 0.757 . . . . 0.0 110.863 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.417 ' C ' ' HA3' ' A' ' 44' ' ' GLY . 53.8 Cg_endo -69.74 170.35 16.75 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.727 2.284 . . . . 0.0 112.358 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.475 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.6 Cg_endo -69.76 155.39 66.07 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.693 2.262 . . . . 0.0 112.403 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.42 ' C ' ' HB2' ' A' ' 102' ' ' SER . 9.6 pt-20 -99.26 167.89 10.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 103' ' ' GLU . . . -63.03 121.32 68.2 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.556 0.693 . . . . 0.0 111.096 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 161.59 45.35 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.685 2.257 . . . . 0.0 112.359 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -46.88 174.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 ttm180 -80.1 124.08 83.07 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.611 0.719 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 140.74 43.43 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.702 2.268 . . . . 0.0 112.387 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.511 ' O ' HD13 ' A' ' 26' ' ' ILE . 2.4 t -94.0 155.77 16.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.159 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.544 HG21 ' CB ' ' A' ' 111' ' ' TYR . 18.9 mm -117.28 128.4 74.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.077 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 m -132.72 176.12 8.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.797 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.5 m -93.47 110.6 22.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.191 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.699 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -111.9 -38.2 4.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.05 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.0 m -161.43 -178.75 6.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.838 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.5 ' HG2' HG23 ' A' ' 32' ' ' THR . 0.4 OUTLIER -84.8 -14.68 47.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.899 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.5 HG23 ' HG2' ' A' ' 31' ' ' GLU . 24.5 p -121.4 -0.02 9.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.161 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.431 ' CB ' HG22 ' A' ' 81' ' ' THR . 6.4 p -145.8 173.13 12.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.0 m -148.98 146.28 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.196 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.699 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 12.0 m-85 -77.21 123.14 26.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.6 t -119.45 124.38 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.203 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.475 HG23 ' HB2' ' A' ' 77' ' ' SER . 47.2 m -126.98 123.24 36.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.152 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.587 ' CD1' HG11 ' A' ' 93' ' ' VAL . 24.4 p90 -120.76 171.27 8.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.953 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.513 HD13 ' O ' ' A' ' 38' ' ' TRP . 18.7 mm -135.08 106.01 10.38 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.592 0.711 . . . . 0.0 111.224 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 142.86 49.26 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.719 2.279 . . . . 0.0 112.357 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -111.54 -70.74 0.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.38 143.58 15.69 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -115.74 17.07 16.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.823 0.344 . . . . 0.0 110.904 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.446 ' N ' ' HA ' ' A' ' 18' ' ' PRO . . . 75.97 -6.35 34.94 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.424 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.59 -19.65 11.36 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.504 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.485 ' CE2' HD13 ' A' ' 15' ' ' LEU . 1.6 m-85 -111.92 162.83 19.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.735 0.778 . . . . 0.0 110.91 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 115.98 4.35 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.69 2.26 . . . . 0.0 112.355 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.52 HD13 ' CE1' ' A' ' 51' ' ' PHE . 97.3 mt -48.0 124.41 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.136 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -79.04 -46.55 17.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.5 m -162.83 161.75 26.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.52 ' CE1' HD13 ' A' ' 48' ' ' ILE . 50.4 m-85 -108.59 175.25 5.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.94 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -147.81 120.19 8.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.908 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.431 HG11 HD11 ' A' ' 80' ' ' ILE . 21.7 t -103.91 131.79 51.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.099 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -131.59 160.91 33.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.936 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.553 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 18.4 p90 -139.07 175.89 9.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.919 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' A' ' 63' ' ' ASP . 16.4 ttpp -146.62 134.08 20.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -81.78 118.36 22.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.93 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 110' ' ' PRO . 72.3 mt -86.06 -42.52 13.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.96 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -85.67 36.89 0.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -172.97 -177.67 1.65 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.2 p -92.3 142.66 12.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.097 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 138.57 141.55 4.16 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.503 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.515 ' O ' ' CD1' ' A' ' 64' ' ' TRP . 0.5 OUTLIER -79.38 -73.77 0.32 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.869 0.366 . . . . 0.0 110.899 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.922 ' O ' HD13 ' A' ' 65' ' ' ILE . 61.0 m95 -152.94 149.94 28.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.922 HD13 ' O ' ' A' ' 64' ' ' TRP . 2.1 mm -131.47 151.18 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.075 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 53' ' ' VAL . 52.4 tp -84.9 134.6 34.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.881 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.623 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -103.18 -68.35 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.057 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.642 ' CG2' HD11 ' A' ' 71' ' ' ILE . 5.2 t -125.55 157.83 36.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.099 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.564 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 92.4 p -153.4 169.44 23.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 75.05 25.07 1.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.051 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.653 HG23 ' HD2' ' A' ' 72' ' ' PRO . 64.3 mt -77.08 138.13 65.14 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.599 0.714 . . . . 0.0 111.132 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.653 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.1 Cg_endo -69.77 157.98 58.53 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.679 2.253 . . . . 0.0 112.32 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -24.0 29.91 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.72 2.28 . . . . 0.0 112.296 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 t -78.54 -28.8 46.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.476 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.5 ttt180 -83.73 101.91 11.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.849 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.9 mt -99.37 11.71 38.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.475 ' HB2' HG23 ' A' ' 37' ' ' THR . 7.8 t -153.89 130.33 10.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.834 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.523 HG11 HD13 ' A' ' 71' ' ' ILE . 2.5 m -146.43 160.31 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.09 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.64 ' OE1' ' HB1' ' A' ' 29' ' ' ALA . 33.6 tt0 -99.25 111.9 24.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.623 HG23 ' HB1' ' A' ' 67' ' ' ALA . 28.8 mm -77.82 102.67 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.431 HG22 ' CB ' ' A' ' 33' ' ' SER . 41.2 p -97.2 162.56 13.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.118 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.34 40.63 5.38 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.47 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.2 mt -105.77 177.9 4.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.821 0.344 . . . . 0.0 110.921 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -123.62 128.62 49.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.859 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -67.15 155.88 37.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.76 14.95 63.73 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.512 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.427 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 25.6 mm -127.96 112.67 28.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.811 0.339 . . . . 0.0 111.145 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.05 141.69 40.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.813 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.427 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -162.25 159.79 26.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.016 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -107.38 179.37 4.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -140.76 160.88 39.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -152.32 -178.6 6.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.587 HG11 ' CD1' ' A' ' 38' ' ' TRP . 83.9 t -144.5 146.69 20.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -138.79 134.45 33.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.837 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -96.71 129.5 44.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.082 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.9 mp -122.01 120.19 33.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.449 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 39.4 p-10 -123.74 -172.82 2.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 18.4 ptm -69.7 1.13 4.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.852 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.599 HD12 ' O ' ' A' ' 16' ' ' SER . 37.6 mt -109.48 -24.73 10.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.901 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.411 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 146.36 -169.98 27.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.467 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.2 pm0 -95.96 158.43 15.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 110.868 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.42 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 4.3 p -94.63 175.45 6.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.881 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 20.6 mt-10 -69.53 157.9 88.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.668 0.747 . . . . 0.0 110.886 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 104.88 1.38 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.706 2.271 . . . . 0.0 112.358 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.9 p -47.14 148.2 1.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -45.96 136.99 6.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.648 0.737 . . . . 0.0 111.057 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.87 99.52 0.77 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.629 2.22 . . . . 0.0 112.375 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.4 p -47.8 170.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -60.61 149.56 78.23 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.609 0.719 . . . . 0.0 110.854 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.455 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.6 Cg_endo -69.74 122.69 9.37 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.741 2.294 . . . . 0.0 112.325 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.544 ' CB ' HG21 ' A' ' 26' ' ' ILE . 48.7 t80 -108.81 122.93 48.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 37.3 t -97.45 105.99 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.6 t -76.35 107.51 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.083 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.0 t -107.79 -41.11 5.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.897 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.61 86.78 1.83 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.482 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.0 m -111.93 -59.5 1.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.381 . . . . 0.0 110.813 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 123.44 170.76 13.47 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.522 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 124.2 10.83 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.644 2.229 . . . . 0.0 112.305 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.3 m -87.29 -50.08 6.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 93.5 p -93.44 94.11 8.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.834 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.458 -179.983 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.7 t -74.09 122.69 23.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.878 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.2 m -89.18 144.39 26.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.23 63.71 0.31 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.472 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.4 m -138.53 137.05 36.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.0 110.834 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.5 m -66.62 -62.06 1.65 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.86 45.78 5.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.505 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -68.99 171.98 7.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 110.886 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -153.21 150.96 24.96 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.622 0.725 . . . . 0.0 110.986 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.437 ' HD3' ' CE ' ' A' ' 98' ' ' MET . 54.0 Cg_endo -69.69 128.56 16.27 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.781 2.321 . . . . 0.0 112.328 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -147.8 148.01 30.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 65.3 m80 51.97 42.24 30.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.61 97.04 0.11 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.504 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -74.19 98.97 3.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.797 0.332 . . . . 0.0 110.79 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.553 HD22 ' HA3' ' A' ' 45' ' ' GLY . 7.8 mt -94.25 -174.99 3.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.928 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.564 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.7 m -138.51 160.9 61.69 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.686 0.755 . . . . 0.0 110.766 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 169.9 17.74 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.718 2.279 . . . . 0.0 112.337 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.52 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.1 Cg_endo -69.77 154.88 67.17 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.713 2.276 . . . . 0.0 112.284 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.434 ' C ' ' HB2' ' A' ' 102' ' ' SER . 10.3 pt-20 -96.97 169.94 9.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.82 121.89 78.01 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.553 0.692 . . . . 0.0 111.079 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 162.23 42.84 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.712 2.275 . . . . 0.0 112.362 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -48.03 174.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.894 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -80.22 124.11 82.84 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.625 0.726 . . . . 0.0 110.857 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.412 ' HB2' HG13 ' A' ' 36' ' ' VAL . 52.7 Cg_endo -69.81 143.19 49.83 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.695 2.263 . . . . 0.0 112.34 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.85 ' O ' HD13 ' A' ' 26' ' ' ILE . 4.8 t -92.64 165.81 12.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.85 HD13 ' O ' ' A' ' 25' ' ' THR . 5.6 mm -128.84 119.52 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 t -123.55 173.95 7.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.0 m -89.41 103.18 15.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.167 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.806 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -106.57 -40.37 5.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.098 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.9 m -160.57 168.07 25.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -72.49 -17.47 61.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.834 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.4 p -119.55 -4.56 10.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.112 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.756 ' CB ' HG22 ' A' ' 81' ' ' THR . 11.2 p -141.75 171.16 14.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.854 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.414 HG11 ' CE1' ' A' ' 111' ' ' TYR . 27.7 m -149.12 149.2 15.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.07 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.806 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 21.3 m-85 -82.84 117.47 22.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.998 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.412 HG13 ' HB2' ' A' ' 24' ' ' PRO . 88.1 t -112.08 130.57 65.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.153 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.413 HG23 ' HB2' ' A' ' 77' ' ' SER . 35.4 m -129.25 125.06 36.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.14 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.663 ' CD1' HG11 ' A' ' 93' ' ' VAL . 25.0 p90 -122.39 169.92 10.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.8 mm -133.46 107.88 12.14 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.645 0.735 . . . . 0.0 111.131 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.77 143.13 49.81 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.666 2.244 . . . . 0.0 112.27 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 mmm-85 -110.88 -70.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.19 153.34 18.1 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.423 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -121.0 5.82 10.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.813 0.339 . . . . 0.0 110.851 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.05 1.36 89.91 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.448 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.553 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 109.97 -23.75 20.63 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.5 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.522 ' CE2' HD13 ' A' ' 15' ' ' LEU . 1.9 m-85 -109.68 162.33 20.7 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.69 0.757 . . . . 0.0 110.865 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 118.42 5.67 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.748 2.299 . . . . 0.0 112.361 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.519 HD13 ' CE1' ' A' ' 51' ' ' PHE . 87.6 mt -48.33 138.3 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -92.85 -51.27 5.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.957 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.1 p -158.39 165.03 35.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.874 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.519 ' CE1' HD13 ' A' ' 48' ' ' ILE . 48.3 m-85 -114.36 170.05 8.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.928 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.761 ' NE ' HD11 ' A' ' 96' ' ' LEU . 50.2 mtm180 -145.57 138.35 25.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.55 ' HB ' HG22 ' A' ' 68' ' ' THR . 47.2 t -117.25 133.98 62.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.125 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -127.14 160.92 29.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.722 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 17.9 p90 -144.55 144.89 31.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.499 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 17.3 ttpp -127.82 133.71 49.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.904 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.57 140.56 48.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.903 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.486 ' CD1' ' HB3' ' A' ' 110' ' ' PRO . 65.0 mt -108.4 -47.74 3.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -42.92 -34.39 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.42 165.59 34.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.621 HG22 ' N ' ' A' ' 62' ' ' GLY . 11.6 p -46.73 165.81 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.129 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.621 ' N ' HG22 ' A' ' 61' ' ' VAL . . . 140.21 100.0 0.43 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.484 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -48.81 176.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.748 0.309 . . . . 0.0 110.903 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.564 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 83.2 m95 -67.25 149.31 50.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.975 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.533 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.4 mm -128.4 154.59 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.138 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.8 tp -87.35 115.6 24.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.795 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -83.84 -58.48 2.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.104 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.55 HG22 ' HB ' ' A' ' 53' ' ' VAL . 14.9 t -139.74 179.7 6.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.123 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.5 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 1.5 t -174.73 172.22 3.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.856 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 71.59 34.08 1.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.115 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.687 HD13 HG11 ' A' ' 78' ' ' VAL . 76.9 mt -88.64 137.93 30.06 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.605 0.717 . . . . 0.0 111.201 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.645 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.1 Cg_endo -69.7 158.35 57.35 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.639 2.226 . . . . 0.0 112.348 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -20.47 34.63 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.698 2.265 . . . . 0.0 112.336 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 79.6 p -84.74 -13.7 50.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.943 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.45 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 12.8 ttt85 -101.28 104.59 15.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.872 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.2 mt -103.31 13.92 32.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.852 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.413 ' HB2' HG23 ' A' ' 37' ' ' THR . 1.7 t -152.22 129.74 11.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.82 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.687 HG11 HD13 ' A' ' 71' ' ' ILE . 2.1 m -146.16 159.54 11.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.09 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.516 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 43.7 tt0 -98.62 114.67 27.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.795 HG23 ' HB1' ' A' ' 67' ' ' ALA . 27.7 mm -82.05 103.28 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.175 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.756 HG22 ' CB ' ' A' ' 33' ' ' SER . 49.5 p -101.9 164.0 11.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.86 38.99 5.93 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.538 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.3 mt -106.75 175.92 5.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.778 0.323 . . . . 0.0 110.917 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -120.09 133.42 55.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -68.05 160.19 29.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.0 13.86 58.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.445 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.517 HG22 ' CD2' ' A' ' 89' ' ' TYR . 17.7 mm -124.17 110.96 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.796 0.332 . . . . 0.0 111.094 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.89 134.16 35.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.866 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.517 ' CD2' HG22 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -156.29 163.43 39.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.4 ' HE3' HD11 ' A' ' 58' ' ' LEU . 19.7 mttt -108.0 178.33 4.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.98 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -135.61 152.8 51.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.912 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.564 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 6.3 ptp180 -147.49 171.55 15.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.663 HG11 ' CD1' ' A' ' 38' ' ' TRP . 84.6 t -137.4 140.36 42.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.1 mtt180 -128.5 134.96 48.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -94.54 132.71 38.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.152 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.761 HD11 ' NE ' ' A' ' 52' ' ' ARG . 4.0 mp -127.26 120.72 29.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.443 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 39.9 p-10 -123.45 -172.26 2.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.931 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.437 ' CE ' ' HD3' ' A' ' 10' ' ' PRO . 21.4 ptm -70.28 2.31 3.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.862 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.564 HD12 ' O ' ' A' ' 16' ' ' SER . 39.9 mt -109.75 -26.36 9.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.947 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.03 -164.67 29.66 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.541 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -104.9 158.45 16.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.839 0.352 . . . . 0.0 110.877 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 53.2 p -96.86 175.08 6.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -70.79 157.69 89.67 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.631 0.729 . . . . 0.0 110.881 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 92' ' ' ARG . 54.0 Cg_endo -69.79 105.32 1.47 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.653 2.235 . . . . 0.0 112.371 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.0 p -44.54 157.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.844 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.58 140.89 18.06 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.625 0.726 . . . . 0.0 111.069 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 100.98 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.658 2.239 . . . . 0.0 112.339 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.9 p -48.0 159.04 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -51.18 152.03 4.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.607 0.718 . . . . 0.0 110.818 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.486 ' HB3' ' CD1' ' A' ' 58' ' ' LEU . 53.6 Cg_endo -69.75 126.71 13.64 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.665 2.243 . . . . 0.0 112.347 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.464 ' CB ' HG21 ' A' ' 26' ' ' ILE . 55.5 t80 -117.28 113.94 22.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.935 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 42.4 t -88.02 106.94 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.175 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.8 t -72.17 106.94 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.141 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 t -106.85 169.64 8.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.822 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -79.32 97.38 1.55 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.52 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.9 t -171.88 171.32 5.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 0.0 110.878 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -164.25 172.49 40.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 107.75 1.93 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.665 2.243 . . . . 0.0 112.392 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.0 m -50.9 121.94 6.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.0 m -166.35 131.21 2.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.837 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.436 179.965 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m -159.73 138.17 10.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.371 . . . . 0.0 110.882 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.2 p -59.4 137.08 58.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.923 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -42.25 148.84 0.45 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.449 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 m -96.92 170.97 8.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.89 0.376 . . . . 0.0 110.827 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 t -153.35 125.29 7.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.897 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.75 133.74 12.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.476 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.9 m -84.18 128.99 34.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.843 0.354 . . . . 0.0 110.88 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -88.11 147.25 40.12 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.6 0.714 . . . . 0.0 110.965 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 132.61 23.66 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.659 2.239 . . . . 0.0 112.325 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -109.95 144.54 38.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.809 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -112.69 -38.93 4.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.81 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.36 86.21 0.52 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.494 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.2 ptt85 -88.57 104.89 17.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.847 0.356 . . . . 0.0 110.883 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.505 HD22 ' HA3' ' A' ' 45' ' ' GLY . 13.5 mt -105.53 -175.01 2.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.945 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.578 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.6 m -144.4 161.91 42.08 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.684 0.754 . . . . 0.0 110.899 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 169.92 17.8 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.696 2.264 . . . . 0.0 112.314 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.506 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.5 Cg_endo -69.82 154.44 67.51 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.691 2.261 . . . . 0.0 112.342 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.43 ' C ' ' HB2' ' A' ' 102' ' ' SER . 4.7 pt-20 -98.89 173.71 6.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.15 121.16 75.02 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.666 0.746 . . . . 0.0 111.101 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 162.83 40.62 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.674 2.25 . . . . 0.0 112.347 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -48.41 172.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -79.9 123.06 83.9 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.581 0.705 . . . . 0.0 110.889 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.404 ' HB2' HG13 ' A' ' 36' ' ' VAL . 54.5 Cg_endo -69.68 144.15 53.56 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.754 2.303 . . . . 0.0 112.399 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.897 ' O ' HD13 ' A' ' 26' ' ' ILE . 15.1 t -95.72 167.26 11.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.897 HD13 ' O ' ' A' ' 25' ' ' THR . 8.2 mm -129.79 118.64 45.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.144 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -120.82 178.96 4.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.825 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.5 m -94.35 98.53 10.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.141 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.868 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -100.72 -40.71 7.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.5 m -159.64 -179.8 8.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -81.8 -21.33 37.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.845 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.2 p -118.27 3.6 11.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.107 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.3 p -144.92 174.66 10.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.7 m -153.2 142.16 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.203 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.868 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 22.6 m-85 -77.77 120.17 22.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.878 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 24' ' ' PRO . 78.9 t -114.88 130.61 69.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.105 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.4 m -128.81 120.29 26.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.715 ' CD1' HG11 ' A' ' 93' ' ' VAL . 24.9 p90 -121.31 170.79 9.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 mm -134.98 110.86 10.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.549 0.69 . . . . 0.0 111.107 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.519 ' HD3' HD22 ' A' ' 76' ' ' LEU . 53.2 Cg_endo -69.83 131.2 20.64 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.667 2.245 . . . . 0.0 112.351 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -95.58 -70.15 0.72 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.15 149.72 16.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.49 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -118.69 8.95 12.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.884 0.373 . . . . 0.0 110.871 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.27 3.05 75.54 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.505 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 107.28 -22.7 28.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.494 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.45 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.4 m-85 -109.91 161.9 22.46 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.738 0.78 . . . . 0.0 110.849 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 114.94 3.86 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.613 2.209 . . . . 0.0 112.377 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.515 HD13 ' CE1' ' A' ' 51' ' ' PHE . 97.7 mt -45.22 128.17 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.142 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -82.33 -47.4 12.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.1 m -163.27 160.76 24.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.844 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.515 ' CE1' HD13 ' A' ' 48' ' ' ILE . 60.7 m-85 -108.09 178.18 4.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.954 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.3 mtt-85 -149.65 121.71 8.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.641 HG11 HD11 ' A' ' 80' ' ' ILE . 23.5 t -105.38 125.57 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -131.83 146.26 52.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.527 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 38.5 p90 -120.14 175.91 5.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.966 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.529 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 13.3 tttt -148.71 135.24 19.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.3 mttp -82.66 125.73 31.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 110' ' ' PRO . 73.5 mt -85.83 -49.01 8.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.934 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.3 tptt -92.39 48.52 1.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -159.54 -178.43 7.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.89 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.4 p -101.32 -25.96 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.116 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -54.75 136.69 44.43 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.489 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.464 ' O ' ' CD1' ' A' ' 65' ' ' ILE . 0.7 OUTLIER -84.69 -175.92 6.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.837 0.351 . . . . 0.0 110.797 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.529 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 77.7 m95 -49.3 134.93 17.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.938 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.558 HG22 ' H ' ' A' ' 66' ' ' LEU . 3.1 mm -120.67 169.73 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.192 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.558 ' H ' HG22 ' A' ' 65' ' ' ILE . 53.0 tp -104.5 121.16 42.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.931 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.842 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -86.76 -67.69 0.8 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.09 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.573 ' CG2' HD11 ' A' ' 71' ' ' ILE . 12.6 t -129.8 -176.61 3.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.216 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 98.2 p -174.29 -178.03 1.36 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.874 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 58.91 27.14 15.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.658 HD13 HG11 ' A' ' 78' ' ' VAL . 58.2 mt -77.17 137.76 64.84 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.591 0.71 . . . . 0.0 111.11 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.639 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.2 Cg_endo -69.8 157.26 60.92 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.727 2.284 . . . . 0.0 112.371 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 -24.16 30.39 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.738 2.292 . . . . 0.0 112.335 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 86.6 p -79.75 -18.19 51.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.463 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.0 ttt180 -96.66 102.68 14.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.519 HD22 ' HD3' ' A' ' 40' ' ' PRO . 54.9 mt -100.19 14.29 31.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.926 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.0 t -156.02 132.61 10.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.833 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.658 HG11 HD13 ' A' ' 71' ' ' ILE . 2.1 m -146.98 162.61 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.119 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.516 ' OE1' ' HB1' ' A' ' 29' ' ' ALA . 33.4 tt0 -98.51 110.72 23.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.842 HG23 ' HB1' ' A' ' 67' ' ' ALA . 40.1 mm -76.69 106.38 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.163 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.9 p -99.6 167.57 10.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.14 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.92 44.19 8.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.573 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.9 mt -98.88 -175.62 3.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.83 0.348 . . . . 0.0 110.93 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -132.85 119.72 20.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.69 156.69 22.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.892 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.47 13.54 44.97 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.45 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.526 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 33.3 mm -126.38 101.63 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.832 0.349 . . . . 0.0 111.175 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.21 141.81 57.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -164.06 162.43 23.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -109.11 -174.76 2.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.863 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.405 ' HE2' HG21 ' A' ' 80' ' ' ILE . 76.9 m-85 -144.57 150.85 38.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.449 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 2.3 ptp180 -141.75 175.07 9.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.715 HG11 ' CD1' ' A' ' 38' ' ' TRP . 57.8 t -142.03 135.7 29.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.1 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.0 mtt180 -124.98 142.5 51.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.813 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -103.41 130.77 50.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.1 mp -124.26 119.12 28.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.453 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.3 p-10 -123.71 -173.6 2.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.915 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.7 ptm -68.49 -0.66 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.838 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.578 HD12 ' O ' ' A' ' 16' ' ' SER . 51.7 mt -106.29 -26.02 11.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.956 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.19 -164.37 28.95 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.481 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.49 157.24 17.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.873 0.368 . . . . 0.0 110.906 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.43 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 7.3 p -96.38 174.92 6.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.936 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -71.11 159.48 85.44 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.663 0.744 . . . . 0.0 110.892 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.449 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.5 Cg_endo -69.65 106.89 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.698 2.265 . . . . 0.0 112.386 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.0 p -45.82 154.46 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.845 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -48.71 139.41 11.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.552 0.691 . . . . 0.0 111.087 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 94.74 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.664 2.243 . . . . 0.0 112.35 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.9 p -42.14 158.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -51.47 152.34 4.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.614 0.721 . . . . 0.0 110.864 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.576 ' HB3' HD11 ' A' ' 58' ' ' LEU . 54.8 Cg_endo -69.68 129.35 17.52 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.68 2.254 . . . . 0.0 112.393 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -119.41 118.08 30.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.4 t -93.3 102.5 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.118 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.6 t -68.67 106.8 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.06 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 t -100.97 -38.36 8.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.854 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.52 -79.82 0.32 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.498 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 60.1 p -47.68 162.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.871 0.367 . . . . 0.0 110.873 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 162.05 169.89 26.02 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.85 -164.56 0.13 Allowed 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.678 2.252 . . . . 0.0 112.357 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 97.1 p -138.06 146.25 42.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.836 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.9 t -52.65 -50.54 62.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.874 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.249 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.464 179.995 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 t -158.68 149.28 20.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.911 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.6 p -166.82 159.76 13.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.0 127.48 1.03 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.442 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.0 t -142.85 126.23 16.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.373 . . . . 0.0 110.839 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.0 t -166.17 144.29 5.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.869 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 157.93 56.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.537 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 m -168.76 164.45 11.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.837 0.351 . . . . 0.0 110.878 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -52.92 137.9 45.19 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.636 0.732 . . . . 0.0 110.952 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 104.3 1.29 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.697 2.265 . . . . 0.0 112.376 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.18 157.69 19.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.848 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.45 ' O ' ' CG ' ' A' ' 12' ' ' HIS . 1.1 p80 -78.42 125.03 28.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.29 -128.28 4.82 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.536 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -59.55 84.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.934 0.397 . . . . 0.0 110.875 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.641 HD13 ' CE2' ' A' ' 46' ' ' PHE . 3.0 mt -89.05 -176.96 5.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.943 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.554 ' O ' HD12 ' A' ' 99' ' ' LEU . 0.6 OUTLIER -144.42 161.61 43.47 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.675 0.75 . . . . 0.0 110.815 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 169.98 17.64 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.668 2.245 . . . . 0.0 112.332 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.476 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.4 Cg_endo -69.76 156.47 63.27 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.732 2.288 . . . . 0.0 112.372 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.419 ' C ' ' HB2' ' A' ' 102' ' ' SER . 4.5 pt-20 -101.6 165.66 11.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.927 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.83 122.76 64.36 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.546 0.689 . . . . 0.0 111.133 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 164.0 36.19 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.72 2.28 . . . . 0.0 112.338 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -51.63 176.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -80.29 122.38 82.71 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.577 0.703 . . . . 0.0 110.895 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.428 ' HB2' HG13 ' A' ' 36' ' ' VAL . 53.1 Cg_endo -69.84 142.52 47.79 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.731 2.287 . . . . 0.0 112.357 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.768 ' O ' HD13 ' A' ' 26' ' ' ILE . 6.3 t -93.13 163.14 13.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.116 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.768 HD13 ' O ' ' A' ' 25' ' ' THR . 8.4 mm -123.63 129.55 74.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.116 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 t -136.05 165.49 25.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.807 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.618 HG21 ' HD2' ' A' ' 118' ' ' PRO . 7.5 m -80.91 109.16 15.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.167 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.735 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -111.86 -35.83 5.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.148 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.9 m -165.19 -177.8 4.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.902 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.651 ' HG2' HG23 ' A' ' 32' ' ' THR . 0.1 OUTLIER -85.92 -14.68 44.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.89 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.651 HG23 ' HG2' ' A' ' 31' ' ' GLU . 36.6 p -122.96 -1.38 8.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.165 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.523 ' CB ' HG22 ' A' ' 81' ' ' THR . 4.7 p -143.18 175.28 10.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.0 m -153.35 144.3 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.735 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 19.0 m-85 -78.39 124.75 28.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.428 HG13 ' HB2' ' A' ' 24' ' ' PRO . 72.3 t -119.93 131.47 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.3 m -129.0 118.66 22.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.101 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.628 ' CD1' HG11 ' A' ' 93' ' ' VAL . 30.2 p90 -115.67 169.92 8.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.4 mm -132.23 107.35 13.53 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.589 0.709 . . . . 0.0 111.131 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.66 134.08 27.32 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.715 2.277 . . . . 0.0 112.355 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -103.89 -70.26 0.77 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.856 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.96 144.09 15.73 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.423 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -116.15 13.21 15.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 0.0 110.827 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 75.31 -0.72 59.0 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.435 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.422 ' HA3' ' CD2' ' A' ' 15' ' ' LEU . . . 111.6 -22.48 19.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.641 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.0 m-85 -109.34 161.74 22.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.651 0.739 . . . . 0.0 110.892 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.66 113.67 3.43 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.68 2.253 . . . . 0.0 112.332 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.588 HD13 ' CE1' ' A' ' 51' ' ' PHE . 91.0 mt -42.69 127.79 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.153 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -82.55 -46.24 13.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.3 p -164.02 160.07 21.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.588 ' CE1' HD13 ' A' ' 48' ' ' ILE . 61.5 m-85 -107.93 173.33 6.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -148.27 124.17 10.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 92' ' ' ARG . 47.6 t -106.2 140.01 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.099 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.44 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 42.0 mt-10 -136.45 151.1 49.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.454 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 35.6 p90 -125.79 165.04 19.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.953 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 89' ' ' TYR . 6.7 ttpm? -143.71 133.06 23.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -81.3 138.05 35.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.414 HD11 ' HB3' ' A' ' 110' ' ' PRO . 87.2 mt -99.6 -40.45 7.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -57.98 -71.54 0.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.891 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.457 ' O ' ' C ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -93.82 -174.5 3.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 61' ' ' VAL . 7.6 p -32.35 107.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.164 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.84 114.74 3.89 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.478 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -141.75 137.53 31.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.75 0.309 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -71.13 119.49 15.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.56 HG22 ' H ' ' A' ' 66' ' ' LEU . 1.8 mm -117.3 171.69 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.56 ' H ' HG22 ' A' ' 65' ' ' ILE . 50.6 tp -104.31 130.6 52.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.909 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.43 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -103.31 -69.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.634 ' CG2' HD11 ' A' ' 71' ' ' ILE . 13.2 t -116.88 171.42 7.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.133 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.496 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 60.4 p -167.7 167.76 13.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.797 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 71.29 27.77 3.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.045 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.634 HD11 ' CG2' ' A' ' 68' ' ' THR . 63.9 mt -78.04 137.55 61.25 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.653 0.739 . . . . 0.0 111.104 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.605 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.7 Cg_endo -69.66 157.24 61.25 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.743 2.295 . . . . 0.0 112.362 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -20.07 35.05 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.674 2.249 . . . . 0.0 112.34 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 92.4 p -83.38 -23.68 32.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.476 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 10.0 ttt180 -90.34 99.24 12.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.3 mt -95.96 15.33 20.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 t -155.54 136.48 13.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.559 HG11 HD13 ' A' ' 71' ' ' ILE . 2.9 m -150.08 163.06 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.151 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.525 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 65.4 tt0 -98.91 112.47 24.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.43 HG23 ' HB1' ' A' ' 67' ' ' ALA . 47.6 mm -79.77 101.73 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.192 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.523 HG22 ' CB ' ' A' ' 33' ' ' SER . 27.7 p -98.1 168.28 10.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.182 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.72 40.28 8.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.48 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 46.2 mt -104.27 -175.29 2.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -127.97 130.85 49.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.43 155.92 40.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.64 11.5 57.27 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.462 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.2 mm -125.01 116.52 47.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.866 0.365 . . . . 0.0 111.132 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.15 135.76 35.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.446 ' CB ' ' O ' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -154.77 162.74 41.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.942 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -107.25 178.21 4.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.947 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -137.16 160.42 39.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.907 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.44 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 2.1 ptp180 -150.97 177.75 9.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.628 HG11 ' CD1' ' A' ' 38' ' ' TRP . 91.6 t -147.44 137.97 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.124 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -129.56 141.65 50.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -101.45 132.17 47.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.022 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mp -125.24 119.59 28.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.944 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.447 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.8 p-10 -123.59 -173.71 2.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.93 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.4 ptm -68.26 -1.07 5.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.893 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 16' ' ' SER . 55.2 mt -106.25 -25.48 11.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.958 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 147.28 -165.55 28.62 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.458 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -100.5 158.11 16.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 110.869 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.419 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 4.0 p -94.47 175.22 6.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.842 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -70.34 159.72 83.7 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.649 0.738 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.432 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.5 Cg_endo -69.78 109.12 2.24 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.74 2.293 . . . . 0.0 112.31 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.7 p -51.01 153.47 1.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.88 140.34 30.17 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.572 0.701 . . . . 0.0 111.128 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 97.42 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.713 2.275 . . . . 0.0 112.354 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 88.2 p -45.75 167.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.16 152.68 50.7 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.666 0.746 . . . . 0.0 110.91 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.414 ' HB3' HD11 ' A' ' 58' ' ' LEU . 54.2 Cg_endo -69.73 135.04 29.51 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.703 2.269 . . . . 0.0 112.32 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -124.22 124.34 42.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.09 101.78 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.152 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.3 t -70.09 105.73 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.055 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 115' ' ' GLY . 1.4 t -115.88 110.07 18.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 114' ' ' SER . . . 34.62 -147.23 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.455 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 65.7 m -81.51 132.8 35.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.951 0.405 . . . . 0.0 110.848 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.33 -160.52 34.34 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.538 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.618 ' HD2' HG21 ' A' ' 28' ' ' THR . 53.8 Cg_endo -69.72 165.82 29.61 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.733 2.288 . . . . 0.0 112.321 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.7 t -125.99 132.94 51.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.922 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.4 m -93.66 103.22 15.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.539 -179.981 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.531 -0.227 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 m -38.39 157.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.914 0.388 . . . . 0.0 110.781 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 m -124.26 157.02 35.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.831 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.86 -159.63 27.23 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.512 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.0 p -92.2 133.71 35.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 0.0 110.88 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.5 t -87.03 163.89 16.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.846 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -129.55 155.62 20.95 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.518 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -63.59 150.61 43.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.81 0.338 . . . . 0.0 110.867 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.476 ' CG ' ' HD2' ' A' ' 10' ' ' PRO . 17.9 tt0 -61.36 140.27 94.65 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.597 0.713 . . . . 0.0 110.942 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.476 ' HD2' ' CG ' ' A' ' 9' ' ' GLN . 53.4 Cg_endo -69.77 157.44 60.35 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.638 2.225 . . . . 0.0 112.362 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -130.53 123.76 30.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -113.52 154.2 27.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.854 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.11 66.2 0.88 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.0 ptt-85 -75.08 96.5 3.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 110.843 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.698 HD13 ' CE2' ' A' ' 46' ' ' PHE . 3.2 mt -85.35 -176.66 6.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.632 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.7 m -146.43 161.54 38.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.68 0.752 . . . . 0.0 110.865 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 169.59 18.57 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.723 2.282 . . . . 0.0 112.337 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.582 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.0 Cg_endo -69.79 150.78 68.47 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.661 2.24 . . . . 0.0 112.32 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.424 ' C ' ' HB2' ' A' ' 102' ' ' SER . 9.1 pt-20 -92.69 174.71 7.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.8 122.4 83.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.573 0.702 . . . . 0.0 111.079 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 161.82 44.46 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.697 2.264 . . . . 0.0 112.317 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -51.77 175.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -80.28 122.82 83.21 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.603 0.716 . . . . 0.0 110.869 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 142.87 49.13 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.701 2.267 . . . . 0.0 112.419 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.659 ' C ' HD13 ' A' ' 26' ' ' ILE . 2.9 t -93.32 159.1 15.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.659 HD13 ' C ' ' A' ' 25' ' ' THR . 3.9 mm -122.13 119.18 57.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.142 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -119.31 -174.96 2.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.918 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 47.0 m -103.15 100.76 10.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.136 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.763 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -103.48 -38.3 7.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.086 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.1 m -161.11 -179.64 7.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -81.47 -21.53 38.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.9 p -116.67 -2.26 11.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.152 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.624 ' CB ' HG22 ' A' ' 81' ' ' THR . 3.9 p -142.58 164.01 31.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.817 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.3 m -143.39 145.19 22.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.179 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.763 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 18.1 m-85 -75.49 113.9 13.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.94 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.7 t -107.07 124.62 62.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.13 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.515 ' HB ' HG22 ' A' ' 25' ' ' THR . 55.9 m -124.71 121.31 34.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.122 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.653 ' CD1' HG11 ' A' ' 93' ' ' VAL . 25.0 p90 -118.18 169.63 9.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.915 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.2 mm -134.35 106.18 11.11 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.632 0.729 . . . . 0.0 111.152 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 142.29 47.55 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.676 2.251 . . . . 0.0 112.321 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -111.69 -69.52 0.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.887 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.0 142.16 15.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.534 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 47.2 p-10 -112.54 9.55 19.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.904 0.383 . . . . 0.0 110.893 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 79.01 0.67 83.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.458 ' HA3' ' CD2' ' A' ' 15' ' ' LEU . . . 111.6 -24.5 15.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.698 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.5 m-85 -108.16 162.11 21.04 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.629 0.728 . . . . 0.0 110.908 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 113.82 3.5 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.669 2.246 . . . . 0.0 112.385 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.519 HD13 ' CE1' ' A' ' 51' ' ' PHE . 97.6 mt -43.58 127.35 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -81.77 -48.32 11.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.936 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.6 m -162.13 162.03 28.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.921 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.519 ' CE1' HD13 ' A' ' 48' ' ' ILE . 51.5 m-85 -109.03 176.31 5.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -149.93 123.42 9.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.36 133.19 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.136 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.405 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 9.4 mt-10 -132.13 162.97 29.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.938 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.582 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 16.1 p90 -148.34 146.18 28.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.522 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 14.8 ttpp -121.93 131.73 54.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.879 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -76.37 128.73 35.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.868 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.2 mt -86.11 160.34 19.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt 58.75 27.23 15.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -150.49 165.18 33.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.833 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.5 p -101.23 139.23 22.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.35 129.55 2.88 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.448 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -52.51 177.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.711 0.291 . . . . 0.0 110.923 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.553 ' O ' HD13 ' A' ' 65' ' ' ILE . 35.9 m95 -61.5 176.68 0.46 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.942 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.582 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 2.3 mm -133.12 164.02 36.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.17 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.408 ' H ' HG22 ' A' ' 65' ' ' ILE . 14.8 tp -102.66 123.36 46.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.663 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -93.78 -66.9 0.89 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.071 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.466 HG21 HD11 ' A' ' 71' ' ' ILE . 11.8 t -128.04 177.81 6.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.113 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.499 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 83.2 p -171.31 167.65 6.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.867 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 71.49 36.13 1.35 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.657 HG23 ' HD2' ' A' ' 72' ' ' PRO . 72.8 mt -87.48 138.29 31.98 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.624 0.726 . . . . 0.0 111.144 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.657 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.9 Cg_endo -69.8 156.69 62.59 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.676 2.251 . . . . 0.0 112.341 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.87 -20.69 33.97 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.696 2.264 . . . . 0.0 112.338 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.1 t -84.32 -10.67 57.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.442 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 12.2 ttt180 -103.38 102.97 12.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.1 mt -100.69 10.47 41.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 t -151.92 129.2 11.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.528 HG11 HD13 ' A' ' 71' ' ' ILE . 2.4 m -144.7 165.04 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.086 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -98.52 113.73 25.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.865 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.663 HG23 ' HB1' ' A' ' 67' ' ' ALA . 40.0 mm -83.63 98.57 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.091 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.624 HG22 ' CB ' ' A' ' 33' ' ' SER . 73.7 p -95.78 165.3 12.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.193 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.69 35.33 9.34 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.497 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.9 mt -94.45 176.49 6.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.866 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -121.7 120.26 34.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -62.82 156.73 23.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.948 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.28 13.9 45.26 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.555 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.1 mm -124.95 104.93 14.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 0.0 111.117 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.55 134.16 47.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -157.01 163.12 39.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.934 -179.813 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -111.01 176.63 4.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.894 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 91' ' ' PHE . 8.0 m-85 -131.96 158.1 42.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.425 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 2.1 ptp180 -149.63 171.87 15.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.653 HG11 ' CD1' ' A' ' 38' ' ' TRP . 94.5 t -139.68 142.77 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -132.41 141.59 48.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.582 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -101.98 125.18 48.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.075 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mp -119.76 118.02 29.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.445 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.3 p-10 -123.6 -174.28 2.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.609 ' HE3' ' CG ' ' A' ' 46' ' ' PHE . 5.0 ptp -67.61 -2.12 6.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.632 HD12 ' O ' ' A' ' 16' ' ' SER . 29.4 mt -105.29 -25.63 12.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.944 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 147.53 -167.16 28.63 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.519 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -101.4 157.54 16.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.819 0.343 . . . . 0.0 110.896 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.424 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 8.7 p -94.22 174.27 7.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.805 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -70.23 160.39 81.08 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.59 0.71 . . . . 0.0 110.929 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.425 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.5 Cg_endo -69.77 105.48 1.49 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.742 2.294 . . . . 0.0 112.306 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.4 p -45.2 156.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.803 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.51 139.93 27.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.564 0.697 . . . . 0.0 111.117 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.69 89.26 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.719 2.279 . . . . 0.0 112.382 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 t -40.7 152.28 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.2 mtt-85 -44.75 153.57 0.47 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.6 0.714 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 132.95 24.33 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.651 2.234 . . . . 0.0 112.367 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -121.17 116.57 25.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.79 107.32 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.094 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.27 111.73 13.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.3 t -113.19 -31.57 6.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.817 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.75 -174.84 46.03 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.465 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 88.4 p -103.86 177.8 4.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.877 0.37 . . . . 0.0 110.935 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -132.04 -158.02 8.86 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.493 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 114.87 3.84 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.692 2.261 . . . . 0.0 112.372 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.7 t -74.08 148.73 41.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.84 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 t -110.26 117.7 34.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.499 -179.962 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 m -105.43 125.97 51.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.905 0.383 . . . . 0.0 110.881 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.8 t -105.94 149.42 26.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.889 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.06 103.3 2.23 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.5 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 t -150.48 134.91 17.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.89 0.376 . . . . 0.0 110.849 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.1 p -125.88 172.19 10.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.871 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.3 140.24 14.78 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.442 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.5 p -167.97 147.15 4.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.9 0.381 . . . . 0.0 110.835 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.6 pm0 -39.86 144.16 0.54 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.609 0.718 . . . . 0.0 110.911 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 113.52 3.4 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.691 2.26 . . . . 0.0 112.308 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 12' ' ' HIS . 5.4 m-20 -83.74 103.5 13.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.463 ' O ' ' CG ' ' A' ' 12' ' ' HIS . 39.4 p-80 -36.19 115.78 0.36 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.854 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.3 -83.53 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.51 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.7 mmt-85 -61.52 87.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.833 0.349 . . . . 0.0 110.917 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.627 HD13 ' CE2' ' A' ' 46' ' ' PHE . 7.7 mt -92.29 -175.35 4.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.616 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.6 m -141.26 161.77 51.28 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.704 0.764 . . . . 0.0 110.772 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 169.77 18.13 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.665 2.244 . . . . 0.0 112.284 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.593 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 54.2 Cg_endo -69.86 159.02 54.84 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.618 2.212 . . . . 0.0 112.316 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.55 165.15 11.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.926 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.2 120.55 52.13 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.621 0.724 . . . . 0.0 111.126 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 166.56 27.17 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.718 2.278 . . . . 0.0 112.307 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -52.53 172.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.935 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.4 ' HB2' ' NH1' ' A' ' 23' ' ' ARG . 13.7 ttm105 -79.83 123.03 84.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.598 0.713 . . . . 0.0 110.849 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.466 ' HB2' ' CG1' ' A' ' 36' ' ' VAL . 53.1 Cg_endo -69.79 141.79 46.07 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.658 2.239 . . . . 0.0 112.35 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.852 ' O ' HD13 ' A' ' 26' ' ' ILE . 6.9 t -92.47 169.22 10.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.119 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.852 HD13 ' O ' ' A' ' 25' ' ' THR . 3.1 mm -129.13 131.99 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.131 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 t -139.31 167.59 21.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.4 m -80.22 108.16 13.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.695 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -113.01 -35.43 5.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.075 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.0 m -164.32 178.84 7.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.812 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.78 -16.68 46.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.851 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 p -122.2 -2.12 9.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.168 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.659 ' CB ' HG22 ' A' ' 81' ' ' THR . 7.0 p -141.11 171.22 14.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.6 m -147.82 145.44 18.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.148 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.695 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 9.7 m-85 -78.86 119.28 21.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.466 ' CG1' ' HB2' ' A' ' 24' ' ' PRO . 92.4 t -115.95 132.17 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.183 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.403 ' HB ' HG22 ' A' ' 25' ' ' THR . 98.7 m -129.2 124.44 34.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.169 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.74 ' CD1' HG11 ' A' ' 93' ' ' VAL . 24.7 p90 -123.13 171.54 9.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.956 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.6 mm -137.2 106.25 8.66 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.677 0.751 . . . . 0.0 111.163 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 135.91 31.47 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.626 2.217 . . . . 0.0 112.35 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.2 mmm-85 -102.17 -70.63 0.74 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.36 152.54 18.41 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.484 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 52.6 p-10 -122.54 12.63 10.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.854 0.359 . . . . 0.0 110.862 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.63 -0.84 59.93 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.511 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.473 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 111.18 -18.79 25.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.464 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.627 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.1 m-85 -113.08 162.32 22.47 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.584 0.707 . . . . 0.0 110.915 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 115.47 4.11 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.639 2.226 . . . . 0.0 112.365 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.607 HD13 ' CZ ' ' A' ' 51' ' ' PHE . 96.7 mt -45.7 132.0 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.106 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -86.87 -47.14 9.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.9 p -164.22 159.14 19.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.861 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.607 ' CZ ' HD13 ' A' ' 48' ' ' ILE . 54.7 m-85 -107.97 173.12 6.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.897 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -150.1 124.92 9.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 92' ' ' ARG . 48.0 t -103.14 136.32 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.168 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -133.89 146.65 50.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.841 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.539 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 26.9 p90 -125.08 174.81 7.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.979 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.459 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 29.6 ttpt -146.47 125.12 12.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -75.03 126.23 30.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.482 HD11 ' HB3' ' A' ' 110' ' ' PRO . 15.4 mt -94.93 -60.67 1.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.857 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -39.03 -41.24 0.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.952 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -122.4 164.2 18.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.955 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.467 HG22 ' N ' ' A' ' 62' ' ' GLY . 10.7 p -71.23 158.94 5.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.169 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.467 ' N ' HG22 ' A' ' 61' ' ' VAL . . . 140.87 125.09 2.11 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.543 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -62.43 -174.87 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.779 0.323 . . . . 0.0 110.859 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.554 ' CH2' ' HD3' ' A' ' 92' ' ' ARG . 89.5 m95 -67.52 137.15 55.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.539 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.2 mm -114.6 164.08 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.125 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.414 ' H ' HG22 ' A' ' 65' ' ' ILE . 43.8 tp -98.33 130.36 45.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.555 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -102.58 -70.27 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.091 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.407 ' CG2' HD11 ' A' ' 71' ' ' ILE . 12.0 t -124.63 164.72 19.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.53 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 1.3 t -163.43 171.26 16.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.89 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 73.13 25.28 2.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.173 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.649 HG23 ' HD2' ' A' ' 72' ' ' PRO . 80.4 mt -76.11 138.12 68.74 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.585 0.707 . . . . 0.0 111.156 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.649 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.8 Cg_endo -69.75 157.04 61.76 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.726 2.284 . . . . 0.0 112.311 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 -17.55 37.16 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.645 2.23 . . . . 0.0 112.357 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 t -87.08 -17.44 32.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.872 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.472 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 6.5 ttt85 -97.21 98.33 9.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.9 mt -92.23 9.94 31.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.7 t -154.92 137.78 15.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.501 HG11 HD13 ' A' ' 71' ' ' ILE . 2.5 m -147.51 167.95 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.101 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.503 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 45.5 tt0 -101.26 104.19 15.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.555 HG23 ' HB1' ' A' ' 67' ' ' ALA . 48.4 mm -71.48 101.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.113 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.659 HG22 ' CB ' ' A' ' 33' ' ' SER . 38.8 p -101.22 161.63 13.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.141 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.72 37.34 6.13 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.452 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.4 mt -100.28 176.58 5.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.73 0.3 . . . . 0.0 110.935 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -120.32 117.92 29.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.81 150.65 27.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.96 12.56 71.47 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.512 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.466 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 39.0 mm -125.11 109.7 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.893 0.378 . . . . 0.0 111.193 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.44 140.71 46.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.466 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -164.11 167.03 20.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.883 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.491 ' O ' ' CB ' ' A' ' 55' ' ' TYR . 58.1 mttt -112.85 -177.18 3.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.862 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -146.19 152.43 39.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.554 ' HD3' ' CH2' ' A' ' 64' ' ' TRP . 6.4 mtm180 -143.62 -178.37 5.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.914 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.74 HG11 ' CD1' ' A' ' 38' ' ' TRP . 61.5 t -142.67 139.02 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.166 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.4 mtt180 -126.87 145.3 50.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.769 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.593 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -103.5 125.25 49.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.101 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.2 mp -120.86 117.78 28.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.454 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 41.1 p-10 -123.85 -173.27 2.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.2 ptm -68.92 -0.39 5.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.926 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.616 HD12 ' O ' ' A' ' 16' ' ' SER . 62.8 mt -106.21 -26.28 11.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.993 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.76 -163.43 29.05 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.499 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -108.83 155.63 20.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.88 0.371 . . . . 0.0 110.838 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 59.3 p -98.99 172.5 7.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.842 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.2 mp0 -69.19 157.32 89.62 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.614 0.721 . . . . 0.0 110.933 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.4 ' HB2' ' NH1' ' A' ' 92' ' ' ARG . 54.1 Cg_endo -69.71 116.1 4.4 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.723 2.282 . . . . 0.0 112.346 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.459 ' O ' ' C ' ' A' ' 106' ' ' ALA . 74.7 p -54.47 148.21 12.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.893 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 105' ' ' SER . . . -32.67 141.7 0.18 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.62 0.724 . . . . 0.0 111.061 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 97.69 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.634 2.223 . . . . 0.0 112.322 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.1 p -42.69 149.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -46.75 151.89 1.01 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.59 0.71 . . . . 0.0 110.871 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.482 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.1 Cg_endo -69.85 119.82 6.7 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.666 2.244 . . . . 0.0 112.303 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -110.47 120.13 41.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.0 t -94.36 102.62 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.174 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.7 t -71.66 109.83 4.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.11 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.9 t -124.07 49.1 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.3 -175.9 38.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.455 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 99.8 p -97.29 131.92 43.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.929 0.395 . . . . 0.0 110.919 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 157.93 164.73 14.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.506 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 91.21 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.736 2.291 . . . . 0.0 112.319 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 58.7 m 56.74 43.16 25.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.793 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 61.0 p -74.96 129.8 38.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.892 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.537 -179.995 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.484 -0.247 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 m -145.62 127.09 15.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 0.0 110.847 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.2 m 62.58 44.67 6.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.866 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.74 140.49 15.35 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.475 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 99.6 p -129.21 133.43 47.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.854 0.359 . . . . 0.0 110.825 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.9 p -83.44 165.53 19.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.62 166.93 32.63 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.486 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.9 m -148.53 146.4 28.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.751 0.31 . . . . 0.0 110.843 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -115.51 142.83 29.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.539 0.685 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.66 144.23 53.91 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -111.34 -45.86 3.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -73.2 101.13 3.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.93 173.6 50.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.475 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.2 62.45 2.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 0.0 110.887 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.698 HD13 ' CE2' ' A' ' 46' ' ' PHE . 7.2 mt -77.55 -175.12 3.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.972 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.643 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.7 m -142.89 161.38 49.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.662 0.744 . . . . 0.0 110.905 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 168.67 20.86 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.667 2.245 . . . . 0.0 112.393 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.486 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.8 Cg_endo -69.72 159.34 53.82 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.689 2.26 . . . . 0.0 112.334 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.426 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.0 pt-20 -103.64 160.03 15.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.7 122.25 44.57 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.556 0.693 . . . . 0.0 111.102 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 163.96 36.34 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.661 2.241 . . . . 0.0 112.365 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -51.5 176.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.84 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -80.05 123.95 83.21 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.654 0.74 . . . . 0.0 110.876 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.45 ' O ' ' CB ' ' A' ' 108' ' ' SER . 53.4 Cg_endo -69.73 143.0 49.59 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.718 2.279 . . . . 0.0 112.283 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.73 ' O ' HD13 ' A' ' 26' ' ' ILE . 3.2 t -95.53 166.8 11.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.73 HD13 ' O ' ' A' ' 25' ' ' THR . 5.1 mm -124.06 118.17 53.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.137 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -117.84 168.59 10.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.6 m -87.52 102.07 14.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.763 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -104.85 -36.04 7.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.05 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.8 m -173.08 173.45 3.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.885 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' HG3' HG23 ' A' ' 32' ' ' THR . 13.6 pt-20 -78.41 -15.26 58.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.992 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.422 HG23 ' HG3' ' A' ' 31' ' ' GLU . 17.2 p -114.8 -6.97 12.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.165 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.625 ' HB3' HG22 ' A' ' 81' ' ' THR . 25.0 p -144.99 171.53 14.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.5 m -145.87 147.32 18.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.158 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.763 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 13.6 m-85 -82.98 115.33 21.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 81.6 t -108.35 130.33 61.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.096 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.475 ' HB ' HG22 ' A' ' 25' ' ' THR . 38.9 m -128.44 120.52 27.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.112 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.607 ' CD1' HG11 ' A' ' 93' ' ' VAL . 27.9 p90 -118.14 170.67 8.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.96 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.6 mm -133.96 106.59 11.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.634 0.731 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 136.82 33.93 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.752 2.301 . . . . 0.0 112.311 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -104.78 -69.98 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.37 145.05 16.31 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.515 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -113.55 4.74 16.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 110.895 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 82.89 1.88 90.64 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.467 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.418 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 111.53 -26.64 11.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.454 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.698 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.4 m-85 -106.81 161.7 22.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.642 0.734 . . . . 0.0 110.898 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 113.82 3.5 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.691 2.261 . . . . 0.0 112.371 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.491 HD13 ' CE1' ' A' ' 51' ' ' PHE . 89.1 mt -42.32 129.43 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.125 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -83.66 -49.02 9.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.908 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.9 p -160.09 163.2 34.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.848 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.491 ' CE1' HD13 ' A' ' 48' ' ' ILE . 52.7 m-85 -108.96 177.89 4.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -149.83 119.85 7.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.13 130.01 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.158 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -132.65 148.31 52.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.522 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 45.2 p90 -123.53 172.91 8.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.421 ' HD3' ' NE1' ' A' ' 64' ' ' TRP . 17.4 ttpt -147.91 135.35 20.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -83.33 130.69 35.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.959 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 59' ' ' LYS . 43.2 mt -97.52 -61.09 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.88 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.435 ' HD3' ' C ' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -36.16 -60.81 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.938 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -105.31 159.32 15.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.22 134.52 29.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.105 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.15 127.1 0.99 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.531 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -66.51 -176.19 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 0.0 110.876 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.421 ' NE1' ' HD3' ' A' ' 56' ' ' LYS . 73.3 m95 -72.72 140.26 47.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.487 HG22 ' H ' ' A' ' 66' ' ' LEU . 1.8 mm -119.95 167.57 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.127 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.487 ' H ' HG22 ' A' ' 65' ' ' ILE . 47.6 tp -102.31 118.97 38.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.964 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.752 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -86.42 -69.37 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.161 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.498 ' CG2' HD11 ' A' ' 71' ' ' ILE . 2.8 t -128.67 -178.94 4.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.127 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.3 p -174.42 -177.3 1.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.841 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 61.4 32.64 19.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.103 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.667 HG23 ' HD2' ' A' ' 72' ' ' PRO . 85.3 mt -84.68 138.47 38.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.581 0.705 . . . . 0.0 111.128 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.667 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.7 Cg_endo -69.74 158.25 57.62 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.705 2.27 . . . . 0.0 112.414 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -29.57 23.78 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.724 2.283 . . . . 0.0 112.397 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.2 m -74.69 -14.24 60.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.437 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.8 ttt180 -99.99 111.25 23.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.811 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.5 mt -107.25 7.18 29.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 t -150.73 131.73 14.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.0 174.82 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.142 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 28.6 tt0 -111.9 115.0 28.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.826 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.752 HG23 ' HB1' ' A' ' 67' ' ' ALA . 23.4 mm -84.66 104.91 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.052 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.625 HG22 ' HB3' ' A' ' 33' ' ' SER . 68.3 p -98.84 168.29 10.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.144 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.01 38.96 8.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.489 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.4 mt -103.25 168.79 8.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.743 0.306 . . . . 0.0 110.874 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -113.29 127.18 56.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.79 153.37 43.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.27 12.57 72.63 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.49 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.406 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 20.1 mm -125.24 111.74 28.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.909 0.385 . . . . 0.0 111.09 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.89 139.42 40.22 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.406 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -160.72 167.35 27.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -113.4 -176.69 2.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.872 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -143.05 152.22 41.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.932 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -141.63 179.78 6.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.607 HG11 ' CD1' ' A' ' 38' ' ' TRP . 92.7 t -147.48 140.15 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.142 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -130.27 141.45 50.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -101.38 125.06 47.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.082 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.452 ' HG ' ' CB ' ' A' ' 101' ' ' GLU . 8.3 mp -121.71 119.67 32.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.949 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.449 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.2 p-10 -123.6 -173.98 2.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.476 ' HE1' ' CE1' ' A' ' 46' ' ' PHE . 4.9 ptp -67.09 -2.59 5.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 16' ' ' SER . 33.9 mt -105.15 -25.31 12.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.898 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.404 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 146.38 -168.47 27.82 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.451 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.452 ' CB ' ' HG ' ' A' ' 96' ' ' LEU . 3.8 pt-20 -101.84 158.03 16.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 0.0 110.923 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 52.6 p -98.94 167.27 10.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -61.4 157.84 42.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.684 0.754 . . . . 0.0 110.865 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 115.04 3.91 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.71 2.273 . . . . 0.0 112.319 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 92.6 p -54.17 158.95 2.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.831 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.19 142.89 56.85 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.566 0.698 . . . . 0.0 111.159 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 102.12 0.99 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.663 2.242 . . . . 0.0 112.377 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 24' ' ' PRO . 59.5 p -51.55 159.48 0.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -50.39 151.22 3.98 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.608 0.718 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 136.69 33.77 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.684 2.256 . . . . 0.0 112.353 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.525 ' CG ' HG21 ' A' ' 26' ' ' ILE . 49.0 t80 -124.73 117.47 24.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 55.3 t -92.6 103.73 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.154 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.7 t -69.47 113.07 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.3 t -113.42 143.39 44.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.891 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 116' ' ' SER . . . -54.08 -90.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.55 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 115' ' ' GLY . 74.3 m -37.03 115.52 0.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.887 0.375 . . . . 0.0 110.832 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -148.67 -164.75 11.68 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.479 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.87 152.63 68.79 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.626 2.217 . . . . 0.0 112.33 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.4 t -93.11 -58.62 2.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.833 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.2 t -165.31 118.05 1.18 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.479 -179.983 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.607 HD22 ' HA3' ' A' ' 45' ' ' GLY . 9.2 mt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.822 0.344 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.549 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.8 m -144.39 161.51 44.03 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.665 0.745 . . . . 0.0 110.863 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 169.3 19.25 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.642 2.228 . . . . 0.0 112.363 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.557 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.7 Cg_endo -69.77 154.33 67.8 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.671 2.248 . . . . 0.0 112.334 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.421 ' C ' ' HB2' ' A' ' 102' ' ' SER . 4.7 pt-20 -98.46 167.69 10.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.841 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.15 122.84 77.81 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.544 0.688 . . . . 0.0 111.076 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.41 ' HG3' HG12 ' A' ' 93' ' ' VAL . 53.4 Cg_endo -69.81 164.38 34.81 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.629 2.219 . . . . 0.0 112.278 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -50.45 176.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.832 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -80.59 123.13 82.89 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.599 0.714 . . . . 0.0 110.863 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 144.0 52.58 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.618 2.212 . . . . 0.0 112.383 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.826 ' O ' HD13 ' A' ' 26' ' ' ILE . 4.0 t -94.58 167.44 11.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.128 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.826 HD13 ' O ' ' A' ' 25' ' ' THR . 6.8 mm -125.75 126.0 69.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.141 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.0 m -129.8 160.42 33.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.6 m -80.46 104.14 10.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.062 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.726 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -106.59 -38.86 6.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.073 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.9 m -164.76 176.57 8.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.62 -17.26 51.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 p -116.91 -3.65 11.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.629 ' CB ' HG22 ' A' ' 81' ' ' THR . 5.5 p -143.07 174.81 10.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.468 HG11 ' CE2' ' A' ' 111' ' ' TYR . 31.0 m -151.85 145.34 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.155 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.726 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 12.3 m-85 -79.67 120.59 24.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.96 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 93.8 t -117.0 130.78 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.149 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 59.1 m -128.96 120.52 26.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.098 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.632 ' CD1' HG11 ' A' ' 93' ' ' VAL . 28.4 p90 -117.68 171.25 8.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 mm -135.99 107.03 9.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.633 0.73 . . . . 0.0 111.136 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 143.73 52.03 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.709 2.273 . . . . 0.0 112.357 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -112.68 -69.95 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.39 146.7 16.28 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.55 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -116.24 7.34 14.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.981 0.42 . . . . 0.0 110.956 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 79.7 2.07 87.7 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.472 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.607 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 110.35 -26.67 12.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.52 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -106.5 161.8 21.73 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.572 0.701 . . . . 0.0 110.899 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 119.21 6.19 Favored 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.712 2.275 . . . . 0.0 112.339 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.539 HD13 ' CE1' ' A' ' 51' ' ' PHE . 93.3 mt -48.25 136.17 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -93.15 -49.44 5.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.943 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.2 p -159.41 158.4 32.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.539 ' CE1' HD13 ' A' ' 48' ' ' ILE . 58.7 m-85 -108.38 173.65 6.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.896 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -144.09 128.51 17.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.573 HG11 HD11 ' A' ' 80' ' ' ILE . 42.4 t -113.08 122.83 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -124.81 157.74 35.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 39.0 p90 -133.07 174.91 9.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 89' ' ' TYR . 5.7 ttpm? -146.83 133.53 19.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -84.68 120.82 26.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.426 HD11 ' HB3' ' A' ' 110' ' ' PRO . 60.3 mt . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.967 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 53.4 m95 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.718 0.294 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.566 HG22 ' H ' ' A' ' 66' ' ' LEU . 2.6 mm -115.63 170.63 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.137 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.566 ' H ' HG22 ' A' ' 65' ' ' ILE . 48.9 tp -103.75 118.9 37.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.964 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.68 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -87.92 -71.58 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.11 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.586 HG21 HD11 ' A' ' 71' ' ' ILE . 3.9 t -123.83 -179.4 4.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.128 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 23.7 p -174.5 174.17 2.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 67.05 30.08 7.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.111 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.691 HD13 HG11 ' A' ' 78' ' ' VAL . 56.0 mt -81.58 138.04 47.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.657 0.742 . . . . 0.0 111.149 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.652 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.0 Cg_endo -69.74 157.85 59.01 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.661 2.24 . . . . 0.0 112.334 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.69 -19.81 35.96 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.704 2.269 . . . . 0.0 112.407 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 t -85.19 -15.91 42.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.472 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 16.4 ttt180 -97.87 101.21 12.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.854 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.5 mt -98.33 7.72 45.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.959 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 t -150.33 132.1 15.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.804 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.691 HG11 HD13 ' A' ' 71' ' ' ILE . 2.2 m -146.69 164.39 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.091 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.466 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 37.3 tt0 -98.43 111.01 23.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.68 HG23 ' HB1' ' A' ' 67' ' ' ALA . 31.3 mm -78.49 101.81 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.169 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.629 HG22 ' CB ' ' A' ' 33' ' ' SER . 35.2 p -98.96 163.95 12.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.076 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.74 36.96 6.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.504 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.9 mt -104.83 168.49 9.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.76 0.314 . . . . 0.0 110.904 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -112.85 125.77 54.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.65 155.09 34.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.01 10.54 59.23 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.415 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.475 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 32.0 mm -121.98 107.87 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.839 0.352 . . . . 0.0 111.148 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.86 140.52 47.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.798 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.475 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -163.59 164.31 24.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.864 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.2 mttt -109.57 -174.83 2.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.892 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -145.4 159.5 42.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.902 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.414 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 2.7 ptp180 -150.47 174.31 13.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.632 HG11 ' CD1' ' A' ' 38' ' ' TRP . 89.1 t -139.2 142.41 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.122 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 33.8 mtt180 -133.15 143.07 49.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.833 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -103.97 129.04 51.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.078 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.1 mp -122.24 118.14 27.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.438 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 41.0 p-10 -123.04 -174.01 2.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 18.8 ptm -67.15 -2.69 6.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.839 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 16' ' ' SER . 67.4 mt -104.4 -26.01 12.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.946 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.6 -165.71 28.74 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.475 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.46 157.25 16.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.872 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.421 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 6.4 p -92.86 175.21 6.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.802 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -73.42 159.49 84.66 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.696 0.76 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.414 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.3 Cg_endo -69.69 107.49 1.86 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.708 2.272 . . . . 0.0 112.316 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.1 p -51.2 152.62 2.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -48.81 138.37 12.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.627 0.727 . . . . 0.0 111.012 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 104.86 1.39 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.634 2.223 . . . . 0.0 112.38 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.4 p -51.31 171.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -62.36 150.7 84.39 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.648 0.737 . . . . 0.0 110.899 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.426 ' HB3' HD11 ' A' ' 58' ' ' LEU . 54.7 Cg_endo -69.65 120.82 7.56 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.698 2.265 . . . . 0.0 112.339 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.512 ' CB ' HG21 ' A' ' 26' ' ' ILE . 85.8 t80 -111.04 120.05 41.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.963 0.411 . . . . 0.0 110.912 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 52.0 t -91.42 103.35 14.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 t -70.11 106.51 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.148 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -179.872 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.545 HD13 ' CE2' ' A' ' 46' ' ' PHE . 6.3 mt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.773 0.32 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.503 ' O ' HD12 ' A' ' 99' ' ' LEU . 0.6 OUTLIER -146.81 161.52 37.14 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.578 0.704 . . . . 0.0 110.904 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 170.03 17.54 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.661 2.241 . . . . 0.0 112.361 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.549 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.5 Cg_endo -69.67 156.49 63.45 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.732 2.288 . . . . 0.0 112.333 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.423 ' C ' ' HB2' ' A' ' 102' ' ' SER . 9.3 pt-20 -100.59 166.45 10.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.07 121.53 56.1 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.646 0.736 . . . . 0.0 111.087 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 162.89 40.3 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.698 2.266 . . . . 0.0 112.353 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -51.57 175.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.793 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.43 ' NE ' ' HA ' ' A' ' 108' ' ' SER . 18.2 ttt180 -79.88 123.29 83.8 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.537 0.684 . . . . 0.0 110.917 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 142.94 48.95 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.682 2.254 . . . . 0.0 112.326 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.798 ' C ' HD13 ' A' ' 26' ' ' ILE . 2.2 t -94.05 165.42 12.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.798 HD13 ' C ' ' A' ' 25' ' ' THR . 4.3 mm -124.49 119.34 56.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.084 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.3 m -122.66 162.02 22.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.2 m -83.46 98.79 9.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.698 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -97.85 -42.22 7.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.068 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.2 m -161.09 -177.75 6.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.528 ' HG3' HG23 ' A' ' 32' ' ' THR . 15.1 pt-20 -84.44 -14.58 48.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.899 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.528 HG23 ' HG3' ' A' ' 31' ' ' GLU . 51.4 p -121.06 -1.73 9.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.106 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.62 ' CB ' HG22 ' A' ' 81' ' ' THR . 10.7 p -145.54 171.89 14.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.1 m -147.88 147.28 17.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.128 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.698 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 13.4 m-85 -82.74 113.66 20.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.851 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.5 t -108.43 128.49 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.153 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.433 HG23 ' HB2' ' A' ' 77' ' ' SER . 39.9 m -125.95 122.33 35.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.117 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.578 ' CD1' HG11 ' A' ' 93' ' ' VAL . 29.4 p90 -120.79 171.27 8.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.4 mm -136.61 106.24 9.12 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.562 0.696 . . . . 0.0 111.12 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 130.07 18.67 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.707 2.272 . . . . 0.0 112.329 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 mmt85 -94.54 -69.33 0.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.867 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.51 146.05 16.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.445 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -113.52 7.92 17.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.922 0.391 . . . . 0.0 110.904 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 80.56 -1.73 81.28 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.494 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.85 -24.51 11.84 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.473 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.613 ' CG ' ' HE3' ' A' ' 98' ' ' MET . 2.0 m-85 -108.32 162.19 20.8 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.646 0.736 . . . . 0.0 110.885 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.85 116.49 4.59 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.698 2.265 . . . . 0.0 112.278 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.54 HD13 ' CE1' ' A' ' 51' ' ' PHE . 85.9 mt -46.86 125.64 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -80.75 -51.51 8.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.2 m -156.6 162.28 39.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.858 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.54 ' CE1' HD13 ' A' ' 48' ' ' ILE . 61.3 m-85 -111.08 178.47 4.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.922 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 75.4 mtt-85 -149.61 124.94 10.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.5 t -110.24 126.47 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.11 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -124.07 155.87 37.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.513 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 39.1 p90 -132.86 158.43 42.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.88 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.459 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 28.9 ttpt -131.78 127.42 36.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.869 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -81.14 115.88 20.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' A' ' 110' ' ' PRO . 57.5 mt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.952 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.69 ' O ' HD13 ' A' ' 65' ' ' ILE . 87.4 m95 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.782 0.325 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.69 HD13 ' O ' ' A' ' 64' ' ' TRP . 4.0 mm -136.41 166.93 25.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.133 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.502 ' H ' HG22 ' A' ' 65' ' ' ILE . 50.3 tp -97.95 126.13 43.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.94 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.659 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -95.62 -69.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.097 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.503 ' CG2' HD11 ' A' ' 71' ' ' ILE . 6.5 t -130.71 165.14 23.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.142 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.504 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 75.5 p -157.9 172.91 17.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 71.92 27.4 2.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.067 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.667 HG23 ' HD2' ' A' ' 72' ' ' PRO . 76.3 mt -78.16 138.52 60.5 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.56 0.695 . . . . 0.0 111.184 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.667 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.2 Cg_endo -69.79 155.99 64.41 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.652 2.235 . . . . 0.0 112.364 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.77 -21.79 32.92 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.615 2.21 . . . . 0.0 112.352 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 54.6 p -82.73 -13.53 56.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.809 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.455 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.3 ttt180 -100.72 106.46 17.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.946 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.2 mt -101.78 7.33 41.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.433 ' HB2' HG23 ' A' ' 37' ' ' THR . 1.4 t -151.84 131.86 13.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.409 HG11 HD13 ' A' ' 71' ' ' ILE . 2.4 m -144.23 167.94 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.079 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.44 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 33.4 tt0 -104.43 110.62 22.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.659 HG23 ' HB1' ' A' ' 67' ' ' ALA . 8.6 mm -80.91 104.03 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.099 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.62 HG22 ' CB ' ' A' ' 33' ' ' SER . 30.3 p -98.13 165.57 11.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.107 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.98 39.07 6.61 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.49 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 65.6 mt -102.91 171.88 7.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.737 0.304 . . . . 0.0 110.945 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -114.99 127.99 56.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -69.9 151.31 45.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.72 10.51 76.55 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.453 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.2 mm -124.27 114.55 41.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.856 0.36 . . . . 0.0 111.136 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.77 137.66 37.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.82 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.34 161.9 37.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -107.46 -174.87 2.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -145.82 158.15 43.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -149.05 176.05 10.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.578 HG11 ' CD1' ' A' ' 38' ' ' TRP . 59.9 t -141.95 146.43 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.112 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -136.4 140.82 43.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -100.62 124.23 45.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.47 118.69 31.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.446 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 41.4 p-10 -123.09 -173.95 2.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.613 ' HE3' ' CG ' ' A' ' 46' ' ' PHE . 5.5 ptp -69.01 -0.41 5.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.84 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.59 HD21 ' CD2' ' A' ' 46' ' ' PHE . 23.9 mt -107.62 -24.04 11.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.937 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.427 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 146.64 -168.4 27.99 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.54 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.68 157.43 16.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.878 0.37 . . . . 0.0 110.891 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.423 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 4.1 p -93.56 175.2 6.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.877 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -69.88 160.36 80.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.631 0.729 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 111.7 2.86 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.638 2.225 . . . . 0.0 112.439 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.0 p -53.9 150.36 7.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.825 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.12 140.66 6.51 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.586 0.708 . . . . 0.0 111.101 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.66 94.29 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.724 2.283 . . . . 0.0 112.383 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.43 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 4.4 p -43.26 165.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -59.81 150.93 66.03 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.645 0.736 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.478 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.9 Cg_endo -69.77 135.75 31.22 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.694 2.263 . . . . 0.0 112.329 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.428 ' CB ' HG21 ' A' ' 26' ' ' ILE . 70.4 t80 -124.86 126.64 45.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.969 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.3 t -98.41 104.46 15.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.111 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 t -72.06 107.19 2.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.13 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.863 -179.861 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.511 HD13 ' CE2' ' A' ' 46' ' ' PHE . 5.9 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.734 0.302 . . . . 0.0 110.959 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.581 ' O ' HD12 ' A' ' 99' ' ' LEU . 0.5 OUTLIER -142.31 161.44 50.32 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.637 0.732 . . . . 0.0 110.855 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 170.1 17.48 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.633 2.222 . . . . 0.0 112.322 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.558 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.5 Cg_endo -69.75 156.13 64.15 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.756 2.304 . . . . 0.0 112.308 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.42 ' C ' ' HB2' ' A' ' 102' ' ' SER . 7.2 pt-20 -101.37 171.81 7.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.431 ' HB1' ' HA ' ' A' ' 105' ' ' SER . . . -66.04 121.03 74.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.543 0.687 . . . . 0.0 111.116 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 164.88 32.85 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.67 2.247 . . . . 0.0 112.36 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -49.78 174.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.816 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.429 ' NH1' ' HB3' ' A' ' 23' ' ' ARG . 13.8 ttp-105 -79.95 124.32 83.19 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.594 0.712 . . . . 0.0 110.869 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 145.36 56.97 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.687 2.258 . . . . 0.0 112.341 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.753 ' O ' HD13 ' A' ' 26' ' ' ILE . 6.5 t -97.42 166.86 11.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.161 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.753 HD13 ' O ' ' A' ' 25' ' ' THR . 8.7 mm -124.7 130.46 73.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.133 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 m -132.9 172.78 12.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.899 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 85.0 m -91.37 105.55 17.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.163 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.798 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -108.61 -38.21 5.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.071 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.9 m -162.98 -176.64 5.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.577 ' HG3' HG23 ' A' ' 32' ' ' THR . 12.3 pt-20 -84.67 -16.79 40.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.577 HG23 ' HG3' ' A' ' 31' ' ' GLU . 46.5 p -122.2 0.99 9.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.654 ' CB ' HG22 ' A' ' 81' ' ' THR . 22.2 p -145.08 164.65 30.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.997 0.427 . . . . 0.0 110.848 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.455 HG11 ' CE2' ' A' ' 111' ' ' TYR . 34.8 m -144.08 145.33 21.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.081 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.798 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 25.3 m-85 -78.33 119.28 21.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.936 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.4 t -113.81 131.82 64.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.096 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.44 ' HB ' HG22 ' A' ' 25' ' ' THR . 55.9 m -128.81 123.57 33.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.085 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.643 ' CD1' HG11 ' A' ' 93' ' ' VAL . 24.0 p90 -123.01 169.23 11.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.881 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.1 mm -134.64 108.56 10.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.677 0.751 . . . . 0.0 111.133 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 140.3 42.17 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.697 2.265 . . . . 0.0 112.346 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -107.39 -69.88 0.82 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.29 142.55 15.78 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.496 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -112.44 7.88 19.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 0.0 110.865 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.07 -1.42 86.87 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.55 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.503 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 113.75 -24.69 11.72 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.516 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.606 ' CD2' HD21 ' A' ' 99' ' ' LEU . 2.4 m-85 -108.06 161.9 21.74 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.656 0.741 . . . . 0.0 110.873 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 117.06 4.86 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.663 2.242 . . . . 0.0 112.362 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.682 HD13 ' CZ ' ' A' ' 51' ' ' PHE . 80.6 mt -45.14 135.21 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -91.97 -46.09 8.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.841 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.0 m -163.24 158.22 21.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.991 0.424 . . . . 0.0 110.857 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.682 ' CZ ' HD13 ' A' ' 48' ' ' ILE . 59.5 m-85 -108.67 170.13 8.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.83 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -144.24 120.77 11.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.427 ' HB ' HG22 ' A' ' 68' ' ' THR . 62.9 t -103.67 133.41 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.107 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -130.67 160.99 32.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.913 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.549 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 27.5 p90 -141.93 143.09 33.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.479 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 26.9 ttpt -117.33 133.45 55.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.872 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -79.1 124.54 28.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.921 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.1 mt . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.99 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.479 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 69.0 m95 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.719 0.295 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.477 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.6 mm -123.42 156.12 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.9 tp -89.5 120.96 31.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.931 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.661 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -89.91 -59.33 2.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.427 HG22 ' HB ' ' A' ' 53' ' ' VAL . 6.2 t -147.63 174.55 11.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.164 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.451 ' OG ' ' N ' ' A' ' 70' ' ' ALA . 4.9 t -168.24 177.06 5.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.853 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.451 ' N ' ' OG ' ' A' ' 69' ' ' SER . . . 69.34 25.74 5.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.111 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.676 HG23 ' HD2' ' A' ' 72' ' ' PRO . 76.1 mt -78.18 138.72 60.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.623 0.725 . . . . 0.0 111.191 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.676 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.9 Cg_endo -69.76 157.07 61.65 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.736 2.291 . . . . 0.0 112.345 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -22.9 31.64 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.695 2.263 . . . . 0.0 112.337 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.2 m -82.57 -9.1 59.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.442 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.4 ttt180 -107.54 102.1 11.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.852 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.9 mt -99.89 12.56 36.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.938 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.6 t -153.32 131.68 12.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.838 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.618 HG11 HD13 ' A' ' 71' ' ' ILE . 2.2 m -145.88 162.32 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.556 ' OE1' ' HB1' ' A' ' 29' ' ' ALA . 32.6 tt0 -98.25 111.5 23.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.661 HG23 ' HB1' ' A' ' 67' ' ' ALA . 33.7 mm -81.32 102.08 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.169 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.654 HG22 ' CB ' ' A' ' 33' ' ' SER . 30.2 p -97.71 168.82 10.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.31 40.04 9.43 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.493 HD21 HG22 ' A' ' 80' ' ' ILE . 25.6 mt -101.32 170.87 7.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.687 0.28 . . . . 0.0 110.969 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -112.45 126.49 55.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -68.79 152.05 45.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.835 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.13 12.25 62.63 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 28.6 mm -122.68 101.12 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.871 0.367 . . . . 0.0 111.104 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.36 133.37 49.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -156.55 164.12 38.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.941 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -111.17 178.45 4.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.887 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -135.44 155.06 51.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 5.8 ptp180 -144.6 179.15 7.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.643 HG11 ' CD1' ' A' ' 38' ' ' TRP . 96.7 t -145.4 141.89 22.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.076 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.6 mtt180 -133.28 137.15 45.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.969 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -98.29 130.4 44.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.045 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mp -123.12 119.6 30.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.444 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.5 p-10 -123.56 -174.46 2.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.908 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.8 ptp -67.36 -2.62 6.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.606 HD21 ' CD2' ' A' ' 46' ' ' PHE . 23.5 mt -104.73 -24.94 12.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 146.5 -168.91 27.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.442 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -97.54 158.49 15.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.845 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.42 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 5.5 p -94.02 175.2 6.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.89 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -73.37 159.56 84.55 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.711 0.767 . . . . 0.0 110.894 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.43 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.9 Cg_endo -69.77 109.26 2.27 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.714 2.276 . . . . 0.0 112.394 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.431 ' HA ' ' HB1' ' A' ' 20' ' ' ALA . 93.8 p -52.62 158.14 1.38 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.846 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.55 140.67 46.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.515 0.674 . . . . 0.0 111.132 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 100.72 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.652 2.235 . . . . 0.0 112.378 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.0 p -47.27 170.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -59.38 150.52 64.08 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.595 0.712 . . . . 0.0 110.881 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.87 122.44 9.09 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.716 2.277 . . . . 0.0 112.267 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.623 ' CG ' HG21 ' A' ' 26' ' ' ILE . 56.2 t80 -111.16 116.46 31.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.953 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 94.7 t -92.28 103.48 14.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.213 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.8 t -70.73 107.09 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.097 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.892 -179.85 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.689 HD13 ' CE2' ' A' ' 46' ' ' PHE . 9.7 mt . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.837 0.351 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.585 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.9 m -144.51 161.08 45.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.718 0.771 . . . . 0.0 110.806 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 170.01 17.56 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.628 2.219 . . . . 0.0 112.354 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.554 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.6 Cg_endo -69.86 154.24 67.58 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.664 2.243 . . . . 0.0 112.317 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.418 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.4 pt-20 -97.29 168.35 10.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.71 121.62 65.79 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.662 0.744 . . . . 0.0 111.154 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 160.9 48.0 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.684 2.256 . . . . 0.0 112.396 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -48.46 175.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.0 ttm105 -80.58 123.84 82.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.595 0.712 . . . . 0.0 110.817 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 143.85 52.27 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.674 2.25 . . . . 0.0 112.374 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.898 ' C ' HD13 ' A' ' 26' ' ' ILE . 4.8 t -96.9 167.59 10.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.112 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.898 HD13 ' C ' ' A' ' 25' ' ' THR . 3.1 mm -125.01 131.78 72.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.153 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 m -135.71 167.31 21.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.7 m -85.73 104.26 15.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.103 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.787 ' HB1' ' OE2' ' A' ' 79' ' ' GLU . . . -106.26 -40.71 5.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.056 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 m -162.77 163.96 26.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -67.73 -14.41 62.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.964 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 p -122.67 -1.13 9.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.165 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.67 ' CB ' HG22 ' A' ' 81' ' ' THR . 51.9 p -142.19 172.37 12.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.402 HG22 HD11 ' A' ' 83' ' ' LEU . 30.0 m -148.02 147.91 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.105 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.741 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 11.7 m-85 -83.42 115.09 21.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.934 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.4 t -109.78 129.05 65.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.12 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.478 ' HB ' HG22 ' A' ' 25' ' ' THR . 84.9 m -129.19 123.59 32.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.657 ' CD1' HG11 ' A' ' 93' ' ' VAL . 33.6 p90 -120.98 171.16 8.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.5 mm -134.77 106.14 10.68 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.612 0.72 . . . . 0.0 111.188 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 136.12 32.23 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.661 2.24 . . . . 0.0 112.36 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -102.74 -69.48 0.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.73 146.91 16.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.463 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 46.0 p-10 -113.84 6.34 16.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.92 0.39 . . . . 0.0 110.937 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.62 -1.52 87.73 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.458 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.15 -25.1 10.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.689 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.5 m-85 -109.21 161.86 22.26 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.63 0.729 . . . . 0.0 110.901 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 114.14 3.6 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.666 2.244 . . . . 0.0 112.366 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.529 HD13 ' CE1' ' A' ' 51' ' ' PHE . 94.6 mt -44.59 131.86 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -85.97 -47.97 9.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.7 p -160.54 163.32 32.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.851 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.529 ' CE1' HD13 ' A' ' 48' ' ' ILE . 65.3 m-85 -111.41 176.38 5.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.886 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -149.03 125.83 11.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.845 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 t -109.22 129.71 63.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.094 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.431 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 2.6 mp0 -126.58 154.87 43.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.872 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.53 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 33.5 p90 -135.58 142.64 45.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.987 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.517 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 33.6 ttpt -115.92 129.22 56.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -78.56 121.56 24.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 69.8 mt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.913 179.911 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.567 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 83.8 m95 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.774 0.321 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.406 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.1 mm -120.51 162.03 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.159 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.2 tp -98.65 123.0 42.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.61 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -91.51 -71.69 0.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.018 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.487 ' CG2' HD11 ' A' ' 71' ' ' ILE . 3.7 t -125.11 178.36 5.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.141 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 92.6 p -172.1 176.09 3.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 69.45 26.61 5.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.668 HG23 ' HD2' ' A' ' 72' ' ' PRO . 83.6 mt -78.22 138.51 60.26 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.574 0.702 . . . . 0.0 111.156 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.668 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.4 Cg_endo -69.8 158.28 57.43 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.755 2.303 . . . . 0.0 112.285 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -24.77 29.21 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.686 2.257 . . . . 0.0 112.367 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.8 p -78.95 -19.9 50.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.457 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 6.1 ttt85 -94.42 108.3 20.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.836 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.0 mt -102.7 11.41 37.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.9 t -155.29 136.07 13.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.464 HG11 HD13 ' A' ' 71' ' ' ILE . 2.4 m -146.03 165.92 9.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.091 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.787 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 39.9 tt0 -101.35 110.09 22.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.61 HG23 ' HB1' ' A' ' 67' ' ' ALA . 27.9 mm -80.16 100.16 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.166 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.67 HG22 ' CB ' ' A' ' 33' ' ' SER . 27.6 p -97.41 168.96 10.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.126 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.63 37.47 11.9 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.495 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.537 HD21 HG22 ' A' ' 80' ' ' ILE . 31.5 mt -96.42 177.37 5.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.762 0.315 . . . . 0.0 110.935 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -119.68 119.29 33.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.832 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.63 153.11 28.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.921 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.59 14.15 64.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.493 HG22 ' CD2' ' A' ' 89' ' ' TYR . 29.0 mm -124.57 113.67 37.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.38 . . . . 0.0 111.092 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.3 131.89 36.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.823 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.493 ' CD2' HG22 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -154.36 162.87 40.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.856 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -107.95 -175.13 2.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.855 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -142.92 154.39 44.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.567 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 4.8 ptp180 -146.56 174.21 11.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.895 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.657 HG11 ' CD1' ' A' ' 38' ' ' TRP . 57.8 t -140.99 143.59 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -133.78 139.58 46.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -98.88 128.68 45.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.2 mp -123.08 118.87 28.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.443 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.5 p-10 -123.52 -173.65 2.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.436 ' HE1' ' CD1' ' A' ' 46' ' ' PHE . 5.8 ptp -68.89 -0.52 5.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.852 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.591 HD21 ' CD2' ' A' ' 46' ' ' PHE . 27.7 mt -107.07 -24.74 11.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 147.43 -167.26 28.57 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.494 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.59 158.34 16.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 0.0 110.934 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.441 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 5.1 p -94.32 175.18 6.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -70.89 160.23 82.89 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.603 0.716 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 108.01 1.98 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.725 2.284 . . . . 0.0 112.393 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.9 p -51.7 150.9 3.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.806 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.79 139.7 6.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.58 0.705 . . . . 0.0 111.114 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 99.5 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.684 2.256 . . . . 0.0 112.325 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 95.7 p -44.8 162.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.872 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.3 mtp85 -56.74 153.01 23.72 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.607 0.718 . . . . 0.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.87 129.59 17.74 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.608 2.205 . . . . 0.0 112.305 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -122.14 117.02 25.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 45.0 t -90.66 102.77 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 113' ' ' VAL . 14.0 t -67.84 103.37 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.057 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.829 -179.827 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.54 HD13 ' CE2' ' A' ' 46' ' ' PHE . 6.3 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.809 0.338 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.591 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.9 m -144.32 161.38 44.87 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.664 0.745 . . . . 0.0 110.877 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 169.94 17.77 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.725 2.283 . . . . 0.0 112.356 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.531 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.5 Cg_endo -69.75 155.5 65.82 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.746 2.297 . . . . 0.0 112.36 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.416 ' C ' ' HB2' ' A' ' 102' ' ' SER . 7.0 pt-20 -97.97 170.08 9.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.874 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.69 122.07 78.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.646 0.736 . . . . 0.0 111.037 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.463 ' HG3' HG12 ' A' ' 93' ' ' VAL . 53.5 Cg_endo -69.76 161.8 44.52 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.711 2.274 . . . . 0.0 112.358 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -47.36 174.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.833 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -80.47 122.84 82.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.599 0.714 . . . . 0.0 110.821 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 144.35 53.62 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.679 2.253 . . . . 0.0 112.323 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.806 ' O ' HD13 ' A' ' 26' ' ' ILE . 6.5 t -94.81 167.89 11.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.075 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.806 HD13 ' O ' ' A' ' 25' ' ' THR . 5.8 mm -125.85 123.08 63.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.117 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -128.09 162.89 25.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.829 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m -83.46 98.56 9.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.079 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.683 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -98.4 -37.66 9.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.08 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.7 m -162.43 -179.47 6.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -79.59 -21.6 44.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.838 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.8 p -120.25 3.46 10.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.246 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.535 ' CB ' HG22 ' A' ' 81' ' ' THR . 12.4 p -145.58 165.74 27.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.4 m -144.16 149.9 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.162 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.683 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 12.3 m-85 -84.48 117.49 23.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.919 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 91.1 t -112.61 131.22 64.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.113 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.0 m -129.1 124.69 35.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.205 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.61 ' CD1' HG11 ' A' ' 93' ' ' VAL . 31.4 p90 -124.52 170.81 10.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 mm -134.93 110.23 10.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.582 0.706 . . . . 0.0 111.12 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 145.19 56.18 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.72 2.28 . . . . 0.0 112.316 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -113.66 -69.21 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.81 143.9 15.82 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.481 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 50.8 p-10 -113.33 9.14 18.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.92 0.39 . . . . 0.0 110.88 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.64 0.1 78.75 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.481 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.5 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 112.87 -25.33 11.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.458 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.54 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.3 m-85 -107.94 162.0 21.34 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.656 0.741 . . . . 0.0 110.877 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 117.57 5.16 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.691 2.261 . . . . 0.0 112.365 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.542 HD13 ' CE1' ' A' ' 51' ' ' PHE . 82.0 mt -48.11 133.37 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.135 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -89.33 -52.51 5.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.7 m -155.91 160.44 40.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.806 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.542 ' CE1' HD13 ' A' ' 48' ' ' ILE . 61.4 m-85 -109.77 171.27 7.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.929 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.687 HH21 HD22 ' A' ' 66' ' ' LEU . 23.1 mtp180 -143.63 123.7 13.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.484 HG11 HD11 ' A' ' 80' ' ' ILE . 25.9 t -104.32 117.04 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -115.78 155.35 27.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.533 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 38.9 p90 -133.62 170.28 15.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 29.4 ttpt -142.32 131.66 23.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -80.17 128.91 34.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.866 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.421 HD11 ' HB3' ' A' ' 110' ' ' PRO . 38.0 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.957 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.561 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 75.5 m95 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.757 0.313 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.533 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 1.8 mm -125.74 155.16 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.687 HD22 HH21 ' A' ' 52' ' ' ARG . 57.5 tp -88.26 121.87 31.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.926 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.683 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -84.91 -67.4 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.448 ' CG2' HD11 ' A' ' 71' ' ' ILE . 13.5 t -129.08 -179.64 5.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.508 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 60.3 p -170.35 170.39 7.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 72.01 32.83 1.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.147 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.762 HD13 HG11 ' A' ' 78' ' ' VAL . 58.2 mt -86.05 137.83 35.13 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.646 0.736 . . . . 0.0 111.107 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.628 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.1 Cg_endo -69.74 157.36 60.69 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.727 2.285 . . . . 0.0 112.364 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.61 -24.7 30.06 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.71 2.273 . . . . 0.0 112.369 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 t -79.53 -15.77 57.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.908 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.457 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 13.8 ttt180 -97.87 105.15 17.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.852 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.5 mt -100.75 13.71 34.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.5 t -155.73 137.35 14.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.762 HG11 HD13 ' A' ' 71' ' ' ILE . 2.0 m -150.11 162.12 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.083 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.496 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 36.7 tt0 -98.06 117.07 31.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.683 HG23 ' HB1' ' A' ' 67' ' ' ALA . 31.9 mm -85.9 95.17 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.118 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.535 HG22 ' CB ' ' A' ' 33' ' ' SER . 23.6 p -88.83 171.72 9.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.189 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.29 44.06 14.45 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.437 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.588 HD21 HG22 ' A' ' 80' ' ' ILE . 39.6 mt -104.59 162.18 13.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.794 0.33 . . . . 0.0 110.924 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -106.58 123.7 48.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.407 ' CG ' HG12 ' A' ' 113' ' ' VAL . 14.2 mttt -64.73 159.98 21.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.12 11.88 20.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.48 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.8 mm -121.09 94.12 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 111.091 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.76 135.36 57.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.929 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -159.51 160.35 34.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -107.52 -179.39 3.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.838 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -139.72 156.66 46.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.561 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 3.8 ptp180 -147.69 178.16 8.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.834 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.61 HG11 ' CD1' ' A' ' 38' ' ' TRP . 91.9 t -141.0 140.71 32.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.128 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -132.49 135.57 46.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.831 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -96.56 129.85 43.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.135 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.8 mp -122.5 115.33 22.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.441 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.5 p-10 -119.87 -173.92 2.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 14.4 ptm -67.77 -1.83 6.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.591 HD12 ' O ' ' A' ' 16' ' ' SER . 51.1 mt -105.42 -25.58 12.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.83 -165.99 28.83 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.403 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -99.09 158.07 15.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 0.0 110.901 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.498 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 5.2 p -92.75 175.23 6.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -72.69 158.83 86.69 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.709 0.766 . . . . 0.0 110.835 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.439 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.8 Cg_endo -69.72 103.81 1.21 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.729 2.286 . . . . 0.0 112.332 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.4 p -48.21 152.18 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.892 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.38 140.8 5.27 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.585 0.707 . . . . 0.0 111.116 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 100.43 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.685 2.257 . . . . 0.0 112.333 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 52.0 p -48.45 157.17 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -49.57 151.6 2.82 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.592 0.711 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.421 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.1 Cg_endo -69.82 129.04 16.85 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.649 2.233 . . . . 0.0 112.332 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.484 ' CG ' HG21 ' A' ' 26' ' ' ILE . 52.3 t80 -117.58 122.65 44.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.1 t -98.22 101.29 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.064 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.407 HG12 ' CG ' ' A' ' 85' ' ' LYS . 22.0 t -69.1 107.08 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.097 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.89 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.612 HD22 ' HA3' ' A' ' 45' ' ' GLY . 10.3 mt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.78 0.324 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.651 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -134.42 160.59 67.91 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.704 0.764 . . . . 0.0 110.891 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 170.05 17.53 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.697 2.265 . . . . 0.0 112.341 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.541 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 52.8 Cg_endo -69.81 152.48 69.06 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.648 2.232 . . . . 0.0 112.337 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.43 ' C ' ' HB2' ' A' ' 102' ' ' SER . 7.5 pt-20 -96.12 161.08 14.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.909 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 103' ' ' GLU . . . -58.61 123.93 69.81 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.518 0.675 . . . . 0.0 111.136 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 165.86 29.55 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.666 2.244 . . . . 0.0 112.304 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -53.97 177.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -80.04 123.58 83.42 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.557 0.694 . . . . 0.0 110.886 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 144.27 53.35 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.664 2.243 . . . . 0.0 112.34 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.88 ' O ' HD13 ' A' ' 26' ' ' ILE . 14.8 t -94.18 165.7 12.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.174 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.88 HD13 ' O ' ' A' ' 25' ' ' THR . 4.2 mm -129.98 121.62 52.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.148 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 m -122.93 -175.99 3.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.3 m -99.85 97.57 8.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.165 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.904 ' HB1' ' OE1' ' A' ' 79' ' ' GLU . . . -98.18 -42.72 7.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.098 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 t -157.43 -175.98 5.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.829 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -81.77 -21.33 37.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 36.0 p -120.61 -0.72 10.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.154 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.533 ' HB3' HG22 ' A' ' 81' ' ' THR . 99.4 p -135.29 173.33 11.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.808 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.3 m -154.83 142.89 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.185 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.586 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 18.6 m-85 -76.95 120.64 22.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.943 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.0 t -116.13 125.56 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.086 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.7 m -126.09 121.62 33.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.152 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.744 ' CD1' HG11 ' A' ' 93' ' ' VAL . 25.3 p90 -119.06 171.09 8.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.8 mm -134.04 107.28 11.46 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.6 0.714 . . . . 0.0 111.193 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 130.88 20.09 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -94.16 -67.76 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.26 161.79 12.82 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.532 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -125.66 4.67 7.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.884 0.373 . . . . 0.0 110.895 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 81.72 2.29 90.48 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.433 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.612 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 109.44 -25.54 17.39 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.42 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.495 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 2.5 m-85 -108.36 162.05 21.31 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.63 0.728 . . . . 0.0 110.891 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.8 116.18 4.44 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.711 2.274 . . . . 0.0 112.303 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.517 HD13 ' CE1' ' A' ' 51' ' ' PHE . 96.4 mt -46.59 135.76 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -90.0 -49.12 6.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 m -161.58 160.1 28.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.863 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.517 ' CE1' HD13 ' A' ' 48' ' ' ILE . 64.4 m-85 -108.0 175.97 5.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -149.22 128.08 12.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.43 HG11 HD11 ' A' ' 80' ' ' ILE . 60.2 t -110.35 130.22 64.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.102 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.475 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 21.4 mt-10 -125.56 157.86 36.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.854 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.504 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 26.9 p90 -139.81 145.4 38.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.988 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.404 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 31.8 ttpt -120.94 134.33 55.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.822 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.4 mttt -82.65 128.54 34.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.917 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.46 HD11 ' HB3' ' A' ' 110' ' ' PRO . 58.5 mt . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.884 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.404 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 78.3 m95 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.767 0.318 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.456 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.7 mm -115.03 162.75 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.109 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.1 tp -98.91 118.06 34.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.643 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -83.35 -68.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.095 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.564 HG21 HD11 ' A' ' 71' ' ' ILE . 7.7 t -128.51 175.79 8.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.15 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.552 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 90.0 p -168.14 167.34 12.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.795 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.552 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 74.39 25.98 1.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.058 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.684 HD13 HG11 ' A' ' 78' ' ' VAL . 52.3 mt -76.9 136.98 66.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.667 0.746 . . . . 0.0 111.139 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.603 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.9 Cg_endo -69.74 156.67 62.81 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.69 2.26 . . . . 0.0 112.358 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.71 -18.54 37.17 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.701 2.267 . . . . 0.0 112.446 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 86.5 p -86.58 -13.05 46.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.461 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 8.6 ttt85 -101.67 98.96 9.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 51.9 mt -96.74 11.62 34.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.836 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 t -153.39 131.72 12.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.684 HG11 HD13 ' A' ' 71' ' ' ILE . 2.2 m -145.7 163.91 11.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.109 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.904 ' OE1' ' HB1' ' A' ' 29' ' ' ALA . 33.5 tt0 -100.47 108.83 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.643 HG23 ' HB1' ' A' ' 67' ' ' ALA . 26.7 mm -75.82 107.39 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.193 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.533 HG22 ' HB3' ' A' ' 33' ' ' SER . 72.0 p -102.89 165.85 10.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.167 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.66 41.11 7.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.464 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.6 mt -99.16 -178.91 4.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.757 0.313 . . . . 0.0 110.9 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -125.05 122.33 36.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -63.83 161.04 16.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.9 12.0 9.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.417 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 26.9 mm -122.23 108.26 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 0.0 111.24 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.26 136.54 42.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.417 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -157.54 168.59 26.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -114.09 -175.45 2.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.904 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -143.85 158.4 43.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.817 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.475 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 2.7 ptp180 -150.45 175.16 12.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.744 HG11 ' CD1' ' A' ' 38' ' ' TRP . 90.8 t -143.18 135.56 24.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.085 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -126.49 144.32 50.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.541 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -104.85 129.52 53.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.155 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mp -123.41 117.32 24.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.867 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.439 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 37.9 p-10 -119.81 -172.61 2.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 12.6 ptm -69.48 1.45 3.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.809 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 16' ' ' SER . 34.3 mt -108.81 -26.59 10.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.908 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.54 -163.09 29.51 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.532 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -104.59 158.14 16.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 110.861 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.43 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 7.5 p -95.39 175.06 6.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.825 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 30.1 mt-10 -70.76 157.01 91.18 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.575 0.703 . . . . 0.0 110.943 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.434 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.7 Cg_endo -69.73 105.2 1.44 Allowed 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.683 2.255 . . . . 0.0 112.294 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.0 p -45.94 150.52 0.55 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -44.0 141.44 2.4 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.556 0.694 . . . . 0.0 111.148 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 97.66 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.684 2.256 . . . . 0.0 112.36 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 t -43.53 154.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.84 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -51.43 153.71 3.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.617 0.722 . . . . 0.0 110.829 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.46 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.5 Cg_endo -69.77 121.92 8.6 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.722 2.281 . . . . 0.0 112.306 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -112.79 120.19 40.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.31 104.96 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.196 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.3 t -73.65 106.45 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.4 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.816 -179.821 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.763 HD13 ' CE2' ' A' ' 46' ' ' PHE . 13.3 mt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.826 0.346 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.654 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.8 m -145.11 161.21 43.25 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.58 0.705 . . . . 0.0 110.892 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 170.14 17.27 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.641 2.227 . . . . 0.0 112.377 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.495 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 54.3 Cg_endo -69.73 156.63 62.92 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.664 2.242 . . . . 0.0 112.331 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.426 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.4 pt-20 -98.11 174.53 6.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.2 123.44 87.38 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.597 0.713 . . . . 0.0 111.082 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 161.33 46.33 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.665 2.243 . . . . 0.0 112.376 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -49.39 174.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -80.43 122.16 82.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.602 0.715 . . . . 0.0 110.908 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HB2' HG13 ' A' ' 36' ' ' VAL . 53.9 Cg_endo -69.69 143.15 50.25 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.666 2.244 . . . . 0.0 112.402 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.917 ' C ' HD13 ' A' ' 26' ' ' ILE . 5.4 t -95.27 165.98 12.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.106 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.917 HD13 ' C ' ' A' ' 25' ' ' THR . 2.8 mm -126.81 125.34 66.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.184 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.6 t -131.44 166.99 20.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.4 m -80.88 107.27 13.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.732 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -111.13 -36.31 5.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 m -164.87 -179.71 5.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -82.99 -19.5 36.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.832 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.8 p -120.33 -1.9 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.715 ' CB ' HG22 ' A' ' 81' ' ' THR . 24.2 p -140.4 171.25 14.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.9 m -149.65 147.43 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.163 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.732 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 15.1 m-85 -82.78 120.49 25.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.407 HG13 ' HB2' ' A' ' 24' ' ' PRO . 92.3 t -115.71 131.46 68.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.105 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.9 m -128.36 120.59 27.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.152 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.568 ' CD1' HG11 ' A' ' 93' ' ' VAL . 28.6 p90 -120.13 170.27 9.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.1 mm -134.3 110.5 11.63 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.59 0.709 . . . . 0.0 111.137 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.453 ' HD3' HD22 ' A' ' 76' ' ' LEU . 53.9 Cg_endo -69.79 137.99 36.66 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.727 2.285 . . . . 0.0 112.312 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -103.58 -69.68 0.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.849 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.48 158.85 14.81 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.509 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -124.25 5.57 8.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.833 0.349 . . . . 0.0 110.815 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.11 0.69 89.27 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.519 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.411 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 108.58 -18.1 32.76 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.548 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.763 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.1 m-85 -114.68 162.24 24.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.617 0.723 . . . . 0.0 110.922 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 114.61 3.75 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.711 2.274 . . . . 0.0 112.33 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.537 HD13 ' CE1' ' A' ' 51' ' ' PHE . 95.8 mt -46.46 141.2 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.36 -52.11 4.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.7 p -159.69 160.61 34.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.537 ' CE1' HD13 ' A' ' 48' ' ' ILE . 52.4 m-85 -108.83 168.32 9.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.928 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.4 mtt-85 -143.39 136.77 28.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.429 ' HB ' HG22 ' A' ' 68' ' ' THR . 58.8 t -116.63 134.8 58.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -133.63 158.84 42.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.545 ' CD2' ' HB2' ' A' ' 67' ' ' ALA . 26.4 p90 -136.82 175.02 10.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.944 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.466 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 36.9 ttpt -147.69 135.62 21.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.944 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -82.34 129.63 34.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 110' ' ' PRO . 28.8 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.907 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.466 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 78.0 m95 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.73 0.3 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.508 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.9 mm -115.14 159.42 15.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.14 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 tp -91.5 122.52 34.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.762 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -91.41 -71.33 0.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.081 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.464 ' CG2' HD11 ' A' ' 71' ' ' ILE . 1.3 t -130.29 165.08 23.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.151 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.9 m -162.85 -175.34 4.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 64.25 29.77 13.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.055 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.594 HG23 ' HD2' ' A' ' 72' ' ' PRO . 61.3 mt -83.37 137.42 42.24 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.641 0.734 . . . . 0.0 111.176 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.594 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.9 Cg_endo -69.7 158.19 57.9 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.633 2.222 . . . . 0.0 112.379 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.72 -11.41 30.82 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.661 2.24 . . . . 0.0 112.323 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.0 t -92.52 -18.16 23.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.854 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.427 ' NE ' HG12 ' A' ' 78' ' ' VAL . 17.0 ttt180 -98.57 103.65 15.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.822 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.453 HD22 ' HD3' ' A' ' 40' ' ' PRO . 46.9 mt -99.46 7.62 45.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.974 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 t -149.45 132.85 16.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.809 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.467 HG11 HD13 ' A' ' 71' ' ' ILE . 2.0 m -148.35 165.17 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.131 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.422 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 28.8 tt0 -99.47 116.03 30.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.762 HG23 ' HB1' ' A' ' 67' ' ' ALA . 45.9 mm -83.3 101.21 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.117 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.715 HG22 ' CB ' ' A' ' 33' ' ' SER . 27.4 p -99.67 168.63 9.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.162 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.09 34.34 9.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.2 mt -102.43 179.5 4.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.769 0.319 . . . . 0.0 110.949 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -124.22 135.57 53.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -71.63 157.3 38.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.35 12.84 59.3 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.457 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.406 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 25.8 mm -124.09 113.9 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 111.147 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.87 139.8 35.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.825 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.406 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -160.76 170.46 20.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.944 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -114.49 -176.14 2.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.843 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -144.43 154.23 42.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.453 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 5.3 ptp180 -146.91 179.86 7.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.568 HG11 ' CD1' ' A' ' 38' ' ' TRP . 74.6 t -145.1 143.58 22.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.115 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -132.77 146.02 51.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -107.39 130.22 54.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.086 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.424 ' HG ' ' CB ' ' A' ' 101' ' ' GLU . 4.3 mp -123.87 120.77 33.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.934 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.438 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 37.0 p-10 -123.74 -172.64 2.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.3 ptm -68.98 0.78 4.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.797 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 16' ' ' SER . 51.2 mt -108.6 -26.38 10.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.935 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.56 -167.5 29.18 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.485 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.424 ' CB ' ' HG ' ' A' ' 96' ' ' LEU . 0.6 OUTLIER -100.54 158.39 15.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 110.866 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.426 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 14.0 p -94.81 175.22 6.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.816 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -71.41 160.68 81.83 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.621 0.724 . . . . 0.0 110.897 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.411 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.9 Cg_endo -69.8 107.69 1.92 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.741 2.294 . . . . 0.0 112.286 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.8 p -47.95 158.88 0.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.35 138.61 48.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.587 0.708 . . . . 0.0 111.128 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 96.89 0.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.73 2.287 . . . . 0.0 112.38 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.5 p -47.21 160.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.841 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -52.42 150.94 8.1 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.607 0.718 . . . . 0.0 110.854 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.465 ' HB3' HD11 ' A' ' 58' ' ' LEU . 54.4 Cg_endo -69.61 129.21 17.36 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.724 2.283 . . . . 0.0 112.392 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -117.53 120.23 37.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.926 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.0 t -92.94 107.42 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.142 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.0 t -73.25 104.56 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.823 -179.837 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.618 HD13 ' CE2' ' A' ' 46' ' ' PHE . 9.0 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.832 0.349 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.65 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.4 m -139.76 161.87 53.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.682 0.753 . . . . 0.0 110.832 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.74 170.09 17.37 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.674 2.249 . . . . 0.0 112.343 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.468 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 54.6 Cg_endo -69.69 155.48 66.07 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.74 2.293 . . . . 0.0 112.375 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.423 ' C ' ' HB2' ' A' ' 102' ' ' SER . 5.0 pt-20 -98.06 175.29 6.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.94 121.12 80.43 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.611 0.72 . . . . 0.0 111.153 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 162.14 43.23 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.711 2.274 . . . . 0.0 112.325 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -50.42 174.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.824 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -80.15 123.63 83.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.583 0.706 . . . . 0.0 110.851 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 144.04 52.78 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.713 2.276 . . . . 0.0 112.369 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.871 ' O ' HD13 ' A' ' 26' ' ' ILE . 4.3 t -94.4 166.17 12.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.203 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 25' ' ' THR . 7.9 mm -128.21 121.42 55.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.129 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -121.17 -177.72 3.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.887 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.3 m -98.68 99.74 10.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.772 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -100.79 -41.1 7.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.016 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.6 m -163.16 -178.75 6.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.834 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.432 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 3.8 pm0 -84.91 -15.04 45.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.852 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.6 p -117.94 -7.1 10.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.179 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.766 ' CB ' HG22 ' A' ' 81' ' ' THR . 36.7 p -143.56 171.9 13.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 m -147.64 150.94 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.137 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.772 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 18.3 m-85 -84.89 119.81 25.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.3 t -113.91 130.61 67.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.167 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 42.0 m -128.28 124.07 35.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.592 ' CD1' HG11 ' A' ' 93' ' ' VAL . 27.4 p90 -121.3 168.39 11.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.1 mm -132.09 108.13 13.82 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.631 0.729 . . . . 0.0 111.153 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 142.92 49.13 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.711 2.274 . . . . 0.0 112.309 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -111.98 -66.86 1.04 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.6 144.52 16.32 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.496 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -115.12 10.0 16.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.965 0.412 . . . . 0.0 110.963 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 78.73 -0.59 76.65 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.467 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.53 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 110.37 -22.88 21.77 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.487 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.62 ' CD2' HD21 ' A' ' 99' ' ' LEU . 2.3 m-85 -109.89 162.03 21.97 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.574 0.702 . . . . 0.0 110.944 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 113.0 3.22 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.655 2.237 . . . . 0.0 112.428 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.518 HD13 ' CE1' ' A' ' 51' ' ' PHE . 80.6 mt -47.07 134.75 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -83.62 -49.96 8.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.952 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 m -162.9 162.7 26.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.809 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.518 ' CE1' HD13 ' A' ' 48' ' ' ILE . 65.5 m-85 -108.42 169.72 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.831 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -145.15 130.25 18.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 92' ' ' ARG . 61.7 t -108.83 136.78 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.417 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 4.0 mp0 -127.59 156.34 42.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.825 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.621 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 12.8 p90 -141.08 147.33 38.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.855 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -129.72 140.65 51.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.971 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.7 mtmm -83.79 129.84 34.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.441 HD11 ' HB3' ' A' ' 110' ' ' PRO . 77.5 mt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.922 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.453 ' O ' HD13 ' A' ' 65' ' ' ILE . 60.8 m95 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.698 0.285 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 64' ' ' TRP . 2.1 mm -129.76 157.97 42.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.183 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 53' ' ' VAL . 1.7 tp -85.43 111.59 20.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.621 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . . . -74.0 -61.64 1.78 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.111 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.421 HG23 HD11 ' A' ' 71' ' ' ILE . 5.3 t -150.88 161.09 43.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.191 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 15.7 m -152.5 -179.59 7.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.854 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 71.67 25.25 3.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.07 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.638 HD13 HG11 ' A' ' 78' ' ' VAL . 71.4 mt -81.5 137.99 48.03 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.594 0.711 . . . . 0.0 111.103 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.638 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.7 Cg_endo -69.79 156.17 63.95 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.616 2.211 . . . . 0.0 112.285 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -12.72 33.44 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.698 2.266 . . . . 0.0 112.375 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.3 t -92.43 -17.32 24.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.806 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.474 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 7.2 ttt85 -96.44 97.54 9.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.2 mt -94.06 13.59 22.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.91 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -154.17 130.95 10.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.8 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.638 HG11 HD13 ' A' ' 71' ' ' ILE . 2.6 m -145.4 160.34 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.114 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.426 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 24.2 tt0 -96.8 115.82 28.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.925 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.601 HG23 ' HB1' ' A' ' 67' ' ' ALA . 22.2 mm -83.63 105.35 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.766 HG22 ' CB ' ' A' ' 33' ' ' SER . 64.2 p -102.56 171.43 7.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.166 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.09 38.38 11.31 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.5 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.5 mt -105.33 176.37 5.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.81 0.338 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -120.19 136.09 54.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.85 150.5 42.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.96 10.66 68.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.46 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.49 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 28.0 mm -121.41 103.88 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.369 . . . . 0.0 111.105 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.02 141.81 52.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.49 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -163.22 163.02 25.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -111.89 169.59 8.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.811 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -129.71 153.89 47.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.429 ' O ' HG13 ' A' ' 53' ' ' VAL . 5.3 ptp180 -143.82 -178.94 6.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.592 HG11 ' CD1' ' A' ' 38' ' ' TRP . 86.4 t -145.13 144.55 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.093 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -134.87 139.13 44.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.822 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -99.69 132.77 44.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.096 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.4 mp -126.35 119.59 27.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.928 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.448 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 38.5 p-10 -123.61 -173.95 2.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.3 ptp -68.87 -0.63 5.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.798 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.65 HD12 ' O ' ' A' ' 16' ' ' SER . 22.4 mt -106.62 -25.66 11.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.972 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 148.26 -165.98 29.02 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -102.01 158.03 16.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.423 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 5.2 p -94.33 175.04 6.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.801 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -71.22 160.39 82.66 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.606 0.717 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 110.33 2.53 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.683 2.255 . . . . 0.0 112.354 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.0 p -53.34 152.14 4.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.43 139.44 8.06 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.599 0.714 . . . . 0.0 111.073 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 100.41 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.66 2.24 . . . . 0.0 112.352 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.3 p -46.1 163.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.85 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -56.83 152.4 27.5 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.529 0.68 . . . . 0.0 110.939 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.441 ' HB3' HD11 ' A' ' 58' ' ' LEU . 54.2 Cg_endo -69.77 123.2 9.87 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.64 2.227 . . . . 0.0 112.395 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.411 ' CB ' HG21 ' A' ' 26' ' ' ILE . 48.5 t80 -112.89 117.21 31.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.8 t -91.76 101.79 12.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.175 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.9 t -67.99 110.55 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 -179.888 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.565 HD13 ' CE2' ' A' ' 46' ' ' PHE . 15.9 mt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.877 0.37 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.601 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.5 p -141.65 160.17 57.42 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.72 0.772 . . . . 0.0 110.819 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 169.83 17.96 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.691 2.261 . . . . 0.0 112.347 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.561 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.0 Cg_endo -69.84 152.72 68.99 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.664 2.243 . . . . 0.0 112.256 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.421 ' C ' ' HB2' ' A' ' 102' ' ' SER . 4.2 pt-20 -94.68 172.46 8.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.01 121.72 79.36 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.544 0.688 . . . . 0.0 111.109 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 161.96 43.93 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.625 2.217 . . . . 0.0 112.337 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -51.27 174.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.832 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -79.99 123.08 83.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.542 0.687 . . . . 0.0 110.849 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 143.51 51.21 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.677 2.252 . . . . 0.0 112.352 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.71 ' O ' HD13 ' A' ' 26' ' ' ILE . 4.8 t -93.38 164.42 13.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.184 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 25' ' ' THR . 12.4 mm -128.07 120.76 54.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.051 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -123.28 -178.76 4.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.858 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.2 m -97.05 98.97 10.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.636 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -100.41 -33.84 10.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.146 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.43 -175.02 3.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -83.49 -20.03 34.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.962 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.7 p -122.92 -0.58 8.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.179 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.652 ' CB ' HG22 ' A' ' 81' ' ' THR . 3.8 p -139.27 163.89 31.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.82 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.72 144.82 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.152 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.636 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 16.8 m-85 -77.8 116.66 18.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.904 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.9 t -108.98 130.72 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.127 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.766 HG23 ' HB2' ' A' ' 77' ' ' SER . 8.8 m -129.16 121.9 28.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.129 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.575 ' CD1' HG11 ' A' ' 93' ' ' VAL . 35.3 p90 -121.63 170.95 9.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.519 HD13 ' O ' ' A' ' 38' ' ' TRP . 18.7 mm -135.76 106.0 9.82 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.631 0.729 . . . . 0.0 111.17 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.411 ' CD ' HD22 ' A' ' 76' ' ' LEU . 53.7 Cg_endo -69.68 129.87 18.44 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.712 2.274 . . . . 0.0 112.347 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -93.0 -70.41 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.49 151.37 16.92 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.445 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 42.4 p-10 -118.03 10.7 13.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 0.0 110.9 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.57 -4.25 60.79 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.436 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.402 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 113.96 -18.05 19.43 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.483 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.565 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.1 m-85 -114.3 162.03 25.33 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.674 0.75 . . . . 0.0 110.873 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 114.8 3.81 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.668 2.245 . . . . 0.0 112.36 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.49 HD13 ' CE1' ' A' ' 51' ' ' PHE . 89.4 mt -45.6 130.37 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -84.99 -46.18 11.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.6 p -162.19 162.53 28.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.757 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.49 ' CE1' HD13 ' A' ' 48' ' ' ILE . 50.1 m-85 -108.89 172.7 6.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.499 ' CZ ' HD21 ' A' ' 96' ' ' LEU . 55.9 mtt180 -145.04 121.29 10.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.977 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.3 t -105.62 128.21 59.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.135 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.422 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 13.9 mt-10 -128.89 152.54 48.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.823 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.54 ' CD2' ' HB2' ' A' ' 67' ' ' ALA . 36.7 p90 -133.34 173.84 11.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.917 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -149.14 137.35 20.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.94 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -83.53 125.91 32.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.966 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 77.8 mt . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.912 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 82.9 m95 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.77 0.319 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.515 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 2.6 mm -120.47 158.93 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.8 tp -93.31 121.93 35.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.712 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -90.19 -69.0 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.096 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.497 ' CG2' HD11 ' A' ' 71' ' ' ILE . 1.4 t -126.49 178.57 5.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.115 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 59.9 p -173.86 178.35 2.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.835 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 67.98 30.67 5.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.079 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.629 HG23 ' HD2' ' A' ' 72' ' ' PRO . 72.2 mt -84.56 137.73 38.72 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.591 0.71 . . . . 0.0 111.151 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.629 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.8 Cg_endo -69.76 159.56 52.95 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.739 2.293 . . . . 0.0 112.321 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 -17.67 37.51 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.71 2.274 . . . . 0.0 112.325 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.4 m -86.48 -23.19 26.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.431 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 15.0 ttt180 -90.01 100.99 13.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.813 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.411 HD22 ' CD ' ' A' ' 40' ' ' PRO . 52.6 mt -95.95 9.58 40.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.839 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.766 ' HB2' HG23 ' A' ' 37' ' ' THR . 11.6 t -153.79 136.6 15.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.563 HG11 HD13 ' A' ' 71' ' ' ILE . 1.9 m -147.31 163.81 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.135 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.561 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 35.0 tt0 -100.4 111.59 23.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.833 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.712 HG23 ' HB1' ' A' ' 67' ' ' ALA . 26.3 mm -80.86 102.94 7.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.102 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.652 HG22 ' CB ' ' A' ' 33' ' ' SER . 77.2 p -97.25 165.35 12.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.059 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.78 37.46 8.58 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.436 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 88.1 mt -97.62 -179.68 4.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.792 0.329 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -126.71 125.25 41.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -65.11 163.06 15.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.64 17.94 22.08 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.536 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.501 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 28.1 mm -129.37 105.05 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 111.114 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.89 141.82 49.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.501 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -162.75 164.53 26.25 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.944 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -111.08 -175.6 2.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.93 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -146.64 161.46 40.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.84 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.439 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 3.5 ptp180 -151.95 173.41 14.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.884 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.575 HG11 ' CD1' ' A' ' 38' ' ' TRP . 71.6 t -140.02 136.4 38.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.125 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -127.05 138.21 53.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.863 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -97.95 126.35 43.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.067 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.499 HD21 ' CZ ' ' A' ' 52' ' ' ARG . 7.0 mp -120.53 118.41 30.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.437 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.7 p-10 -123.39 -173.72 2.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.1 ptm -68.07 -1.48 5.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 16' ' ' SER . 44.5 mt -105.65 -25.78 12.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.988 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.99 -166.04 28.9 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.511 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.4 156.39 17.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.858 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.421 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 5.5 p -93.39 175.11 6.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.895 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -70.27 157.89 88.86 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.634 0.731 . . . . 0.0 110.856 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.439 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.5 Cg_endo -69.74 102.95 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.66 2.24 . . . . 0.0 112.324 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.9 p -43.93 153.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.81 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.71 141.65 17.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.586 0.707 . . . . 0.0 111.076 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 98.05 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.687 2.258 . . . . 0.0 112.373 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.0 p -45.8 151.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.817 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.2 mmm-85 -45.57 156.18 0.43 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.593 0.711 . . . . 0.0 110.823 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 131.45 21.15 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.638 2.226 . . . . 0.0 112.28 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.579 ' CG ' HG21 ' A' ' 26' ' ' ILE . 39.7 t80 -121.04 113.28 19.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.9 t -91.13 102.81 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.146 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.9 t -69.09 105.7 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.164 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.6 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 -179.894 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.668 ' CD1' ' CE2' ' A' ' 46' ' ' PHE . 9.1 mt . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.884 0.373 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.694 ' O ' HD12 ' A' ' 99' ' ' LEU . 0.9 OUTLIER -134.84 159.63 71.42 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.716 0.769 . . . . 0.0 110.835 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 170.22 17.03 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.727 2.285 . . . . 0.0 112.323 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.51 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.5 Cg_endo -69.83 154.56 67.31 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.612 2.208 . . . . 0.0 112.341 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.416 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.1 pt-20 -95.7 174.11 7.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.868 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.65 122.04 84.46 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.645 0.736 . . . . 0.0 111.071 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 160.79 48.38 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.644 2.229 . . . . 0.0 112.343 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -49.51 174.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -80.03 123.51 83.48 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.702 0.763 . . . . 0.0 110.83 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.427 ' HB2' HG13 ' A' ' 36' ' ' VAL . 53.8 Cg_endo -69.81 144.27 53.23 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.629 2.219 . . . . 0.0 112.319 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.727 ' O ' HD13 ' A' ' 26' ' ' ILE . 13.4 t -93.87 166.41 12.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.109 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.727 HD13 ' O ' ' A' ' 25' ' ' THR . 8.1 mm -126.01 125.83 68.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -125.79 179.23 5.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.5 m -98.23 98.68 9.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.116 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.684 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -102.48 -40.02 6.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.072 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.2 m -165.2 168.99 16.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.819 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -74.29 -14.03 60.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.2 p -118.24 -3.28 11.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.123 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.845 ' CB ' HG22 ' A' ' 81' ' ' THR . 6.5 p -146.45 177.46 9.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.8 m -154.56 149.19 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.178 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.684 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 17.1 m-85 -82.44 118.16 23.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' A' ' 24' ' ' PRO . 91.7 t -113.4 130.84 66.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.069 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.417 ' HB ' HG22 ' A' ' 25' ' ' THR . 62.7 m -128.88 120.34 26.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.197 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.564 ' CD1' HG11 ' A' ' 93' ' ' VAL . 26.3 p90 -118.76 170.92 8.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mm -134.93 108.56 10.65 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.615 0.722 . . . . 0.0 111.102 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 140.23 42.38 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.704 2.269 . . . . 0.0 112.363 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -109.43 -69.14 0.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.85 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.23 147.6 16.31 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.528 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 51.9 p-10 -117.82 5.79 12.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.804 0.335 . . . . 0.0 110.84 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 81.89 4.36 90.32 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.485 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.446 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 105.38 -16.78 44.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.487 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.668 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 1.9 m-85 -115.44 162.24 25.82 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.654 0.74 . . . . 0.0 110.869 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.64 118.24 5.56 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.7 2.266 . . . . 0.0 112.399 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.569 HD13 ' CE1' ' A' ' 51' ' ' PHE . 91.7 mt -49.26 131.88 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.172 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -85.77 -49.27 8.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.954 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.1 m -161.51 161.29 29.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.841 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.569 ' CE1' HD13 ' A' ' 48' ' ' ILE . 60.9 m-85 -109.91 171.26 7.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -146.19 134.3 21.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.863 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.2 135.02 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.155 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.474 ' N ' ' OE1' ' A' ' 54' ' ' GLU . 26.4 mp0 -136.25 146.01 46.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.547 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 26.3 p90 -124.43 179.27 4.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.462 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 22.4 ttpp -149.4 136.41 19.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -84.23 119.87 25.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.3 mt . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 179.948 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.462 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 84.0 m95 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.684 0.278 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.547 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 5.2 mm -115.02 159.62 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.151 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.4 tp -93.37 125.32 37.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.749 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -94.16 -69.84 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.126 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.2 t -131.63 173.19 11.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.146 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.452 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 6.3 t -169.45 176.74 4.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.801 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 69.68 28.65 4.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.106 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.637 HG23 ' HD2' ' A' ' 72' ' ' PRO . 73.6 mt -80.26 137.88 52.47 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.65 0.738 . . . . 0.0 111.155 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.637 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.2 Cg_endo -69.64 158.06 58.42 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.757 2.305 . . . . 0.0 112.378 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -21.89 33.05 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.686 2.258 . . . . 0.0 112.324 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.6 m -82.01 -14.99 55.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -101.84 107.59 18.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.857 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.7 mt -103.86 11.47 35.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -153.2 132.48 12.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.776 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.511 HG11 HD13 ' A' ' 71' ' ' ILE . 2.4 m -145.9 165.63 9.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.098 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.455 ' OE1' ' HB1' ' A' ' 29' ' ' ALA . 33.1 tt0 -102.55 109.32 20.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.808 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.749 HG23 ' HB1' ' A' ' 67' ' ' ALA . 16.1 mm -79.04 103.32 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.15 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.845 HG22 ' CB ' ' A' ' 33' ' ' SER . 29.7 p -102.84 167.95 9.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.085 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.75 36.69 7.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.462 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.8 mt -103.65 -178.85 3.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 110.93 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -118.55 126.84 52.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -67.66 153.74 43.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.43 11.96 62.89 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.458 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.457 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 23.2 mm -124.47 112.66 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.804 0.335 . . . . 0.0 111.194 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.23 141.56 45.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.851 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.457 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -161.66 162.78 30.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.947 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -107.54 -175.82 2.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -145.83 151.43 37.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 1.9 ptp180 -144.12 176.73 9.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.564 HG11 ' CD1' ' A' ' 38' ' ' TRP . 86.8 t -142.87 139.78 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.13 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 -129.57 139.97 51.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -101.23 128.87 47.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.3 mp -122.21 120.0 32.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.443 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 38.1 p-10 -123.55 -173.1 2.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.7 ptm -68.72 0.65 3.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.694 HD12 ' O ' ' A' ' 16' ' ' SER . 38.7 mt -108.37 -26.2 10.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.62 -167.38 29.22 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.525 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.36 158.27 15.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 110.879 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.444 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 5.2 p -93.81 175.29 6.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -71.6 158.14 88.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.638 0.732 . . . . 0.0 110.93 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.43 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 52.9 Cg_endo -69.77 102.86 1.08 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.687 2.258 . . . . 0.0 112.276 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.3 p -46.32 154.57 0.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.855 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.04 143.39 4.61 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.5 0.667 . . . . 0.0 111.149 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 92.98 0.52 Allowed 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.726 2.284 . . . . 0.0 112.344 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.0 t -40.67 146.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -44.62 150.22 0.71 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.654 0.74 . . . . 0.0 110.845 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 124.31 10.95 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.661 2.241 . . . . 0.0 112.357 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.556 ' CB ' HG21 ' A' ' 26' ' ' ILE . 65.4 t80 -115.25 120.7 40.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.5 t -93.64 107.18 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.139 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.8 t -72.6 102.63 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.14 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.8 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.904 -179.861 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.551 ' CD1' ' CE2' ' A' ' 46' ' ' PHE . 13.7 mt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.79 0.328 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.648 ' O ' HD12 ' A' ' 99' ' ' LEU . 3.1 m -137.78 160.08 66.23 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.699 0.762 . . . . 0.0 110.874 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 170.09 17.5 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.678 2.252 . . . . 0.0 112.302 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.464 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.6 Cg_endo -69.72 155.75 65.25 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.694 2.263 . . . . 0.0 112.337 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.426 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.6 pt-20 -99.12 168.83 9.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.92 123.01 82.52 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.534 0.683 . . . . 0.0 111.117 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 165.1 32.15 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.72 2.28 . . . . 0.0 112.266 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -52.44 175.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -79.99 122.83 83.61 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.622 0.725 . . . . 0.0 110.912 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 143.3 50.46 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.707 2.272 . . . . 0.0 112.375 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.782 ' C ' HD13 ' A' ' 26' ' ' ILE . 6.8 t -94.24 165.25 12.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.133 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.782 HD13 ' C ' ' A' ' 25' ' ' THR . 3.9 mm -125.92 125.61 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.159 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 m -127.7 178.18 6.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.6 m -95.48 101.01 12.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.138 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.645 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -102.1 -41.4 6.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.08 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.02 -175.0 5.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -85.0 -16.75 39.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.7 p -123.27 2.04 9.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.112 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.617 ' CB ' HG22 ' A' ' 81' ' ' THR . 18.7 p -144.7 168.0 21.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.832 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.9 m -147.07 145.81 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.645 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 19.7 m-85 -77.85 117.71 19.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.859 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.1 t -111.97 129.7 66.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.095 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.428 ' HB ' HG22 ' A' ' 25' ' ' THR . 87.6 m -128.74 123.51 33.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.187 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.589 ' CD1' HG11 ' A' ' 93' ' ' VAL . 25.5 p90 -122.43 169.66 10.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.899 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.423 HD13 ' O ' ' A' ' 38' ' ' TRP . 21.0 mm -133.29 107.35 12.24 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.668 0.747 . . . . 0.0 111.191 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 135.5 30.62 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.726 2.284 . . . . 0.0 112.332 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -100.32 -70.44 0.74 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.5 159.89 14.72 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.516 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -125.1 4.72 7.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.878 0.37 . . . . 0.0 110.85 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.55 0.56 90.07 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.549 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.541 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 110.32 -24.05 19.07 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.503 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.551 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 2.4 m-85 -108.68 162.24 20.7 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.637 0.732 . . . . 0.0 110.851 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 116.32 4.5 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.659 2.239 . . . . 0.0 112.379 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.526 HD13 ' CE1' ' A' ' 51' ' ' PHE . 96.3 mt -47.81 135.0 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.187 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -86.07 -52.51 5.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.856 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.1 m -160.3 162.16 33.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.862 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.526 ' CE1' HD13 ' A' ' 48' ' ' ILE . 56.7 m-85 -109.85 166.96 10.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.649 HH21 HD21 ' A' ' 66' ' ' LEU . 21.6 mtp85 -142.22 143.26 32.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.821 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.447 ' O ' HD12 ' A' ' 66' ' ' LEU . 58.6 t -120.61 137.47 54.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.107 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -133.7 162.55 31.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.473 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 46.1 p90 -142.05 158.94 43.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.46 ' HD3' ' NE1' ' A' ' 64' ' ' TRP . 37.6 ttpt -130.7 129.72 42.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.931 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -80.07 120.34 24.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.532 HD11 ' HB3' ' A' ' 110' ' ' PRO . 51.2 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.46 ' NE1' ' HD3' ' A' ' 56' ' ' LYS . 47.1 m95 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.736 0.303 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.473 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 1.8 mm -128.04 160.28 38.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.108 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.649 HD21 HH21 ' A' ' 52' ' ' ARG . 39.6 tp -99.89 116.11 31.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.581 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -84.22 -69.79 0.62 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.121 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 t -128.0 166.66 17.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.213 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 12.2 m -161.8 178.65 8.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 70.56 27.54 3.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.103 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.65 HG23 ' HD2' ' A' ' 72' ' ' PRO . 74.9 mt -78.32 138.15 59.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.584 0.707 . . . . 0.0 111.16 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.65 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.1 Cg_endo -69.73 156.49 63.3 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.678 2.252 . . . . 0.0 112.375 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.64 -17.54 38.05 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.647 2.231 . . . . 0.0 112.403 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.3 m -87.6 -13.46 42.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.455 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 15.7 ttt180 -101.04 104.52 15.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.842 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.4 mt -100.4 12.49 37.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -154.93 132.05 10.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.467 HG11 HD13 ' A' ' 71' ' ' ILE . 2.2 m -147.37 165.27 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.101 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -100.26 118.28 36.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.581 HG23 ' HB1' ' A' ' 67' ' ' ALA . 32.7 mm -86.98 98.19 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.083 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.617 HG22 ' CB ' ' A' ' 33' ' ' SER . 32.0 p -93.4 174.15 7.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.3 40.04 17.21 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.509 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.1 mt -100.67 -179.24 4.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.729 0.299 . . . . 0.0 110.921 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -125.27 130.45 52.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.935 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.0 151.57 43.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.77 10.5 64.39 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.452 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.419 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 25.9 mm -122.22 112.66 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.352 . . . . 0.0 111.103 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.22 138.75 38.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.83 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.419 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -161.59 161.21 29.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.951 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -107.53 177.22 4.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -135.31 158.89 43.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.434 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 1.2 ptp180 -151.13 177.9 9.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.589 HG11 ' CD1' ' A' ' 38' ' ' TRP . 95.0 t -143.58 141.83 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.152 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.2 mtt180 -131.94 143.42 50.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.464 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -105.97 131.18 53.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.108 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.455 HD12 ' C ' ' A' ' 95' ' ' ALA . 9.1 mp -124.39 120.74 32.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.915 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.442 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 38.3 p-10 -123.61 -172.77 2.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.935 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.0 ptm -69.03 0.73 4.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 16' ' ' SER . 46.3 mt -108.5 -26.14 10.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.926 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.39 -166.56 29.09 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.499 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.13 158.74 15.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.889 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.426 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 4.8 p -95.51 175.23 6.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.839 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -70.93 157.98 89.13 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.57 0.7 . . . . 0.0 110.907 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.434 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.9 Cg_endo -69.75 104.72 1.36 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.649 2.233 . . . . 0.0 112.385 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.5 p -44.31 151.95 0.22 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.01 139.38 6.96 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.562 0.696 . . . . 0.0 111.106 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 97.11 0.62 Allowed 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.682 2.255 . . . . 0.0 112.373 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 t -48.3 159.59 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.75 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.98 152.58 5.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.675 0.75 . . . . 0.0 110.857 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.532 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.5 Cg_endo -69.65 131.91 22.4 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.698 2.265 . . . . 0.0 112.372 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -117.85 119.47 34.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.977 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.4 t -95.15 102.2 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.099 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.5 t -69.67 106.47 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.828 -179.858 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.639 ' CD1' ' CE2' ' A' ' 46' ' ' PHE . 16.8 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.634 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.4 p -141.7 160.01 57.86 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.738 0.78 . . . . 0.0 110.861 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 169.19 19.49 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.7 2.267 . . . . 0.0 112.302 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.527 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.4 Cg_endo -69.78 157.41 60.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.698 2.265 . . . . 0.0 112.334 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.438 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.6 pt-20 -99.25 163.25 12.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.35 122.32 58.72 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.539 0.685 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 163.76 37.1 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.672 2.248 . . . . 0.0 112.34 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -50.0 177.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -83.27 124.39 76.12 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.648 0.737 . . . . 0.0 110.85 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HB2' HG13 ' A' ' 36' ' ' VAL . 53.8 Cg_endo -69.75 147.36 62.76 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.676 2.251 . . . . 0.0 112.336 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.676 ' O ' HD13 ' A' ' 26' ' ' ILE . 5.1 t -99.58 164.51 12.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.15 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.676 HD13 ' O ' ' A' ' 25' ' ' THR . 8.7 mm -122.67 118.25 54.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.103 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.1 m -121.69 165.31 15.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.836 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.1 m -83.03 104.75 13.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.767 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -108.45 -37.96 5.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.059 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 m -166.16 175.72 8.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.443 ' HG2' HG23 ' A' ' 32' ' ' THR . 1.0 OUTLIER -79.64 -16.73 55.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.898 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.443 HG23 ' HG2' ' A' ' 31' ' ' GLU . 10.7 p -119.0 -6.35 10.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.145 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.852 ' HB3' HG22 ' A' ' 81' ' ' THR . 89.3 p -138.51 171.96 13.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 m -149.55 145.47 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.123 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.767 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 17.6 m-85 -81.63 115.34 20.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.407 HG13 ' HB2' ' A' ' 24' ' ' PRO . 97.0 t -109.11 127.24 65.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.149 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.41 ' HB ' HG22 ' A' ' 25' ' ' THR . 55.8 m -125.78 121.71 34.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.058 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.645 ' CD1' HG11 ' A' ' 93' ' ' VAL . 29.4 p90 -121.47 171.07 9.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.5 mm -135.1 107.12 10.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.632 0.73 . . . . 0.0 111.068 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 139.8 41.16 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.697 2.265 . . . . 0.0 112.343 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 mmt85 -103.31 -70.45 0.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.72 159.21 14.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.489 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -123.03 4.51 9.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 110.887 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.56 -1.41 87.87 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.491 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.461 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 113.32 -23.85 13.29 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.639 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 2.1 m-85 -110.11 162.25 21.17 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.641 0.734 . . . . 0.0 110.869 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.71 114.72 3.79 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.676 2.251 . . . . 0.0 112.427 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.457 HD13 ' CE1' ' A' ' 51' ' ' PHE . 81.6 mt -47.09 132.08 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.128 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -85.15 -50.36 7.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.2 p -159.7 163.24 34.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.457 ' CE1' HD13 ' A' ' 48' ' ' ILE . 54.8 m-85 -108.86 171.78 7.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.701 ' CZ ' HD11 ' A' ' 96' ' ' LEU . 4.9 mtm180 -143.45 129.01 19.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.827 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.457 HG11 HD11 ' A' ' 80' ' ' ILE . 38.4 t -111.4 133.14 57.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.07 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -135.42 152.4 51.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.486 ' CD2' ' HB2' ' A' ' 67' ' ' ALA . 31.1 p90 -129.37 175.75 8.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.5 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 24.6 ttpt -147.88 132.24 17.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.869 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -81.43 126.23 31.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.441 HD11 ' HB3' ' A' ' 110' ' ' PRO . 58.5 mt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.5 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 77.1 m95 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.783 0.325 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.47 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 2.7 mm -116.71 164.2 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.8 tp -96.96 124.1 40.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.746 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -92.52 -64.71 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.058 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.603 ' CG2' HD11 ' A' ' 71' ' ' ILE . 1.8 t -131.83 179.33 6.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.0 p -173.15 178.16 2.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 64.15 32.33 12.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.094 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.67 HG23 ' HD2' ' A' ' 72' ' ' PRO . 88.2 mt -84.61 138.55 38.18 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.582 0.706 . . . . 0.0 111.129 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.67 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.0 Cg_endo -69.75 156.9 62.18 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.719 2.28 . . . . 0.0 112.305 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 -19.56 35.83 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.742 2.295 . . . . 0.0 112.33 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 t -84.7 -15.26 45.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.437 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 8.5 ttt85 -99.17 101.33 12.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.4 mt -96.64 8.99 42.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.928 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.5 t -151.34 134.08 15.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.589 HG11 HD13 ' A' ' 71' ' ' ILE . 2.1 m -146.5 161.95 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.131 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.559 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 39.5 tt0 -97.97 110.23 22.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.746 HG23 ' HB1' ' A' ' 67' ' ' ALA . 17.6 mm -80.1 109.76 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.154 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.852 HG22 ' HB3' ' A' ' 33' ' ' SER . 66.1 p -107.57 166.42 10.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.97 33.46 8.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.498 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.3 mt -101.65 170.31 8.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.736 0.303 . . . . 0.0 110.898 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -114.2 132.86 55.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.855 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -68.01 156.84 36.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.54 12.01 44.36 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.516 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.512 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 32.1 mm -120.76 103.23 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.836 0.351 . . . . 0.0 111.134 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.44 140.16 51.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.512 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -163.12 163.11 25.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.992 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -109.08 -175.97 2.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.936 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -141.82 164.6 29.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.917 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -157.54 170.09 23.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.645 HG11 ' CD1' ' A' ' 38' ' ' TRP . 99.7 t -137.2 140.14 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.134 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.408 HH21 ' CG ' ' A' ' 104' ' ' PRO . 33.8 mtt180 -129.28 136.35 49.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.847 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -93.64 128.5 39.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.101 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.701 HD11 ' CZ ' ' A' ' 52' ' ' ARG . 3.3 mp -123.6 120.12 31.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.448 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 38.3 p-10 -123.56 -172.79 2.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.3 ptm -69.84 1.56 4.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.834 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.634 HD12 ' O ' ' A' ' 16' ' ' SER . 30.3 mt -108.83 -26.25 10.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.953 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 149.49 -162.54 29.08 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.513 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.408 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 26.3 pm0 -107.09 157.42 17.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.892 0.377 . . . . 0.0 110.918 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 54.4 p -96.2 174.99 6.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.851 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -68.47 157.82 86.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.654 0.74 . . . . 0.0 110.884 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.408 ' CG ' HH21 ' A' ' 94' ' ' ARG . 54.1 Cg_endo -69.81 111.23 2.76 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.669 2.246 . . . . 0.0 112.284 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.7 p -50.44 154.17 1.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.49 141.0 7.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.539 0.685 . . . . 0.0 111.047 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 98.06 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.637 2.224 . . . . 0.0 112.388 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.4 p -45.19 164.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.892 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.3 mtm105 -58.31 152.12 44.62 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.505 0.669 . . . . 0.0 110.942 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.441 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.5 Cg_endo -69.78 122.61 9.28 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.637 2.225 . . . . 0.0 112.345 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.638 ' CG ' HG21 ' A' ' 26' ' ' ILE . 52.7 t80 -111.98 121.1 44.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.933 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.9 t -95.03 105.43 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.114 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.0 t -74.95 108.68 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.083 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.878 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.681 HD13 ' CE2' ' A' ' 46' ' ' PHE . 6.4 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.833 0.349 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.642 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.4 p -137.65 160.34 65.44 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.681 0.753 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 169.98 17.66 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.682 2.255 . . . . 0.0 112.355 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.503 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.9 Cg_endo -69.81 152.74 69.12 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.628 2.219 . . . . 0.0 112.348 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.424 ' C ' ' HB2' ' A' ' 102' ' ' SER . 9.2 pt-20 -98.16 160.48 14.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 103' ' ' GLU . . . -56.09 122.79 50.26 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.559 0.695 . . . . 0.0 111.069 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 166.42 27.7 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.7 2.266 . . . . 0.0 112.304 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -51.67 174.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -80.22 122.73 83.18 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.624 0.726 . . . . 0.0 110.932 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 142.44 47.98 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.671 2.248 . . . . 0.0 112.306 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.812 ' O ' HD13 ' A' ' 26' ' ' ILE . 9.6 t -93.43 167.49 11.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.164 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.812 HD13 ' O ' ' A' ' 25' ' ' THR . 10.4 mm -127.44 124.68 64.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.193 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 m -128.31 175.75 8.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.813 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.4 m -94.51 101.36 13.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.1 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.703 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -102.42 -41.15 6.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 t -156.86 -178.34 7.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.833 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -81.17 -20.52 41.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.465 HG22 ' HE3' ' A' ' 85' ' ' LYS . 16.3 p -121.72 4.59 10.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.151 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 84.1 p -139.6 175.97 9.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.3 m -154.64 143.67 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.703 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 11.0 m-85 -79.69 117.52 20.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.8 t -111.93 129.17 67.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.133 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.629 HG23 ' HB2' ' A' ' 77' ' ' SER . 32.5 m -128.91 118.39 22.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.14 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.488 ' CD1' HG11 ' A' ' 93' ' ' VAL . 33.1 p90 -118.58 169.16 10.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 mm -133.59 108.39 12.06 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.62 0.724 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.437 ' CD ' HD22 ' A' ' 76' ' ' LEU . 53.8 Cg_endo -69.78 141.73 45.95 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.693 2.262 . . . . 0.0 112.333 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -109.81 -70.34 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.66 147.06 16.15 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.526 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 48.2 p-10 -114.47 2.55 14.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 0.0 110.925 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 85.26 2.3 87.84 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.507 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.535 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 107.3 -15.04 39.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.438 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.681 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.5 m-85 -118.24 161.98 32.29 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.629 0.728 . . . . 0.0 110.839 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 115.52 4.14 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.68 2.253 . . . . 0.0 112.311 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.455 HD13 ' CE1' ' A' ' 51' ' ' PHE . 92.4 mt -47.71 131.22 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.046 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -82.68 -48.23 11.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.87 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.9 p -163.7 164.16 23.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.455 ' CE1' HD13 ' A' ' 48' ' ' ILE . 55.4 m-85 -109.39 174.53 5.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.1 mtt-85 -149.56 124.04 9.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.2 t -107.99 136.39 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.135 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -137.2 152.66 50.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.875 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.569 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 44.0 p90 -127.84 144.1 51.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.524 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 22.1 ttpt -114.37 128.98 56.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.907 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -76.67 136.02 39.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 110' ' ' PRO . 51.4 mt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.907 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.534 ' O ' HD13 ' A' ' 65' ' ' ILE . 97.3 m95 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.783 0.325 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.569 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 4.6 mm -134.89 141.83 41.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.198 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.9 tp -78.41 126.09 30.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.826 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -101.69 -58.58 1.86 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.58 ' CG2' HD11 ' A' ' 71' ' ' ILE . 6.8 t -136.48 165.29 26.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.165 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 99.9 p -160.51 175.77 12.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.789 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 68.95 26.94 5.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.149 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.598 HG23 ' HD2' ' A' ' 72' ' ' PRO . 58.8 mt -79.76 137.43 54.45 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.635 0.731 . . . . 0.0 111.163 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.598 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.0 Cg_endo -69.66 159.06 54.9 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.728 2.285 . . . . 0.0 112.306 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.75 -25.4 28.68 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.688 2.259 . . . . 0.0 112.361 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 81.1 p -77.57 -25.72 50.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.854 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.457 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.1 ttt180 -86.4 106.59 17.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.838 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.437 HD22 ' CD ' ' A' ' 40' ' ' PRO . 46.6 mt -101.74 9.89 40.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.957 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.629 ' HB2' HG23 ' A' ' 37' ' ' THR . 26.3 t -155.82 137.16 13.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.45 HG12 ' CD ' ' A' ' 75' ' ' ARG . 2.2 m -149.92 168.67 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.148 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.684 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 30.3 tt0 -103.26 115.43 30.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.826 HG23 ' HB1' ' A' ' 67' ' ' ALA . 37.0 mm -81.83 102.69 8.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.7 p -97.46 164.04 12.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.117 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.37 33.59 19.43 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.503 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.8 mt -87.45 -176.26 5.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.803 0.335 . . . . 0.0 110.915 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -126.64 122.4 34.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.465 ' HE3' HG22 ' A' ' 32' ' ' THR . 0.6 OUTLIER -67.4 155.92 37.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.43 15.41 45.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.484 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.401 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 27.3 mm -126.87 103.68 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.861 0.362 . . . . 0.0 111.114 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.54 137.87 52.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.856 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.401 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -158.77 167.83 28.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.92 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -110.73 -176.49 2.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.909 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -146.26 142.9 28.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.428 HH21 ' CB ' ' A' ' 64' ' ' TRP . 5.5 ptt180 -139.26 177.89 7.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.488 HG11 ' CD1' ' A' ' 38' ' ' TRP . 87.2 t -140.73 143.02 29.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.097 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.402 ' CZ ' HH12 ' A' ' 92' ' ' ARG . 34.7 mtt180 -131.0 140.59 50.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.503 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -103.2 127.54 50.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.087 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.07 120.68 35.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.908 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.449 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 36.5 p-10 -123.61 -172.41 2.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.4 ptm -69.58 1.69 3.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.642 HD12 ' O ' ' A' ' 16' ' ' SER . 36.0 mt -109.67 -26.35 9.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.99 -165.93 29.33 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.526 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.61 158.05 16.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.814 0.34 . . . . 0.0 110.903 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 19.9 p -97.44 175.17 6.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 17.2 mt-10 -69.13 157.16 90.0 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.622 0.725 . . . . 0.0 110.918 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.425 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.4 Cg_endo -69.81 104.56 1.35 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.674 2.249 . . . . 0.0 112.318 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.5 p -41.7 150.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.843 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -43.07 140.48 1.97 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.601 0.715 . . . . 0.0 111.097 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 88.81 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.68 2.253 . . . . 0.0 112.285 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 99.2 p -41.06 153.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.861 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -48.96 151.81 2.08 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.628 0.728 . . . . 0.0 110.829 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.474 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.2 Cg_endo -69.81 144.65 54.45 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.664 2.243 . . . . 0.0 112.315 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -132.7 115.75 15.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.849 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.6 t -88.95 103.18 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.083 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.5 t -73.66 111.66 9.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.13 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 -179.814 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.485 HD13 ' CE2' ' A' ' 46' ' ' PHE . 9.0 mt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.805 0.336 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.599 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.7 m -144.99 161.62 41.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.69 0.757 . . . . 0.0 110.863 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.417 ' C ' ' HA3' ' A' ' 44' ' ' GLY . 53.8 Cg_endo -69.74 170.35 16.75 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.727 2.284 . . . . 0.0 112.358 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.475 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.6 Cg_endo -69.76 155.39 66.07 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.693 2.262 . . . . 0.0 112.403 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.42 ' C ' ' HB2' ' A' ' 102' ' ' SER . 9.6 pt-20 -99.26 167.89 10.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 103' ' ' GLU . . . -63.03 121.32 68.2 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.556 0.693 . . . . 0.0 111.096 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 161.59 45.35 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.685 2.257 . . . . 0.0 112.359 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -46.88 174.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 ttm180 -80.1 124.08 83.07 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.611 0.719 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 140.74 43.43 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.702 2.268 . . . . 0.0 112.387 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.511 ' O ' HD13 ' A' ' 26' ' ' ILE . 2.4 t -94.0 155.77 16.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.159 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.544 HG21 ' CB ' ' A' ' 111' ' ' TYR . 18.9 mm -117.28 128.4 74.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.077 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 m -132.72 176.12 8.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.797 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.5 m -93.47 110.6 22.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.191 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.699 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -111.9 -38.2 4.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.05 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.0 m -161.43 -178.75 6.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.838 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.5 ' HG2' HG23 ' A' ' 32' ' ' THR . 0.4 OUTLIER -84.8 -14.68 47.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.899 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.5 HG23 ' HG2' ' A' ' 31' ' ' GLU . 24.5 p -121.4 -0.02 9.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.161 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.431 ' CB ' HG22 ' A' ' 81' ' ' THR . 6.4 p -145.8 173.13 12.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.0 m -148.98 146.28 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.196 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.699 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 12.0 m-85 -77.21 123.14 26.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.6 t -119.45 124.38 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.203 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.475 HG23 ' HB2' ' A' ' 77' ' ' SER . 47.2 m -126.98 123.24 36.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.152 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.587 ' CD1' HG11 ' A' ' 93' ' ' VAL . 24.4 p90 -120.76 171.27 8.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.953 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.513 HD13 ' O ' ' A' ' 38' ' ' TRP . 18.7 mm -135.08 106.01 10.38 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.592 0.711 . . . . 0.0 111.224 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 142.86 49.26 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.719 2.279 . . . . 0.0 112.357 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -111.54 -70.74 0.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.38 143.58 15.69 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -115.74 17.07 16.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.823 0.344 . . . . 0.0 110.904 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.446 ' N ' ' HA ' ' A' ' 18' ' ' PRO . . . 75.97 -6.35 34.94 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.424 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.59 -19.65 11.36 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.504 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.485 ' CE2' HD13 ' A' ' 15' ' ' LEU . 1.6 m-85 -111.92 162.83 19.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.735 0.778 . . . . 0.0 110.91 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 115.98 4.35 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.69 2.26 . . . . 0.0 112.355 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.52 HD13 ' CE1' ' A' ' 51' ' ' PHE . 97.3 mt -48.0 124.41 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.136 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -79.04 -46.55 17.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.5 m -162.83 161.75 26.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.52 ' CE1' HD13 ' A' ' 48' ' ' ILE . 50.4 m-85 -108.59 175.25 5.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.94 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -147.81 120.19 8.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.908 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.431 HG11 HD11 ' A' ' 80' ' ' ILE . 21.7 t -103.91 131.79 51.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.099 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -131.59 160.91 33.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.936 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.553 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 18.4 p90 -139.07 175.89 9.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.919 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.431 ' HD3' ' NE1' ' A' ' 64' ' ' TRP . 16.4 ttpp -146.62 134.08 20.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -81.78 118.36 22.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.93 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 110' ' ' PRO . 72.3 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.96 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.922 ' O ' HD13 ' A' ' 65' ' ' ILE . 61.0 m95 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.759 0.314 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.922 HD13 ' O ' ' A' ' 64' ' ' TRP . 2.1 mm -131.47 151.18 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.075 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 53' ' ' VAL . 52.4 tp -84.9 134.6 34.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.881 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.623 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -103.18 -68.35 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.057 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.642 ' CG2' HD11 ' A' ' 71' ' ' ILE . 5.2 t -125.55 157.83 36.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.099 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.564 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 92.4 p -153.4 169.44 23.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 75.05 25.07 1.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.051 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.653 HG23 ' HD2' ' A' ' 72' ' ' PRO . 64.3 mt -77.08 138.13 65.14 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.599 0.714 . . . . 0.0 111.132 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.653 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.1 Cg_endo -69.77 157.98 58.53 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.679 2.253 . . . . 0.0 112.32 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -24.0 29.91 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.72 2.28 . . . . 0.0 112.296 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 t -78.54 -28.8 46.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.476 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.5 ttt180 -83.73 101.91 11.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.849 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.9 mt -99.37 11.71 38.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.475 ' HB2' HG23 ' A' ' 37' ' ' THR . 7.8 t -153.89 130.33 10.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.834 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.523 HG11 HD13 ' A' ' 71' ' ' ILE . 2.5 m -146.43 160.31 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.09 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.64 ' OE1' ' HB1' ' A' ' 29' ' ' ALA . 33.6 tt0 -99.25 111.9 24.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.623 HG23 ' HB1' ' A' ' 67' ' ' ALA . 28.8 mm -77.82 102.67 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.431 HG22 ' CB ' ' A' ' 33' ' ' SER . 41.2 p -97.2 162.56 13.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.118 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.34 40.63 5.38 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.47 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.2 mt -105.77 177.9 4.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.821 0.344 . . . . 0.0 110.921 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -123.62 128.62 49.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.859 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -67.15 155.88 37.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.76 14.95 63.73 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.512 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.427 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 25.6 mm -127.96 112.67 28.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.811 0.339 . . . . 0.0 111.145 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.05 141.69 40.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.813 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.427 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -162.25 159.79 26.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.016 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -107.38 179.37 4.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -140.76 160.88 39.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -152.32 -178.6 6.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.587 HG11 ' CD1' ' A' ' 38' ' ' TRP . 83.9 t -144.5 146.69 20.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -138.79 134.45 33.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.837 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -96.71 129.5 44.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.082 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.9 mp -122.01 120.19 33.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.449 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 39.4 p-10 -123.74 -172.82 2.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 18.4 ptm -69.7 1.13 4.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.852 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.599 HD12 ' O ' ' A' ' 16' ' ' SER . 37.6 mt -109.48 -24.73 10.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.901 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.411 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 146.36 -169.98 27.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.467 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.2 pm0 -95.96 158.43 15.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 110.868 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.42 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 4.3 p -94.63 175.45 6.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.881 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 20.6 mt-10 -69.53 157.9 88.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.668 0.747 . . . . 0.0 110.886 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 104.88 1.38 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.706 2.271 . . . . 0.0 112.358 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.9 p -47.14 148.2 1.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -45.96 136.99 6.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.648 0.737 . . . . 0.0 111.057 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.87 99.52 0.77 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.629 2.22 . . . . 0.0 112.375 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.4 p -47.8 170.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -60.61 149.56 78.23 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.609 0.719 . . . . 0.0 110.854 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.455 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.6 Cg_endo -69.74 122.69 9.37 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.741 2.294 . . . . 0.0 112.325 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.544 ' CB ' HG21 ' A' ' 26' ' ' ILE . 48.7 t80 -108.81 122.93 48.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 37.3 t -97.45 105.99 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.6 t -76.35 107.51 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.083 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.897 -179.892 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.553 HD22 ' HA3' ' A' ' 45' ' ' GLY . 7.8 mt . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.827 0.346 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.564 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.7 m -138.51 160.9 61.69 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.686 0.755 . . . . 0.0 110.766 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 169.9 17.74 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.718 2.279 . . . . 0.0 112.337 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.52 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.1 Cg_endo -69.77 154.88 67.17 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.713 2.276 . . . . 0.0 112.284 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.434 ' C ' ' HB2' ' A' ' 102' ' ' SER . 10.3 pt-20 -96.97 169.94 9.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.82 121.89 78.01 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.553 0.692 . . . . 0.0 111.079 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 162.23 42.84 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.712 2.275 . . . . 0.0 112.362 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -48.03 174.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.894 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -80.22 124.11 82.84 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.625 0.726 . . . . 0.0 110.857 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.412 ' HB2' HG13 ' A' ' 36' ' ' VAL . 52.7 Cg_endo -69.81 143.19 49.83 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.695 2.263 . . . . 0.0 112.34 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.85 ' O ' HD13 ' A' ' 26' ' ' ILE . 4.8 t -92.64 165.81 12.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.85 HD13 ' O ' ' A' ' 25' ' ' THR . 5.6 mm -128.84 119.52 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 t -123.55 173.95 7.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.0 m -89.41 103.18 15.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.167 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.806 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -106.57 -40.37 5.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.098 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.9 m -160.57 168.07 25.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -72.49 -17.47 61.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.834 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.4 p -119.55 -4.56 10.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.112 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.756 ' CB ' HG22 ' A' ' 81' ' ' THR . 11.2 p -141.75 171.16 14.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.854 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.414 HG11 ' CE1' ' A' ' 111' ' ' TYR . 27.7 m -149.12 149.2 15.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.07 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.806 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 21.3 m-85 -82.84 117.47 22.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.998 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.412 HG13 ' HB2' ' A' ' 24' ' ' PRO . 88.1 t -112.08 130.57 65.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.153 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.413 HG23 ' HB2' ' A' ' 77' ' ' SER . 35.4 m -129.25 125.06 36.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.14 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.663 ' CD1' HG11 ' A' ' 93' ' ' VAL . 25.0 p90 -122.39 169.92 10.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.8 mm -133.46 107.88 12.14 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.645 0.735 . . . . 0.0 111.131 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.77 143.13 49.81 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.666 2.244 . . . . 0.0 112.27 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 mmm-85 -110.88 -70.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.19 153.34 18.1 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.423 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -121.0 5.82 10.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.813 0.339 . . . . 0.0 110.851 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.05 1.36 89.91 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.448 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.553 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 109.97 -23.75 20.63 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.5 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.522 ' CE2' HD13 ' A' ' 15' ' ' LEU . 1.9 m-85 -109.68 162.33 20.7 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.69 0.757 . . . . 0.0 110.865 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 118.42 5.67 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.748 2.299 . . . . 0.0 112.361 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.519 HD13 ' CE1' ' A' ' 51' ' ' PHE . 87.6 mt -48.33 138.3 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -92.85 -51.27 5.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.957 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.1 p -158.39 165.03 35.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.874 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.519 ' CE1' HD13 ' A' ' 48' ' ' ILE . 48.3 m-85 -114.36 170.05 8.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.928 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.761 ' NE ' HD11 ' A' ' 96' ' ' LEU . 50.2 mtm180 -145.57 138.35 25.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.55 ' HB ' HG22 ' A' ' 68' ' ' THR . 47.2 t -117.25 133.98 62.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.125 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -127.14 160.92 29.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.722 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 17.9 p90 -144.55 144.89 31.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.499 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 17.3 ttpp -127.82 133.71 49.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.904 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.57 140.56 48.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.903 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.486 ' CD1' ' HB3' ' A' ' 110' ' ' PRO . 65.0 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.564 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 83.2 m95 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.717 0.294 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.533 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.4 mm -128.4 154.59 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.138 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.8 tp -87.35 115.6 24.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.795 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -83.84 -58.48 2.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.104 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.55 HG22 ' HB ' ' A' ' 53' ' ' VAL . 14.9 t -139.74 179.7 6.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.123 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.5 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 1.5 t -174.73 172.22 3.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.856 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 71.59 34.08 1.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.115 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.687 HD13 HG11 ' A' ' 78' ' ' VAL . 76.9 mt -88.64 137.93 30.06 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.605 0.717 . . . . 0.0 111.201 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.645 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.1 Cg_endo -69.7 158.35 57.35 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.639 2.226 . . . . 0.0 112.348 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -20.47 34.63 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.698 2.265 . . . . 0.0 112.336 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 79.6 p -84.74 -13.7 50.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.943 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.45 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 12.8 ttt85 -101.28 104.59 15.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.872 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.2 mt -103.31 13.92 32.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.852 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.413 ' HB2' HG23 ' A' ' 37' ' ' THR . 1.7 t -152.22 129.74 11.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.82 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.687 HG11 HD13 ' A' ' 71' ' ' ILE . 2.1 m -146.16 159.54 11.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.09 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.516 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 43.7 tt0 -98.62 114.67 27.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.795 HG23 ' HB1' ' A' ' 67' ' ' ALA . 27.7 mm -82.05 103.28 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.175 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.756 HG22 ' CB ' ' A' ' 33' ' ' SER . 49.5 p -101.9 164.0 11.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.86 38.99 5.93 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.538 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.3 mt -106.75 175.92 5.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.778 0.323 . . . . 0.0 110.917 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -120.09 133.42 55.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -68.05 160.19 29.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.0 13.86 58.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.445 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.517 HG22 ' CD2' ' A' ' 89' ' ' TYR . 17.7 mm -124.17 110.96 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.796 0.332 . . . . 0.0 111.094 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.89 134.16 35.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.866 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.517 ' CD2' HG22 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -156.29 163.43 39.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.4 ' HE3' HD11 ' A' ' 58' ' ' LEU . 19.7 mttt -108.0 178.33 4.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.98 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -135.61 152.8 51.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.912 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.564 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 6.3 ptp180 -147.49 171.55 15.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.663 HG11 ' CD1' ' A' ' 38' ' ' TRP . 84.6 t -137.4 140.36 42.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.1 mtt180 -128.5 134.96 48.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -94.54 132.71 38.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.152 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.761 HD11 ' NE ' ' A' ' 52' ' ' ARG . 4.0 mp -127.26 120.72 29.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.443 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 39.9 p-10 -123.45 -172.26 2.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.931 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.4 ptm -70.28 2.31 3.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.862 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.564 HD12 ' O ' ' A' ' 16' ' ' SER . 39.9 mt -109.75 -26.36 9.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.947 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.03 -164.67 29.66 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.541 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -104.9 158.45 16.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.839 0.352 . . . . 0.0 110.877 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 53.2 p -96.86 175.08 6.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -70.79 157.69 89.67 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.631 0.729 . . . . 0.0 110.881 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 92' ' ' ARG . 54.0 Cg_endo -69.79 105.32 1.47 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.653 2.235 . . . . 0.0 112.371 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.0 p -44.54 157.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.844 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.58 140.89 18.06 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.625 0.726 . . . . 0.0 111.069 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 100.98 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.658 2.239 . . . . 0.0 112.339 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.9 p -48.0 159.04 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -51.18 152.03 4.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.607 0.718 . . . . 0.0 110.818 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.486 ' HB3' ' CD1' ' A' ' 58' ' ' LEU . 53.6 Cg_endo -69.75 126.71 13.64 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.665 2.243 . . . . 0.0 112.347 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.464 ' CB ' HG21 ' A' ' 26' ' ' ILE . 55.5 t80 -117.28 113.94 22.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.935 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 42.4 t -88.02 106.94 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.175 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.8 t -72.17 106.94 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.141 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.822 -179.815 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.505 HD22 ' HA3' ' A' ' 45' ' ' GLY . 13.5 mt . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.766 0.317 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.578 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.6 m -144.4 161.91 42.08 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.684 0.754 . . . . 0.0 110.899 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 169.92 17.8 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.696 2.264 . . . . 0.0 112.314 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.506 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.5 Cg_endo -69.82 154.44 67.51 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.691 2.261 . . . . 0.0 112.342 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.43 ' C ' ' HB2' ' A' ' 102' ' ' SER . 4.7 pt-20 -98.89 173.71 6.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.15 121.16 75.02 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.666 0.746 . . . . 0.0 111.101 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 162.83 40.62 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.674 2.25 . . . . 0.0 112.347 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -48.41 172.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -79.9 123.06 83.9 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.581 0.705 . . . . 0.0 110.889 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.404 ' HB2' HG13 ' A' ' 36' ' ' VAL . 54.5 Cg_endo -69.68 144.15 53.56 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.754 2.303 . . . . 0.0 112.399 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.897 ' O ' HD13 ' A' ' 26' ' ' ILE . 15.1 t -95.72 167.26 11.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.897 HD13 ' O ' ' A' ' 25' ' ' THR . 8.2 mm -129.79 118.64 45.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.144 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -120.82 178.96 4.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.825 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.5 m -94.35 98.53 10.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.141 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.868 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -100.72 -40.71 7.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.5 m -159.64 -179.8 8.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -81.8 -21.33 37.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.845 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.2 p -118.27 3.6 11.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.107 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.3 p -144.92 174.66 10.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.7 m -153.2 142.16 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.203 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.868 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 22.6 m-85 -77.77 120.17 22.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.878 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 24' ' ' PRO . 78.9 t -114.88 130.61 69.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.105 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.4 m -128.81 120.29 26.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.715 ' CD1' HG11 ' A' ' 93' ' ' VAL . 24.9 p90 -121.31 170.79 9.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 mm -134.98 110.86 10.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.549 0.69 . . . . 0.0 111.107 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.519 ' HD3' HD22 ' A' ' 76' ' ' LEU . 53.2 Cg_endo -69.83 131.2 20.64 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.667 2.245 . . . . 0.0 112.351 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -95.58 -70.15 0.72 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.15 149.72 16.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.49 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -118.69 8.95 12.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.884 0.373 . . . . 0.0 110.871 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.27 3.05 75.54 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.505 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 107.28 -22.7 28.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.494 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.45 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.4 m-85 -109.91 161.9 22.46 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.738 0.78 . . . . 0.0 110.849 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 114.94 3.86 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.613 2.209 . . . . 0.0 112.377 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.515 HD13 ' CE1' ' A' ' 51' ' ' PHE . 97.7 mt -45.22 128.17 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.142 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -82.33 -47.4 12.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.1 m -163.27 160.76 24.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.844 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.515 ' CE1' HD13 ' A' ' 48' ' ' ILE . 60.7 m-85 -108.09 178.18 4.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.954 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.3 mtt-85 -149.65 121.71 8.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.641 HG11 HD11 ' A' ' 80' ' ' ILE . 23.5 t -105.38 125.57 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -131.83 146.26 52.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.527 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 38.5 p90 -120.14 175.91 5.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.966 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.529 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 13.3 tttt -148.71 135.24 19.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.3 mttp -82.66 125.73 31.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 110' ' ' PRO . 73.5 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.934 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.529 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 77.7 m95 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.722 0.296 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.558 HG22 ' H ' ' A' ' 66' ' ' LEU . 3.1 mm -120.67 169.73 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.192 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.558 ' H ' HG22 ' A' ' 65' ' ' ILE . 53.0 tp -104.5 121.16 42.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.931 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.842 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -86.76 -67.69 0.8 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.09 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.573 ' CG2' HD11 ' A' ' 71' ' ' ILE . 12.6 t -129.8 -176.61 3.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.216 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 98.2 p -174.29 -178.03 1.36 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.874 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 58.91 27.14 15.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.658 HD13 HG11 ' A' ' 78' ' ' VAL . 58.2 mt -77.17 137.76 64.84 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.591 0.71 . . . . 0.0 111.11 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.639 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.2 Cg_endo -69.8 157.26 60.92 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.727 2.284 . . . . 0.0 112.371 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 -24.16 30.39 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.738 2.292 . . . . 0.0 112.335 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 86.6 p -79.75 -18.19 51.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.463 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.0 ttt180 -96.66 102.68 14.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.519 HD22 ' HD3' ' A' ' 40' ' ' PRO . 54.9 mt -100.19 14.29 31.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.926 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.0 t -156.02 132.61 10.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.833 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.658 HG11 HD13 ' A' ' 71' ' ' ILE . 2.1 m -146.98 162.61 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.119 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.516 ' OE1' ' HB1' ' A' ' 29' ' ' ALA . 33.4 tt0 -98.51 110.72 23.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.842 HG23 ' HB1' ' A' ' 67' ' ' ALA . 40.1 mm -76.69 106.38 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.163 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.9 p -99.6 167.57 10.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.14 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.92 44.19 8.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.573 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.9 mt -98.88 -175.62 3.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.83 0.348 . . . . 0.0 110.93 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -132.85 119.72 20.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.69 156.69 22.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.892 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.47 13.54 44.97 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.45 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.526 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 33.3 mm -126.38 101.63 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.832 0.349 . . . . 0.0 111.175 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.21 141.81 57.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -164.06 162.43 23.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -109.11 -174.76 2.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.863 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.405 ' HE2' HG21 ' A' ' 80' ' ' ILE . 76.9 m-85 -144.57 150.85 38.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.449 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 2.3 ptp180 -141.75 175.07 9.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.715 HG11 ' CD1' ' A' ' 38' ' ' TRP . 57.8 t -142.03 135.7 29.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.1 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.0 mtt180 -124.98 142.5 51.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.813 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -103.41 130.77 50.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.1 mp -124.26 119.12 28.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.453 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.3 p-10 -123.71 -173.6 2.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.915 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.7 ptm -68.49 -0.66 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.838 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.578 HD12 ' O ' ' A' ' 16' ' ' SER . 51.7 mt -106.29 -26.02 11.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.956 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.19 -164.37 28.95 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.481 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.49 157.24 17.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.873 0.368 . . . . 0.0 110.906 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.43 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 7.3 p -96.38 174.92 6.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.936 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -71.11 159.48 85.44 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.663 0.744 . . . . 0.0 110.892 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.449 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.5 Cg_endo -69.65 106.89 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.698 2.265 . . . . 0.0 112.386 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.0 p -45.82 154.46 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.845 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -48.71 139.41 11.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.552 0.691 . . . . 0.0 111.087 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 94.74 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.664 2.243 . . . . 0.0 112.35 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.9 p -42.14 158.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -51.47 152.34 4.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.614 0.721 . . . . 0.0 110.864 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.576 ' HB3' HD11 ' A' ' 58' ' ' LEU . 54.8 Cg_endo -69.68 129.35 17.52 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.68 2.254 . . . . 0.0 112.393 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -119.41 118.08 30.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.4 t -93.3 102.5 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.118 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.6 t -68.67 106.8 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.06 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.854 -179.894 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.641 HD13 ' CE2' ' A' ' 46' ' ' PHE . 3.0 mt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.788 0.328 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.554 ' O ' HD12 ' A' ' 99' ' ' LEU . 0.6 OUTLIER -144.42 161.61 43.47 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.675 0.75 . . . . 0.0 110.815 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 169.98 17.64 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.668 2.245 . . . . 0.0 112.332 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.476 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.4 Cg_endo -69.76 156.47 63.27 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.732 2.288 . . . . 0.0 112.372 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.419 ' C ' ' HB2' ' A' ' 102' ' ' SER . 4.5 pt-20 -101.6 165.66 11.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.927 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.83 122.76 64.36 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.546 0.689 . . . . 0.0 111.133 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 164.0 36.19 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.72 2.28 . . . . 0.0 112.338 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -51.63 176.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -80.29 122.38 82.71 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.577 0.703 . . . . 0.0 110.895 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.428 ' HB2' HG13 ' A' ' 36' ' ' VAL . 53.1 Cg_endo -69.84 142.52 47.79 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.731 2.287 . . . . 0.0 112.357 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.768 ' O ' HD13 ' A' ' 26' ' ' ILE . 6.3 t -93.13 163.14 13.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.116 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.768 HD13 ' O ' ' A' ' 25' ' ' THR . 8.4 mm -123.63 129.55 74.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.116 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 t -136.05 165.49 25.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.807 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.5 m -80.91 109.16 15.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.167 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.735 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -111.86 -35.83 5.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.148 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.9 m -165.19 -177.8 4.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.902 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.651 ' HG2' HG23 ' A' ' 32' ' ' THR . 0.1 OUTLIER -85.92 -14.68 44.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.89 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.651 HG23 ' HG2' ' A' ' 31' ' ' GLU . 36.6 p -122.96 -1.38 8.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.165 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.523 ' CB ' HG22 ' A' ' 81' ' ' THR . 4.7 p -143.18 175.28 10.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.0 m -153.35 144.3 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.735 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 19.0 m-85 -78.39 124.75 28.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.428 HG13 ' HB2' ' A' ' 24' ' ' PRO . 72.3 t -119.93 131.47 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.3 m -129.0 118.66 22.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.101 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.628 ' CD1' HG11 ' A' ' 93' ' ' VAL . 30.2 p90 -115.67 169.92 8.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.4 mm -132.23 107.35 13.53 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.589 0.709 . . . . 0.0 111.131 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.66 134.08 27.32 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.715 2.277 . . . . 0.0 112.355 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -103.89 -70.26 0.77 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.856 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.96 144.09 15.73 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.423 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -116.15 13.21 15.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 0.0 110.827 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 75.31 -0.72 59.0 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.435 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.422 ' HA3' ' CD2' ' A' ' 15' ' ' LEU . . . 111.6 -22.48 19.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.641 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.0 m-85 -109.34 161.74 22.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.651 0.739 . . . . 0.0 110.892 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.66 113.67 3.43 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.68 2.253 . . . . 0.0 112.332 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.588 HD13 ' CE1' ' A' ' 51' ' ' PHE . 91.0 mt -42.69 127.79 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.153 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -82.55 -46.24 13.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.3 p -164.02 160.07 21.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.588 ' CE1' HD13 ' A' ' 48' ' ' ILE . 61.5 m-85 -107.93 173.33 6.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -148.27 124.17 10.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 92' ' ' ARG . 47.6 t -106.2 140.01 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.099 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.44 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 42.0 mt-10 -136.45 151.1 49.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.454 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 35.6 p90 -125.79 165.04 19.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.953 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 89' ' ' TYR . 6.7 ttpm? -143.71 133.06 23.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -81.3 138.05 35.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.414 HD11 ' HB3' ' A' ' 110' ' ' PRO . 87.2 mt . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.6 m95 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.739 0.304 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.56 HG22 ' H ' ' A' ' 66' ' ' LEU . 1.8 mm -117.3 171.69 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.56 ' H ' HG22 ' A' ' 65' ' ' ILE . 50.6 tp -104.31 130.6 52.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.909 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.43 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -103.31 -69.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.634 ' CG2' HD11 ' A' ' 71' ' ' ILE . 13.2 t -116.88 171.42 7.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.133 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.496 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 60.4 p -167.7 167.76 13.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.797 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 71.29 27.77 3.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.045 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.634 HD11 ' CG2' ' A' ' 68' ' ' THR . 63.9 mt -78.04 137.55 61.25 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.653 0.739 . . . . 0.0 111.104 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.605 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.7 Cg_endo -69.66 157.24 61.25 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.743 2.295 . . . . 0.0 112.362 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -20.07 35.05 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.674 2.249 . . . . 0.0 112.34 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 92.4 p -83.38 -23.68 32.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.476 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 10.0 ttt180 -90.34 99.24 12.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.3 mt -95.96 15.33 20.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 t -155.54 136.48 13.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.559 HG11 HD13 ' A' ' 71' ' ' ILE . 2.9 m -150.08 163.06 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.151 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.525 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 65.4 tt0 -98.91 112.47 24.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.43 HG23 ' HB1' ' A' ' 67' ' ' ALA . 47.6 mm -79.77 101.73 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.192 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.523 HG22 ' CB ' ' A' ' 33' ' ' SER . 27.7 p -98.1 168.28 10.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.182 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.72 40.28 8.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.48 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 46.2 mt -104.27 -175.29 2.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -127.97 130.85 49.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.43 155.92 40.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.64 11.5 57.27 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.462 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.2 mm -125.01 116.52 47.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.866 0.365 . . . . 0.0 111.132 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.15 135.76 35.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.446 ' CB ' ' O ' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -154.77 162.74 41.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.942 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -107.25 178.21 4.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.947 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -137.16 160.42 39.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.907 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.44 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 2.1 ptp180 -150.97 177.75 9.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.628 HG11 ' CD1' ' A' ' 38' ' ' TRP . 91.6 t -147.44 137.97 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.124 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -129.56 141.65 50.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -101.45 132.17 47.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.022 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mp -125.24 119.59 28.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.944 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.447 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.8 p-10 -123.59 -173.71 2.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.93 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.4 ptm -68.26 -1.07 5.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.893 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 16' ' ' SER . 55.2 mt -106.25 -25.48 11.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.958 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 147.28 -165.55 28.62 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.458 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -100.5 158.11 16.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 110.869 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.419 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 4.0 p -94.47 175.22 6.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.842 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -70.34 159.72 83.7 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.649 0.738 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.432 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.5 Cg_endo -69.78 109.12 2.24 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.74 2.293 . . . . 0.0 112.31 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.7 p -51.01 153.47 1.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.88 140.34 30.17 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.572 0.701 . . . . 0.0 111.128 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 97.42 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.713 2.275 . . . . 0.0 112.354 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 88.2 p -45.75 167.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.16 152.68 50.7 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.666 0.746 . . . . 0.0 110.91 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.414 ' HB3' HD11 ' A' ' 58' ' ' LEU . 54.2 Cg_endo -69.73 135.04 29.51 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.703 2.269 . . . . 0.0 112.32 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -124.22 124.34 42.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.09 101.78 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.152 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.3 t -70.09 105.73 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.055 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 -179.918 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.698 HD13 ' CE2' ' A' ' 46' ' ' PHE . 3.2 mt . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.764 0.316 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.632 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.7 m -146.43 161.54 38.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.68 0.752 . . . . 0.0 110.865 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 169.59 18.57 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.723 2.282 . . . . 0.0 112.337 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.582 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.0 Cg_endo -69.79 150.78 68.47 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.661 2.24 . . . . 0.0 112.32 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.424 ' C ' ' HB2' ' A' ' 102' ' ' SER . 9.1 pt-20 -92.69 174.71 7.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.8 122.4 83.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.573 0.702 . . . . 0.0 111.079 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 161.82 44.46 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.697 2.264 . . . . 0.0 112.317 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -51.77 175.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -80.28 122.82 83.21 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.603 0.716 . . . . 0.0 110.869 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 142.87 49.13 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.701 2.267 . . . . 0.0 112.419 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.659 ' C ' HD13 ' A' ' 26' ' ' ILE . 2.9 t -93.32 159.1 15.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.659 HD13 ' C ' ' A' ' 25' ' ' THR . 3.9 mm -122.13 119.18 57.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.142 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -119.31 -174.96 2.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.918 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 47.0 m -103.15 100.76 10.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.136 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.763 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -103.48 -38.3 7.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.086 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.1 m -161.11 -179.64 7.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -81.47 -21.53 38.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.9 p -116.67 -2.26 11.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.152 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.624 ' CB ' HG22 ' A' ' 81' ' ' THR . 3.9 p -142.58 164.01 31.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.817 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.3 m -143.39 145.19 22.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.179 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.763 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 18.1 m-85 -75.49 113.9 13.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.94 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.7 t -107.07 124.62 62.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.13 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.515 ' HB ' HG22 ' A' ' 25' ' ' THR . 55.9 m -124.71 121.31 34.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.122 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.653 ' CD1' HG11 ' A' ' 93' ' ' VAL . 25.0 p90 -118.18 169.63 9.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.915 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.2 mm -134.35 106.18 11.11 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.632 0.729 . . . . 0.0 111.152 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 142.29 47.55 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.676 2.251 . . . . 0.0 112.321 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -111.69 -69.52 0.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.887 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.0 142.16 15.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.534 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 47.2 p-10 -112.54 9.55 19.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.904 0.383 . . . . 0.0 110.893 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 79.01 0.67 83.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.458 ' HA3' ' CD2' ' A' ' 15' ' ' LEU . . . 111.6 -24.5 15.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.698 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.5 m-85 -108.16 162.11 21.04 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.629 0.728 . . . . 0.0 110.908 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 113.82 3.5 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.669 2.246 . . . . 0.0 112.385 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.519 HD13 ' CE1' ' A' ' 51' ' ' PHE . 97.6 mt -43.58 127.35 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -81.77 -48.32 11.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.936 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.6 m -162.13 162.03 28.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.921 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.519 ' CE1' HD13 ' A' ' 48' ' ' ILE . 51.5 m-85 -109.03 176.31 5.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -149.93 123.42 9.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.36 133.19 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.136 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.405 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 9.4 mt-10 -132.13 162.97 29.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.938 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.582 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 16.1 p90 -148.34 146.18 28.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.522 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 14.8 ttpp -121.93 131.73 54.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.879 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -76.37 128.73 35.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.868 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.2 mt . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.889 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.553 ' O ' HD13 ' A' ' 65' ' ' ILE . 35.9 m95 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.707 0.289 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.582 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 2.3 mm -133.12 164.02 36.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.17 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.408 ' H ' HG22 ' A' ' 65' ' ' ILE . 14.8 tp -102.66 123.36 46.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.663 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -93.78 -66.9 0.89 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.071 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.466 HG21 HD11 ' A' ' 71' ' ' ILE . 11.8 t -128.04 177.81 6.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.113 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.499 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 83.2 p -171.31 167.65 6.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.867 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 71.49 36.13 1.35 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.657 HG23 ' HD2' ' A' ' 72' ' ' PRO . 72.8 mt -87.48 138.29 31.98 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.624 0.726 . . . . 0.0 111.144 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.657 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.9 Cg_endo -69.8 156.69 62.59 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.676 2.251 . . . . 0.0 112.341 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.87 -20.69 33.97 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.696 2.264 . . . . 0.0 112.338 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.1 t -84.32 -10.67 57.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.442 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 12.2 ttt180 -103.38 102.97 12.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.1 mt -100.69 10.47 41.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 t -151.92 129.2 11.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.528 HG11 HD13 ' A' ' 71' ' ' ILE . 2.4 m -144.7 165.04 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.086 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -98.52 113.73 25.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.865 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.663 HG23 ' HB1' ' A' ' 67' ' ' ALA . 40.0 mm -83.63 98.57 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.091 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.624 HG22 ' CB ' ' A' ' 33' ' ' SER . 73.7 p -95.78 165.3 12.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.193 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.69 35.33 9.34 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.497 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.9 mt -94.45 176.49 6.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.866 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -121.7 120.26 34.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -62.82 156.73 23.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.948 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.28 13.9 45.26 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.555 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.1 mm -124.95 104.93 14.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 0.0 111.117 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.55 134.16 47.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -157.01 163.12 39.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.934 -179.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -111.01 176.63 4.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.894 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 91' ' ' PHE . 8.0 m-85 -131.96 158.1 42.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.425 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 2.1 ptp180 -149.63 171.87 15.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.653 HG11 ' CD1' ' A' ' 38' ' ' TRP . 94.5 t -139.68 142.77 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -132.41 141.59 48.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.582 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -101.98 125.18 48.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.075 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mp -119.76 118.02 29.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.445 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.3 p-10 -123.6 -174.28 2.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.609 ' HE3' ' CG ' ' A' ' 46' ' ' PHE . 5.0 ptp -67.61 -2.12 6.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.632 HD12 ' O ' ' A' ' 16' ' ' SER . 29.4 mt -105.29 -25.63 12.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.944 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 147.53 -167.16 28.63 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.519 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -101.4 157.54 16.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.819 0.343 . . . . 0.0 110.896 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.424 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 8.7 p -94.22 174.27 7.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.805 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -70.23 160.39 81.08 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.59 0.71 . . . . 0.0 110.929 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.425 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.5 Cg_endo -69.77 105.48 1.49 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.742 2.294 . . . . 0.0 112.306 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.4 p -45.2 156.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.803 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.51 139.93 27.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.564 0.697 . . . . 0.0 111.117 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.69 89.26 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.719 2.279 . . . . 0.0 112.382 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 t -40.7 152.28 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.2 mtt-85 -44.75 153.57 0.47 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.6 0.714 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 132.95 24.33 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.651 2.234 . . . . 0.0 112.367 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -121.17 116.57 25.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.79 107.32 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.094 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.27 111.73 13.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.817 -179.827 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.627 HD13 ' CE2' ' A' ' 46' ' ' PHE . 7.7 mt . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.746 0.308 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.616 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.6 m -141.26 161.77 51.28 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.704 0.764 . . . . 0.0 110.772 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 169.77 18.13 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.665 2.244 . . . . 0.0 112.284 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.593 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 54.2 Cg_endo -69.86 159.02 54.84 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.618 2.212 . . . . 0.0 112.316 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.55 165.15 11.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.926 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.2 120.55 52.13 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.621 0.724 . . . . 0.0 111.126 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 166.56 27.17 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.718 2.278 . . . . 0.0 112.307 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -52.53 172.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.935 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.4 ' HB2' ' NH1' ' A' ' 23' ' ' ARG . 13.7 ttm105 -79.83 123.03 84.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.598 0.713 . . . . 0.0 110.849 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.466 ' HB2' ' CG1' ' A' ' 36' ' ' VAL . 53.1 Cg_endo -69.79 141.79 46.07 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.658 2.239 . . . . 0.0 112.35 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.852 ' O ' HD13 ' A' ' 26' ' ' ILE . 6.9 t -92.47 169.22 10.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.119 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.852 HD13 ' O ' ' A' ' 25' ' ' THR . 3.1 mm -129.13 131.99 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.131 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 t -139.31 167.59 21.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.4 m -80.22 108.16 13.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.695 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -113.01 -35.43 5.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.075 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.0 m -164.32 178.84 7.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.812 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.78 -16.68 46.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.851 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 p -122.2 -2.12 9.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.168 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.659 ' CB ' HG22 ' A' ' 81' ' ' THR . 7.0 p -141.11 171.22 14.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.6 m -147.82 145.44 18.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.148 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.695 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 9.7 m-85 -78.86 119.28 21.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.466 ' CG1' ' HB2' ' A' ' 24' ' ' PRO . 92.4 t -115.95 132.17 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.183 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.403 ' HB ' HG22 ' A' ' 25' ' ' THR . 98.7 m -129.2 124.44 34.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.169 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.74 ' CD1' HG11 ' A' ' 93' ' ' VAL . 24.7 p90 -123.13 171.54 9.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.956 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.6 mm -137.2 106.25 8.66 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.677 0.751 . . . . 0.0 111.163 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 135.91 31.47 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.626 2.217 . . . . 0.0 112.35 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.2 mmm-85 -102.17 -70.63 0.74 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.36 152.54 18.41 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.484 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 52.6 p-10 -122.54 12.63 10.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.854 0.359 . . . . 0.0 110.862 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.63 -0.84 59.93 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.511 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.473 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 111.18 -18.79 25.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.464 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.627 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.1 m-85 -113.08 162.32 22.47 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.584 0.707 . . . . 0.0 110.915 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 115.47 4.11 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.639 2.226 . . . . 0.0 112.365 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.607 HD13 ' CZ ' ' A' ' 51' ' ' PHE . 96.7 mt -45.7 132.0 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.106 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -86.87 -47.14 9.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.9 p -164.22 159.14 19.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.861 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.607 ' CZ ' HD13 ' A' ' 48' ' ' ILE . 54.7 m-85 -107.97 173.12 6.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.897 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -150.1 124.92 9.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 92' ' ' ARG . 48.0 t -103.14 136.32 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.168 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -133.89 146.65 50.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.841 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.539 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 26.9 p90 -125.08 174.81 7.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.979 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.459 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 29.6 ttpt -146.47 125.12 12.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -75.03 126.23 30.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.482 HD11 ' HB3' ' A' ' 110' ' ' PRO . 15.4 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.857 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.554 ' CH2' ' HD3' ' A' ' 92' ' ' ARG . 89.5 m95 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.802 0.335 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.539 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.2 mm -114.6 164.08 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.125 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.414 ' H ' HG22 ' A' ' 65' ' ' ILE . 43.8 tp -98.33 130.36 45.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.555 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -102.58 -70.27 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.091 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.407 ' CG2' HD11 ' A' ' 71' ' ' ILE . 12.0 t -124.63 164.72 19.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.53 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 1.3 t -163.43 171.26 16.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.89 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 73.13 25.28 2.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.173 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.649 HG23 ' HD2' ' A' ' 72' ' ' PRO . 80.4 mt -76.11 138.12 68.74 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.585 0.707 . . . . 0.0 111.156 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.649 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.8 Cg_endo -69.75 157.04 61.76 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.726 2.284 . . . . 0.0 112.311 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 -17.55 37.16 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.645 2.23 . . . . 0.0 112.357 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 t -87.08 -17.44 32.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.872 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.472 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 6.5 ttt85 -97.21 98.33 9.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.9 mt -92.23 9.94 31.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.7 t -154.92 137.78 15.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.501 HG11 HD13 ' A' ' 71' ' ' ILE . 2.5 m -147.51 167.95 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.101 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.503 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 45.5 tt0 -101.26 104.19 15.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.555 HG23 ' HB1' ' A' ' 67' ' ' ALA . 48.4 mm -71.48 101.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.113 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.659 HG22 ' CB ' ' A' ' 33' ' ' SER . 38.8 p -101.22 161.63 13.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.141 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.72 37.34 6.13 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.452 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.4 mt -100.28 176.58 5.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.73 0.3 . . . . 0.0 110.935 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -120.32 117.92 29.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.81 150.65 27.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.96 12.56 71.47 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.512 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.466 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 39.0 mm -125.11 109.7 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.893 0.378 . . . . 0.0 111.193 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.44 140.71 46.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.466 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -164.11 167.03 20.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.883 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.491 ' O ' ' CB ' ' A' ' 55' ' ' TYR . 58.1 mttt -112.85 -177.18 3.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.862 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -146.19 152.43 39.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.554 ' HD3' ' CH2' ' A' ' 64' ' ' TRP . 6.4 mtm180 -143.62 -178.37 5.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.914 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.74 HG11 ' CD1' ' A' ' 38' ' ' TRP . 61.5 t -142.67 139.02 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.166 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.4 mtt180 -126.87 145.3 50.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.769 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.593 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -103.5 125.25 49.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.101 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.2 mp -120.86 117.78 28.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.454 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 41.1 p-10 -123.85 -173.27 2.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.2 ptm -68.92 -0.39 5.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.926 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.616 HD12 ' O ' ' A' ' 16' ' ' SER . 62.8 mt -106.21 -26.28 11.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.993 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.76 -163.43 29.05 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.499 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -108.83 155.63 20.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.88 0.371 . . . . 0.0 110.838 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 59.3 p -98.99 172.5 7.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.842 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.2 mp0 -69.19 157.32 89.62 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.614 0.721 . . . . 0.0 110.933 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.4 ' HB2' ' NH1' ' A' ' 92' ' ' ARG . 54.1 Cg_endo -69.71 116.1 4.4 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.723 2.282 . . . . 0.0 112.346 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.459 ' O ' ' C ' ' A' ' 106' ' ' ALA . 74.7 p -54.47 148.21 12.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.893 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 105' ' ' SER . . . -32.67 141.7 0.18 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.62 0.724 . . . . 0.0 111.061 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 97.69 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.634 2.223 . . . . 0.0 112.322 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.1 p -42.69 149.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -46.75 151.89 1.01 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.59 0.71 . . . . 0.0 110.871 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.482 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.1 Cg_endo -69.85 119.82 6.7 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.666 2.244 . . . . 0.0 112.303 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -110.47 120.13 41.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.0 t -94.36 102.62 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.174 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.7 t -71.66 109.83 4.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.11 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.883 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.698 HD13 ' CE2' ' A' ' 46' ' ' PHE . 7.2 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.789 0.328 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.643 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.7 m -142.89 161.38 49.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.662 0.744 . . . . 0.0 110.905 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 168.67 20.86 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.667 2.245 . . . . 0.0 112.393 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.486 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.8 Cg_endo -69.72 159.34 53.82 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.689 2.26 . . . . 0.0 112.334 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.426 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.0 pt-20 -103.64 160.03 15.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.7 122.25 44.57 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.556 0.693 . . . . 0.0 111.102 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 163.96 36.34 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.661 2.241 . . . . 0.0 112.365 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -51.5 176.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.84 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -80.05 123.95 83.21 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.654 0.74 . . . . 0.0 110.876 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.45 ' O ' ' CB ' ' A' ' 108' ' ' SER . 53.4 Cg_endo -69.73 143.0 49.59 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.718 2.279 . . . . 0.0 112.283 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.73 ' O ' HD13 ' A' ' 26' ' ' ILE . 3.2 t -95.53 166.8 11.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.73 HD13 ' O ' ' A' ' 25' ' ' THR . 5.1 mm -124.06 118.17 53.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.137 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -117.84 168.59 10.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.6 m -87.52 102.07 14.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.763 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -104.85 -36.04 7.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.05 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.8 m -173.08 173.45 3.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.885 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' HG3' HG23 ' A' ' 32' ' ' THR . 13.6 pt-20 -78.41 -15.26 58.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.992 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.422 HG23 ' HG3' ' A' ' 31' ' ' GLU . 17.2 p -114.8 -6.97 12.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.165 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.625 ' HB3' HG22 ' A' ' 81' ' ' THR . 25.0 p -144.99 171.53 14.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.5 m -145.87 147.32 18.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.158 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.763 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 13.6 m-85 -82.98 115.33 21.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 81.6 t -108.35 130.33 61.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.096 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.475 ' HB ' HG22 ' A' ' 25' ' ' THR . 38.9 m -128.44 120.52 27.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.112 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.607 ' CD1' HG11 ' A' ' 93' ' ' VAL . 27.9 p90 -118.14 170.67 8.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.96 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.6 mm -133.96 106.59 11.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.634 0.731 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 136.82 33.93 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.752 2.301 . . . . 0.0 112.311 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -104.78 -69.98 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.37 145.05 16.31 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.515 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -113.55 4.74 16.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 110.895 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 82.89 1.88 90.64 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.467 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.418 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 111.53 -26.64 11.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.454 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.698 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.4 m-85 -106.81 161.7 22.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.642 0.734 . . . . 0.0 110.898 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 113.82 3.5 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.691 2.261 . . . . 0.0 112.371 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.491 HD13 ' CE1' ' A' ' 51' ' ' PHE . 89.1 mt -42.32 129.43 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.125 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -83.66 -49.02 9.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.908 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.9 p -160.09 163.2 34.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.848 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.491 ' CE1' HD13 ' A' ' 48' ' ' ILE . 52.7 m-85 -108.96 177.89 4.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -149.83 119.85 7.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.13 130.01 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.158 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -132.65 148.31 52.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.522 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 45.2 p90 -123.53 172.91 8.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.421 ' HD3' ' NE1' ' A' ' 64' ' ' TRP . 17.4 ttpt -147.91 135.35 20.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -83.33 130.69 35.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.959 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 43.2 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.88 179.987 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.421 ' NE1' ' HD3' ' A' ' 56' ' ' LYS . 73.3 m95 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.796 0.332 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.487 HG22 ' H ' ' A' ' 66' ' ' LEU . 1.8 mm -119.95 167.57 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.127 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.487 ' H ' HG22 ' A' ' 65' ' ' ILE . 47.6 tp -102.31 118.97 38.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.964 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.752 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -86.42 -69.37 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.161 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.498 ' CG2' HD11 ' A' ' 71' ' ' ILE . 2.8 t -128.67 -178.94 4.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.127 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.3 p -174.42 -177.3 1.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.841 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 61.4 32.64 19.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.103 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.667 HG23 ' HD2' ' A' ' 72' ' ' PRO . 85.3 mt -84.68 138.47 38.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.581 0.705 . . . . 0.0 111.128 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.667 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.7 Cg_endo -69.74 158.25 57.62 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.705 2.27 . . . . 0.0 112.414 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -29.57 23.78 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.724 2.283 . . . . 0.0 112.397 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.2 m -74.69 -14.24 60.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.437 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.8 ttt180 -99.99 111.25 23.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.811 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.5 mt -107.25 7.18 29.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 t -150.73 131.73 14.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.0 174.82 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.142 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 28.6 tt0 -111.9 115.0 28.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.826 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.752 HG23 ' HB1' ' A' ' 67' ' ' ALA . 23.4 mm -84.66 104.91 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.052 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.625 HG22 ' HB3' ' A' ' 33' ' ' SER . 68.3 p -98.84 168.29 10.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.144 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.01 38.96 8.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.489 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.4 mt -103.25 168.79 8.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.743 0.306 . . . . 0.0 110.874 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -113.29 127.18 56.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.79 153.37 43.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.27 12.57 72.63 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.49 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.406 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 20.1 mm -125.24 111.74 28.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.909 0.385 . . . . 0.0 111.09 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.89 139.42 40.22 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.406 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -160.72 167.35 27.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -113.4 -176.69 2.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.872 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -143.05 152.22 41.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.932 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -141.63 179.78 6.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.607 HG11 ' CD1' ' A' ' 38' ' ' TRP . 92.7 t -147.48 140.15 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.142 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -130.27 141.45 50.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -101.38 125.06 47.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.082 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.452 ' HG ' ' CB ' ' A' ' 101' ' ' GLU . 8.3 mp -121.71 119.67 32.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.949 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.449 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.2 p-10 -123.6 -173.98 2.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.476 ' HE1' ' CE1' ' A' ' 46' ' ' PHE . 4.9 ptp -67.09 -2.59 5.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 16' ' ' SER . 33.9 mt -105.15 -25.31 12.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.898 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.404 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 146.38 -168.47 27.82 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.451 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.452 ' CB ' ' HG ' ' A' ' 96' ' ' LEU . 3.8 pt-20 -101.84 158.03 16.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 0.0 110.923 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 52.6 p -98.94 167.27 10.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -61.4 157.84 42.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.684 0.754 . . . . 0.0 110.865 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 115.04 3.91 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.71 2.273 . . . . 0.0 112.319 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 92.6 p -54.17 158.95 2.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.831 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.19 142.89 56.85 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.566 0.698 . . . . 0.0 111.159 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 102.12 0.99 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.663 2.242 . . . . 0.0 112.377 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 24' ' ' PRO . 59.5 p -51.55 159.48 0.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -50.39 151.22 3.98 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.608 0.718 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 136.69 33.77 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.684 2.256 . . . . 0.0 112.353 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.525 ' CG ' HG21 ' A' ' 26' ' ' ILE . 49.0 t80 -124.73 117.47 24.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 55.3 t -92.6 103.73 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.154 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.7 t -69.47 113.07 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.3 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.891 -179.88 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 1' ' ' GLY . 69.0 m 38.1 42.27 0.46 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.921 0.391 . . . . 0.0 110.89 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.7 t -43.79 147.71 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.838 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.48 -131.63 5.42 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.484 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 6' ' ' SER . 90.3 p -77.07 -47.72 19.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.904 0.383 . . . . 0.0 110.869 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 5' ' ' SER . 58.0 p 37.42 43.36 0.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.889 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -113.88 126.14 7.22 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.466 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.9 m -85.44 124.52 32.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.806 0.336 . . . . 0.0 110.868 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -152.15 151.34 27.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.576 0.703 . . . . 0.0 110.932 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 98.03 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.695 2.263 . . . . 0.0 112.359 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.21 167.13 5.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -126.0 -44.86 1.75 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.13 -62.81 0.16 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.432 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.4 mmm-85 -67.42 90.62 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.902 0.382 . . . . 0.0 110.842 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.607 HD22 ' HA3' ' A' ' 45' ' ' GLY . 9.2 mt -81.69 -175.1 5.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.943 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.549 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.8 m -144.39 161.51 44.03 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.665 0.745 . . . . 0.0 110.863 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 169.3 19.25 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.642 2.228 . . . . 0.0 112.363 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.557 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.7 Cg_endo -69.77 154.33 67.8 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.671 2.248 . . . . 0.0 112.334 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.421 ' C ' ' HB2' ' A' ' 102' ' ' SER . 4.7 pt-20 -98.46 167.69 10.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.841 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.15 122.84 77.81 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.544 0.688 . . . . 0.0 111.076 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.41 ' HG3' HG12 ' A' ' 93' ' ' VAL . 53.4 Cg_endo -69.81 164.38 34.81 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.629 2.219 . . . . 0.0 112.278 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -50.45 176.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.832 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -80.59 123.13 82.89 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.599 0.714 . . . . 0.0 110.863 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 144.0 52.58 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.618 2.212 . . . . 0.0 112.383 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.826 ' O ' HD13 ' A' ' 26' ' ' ILE . 4.0 t -94.58 167.44 11.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.128 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.826 HD13 ' O ' ' A' ' 25' ' ' THR . 6.8 mm -125.75 126.0 69.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.141 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.0 m -129.8 160.42 33.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.434 HG21 ' HA3' ' A' ' 117' ' ' GLY . 82.6 m -80.46 104.14 10.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.062 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.726 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -106.59 -38.86 6.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.073 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.9 m -164.76 176.57 8.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.62 -17.26 51.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 p -116.91 -3.65 11.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.629 ' CB ' HG22 ' A' ' 81' ' ' THR . 5.5 p -143.07 174.81 10.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.468 HG11 ' CE2' ' A' ' 111' ' ' TYR . 31.0 m -151.85 145.34 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.155 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.726 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 12.3 m-85 -79.67 120.59 24.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.96 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 93.8 t -117.0 130.78 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.149 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 59.1 m -128.96 120.52 26.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.098 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.632 ' CD1' HG11 ' A' ' 93' ' ' VAL . 28.4 p90 -117.68 171.25 8.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 mm -135.99 107.03 9.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.633 0.73 . . . . 0.0 111.136 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 143.73 52.03 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.709 2.273 . . . . 0.0 112.357 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -112.68 -69.95 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.39 146.7 16.28 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.55 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -116.24 7.34 14.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.981 0.42 . . . . 0.0 110.956 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 79.7 2.07 87.7 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.472 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.607 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 110.35 -26.67 12.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.52 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -106.5 161.8 21.73 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.572 0.701 . . . . 0.0 110.899 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 119.21 6.19 Favored 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.712 2.275 . . . . 0.0 112.339 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.539 HD13 ' CE1' ' A' ' 51' ' ' PHE . 93.3 mt -48.25 136.17 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -93.15 -49.44 5.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.943 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.2 p -159.41 158.4 32.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.539 ' CE1' HD13 ' A' ' 48' ' ' ILE . 58.7 m-85 -108.38 173.65 6.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.896 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -144.09 128.51 17.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.573 HG11 HD11 ' A' ' 80' ' ' ILE . 42.4 t -113.08 122.83 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -124.81 157.74 35.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 39.0 p90 -133.07 174.91 9.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 89' ' ' TYR . 5.7 ttpm? -146.83 133.53 19.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -84.68 120.82 26.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.426 HD11 ' HB3' ' A' ' 110' ' ' PRO . 60.3 mt -82.59 -53.62 5.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.967 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.54 -34.12 75.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -109.19 138.95 44.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.911 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 p -74.02 131.32 35.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.167 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.99 129.15 1.0 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.497 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -52.15 -179.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.776 0.322 . . . . 0.0 110.841 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -66.62 145.74 55.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.566 HG22 ' H ' ' A' ' 66' ' ' LEU . 2.6 mm -115.63 170.63 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.137 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.566 ' H ' HG22 ' A' ' 65' ' ' ILE . 48.9 tp -103.75 118.9 37.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.964 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.68 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -87.92 -71.58 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.11 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.586 HG21 HD11 ' A' ' 71' ' ' ILE . 3.9 t -123.83 -179.4 4.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.128 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 23.7 p -174.5 174.17 2.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 67.05 30.08 7.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.111 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.691 HD13 HG11 ' A' ' 78' ' ' VAL . 56.0 mt -81.58 138.04 47.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.657 0.742 . . . . 0.0 111.149 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.652 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.0 Cg_endo -69.74 157.85 59.01 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.661 2.24 . . . . 0.0 112.334 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.69 -19.81 35.96 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.704 2.269 . . . . 0.0 112.407 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 t -85.19 -15.91 42.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.472 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 16.4 ttt180 -97.87 101.21 12.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.854 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.5 mt -98.33 7.72 45.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.959 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 t -150.33 132.1 15.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.804 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.691 HG11 HD13 ' A' ' 71' ' ' ILE . 2.2 m -146.69 164.39 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.091 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.466 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 37.3 tt0 -98.43 111.01 23.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.68 HG23 ' HB1' ' A' ' 67' ' ' ALA . 31.3 mm -78.49 101.81 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.169 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.629 HG22 ' CB ' ' A' ' 33' ' ' SER . 35.2 p -98.96 163.95 12.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.076 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.74 36.96 6.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.504 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.9 mt -104.83 168.49 9.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.76 0.314 . . . . 0.0 110.904 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -112.85 125.77 54.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.65 155.09 34.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.01 10.54 59.23 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.415 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.475 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 32.0 mm -121.98 107.87 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.839 0.352 . . . . 0.0 111.148 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.86 140.52 47.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.798 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.475 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -163.59 164.31 24.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.864 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.2 mttt -109.57 -174.83 2.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.892 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -145.4 159.5 42.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.902 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.414 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 2.7 ptp180 -150.47 174.31 13.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.632 HG11 ' CD1' ' A' ' 38' ' ' TRP . 89.1 t -139.2 142.41 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.122 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 33.8 mtt180 -133.15 143.07 49.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.833 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -103.97 129.04 51.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.078 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.1 mp -122.24 118.14 27.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.438 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 41.0 p-10 -123.04 -174.01 2.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 18.8 ptm -67.15 -2.69 6.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.839 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 16' ' ' SER . 67.4 mt -104.4 -26.01 12.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.946 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.6 -165.71 28.74 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.475 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.46 157.25 16.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.872 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.421 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 6.4 p -92.86 175.21 6.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.802 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -73.42 159.49 84.66 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.696 0.76 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.414 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.3 Cg_endo -69.69 107.49 1.86 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.708 2.272 . . . . 0.0 112.316 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.1 p -51.2 152.62 2.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -48.81 138.37 12.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.627 0.727 . . . . 0.0 111.012 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 104.86 1.39 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.634 2.223 . . . . 0.0 112.38 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.4 p -51.31 171.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -62.36 150.7 84.39 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.648 0.737 . . . . 0.0 110.899 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.426 ' HB3' HD11 ' A' ' 58' ' ' LEU . 54.7 Cg_endo -69.65 120.82 7.56 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.698 2.265 . . . . 0.0 112.339 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.512 ' CB ' HG21 ' A' ' 26' ' ' ILE . 85.8 t80 -111.04 120.05 41.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.963 0.411 . . . . 0.0 110.912 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 52.0 t -91.42 103.35 14.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 t -70.11 106.51 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.148 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 t -100.9 -51.32 3.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -166.24 -150.05 6.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.455 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 85.2 p -87.41 43.93 1.14 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.905 0.383 . . . . 0.0 110.884 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.434 ' HA3' HG21 ' A' ' 28' ' ' THR . . . 53.27 -152.17 8.92 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.467 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -168.24 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.694 2.262 . . . . 0.0 112.379 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.3 m -135.46 170.35 16.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.92 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.8 t -92.3 -40.67 10.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.937 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.516 179.931 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.5 p 46.37 41.66 9.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.903 0.382 . . . . 0.0 110.852 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 99.4 p -100.09 166.97 10.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.28 -137.7 9.86 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.491 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 p -147.17 106.3 3.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.916 0.389 . . . . 0.0 110.837 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 m -120.55 139.81 52.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.829 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.37 -42.08 0.11 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.4 m -41.52 128.34 3.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.829 0.347 . . . . 0.0 110.896 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -121.07 146.66 44.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.614 0.721 . . . . 0.0 110.916 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.412 ' O ' ' CG ' ' A' ' 11' ' ' ASP . 54.4 Cg_endo -69.65 96.68 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.661 2.241 . . . . 0.0 112.436 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 13' ' ' GLY . 3.7 m-20 -174.71 -177.87 1.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.881 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -40.62 96.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.828 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . 151.96 -88.15 0.13 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.438 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -67.39 91.19 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.905 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.545 HD13 ' CE2' ' A' ' 46' ' ' PHE . 6.3 mt -92.76 -175.67 4.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.503 ' O ' HD12 ' A' ' 99' ' ' LEU . 0.6 OUTLIER -146.81 161.52 37.14 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.578 0.704 . . . . 0.0 110.904 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 170.03 17.54 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.661 2.241 . . . . 0.0 112.361 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.549 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.5 Cg_endo -69.67 156.49 63.45 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.732 2.288 . . . . 0.0 112.333 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.423 ' C ' ' HB2' ' A' ' 102' ' ' SER . 9.3 pt-20 -100.59 166.45 10.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.07 121.53 56.1 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.646 0.736 . . . . 0.0 111.087 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 162.89 40.3 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.698 2.266 . . . . 0.0 112.353 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -51.57 175.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.793 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.43 ' NE ' ' HA ' ' A' ' 108' ' ' SER . 18.2 ttt180 -79.88 123.29 83.8 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.537 0.684 . . . . 0.0 110.917 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 142.94 48.95 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.682 2.254 . . . . 0.0 112.326 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.798 ' C ' HD13 ' A' ' 26' ' ' ILE . 2.2 t -94.05 165.42 12.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.798 HD13 ' C ' ' A' ' 25' ' ' THR . 4.3 mm -124.49 119.34 56.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.084 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.3 m -122.66 162.02 22.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.2 m -83.46 98.79 9.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.698 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -97.85 -42.22 7.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.068 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.2 m -161.09 -177.75 6.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.528 ' HG3' HG23 ' A' ' 32' ' ' THR . 15.1 pt-20 -84.44 -14.58 48.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.899 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.528 HG23 ' HG3' ' A' ' 31' ' ' GLU . 51.4 p -121.06 -1.73 9.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.106 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.62 ' CB ' HG22 ' A' ' 81' ' ' THR . 10.7 p -145.54 171.89 14.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.1 m -147.88 147.28 17.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.128 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.698 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 13.4 m-85 -82.74 113.66 20.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.851 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.5 t -108.43 128.49 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.153 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.433 HG23 ' HB2' ' A' ' 77' ' ' SER . 39.9 m -125.95 122.33 35.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.117 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.578 ' CD1' HG11 ' A' ' 93' ' ' VAL . 29.4 p90 -120.79 171.27 8.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.4 mm -136.61 106.24 9.12 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.562 0.696 . . . . 0.0 111.12 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 130.07 18.67 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.707 2.272 . . . . 0.0 112.329 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 mmt85 -94.54 -69.33 0.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.867 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.51 146.05 16.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.445 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -113.52 7.92 17.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.922 0.391 . . . . 0.0 110.904 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 80.56 -1.73 81.28 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.494 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.85 -24.51 11.84 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.473 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.613 ' CG ' ' HE3' ' A' ' 98' ' ' MET . 2.0 m-85 -108.32 162.19 20.8 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.646 0.736 . . . . 0.0 110.885 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.85 116.49 4.59 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.698 2.265 . . . . 0.0 112.278 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.54 HD13 ' CE1' ' A' ' 51' ' ' PHE . 85.9 mt -46.86 125.64 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -80.75 -51.51 8.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.2 m -156.6 162.28 39.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.858 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.54 ' CE1' HD13 ' A' ' 48' ' ' ILE . 61.3 m-85 -111.08 178.47 4.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.922 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 75.4 mtt-85 -149.61 124.94 10.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.5 t -110.24 126.47 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.11 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -124.07 155.87 37.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.513 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 39.1 p90 -132.86 158.43 42.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.88 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.459 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 28.9 ttpt -131.78 127.42 36.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.869 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -81.14 115.88 20.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' A' ' 110' ' ' PRO . 57.5 mt -78.67 -70.85 0.47 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.952 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -39.03 -67.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.888 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -79.83 138.56 37.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.4 p -62.64 131.48 28.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.086 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.91 148.25 5.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.5 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -83.54 -175.08 5.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.794 0.33 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.69 ' O ' HD13 ' A' ' 65' ' ' ILE . 87.4 m95 -63.95 155.15 31.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.69 HD13 ' O ' ' A' ' 64' ' ' TRP . 4.0 mm -136.41 166.93 25.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.133 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.502 ' H ' HG22 ' A' ' 65' ' ' ILE . 50.3 tp -97.95 126.13 43.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.94 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.659 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -95.62 -69.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.097 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.503 ' CG2' HD11 ' A' ' 71' ' ' ILE . 6.5 t -130.71 165.14 23.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.142 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.504 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 75.5 p -157.9 172.91 17.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 71.92 27.4 2.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.067 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.667 HG23 ' HD2' ' A' ' 72' ' ' PRO . 76.3 mt -78.16 138.52 60.5 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.56 0.695 . . . . 0.0 111.184 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.667 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.2 Cg_endo -69.79 155.99 64.41 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.652 2.235 . . . . 0.0 112.364 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.77 -21.79 32.92 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.615 2.21 . . . . 0.0 112.352 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 54.6 p -82.73 -13.53 56.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.809 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.455 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.3 ttt180 -100.72 106.46 17.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.946 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.2 mt -101.78 7.33 41.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.433 ' HB2' HG23 ' A' ' 37' ' ' THR . 1.4 t -151.84 131.86 13.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.409 HG11 HD13 ' A' ' 71' ' ' ILE . 2.4 m -144.23 167.94 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.079 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.44 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 33.4 tt0 -104.43 110.62 22.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.659 HG23 ' HB1' ' A' ' 67' ' ' ALA . 8.6 mm -80.91 104.03 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.099 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.62 HG22 ' CB ' ' A' ' 33' ' ' SER . 30.3 p -98.13 165.57 11.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.107 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.98 39.07 6.61 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.49 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 65.6 mt -102.91 171.88 7.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.737 0.304 . . . . 0.0 110.945 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -114.99 127.99 56.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -69.9 151.31 45.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.72 10.51 76.55 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.453 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.2 mm -124.27 114.55 41.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.856 0.36 . . . . 0.0 111.136 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.77 137.66 37.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.82 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.34 161.9 37.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -107.46 -174.87 2.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -145.82 158.15 43.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -149.05 176.05 10.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.578 HG11 ' CD1' ' A' ' 38' ' ' TRP . 59.9 t -141.95 146.43 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.112 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -136.4 140.82 43.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -100.62 124.23 45.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.47 118.69 31.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.446 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 41.4 p-10 -123.09 -173.95 2.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.613 ' HE3' ' CG ' ' A' ' 46' ' ' PHE . 5.5 ptp -69.01 -0.41 5.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.84 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.59 HD21 ' CD2' ' A' ' 46' ' ' PHE . 23.9 mt -107.62 -24.04 11.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.937 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.427 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 146.64 -168.4 27.99 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.54 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.68 157.43 16.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.878 0.37 . . . . 0.0 110.891 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.423 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 4.1 p -93.56 175.2 6.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.877 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -69.88 160.36 80.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.631 0.729 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 111.7 2.86 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.638 2.225 . . . . 0.0 112.439 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.0 p -53.9 150.36 7.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.825 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.12 140.66 6.51 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.586 0.708 . . . . 0.0 111.101 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.66 94.29 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.724 2.283 . . . . 0.0 112.383 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.43 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 4.4 p -43.26 165.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -59.81 150.93 66.03 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.645 0.736 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.478 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.9 Cg_endo -69.77 135.75 31.22 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.694 2.263 . . . . 0.0 112.329 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.428 ' CB ' HG21 ' A' ' 26' ' ' ILE . 70.4 t80 -124.86 126.64 45.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.969 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.3 t -98.41 104.46 15.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.111 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 t -72.06 107.19 2.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.13 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.0 t -102.88 -52.05 3.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.863 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -174.01 -122.08 0.66 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.446 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 87.6 p -96.23 50.56 1.17 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.885 0.374 . . . . 0.0 110.84 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 95.95 -175.27 32.28 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.457 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 119' ' ' SER . 53.8 Cg_endo -69.73 94.78 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.619 2.213 . . . . 0.0 112.353 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 118' ' ' PRO . 10.2 t -35.89 101.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 50.0 m -116.43 105.19 12.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.81 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.402 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.53 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.2 m -126.49 164.39 21.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 110.856 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 94.6 p -55.5 134.93 50.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.848 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.38 107.84 3.53 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.52 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.6 p -101.65 -44.76 5.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.847 0.355 . . . . 0.0 110.849 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 t -38.5 -62.14 0.63 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.88 126.45 8.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.523 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.0 m -85.0 163.74 18.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.784 0.326 . . . . 0.0 110.845 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -76.66 151.31 82.58 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.595 0.712 . . . . 0.0 110.903 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -170.82 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.647 2.231 . . . . 0.0 112.3 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -67.1 -64.75 0.79 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.802 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.507 ' O ' ' CG ' ' A' ' 12' ' ' HIS . 6.4 p-80 -46.36 120.03 2.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.87 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.39 -125.86 2.09 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.508 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -66.71 79.43 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.832 0.349 . . . . 0.0 110.842 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.511 HD13 ' CE2' ' A' ' 46' ' ' PHE . 5.9 mt -89.82 -175.41 4.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.959 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.581 ' O ' HD12 ' A' ' 99' ' ' LEU . 0.5 OUTLIER -142.31 161.44 50.32 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.637 0.732 . . . . 0.0 110.855 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 170.1 17.48 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.633 2.222 . . . . 0.0 112.322 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.558 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.5 Cg_endo -69.75 156.13 64.15 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.756 2.304 . . . . 0.0 112.308 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.42 ' C ' ' HB2' ' A' ' 102' ' ' SER . 7.2 pt-20 -101.37 171.81 7.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.431 ' HB1' ' HA ' ' A' ' 105' ' ' SER . . . -66.04 121.03 74.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.543 0.687 . . . . 0.0 111.116 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 164.88 32.85 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.67 2.247 . . . . 0.0 112.36 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -49.78 174.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.816 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.429 ' NH1' ' HB3' ' A' ' 23' ' ' ARG . 13.8 ttp-105 -79.95 124.32 83.19 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.594 0.712 . . . . 0.0 110.869 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 145.36 56.97 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.687 2.258 . . . . 0.0 112.341 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.753 ' O ' HD13 ' A' ' 26' ' ' ILE . 6.5 t -97.42 166.86 11.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.161 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.753 HD13 ' O ' ' A' ' 25' ' ' THR . 8.7 mm -124.7 130.46 73.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.133 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 m -132.9 172.78 12.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.899 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 85.0 m -91.37 105.55 17.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.163 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.798 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -108.61 -38.21 5.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.071 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.9 m -162.98 -176.64 5.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.577 ' HG3' HG23 ' A' ' 32' ' ' THR . 12.3 pt-20 -84.67 -16.79 40.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.577 HG23 ' HG3' ' A' ' 31' ' ' GLU . 46.5 p -122.2 0.99 9.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.654 ' CB ' HG22 ' A' ' 81' ' ' THR . 22.2 p -145.08 164.65 30.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.997 0.427 . . . . 0.0 110.848 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.455 HG11 ' CE2' ' A' ' 111' ' ' TYR . 34.8 m -144.08 145.33 21.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.081 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.798 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 25.3 m-85 -78.33 119.28 21.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.936 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.4 t -113.81 131.82 64.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.096 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.44 ' HB ' HG22 ' A' ' 25' ' ' THR . 55.9 m -128.81 123.57 33.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.085 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.643 ' CD1' HG11 ' A' ' 93' ' ' VAL . 24.0 p90 -123.01 169.23 11.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.881 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.1 mm -134.64 108.56 10.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.677 0.751 . . . . 0.0 111.133 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 140.3 42.17 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.697 2.265 . . . . 0.0 112.346 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -107.39 -69.88 0.82 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.29 142.55 15.78 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.496 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -112.44 7.88 19.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 0.0 110.865 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.07 -1.42 86.87 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.55 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.503 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 113.75 -24.69 11.72 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.516 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.606 ' CD2' HD21 ' A' ' 99' ' ' LEU . 2.4 m-85 -108.06 161.9 21.74 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.656 0.741 . . . . 0.0 110.873 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 117.06 4.86 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.663 2.242 . . . . 0.0 112.362 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.682 HD13 ' CZ ' ' A' ' 51' ' ' PHE . 80.6 mt -45.14 135.21 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -91.97 -46.09 8.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.841 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.0 m -163.24 158.22 21.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.991 0.424 . . . . 0.0 110.857 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.682 ' CZ ' HD13 ' A' ' 48' ' ' ILE . 59.5 m-85 -108.67 170.13 8.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.83 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -144.24 120.77 11.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.427 ' HB ' HG22 ' A' ' 68' ' ' THR . 62.9 t -103.67 133.41 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.107 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -130.67 160.99 32.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.913 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.549 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 27.5 p90 -141.93 143.09 33.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.479 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 26.9 ttpt -117.33 133.45 55.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.872 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -79.1 124.54 28.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.921 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.1 mt -85.38 -60.88 1.9 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -53.94 -46.94 71.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.8 ttpp -91.92 157.24 16.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.607 HG13 ' O ' ' A' ' 61' ' ' VAL . 7.6 p -93.46 116.15 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.165 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.76 131.92 1.65 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.519 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -52.02 177.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.756 0.312 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.479 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 69.0 m95 -61.18 151.5 31.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.961 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.477 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.6 mm -123.42 156.12 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.9 tp -89.5 120.96 31.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.931 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.661 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -89.91 -59.33 2.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.427 HG22 ' HB ' ' A' ' 53' ' ' VAL . 6.2 t -147.63 174.55 11.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.164 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.451 ' OG ' ' N ' ' A' ' 70' ' ' ALA . 4.9 t -168.24 177.06 5.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.853 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.451 ' N ' ' OG ' ' A' ' 69' ' ' SER . . . 69.34 25.74 5.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.111 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.676 HG23 ' HD2' ' A' ' 72' ' ' PRO . 76.1 mt -78.18 138.72 60.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.623 0.725 . . . . 0.0 111.191 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.676 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.9 Cg_endo -69.76 157.07 61.65 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.736 2.291 . . . . 0.0 112.345 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -22.9 31.64 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.695 2.263 . . . . 0.0 112.337 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.2 m -82.57 -9.1 59.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.442 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.4 ttt180 -107.54 102.1 11.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.852 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.9 mt -99.89 12.56 36.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.938 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.6 t -153.32 131.68 12.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.838 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.618 HG11 HD13 ' A' ' 71' ' ' ILE . 2.2 m -145.88 162.32 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.556 ' OE1' ' HB1' ' A' ' 29' ' ' ALA . 32.6 tt0 -98.25 111.5 23.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.661 HG23 ' HB1' ' A' ' 67' ' ' ALA . 33.7 mm -81.32 102.08 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.169 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.654 HG22 ' CB ' ' A' ' 33' ' ' SER . 30.2 p -97.71 168.82 10.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.31 40.04 9.43 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.493 HD21 HG22 ' A' ' 80' ' ' ILE . 25.6 mt -101.32 170.87 7.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.687 0.28 . . . . 0.0 110.969 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -112.45 126.49 55.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -68.79 152.05 45.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.835 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.13 12.25 62.63 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 28.6 mm -122.68 101.12 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.871 0.367 . . . . 0.0 111.104 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.36 133.37 49.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -156.55 164.12 38.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.941 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -111.17 178.45 4.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.887 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -135.44 155.06 51.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 5.8 ptp180 -144.6 179.15 7.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.643 HG11 ' CD1' ' A' ' 38' ' ' TRP . 96.7 t -145.4 141.89 22.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.076 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.6 mtt180 -133.28 137.15 45.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.969 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -98.29 130.4 44.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.045 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mp -123.12 119.6 30.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.444 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.5 p-10 -123.56 -174.46 2.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.908 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.8 ptp -67.36 -2.62 6.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.606 HD21 ' CD2' ' A' ' 46' ' ' PHE . 23.5 mt -104.73 -24.94 12.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 146.5 -168.91 27.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.442 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -97.54 158.49 15.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.845 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.42 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 5.5 p -94.02 175.2 6.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.89 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -73.37 159.56 84.55 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.711 0.767 . . . . 0.0 110.894 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.43 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.9 Cg_endo -69.77 109.26 2.27 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.714 2.276 . . . . 0.0 112.394 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.431 ' HA ' ' HB1' ' A' ' 20' ' ' ALA . 93.8 p -52.62 158.14 1.38 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.846 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.55 140.67 46.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.515 0.674 . . . . 0.0 111.132 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 100.72 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.652 2.235 . . . . 0.0 112.378 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.0 p -47.27 170.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -59.38 150.52 64.08 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.595 0.712 . . . . 0.0 110.881 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.87 122.44 9.09 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.716 2.277 . . . . 0.0 112.267 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.623 ' CG ' HG21 ' A' ' 26' ' ' ILE . 56.2 t80 -111.16 116.46 31.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.953 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 94.7 t -92.28 103.48 14.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.213 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.8 t -70.73 107.09 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.097 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.5 t -111.23 46.9 1.04 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.892 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.1 -160.48 54.0 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.451 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 86.8 p -40.35 -47.08 2.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.962 0.41 . . . . 0.0 110.873 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.79 -159.46 21.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.494 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 2.05 3.87 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.693 2.262 . . . . 0.0 112.34 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.1 p -38.57 119.98 0.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.911 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.1 p -130.83 172.34 12.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.879 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.418 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 91.6 p -90.67 138.44 31.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.877 0.37 . . . . 0.0 110.847 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m -107.41 -44.43 4.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.48 177.38 18.57 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.451 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.3 t -163.62 132.91 3.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.822 0.344 . . . . 0.0 110.865 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 t -135.84 164.25 28.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.801 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.01 -56.28 1.28 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.495 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.3 p -58.35 110.72 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.821 0.343 . . . . 0.0 110.897 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -50.77 150.22 5.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.562 0.696 . . . . 0.0 110.939 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.78 5.56 1.65 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.678 2.252 . . . . 0.0 112.34 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.82 141.9 46.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -55.81 150.02 13.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.82 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 179.34 -49.62 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.474 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -47.87 96.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.88 0.372 . . . . 0.0 110.868 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.689 HD13 ' CE2' ' A' ' 46' ' ' PHE . 9.7 mt -99.85 -175.92 3.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.585 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.9 m -144.51 161.08 45.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.718 0.771 . . . . 0.0 110.806 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 170.01 17.56 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.628 2.219 . . . . 0.0 112.354 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.554 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.6 Cg_endo -69.86 154.24 67.58 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.664 2.243 . . . . 0.0 112.317 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.418 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.4 pt-20 -97.29 168.35 10.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.71 121.62 65.79 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.662 0.744 . . . . 0.0 111.154 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 160.9 48.0 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.684 2.256 . . . . 0.0 112.396 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -48.46 175.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.0 ttm105 -80.58 123.84 82.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.595 0.712 . . . . 0.0 110.817 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 143.85 52.27 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.674 2.25 . . . . 0.0 112.374 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.898 ' C ' HD13 ' A' ' 26' ' ' ILE . 4.8 t -96.9 167.59 10.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.112 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.898 HD13 ' C ' ' A' ' 25' ' ' THR . 3.1 mm -125.01 131.78 72.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.153 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 m -135.71 167.31 21.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.7 m -85.73 104.26 15.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.103 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.787 ' HB1' ' OE2' ' A' ' 79' ' ' GLU . . . -106.26 -40.71 5.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.056 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 m -162.77 163.96 26.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -67.73 -14.41 62.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.964 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 p -122.67 -1.13 9.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.165 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.67 ' CB ' HG22 ' A' ' 81' ' ' THR . 51.9 p -142.19 172.37 12.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.402 HG22 HD11 ' A' ' 83' ' ' LEU . 30.0 m -148.02 147.91 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.105 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.741 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 11.7 m-85 -83.42 115.09 21.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.934 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.4 t -109.78 129.05 65.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.12 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.478 ' HB ' HG22 ' A' ' 25' ' ' THR . 84.9 m -129.19 123.59 32.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.657 ' CD1' HG11 ' A' ' 93' ' ' VAL . 33.6 p90 -120.98 171.16 8.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.5 mm -134.77 106.14 10.68 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.612 0.72 . . . . 0.0 111.188 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 136.12 32.23 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.661 2.24 . . . . 0.0 112.36 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -102.74 -69.48 0.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.73 146.91 16.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.463 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 46.0 p-10 -113.84 6.34 16.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.92 0.39 . . . . 0.0 110.937 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.62 -1.52 87.73 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.458 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.15 -25.1 10.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.689 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.5 m-85 -109.21 161.86 22.26 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.63 0.729 . . . . 0.0 110.901 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 114.14 3.6 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.666 2.244 . . . . 0.0 112.366 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.529 HD13 ' CE1' ' A' ' 51' ' ' PHE . 94.6 mt -44.59 131.86 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -85.97 -47.97 9.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.7 p -160.54 163.32 32.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.851 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.529 ' CE1' HD13 ' A' ' 48' ' ' ILE . 65.3 m-85 -111.41 176.38 5.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.886 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -149.03 125.83 11.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.845 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 t -109.22 129.71 63.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.094 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.431 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 2.6 mp0 -126.58 154.87 43.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.872 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.53 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 33.5 p90 -135.58 142.64 45.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.987 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.517 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 33.6 ttpt -115.92 129.22 56.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -78.56 121.56 24.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 69.8 mt -84.22 174.12 10.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.913 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt 42.35 31.65 0.28 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -154.83 140.22 17.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 61' ' ' VAL . 8.8 p -77.79 122.5 32.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.14 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.78 -130.46 1.71 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.473 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -168.21 -178.65 3.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.785 0.326 . . . . 0.0 110.854 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.567 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 83.8 m95 -66.38 142.47 57.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.406 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.1 mm -120.51 162.03 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.159 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.2 tp -98.65 123.0 42.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.61 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -91.51 -71.69 0.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.018 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.487 ' CG2' HD11 ' A' ' 71' ' ' ILE . 3.7 t -125.11 178.36 5.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.141 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 92.6 p -172.1 176.09 3.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 69.45 26.61 5.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.668 HG23 ' HD2' ' A' ' 72' ' ' PRO . 83.6 mt -78.22 138.51 60.26 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.574 0.702 . . . . 0.0 111.156 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.668 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.4 Cg_endo -69.8 158.28 57.43 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.755 2.303 . . . . 0.0 112.285 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -24.77 29.21 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.686 2.257 . . . . 0.0 112.367 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.8 p -78.95 -19.9 50.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.457 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 6.1 ttt85 -94.42 108.3 20.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.836 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.0 mt -102.7 11.41 37.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.9 t -155.29 136.07 13.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.464 HG11 HD13 ' A' ' 71' ' ' ILE . 2.4 m -146.03 165.92 9.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.091 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.787 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 39.9 tt0 -101.35 110.09 22.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.61 HG23 ' HB1' ' A' ' 67' ' ' ALA . 27.9 mm -80.16 100.16 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.166 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.67 HG22 ' CB ' ' A' ' 33' ' ' SER . 27.6 p -97.41 168.96 10.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.126 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.63 37.47 11.9 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.495 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.537 HD21 HG22 ' A' ' 80' ' ' ILE . 31.5 mt -96.42 177.37 5.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.762 0.315 . . . . 0.0 110.935 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -119.68 119.29 33.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.832 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.418 ' HG2' ' N ' ' A' ' 115' ' ' GLY . 0.5 OUTLIER -61.63 153.11 28.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.921 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.59 14.15 64.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.493 HG22 ' CD2' ' A' ' 89' ' ' TYR . 29.0 mm -124.57 113.67 37.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.38 . . . . 0.0 111.092 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.3 131.89 36.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.823 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.493 ' CD2' HG22 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -154.36 162.87 40.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.856 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -107.95 -175.13 2.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.855 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -142.92 154.39 44.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.567 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 4.8 ptp180 -146.56 174.21 11.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.895 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.657 HG11 ' CD1' ' A' ' 38' ' ' TRP . 57.8 t -140.99 143.59 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -133.78 139.58 46.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -98.88 128.68 45.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.2 mp -123.08 118.87 28.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.443 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.5 p-10 -123.52 -173.65 2.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.436 ' HE1' ' CD1' ' A' ' 46' ' ' PHE . 5.8 ptp -68.89 -0.52 5.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.852 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.591 HD21 ' CD2' ' A' ' 46' ' ' PHE . 27.7 mt -107.07 -24.74 11.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 147.43 -167.26 28.57 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.494 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.59 158.34 16.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 0.0 110.934 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.441 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 5.1 p -94.32 175.18 6.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -70.89 160.23 82.89 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.603 0.716 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 108.01 1.98 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.725 2.284 . . . . 0.0 112.393 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.9 p -51.7 150.9 3.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.806 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.79 139.7 6.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.58 0.705 . . . . 0.0 111.114 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 99.5 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.684 2.256 . . . . 0.0 112.325 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 95.7 p -44.8 162.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.872 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.3 mtp85 -56.74 153.01 23.72 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.607 0.718 . . . . 0.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.87 129.59 17.74 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.608 2.205 . . . . 0.0 112.305 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -122.14 117.02 25.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 45.0 t -90.66 102.77 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 113' ' ' VAL . 14.0 t -67.84 103.37 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.057 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.3 t -99.89 44.21 1.03 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.829 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.418 ' N ' ' HG2' ' A' ' 85' ' ' LYS . . . 41.96 67.0 0.91 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.508 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.2 t -120.71 103.28 8.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.942 0.401 . . . . 0.0 110.884 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -94.24 174.01 33.46 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.524 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -34.14 15.18 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.751 2.3 . . . . 0.0 112.329 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.9 t 55.13 41.5 31.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.809 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 73.7 m -58.45 138.93 56.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.39 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.506 -179.972 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -164.0 173.58 12.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.374 . . . . 0.0 110.879 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 t -138.74 171.77 13.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.65 103.8 3.08 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.489 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 88.9 p -103.44 164.21 11.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.895 0.379 . . . . 0.0 110.871 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.7 p -86.82 110.72 20.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.796 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.25 -178.42 36.99 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.511 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 t -44.77 95.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.777 0.322 . . . . 0.0 110.881 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -156.85 135.18 7.44 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.572 0.701 . . . . 0.0 110.891 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -167.79 0.24 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.725 2.283 . . . . 0.0 112.377 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -79.4 48.16 0.87 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.528 ' O ' ' CG ' ' A' ' 12' ' ' HIS . 0.5 OUTLIER -93.38 70.02 4.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.846 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.54 -102.71 0.16 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.53 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -79.97 85.5 5.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.834 0.349 . . . . 0.0 110.894 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.54 HD13 ' CE2' ' A' ' 46' ' ' PHE . 6.3 mt -90.08 -175.07 4.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.93 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.591 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.9 m -144.32 161.38 44.87 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.664 0.745 . . . . 0.0 110.877 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 169.94 17.77 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.725 2.283 . . . . 0.0 112.356 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.531 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.5 Cg_endo -69.75 155.5 65.82 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.746 2.297 . . . . 0.0 112.36 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.416 ' C ' ' HB2' ' A' ' 102' ' ' SER . 7.0 pt-20 -97.97 170.08 9.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.874 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.69 122.07 78.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.646 0.736 . . . . 0.0 111.037 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.463 ' HG3' HG12 ' A' ' 93' ' ' VAL . 53.5 Cg_endo -69.76 161.8 44.52 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.711 2.274 . . . . 0.0 112.358 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -47.36 174.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.833 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -80.47 122.84 82.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.599 0.714 . . . . 0.0 110.821 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 144.35 53.62 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.679 2.253 . . . . 0.0 112.323 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.806 ' O ' HD13 ' A' ' 26' ' ' ILE . 6.5 t -94.81 167.89 11.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.075 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.806 HD13 ' O ' ' A' ' 25' ' ' THR . 5.8 mm -125.85 123.08 63.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.117 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -128.09 162.89 25.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.829 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m -83.46 98.56 9.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.079 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.683 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -98.4 -37.66 9.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.08 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.7 m -162.43 -179.47 6.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -79.59 -21.6 44.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.838 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.8 p -120.25 3.46 10.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.246 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.535 ' CB ' HG22 ' A' ' 81' ' ' THR . 12.4 p -145.58 165.74 27.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.4 m -144.16 149.9 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.162 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.683 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 12.3 m-85 -84.48 117.49 23.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.919 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 91.1 t -112.61 131.22 64.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.113 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.0 m -129.1 124.69 35.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.205 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.61 ' CD1' HG11 ' A' ' 93' ' ' VAL . 31.4 p90 -124.52 170.81 10.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 mm -134.93 110.23 10.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.582 0.706 . . . . 0.0 111.12 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 145.19 56.18 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.72 2.28 . . . . 0.0 112.316 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -113.66 -69.21 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.81 143.9 15.82 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.481 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 50.8 p-10 -113.33 9.14 18.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.92 0.39 . . . . 0.0 110.88 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.64 0.1 78.75 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.481 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.5 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 112.87 -25.33 11.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.458 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.54 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.3 m-85 -107.94 162.0 21.34 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.656 0.741 . . . . 0.0 110.877 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 117.57 5.16 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.691 2.261 . . . . 0.0 112.365 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.542 HD13 ' CE1' ' A' ' 51' ' ' PHE . 82.0 mt -48.11 133.37 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.135 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -89.33 -52.51 5.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.7 m -155.91 160.44 40.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.806 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.542 ' CE1' HD13 ' A' ' 48' ' ' ILE . 61.4 m-85 -109.77 171.27 7.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.929 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.687 HH21 HD22 ' A' ' 66' ' ' LEU . 23.1 mtp180 -143.63 123.7 13.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.484 HG11 HD11 ' A' ' 80' ' ' ILE . 25.9 t -104.32 117.04 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -115.78 155.35 27.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.533 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 38.9 p90 -133.62 170.28 15.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 29.4 ttpt -142.32 131.66 23.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -80.17 128.91 34.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.866 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.421 HD11 ' HB3' ' A' ' 110' ' ' PRO . 38.0 mt -91.29 147.52 22.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.957 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt 53.94 30.73 12.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.871 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.0 mmmt -139.4 -175.03 4.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.03 138.6 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.106 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 124.2 142.65 6.02 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.475 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.449 ' O ' ' CD1' ' A' ' 65' ' ' ILE . 12.0 m-20 -84.12 -177.5 6.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.831 0.348 . . . . 0.0 110.906 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.561 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 75.5 m95 -52.36 146.4 9.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.868 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.533 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 1.8 mm -125.74 155.16 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.687 HD22 HH21 ' A' ' 52' ' ' ARG . 57.5 tp -88.26 121.87 31.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.926 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.683 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -84.91 -67.4 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.448 ' CG2' HD11 ' A' ' 71' ' ' ILE . 13.5 t -129.08 -179.64 5.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.508 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 60.3 p -170.35 170.39 7.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 72.01 32.83 1.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.147 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.762 HD13 HG11 ' A' ' 78' ' ' VAL . 58.2 mt -86.05 137.83 35.13 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.646 0.736 . . . . 0.0 111.107 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.628 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.1 Cg_endo -69.74 157.36 60.69 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.727 2.285 . . . . 0.0 112.364 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.61 -24.7 30.06 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.71 2.273 . . . . 0.0 112.369 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 t -79.53 -15.77 57.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.908 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.457 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 13.8 ttt180 -97.87 105.15 17.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.852 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.5 mt -100.75 13.71 34.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.5 t -155.73 137.35 14.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.762 HG11 HD13 ' A' ' 71' ' ' ILE . 2.0 m -150.11 162.12 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.083 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.496 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 36.7 tt0 -98.06 117.07 31.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.683 HG23 ' HB1' ' A' ' 67' ' ' ALA . 31.9 mm -85.9 95.17 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.118 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.535 HG22 ' CB ' ' A' ' 33' ' ' SER . 23.6 p -88.83 171.72 9.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.189 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.29 44.06 14.45 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.437 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.588 HD21 HG22 ' A' ' 80' ' ' ILE . 39.6 mt -104.59 162.18 13.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.794 0.33 . . . . 0.0 110.924 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -106.58 123.7 48.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.407 ' CG ' HG12 ' A' ' 113' ' ' VAL . 14.2 mttt -64.73 159.98 21.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.12 11.88 20.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.48 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.8 mm -121.09 94.12 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 111.091 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.76 135.36 57.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.929 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -159.51 160.35 34.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -107.52 -179.39 3.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.838 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -139.72 156.66 46.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.561 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 3.8 ptp180 -147.69 178.16 8.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.834 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.61 HG11 ' CD1' ' A' ' 38' ' ' TRP . 91.9 t -141.0 140.71 32.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.128 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -132.49 135.57 46.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.831 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -96.56 129.85 43.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.135 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.8 mp -122.5 115.33 22.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.441 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.5 p-10 -119.87 -173.92 2.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 14.4 ptm -67.77 -1.83 6.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.591 HD12 ' O ' ' A' ' 16' ' ' SER . 51.1 mt -105.42 -25.58 12.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.83 -165.99 28.83 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.403 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -99.09 158.07 15.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 0.0 110.901 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.498 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 5.2 p -92.75 175.23 6.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -72.69 158.83 86.69 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.709 0.766 . . . . 0.0 110.835 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.439 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.8 Cg_endo -69.72 103.81 1.21 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.729 2.286 . . . . 0.0 112.332 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.4 p -48.21 152.18 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.892 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.38 140.8 5.27 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.585 0.707 . . . . 0.0 111.116 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 100.43 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.685 2.257 . . . . 0.0 112.333 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 52.0 p -48.45 157.17 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -49.57 151.6 2.82 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.592 0.711 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.421 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.1 Cg_endo -69.82 129.04 16.85 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.649 2.233 . . . . 0.0 112.332 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.484 ' CG ' HG21 ' A' ' 26' ' ' ILE . 52.3 t80 -117.58 122.65 44.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.1 t -98.22 101.29 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.064 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.407 HG12 ' CG ' ' A' ' 85' ' ' LYS . 22.0 t -69.1 107.08 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.097 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.6 t -104.94 21.81 16.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.45 -121.83 6.57 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.522 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.1 m -83.27 95.22 8.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.924 0.392 . . . . 0.0 110.905 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.26 -156.69 24.88 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.448 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 135.7 31.11 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.674 2.249 . . . . 0.0 112.409 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.5 m -119.08 135.36 54.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.824 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 65.3 p -151.67 165.48 34.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.917 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.438 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.6 t -167.6 149.52 5.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.955 0.407 . . . . 0.0 110.838 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m -93.27 158.22 15.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.6 -163.9 39.66 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.461 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.8 p -137.23 123.64 20.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.85 0.357 . . . . 0.0 110.856 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 t -69.11 151.45 46.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.836 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.89 -161.19 31.82 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.494 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.3 t -68.54 132.56 47.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.821 0.343 . . . . 0.0 110.863 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.451 ' CG ' ' HD2' ' A' ' 10' ' ' PRO . 51.0 tt0 -96.29 138.77 21.53 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.602 0.715 . . . . 0.0 110.835 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.451 ' HD2' ' CG ' ' A' ' 9' ' ' GLN . 54.1 Cg_endo -69.77 3.85 2.54 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.66 2.24 . . . . 0.0 112.345 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -139.81 149.6 43.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -46.5 113.55 0.66 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -163.92 -78.52 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.47 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -73.0 92.42 1.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.847 0.356 . . . . 0.0 110.921 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.612 HD22 ' HA3' ' A' ' 45' ' ' GLY . 10.3 mt -92.72 -175.46 3.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.943 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.651 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -134.42 160.59 67.91 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.704 0.764 . . . . 0.0 110.891 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 170.05 17.53 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.697 2.265 . . . . 0.0 112.341 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.541 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 52.8 Cg_endo -69.81 152.48 69.06 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.648 2.232 . . . . 0.0 112.337 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.43 ' C ' ' HB2' ' A' ' 102' ' ' SER . 7.5 pt-20 -96.12 161.08 14.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.909 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 103' ' ' GLU . . . -58.61 123.93 69.81 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.518 0.675 . . . . 0.0 111.136 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 165.86 29.55 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.666 2.244 . . . . 0.0 112.304 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -53.97 177.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -80.04 123.58 83.42 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.557 0.694 . . . . 0.0 110.886 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 144.27 53.35 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.664 2.243 . . . . 0.0 112.34 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.88 ' O ' HD13 ' A' ' 26' ' ' ILE . 14.8 t -94.18 165.7 12.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.174 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.88 HD13 ' O ' ' A' ' 25' ' ' THR . 4.2 mm -129.98 121.62 52.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.148 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 m -122.93 -175.99 3.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.889 HG21 ' HA2' ' A' ' 117' ' ' GLY . 30.3 m -99.85 97.57 8.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.165 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.904 ' HB1' ' OE1' ' A' ' 79' ' ' GLU . . . -98.18 -42.72 7.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.098 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 t -157.43 -175.98 5.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.829 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -81.77 -21.33 37.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 36.0 p -120.61 -0.72 10.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.154 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.533 ' HB3' HG22 ' A' ' 81' ' ' THR . 99.4 p -135.29 173.33 11.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.808 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.3 m -154.83 142.89 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.185 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.586 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 18.6 m-85 -76.95 120.64 22.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.943 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.0 t -116.13 125.56 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.086 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.7 m -126.09 121.62 33.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.152 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.744 ' CD1' HG11 ' A' ' 93' ' ' VAL . 25.3 p90 -119.06 171.09 8.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.8 mm -134.04 107.28 11.46 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.6 0.714 . . . . 0.0 111.193 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 130.88 20.09 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -94.16 -67.76 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.26 161.79 12.82 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.532 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -125.66 4.67 7.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.884 0.373 . . . . 0.0 110.895 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 81.72 2.29 90.48 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.433 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.612 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 109.44 -25.54 17.39 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.42 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.495 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 2.5 m-85 -108.36 162.05 21.31 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.63 0.728 . . . . 0.0 110.891 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.8 116.18 4.44 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.711 2.274 . . . . 0.0 112.303 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.517 HD13 ' CE1' ' A' ' 51' ' ' PHE . 96.4 mt -46.59 135.76 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -90.0 -49.12 6.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 m -161.58 160.1 28.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.863 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.517 ' CE1' HD13 ' A' ' 48' ' ' ILE . 64.4 m-85 -108.0 175.97 5.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -149.22 128.08 12.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.43 HG11 HD11 ' A' ' 80' ' ' ILE . 60.2 t -110.35 130.22 64.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.102 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.475 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 21.4 mt-10 -125.56 157.86 36.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.854 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.504 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 26.9 p90 -139.81 145.4 38.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.988 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.404 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 31.8 ttpt -120.94 134.33 55.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.822 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.4 mttt -82.65 128.54 34.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.917 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.46 HD11 ' HB3' ' A' ' 110' ' ' PRO . 58.5 mt -91.73 -71.31 0.64 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.884 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -40.53 -26.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -118.97 140.11 50.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -73.93 127.89 36.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.113 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.06 179.85 48.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.481 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -101.0 -175.6 2.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.9 0.381 . . . . 0.0 110.81 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.404 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 78.3 m95 -75.24 139.82 42.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.456 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.7 mm -115.03 162.75 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.109 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.1 tp -98.91 118.06 34.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.643 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -83.35 -68.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.095 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.564 HG21 HD11 ' A' ' 71' ' ' ILE . 7.7 t -128.51 175.79 8.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.15 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.552 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 90.0 p -168.14 167.34 12.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.795 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.552 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 74.39 25.98 1.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.058 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.684 HD13 HG11 ' A' ' 78' ' ' VAL . 52.3 mt -76.9 136.98 66.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.667 0.746 . . . . 0.0 111.139 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.603 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.9 Cg_endo -69.74 156.67 62.81 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.69 2.26 . . . . 0.0 112.358 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.71 -18.54 37.17 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.701 2.267 . . . . 0.0 112.446 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 86.5 p -86.58 -13.05 46.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.461 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 8.6 ttt85 -101.67 98.96 9.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 51.9 mt -96.74 11.62 34.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.836 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 t -153.39 131.72 12.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.684 HG11 HD13 ' A' ' 71' ' ' ILE . 2.2 m -145.7 163.91 11.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.109 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.904 ' OE1' ' HB1' ' A' ' 29' ' ' ALA . 33.5 tt0 -100.47 108.83 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.643 HG23 ' HB1' ' A' ' 67' ' ' ALA . 26.7 mm -75.82 107.39 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.193 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.533 HG22 ' HB3' ' A' ' 33' ' ' SER . 72.0 p -102.89 165.85 10.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.167 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.66 41.11 7.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.464 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.6 mt -99.16 -178.91 4.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.757 0.313 . . . . 0.0 110.9 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -125.05 122.33 36.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -63.83 161.04 16.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.9 12.0 9.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.417 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 26.9 mm -122.23 108.26 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 0.0 111.24 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.26 136.54 42.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.417 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -157.54 168.59 26.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -114.09 -175.45 2.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.904 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -143.85 158.4 43.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.817 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.475 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 2.7 ptp180 -150.45 175.16 12.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.744 HG11 ' CD1' ' A' ' 38' ' ' TRP . 90.8 t -143.18 135.56 24.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.085 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -126.49 144.32 50.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.541 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -104.85 129.52 53.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.155 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mp -123.41 117.32 24.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.867 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.439 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 37.9 p-10 -119.81 -172.61 2.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 12.6 ptm -69.48 1.45 3.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.809 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 16' ' ' SER . 34.3 mt -108.81 -26.59 10.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.908 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.54 -163.09 29.51 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.532 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -104.59 158.14 16.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 110.861 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.43 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 7.5 p -95.39 175.06 6.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.825 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 30.1 mt-10 -70.76 157.01 91.18 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.575 0.703 . . . . 0.0 110.943 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.434 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.7 Cg_endo -69.73 105.2 1.44 Allowed 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.683 2.255 . . . . 0.0 112.294 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.0 p -45.94 150.52 0.55 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -44.0 141.44 2.4 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.556 0.694 . . . . 0.0 111.148 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 97.66 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.684 2.256 . . . . 0.0 112.36 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 t -43.53 154.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.84 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -51.43 153.71 3.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.617 0.722 . . . . 0.0 110.829 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.46 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.5 Cg_endo -69.77 121.92 8.6 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.722 2.281 . . . . 0.0 112.306 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -112.79 120.19 40.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.31 104.96 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.196 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.3 t -73.65 106.45 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.4 t -103.77 -45.2 4.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.816 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -165.04 -174.67 34.99 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.461 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 93.8 p -86.14 106.28 17.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.938 0.399 . . . . 0.0 110.846 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.889 ' HA2' HG21 ' A' ' 28' ' ' THR . . . 51.09 -156.44 2.93 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.465 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 119' ' ' SER . 52.7 Cg_endo -69.92 3.96 2.54 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.705 2.27 . . . . 0.0 112.327 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 118' ' ' PRO . 41.6 t -34.01 -40.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.814 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.9 m -89.85 -64.32 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.446 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.0 t -64.23 164.37 11.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.932 0.396 . . . . 0.0 110.871 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 m -124.7 -43.67 2.0 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.864 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.86 -170.93 21.06 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.452 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.6 m -47.61 122.2 4.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.872 0.368 . . . . 0.0 110.783 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.7 p -63.51 170.3 3.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.77 -154.59 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.462 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.8 m -128.69 112.19 13.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.822 0.344 . . . . 0.0 110.826 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -39.66 154.65 0.17 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.614 0.721 . . . . 0.0 110.836 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 3.94 2.48 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.704 2.269 . . . . 0.0 112.342 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -83.29 168.15 16.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -171.61 171.81 5.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.99 85.44 1.36 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.43 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.0 mtt-85 -73.59 89.96 1.75 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.91 0.386 . . . . 0.0 110.874 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.763 HD13 ' CE2' ' A' ' 46' ' ' PHE . 13.3 mt -91.96 -175.03 3.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.654 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.8 m -145.11 161.21 43.25 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.58 0.705 . . . . 0.0 110.892 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 170.14 17.27 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.641 2.227 . . . . 0.0 112.377 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.495 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 54.3 Cg_endo -69.73 156.63 62.92 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.664 2.242 . . . . 0.0 112.331 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.426 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.4 pt-20 -98.11 174.53 6.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.2 123.44 87.38 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.597 0.713 . . . . 0.0 111.082 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 161.33 46.33 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.665 2.243 . . . . 0.0 112.376 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -49.39 174.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -80.43 122.16 82.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.602 0.715 . . . . 0.0 110.908 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HB2' HG13 ' A' ' 36' ' ' VAL . 53.9 Cg_endo -69.69 143.15 50.25 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.666 2.244 . . . . 0.0 112.402 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.917 ' C ' HD13 ' A' ' 26' ' ' ILE . 5.4 t -95.27 165.98 12.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.106 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.917 HD13 ' C ' ' A' ' 25' ' ' THR . 2.8 mm -126.81 125.34 66.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.184 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.6 t -131.44 166.99 20.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.4 m -80.88 107.27 13.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.732 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -111.13 -36.31 5.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 m -164.87 -179.71 5.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -82.99 -19.5 36.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.832 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.8 p -120.33 -1.9 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.715 ' CB ' HG22 ' A' ' 81' ' ' THR . 24.2 p -140.4 171.25 14.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.9 m -149.65 147.43 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.163 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.732 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 15.1 m-85 -82.78 120.49 25.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.407 HG13 ' HB2' ' A' ' 24' ' ' PRO . 92.3 t -115.71 131.46 68.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.105 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.9 m -128.36 120.59 27.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.152 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.568 ' CD1' HG11 ' A' ' 93' ' ' VAL . 28.6 p90 -120.13 170.27 9.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.1 mm -134.3 110.5 11.63 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.59 0.709 . . . . 0.0 111.137 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.453 ' HD3' HD22 ' A' ' 76' ' ' LEU . 53.9 Cg_endo -69.79 137.99 36.66 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.727 2.285 . . . . 0.0 112.312 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -103.58 -69.68 0.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.849 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.48 158.85 14.81 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.509 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -124.25 5.57 8.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.833 0.349 . . . . 0.0 110.815 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.11 0.69 89.27 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.519 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.411 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 108.58 -18.1 32.76 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.548 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.763 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.1 m-85 -114.68 162.24 24.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.617 0.723 . . . . 0.0 110.922 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 114.61 3.75 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.711 2.274 . . . . 0.0 112.33 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.537 HD13 ' CE1' ' A' ' 51' ' ' PHE . 95.8 mt -46.46 141.2 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.36 -52.11 4.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.7 p -159.69 160.61 34.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.537 ' CE1' HD13 ' A' ' 48' ' ' ILE . 52.4 m-85 -108.83 168.32 9.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.928 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.4 mtt-85 -143.39 136.77 28.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.429 ' HB ' HG22 ' A' ' 68' ' ' THR . 58.8 t -116.63 134.8 58.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -133.63 158.84 42.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.545 ' CD2' ' HB2' ' A' ' 67' ' ' ALA . 26.4 p90 -136.82 175.02 10.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.944 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.466 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 36.9 ttpt -147.69 135.62 21.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.944 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -82.34 129.63 34.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 110' ' ' PRO . 28.8 mt -96.31 -65.46 0.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.907 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -50.98 -21.28 1.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.942 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -128.27 128.57 44.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.856 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 61' ' ' VAL . 6.1 p -58.95 118.12 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.84 131.27 2.0 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.484 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -59.88 -175.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.789 0.328 . . . . 0.0 110.872 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.466 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 78.0 m95 -75.21 135.59 41.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.89 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.508 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.9 mm -115.14 159.42 15.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.14 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 tp -91.5 122.52 34.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.762 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -91.41 -71.33 0.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.081 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.464 ' CG2' HD11 ' A' ' 71' ' ' ILE . 1.3 t -130.29 165.08 23.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.151 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.9 m -162.85 -175.34 4.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 64.25 29.77 13.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.055 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.594 HG23 ' HD2' ' A' ' 72' ' ' PRO . 61.3 mt -83.37 137.42 42.24 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.641 0.734 . . . . 0.0 111.176 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.594 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.9 Cg_endo -69.7 158.19 57.9 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.633 2.222 . . . . 0.0 112.379 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.72 -11.41 30.82 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.661 2.24 . . . . 0.0 112.323 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.0 t -92.52 -18.16 23.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.854 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.427 ' NE ' HG12 ' A' ' 78' ' ' VAL . 17.0 ttt180 -98.57 103.65 15.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.822 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.453 HD22 ' HD3' ' A' ' 40' ' ' PRO . 46.9 mt -99.46 7.62 45.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.974 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 t -149.45 132.85 16.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.809 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.467 HG11 HD13 ' A' ' 71' ' ' ILE . 2.0 m -148.35 165.17 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.131 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.422 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 28.8 tt0 -99.47 116.03 30.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.762 HG23 ' HB1' ' A' ' 67' ' ' ALA . 45.9 mm -83.3 101.21 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.117 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.715 HG22 ' CB ' ' A' ' 33' ' ' SER . 27.4 p -99.67 168.63 9.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.162 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.09 34.34 9.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.2 mt -102.43 179.5 4.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.769 0.319 . . . . 0.0 110.949 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -124.22 135.57 53.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -71.63 157.3 38.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.35 12.84 59.3 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.457 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.406 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 25.8 mm -124.09 113.9 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 111.147 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.87 139.8 35.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.825 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.406 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -160.76 170.46 20.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.944 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -114.49 -176.14 2.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.843 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -144.43 154.23 42.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.453 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 5.3 ptp180 -146.91 179.86 7.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.568 HG11 ' CD1' ' A' ' 38' ' ' TRP . 74.6 t -145.1 143.58 22.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.115 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -132.77 146.02 51.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -107.39 130.22 54.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.086 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.424 ' HG ' ' CB ' ' A' ' 101' ' ' GLU . 4.3 mp -123.87 120.77 33.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.934 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.438 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 37.0 p-10 -123.74 -172.64 2.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.3 ptm -68.98 0.78 4.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.797 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 16' ' ' SER . 51.2 mt -108.6 -26.38 10.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.935 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.56 -167.5 29.18 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.485 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.424 ' CB ' ' HG ' ' A' ' 96' ' ' LEU . 0.6 OUTLIER -100.54 158.39 15.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 110.866 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.426 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 14.0 p -94.81 175.22 6.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.816 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -71.41 160.68 81.83 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.621 0.724 . . . . 0.0 110.897 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.411 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.9 Cg_endo -69.8 107.69 1.92 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.741 2.294 . . . . 0.0 112.286 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.8 p -47.95 158.88 0.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.35 138.61 48.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.587 0.708 . . . . 0.0 111.128 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 96.89 0.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.73 2.287 . . . . 0.0 112.38 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.5 p -47.21 160.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.841 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -52.42 150.94 8.1 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.607 0.718 . . . . 0.0 110.854 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.465 ' HB3' HD11 ' A' ' 58' ' ' LEU . 54.4 Cg_endo -69.61 129.21 17.36 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.724 2.283 . . . . 0.0 112.392 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -117.53 120.23 37.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.926 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.0 t -92.94 107.42 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.142 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.0 t -73.25 104.56 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 t -102.06 146.29 28.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.823 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -48.75 -54.2 14.78 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.46 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.6 t -112.38 134.8 53.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.855 0.359 . . . . 0.0 110.857 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -148.55 -177.06 22.49 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.493 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 134.73 28.69 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.68 2.253 . . . . 0.0 112.316 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 55.2 m -131.0 127.87 39.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.2 m -151.05 150.33 30.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.519 179.974 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.8 m -141.82 175.41 9.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.835 0.35 . . . . 0.0 110.895 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.4 p -60.47 133.87 56.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.911 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.11 -55.48 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.531 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.7 p -61.7 169.22 2.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.931 0.396 . . . . 0.0 110.867 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.8 p -101.94 167.57 9.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -108.67 166.45 12.82 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.548 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 52.0 p -57.85 130.07 44.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 110.847 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -161.75 153.8 16.32 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.618 0.723 . . . . 0.0 110.898 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 3.23 2.84 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.751 2.301 . . . . 0.0 112.368 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -111.72 93.09 4.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -45.38 124.95 5.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.829 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.12 -106.23 1.5 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.506 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -63.42 89.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.902 0.382 . . . . 0.0 110.828 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.618 HD13 ' CE2' ' A' ' 46' ' ' PHE . 9.0 mt -84.59 178.77 7.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.913 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.65 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.4 m -139.76 161.87 53.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.682 0.753 . . . . 0.0 110.832 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.74 170.09 17.37 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.674 2.249 . . . . 0.0 112.343 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.468 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 54.6 Cg_endo -69.69 155.48 66.07 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.74 2.293 . . . . 0.0 112.375 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.423 ' C ' ' HB2' ' A' ' 102' ' ' SER . 5.0 pt-20 -98.06 175.29 6.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.94 121.12 80.43 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.611 0.72 . . . . 0.0 111.153 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 162.14 43.23 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.711 2.274 . . . . 0.0 112.325 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -50.42 174.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.824 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -80.15 123.63 83.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.583 0.706 . . . . 0.0 110.851 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 144.04 52.78 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.713 2.276 . . . . 0.0 112.369 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.871 ' O ' HD13 ' A' ' 26' ' ' ILE . 4.3 t -94.4 166.17 12.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.203 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 25' ' ' THR . 7.9 mm -128.21 121.42 55.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.129 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -121.17 -177.72 3.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.887 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.3 m -98.68 99.74 10.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.772 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -100.79 -41.1 7.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.016 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.6 m -163.16 -178.75 6.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.834 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.432 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 3.8 pm0 -84.91 -15.04 45.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.852 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.6 p -117.94 -7.1 10.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.179 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.766 ' CB ' HG22 ' A' ' 81' ' ' THR . 36.7 p -143.56 171.9 13.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 m -147.64 150.94 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.137 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.772 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 18.3 m-85 -84.89 119.81 25.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.3 t -113.91 130.61 67.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.167 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 42.0 m -128.28 124.07 35.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.592 ' CD1' HG11 ' A' ' 93' ' ' VAL . 27.4 p90 -121.3 168.39 11.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.1 mm -132.09 108.13 13.82 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.631 0.729 . . . . 0.0 111.153 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 142.92 49.13 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.711 2.274 . . . . 0.0 112.309 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -111.98 -66.86 1.04 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.6 144.52 16.32 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.496 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -115.12 10.0 16.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.965 0.412 . . . . 0.0 110.963 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 78.73 -0.59 76.65 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.467 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.53 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 110.37 -22.88 21.77 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.487 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.62 ' CD2' HD21 ' A' ' 99' ' ' LEU . 2.3 m-85 -109.89 162.03 21.97 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.574 0.702 . . . . 0.0 110.944 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 113.0 3.22 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.655 2.237 . . . . 0.0 112.428 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.518 HD13 ' CE1' ' A' ' 51' ' ' PHE . 80.6 mt -47.07 134.75 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -83.62 -49.96 8.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.952 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 m -162.9 162.7 26.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.809 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.518 ' CE1' HD13 ' A' ' 48' ' ' ILE . 65.5 m-85 -108.42 169.72 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.831 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -145.15 130.25 18.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 92' ' ' ARG . 61.7 t -108.83 136.78 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.417 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 4.0 mp0 -127.59 156.34 42.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.825 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.621 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 12.8 p90 -141.08 147.33 38.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.855 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -129.72 140.65 51.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.971 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.7 mtmm -83.79 129.84 34.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.441 HD11 ' HB3' ' A' ' 110' ' ' PRO . 77.5 mt -85.62 -31.16 22.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.922 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 60' ' ' LYS . 7.9 mtpp -91.81 35.11 0.97 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.83 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.49 ' CG ' ' O ' ' A' ' 59' ' ' LYS . 35.3 mttt -165.32 178.68 6.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.893 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 62' ' ' GLY . 1.4 p -99.55 -29.51 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.132 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 61' ' ' VAL . . . -35.48 122.21 0.58 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.485 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.06 -175.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.78 0.324 . . . . 0.0 110.842 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.453 ' O ' HD13 ' A' ' 65' ' ' ILE . 60.8 m95 -62.15 152.14 33.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.97 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 64' ' ' TRP . 2.1 mm -129.76 157.97 42.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.183 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 53' ' ' VAL . 1.7 tp -85.43 111.59 20.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.621 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . . . -74.0 -61.64 1.78 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.111 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.421 HG23 HD11 ' A' ' 71' ' ' ILE . 5.3 t -150.88 161.09 43.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.191 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 15.7 m -152.5 -179.59 7.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.854 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 71.67 25.25 3.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.07 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.638 HD13 HG11 ' A' ' 78' ' ' VAL . 71.4 mt -81.5 137.99 48.03 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.594 0.711 . . . . 0.0 111.103 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.638 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.7 Cg_endo -69.79 156.17 63.95 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.616 2.211 . . . . 0.0 112.285 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -12.72 33.44 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.698 2.266 . . . . 0.0 112.375 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.3 t -92.43 -17.32 24.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.806 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.474 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 7.2 ttt85 -96.44 97.54 9.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.2 mt -94.06 13.59 22.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.91 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -154.17 130.95 10.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.8 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.638 HG11 HD13 ' A' ' 71' ' ' ILE . 2.6 m -145.4 160.34 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.114 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.426 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 24.2 tt0 -96.8 115.82 28.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.925 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.601 HG23 ' HB1' ' A' ' 67' ' ' ALA . 22.2 mm -83.63 105.35 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.766 HG22 ' CB ' ' A' ' 33' ' ' SER . 64.2 p -102.56 171.43 7.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.166 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.09 38.38 11.31 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.5 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.5 mt -105.33 176.37 5.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.81 0.338 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -120.19 136.09 54.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.85 150.5 42.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.96 10.66 68.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.46 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.49 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 28.0 mm -121.41 103.88 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.369 . . . . 0.0 111.105 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.02 141.81 52.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.49 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -163.22 163.02 25.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -111.89 169.59 8.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.811 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -129.71 153.89 47.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.429 ' O ' HG13 ' A' ' 53' ' ' VAL . 5.3 ptp180 -143.82 -178.94 6.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.592 HG11 ' CD1' ' A' ' 38' ' ' TRP . 86.4 t -145.13 144.55 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.093 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -134.87 139.13 44.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.822 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -99.69 132.77 44.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.096 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.4 mp -126.35 119.59 27.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.928 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.448 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 38.5 p-10 -123.61 -173.95 2.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.3 ptp -68.87 -0.63 5.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.798 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.65 HD12 ' O ' ' A' ' 16' ' ' SER . 22.4 mt -106.62 -25.66 11.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.972 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 148.26 -165.98 29.02 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -102.01 158.03 16.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.423 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 5.2 p -94.33 175.04 6.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.801 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -71.22 160.39 82.66 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.606 0.717 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 110.33 2.53 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.683 2.255 . . . . 0.0 112.354 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.0 p -53.34 152.14 4.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.43 139.44 8.06 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.599 0.714 . . . . 0.0 111.073 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 100.41 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.66 2.24 . . . . 0.0 112.352 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.3 p -46.1 163.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.85 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -56.83 152.4 27.5 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.529 0.68 . . . . 0.0 110.939 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.441 ' HB3' HD11 ' A' ' 58' ' ' LEU . 54.2 Cg_endo -69.77 123.2 9.87 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.64 2.227 . . . . 0.0 112.395 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.411 ' CB ' HG21 ' A' ' 26' ' ' ILE . 48.5 t80 -112.89 117.21 31.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.8 t -91.76 101.79 12.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.175 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.9 t -67.99 110.55 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.9 t -107.07 158.25 17.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -40.7 -66.44 0.87 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.479 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.4 m -123.15 175.81 6.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.893 0.378 . . . . 0.0 110.902 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 172.1 -160.06 31.46 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.455 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 90.36 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.675 2.25 . . . . 0.0 112.351 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.5 m -93.81 169.87 9.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.7 t -133.09 -43.78 0.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.82 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.517 -179.953 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.6 m -160.84 178.2 9.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.915 0.388 . . . . 0.0 110.832 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.7 m -141.36 177.1 8.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.863 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.87 -166.09 19.99 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.474 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 t -164.05 124.42 2.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.899 0.381 . . . . 0.0 110.838 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 t -125.9 175.95 7.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.831 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.38 -134.98 6.88 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.467 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -174.58 177.51 2.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 0.0 110.828 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -147.28 143.98 18.94 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.645 0.736 . . . . 0.0 110.863 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -175.17 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.72 2.28 . . . . 0.0 112.384 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -162.91 148.96 12.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.856 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -148.59 162.46 39.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.56 126.42 4.65 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.434 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -72.98 83.06 1.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.359 . . . . 0.0 110.864 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.565 HD13 ' CE2' ' A' ' 46' ' ' PHE . 15.9 mt -99.71 -176.32 3.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.601 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.5 p -141.65 160.17 57.42 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.72 0.772 . . . . 0.0 110.819 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 169.83 17.96 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.691 2.261 . . . . 0.0 112.347 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.561 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.0 Cg_endo -69.84 152.72 68.99 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.664 2.243 . . . . 0.0 112.256 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.421 ' C ' ' HB2' ' A' ' 102' ' ' SER . 4.2 pt-20 -94.68 172.46 8.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.01 121.72 79.36 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.544 0.688 . . . . 0.0 111.109 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 161.96 43.93 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.625 2.217 . . . . 0.0 112.337 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -51.27 174.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.832 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -79.99 123.08 83.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.542 0.687 . . . . 0.0 110.849 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 143.51 51.21 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.677 2.252 . . . . 0.0 112.352 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.71 ' O ' HD13 ' A' ' 26' ' ' ILE . 4.8 t -93.38 164.42 13.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.184 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 25' ' ' THR . 12.4 mm -128.07 120.76 54.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.051 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -123.28 -178.76 4.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.858 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.2 m -97.05 98.97 10.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.636 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -100.41 -33.84 10.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.146 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.43 -175.02 3.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -83.49 -20.03 34.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.962 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.7 p -122.92 -0.58 8.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.179 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.652 ' CB ' HG22 ' A' ' 81' ' ' THR . 3.8 p -139.27 163.89 31.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.82 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.72 144.82 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.152 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.636 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 16.8 m-85 -77.8 116.66 18.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.904 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.9 t -108.98 130.72 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.127 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.766 HG23 ' HB2' ' A' ' 77' ' ' SER . 8.8 m -129.16 121.9 28.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.129 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.575 ' CD1' HG11 ' A' ' 93' ' ' VAL . 35.3 p90 -121.63 170.95 9.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.519 HD13 ' O ' ' A' ' 38' ' ' TRP . 18.7 mm -135.76 106.0 9.82 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.631 0.729 . . . . 0.0 111.17 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.411 ' CD ' HD22 ' A' ' 76' ' ' LEU . 53.7 Cg_endo -69.68 129.87 18.44 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.712 2.274 . . . . 0.0 112.347 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -93.0 -70.41 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.49 151.37 16.92 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.445 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 42.4 p-10 -118.03 10.7 13.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 0.0 110.9 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.57 -4.25 60.79 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.436 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.402 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 113.96 -18.05 19.43 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.483 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.565 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.1 m-85 -114.3 162.03 25.33 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.674 0.75 . . . . 0.0 110.873 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 114.8 3.81 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.668 2.245 . . . . 0.0 112.36 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.49 HD13 ' CE1' ' A' ' 51' ' ' PHE . 89.4 mt -45.6 130.37 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -84.99 -46.18 11.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.6 p -162.19 162.53 28.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.757 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.49 ' CE1' HD13 ' A' ' 48' ' ' ILE . 50.1 m-85 -108.89 172.7 6.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.499 ' CZ ' HD21 ' A' ' 96' ' ' LEU . 55.9 mtt180 -145.04 121.29 10.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.977 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.3 t -105.62 128.21 59.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.135 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.422 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 13.9 mt-10 -128.89 152.54 48.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.823 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.54 ' CD2' ' HB2' ' A' ' 67' ' ' ALA . 36.7 p90 -133.34 173.84 11.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.917 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -149.14 137.35 20.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.94 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -83.53 125.91 32.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.966 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.441 ' O ' ' C ' ' A' ' 59' ' ' LYS . 77.8 mt -87.48 -70.71 0.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.912 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 58' ' ' LEU . 12.2 tttm -34.72 -38.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.844 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -116.03 131.66 56.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.895 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 61' ' ' VAL . 7.5 p -63.04 119.77 7.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.067 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -167.75 159.06 32.21 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.497 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.54 -175.26 4.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.793 0.33 . . . . 0.0 110.822 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -79.85 142.51 35.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.515 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 2.6 mm -120.47 158.93 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.8 tp -93.31 121.93 35.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.712 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -90.19 -69.0 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.096 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.497 ' CG2' HD11 ' A' ' 71' ' ' ILE . 1.4 t -126.49 178.57 5.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.115 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 59.9 p -173.86 178.35 2.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.835 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 67.98 30.67 5.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.079 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.629 HG23 ' HD2' ' A' ' 72' ' ' PRO . 72.2 mt -84.56 137.73 38.72 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.591 0.71 . . . . 0.0 111.151 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.629 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.8 Cg_endo -69.76 159.56 52.95 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.739 2.293 . . . . 0.0 112.321 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 -17.67 37.51 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.71 2.274 . . . . 0.0 112.325 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.4 m -86.48 -23.19 26.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.431 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 15.0 ttt180 -90.01 100.99 13.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.813 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.411 HD22 ' CD ' ' A' ' 40' ' ' PRO . 52.6 mt -95.95 9.58 40.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.839 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.766 ' HB2' HG23 ' A' ' 37' ' ' THR . 11.6 t -153.79 136.6 15.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.563 HG11 HD13 ' A' ' 71' ' ' ILE . 1.9 m -147.31 163.81 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.135 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.561 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 35.0 tt0 -100.4 111.59 23.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.833 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.712 HG23 ' HB1' ' A' ' 67' ' ' ALA . 26.3 mm -80.86 102.94 7.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.102 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.652 HG22 ' CB ' ' A' ' 33' ' ' SER . 77.2 p -97.25 165.35 12.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.059 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.78 37.46 8.58 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.436 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 88.1 mt -97.62 -179.68 4.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.792 0.329 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -126.71 125.25 41.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -65.11 163.06 15.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.64 17.94 22.08 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.536 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.501 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 28.1 mm -129.37 105.05 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 111.114 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.89 141.82 49.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.501 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -162.75 164.53 26.25 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.944 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -111.08 -175.6 2.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.93 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -146.64 161.46 40.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.84 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.439 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 3.5 ptp180 -151.95 173.41 14.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.884 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.575 HG11 ' CD1' ' A' ' 38' ' ' TRP . 71.6 t -140.02 136.4 38.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.125 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -127.05 138.21 53.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.863 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -97.95 126.35 43.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.067 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.499 HD21 ' CZ ' ' A' ' 52' ' ' ARG . 7.0 mp -120.53 118.41 30.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.437 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.7 p-10 -123.39 -173.72 2.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.1 ptm -68.07 -1.48 5.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 16' ' ' SER . 44.5 mt -105.65 -25.78 12.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.988 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 147.99 -166.04 28.9 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.511 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.4 156.39 17.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.858 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.421 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 5.5 p -93.39 175.11 6.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.895 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -70.27 157.89 88.86 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.634 0.731 . . . . 0.0 110.856 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.439 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.5 Cg_endo -69.74 102.95 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.66 2.24 . . . . 0.0 112.324 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.9 p -43.93 153.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.81 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.71 141.65 17.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.586 0.707 . . . . 0.0 111.076 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 98.05 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.687 2.258 . . . . 0.0 112.373 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.0 p -45.8 151.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.817 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.2 mmm-85 -45.57 156.18 0.43 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.593 0.711 . . . . 0.0 110.823 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 131.45 21.15 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.638 2.226 . . . . 0.0 112.28 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.579 ' CG ' HG21 ' A' ' 26' ' ' ILE . 39.7 t80 -121.04 113.28 19.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.9 t -91.13 102.81 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.146 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.9 t -69.09 105.7 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.164 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.6 t -104.84 43.01 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 51.27 68.63 1.42 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.498 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 80.8 p -131.27 118.61 20.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.926 0.393 . . . . 0.0 110.826 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -162.38 -158.09 9.39 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.438 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 170.07 17.45 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.634 2.223 . . . . 0.0 112.371 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.7 m -99.46 -44.24 6.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.906 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.0 t -136.4 110.43 8.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.857 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.455 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.1 p -168.43 169.07 10.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 110.869 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.1 p -144.11 155.18 43.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.825 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.59 144.65 18.5 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.462 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 p -71.7 172.67 9.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.894 0.378 . . . . 0.0 110.857 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 t -61.96 156.41 21.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.77 -89.71 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.476 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 t 51.65 29.29 5.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.819 0.342 . . . . 0.0 110.887 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -107.47 141.41 22.94 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.587 0.708 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.86 82.96 0.74 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.655 2.237 . . . . 0.0 112.28 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -132.82 168.24 18.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -38.19 -51.18 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.29 -81.52 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.448 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -77.21 90.64 3.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 0.0 110.877 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.668 ' CD1' ' CE2' ' A' ' 46' ' ' PHE . 9.1 mt -105.01 -174.62 2.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.845 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.694 ' O ' HD12 ' A' ' 99' ' ' LEU . 0.9 OUTLIER -134.84 159.63 71.42 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.716 0.769 . . . . 0.0 110.835 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 170.22 17.03 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.727 2.285 . . . . 0.0 112.323 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.51 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.5 Cg_endo -69.83 154.56 67.31 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.612 2.208 . . . . 0.0 112.341 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.416 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.1 pt-20 -95.7 174.11 7.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.868 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.65 122.04 84.46 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.645 0.736 . . . . 0.0 111.071 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 160.79 48.38 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.644 2.229 . . . . 0.0 112.343 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -49.51 174.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -80.03 123.51 83.48 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.702 0.763 . . . . 0.0 110.83 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.427 ' HB2' HG13 ' A' ' 36' ' ' VAL . 53.8 Cg_endo -69.81 144.27 53.23 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.629 2.219 . . . . 0.0 112.319 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.727 ' O ' HD13 ' A' ' 26' ' ' ILE . 13.4 t -93.87 166.41 12.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.109 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.727 HD13 ' O ' ' A' ' 25' ' ' THR . 8.1 mm -126.01 125.83 68.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -125.79 179.23 5.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.5 m -98.23 98.68 9.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.116 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.684 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -102.48 -40.02 6.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.072 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.2 m -165.2 168.99 16.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.819 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -74.29 -14.03 60.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.2 p -118.24 -3.28 11.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.123 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.845 ' CB ' HG22 ' A' ' 81' ' ' THR . 6.5 p -146.45 177.46 9.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.8 m -154.56 149.19 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.178 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.684 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 17.1 m-85 -82.44 118.16 23.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' A' ' 24' ' ' PRO . 91.7 t -113.4 130.84 66.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.069 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.417 ' HB ' HG22 ' A' ' 25' ' ' THR . 62.7 m -128.88 120.34 26.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.197 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.564 ' CD1' HG11 ' A' ' 93' ' ' VAL . 26.3 p90 -118.76 170.92 8.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mm -134.93 108.56 10.65 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.615 0.722 . . . . 0.0 111.102 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 140.23 42.38 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.704 2.269 . . . . 0.0 112.363 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -109.43 -69.14 0.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.85 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.23 147.6 16.31 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.528 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 51.9 p-10 -117.82 5.79 12.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.804 0.335 . . . . 0.0 110.84 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 81.89 4.36 90.32 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.485 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.446 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 105.38 -16.78 44.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.487 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.668 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 1.9 m-85 -115.44 162.24 25.82 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.654 0.74 . . . . 0.0 110.869 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.64 118.24 5.56 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.7 2.266 . . . . 0.0 112.399 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.569 HD13 ' CE1' ' A' ' 51' ' ' PHE . 91.7 mt -49.26 131.88 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.172 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -85.77 -49.27 8.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.954 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.1 m -161.51 161.29 29.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.841 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.569 ' CE1' HD13 ' A' ' 48' ' ' ILE . 60.9 m-85 -109.91 171.26 7.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -146.19 134.3 21.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.863 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.2 135.02 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.155 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.474 ' N ' ' OE1' ' A' ' 54' ' ' GLU . 26.4 mp0 -136.25 146.01 46.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.547 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 26.3 p90 -124.43 179.27 4.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.462 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 22.4 ttpp -149.4 136.41 19.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -84.23 119.87 25.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.3 mt -90.37 -68.55 0.78 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.45 -31.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.895 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -121.19 139.71 53.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.919 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.3 p -63.28 129.67 27.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 174.81 161.78 25.17 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.478 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -90.27 -179.3 5.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.85 0.357 . . . . 0.0 110.881 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.462 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 84.0 m95 -69.28 136.58 52.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.867 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.547 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 5.2 mm -115.02 159.62 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.151 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.4 tp -93.37 125.32 37.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.749 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -94.16 -69.84 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.126 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.2 t -131.63 173.19 11.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.146 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.452 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 6.3 t -169.45 176.74 4.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.801 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 69.68 28.65 4.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.106 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.637 HG23 ' HD2' ' A' ' 72' ' ' PRO . 73.6 mt -80.26 137.88 52.47 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.65 0.738 . . . . 0.0 111.155 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.637 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.2 Cg_endo -69.64 158.06 58.42 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.757 2.305 . . . . 0.0 112.378 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -21.89 33.05 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.686 2.258 . . . . 0.0 112.324 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.6 m -82.01 -14.99 55.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -101.84 107.59 18.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.857 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.7 mt -103.86 11.47 35.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -153.2 132.48 12.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.776 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.511 HG11 HD13 ' A' ' 71' ' ' ILE . 2.4 m -145.9 165.63 9.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.098 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.455 ' OE1' ' HB1' ' A' ' 29' ' ' ALA . 33.1 tt0 -102.55 109.32 20.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.808 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.749 HG23 ' HB1' ' A' ' 67' ' ' ALA . 16.1 mm -79.04 103.32 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.15 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.845 HG22 ' CB ' ' A' ' 33' ' ' SER . 29.7 p -102.84 167.95 9.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.085 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.75 36.69 7.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.462 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.8 mt -103.65 -178.85 3.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 110.93 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -118.55 126.84 52.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -67.66 153.74 43.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.43 11.96 62.89 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.458 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.457 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 23.2 mm -124.47 112.66 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.804 0.335 . . . . 0.0 111.194 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.23 141.56 45.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.851 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.457 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -161.66 162.78 30.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.947 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -107.54 -175.82 2.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -145.83 151.43 37.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 1.9 ptp180 -144.12 176.73 9.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.564 HG11 ' CD1' ' A' ' 38' ' ' TRP . 86.8 t -142.87 139.78 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.13 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 -129.57 139.97 51.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -101.23 128.87 47.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.3 mp -122.21 120.0 32.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.443 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 38.1 p-10 -123.55 -173.1 2.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.7 ptm -68.72 0.65 3.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.694 HD12 ' O ' ' A' ' 16' ' ' SER . 38.7 mt -108.37 -26.2 10.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.62 -167.38 29.22 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.525 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.36 158.27 15.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 110.879 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.444 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 5.2 p -93.81 175.29 6.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -71.6 158.14 88.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.638 0.732 . . . . 0.0 110.93 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.43 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 52.9 Cg_endo -69.77 102.86 1.08 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.687 2.258 . . . . 0.0 112.276 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.3 p -46.32 154.57 0.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.855 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.04 143.39 4.61 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.5 0.667 . . . . 0.0 111.149 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 92.98 0.52 Allowed 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.726 2.284 . . . . 0.0 112.344 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.0 t -40.67 146.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -44.62 150.22 0.71 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.654 0.74 . . . . 0.0 110.845 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 124.31 10.95 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.661 2.241 . . . . 0.0 112.357 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.556 ' CB ' HG21 ' A' ' 26' ' ' ILE . 65.4 t80 -115.25 120.7 40.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.5 t -93.64 107.18 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.139 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.8 t -72.6 102.63 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.14 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.8 t -91.62 -60.07 1.97 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.904 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -167.29 -170.63 32.39 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.45 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.4 t -74.26 108.96 7.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.915 0.388 . . . . 0.0 110.866 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.12 -168.42 0.36 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.441 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 1.83 4.09 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.637 2.225 . . . . 0.0 112.348 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.0 t 74.51 51.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.8 t -125.89 128.75 48.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.905 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.503 -179.962 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 m -163.89 144.59 8.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.358 . . . . 0.0 110.832 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.9 p -155.49 176.76 12.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.787 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.82 -136.07 4.03 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.551 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.5 t 62.29 45.43 6.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.803 0.335 . . . . 0.0 110.857 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.1 p -116.98 149.99 39.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -129.37 164.99 22.16 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.49 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.2 m -138.39 163.05 32.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 110.829 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -68.73 140.31 91.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.523 0.678 . . . . 0.0 110.965 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 103.08 1.11 Allowed 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 122.746 2.298 . . . . 0.0 112.278 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 12' ' ' HIS . 50.1 m-20 -109.07 98.56 8.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.895 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 11' ' ' ASP . 17.2 m-70 -35.86 152.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.81 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.34 -55.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.508 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -57.1 95.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.934 0.397 . . . . 0.0 110.848 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.551 ' CD1' ' CE2' ' A' ' 46' ' ' PHE . 13.7 mt -104.34 -175.09 2.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.888 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.648 ' O ' HD12 ' A' ' 99' ' ' LEU . 3.1 m -137.78 160.08 66.23 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.699 0.762 . . . . 0.0 110.874 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 170.09 17.5 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.678 2.252 . . . . 0.0 112.302 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.464 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.6 Cg_endo -69.72 155.75 65.25 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.694 2.263 . . . . 0.0 112.337 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.426 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.6 pt-20 -99.12 168.83 9.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.92 123.01 82.52 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.534 0.683 . . . . 0.0 111.117 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 165.1 32.15 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.72 2.28 . . . . 0.0 112.266 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -52.44 175.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -79.99 122.83 83.61 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.622 0.725 . . . . 0.0 110.912 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 143.3 50.46 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.707 2.272 . . . . 0.0 112.375 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.782 ' C ' HD13 ' A' ' 26' ' ' ILE . 6.8 t -94.24 165.25 12.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.133 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.782 HD13 ' C ' ' A' ' 25' ' ' THR . 3.9 mm -125.92 125.61 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.159 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 m -127.7 178.18 6.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.6 m -95.48 101.01 12.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.138 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.645 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -102.1 -41.4 6.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.08 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.02 -175.0 5.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -85.0 -16.75 39.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.7 p -123.27 2.04 9.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.112 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.617 ' CB ' HG22 ' A' ' 81' ' ' THR . 18.7 p -144.7 168.0 21.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.832 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.9 m -147.07 145.81 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.645 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 19.7 m-85 -77.85 117.71 19.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.859 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.1 t -111.97 129.7 66.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.095 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.428 ' HB ' HG22 ' A' ' 25' ' ' THR . 87.6 m -128.74 123.51 33.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.187 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.589 ' CD1' HG11 ' A' ' 93' ' ' VAL . 25.5 p90 -122.43 169.66 10.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.899 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.423 HD13 ' O ' ' A' ' 38' ' ' TRP . 21.0 mm -133.29 107.35 12.24 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.668 0.747 . . . . 0.0 111.191 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 135.5 30.62 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.726 2.284 . . . . 0.0 112.332 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -100.32 -70.44 0.74 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.5 159.89 14.72 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.516 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -125.1 4.72 7.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.878 0.37 . . . . 0.0 110.85 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.55 0.56 90.07 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.549 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.541 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 110.32 -24.05 19.07 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.503 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.551 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 2.4 m-85 -108.68 162.24 20.7 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.637 0.732 . . . . 0.0 110.851 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 116.32 4.5 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.659 2.239 . . . . 0.0 112.379 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.526 HD13 ' CE1' ' A' ' 51' ' ' PHE . 96.3 mt -47.81 135.0 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.187 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -86.07 -52.51 5.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.856 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.1 m -160.3 162.16 33.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.862 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.526 ' CE1' HD13 ' A' ' 48' ' ' ILE . 56.7 m-85 -109.85 166.96 10.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.649 HH21 HD21 ' A' ' 66' ' ' LEU . 21.6 mtp85 -142.22 143.26 32.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.821 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.447 ' O ' HD12 ' A' ' 66' ' ' LEU . 58.6 t -120.61 137.47 54.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.107 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -133.7 162.55 31.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.473 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 46.1 p90 -142.05 158.94 43.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.46 ' HD3' ' NE1' ' A' ' 64' ' ' TRP . 37.6 ttpt -130.7 129.72 42.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.931 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -80.07 120.34 24.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.532 HD11 ' HB3' ' A' ' 110' ' ' PRO . 51.2 mt -82.53 -40.13 21.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -91.89 35.54 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.862 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -169.19 160.42 9.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 p -92.16 152.52 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.194 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 127.09 125.09 2.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.482 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -50.34 -179.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.731 0.3 . . . . 0.0 110.859 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.46 ' NE1' ' HD3' ' A' ' 56' ' ' LYS . 47.1 m95 -58.67 159.91 6.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.95 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.473 ' HB ' ' CZ ' ' A' ' 55' ' ' TYR . 1.8 mm -128.04 160.28 38.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.108 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.649 HD21 HH21 ' A' ' 52' ' ' ARG . 39.6 tp -99.89 116.11 31.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.581 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -84.22 -69.79 0.62 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.121 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 t -128.0 166.66 17.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.213 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 12.2 m -161.8 178.65 8.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 70.56 27.54 3.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.103 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.65 HG23 ' HD2' ' A' ' 72' ' ' PRO . 74.9 mt -78.32 138.15 59.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.584 0.707 . . . . 0.0 111.16 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.65 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.1 Cg_endo -69.73 156.49 63.3 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.678 2.252 . . . . 0.0 112.375 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.64 -17.54 38.05 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.647 2.231 . . . . 0.0 112.403 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.3 m -87.6 -13.46 42.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.455 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 15.7 ttt180 -101.04 104.52 15.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.842 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.4 mt -100.4 12.49 37.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -154.93 132.05 10.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.467 HG11 HD13 ' A' ' 71' ' ' ILE . 2.2 m -147.37 165.27 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.101 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -100.26 118.28 36.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.581 HG23 ' HB1' ' A' ' 67' ' ' ALA . 32.7 mm -86.98 98.19 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.083 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.617 HG22 ' CB ' ' A' ' 33' ' ' SER . 32.0 p -93.4 174.15 7.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.3 40.04 17.21 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.509 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.1 mt -100.67 -179.24 4.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.729 0.299 . . . . 0.0 110.921 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -125.27 130.45 52.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.935 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.0 151.57 43.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.77 10.5 64.39 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.452 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.419 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 25.9 mm -122.22 112.66 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.352 . . . . 0.0 111.103 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.22 138.75 38.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.83 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.419 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -161.59 161.21 29.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.951 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -107.53 177.22 4.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -135.31 158.89 43.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.434 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 1.2 ptp180 -151.13 177.9 9.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.589 HG11 ' CD1' ' A' ' 38' ' ' TRP . 95.0 t -143.58 141.83 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.152 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.2 mtt180 -131.94 143.42 50.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.464 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -105.97 131.18 53.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.108 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.455 HD12 ' C ' ' A' ' 95' ' ' ALA . 9.1 mp -124.39 120.74 32.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.915 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.442 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 38.3 p-10 -123.61 -172.77 2.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.935 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.0 ptm -69.03 0.73 4.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 16' ' ' SER . 46.3 mt -108.5 -26.14 10.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.926 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.39 -166.56 29.09 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.499 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.13 158.74 15.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.889 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.426 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 4.8 p -95.51 175.23 6.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.839 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -70.93 157.98 89.13 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.57 0.7 . . . . 0.0 110.907 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.434 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.9 Cg_endo -69.75 104.72 1.36 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.649 2.233 . . . . 0.0 112.385 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.5 p -44.31 151.95 0.22 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.01 139.38 6.96 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.562 0.696 . . . . 0.0 111.106 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 97.11 0.62 Allowed 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.682 2.255 . . . . 0.0 112.373 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 t -48.3 159.59 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.75 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.98 152.58 5.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.675 0.75 . . . . 0.0 110.857 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.532 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.5 Cg_endo -69.65 131.91 22.4 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.698 2.265 . . . . 0.0 112.372 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -117.85 119.47 34.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.977 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.4 t -95.15 102.2 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.099 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.5 t -69.67 106.47 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 t -114.67 50.01 0.99 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.828 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 59.41 -119.41 18.01 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.482 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 92.3 p -77.04 121.32 23.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.927 0.394 . . . . 0.0 110.846 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -108.8 173.74 17.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.53 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 125.87 12.65 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.706 2.27 . . . . 0.0 112.318 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.8 m -143.08 162.7 34.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.2 t -159.59 159.09 32.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.89 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.45 179.99 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.4 m -158.4 159.49 35.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 110.871 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.2 m -87.81 173.44 8.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.833 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.16 139.61 47.49 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.458 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.3 m -161.43 175.29 12.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.902 0.382 . . . . 0.0 110.806 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.2 p -61.9 112.28 2.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.837 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 155.44 122.54 0.79 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.451 ' C ' ' OE1' ' A' ' 9' ' ' GLN . 77.6 p -148.43 151.67 35.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.451 ' OE1' ' C ' ' A' ' 8' ' ' SER . 0.8 OUTLIER -119.27 143.5 34.39 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.559 0.695 . . . . 0.0 110.977 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.78 108.54 2.11 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.745 2.297 . . . . 0.0 112.244 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -167.95 143.5 3.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.817 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -65.21 99.53 0.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 15' ' ' LEU . . . 175.85 -54.0 0.12 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.489 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -48.0 91.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.756 0.312 . . . . 0.0 110.807 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.639 ' CD1' ' CE2' ' A' ' 46' ' ' PHE . 16.8 mt -94.94 -174.89 3.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.923 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.634 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.4 p -141.7 160.01 57.86 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.738 0.78 . . . . 0.0 110.861 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 169.19 19.49 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.7 2.267 . . . . 0.0 112.302 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.527 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.4 Cg_endo -69.78 157.41 60.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.698 2.265 . . . . 0.0 112.334 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.438 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.6 pt-20 -99.25 163.25 12.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.35 122.32 58.72 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.539 0.685 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 163.76 37.1 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.672 2.248 . . . . 0.0 112.34 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -50.0 177.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -83.27 124.39 76.12 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.648 0.737 . . . . 0.0 110.85 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HB2' HG13 ' A' ' 36' ' ' VAL . 53.8 Cg_endo -69.75 147.36 62.76 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.676 2.251 . . . . 0.0 112.336 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.676 ' O ' HD13 ' A' ' 26' ' ' ILE . 5.1 t -99.58 164.51 12.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.15 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.676 HD13 ' O ' ' A' ' 25' ' ' THR . 8.7 mm -122.67 118.25 54.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.103 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.1 m -121.69 165.31 15.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.836 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.1 m -83.03 104.75 13.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.767 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -108.45 -37.96 5.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.059 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 m -166.16 175.72 8.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.443 ' HG2' HG23 ' A' ' 32' ' ' THR . 1.0 OUTLIER -79.64 -16.73 55.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.898 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.443 HG23 ' HG2' ' A' ' 31' ' ' GLU . 10.7 p -119.0 -6.35 10.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.145 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.852 ' HB3' HG22 ' A' ' 81' ' ' THR . 89.3 p -138.51 171.96 13.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 m -149.55 145.47 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.123 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.767 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 17.6 m-85 -81.63 115.34 20.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.407 HG13 ' HB2' ' A' ' 24' ' ' PRO . 97.0 t -109.11 127.24 65.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.149 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.41 ' HB ' HG22 ' A' ' 25' ' ' THR . 55.8 m -125.78 121.71 34.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.058 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.645 ' CD1' HG11 ' A' ' 93' ' ' VAL . 29.4 p90 -121.47 171.07 9.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.5 mm -135.1 107.12 10.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.632 0.73 . . . . 0.0 111.068 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 139.8 41.16 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.697 2.265 . . . . 0.0 112.343 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 mmt85 -103.31 -70.45 0.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.72 159.21 14.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.489 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -123.03 4.51 9.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 110.887 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.56 -1.41 87.87 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.491 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.461 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 113.32 -23.85 13.29 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.639 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 2.1 m-85 -110.11 162.25 21.17 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.641 0.734 . . . . 0.0 110.869 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.71 114.72 3.79 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.676 2.251 . . . . 0.0 112.427 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.457 HD13 ' CE1' ' A' ' 51' ' ' PHE . 81.6 mt -47.09 132.08 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.128 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -85.15 -50.36 7.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.2 p -159.7 163.24 34.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.457 ' CE1' HD13 ' A' ' 48' ' ' ILE . 54.8 m-85 -108.86 171.78 7.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.701 ' CZ ' HD11 ' A' ' 96' ' ' LEU . 4.9 mtm180 -143.45 129.01 19.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.827 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.457 HG11 HD11 ' A' ' 80' ' ' ILE . 38.4 t -111.4 133.14 57.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.07 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -135.42 152.4 51.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.486 ' CD2' ' HB2' ' A' ' 67' ' ' ALA . 31.1 p90 -129.37 175.75 8.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.5 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 24.6 ttpt -147.88 132.24 17.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.869 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -81.43 126.23 31.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.441 HD11 ' HB3' ' A' ' 110' ' ' PRO . 58.5 mt -91.13 -61.85 1.57 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 58' ' ' LEU . 3.3 tmtt? -37.4 -36.45 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.887 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.1 mtmm -127.69 136.26 51.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.929 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 61' ' ' VAL . 7.2 p -60.43 117.21 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.173 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.09 129.42 1.94 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.491 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.34 -176.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.817 0.342 . . . . 0.0 110.842 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.5 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 77.1 m95 -80.27 142.59 34.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.879 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.47 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 2.7 mm -116.71 164.2 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.8 tp -96.96 124.1 40.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.746 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -92.52 -64.71 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.058 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.603 ' CG2' HD11 ' A' ' 71' ' ' ILE . 1.8 t -131.83 179.33 6.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.0 p -173.15 178.16 2.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 64.15 32.33 12.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.094 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.67 HG23 ' HD2' ' A' ' 72' ' ' PRO . 88.2 mt -84.61 138.55 38.18 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.582 0.706 . . . . 0.0 111.129 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.67 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.0 Cg_endo -69.75 156.9 62.18 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.719 2.28 . . . . 0.0 112.305 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 -19.56 35.83 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.742 2.295 . . . . 0.0 112.33 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 t -84.7 -15.26 45.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.437 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 8.5 ttt85 -99.17 101.33 12.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.4 mt -96.64 8.99 42.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.928 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.5 t -151.34 134.08 15.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.589 HG11 HD13 ' A' ' 71' ' ' ILE . 2.1 m -146.5 161.95 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.131 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.559 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 39.5 tt0 -97.97 110.23 22.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.746 HG23 ' HB1' ' A' ' 67' ' ' ALA . 17.6 mm -80.1 109.76 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.154 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.852 HG22 ' HB3' ' A' ' 33' ' ' SER . 66.1 p -107.57 166.42 10.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.97 33.46 8.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.498 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.3 mt -101.65 170.31 8.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.736 0.303 . . . . 0.0 110.898 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -114.2 132.86 55.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.855 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -68.01 156.84 36.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.54 12.01 44.36 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.516 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.512 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 32.1 mm -120.76 103.23 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.836 0.351 . . . . 0.0 111.134 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.44 140.16 51.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.512 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -163.12 163.11 25.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.992 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -109.08 -175.97 2.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.936 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -141.82 164.6 29.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.917 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -157.54 170.09 23.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.645 HG11 ' CD1' ' A' ' 38' ' ' TRP . 99.7 t -137.2 140.14 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.134 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.408 HH21 ' CG ' ' A' ' 104' ' ' PRO . 33.8 mtt180 -129.28 136.35 49.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.847 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -93.64 128.5 39.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.101 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.701 HD11 ' CZ ' ' A' ' 52' ' ' ARG . 3.3 mp -123.6 120.12 31.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.448 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 38.3 p-10 -123.56 -172.79 2.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.3 ptm -69.84 1.56 4.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.834 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.634 HD12 ' O ' ' A' ' 16' ' ' SER . 30.3 mt -108.83 -26.25 10.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.953 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 149.49 -162.54 29.08 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.513 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.408 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 26.3 pm0 -107.09 157.42 17.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.892 0.377 . . . . 0.0 110.918 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 54.4 p -96.2 174.99 6.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.851 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -68.47 157.82 86.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.654 0.74 . . . . 0.0 110.884 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.408 ' CG ' HH21 ' A' ' 94' ' ' ARG . 54.1 Cg_endo -69.81 111.23 2.76 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.669 2.246 . . . . 0.0 112.284 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.7 p -50.44 154.17 1.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.49 141.0 7.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.539 0.685 . . . . 0.0 111.047 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 98.06 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.637 2.224 . . . . 0.0 112.388 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.4 p -45.19 164.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.892 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.3 mtm105 -58.31 152.12 44.62 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.505 0.669 . . . . 0.0 110.942 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.441 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.5 Cg_endo -69.78 122.61 9.28 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.637 2.225 . . . . 0.0 112.345 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.638 ' CG ' HG21 ' A' ' 26' ' ' ILE . 52.7 t80 -111.98 121.1 44.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.933 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.9 t -95.03 105.43 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.114 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.0 t -74.95 108.68 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.083 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.0 t -108.14 164.37 12.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 116' ' ' SER . . . -45.8 -53.26 8.81 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.543 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 115' ' ' GLY . 42.1 m -36.52 136.94 0.31 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.866 0.365 . . . . 0.0 110.921 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 174.73 164.79 30.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.543 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.66 -169.27 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.645 2.23 . . . . 0.0 112.372 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.4 p -125.5 139.23 53.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.6 t -80.61 -52.8 7.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.529 -179.951 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.1 p -171.37 166.08 7.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.905 0.383 . . . . 0.0 110.844 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.7 p -112.61 171.04 7.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.863 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.68 163.57 36.35 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.535 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 t -62.39 142.62 57.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.0 110.806 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.7 m -88.99 158.71 17.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.857 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.63 -116.78 3.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.451 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.441 ' C ' ' OE1' ' A' ' 9' ' ' GLN . 82.8 p -130.21 118.85 22.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.818 0.342 . . . . 0.0 110.853 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.441 ' OE1' ' C ' ' A' ' 8' ' ' SER . 2.3 mp0 -119.51 143.96 35.73 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.656 0.741 . . . . 0.0 110.939 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 169.03 19.84 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.726 2.284 . . . . 0.0 112.331 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.87 78.58 3.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -165.78 142.88 5.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.29 -57.56 2.76 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.52 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 30.1 mtm-85 -70.74 91.05 0.8 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.893 0.378 . . . . 0.0 110.867 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.681 HD13 ' CE2' ' A' ' 46' ' ' PHE . 6.4 mt -105.19 -174.79 2.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.964 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.642 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.4 p -137.65 160.34 65.44 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.681 0.753 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 169.98 17.66 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.682 2.255 . . . . 0.0 112.355 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.503 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.9 Cg_endo -69.81 152.74 69.12 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.628 2.219 . . . . 0.0 112.348 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.424 ' C ' ' HB2' ' A' ' 102' ' ' SER . 9.2 pt-20 -98.16 160.48 14.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 103' ' ' GLU . . . -56.09 122.79 50.26 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.559 0.695 . . . . 0.0 111.069 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 166.42 27.7 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.7 2.266 . . . . 0.0 112.304 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -51.67 174.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -80.22 122.73 83.18 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.624 0.726 . . . . 0.0 110.932 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 142.44 47.98 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.671 2.248 . . . . 0.0 112.306 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.812 ' O ' HD13 ' A' ' 26' ' ' ILE . 9.6 t -93.43 167.49 11.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.164 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.812 HD13 ' O ' ' A' ' 25' ' ' THR . 10.4 mm -127.44 124.68 64.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.193 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 m -128.31 175.75 8.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.813 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.431 HG21 ' HG2' ' A' ' 118' ' ' PRO . 9.4 m -94.51 101.36 13.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.1 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.703 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -102.42 -41.15 6.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 t -156.86 -178.34 7.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.833 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -81.17 -20.52 41.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.465 HG22 ' HE3' ' A' ' 85' ' ' LYS . 16.3 p -121.72 4.59 10.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.151 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 84.1 p -139.6 175.97 9.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.3 m -154.64 143.67 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.703 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 11.0 m-85 -79.69 117.52 20.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.8 t -111.93 129.17 67.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.133 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.629 HG23 ' HB2' ' A' ' 77' ' ' SER . 32.5 m -128.91 118.39 22.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.14 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.488 ' CD1' HG11 ' A' ' 93' ' ' VAL . 33.1 p90 -118.58 169.16 10.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 mm -133.59 108.39 12.06 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.62 0.724 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.437 ' CD ' HD22 ' A' ' 76' ' ' LEU . 53.8 Cg_endo -69.78 141.73 45.95 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.693 2.262 . . . . 0.0 112.333 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -109.81 -70.34 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.66 147.06 16.15 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.526 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 48.2 p-10 -114.47 2.55 14.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 0.0 110.925 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 85.26 2.3 87.84 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.507 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.535 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 107.3 -15.04 39.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.438 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.681 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.5 m-85 -118.24 161.98 32.29 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.629 0.728 . . . . 0.0 110.839 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 115.52 4.14 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.68 2.253 . . . . 0.0 112.311 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.455 HD13 ' CE1' ' A' ' 51' ' ' PHE . 92.4 mt -47.71 131.22 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.046 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -82.68 -48.23 11.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.87 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.9 p -163.7 164.16 23.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.455 ' CE1' HD13 ' A' ' 48' ' ' ILE . 55.4 m-85 -109.39 174.53 5.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.1 mtt-85 -149.56 124.04 9.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.2 t -107.99 136.39 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.135 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -137.2 152.66 50.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.875 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.569 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 44.0 p90 -127.84 144.1 51.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.524 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 22.1 ttpt -114.37 128.98 56.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.907 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -76.67 136.02 39.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 110' ' ' PRO . 51.4 mt -105.56 -71.25 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.907 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -40.85 -35.9 0.56 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -123.6 122.78 39.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.892 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.1 p -45.71 126.35 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.119 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 63' ' ' ASP . . . 177.85 112.96 0.34 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.407 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 62' ' ' GLY . 8.2 p-10 -50.09 -178.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.787 0.327 . . . . 0.0 110.891 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.534 ' O ' HD13 ' A' ' 65' ' ' ILE . 97.3 m95 -59.25 153.56 18.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.569 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 4.6 mm -134.89 141.83 41.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.198 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.9 tp -78.41 126.09 30.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.826 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -101.69 -58.58 1.86 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.58 ' CG2' HD11 ' A' ' 71' ' ' ILE . 6.8 t -136.48 165.29 26.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.165 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 99.9 p -160.51 175.77 12.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.789 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 68.95 26.94 5.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.149 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.598 HG23 ' HD2' ' A' ' 72' ' ' PRO . 58.8 mt -79.76 137.43 54.45 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.635 0.731 . . . . 0.0 111.163 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.598 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.0 Cg_endo -69.66 159.06 54.9 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.728 2.285 . . . . 0.0 112.306 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.75 -25.4 28.68 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.688 2.259 . . . . 0.0 112.361 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 81.1 p -77.57 -25.72 50.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.854 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.457 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.1 ttt180 -86.4 106.59 17.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.838 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.437 HD22 ' CD ' ' A' ' 40' ' ' PRO . 46.6 mt -101.74 9.89 40.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.957 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.629 ' HB2' HG23 ' A' ' 37' ' ' THR . 26.3 t -155.82 137.16 13.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.45 HG12 ' CD ' ' A' ' 75' ' ' ARG . 2.2 m -149.92 168.67 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.148 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.684 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 30.3 tt0 -103.26 115.43 30.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.826 HG23 ' HB1' ' A' ' 67' ' ' ALA . 37.0 mm -81.83 102.69 8.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.7 p -97.46 164.04 12.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.117 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.37 33.59 19.43 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.503 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.8 mt -87.45 -176.26 5.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.803 0.335 . . . . 0.0 110.915 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -126.64 122.4 34.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.465 ' HE3' HG22 ' A' ' 32' ' ' THR . 0.6 OUTLIER -67.4 155.92 37.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.43 15.41 45.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.484 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.401 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 27.3 mm -126.87 103.68 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.861 0.362 . . . . 0.0 111.114 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.54 137.87 52.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.856 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.401 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -158.77 167.83 28.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.92 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -110.73 -176.49 2.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.909 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -146.26 142.9 28.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.428 HH21 ' CB ' ' A' ' 64' ' ' TRP . 5.5 ptt180 -139.26 177.89 7.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.488 HG11 ' CD1' ' A' ' 38' ' ' TRP . 87.2 t -140.73 143.02 29.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.097 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.402 ' CZ ' HH12 ' A' ' 92' ' ' ARG . 34.7 mtt180 -131.0 140.59 50.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.503 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -103.2 127.54 50.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.087 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.07 120.68 35.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.908 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.449 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 36.5 p-10 -123.61 -172.41 2.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.4 ptm -69.58 1.69 3.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.642 HD12 ' O ' ' A' ' 16' ' ' SER . 36.0 mt -109.67 -26.35 9.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.99 -165.93 29.33 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.526 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.61 158.05 16.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.814 0.34 . . . . 0.0 110.903 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 19.9 p -97.44 175.17 6.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 17.2 mt-10 -69.13 157.16 90.0 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.622 0.725 . . . . 0.0 110.918 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.425 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.4 Cg_endo -69.81 104.56 1.35 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.674 2.249 . . . . 0.0 112.318 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.5 p -41.7 150.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.843 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -43.07 140.48 1.97 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.601 0.715 . . . . 0.0 111.097 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 88.81 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.68 2.253 . . . . 0.0 112.285 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 99.2 p -41.06 153.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.861 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -48.96 151.81 2.08 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.628 0.728 . . . . 0.0 110.829 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.474 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.2 Cg_endo -69.81 144.65 54.45 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.664 2.243 . . . . 0.0 112.315 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -132.7 115.75 15.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.849 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.6 t -88.95 103.18 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.083 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.5 t -73.66 111.66 9.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.13 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.1 t -107.94 174.01 6.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 116' ' ' SER . . . -69.34 -134.35 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.466 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 115' ' ' GLY . 3.2 t -35.02 123.33 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.906 0.384 . . . . 0.0 110.815 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -141.41 -160.89 8.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.45 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.431 ' HG2' HG21 ' A' ' 28' ' ' THR . 53.3 Cg_endo -69.74 177.25 5.75 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.713 2.276 . . . . 0.0 112.364 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 60.6 p -114.14 165.37 12.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 18.2 t -151.23 121.51 7.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.908 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.461 -179.943 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.548 -0.221 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m -149.16 150.2 32.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.982 0.42 . . . . 0.0 110.865 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.9 m -56.0 164.45 1.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.903 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.37 -168.08 17.57 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.405 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.2 m -65.06 152.56 43.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.901 0.381 . . . . 0.0 110.806 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.6 m -132.22 -55.7 0.97 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.946 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.25 147.87 22.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.464 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.9 t -63.44 126.22 26.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 0.0 110.852 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -70.09 138.8 87.37 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.56 0.695 . . . . 0.0 110.956 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 176.51 6.6 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.758 2.306 . . . . 0.0 112.323 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.411 ' CG ' ' O ' ' A' ' 11' ' ' ASP . 4.8 p-10 -41.59 100.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -137.36 -179.69 5.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.63 109.77 0.22 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.513 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -66.73 104.3 1.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.899 0.38 . . . . 0.0 110.877 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.485 HD13 ' CE2' ' A' ' 46' ' ' PHE . 9.0 mt -99.86 -176.38 3.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.599 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.7 m -144.99 161.62 41.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.69 0.757 . . . . 0.0 110.863 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.417 ' C ' ' HA3' ' A' ' 44' ' ' GLY . 53.8 Cg_endo -69.74 170.35 16.75 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.727 2.284 . . . . 0.0 112.358 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.475 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.6 Cg_endo -69.76 155.39 66.07 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.693 2.262 . . . . 0.0 112.403 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.42 ' C ' ' HB2' ' A' ' 102' ' ' SER . 9.6 pt-20 -99.26 167.89 10.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 103' ' ' GLU . . . -63.03 121.32 68.2 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.556 0.693 . . . . 0.0 111.096 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 161.59 45.35 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.685 2.257 . . . . 0.0 112.359 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -46.88 174.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 ttm180 -80.1 124.08 83.07 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.611 0.719 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 140.74 43.43 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.702 2.268 . . . . 0.0 112.387 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.511 ' O ' HD13 ' A' ' 26' ' ' ILE . 2.4 t -94.0 155.77 16.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.159 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.544 HG21 ' CB ' ' A' ' 111' ' ' TYR . 18.9 mm -117.28 128.4 74.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.077 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 m -132.72 176.12 8.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.797 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.5 m -93.47 110.6 22.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.191 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.699 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -111.9 -38.2 4.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.05 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.0 m -161.43 -178.75 6.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.838 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.5 ' HG2' HG23 ' A' ' 32' ' ' THR . 0.4 OUTLIER -84.8 -14.68 47.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.899 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.5 HG23 ' HG2' ' A' ' 31' ' ' GLU . 24.5 p -121.4 -0.02 9.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.161 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.431 ' CB ' HG22 ' A' ' 81' ' ' THR . 6.4 p -145.8 173.13 12.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.0 m -148.98 146.28 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.196 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.699 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 12.0 m-85 -77.21 123.14 26.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.6 t -119.45 124.38 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.203 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.475 HG23 ' HB2' ' A' ' 77' ' ' SER . 47.2 m -126.98 123.24 36.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.152 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.587 ' CD1' HG11 ' A' ' 93' ' ' VAL . 24.4 p90 -120.76 171.27 8.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.953 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.513 HD13 ' O ' ' A' ' 38' ' ' TRP . 18.7 mm -135.08 106.01 10.38 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.592 0.711 . . . . 0.0 111.224 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 142.86 49.26 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.719 2.279 . . . . 0.0 112.357 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -111.54 -70.74 0.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.38 143.58 15.69 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -115.74 17.07 16.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.823 0.344 . . . . 0.0 110.904 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.446 ' N ' ' HA ' ' A' ' 18' ' ' PRO . . . 75.97 -6.35 34.94 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.424 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.59 -19.65 11.36 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.504 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.485 ' CE2' HD13 ' A' ' 15' ' ' LEU . 1.6 m-85 -111.92 162.83 19.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.735 0.778 . . . . 0.0 110.91 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 115.98 4.35 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.69 2.26 . . . . 0.0 112.355 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.52 HD13 ' CE1' ' A' ' 51' ' ' PHE . 97.3 mt -48.0 124.41 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.136 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -79.04 -46.55 17.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.5 m -162.83 161.75 26.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.52 ' CE1' HD13 ' A' ' 48' ' ' ILE . 50.4 m-85 -108.59 175.25 5.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.94 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -147.81 120.19 8.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.908 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.431 HG11 HD11 ' A' ' 80' ' ' ILE . 21.7 t -103.91 131.79 51.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.099 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -131.59 160.91 33.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.936 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.553 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 18.4 p90 -139.07 175.89 9.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.919 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' A' ' 63' ' ' ASP . 16.4 ttpp -146.62 134.08 20.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -81.78 118.36 22.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.93 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 110' ' ' PRO . 72.3 mt -86.06 -42.52 13.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.96 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -85.67 36.89 0.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -172.97 -177.67 1.65 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.2 p -92.3 142.66 12.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.097 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 138.57 141.55 4.16 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.503 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.515 ' O ' ' CD1' ' A' ' 64' ' ' TRP . 0.5 OUTLIER -79.38 -73.77 0.32 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.869 0.366 . . . . 0.0 110.899 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.922 ' O ' HD13 ' A' ' 65' ' ' ILE . 61.0 m95 -152.94 149.94 28.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.922 HD13 ' O ' ' A' ' 64' ' ' TRP . 2.1 mm -131.47 151.18 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.075 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 53' ' ' VAL . 52.4 tp -84.9 134.6 34.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.881 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.623 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -103.18 -68.35 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.057 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.642 ' CG2' HD11 ' A' ' 71' ' ' ILE . 5.2 t -125.55 157.83 36.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.099 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.564 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 92.4 p -153.4 169.44 23.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 75.05 25.07 1.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.051 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.653 HG23 ' HD2' ' A' ' 72' ' ' PRO . 64.3 mt -77.08 138.13 65.14 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.599 0.714 . . . . 0.0 111.132 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.653 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.1 Cg_endo -69.77 157.98 58.53 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.679 2.253 . . . . 0.0 112.32 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -24.0 29.91 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.72 2.28 . . . . 0.0 112.296 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 t -78.54 -28.8 46.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.476 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.5 ttt180 -83.73 101.91 11.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.849 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.9 mt -99.37 11.71 38.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.475 ' HB2' HG23 ' A' ' 37' ' ' THR . 7.8 t -153.89 130.33 10.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.834 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.523 HG11 HD13 ' A' ' 71' ' ' ILE . 2.5 m -146.43 160.31 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.09 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.64 ' OE1' ' HB1' ' A' ' 29' ' ' ALA . 33.6 tt0 -99.25 111.9 24.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.623 HG23 ' HB1' ' A' ' 67' ' ' ALA . 28.8 mm -77.82 102.67 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.431 HG22 ' CB ' ' A' ' 33' ' ' SER . 41.2 p -97.2 162.56 13.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.118 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.34 40.63 5.38 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.47 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.2 mt -105.77 177.9 4.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.821 0.344 . . . . 0.0 110.921 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -123.62 128.62 49.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.859 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -67.15 155.88 37.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.76 14.95 63.73 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.512 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.427 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 25.6 mm -127.96 112.67 28.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.811 0.339 . . . . 0.0 111.145 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.05 141.69 40.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.813 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.427 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -162.25 159.79 26.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.016 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -107.38 179.37 4.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -140.76 160.88 39.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -152.32 -178.6 6.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.587 HG11 ' CD1' ' A' ' 38' ' ' TRP . 83.9 t -144.5 146.69 20.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -138.79 134.45 33.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.837 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -96.71 129.5 44.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.082 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.9 mp -122.01 120.19 33.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.449 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 39.4 p-10 -123.74 -172.82 2.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 18.4 ptm -69.7 1.13 4.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.852 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.599 HD12 ' O ' ' A' ' 16' ' ' SER . 37.6 mt -109.48 -24.73 10.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.901 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.411 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 146.36 -169.98 27.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.467 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.2 pm0 -95.96 158.43 15.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 110.868 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.42 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 4.3 p -94.63 175.45 6.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.881 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 20.6 mt-10 -69.53 157.9 88.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.668 0.747 . . . . 0.0 110.886 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 104.88 1.38 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.706 2.271 . . . . 0.0 112.358 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.9 p -47.14 148.2 1.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -45.96 136.99 6.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.648 0.737 . . . . 0.0 111.057 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.87 99.52 0.77 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.629 2.22 . . . . 0.0 112.375 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.4 p -47.8 170.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -60.61 149.56 78.23 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.609 0.719 . . . . 0.0 110.854 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.455 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.6 Cg_endo -69.74 122.69 9.37 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.741 2.294 . . . . 0.0 112.325 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.544 ' CB ' HG21 ' A' ' 26' ' ' ILE . 48.7 t80 -108.81 122.93 48.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 37.3 t -97.45 105.99 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.6 t -76.35 107.51 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.083 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.0 t -107.79 -41.11 5.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.897 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.61 86.78 1.83 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.482 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.0 m -111.93 -59.5 1.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.381 . . . . 0.0 110.813 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 123.44 170.76 13.47 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.522 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 124.2 10.83 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.644 2.229 . . . . 0.0 112.305 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.3 m -87.29 -50.08 6.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 93.5 p -93.44 94.11 8.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.834 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.458 -179.983 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.7 t -74.09 122.69 23.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.878 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.2 m -89.18 144.39 26.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.23 63.71 0.31 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.472 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.4 m -138.53 137.05 36.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.0 110.834 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.5 m -66.62 -62.06 1.65 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.86 45.78 5.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.505 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -68.99 171.98 7.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 110.886 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -153.21 150.96 24.96 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.622 0.725 . . . . 0.0 110.986 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.437 ' HD3' ' CE ' ' A' ' 98' ' ' MET . 54.0 Cg_endo -69.69 128.56 16.27 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.781 2.321 . . . . 0.0 112.328 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -147.8 148.01 30.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 65.3 m80 51.97 42.24 30.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.61 97.04 0.11 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.504 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -74.19 98.97 3.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.797 0.332 . . . . 0.0 110.79 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.553 HD22 ' HA3' ' A' ' 45' ' ' GLY . 7.8 mt -94.25 -174.99 3.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.928 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.564 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.7 m -138.51 160.9 61.69 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.686 0.755 . . . . 0.0 110.766 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 169.9 17.74 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.718 2.279 . . . . 0.0 112.337 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.52 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.1 Cg_endo -69.77 154.88 67.17 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.713 2.276 . . . . 0.0 112.284 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.434 ' C ' ' HB2' ' A' ' 102' ' ' SER . 10.3 pt-20 -96.97 169.94 9.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.82 121.89 78.01 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.553 0.692 . . . . 0.0 111.079 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 162.23 42.84 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.712 2.275 . . . . 0.0 112.362 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -48.03 174.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.894 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -80.22 124.11 82.84 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.625 0.726 . . . . 0.0 110.857 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.412 ' HB2' HG13 ' A' ' 36' ' ' VAL . 52.7 Cg_endo -69.81 143.19 49.83 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.695 2.263 . . . . 0.0 112.34 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.85 ' O ' HD13 ' A' ' 26' ' ' ILE . 4.8 t -92.64 165.81 12.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.85 HD13 ' O ' ' A' ' 25' ' ' THR . 5.6 mm -128.84 119.52 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 t -123.55 173.95 7.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.0 m -89.41 103.18 15.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.167 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.806 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -106.57 -40.37 5.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.098 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.9 m -160.57 168.07 25.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -72.49 -17.47 61.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.834 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.4 p -119.55 -4.56 10.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.112 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.756 ' CB ' HG22 ' A' ' 81' ' ' THR . 11.2 p -141.75 171.16 14.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.854 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.414 HG11 ' CE1' ' A' ' 111' ' ' TYR . 27.7 m -149.12 149.2 15.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.07 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.806 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 21.3 m-85 -82.84 117.47 22.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.998 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.412 HG13 ' HB2' ' A' ' 24' ' ' PRO . 88.1 t -112.08 130.57 65.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.153 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.413 HG23 ' HB2' ' A' ' 77' ' ' SER . 35.4 m -129.25 125.06 36.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.14 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.663 ' CD1' HG11 ' A' ' 93' ' ' VAL . 25.0 p90 -122.39 169.92 10.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.8 mm -133.46 107.88 12.14 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.645 0.735 . . . . 0.0 111.131 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.77 143.13 49.81 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.666 2.244 . . . . 0.0 112.27 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 mmm-85 -110.88 -70.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.19 153.34 18.1 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.423 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -121.0 5.82 10.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.813 0.339 . . . . 0.0 110.851 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.05 1.36 89.91 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.448 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.553 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 109.97 -23.75 20.63 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.5 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.522 ' CE2' HD13 ' A' ' 15' ' ' LEU . 1.9 m-85 -109.68 162.33 20.7 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.69 0.757 . . . . 0.0 110.865 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 118.42 5.67 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.748 2.299 . . . . 0.0 112.361 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.519 HD13 ' CE1' ' A' ' 51' ' ' PHE . 87.6 mt -48.33 138.3 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -92.85 -51.27 5.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.957 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.1 p -158.39 165.03 35.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.874 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.519 ' CE1' HD13 ' A' ' 48' ' ' ILE . 48.3 m-85 -114.36 170.05 8.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.928 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.761 ' NE ' HD11 ' A' ' 96' ' ' LEU . 50.2 mtm180 -145.57 138.35 25.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.55 ' HB ' HG22 ' A' ' 68' ' ' THR . 47.2 t -117.25 133.98 62.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.125 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -127.14 160.92 29.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.722 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 17.9 p90 -144.55 144.89 31.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.499 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 17.3 ttpp -127.82 133.71 49.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.904 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.57 140.56 48.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.903 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.486 ' CD1' ' HB3' ' A' ' 110' ' ' PRO . 65.0 mt -108.4 -47.74 3.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -42.92 -34.39 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.42 165.59 34.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.621 HG22 ' N ' ' A' ' 62' ' ' GLY . 11.6 p -46.73 165.81 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.129 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.621 ' N ' HG22 ' A' ' 61' ' ' VAL . . . 140.21 100.0 0.43 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.484 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -48.81 176.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.748 0.309 . . . . 0.0 110.903 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.564 ' CE2' ' NH2' ' A' ' 92' ' ' ARG . 83.2 m95 -67.25 149.31 50.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.975 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.533 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.4 mm -128.4 154.59 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.138 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.8 tp -87.35 115.6 24.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.795 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -83.84 -58.48 2.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.104 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.55 HG22 ' HB ' ' A' ' 53' ' ' VAL . 14.9 t -139.74 179.7 6.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.123 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.5 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 1.5 t -174.73 172.22 3.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.856 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 71.59 34.08 1.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.115 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.687 HD13 HG11 ' A' ' 78' ' ' VAL . 76.9 mt -88.64 137.93 30.06 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.605 0.717 . . . . 0.0 111.201 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.645 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.1 Cg_endo -69.7 158.35 57.35 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.639 2.226 . . . . 0.0 112.348 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -20.47 34.63 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.698 2.265 . . . . 0.0 112.336 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 79.6 p -84.74 -13.7 50.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.943 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.45 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 12.8 ttt85 -101.28 104.59 15.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.872 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.2 mt -103.31 13.92 32.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.852 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.413 ' HB2' HG23 ' A' ' 37' ' ' THR . 1.7 t -152.22 129.74 11.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.82 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.687 HG11 HD13 ' A' ' 71' ' ' ILE . 2.1 m -146.16 159.54 11.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.09 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.516 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 43.7 tt0 -98.62 114.67 27.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.795 HG23 ' HB1' ' A' ' 67' ' ' ALA . 27.7 mm -82.05 103.28 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.175 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.756 HG22 ' CB ' ' A' ' 33' ' ' SER . 49.5 p -101.9 164.0 11.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.86 38.99 5.93 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.538 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.3 mt -106.75 175.92 5.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.778 0.323 . . . . 0.0 110.917 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -120.09 133.42 55.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -68.05 160.19 29.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.0 13.86 58.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.445 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.517 HG22 ' CD2' ' A' ' 89' ' ' TYR . 17.7 mm -124.17 110.96 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.796 0.332 . . . . 0.0 111.094 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.89 134.16 35.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.866 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.517 ' CD2' HG22 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -156.29 163.43 39.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.4 ' HE3' HD11 ' A' ' 58' ' ' LEU . 19.7 mttt -108.0 178.33 4.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.98 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -135.61 152.8 51.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.912 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.564 ' NH2' ' CE2' ' A' ' 64' ' ' TRP . 6.3 ptp180 -147.49 171.55 15.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.663 HG11 ' CD1' ' A' ' 38' ' ' TRP . 84.6 t -137.4 140.36 42.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.1 mtt180 -128.5 134.96 48.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -94.54 132.71 38.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.152 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.761 HD11 ' NE ' ' A' ' 52' ' ' ARG . 4.0 mp -127.26 120.72 29.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.443 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 39.9 p-10 -123.45 -172.26 2.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.931 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.437 ' CE ' ' HD3' ' A' ' 10' ' ' PRO . 21.4 ptm -70.28 2.31 3.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.862 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.564 HD12 ' O ' ' A' ' 16' ' ' SER . 39.9 mt -109.75 -26.36 9.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.947 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.03 -164.67 29.66 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.541 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -104.9 158.45 16.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.839 0.352 . . . . 0.0 110.877 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 53.2 p -96.86 175.08 6.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -70.79 157.69 89.67 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.631 0.729 . . . . 0.0 110.881 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 92' ' ' ARG . 54.0 Cg_endo -69.79 105.32 1.47 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.653 2.235 . . . . 0.0 112.371 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.0 p -44.54 157.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.844 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.58 140.89 18.06 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.625 0.726 . . . . 0.0 111.069 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 100.98 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.658 2.239 . . . . 0.0 112.339 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.9 p -48.0 159.04 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -51.18 152.03 4.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.607 0.718 . . . . 0.0 110.818 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.486 ' HB3' ' CD1' ' A' ' 58' ' ' LEU . 53.6 Cg_endo -69.75 126.71 13.64 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.665 2.243 . . . . 0.0 112.347 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.464 ' CB ' HG21 ' A' ' 26' ' ' ILE . 55.5 t80 -117.28 113.94 22.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.935 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 42.4 t -88.02 106.94 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.175 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.8 t -72.17 106.94 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.141 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 t -106.85 169.64 8.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.822 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -79.32 97.38 1.55 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.52 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.9 t -171.88 171.32 5.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 0.0 110.878 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -164.25 172.49 40.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 107.75 1.93 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.665 2.243 . . . . 0.0 112.392 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.0 m -50.9 121.94 6.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.0 m -166.35 131.21 2.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.837 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.436 179.965 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m -159.73 138.17 10.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.371 . . . . 0.0 110.882 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.2 p -59.4 137.08 58.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.923 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -42.25 148.84 0.45 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.449 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 m -96.92 170.97 8.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.89 0.376 . . . . 0.0 110.827 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 t -153.35 125.29 7.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.897 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.75 133.74 12.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.476 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.9 m -84.18 128.99 34.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.843 0.354 . . . . 0.0 110.88 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -88.11 147.25 40.12 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.6 0.714 . . . . 0.0 110.965 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 132.61 23.66 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.659 2.239 . . . . 0.0 112.325 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -109.95 144.54 38.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.809 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -112.69 -38.93 4.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.81 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.36 86.21 0.52 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.494 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.2 ptt85 -88.57 104.89 17.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.847 0.356 . . . . 0.0 110.883 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.505 HD22 ' HA3' ' A' ' 45' ' ' GLY . 13.5 mt -105.53 -175.01 2.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.945 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.578 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.6 m -144.4 161.91 42.08 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.684 0.754 . . . . 0.0 110.899 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 169.92 17.8 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.696 2.264 . . . . 0.0 112.314 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.506 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.5 Cg_endo -69.82 154.44 67.51 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.691 2.261 . . . . 0.0 112.342 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.43 ' C ' ' HB2' ' A' ' 102' ' ' SER . 4.7 pt-20 -98.89 173.71 6.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.15 121.16 75.02 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.666 0.746 . . . . 0.0 111.101 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 162.83 40.62 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.674 2.25 . . . . 0.0 112.347 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -48.41 172.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -79.9 123.06 83.9 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.581 0.705 . . . . 0.0 110.889 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.404 ' HB2' HG13 ' A' ' 36' ' ' VAL . 54.5 Cg_endo -69.68 144.15 53.56 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.754 2.303 . . . . 0.0 112.399 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.897 ' O ' HD13 ' A' ' 26' ' ' ILE . 15.1 t -95.72 167.26 11.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.897 HD13 ' O ' ' A' ' 25' ' ' THR . 8.2 mm -129.79 118.64 45.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.144 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -120.82 178.96 4.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.825 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.5 m -94.35 98.53 10.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.141 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.868 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -100.72 -40.71 7.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.5 m -159.64 -179.8 8.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -81.8 -21.33 37.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.845 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.2 p -118.27 3.6 11.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.107 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.3 p -144.92 174.66 10.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.7 m -153.2 142.16 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.203 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.868 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 22.6 m-85 -77.77 120.17 22.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.878 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 24' ' ' PRO . 78.9 t -114.88 130.61 69.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.105 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.4 m -128.81 120.29 26.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.715 ' CD1' HG11 ' A' ' 93' ' ' VAL . 24.9 p90 -121.31 170.79 9.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 mm -134.98 110.86 10.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.549 0.69 . . . . 0.0 111.107 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.519 ' HD3' HD22 ' A' ' 76' ' ' LEU . 53.2 Cg_endo -69.83 131.2 20.64 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.667 2.245 . . . . 0.0 112.351 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -95.58 -70.15 0.72 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.15 149.72 16.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.49 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -118.69 8.95 12.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.884 0.373 . . . . 0.0 110.871 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.27 3.05 75.54 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.505 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 107.28 -22.7 28.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.494 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.45 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.4 m-85 -109.91 161.9 22.46 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.738 0.78 . . . . 0.0 110.849 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 114.94 3.86 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.613 2.209 . . . . 0.0 112.377 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.515 HD13 ' CE1' ' A' ' 51' ' ' PHE . 97.7 mt -45.22 128.17 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.142 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -82.33 -47.4 12.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.1 m -163.27 160.76 24.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.844 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.515 ' CE1' HD13 ' A' ' 48' ' ' ILE . 60.7 m-85 -108.09 178.18 4.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.954 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.3 mtt-85 -149.65 121.71 8.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.641 HG11 HD11 ' A' ' 80' ' ' ILE . 23.5 t -105.38 125.57 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -131.83 146.26 52.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.527 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 38.5 p90 -120.14 175.91 5.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.966 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.529 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 13.3 tttt -148.71 135.24 19.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.3 mttp -82.66 125.73 31.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 110' ' ' PRO . 73.5 mt -85.83 -49.01 8.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.934 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.3 tptt -92.39 48.52 1.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -159.54 -178.43 7.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.89 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.4 p -101.32 -25.96 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.116 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -54.75 136.69 44.43 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.489 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.464 ' O ' ' CD1' ' A' ' 65' ' ' ILE . 0.7 OUTLIER -84.69 -175.92 6.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.837 0.351 . . . . 0.0 110.797 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.529 ' CD2' ' HB2' ' A' ' 56' ' ' LYS . 77.7 m95 -49.3 134.93 17.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.938 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.558 HG22 ' H ' ' A' ' 66' ' ' LEU . 3.1 mm -120.67 169.73 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.192 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.558 ' H ' HG22 ' A' ' 65' ' ' ILE . 53.0 tp -104.5 121.16 42.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.931 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.842 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -86.76 -67.69 0.8 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.09 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.573 ' CG2' HD11 ' A' ' 71' ' ' ILE . 12.6 t -129.8 -176.61 3.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.216 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 98.2 p -174.29 -178.03 1.36 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.874 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 58.91 27.14 15.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.658 HD13 HG11 ' A' ' 78' ' ' VAL . 58.2 mt -77.17 137.76 64.84 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.591 0.71 . . . . 0.0 111.11 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.639 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.2 Cg_endo -69.8 157.26 60.92 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.727 2.284 . . . . 0.0 112.371 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 -24.16 30.39 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.738 2.292 . . . . 0.0 112.335 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 86.6 p -79.75 -18.19 51.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.463 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.0 ttt180 -96.66 102.68 14.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.519 HD22 ' HD3' ' A' ' 40' ' ' PRO . 54.9 mt -100.19 14.29 31.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.926 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.0 t -156.02 132.61 10.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.833 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.658 HG11 HD13 ' A' ' 71' ' ' ILE . 2.1 m -146.98 162.61 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.119 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.516 ' OE1' ' HB1' ' A' ' 29' ' ' ALA . 33.4 tt0 -98.51 110.72 23.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.842 HG23 ' HB1' ' A' ' 67' ' ' ALA . 40.1 mm -76.69 106.38 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.163 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.9 p -99.6 167.57 10.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.14 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.92 44.19 8.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.573 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.9 mt -98.88 -175.62 3.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.83 0.348 . . . . 0.0 110.93 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -132.85 119.72 20.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.69 156.69 22.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.892 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.47 13.54 44.97 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.45 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.526 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 33.3 mm -126.38 101.63 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.832 0.349 . . . . 0.0 111.175 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.21 141.81 57.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -164.06 162.43 23.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -109.11 -174.76 2.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.863 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.405 ' HE2' HG21 ' A' ' 80' ' ' ILE . 76.9 m-85 -144.57 150.85 38.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.449 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 2.3 ptp180 -141.75 175.07 9.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.715 HG11 ' CD1' ' A' ' 38' ' ' TRP . 57.8 t -142.03 135.7 29.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.1 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.0 mtt180 -124.98 142.5 51.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.813 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -103.41 130.77 50.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.1 mp -124.26 119.12 28.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.453 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.3 p-10 -123.71 -173.6 2.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.915 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.7 ptm -68.49 -0.66 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.838 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.578 HD12 ' O ' ' A' ' 16' ' ' SER . 51.7 mt -106.29 -26.02 11.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.956 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.19 -164.37 28.95 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.481 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.49 157.24 17.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.873 0.368 . . . . 0.0 110.906 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.43 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 7.3 p -96.38 174.92 6.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.936 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -71.11 159.48 85.44 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.663 0.744 . . . . 0.0 110.892 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.449 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.5 Cg_endo -69.65 106.89 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.698 2.265 . . . . 0.0 112.386 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.0 p -45.82 154.46 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.845 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -48.71 139.41 11.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.552 0.691 . . . . 0.0 111.087 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 94.74 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.664 2.243 . . . . 0.0 112.35 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.9 p -42.14 158.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -51.47 152.34 4.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.614 0.721 . . . . 0.0 110.864 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.576 ' HB3' HD11 ' A' ' 58' ' ' LEU . 54.8 Cg_endo -69.68 129.35 17.52 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.68 2.254 . . . . 0.0 112.393 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -119.41 118.08 30.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.4 t -93.3 102.5 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.118 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.6 t -68.67 106.8 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.06 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 t -100.97 -38.36 8.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.854 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.52 -79.82 0.32 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.498 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 60.1 p -47.68 162.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.871 0.367 . . . . 0.0 110.873 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 162.05 169.89 26.02 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.85 -164.56 0.13 Allowed 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.678 2.252 . . . . 0.0 112.357 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 97.1 p -138.06 146.25 42.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.836 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.9 t -52.65 -50.54 62.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.874 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.249 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.464 179.995 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 t -158.68 149.28 20.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.911 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.6 p -166.82 159.76 13.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.0 127.48 1.03 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.442 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.0 t -142.85 126.23 16.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.373 . . . . 0.0 110.839 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.0 t -166.17 144.29 5.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.869 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 157.93 56.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.537 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 m -168.76 164.45 11.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.837 0.351 . . . . 0.0 110.878 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -52.92 137.9 45.19 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.636 0.732 . . . . 0.0 110.952 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 104.3 1.29 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.697 2.265 . . . . 0.0 112.376 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.18 157.69 19.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.848 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.45 ' O ' ' CG ' ' A' ' 12' ' ' HIS . 1.1 p80 -78.42 125.03 28.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.29 -128.28 4.82 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.536 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -59.55 84.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.934 0.397 . . . . 0.0 110.875 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.641 HD13 ' CE2' ' A' ' 46' ' ' PHE . 3.0 mt -89.05 -176.96 5.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.943 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.554 ' O ' HD12 ' A' ' 99' ' ' LEU . 0.6 OUTLIER -144.42 161.61 43.47 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.675 0.75 . . . . 0.0 110.815 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 169.98 17.64 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.668 2.245 . . . . 0.0 112.332 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.476 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.4 Cg_endo -69.76 156.47 63.27 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.732 2.288 . . . . 0.0 112.372 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.419 ' C ' ' HB2' ' A' ' 102' ' ' SER . 4.5 pt-20 -101.6 165.66 11.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.927 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.83 122.76 64.36 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.546 0.689 . . . . 0.0 111.133 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 164.0 36.19 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.72 2.28 . . . . 0.0 112.338 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -51.63 176.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -80.29 122.38 82.71 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.577 0.703 . . . . 0.0 110.895 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.428 ' HB2' HG13 ' A' ' 36' ' ' VAL . 53.1 Cg_endo -69.84 142.52 47.79 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.731 2.287 . . . . 0.0 112.357 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.768 ' O ' HD13 ' A' ' 26' ' ' ILE . 6.3 t -93.13 163.14 13.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.116 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.768 HD13 ' O ' ' A' ' 25' ' ' THR . 8.4 mm -123.63 129.55 74.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.116 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 t -136.05 165.49 25.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.807 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.618 HG21 ' HD2' ' A' ' 118' ' ' PRO . 7.5 m -80.91 109.16 15.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.167 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.735 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -111.86 -35.83 5.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.148 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.9 m -165.19 -177.8 4.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.902 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.651 ' HG2' HG23 ' A' ' 32' ' ' THR . 0.1 OUTLIER -85.92 -14.68 44.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.89 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.651 HG23 ' HG2' ' A' ' 31' ' ' GLU . 36.6 p -122.96 -1.38 8.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.165 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.523 ' CB ' HG22 ' A' ' 81' ' ' THR . 4.7 p -143.18 175.28 10.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.0 m -153.35 144.3 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.735 ' CD2' ' HB2' ' A' ' 29' ' ' ALA . 19.0 m-85 -78.39 124.75 28.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.428 HG13 ' HB2' ' A' ' 24' ' ' PRO . 72.3 t -119.93 131.47 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.3 m -129.0 118.66 22.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.101 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.628 ' CD1' HG11 ' A' ' 93' ' ' VAL . 30.2 p90 -115.67 169.92 8.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.4 mm -132.23 107.35 13.53 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.589 0.709 . . . . 0.0 111.131 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.66 134.08 27.32 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.715 2.277 . . . . 0.0 112.355 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -103.89 -70.26 0.77 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.856 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.96 144.09 15.73 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.423 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -116.15 13.21 15.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 0.0 110.827 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 75.31 -0.72 59.0 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.435 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.422 ' HA3' ' CD2' ' A' ' 15' ' ' LEU . . . 111.6 -22.48 19.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.641 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.0 m-85 -109.34 161.74 22.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.651 0.739 . . . . 0.0 110.892 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.66 113.67 3.43 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.68 2.253 . . . . 0.0 112.332 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.588 HD13 ' CE1' ' A' ' 51' ' ' PHE . 91.0 mt -42.69 127.79 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.153 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -82.55 -46.24 13.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.3 p -164.02 160.07 21.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.588 ' CE1' HD13 ' A' ' 48' ' ' ILE . 61.5 m-85 -107.93 173.33 6.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -148.27 124.17 10.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 92' ' ' ARG . 47.6 t -106.2 140.01 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.099 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.44 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 42.0 mt-10 -136.45 151.1 49.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.454 ' CZ ' ' HB ' ' A' ' 65' ' ' ILE . 35.6 p90 -125.79 165.04 19.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.953 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 89' ' ' TYR . 6.7 ttpm? -143.71 133.06 23.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -81.3 138.05 35.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.414 HD11 ' HB3' ' A' ' 110' ' ' PRO . 87.2 mt -99.6 -40.45 7.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -57.98 -71.54 0.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.891 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.457 ' O ' ' C ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -93.82 -174.5 3.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 61' ' ' VAL . 7.6 p -32.35 107.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.164 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.84 114.74 3.89 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.478 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -141.75 137.53 31.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.75 0.309 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -71.13 119.49 15.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.56 HG22 ' H ' ' A' ' 66' ' ' LEU . 1.8 mm -117.3 171.69 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.56 ' H ' HG22 ' A' ' 65' ' ' ILE . 50.6 tp -104.31 130.6 52.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.909 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.43 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -103.31 -69.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.634 ' CG2' HD11 ' A' ' 71' ' ' ILE . 13.2 t -116.88 171.42 7.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.133 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.496 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 60.4 p -167.7 167.76 13.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.797 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 71.29 27.77 3.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.045 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.634 HD11 ' CG2' ' A' ' 68' ' ' THR . 63.9 mt -78.04 137.55 61.25 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.653 0.739 . . . . 0.0 111.104 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.605 ' HD2' HG23 ' A' ' 71' ' ' ILE . 54.7 Cg_endo -69.66 157.24 61.25 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.743 2.295 . . . . 0.0 112.362 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -20.07 35.05 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.674 2.249 . . . . 0.0 112.34 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 92.4 p -83.38 -23.68 32.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.476 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 10.0 ttt180 -90.34 99.24 12.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.3 mt -95.96 15.33 20.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 t -155.54 136.48 13.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.559 HG11 HD13 ' A' ' 71' ' ' ILE . 2.9 m -150.08 163.06 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.151 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.525 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 65.4 tt0 -98.91 112.47 24.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.43 HG23 ' HB1' ' A' ' 67' ' ' ALA . 47.6 mm -79.77 101.73 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.192 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.523 HG22 ' CB ' ' A' ' 33' ' ' SER . 27.7 p -98.1 168.28 10.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.182 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.72 40.28 8.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.48 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 46.2 mt -104.27 -175.29 2.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -127.97 130.85 49.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.43 155.92 40.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.64 11.5 57.27 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.462 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.2 mm -125.01 116.52 47.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.866 0.365 . . . . 0.0 111.132 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.15 135.76 35.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.446 ' CB ' ' O ' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -154.77 162.74 41.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.942 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -107.25 178.21 4.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.947 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -137.16 160.42 39.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.907 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.44 ' CG ' ' HB2' ' A' ' 54' ' ' GLU . 2.1 ptp180 -150.97 177.75 9.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.628 HG11 ' CD1' ' A' ' 38' ' ' TRP . 91.6 t -147.44 137.97 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.124 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -129.56 141.65 50.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -101.45 132.17 47.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.022 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mp -125.24 119.59 28.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.944 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.447 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.8 p-10 -123.59 -173.71 2.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.93 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.4 ptm -68.26 -1.07 5.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.893 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 16' ' ' SER . 55.2 mt -106.25 -25.48 11.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.958 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 147.28 -165.55 28.62 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.458 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -100.5 158.11 16.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 110.869 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.419 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 4.0 p -94.47 175.22 6.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.842 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -70.34 159.72 83.7 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.649 0.738 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.432 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.5 Cg_endo -69.78 109.12 2.24 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.74 2.293 . . . . 0.0 112.31 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.7 p -51.01 153.47 1.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.88 140.34 30.17 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.572 0.701 . . . . 0.0 111.128 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 97.42 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.713 2.275 . . . . 0.0 112.354 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 88.2 p -45.75 167.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.16 152.68 50.7 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.666 0.746 . . . . 0.0 110.91 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.414 ' HB3' HD11 ' A' ' 58' ' ' LEU . 54.2 Cg_endo -69.73 135.04 29.51 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.703 2.269 . . . . 0.0 112.32 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -124.22 124.34 42.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.09 101.78 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.152 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.3 t -70.09 105.73 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.055 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 115' ' ' GLY . 1.4 t -115.88 110.07 18.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 114' ' ' SER . . . 34.62 -147.23 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.455 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 65.7 m -81.51 132.8 35.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.951 0.405 . . . . 0.0 110.848 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.33 -160.52 34.34 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.538 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.618 ' HD2' HG21 ' A' ' 28' ' ' THR . 53.8 Cg_endo -69.72 165.82 29.61 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.733 2.288 . . . . 0.0 112.321 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.7 t -125.99 132.94 51.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.922 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.4 m -93.66 103.22 15.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.539 -179.981 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.531 -0.227 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 m -38.39 157.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.914 0.388 . . . . 0.0 110.781 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 m -124.26 157.02 35.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.831 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.86 -159.63 27.23 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.512 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.0 p -92.2 133.71 35.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 0.0 110.88 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.5 t -87.03 163.89 16.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.846 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -129.55 155.62 20.95 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.518 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -63.59 150.61 43.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.81 0.338 . . . . 0.0 110.867 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.476 ' CG ' ' HD2' ' A' ' 10' ' ' PRO . 17.9 tt0 -61.36 140.27 94.65 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.597 0.713 . . . . 0.0 110.942 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.476 ' HD2' ' CG ' ' A' ' 9' ' ' GLN . 53.4 Cg_endo -69.77 157.44 60.35 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.638 2.225 . . . . 0.0 112.362 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -130.53 123.76 30.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -113.52 154.2 27.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.854 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.11 66.2 0.88 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.0 ptt-85 -75.08 96.5 3.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 110.843 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.698 HD13 ' CE2' ' A' ' 46' ' ' PHE . 3.2 mt -85.35 -176.66 6.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.632 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.7 m -146.43 161.54 38.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.68 0.752 . . . . 0.0 110.865 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 169.59 18.57 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.723 2.282 . . . . 0.0 112.337 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.582 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.0 Cg_endo -69.79 150.78 68.47 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.661 2.24 . . . . 0.0 112.32 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.424 ' C ' ' HB2' ' A' ' 102' ' ' SER . 9.1 pt-20 -92.69 174.71 7.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.8 122.4 83.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.573 0.702 . . . . 0.0 111.079 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 161.82 44.46 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.697 2.264 . . . . 0.0 112.317 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -51.77 175.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -80.28 122.82 83.21 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.603 0.716 . . . . 0.0 110.869 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 142.87 49.13 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.701 2.267 . . . . 0.0 112.419 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.659 ' C ' HD13 ' A' ' 26' ' ' ILE . 2.9 t -93.32 159.1 15.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.659 HD13 ' C ' ' A' ' 25' ' ' THR . 3.9 mm -122.13 119.18 57.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.142 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -119.31 -174.96 2.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.918 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 47.0 m -103.15 100.76 10.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.136 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.763 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -103.48 -38.3 7.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.086 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.1 m -161.11 -179.64 7.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -81.47 -21.53 38.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.9 p -116.67 -2.26 11.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.152 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.624 ' CB ' HG22 ' A' ' 81' ' ' THR . 3.9 p -142.58 164.01 31.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.817 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.3 m -143.39 145.19 22.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.179 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.763 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 18.1 m-85 -75.49 113.9 13.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.94 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.7 t -107.07 124.62 62.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.13 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.515 ' HB ' HG22 ' A' ' 25' ' ' THR . 55.9 m -124.71 121.31 34.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.122 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.653 ' CD1' HG11 ' A' ' 93' ' ' VAL . 25.0 p90 -118.18 169.63 9.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.915 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.2 mm -134.35 106.18 11.11 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.632 0.729 . . . . 0.0 111.152 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 142.29 47.55 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.676 2.251 . . . . 0.0 112.321 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -111.69 -69.52 0.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.887 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.0 142.16 15.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.534 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 47.2 p-10 -112.54 9.55 19.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.904 0.383 . . . . 0.0 110.893 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 79.01 0.67 83.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.458 ' HA3' ' CD2' ' A' ' 15' ' ' LEU . . . 111.6 -24.5 15.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.698 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.5 m-85 -108.16 162.11 21.04 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.629 0.728 . . . . 0.0 110.908 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 113.82 3.5 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.669 2.246 . . . . 0.0 112.385 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.519 HD13 ' CE1' ' A' ' 51' ' ' PHE . 97.6 mt -43.58 127.35 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -81.77 -48.32 11.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.936 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.6 m -162.13 162.03 28.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.921 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.519 ' CE1' HD13 ' A' ' 48' ' ' ILE . 51.5 m-85 -109.03 176.31 5.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -149.93 123.42 9.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.36 133.19 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.136 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.405 ' HB2' ' CG ' ' A' ' 92' ' ' ARG . 9.4 mt-10 -132.13 162.97 29.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.938 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.582 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 16.1 p90 -148.34 146.18 28.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.522 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 14.8 ttpp -121.93 131.73 54.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.879 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -76.37 128.73 35.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.868 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.2 mt -86.11 160.34 19.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt 58.75 27.23 15.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -150.49 165.18 33.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.833 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.5 p -101.23 139.23 22.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.35 129.55 2.88 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.448 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -52.51 177.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.711 0.291 . . . . 0.0 110.923 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.553 ' O ' HD13 ' A' ' 65' ' ' ILE . 35.9 m95 -61.5 176.68 0.46 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.942 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.582 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 2.3 mm -133.12 164.02 36.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.17 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.408 ' H ' HG22 ' A' ' 65' ' ' ILE . 14.8 tp -102.66 123.36 46.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.941 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.663 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -93.78 -66.9 0.89 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.071 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.466 HG21 HD11 ' A' ' 71' ' ' ILE . 11.8 t -128.04 177.81 6.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.113 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.499 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 83.2 p -171.31 167.65 6.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.867 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 71.49 36.13 1.35 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.657 HG23 ' HD2' ' A' ' 72' ' ' PRO . 72.8 mt -87.48 138.29 31.98 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.624 0.726 . . . . 0.0 111.144 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.657 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.9 Cg_endo -69.8 156.69 62.59 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.676 2.251 . . . . 0.0 112.341 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.87 -20.69 33.97 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.696 2.264 . . . . 0.0 112.338 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.1 t -84.32 -10.67 57.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.442 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 12.2 ttt180 -103.38 102.97 12.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.1 mt -100.69 10.47 41.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 t -151.92 129.2 11.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.528 HG11 HD13 ' A' ' 71' ' ' ILE . 2.4 m -144.7 165.04 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.086 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -98.52 113.73 25.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.865 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.663 HG23 ' HB1' ' A' ' 67' ' ' ALA . 40.0 mm -83.63 98.57 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.091 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.624 HG22 ' CB ' ' A' ' 33' ' ' SER . 73.7 p -95.78 165.3 12.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.193 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.69 35.33 9.34 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.497 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.9 mt -94.45 176.49 6.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.866 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -121.7 120.26 34.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -62.82 156.73 23.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.948 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.28 13.9 45.26 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.555 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.1 mm -124.95 104.93 14.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 0.0 111.117 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.55 134.16 47.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -157.01 163.12 39.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.934 -179.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -111.01 176.63 4.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.894 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 91' ' ' PHE . 8.0 m-85 -131.96 158.1 42.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.425 ' NH1' ' HB3' ' A' ' 104' ' ' PRO . 2.1 ptp180 -149.63 171.87 15.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.653 HG11 ' CD1' ' A' ' 38' ' ' TRP . 94.5 t -139.68 142.77 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.124 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -132.41 141.59 48.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.582 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -101.98 125.18 48.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.075 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mp -119.76 118.02 29.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.445 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.3 p-10 -123.6 -174.28 2.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.609 ' HE3' ' CG ' ' A' ' 46' ' ' PHE . 5.0 ptp -67.61 -2.12 6.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.632 HD12 ' O ' ' A' ' 16' ' ' SER . 29.4 mt -105.29 -25.63 12.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.944 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 147.53 -167.16 28.63 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.519 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -101.4 157.54 16.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.819 0.343 . . . . 0.0 110.896 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.424 ' HB2' ' C ' ' A' ' 19' ' ' GLU . 8.7 p -94.22 174.27 7.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.805 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -70.23 160.39 81.08 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.59 0.71 . . . . 0.0 110.929 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.425 ' HB3' ' NH1' ' A' ' 92' ' ' ARG . 53.5 Cg_endo -69.77 105.48 1.49 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.742 2.294 . . . . 0.0 112.306 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.4 p -45.2 156.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.803 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.51 139.93 27.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.564 0.697 . . . . 0.0 111.117 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.69 89.26 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.719 2.279 . . . . 0.0 112.382 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 t -40.7 152.28 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.2 mtt-85 -44.75 153.57 0.47 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.6 0.714 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 132.95 24.33 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.651 2.234 . . . . 0.0 112.367 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -121.17 116.57 25.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.79 107.32 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.094 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.27 111.73 13.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.3 t -113.19 -31.57 6.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.817 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.75 -174.84 46.03 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.465 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 88.4 p -103.86 177.8 4.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.877 0.37 . . . . 0.0 110.935 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -132.04 -158.02 8.86 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.493 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 114.87 3.84 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.692 2.261 . . . . 0.0 112.372 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.7 t -74.08 148.73 41.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.84 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 t -110.26 117.7 34.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.499 -179.962 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 m -105.43 125.97 51.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.905 0.383 . . . . 0.0 110.881 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.8 t -105.94 149.42 26.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.889 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.06 103.3 2.23 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.5 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 t -150.48 134.91 17.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.89 0.376 . . . . 0.0 110.849 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.1 p -125.88 172.19 10.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.871 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.3 140.24 14.78 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.442 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.5 p -167.97 147.15 4.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.9 0.381 . . . . 0.0 110.835 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.6 pm0 -39.86 144.16 0.54 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.609 0.718 . . . . 0.0 110.911 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 113.52 3.4 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.691 2.26 . . . . 0.0 112.308 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 12' ' ' HIS . 5.4 m-20 -83.74 103.5 13.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.463 ' O ' ' CG ' ' A' ' 12' ' ' HIS . 39.4 p-80 -36.19 115.78 0.36 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.854 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.3 -83.53 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.51 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.7 mmt-85 -61.52 87.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.833 0.349 . . . . 0.0 110.917 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.627 HD13 ' CE2' ' A' ' 46' ' ' PHE . 7.7 mt -92.29 -175.35 4.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.616 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.6 m -141.26 161.77 51.28 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.704 0.764 . . . . 0.0 110.772 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 169.77 18.13 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.665 2.244 . . . . 0.0 112.284 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.593 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 54.2 Cg_endo -69.86 159.02 54.84 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.618 2.212 . . . . 0.0 112.316 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.55 165.15 11.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.926 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.2 120.55 52.13 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.621 0.724 . . . . 0.0 111.126 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 166.56 27.17 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.718 2.278 . . . . 0.0 112.307 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -52.53 172.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.935 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.4 ' HB2' ' NH1' ' A' ' 23' ' ' ARG . 13.7 ttm105 -79.83 123.03 84.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.598 0.713 . . . . 0.0 110.849 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.466 ' HB2' ' CG1' ' A' ' 36' ' ' VAL . 53.1 Cg_endo -69.79 141.79 46.07 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.658 2.239 . . . . 0.0 112.35 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.852 ' O ' HD13 ' A' ' 26' ' ' ILE . 6.9 t -92.47 169.22 10.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.119 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.852 HD13 ' O ' ' A' ' 25' ' ' THR . 3.1 mm -129.13 131.99 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.131 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 t -139.31 167.59 21.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.4 m -80.22 108.16 13.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.695 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -113.01 -35.43 5.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.075 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.0 m -164.32 178.84 7.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.812 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.78 -16.68 46.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.851 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 p -122.2 -2.12 9.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.168 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.659 ' CB ' HG22 ' A' ' 81' ' ' THR . 7.0 p -141.11 171.22 14.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.6 m -147.82 145.44 18.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.148 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.695 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 9.7 m-85 -78.86 119.28 21.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.466 ' CG1' ' HB2' ' A' ' 24' ' ' PRO . 92.4 t -115.95 132.17 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.183 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.403 ' HB ' HG22 ' A' ' 25' ' ' THR . 98.7 m -129.2 124.44 34.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.169 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.74 ' CD1' HG11 ' A' ' 93' ' ' VAL . 24.7 p90 -123.13 171.54 9.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.956 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.6 mm -137.2 106.25 8.66 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.677 0.751 . . . . 0.0 111.163 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 135.91 31.47 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.626 2.217 . . . . 0.0 112.35 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.2 mmm-85 -102.17 -70.63 0.74 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.36 152.54 18.41 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.484 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 46' ' ' PHE . 52.6 p-10 -122.54 12.63 10.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.854 0.359 . . . . 0.0 110.862 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.63 -0.84 59.93 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.511 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.473 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 111.18 -18.79 25.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.464 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.627 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.1 m-85 -113.08 162.32 22.47 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.584 0.707 . . . . 0.0 110.915 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 115.47 4.11 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.639 2.226 . . . . 0.0 112.365 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.607 HD13 ' CZ ' ' A' ' 51' ' ' PHE . 96.7 mt -45.7 132.0 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.106 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -86.87 -47.14 9.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.9 p -164.22 159.14 19.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.861 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.607 ' CZ ' HD13 ' A' ' 48' ' ' ILE . 54.7 m-85 -107.97 173.12 6.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.897 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -150.1 124.92 9.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 92' ' ' ARG . 48.0 t -103.14 136.32 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.168 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -133.89 146.65 50.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.841 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.539 ' CE1' ' HB ' ' A' ' 65' ' ' ILE . 26.9 p90 -125.08 174.81 7.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.979 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.459 ' HB2' ' CD2' ' A' ' 64' ' ' TRP . 29.6 ttpt -146.47 125.12 12.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -75.03 126.23 30.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.482 HD11 ' HB3' ' A' ' 110' ' ' PRO . 15.4 mt -94.93 -60.67 1.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.857 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -39.03 -41.24 0.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.952 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -122.4 164.2 18.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.955 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.467 HG22 ' N ' ' A' ' 62' ' ' GLY . 10.7 p -71.23 158.94 5.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.169 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.467 ' N ' HG22 ' A' ' 61' ' ' VAL . . . 140.87 125.09 2.11 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.543 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -62.43 -174.87 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.779 0.323 . . . . 0.0 110.859 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.554 ' CH2' ' HD3' ' A' ' 92' ' ' ARG . 89.5 m95 -67.52 137.15 55.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.539 ' HB ' ' CE1' ' A' ' 55' ' ' TYR . 3.2 mm -114.6 164.08 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.125 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.414 ' H ' HG22 ' A' ' 65' ' ' ILE . 43.8 tp -98.33 130.36 45.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.555 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -102.58 -70.27 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.091 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.407 ' CG2' HD11 ' A' ' 71' ' ' ILE . 12.0 t -124.63 164.72 19.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.53 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 1.3 t -163.43 171.26 16.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.89 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 69' ' ' SER . . . 73.13 25.28 2.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.173 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.649 HG23 ' HD2' ' A' ' 72' ' ' PRO . 80.4 mt -76.11 138.12 68.74 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.585 0.707 . . . . 0.0 111.156 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.649 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.8 Cg_endo -69.75 157.04 61.76 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.726 2.284 . . . . 0.0 112.311 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 -17.55 37.16 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.645 2.23 . . . . 0.0 112.357 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 t -87.08 -17.44 32.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.872 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.472 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 6.5 ttt85 -97.21 98.33 9.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.9 mt -92.23 9.94 31.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.7 t -154.92 137.78 15.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.501 HG11 HD13 ' A' ' 71' ' ' ILE . 2.5 m -147.51 167.95 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.101 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.503 ' OE2' ' HB1' ' A' ' 29' ' ' ALA . 45.5 tt0 -101.26 104.19 15.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.555 HG23 ' HB1' ' A' ' 67' ' ' ALA . 48.4 mm -71.48 101.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.113 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.659 HG22 ' CB ' ' A' ' 33' ' ' SER . 38.8 p -101.22 161.63 13.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.141 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.72 37.34 6.13 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.452 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.4 mt -100.28 176.58 5.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.73 0.3 . . . . 0.0 110.935 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -120.32 117.92 29.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.81 150.65 27.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.96 12.56 71.47 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.512 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.466 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 39.0 mm -125.11 109.7 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.893 0.378 . . . . 0.0 111.193 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.44 140.71 46.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.466 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -164.11 167.03 20.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.883 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.491 ' O ' ' CB ' ' A' ' 55' ' ' TYR . 58.1 mttt -112.85 -177.18 3.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.862 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -146.19 152.43 39.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.554 ' HD3' ' CH2' ' A' ' 64' ' ' TRP . 6.4 mtm180 -143.62 -178.37 5.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.914 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.74 HG11 ' CD1' ' A' ' 38' ' ' TRP . 61.5 t -142.67 139.02 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.166 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.4 mtt180 -126.87 145.3 50.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.769 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.593 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -103.5 125.25 49.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.101 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.2 mp -120.86 117.78 28.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.454 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 41.1 p-10 -123.85 -173.27 2.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.2 ptm -68.92 -0.39 5.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.926 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.616 HD12 ' O ' ' A' ' 16' ' ' SER . 62.8 mt -106.21 -26.28 11.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.993 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.76 -163.43 29.05 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.499 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -108.83 155.63 20.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.88 0.371 . . . . 0.0 110.838 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 59.3 p -98.99 172.5 7.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.842 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.2 mp0 -69.19 157.32 89.62 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.614 0.721 . . . . 0.0 110.933 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.4 ' HB2' ' NH1' ' A' ' 92' ' ' ARG . 54.1 Cg_endo -69.71 116.1 4.4 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.723 2.282 . . . . 0.0 112.346 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.459 ' O ' ' C ' ' A' ' 106' ' ' ALA . 74.7 p -54.47 148.21 12.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.893 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 105' ' ' SER . . . -32.67 141.7 0.18 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.62 0.724 . . . . 0.0 111.061 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 97.69 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.634 2.223 . . . . 0.0 112.322 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.1 p -42.69 149.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -46.75 151.89 1.01 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.59 0.71 . . . . 0.0 110.871 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.482 ' HB3' HD11 ' A' ' 58' ' ' LEU . 53.1 Cg_endo -69.85 119.82 6.7 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.666 2.244 . . . . 0.0 112.303 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -110.47 120.13 41.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.0 t -94.36 102.62 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.174 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.7 t -71.66 109.83 4.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.11 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.9 t -124.07 49.1 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.3 -175.9 38.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.455 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 99.8 p -97.29 131.92 43.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.929 0.395 . . . . 0.0 110.919 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 157.93 164.73 14.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.506 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 91.21 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.736 2.291 . . . . 0.0 112.319 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 58.7 m 56.74 43.16 25.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.793 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 61.0 p -74.96 129.8 38.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.892 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.537 -179.995 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.484 -0.247 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 m -145.62 127.09 15.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 0.0 110.847 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.2 m 62.58 44.67 6.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.866 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.74 140.49 15.35 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.475 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 99.6 p -129.21 133.43 47.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.854 0.359 . . . . 0.0 110.825 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.9 p -83.44 165.53 19.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.62 166.93 32.63 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.486 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.9 m -148.53 146.4 28.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.751 0.31 . . . . 0.0 110.843 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -115.51 142.83 29.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.539 0.685 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.66 144.23 53.91 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -111.34 -45.86 3.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -73.2 101.13 3.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.93 173.6 50.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.475 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.2 62.45 2.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 0.0 110.887 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.698 HD13 ' CE2' ' A' ' 46' ' ' PHE . 7.2 mt -77.55 -175.12 3.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.972 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.643 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.7 m -142.89 161.38 49.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.662 0.744 . . . . 0.0 110.905 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 168.67 20.86 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.667 2.245 . . . . 0.0 112.393 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.486 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 53.8 Cg_endo -69.72 159.34 53.82 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.689 2.26 . . . . 0.0 112.334 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.426 ' C ' ' HB2' ' A' ' 102' ' ' SER . 6.0 pt-20 -103.64 160.03 15.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.7 122.25 44.57 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.556 0.693 . . . . 0.0 111.102 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 163.96 36.34 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.661 2.241 . . . . 0.0 112.365 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -51.5 176.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.84 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -80.05 123.95 83.21 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.654 0.74 . . . . 0.0 110.876 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.45 ' O ' ' CB ' ' A' ' 108' ' ' SER . 53.4 Cg_endo -69.73 143.0 49.59 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.718 2.279 . . . . 0.0 112.283 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.73 ' O ' HD13 ' A' ' 26' ' ' ILE . 3.2 t -95.53 166.8 11.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.73 HD13 ' O ' ' A' ' 25' ' ' THR . 5.1 mm -124.06 118.17 53.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.137 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -117.84 168.59 10.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.6 m -87.52 102.07 14.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.763 ' HB2' ' CG ' ' A' ' 35' ' ' TYR . . . -104.85 -36.04 7.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.05 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.8 m -173.08 173.45 3.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.885 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' HG3' HG23 ' A' ' 32' ' ' THR . 13.6 pt-20 -78.41 -15.26 58.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.992 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.422 HG23 ' HG3' ' A' ' 31' ' ' GLU . 17.2 p -114.8 -6.97 12.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.165 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.625 ' HB3' HG22 ' A' ' 81' ' ' THR . 25.0 p -144.99 171.53 14.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.5 m -145.87 147.32 18.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.158 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.763 ' CG ' ' HB2' ' A' ' 29' ' ' ALA . 13.6 m-85 -82.98 115.33 21.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 81.6 t -108.35 130.33 61.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.096 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.475 ' HB ' HG22 ' A' ' 25' ' ' THR . 38.9 m -128.44 120.52 27.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.112 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.607 ' CD1' HG11 ' A' ' 93' ' ' VAL . 27.9 p90 -118.14 170.67 8.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.96 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.6 mm -133.96 106.59 11.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.634 0.731 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 136.82 33.93 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.752 2.301 . . . . 0.0 112.311 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -104.78 -69.98 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.37 145.05 16.31 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.515 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -113.55 4.74 16.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 110.895 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 16' ' ' SER . . . 82.89 1.88 90.64 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.467 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.418 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 111.53 -26.64 11.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.454 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.698 ' CE2' HD13 ' A' ' 15' ' ' LEU . 2.4 m-85 -106.81 161.7 22.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.642 0.734 . . . . 0.0 110.898 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 113.82 3.5 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.691 2.261 . . . . 0.0 112.371 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.491 HD13 ' CE1' ' A' ' 51' ' ' PHE . 89.1 mt -42.32 129.43 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.125 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -83.66 -49.02 9.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.908 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.9 p -160.09 163.2 34.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.848 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.491 ' CE1' HD13 ' A' ' 48' ' ' ILE . 52.7 m-85 -108.96 177.89 4.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -149.83 119.85 7.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.13 130.01 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.158 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -132.65 148.31 52.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.522 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 45.2 p90 -123.53 172.91 8.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.421 ' HD3' ' NE1' ' A' ' 64' ' ' TRP . 17.4 ttpt -147.91 135.35 20.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -83.33 130.69 35.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.959 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 59' ' ' LYS . 43.2 mt -97.52 -61.09 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.88 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.435 ' HD3' ' C ' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -36.16 -60.81 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.938 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -105.31 159.32 15.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.22 134.52 29.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.105 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.15 127.1 0.99 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.531 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -66.51 -176.19 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 0.0 110.876 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.421 ' NE1' ' HD3' ' A' ' 56' ' ' LYS . 73.3 m95 -72.72 140.26 47.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.487 HG22 ' H ' ' A' ' 66' ' ' LEU . 1.8 mm -119.95 167.57 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.127 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.487 ' H ' HG22 ' A' ' 65' ' ' ILE . 47.6 tp -102.31 118.97 38.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.964 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.752 ' HB1' HG23 ' A' ' 80' ' ' ILE . . . -86.42 -69.37 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.161 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.498 ' CG2' HD11 ' A' ' 71' ' ' ILE . 2.8 t -128.67 -178.94 4.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.127 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.3 p -174.42 -177.3 1.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.841 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 61.4 32.64 19.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.103 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.667 HG23 ' HD2' ' A' ' 72' ' ' PRO . 85.3 mt -84.68 138.47 38.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.581 0.705 . . . . 0.0 111.128 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.667 ' HD2' HG23 ' A' ' 71' ' ' ILE . 53.7 Cg_endo -69.74 158.25 57.62 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.705 2.27 . . . . 0.0 112.414 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -29.57 23.78 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.724 2.283 . . . . 0.0 112.397 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.2 m -74.69 -14.24 60.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.437 ' CB ' ' HG2' ' A' ' 72' ' ' PRO . 11.8 ttt180 -99.99 111.25 23.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.811 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.5 mt -107.25 7.18 29.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 t -150.73 131.73 14.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.0 174.82 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.142 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 28.6 tt0 -111.9 115.0 28.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.826 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.752 HG23 ' HB1' ' A' ' 67' ' ' ALA . 23.4 mm -84.66 104.91 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.052 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.625 HG22 ' HB3' ' A' ' 33' ' ' SER . 68.3 p -98.84 168.29 10.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.144 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.01 38.96 8.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.489 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.4 mt -103.25 168.79 8.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.743 0.306 . . . . 0.0 110.874 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -113.29 127.18 56.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.79 153.37 43.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.27 12.57 72.63 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.49 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.406 ' O ' ' CE2' ' A' ' 89' ' ' TYR . 20.1 mm -125.24 111.74 28.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.909 0.385 . . . . 0.0 111.09 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.89 139.42 40.22 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.406 ' CE2' ' O ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -160.72 167.35 27.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -113.4 -176.69 2.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.872 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -143.05 152.22 41.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.932 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -141.63 179.78 6.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.607 HG11 ' CD1' ' A' ' 38' ' ' TRP . 92.7 t -147.48 140.15 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.142 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -130.27 141.45 50.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . . . -101.38 125.06 47.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.082 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.452 ' HG ' ' CB ' ' A' ' 101' ' ' GLU . 8.3 mp -121.71 119.67 32.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.949 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.449 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 40.2 p-10 -123.6 -173.98 2.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.476 ' HE1' ' CE1' ' A' ' 46' ' ' PHE . 4.9 ptp -67.09 -2.59 5.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 16' ' ' SER . 33.9 mt -105.15 -25.31 12.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.898 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.404 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 146.38 -168.47 27.82 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.451 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.452 ' CB ' ' HG ' ' A' ' 96' ' ' LEU . 3.8 pt-20 -101.84 158.03 16.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 0.0 110.923 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 52.6 p -98.94 167.27 10.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -61.4 157.84 42.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.684 0.754 . . . . 0.0 110.865 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 115.04 3.91 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.71 2.273 . . . . 0.0 112.319 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 92.6 p -54.17 158.95 2.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.831 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.19 142.89 56.85 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.566 0.698 . . . . 0.0 111.159 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 102.12 0.99 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.663 2.242 . . . . 0.0 112.377 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 24' ' ' PRO . 59.5 p -51.55 159.48 0.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -50.39 151.22 3.98 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.608 0.718 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 136.69 33.77 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.684 2.256 . . . . 0.0 112.353 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.525 ' CG ' HG21 ' A' ' 26' ' ' ILE . 49.0 t80 -124.73 117.47 24.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 55.3 t -92.6 103.73 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.154 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.7 t -69.47 113.07 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.3 t -113.42 143.39 44.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.891 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 116' ' ' SER . . . -54.08 -90.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.55 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 115' ' ' GLY . 74.3 m -37.03 115.52 0.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.887 0.375 . . . . 0.0 110.832 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -148.67 -164.75 11.68 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.479 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.87 152.63 68.79 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.626 2.217 . . . . 0.0 112.33 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.4 t -93.11 -58.62 2.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.833 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.2 t -165.31 118.05 1.18 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.479 -179.983 . . . . . . . . 0 0 . 1 stop_ save_